Enrichment analysis report,,,,,,,,,,,,,
Enrichment by Pathway Maps,,,,,transformed_FC,,,,rna_all_FC,,,,
#,Maps,Total,min(pValue),Min FDR,p-value,FDR,In Data,"Network Objects from
Active Data",p-value,FDR,In Data,"Network Objects from
Active Data",
1,Development_Positive regulation of WNT/Beta-catenin signaling at the receptor level,64,4.778E-18,7.148E-15,4.778E-18,7.148E-15,56,"Biglycan, Bcl-9, TrkA, RECK, FGFR2, CD44, LYPD6, SFRP2, CRIPTO, ERK1/2, LGR4, Dsh, Tenascin-N, IQGAP, R-spondin 1, FZD2, p38beta (MAPK11), LGR6, Tenascin-C, Glypican-3, WNT7A, Itch, WLS, LRP5, MEK1/2, MESD, Rab8B, DKK2, Stromelysin-1, WNT5B, LRP5/LRP6, GPR37, Tcf(Lef), Porcn, EGFR, MEK3(MAP2K3), R-spondins, MKK7 (MAP2K7), GPR124, JNK1(MAPK8), ELAVL1 (HuR), RNF43, USP19, ZNRF3, WNT7B, WNT, FZD5, LRP6, RAP-2A, LGR5, Filamin A, SFRP1, Caveolin-1, Glypican-4, Formin 2, Frizzled",2.628E-10,1.228E-08,45,"p38alpha (MAPK14), Biglycan, Bcl-9, RECK, FGFR2, CD44, SFRP2, CRIPTO, ERK1/2, LGR4, Dsh, IQGAP, FZD2, LGR6, Tenascin-C, Glypican-3, WNT7A, Itch, WLS, MEK1/2, MESD, Rab8B, Stromelysin-1, WNT5B, GPR37, Tcf(Lef), Porcn, EGFR, MEK3(MAP2K3), R-spondins, GPR124, JNK1(MAPK8), ELAVL1 (HuR), ZNRF3, WNT7B, WNT, FZD5, LRP6, RAP-2A, LGR5, Filamin A, SFRP1, Caveolin-1, Glypican-4, Frizzled",
2,Immune response_IFN-alpha/beta signaling via JAK/STAT,64,3.950E-16,5.755E-13,2.339E-12,2.916E-10,50,"CBP, PML, IP10, ISG15, JAK1, CCL2, Tyk2, P73 dN-Alpha, RIG-G, CrkL, IL1RN, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IRF1, IFNAR1, Caspase-8, ERAP140, IFN-beta, STAT1, USP18, RAP-1A, TAP1 (PSF1), OAS1, Bax, MxB, STAT4, IFN-alpha, ISG54, SOCS3, MHC class I, RSAD2, XAF1, IFI17, IFI27, c-Cbl, PKR, HIF1A, IFI6, I-TAC, ADAR1, IFNAR2, IRF9, GBP4, C3G, GBP1, Caspase-7, PNPase(old-35), IRF7, STAT5, p53",3.950E-16,5.755E-13,52,"MIG, CBP, PML, IP10, ISG15, JAK1, CCL2, Tyk2, P73 dN-Alpha, IFN-gamma, RIG-G, CrkL, IL1RN, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IRF1, IFNAR1, Caspase-8, ERAP140, IFN-beta, STAT1, USP18, RAP-1A, TAP1 (PSF1), OAS1, Bax, MxB, STAT4, IFN-alpha, ISG54, SOCS3, MHC class I, PIG3, RSAD2, XAF1, IFI17, IFI27, c-Cbl, PKR, HIF1A, IFI6, I-TAC, ADAR1, IFNAR2, IRF9, GBP4, STAT3, GBP1, PNPase(old-35), IRF7, STAT5, p53",
3,Macrophage and dendritic cell phenotype shift in cancer,100,7.699E-16,5.755E-13,2.663E-13,5.691E-11,71,"IDO1, TGF-beta 1, MHC class II, NOTCH1 receptor, IP10, c-Rel (NF-kB subunit), IL-4R type I, PLGF, IL-10, MSR1, M-CSF receptor, SOCS1, Gas6, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IFN-beta, STAT1, NF-kB p50/p50, IL-1 beta, I-kB, GSK3 beta, PI3K reg class IA, IFN-alpha, alpha-V/beta-3 integrin, GM-CSF, SOCS3, RIPK1, IL-13, MHC class I, IL-6, IL-10 receptor, NF-kB, SHIP, TLR9, NF-kB p50/p65, RBP-J kappa (CBF1), OSF-2, TNF-R1, ILT3, TNF-alpha, PGE2R2, MFGE8, HPRG, IFNGR1, PGE2R4, IL-12 receptor, RelA (p65 NF-kB subunit), iNOS, Activin A, HIF1A, TRAF6, IL-4R type II, MER, CSF1, Thrombospondin 1, IRF4, DLL4, COX-2 (PTGS2), WNT5A, TLR4, EPAS1, PERC, CD137 ligand(TNFSF9), TLR7, Jagged1, Calcineurin B (regulatory), p38 MAPK, IL-12 beta, CD86, TLR2, TGF-beta receptor type I",7.699E-16,5.755E-13,71,"IDO1, TGF-beta 1, MHC class II, NOTCH1 receptor, IP10, c-Rel (NF-kB subunit), IL-4R type I, PLGF, IL-10, MSR1, M-CSF receptor, IFN-gamma, SOCS1, Gas6, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IFN-beta, STAT1, NF-kB p50/p50, IL-1 beta, I-kB, GSK3 beta, PI3K reg class IA, IFN-alpha, alpha-V/beta-3 integrin, GM-CSF, SOCS3, RIPK1, MHC class I, IL-6, IL-10 receptor, NF-kB, TLR9, NF-kB p50/p65, RBP-J kappa (CBF1), OSF-2, TNF-R1, CD40L(TNFSF5), TNF-alpha, PGE2R2, MFGE8, HPRG, IFNGR1, PGE2R4, CD80, IL-12 receptor, RelA (p65 NF-kB subunit), iNOS, Activin A, HIF1A, TRAF6, IL-4R type II, MER, CSF1, Thrombospondin 1, IRF4, STAT3, COX-2 (PTGS2), WNT5A, TLR4, EPAS1, PERC, CD137 ligand(TNFSF9), TLR7, Jagged1, Calcineurin B (regulatory), p38 MAPK, IL-12 beta, CD86, TLR2, TGF-beta receptor type I",
4,Development_Regulation of epithelial-to-mesenchymal transition (EMT),64,5.395E-15,4.035E-12,5.395E-15,4.035E-12,53,"VE-cadherin, Arkadia, TGF-beta 1, NOTCH1 receptor, Lef-1, Sno-N, Caldesmon, TGIF, PDGF-R-alpha, SMAD2, Fibronectin, Vimentin, Claudin-1, IL-1 beta, Endothelin-1, SIP1 (ZFHX1B), MMP-2, CREB1, NOTCH4, TWIST1, TNF-R1, PDGF-D, ACTB, TNF-alpha, HGF, HEY1, N-cadherin, TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta receptor type II, EGFR, ZO-1, c-Jun, PDGF-A, FGF2, TCF8, DLL4, ATF-2, WNT, SLUG, Oncostatin M, ACTA2, Tropomyosin-1, SNAIL1, HGF receptor (Met), Jagged1, MMP-9, PAI1, SRF, Frizzled, EDNRA, TGF-beta receptor type I, PDGF-R-beta",2.043E-13,6.107E-11,49,"VE-cadherin, Arkadia, TGF-beta 1, NOTCH1 receptor, Sno-N, Caldesmon, TGIF, PDGF-R-alpha, SMAD2, Fibronectin, Vimentin, Claudin-1, IL-1 beta, Endothelin-1, SIP1 (ZFHX1B), MMP-2, CREB1, NOTCH4, TWIST1, TNF-R1, PDGF-D, ACTB, TNF-alpha, HGF, N-cadherin, TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta receptor type II, EGFR, ZO-1, PDGF-A, FGF2, TCF8, ATF-2, WNT, SLUG, Oncostatin M, ACTA2, Tropomyosin-1, SNAIL1, HGF receptor (Met), Jagged1, MMP-9, PAI1, SRF, Frizzled, EDNRA, TGF-beta receptor type I, PDGF-R-beta",
5,Chemotaxis_Lysophosphatidic acid signaling via GPCRs,129,1.730E-14,8.627E-12,1.730E-14,8.627E-12,88,"LPAR3, PLD1, alpha-6/beta-1 integrin, PI3K cat class IA (p110-beta), LARG, ROCK1, ERK1/2, PRK1, ARHGEF1 (p115RhoGEF), HB-EGF, PKC-zeta, Beta-catenin, EGR1, CRK, HDAC7, G-protein alpha-q/11, PKC-epsilon, TRIP6, Rac1, IP3 receptor, ATF-2/c-Jun, LPAR2, MLCP (reg), PI3K reg class IA (p85), Bax, GSK3 beta, PLC-beta, FKHR, PLEKHG2, DIA1, HAS2, alpha-V/beta-3 integrin, LPAR5, Caspase-3, Cyr61, CREB1, MEK1/2, G-protein beta/gamma, CDC42, Actin cytoskeletal, N-CoR, TAZ, AKT(PKB), c-Src, PLC-epsilon, RhoA, Tiam1, cPKC (conventional), G-protein alpha-12 family, LPAR1, PKC-delta, Tcf(Lef), IL-8, EGFR, G-protein alpha-i family, TRAF6, F-Actin cytoskeleton, c-Jun, Caspase-9, LIMK, PLD2, Paxillin, G-protein gamma 12, MEK4(MAP2K4), 4E-BP1, p130CAS, ROCK, AP-1, Caspase-7, PAK, PDZ-RhoGEF, PKC, Vinculin, ATF-2, PLC-delta 1, FasR(CD95), Rho GTPase, JNK(MAPK8-10), MKL1, CTGF, p53, PLC-beta3, ADAM17, p38 MAPK, Elk-1, SRF, Cofilin, mTOR",1.263E-12,2.359E-10,80,"LPAR3, PLD1, alpha-6/beta-1 integrin, PI3K cat class IA (p110-beta), ROCK1, ERK1/2, PRK1, ARHGEF1 (p115RhoGEF), HB-EGF, Beta-catenin, CRK, c-Raf-1, HDAC7, G-protein alpha-q/11, PKC-epsilon, TRIP6, IP3 receptor, YAP1 (YAp65), LPAR2, MLCP (reg), PI3K reg class IA (p85), Bax, GSK3 beta, PLC-beta, FKHR, PLEKHG2, DIA1, HAS2, alpha-V/beta-3 integrin, LPAR5, Caspase-3, Cyr61, CREB1, MEK1/2, G-protein beta/gamma, CDC42, Actin cytoskeletal, N-CoR, TAZ, IL13RA2, AKT(PKB), c-Src, PLC-epsilon, RhoA, Tiam1, cPKC (conventional), G-protein alpha-12 family, LPAR1, Tcf(Lef), IL-8, EGFR, G-protein alpha-i family, TRAF6, F-Actin cytoskeleton, Caspase-9, LIMK, PLD2, MEK4(MAP2K4), G-protein gamma 12, p130CAS, ROCK, PAK, PDZ-RhoGEF, PKC, Vinculin, ATF-2, PLC-delta 1, FasR(CD95), Rho GTPase, JNK(MAPK8-10), MKL1, CTGF, p53, PLC-beta3, ADAM17, p38 MAPK, Elk-1, SRF, Cofilin, mTOR",
6,Immune response_IL-1 signaling pathway,82,7.812E-14,2.723E-11,7.812E-14,2.723E-11,62,"SPHK1, JAM2, IL-1 alpha, IP10, ICAM1, CD44, CCL2, RANKL(TNFSF11), ERK1/2, PKC-zeta, EGR1, IRF1, IFN-beta, MEK4/7, STAT1, IL-1 beta, I-kB, PI3K reg class IA (p85), NF-kB2 (p100), GRO-1, GM-CSF, NF-kB p52/RelB, IL-6, MEK1/2, TPL2(MAP3K8), NF-kB, AKT(PKB), NF-kB p50/p65, MYLK1, PPAR-gamma, TAK1(MAP3K7), TNF-alpha, Sequestosome 1(p62), c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), MMP-13, MCPIP, iNOS, NF-kB1 (p105), NF-kB1 (p50), NF-kB2 (p52), IL-8, TRAF6, MEK3(MAP2K3), IL1RAP, FGF2, PGES, NIK(MAP3K14), PLAU (UPA), MEK4(MAP2K4), CCL7, COX-2 (PTGS2), KHSRP, AP-1, RUNX2, MEKK1(MAP3K1), MAP3K3, IRAK1, JNK(MAPK8-10), Elk-1, MMP-9",4.501E-13,1.122E-10,58,"SPHK1, p38alpha (MAPK14), IL-1 alpha, IP10, ICAM1, CD44, CCL2, RANKL(TNFSF11), ERK1/2, IRF1, IFN-beta, MEK4/7, STAT1, IL-1 beta, I-kB, PI3K reg class IA (p85), NF-kB2 (p100), GRO-1, GM-CSF, NF-kB p52/RelB, IL-6, MEK1/2, TPL2(MAP3K8), NF-kB, AKT(PKB), NF-kB p50/p65, MYLK1, PPAR-gamma, TAK1(MAP3K7), TNF-alpha, Sequestosome 1(p62), c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), MMP-13, MCPIP, iNOS, NF-kB1 (p105), NF-kB1 (p50), NF-kB2 (p52), IL-8, TRAF6, MEK3(MAP2K3), IL1RAP, FGF2, PGES, NIK(MAP3K14), PLAU (UPA), MEK4(MAP2K4), CCL7, COX-2 (PTGS2), KHSRP, RUNX2, MAP3K3, IRAK1, JNK(MAPK8-10), Elk-1, MMP-9",
7,Cell cycle_The metaphase checkpoint,36,9.455E-14,2.723E-11,9.455E-14,2.723E-11,34,"Nek2A, CDC20, MAD2a, MAD2b, PMF1, DSN1, CENP-C, CENP-E, BUB1, CENP-F, MAD1 (mitotic checkpoint), Dynein 1, cytoplasmic, heavy chain, Survivin, BUBR1, PLK1, HP1 gamma, NSL1, MIS12, CENP-B, ZW10, CENP-A, SPBC24, CENP-H, INCENP, SPBC25, BUB3, Rod, Aurora-A, CDCA1, Aurora-B, HEC, HP1 alpha, Zwilch, AF15q14",1.454E-12,2.416E-10,32,"Nek2A, CDC20, MAD2a, MAD2b, PMF1, CENP-C, CENP-E, BUB1, CENP-F, MAD1 (mitotic checkpoint), Dynein 1, cytoplasmic, heavy chain, Survivin, BUBR1, PLK1, HP1 gamma, NSL1, MIS12, CENP-B, ZW10, CENP-A, SPBC24, CENP-H, INCENP, SPBC25, BUB3, Rod, CDCA1, Aurora-B, HEC, HP1 alpha, Zwilch, AF15q14",
8,T follicular helper cell dysfunction in SLE,90,9.554E-14,4.761E-11,1.362E-08,2.343E-07,58,"OX40L(TNFSF4), IL-7 receptor, MHC class II, IL-7, JAK1, Tyk2, CD28, OX40(TNFRSF4), SLAM, IFN-alpha/beta receptor, IFN-beta, STAT1, I-kB, PI3K reg class IA (p85), PKC-theta, FKHR, IKK-alpha, IFN-alpha, RIPK1, CD4, CD84, IL-6, CTLA-4, Fyn, NF-kB, IL-23, AKT(PKB), ICOS, IL-2, BAFF(TNFSF13B), IFNGR1, NTB-A, Osteopontin, PI3K cat class IA, IL-12 receptor, DDX6, PI3K reg class IA (p85-alpha), MCPIP, BAFF-R, IL4RA, NIK(MAP3K14), Bcl-6, IRF4, A20, JAK3, CARD11, RC3H2, 4E-BP1, Hedls, c-Maf, MALT1, CXCL13, PD-1, Bcl-10, TLR7, IL-21 receptor, CD86, BLIMP1 (PRDI-BF1)",9.554E-14,4.761E-11,63,"OX40L(TNFSF4), IL-7 receptor, MHC class II, IL-7, JAK1, Tyk2, IFN-gamma, CXCR5, CD28, OX40(TNFRSF4), IL-17, SLAM, IFN-alpha/beta receptor, IFN-beta, STAT1, I-kB, PI3K reg class IA (p85), PKC-theta, FKHR, IFN-alpha, RIPK1, CD4, CD84, IL-6, CTLA-4, Fyn, NF-kB, IL-23, AKT(PKB), IL-2, CD40L(TNFSF5), BAFF(TNFSF13B), IFNGR1, CD80, NTB-A, Osteopontin, PI3K cat class IA, IL-12 receptor, DDX6, PI3K reg class IA (p85-alpha), MCPIP, BAFF-R, IL4RA, NIK(MAP3K14), Bcl-6, IRF4, A20, JAK3, CARD11, STAT3, RC3H2, Hedls, c-Maf, MALT1, CXCL13, SAP, PD-1, Bcl-10, TLR7, IL-21 receptor, IL-21, CD86, BLIMP1 (PRDI-BF1)",
9,FAK1 signaling in melanoma,42,1.092E-13,2.723E-11,1.092E-13,2.723E-11,38,"ERK1/2, VEGF-A, CRK, RhoC, Fibronectin, Rac1, Talin, Shc, alpha-V/beta-3 integrin, N-Ras, MMP-2, MEK1/2, Actin cytoskeletal, NF-kB, CAS-L, NF-kB p50/p65, TIMP2, c-Src, RhoA, ITGB1, ARCGAP22, RelA (p65 NF-kB subunit), B-Raf, Syntenin 1, NF-kB1 (p50), ROCK2, ITGB3, alpha-5/beta-1 integrin, SOS, PLAU (UPA), Paxillin, DOCK3, p130CAS, PKC-alpha, MMP-14, Caveolin-1, ITGA5, WASF2",6.973E-12,7.446E-10,35,"ERK1/2, VEGF-A, CRK, Fibronectin, Talin, Shc, alpha-V/beta-3 integrin, N-Ras, MMP-2, MEK1/2, Actin cytoskeletal, NF-kB, CAS-L, NF-kB p50/p65, TIMP2, c-Src, RhoA, ITGB1, ARCGAP22, RelA (p65 NF-kB subunit), B-Raf, Syntenin 1, NF-kB1 (p50), ROCK2, ITGB3, alpha-5/beta-1 integrin, SOS, PLAU (UPA), DOCK3, p130CAS, PKC-alpha, MMP-14, Caveolin-1, ITGA5, WASF2",
10,Role of stellate cells in progression of pancreatic cancer,60,1.397E-13,5.223E-11,1.299E-12,1.944E-10,48,"COL1A1, GRO-2, TGF-beta 1, RECK, CCL2, ERK1/2, HB-EGF, ID1, SMAD4, PDGF-R-alpha, SMAD2, Fibronectin, Shc, PI3K reg class IA (p85), IKK-alpha, alpha-V/beta-3 integrin, MEK2(MAP2K2), MMP-2, IL-6, COL1A2, AKT(PKB), PDGF receptor, NF-kB p50/p65, OSF-2, Stromelysin-1, PI3K cat class IA, RelA (p65 NF-kB subunit), MMP-13, IL-8, TGF-beta receptor type II, EGFR, c-Jun, PDGF-A, alpha-5/beta-1 integrin, FGF2, SOS, TIMP1, NF-kB p65/p65, Collagen III, NGF, Galectin-1, ACTA2, SMAD3, CTGF, Fibrinogen (fibrin), Collagen I, TGF-beta receptor type I, PDGF-R-beta",1.397E-13,5.223E-11,47,"COL1A1, GRO-2, TGF-beta 1, RECK, CCL2, ERK1/2, HB-EGF, ID1, c-Raf-1, SMAD4, PDGF-R-alpha, SMAD2, Fibronectin, Shc, PI3K reg class IA (p85), alpha-V/beta-3 integrin, MEK2(MAP2K2), MMP-2, IL-6, COL1A2, AKT(PKB), PDGF receptor, NF-kB p50/p65, OSF-2, Stromelysin-1, MEK1(MAP2K1), PI3K cat class IA, RelA (p65 NF-kB subunit), MMP-13, IL-8, TGF-beta receptor type II, EGFR, PDGF-A, alpha-5/beta-1 integrin, FGF2, SOS, TIMP1, NF-kB p65/p65, Collagen III, NGF, Galectin-1, ACTA2, SMAD3, CTGF, Collagen I, TGF-beta receptor type I, PDGF-R-beta",
11,Development_Regulation of cytoskeleton proteins in oligodendrocyte differentiation and myelination,59,3.946E-13,7.379E-11,3.946E-13,7.379E-11,48,"CNTN1 (F3), CDK5R1 (p35), CDK5, NCAM1, alpha-6/beta-1 integrin, chTOG, HDAC6, KLHL2, PDGF-R-alpha, LIMK1, Gelsolin, VAV-1, Rac1, MLCP (reg), PCBP-1, Laminin 2, MAP2, L1CAM, TPPP (p24), ERMN, CDC42, Actin cytoskeletal, Fyn, PDGF receptor, WASF1(WAVE1), Tubulin (in microtubules), MLCP (cat), Tubulin beta, RhoA, MAP-1B, ROCK2, PDGF-A, Myosin II, hnRNP A2, Paxillin, Myelin basic protein, Tubulin alpha, MAP4, CNP1, PTPR-alpha, N-WASP, MRLC, Tubulin beta 4, MAG, CDK5R2 (p39), MELC, WASF2, Cofilin",1.007E-10,5.379E-09,43,"CNTN1 (F3), CDK5R1 (p35), CDK5, NCAM1, alpha-6/beta-1 integrin, chTOG, HDAC6, KLHL2, PDGF-R-alpha, LIMK1, Gelsolin, VAV-1, MLCP (reg), Laminin 2, MAP2, L1CAM, TPPP (p24), ERMN, CDC42, Actin cytoskeletal, Fyn, PDGF receptor, WASF1(WAVE1), Tubulin (in microtubules), MLCP (cat), Tubulin beta, RhoA, MAP-1B, ROCK2, PDGF-A, Myosin II, hnRNP A2, Myelin basic protein, Tubulin alpha, MAP4, CNP1, PTPR-alpha, MRLC, Tubulin beta 4, CDK5R2 (p39), MELC, WASF2, Cofilin",
12,Transcription_HIF-1 targets,95,4.523E-13,7.518E-11,4.523E-13,7.518E-11,68,"NIX, TGF-beta 1, EG-VEGF, PLGF, Oct-3/4, P4HA2, REDD1, VEGF-A, Cyclin G2, 5'-NTD, GLUT3, ENO1, MSH6, Carbonic anhydrase IX, PGK1, MDR1, AK3, IBP3, FECH, Adipophilin, F263, Endothelin-1, Nucleophosmin, MMP-2, PLAUR (uPAR), WT1, Alpha-1B adrenergic receptor, DEC1 (Stra13), ALDOC, c-Myc, Mcl-1, CXCR4, LRP1, TERT, PKM2, G3P2, ARNT, Heme oxygenase 1, TGF-beta 2, DEC2, Ceruloplasmin, iNOS, Lysyl oxidase, Adrenomedullin, HIF1A, HIF-1, GPI, Endoglin, P4HA1, FGF2, Angiopoietin 2, IBP1, Thrombospondin 1, TfR1, Mxi1, MSH2, Transferrin, LOXL2, TGM2, Galectin-1, NOXA, CTGF, MCT4, LDHA, p53, HGF receptor (Met), MMP-9, PAI1",7.344E-11,4.295E-09,61,"PDK1, NIX, TGF-beta 1, EG-VEGF, PLGF, Oct-3/4, P4HA2, REDD1, VEGF-A, 5'-NTD, GLUT3, ENO1, MSH6, Carbonic anhydrase IX, PGK1, MDR1, AK3, IBP3, Adipophilin, F263, Endothelin-1, MMP-2, PLAUR (uPAR), WT1, Alpha-1B adrenergic receptor, DEC1 (Stra13), ALDOC, Mcl-1, CXCR4, LRP1, TERT, PKM2, Heme oxygenase 1, TGF-beta 2, DEC2, Ceruloplasmin, iNOS, Lysyl oxidase, ROR-alpha, Adrenomedullin, HIF1A, Endoglin, P4HA1, FGF2, Angiopoietin 2, IBP1, Thrombospondin 1, TfR1, MSH2, Transferrin, LOXL2, TGM2, Galectin-1, NOXA, CTGF, MCT4, LDHA, p53, HGF receptor (Met), MMP-9, PAI1",
13,Glucocorticoid-induced elevation of intraocular pressure as glaucoma risk factor,62,1.205E-12,2.359E-10,1.171E-11,7.617E-10,48,"TRIO, Laminin 5, C/EBP zeta, GCR Beta, GCR, PI3K cat class IA (p110-beta), Elastin, Antileukoproteinase 1, Syndecan-4, Alpha-actinin, CLIM1, Fibronectin, PKC-epsilon, LAMA1, Rac1, PLAT (TPA), alpha-V/beta-3 integrin, MMP-2, SENP1, CDC42, Actin cytoskeletal, Collagen IV, Stromelysin-1, c-Src, MLCK, RhoA, ITGB1, PI3K cat class IA, PI3K reg class IA (p85-alpha), ITGB3, EGFR, SERPINA3 (ACT), Laminin 1, Thrombospondin 1, alpha-V/beta-5 integrin, RhoGDI alpha, COX-2 (PTGS2), ROCK, WNT5A, COL4A1, Myocilin, WNT2, GCR Alpha, Filamin A, LAMB3, HGF receptor (Met), PAI1, CD47",1.205E-12,2.359E-10,47,"TRIO, Laminin 5, C/EBP zeta, GCR Beta, GCR, PI3K cat class IA (p110-beta), Elastin, Antileukoproteinase 1, Syndecan-4, Alpha-actinin, CLIM1, Fibronectin, PKC-epsilon, LAMA1, PLAT (TPA), alpha-V/beta-3 integrin, MMP-2, SENP1, CDC42, Actin cytoskeletal, Collagen IV, Stromelysin-1, c-Src, MLCK, RhoA, ITGB1, PI3K cat class IA, PI3K reg class IA (p85-alpha), ITGB3, EGFR, SERPINA3 (ACT), Laminin 1, Thrombospondin 1, RhoGDI alpha, COX-2 (PTGS2), ROCK, WNT5A, COL4A1, Myocilin, WNT2, Cdt6 (angiopoietin-like), GCR Alpha, Filamin A, LAMB3, HGF receptor (Met), PAI1, CD47",
14,Oxidative stress_ROS-induced cellular signaling,108,1.497E-12,2.036E-10,1.497E-12,2.036E-10,74,"Casein kinase II, alpha chains, HES5, ERK1/2, EGR1, VEGF-A, PKA-reg (cAMP-dependent), Bak, Carbonic anhydrase IX, Syk, IL-1 beta, Bax, PAX5, GSK3 beta, FTL, IKK-alpha, FTH1, IRP2, IL-6, SENP1, GADD45 alpha, NF-kB, AKT(PKB), Catalase, NF-kB p50/p65, Cyclin B1, c-Src, Suv39H1, TNF-alpha, NOTCH1 (NICD), Thioredoxin, Heme oxygenase 1, PLK3 (CNK), RelA (p65 NF-kB subunit), iNOS, KEAP1, Adrenomedullin, IRP1, PKA-cat alpha, HIF1A, IL-8, SRX1, AMPK alpha subunit, Pin1, NIK(MAP3K14), Isoform p66 Shc, p300, JNK1(MAPK8), GSTP1, TfR1, COX-2 (PTGS2), ELAVL1 (HuR), HSF1, PKC-beta, NOTCH3 (3ICD), GPX1, PKC, MEKK1(MAP3K1), HES1, ATM, DLC1 (Dynein LC8a), c-Abl, NOXA, JNK(MAPK8-10), HIF-prolyl hydroxylase, HDAC1, SAE2, p53, NRF2, ADAM17, p38 MAPK, APEX, PAI1, mTOR, NALP3",8.278E-11,4.584E-09,67,"Casein kinase II, alpha chains, p38alpha (MAPK14), HES5, ERK1/2, VEGF-A, Carbonic anhydrase IX, Syk, IL-1 beta, Bax, PAX5, GSK3 beta, FTL, FTH1, IL-6, SENP1, GADD45 alpha, NF-kB, AKT(PKB), Catalase, NF-kB p50/p65, Cyclin B1, c-Src, TNF-alpha, NOTCH1 (NICD), Heme oxygenase 1, PLK3 (CNK), Chk2, RelA (p65 NF-kB subunit), iNOS, KEAP1, Adrenomedullin, IRP1, PKA-cat alpha, HIF1A, IL-8, SRX1, AMPK alpha subunit, Pin1, NIK(MAP3K14), Isoform p66 Shc, Glutaredoxin 1, p300, JNK1(MAPK8), GSTP1, TfR1, COX-2 (PTGS2), ELAVL1 (HuR), PKC-beta, NOTCH3 (3ICD), GPX1, PKC, HES1, ATM, c-Abl, NOXA, JNK(MAPK8-10), HIF-prolyl hydroxylase, HDAC1, SAE2, p53, NRF2, ADAM17, p38 MAPK, APEX, PAI1, mTOR, NALP3",
15,"Signal transduction_Angiotensin II/AGTR1 signaling via Notch, Beta-catenin and NF-kB pathways",76,2.160E-12,3.229E-10,3.895E-11,2.081E-09,55,"COL1A1, CBP, NOTCH1 receptor, HES5, CCL2, TCF7L2 (TCF4), ROCK1, ERK1/2, Beta-catenin, VEGF-A, TRPC6, Angiotensin II, Fibronectin, Rac1, I-kB, GSK3 beta, NF-kB2 (p100), IKK-alpha, PLC-gamma 1, MMP-2, Axin2, IL-6, NF-kB, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, RBP-J kappa (CBF1), c-Myc, TAK1(MAP3K7), NOTCH1 (NICD), RhoA, HEY1, RelA (p65 NF-kB subunit), NF-kB2 (p52), IL-8, TRAF6, CARD10/BCL10/MALT1, NIK(MAP3K14), p300, NOTCH3 (3ICD), PKC, HES1, WISP1, ACTA2, Angiotensinogen, SNAIL1, NCOA1 (SRC1), CTGF, NOTCH1 (NEXT), ADAM17, p38 MAPK, MMP-9, PKA-cat (cAMP-dependent), mTOR, NOTCH3",2.160E-12,3.229E-10,54,"COL1A1, CBP, NOTCH1 receptor, HES5, CCL2, TCF7L2 (TCF4), ROCK1, ERK1/2, Beta-catenin, VEGF-A, TRPC6, Angiotensin II, Fibronectin, YAP1 (YAp65), I-kB, GSK3 beta, NF-kB2 (p100), PLC-gamma 1, MMP-2, Axin2, IL-6, NF-kB, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, RBP-J kappa (CBF1), TAK1(MAP3K7), NOTCH1 (NICD), RhoA, RelA (p65 NF-kB subunit), NF-kB2 (p52), IL-8, TRAF6, CARD10/BCL10/MALT1, p90RSK1, NIK(MAP3K14), p300, NOTCH3 (3ICD), PKC, HES1, WISP1, Connexin 43, ACTA2, Angiotensinogen, SNAIL1, NCOA1 (SRC1), CTGF, NOTCH1 (NEXT), ADAM17, p38 MAPK, MMP-9, PKA-cat (cAMP-dependent), mTOR, NOTCH3",
16,TGF-beta 1-mediated induction of EMT in normal and asthmatic airway epithelium,44,2.997E-12,3.449E-10,2.997E-12,3.449E-10,38,"COL1A1, TGF-beta 1, CD44, BMP4, SMAD4, SMAD2, Fibronectin, Vimentin, IL-1 beta, Tenascin-C, MMP-2, TWIST1, TAK1(MAP3K7), TNF-alpha, N-cadherin, SMAD7, ITGB3, ETS1, TGF-beta receptor type II, ZO-1, c-Jun, Uteroglobin, MKK7 (MAP2K7), JNK1(MAPK8), MEK4(MAP2K4), AP-1, SLUG, ACTA2, JNK(MAPK8-10), HMGA2, SNAIL1, SMAD3, CTGF, Jagged1, p38 MAPK, MMP-9, PAI1, TGF-beta receptor type I",6.802E-10,2.825E-08,34,"COL1A1, TGF-beta 1, CD44, BMP4, SMAD4, SMAD2, Fibronectin, Vimentin, IL-1 beta, Tenascin-C, MMP-2, TWIST1, TAK1(MAP3K7), TNF-alpha, N-cadherin, SMAD7, ITGB3, ETS1, TGF-beta receptor type II, ZO-1, JNK1(MAPK8), MEK4(MAP2K4), SLUG, ACTA2, JNK(MAPK8-10), HMGA2, SNAIL1, SMAD3, CTGF, Jagged1, p38 MAPK, MMP-9, PAI1, TGF-beta receptor type I",
17,Role of activation of WNT signaling in the progression of lung cancer,77,3.631E-12,3.621E-10,3.631E-12,3.621E-10,57,"DVL-3, RUNX3, WNT3A, FZD6, Oct-3/4, NKD1, SFRP2, Krm1, APC protein, Lef-1, TCF7L2 (TCF4), DKK1, FZD8, Beta-catenin, Matrilysin (MMP-7), VEGF-A, Dsh, Rac1, GSK3 beta, FZD2, Survivin, DKK3, Axin2, EZH2, SKP2, FZD9, c-Myc, FZD7, DVL-2, Axin, CD147, RUVBL1, iNOS, Tcf(Lef), Porcn, WNT3, FZD3, ARD1, MKK7 (MAP2K7), JNK1(MAPK8), SFRP5, WNT1, SFRP4, WNT2B, WNT5A, MEKK1(MAP3K1), WNT, FZD5, WNT10B, WNT2, LRP6, SUZ12, FZD1, SFRP1, p38 MAPK, Frizzled, NOTCH3",1.185E-06,9.577E-06,45,"RUNX3, FZD6, Oct-3/4, SFRP2, Krm1, APC protein, TCF7L2 (TCF4), DKK1, FZD8, Beta-catenin, Matrilysin (MMP-7), VEGF-A, Dsh, GSK3 beta, FZD2, Survivin, DKK3, Axin2, EZH2, SKP2, FZD9, FZD7, DVL-2, Axin, CD147, RUVBL1, iNOS, Tcf(Lef), Porcn, WNT3, ARD1, JNK1(MAPK8), SFRP5, WNT2B, WNT5A, WNT, FZD5, WNT2, LRP6, SUZ12, FZD1, SFRP1, p38 MAPK, Frizzled, NOTCH3",
18,Immune response_IFN-alpha/beta signaling via MAPKs,77,3.631E-12,3.621E-10,3.631E-12,3.621E-10,57,"PML, IP10, ISG15, JAK1, Tyk2, TCF7L2 (TCF4), RIG-G, ERK1/2, Beta-catenin, Matrilysin (MMP-7), SMAD4, PIAS1, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IFNAR1, IFN-beta, VAV-1, p47-phox, STAT1, Rac1, PL scramblase 1, Ubiquitin, TAP1 (PSF1), PKC-theta, ZAP70, IFN-alpha, ISG54, Axin2, RSAD2, AKT(PKB), FZD7, HIP-2, Lck, CD45, PKR, PKC-delta, SMAD7, MEK3(MAP2K3), c-Jun, IFNAR2, IRF9, JNK1(MAPK8), MEK4(MAP2K4), Ku80, MAPKAPK3, AP-1, MEKK1(MAP3K1), SP5, FOXO3A, FasR(CD95), TRIM6, IRF7, JNK(MAPK8-10), HDAC1, SMAD3, p38 MAPK, mTOR",3.136E-08,6.088E-07,48,"PML, IP10, ISG15, JAK1, Tyk2, TCF7L2 (TCF4), RIG-G, ERK1/2, Beta-catenin, Matrilysin (MMP-7), SMAD4, PIAS1, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IFNAR1, IFN-beta, VAV-1, p47-phox, STAT1, PL scramblase 1, Ubiquitin, TAP1 (PSF1), PKC-theta, IFN-alpha, ISG54, Axin2, RSAD2, AKT(PKB), FZD7, Lck, CD45, PKR, SMAD7, MEK3(MAP2K3), IFNAR2, IRF9, JNK1(MAPK8), MEK4(MAP2K4), Ku80, SP5, FasR(CD95), TRIM6, IRF7, JNK(MAPK8-10), HDAC1, SMAD3, p38 MAPK, mTOR",
19,Renal tubulointerstitial injury in Lupus Nephritis ,65,3.644E-12,4.712E-10,2.219E-08,3.570E-07,45,"TNF-R2, TGF-beta 1, MHC class II, alpha-4/beta-1 integrin, ICAM1, CD44, CCL2, M-CSF receptor, SOCS1, IFN-alpha/beta receptor, TIG2, Fibronectin, Vimentin, FN14(TNFRSF12A), IL-1 beta, I-kB, IKK-alpha, IFN-alpha, HAS2, GM-CSF, NF-kB p52/RelB, RIPK1, CD4, BCMA(TNFRSF17), IL-6, NF-kB p50/p65, TNF-R1, BAFF(TNFSF13B), TNF-alpha, VCAM1, RelA (p65 NF-kB subunit), APRIL(TNFSF13), IL-8, BAFF-R, CCL19, IFN-gamma receptor, CSF1, PLAU (UPA), Collagen III, CMKLR1, CXCL13, TACI(TNFRSF13B), TWEAK(TNFSF12), PAI1, Collagen I",3.644E-12,4.712E-10,48,"TNF-R2, TGF-beta 1, MHC class II, CCL21, alpha-4/beta-1 integrin, ICAM1, CD44, CCL2, M-CSF receptor, IFN-gamma, SOCS1, CXCR5, IFN-alpha/beta receptor, TIG2, Fibronectin, Vimentin, FN14(TNFRSF12A), IL-1 beta, I-kB, IFN-alpha, HAS2, GM-CSF, NF-kB p52/RelB, RIPK1, CD4, BCMA(TNFRSF17), IL-6, NF-kB p50/p65, TNF-R1, CD40L(TNFSF5), BAFF(TNFSF13B), TNF-alpha, VCAM1, RelA (p65 NF-kB subunit), APRIL(TNFSF13), IL-8, BAFF-R, CCL19, IFN-gamma receptor, CSF1, PLAU (UPA), Collagen III, CMKLR1, CXCL13, TACI(TNFRSF13B), TWEAK(TNFSF12), PAI1, Collagen I",
20,B-regulatory cells and tumor cells intercellular interaction,67,3.973E-12,4.712E-10,5.491E-09,1.125E-07,47,"OX40L(TNFSF4), TNF-R2, TGF-beta 1, JAK1, CCL2, IL-10, PPAR-alpha, IL27RA, CD28, VEGF-A, OX40(TNFRSF4), VEGFR-2, STAT1, IL-1 beta, EBI3, GM-CSF, IL-6, FasL(TNFSF6), NF-kB, CD5, TLR9, TNF-alpha, FPRL1, JAK2, MCAM, LTBR(TNFRSF3), RelA (p65 NF-kB subunit), BRD4, IL4RA, Bcl-6, JAK3, NF-kB p65/p65, ST2(L), c-Maf, TLR4, IL-33, FasR(CD95), LTB, PD-1, JNK(MAPK8-10), TLR7, IL-21 receptor, p38 MAPK, CD86, TGF-beta receptor type I, PD-L1, IL-12RB2",3.973E-12,4.712E-10,49,"OX40L(TNFSF4), TNF-R2, TGF-beta 1, JAK1, CCL2, IL-10, PPAR-alpha, IL27RA, CD28, VEGF-A, OX40(TNFRSF4), VEGFR-2, STAT1, IL-1 beta, EBI3, GM-CSF, IL-6, NF-kB, TLR9, CD40L(TNFSF5), TNF-alpha, FPRL1, JAK2, CD80, MCAM, LTBR(TNFRSF3), RelA (p65 NF-kB subunit), BRD4, IL4RA, Bcl-6, JAK3, NF-kB p65/p65, STAT3, ST2(L), c-Maf, TLR4, IL-33, FasR(CD95), LTB, PD-1, JNK(MAPK8-10), TLR7, IL-21 receptor, IL-21, p38 MAPK, CD86, TGF-beta receptor type I, PD-L1, IL-12RB2",
21,Extracellular matrix-regulated proliferation of airway smooth muscle cells in asthma,35,4.097E-12,4.409E-10,5.305E-12,4.409E-10,32,"COL1A1, TGF-beta 1, alpha-4/beta-1 integrin, ERK1/2, SMAD4, SMAD2, Fibronectin, LAMA1, PI3K reg class IA (p85), Decorin, Collagen IV, TAK1(MAP3K7), PI3K cat class IA, SMAD7, TGF-beta receptor type II, EGFR, alpha-5/beta-1 integrin, Fibulin-1, MKK7 (MAP2K7), JNK1(MAPK8), MEK4(MAP2K4), Collagen III, ITGA3, ATF-2, Perlecan, alpha-2/beta-1 integrin, JNK(MAPK8-10), SMAD3, CTGF, p38 MAPK, Collagen I, TGF-beta receptor type I",4.097E-12,4.712E-10,31,"COL1A1, TGF-beta 1, alpha-4/beta-1 integrin, ERK1/2, SMAD4, SMAD2, Fibronectin, LAMA1, PI3K reg class IA (p85), Decorin, Collagen IV, TAK1(MAP3K7), PI3K cat class IA, SMAD7, TGF-beta receptor type II, EGFR, alpha-5/beta-1 integrin, Fibulin-1, JNK1(MAPK8), MEK4(MAP2K4), Collagen III, ITGA3, ATF-2, Perlecan, alpha-2/beta-1 integrin, JNK(MAPK8-10), SMAD3, CTGF, p38 MAPK, Collagen I, TGF-beta receptor type I",
22,CHDI_Correlations from Replication data_Causal network (positive correlations),79,4.206E-12,3.932E-10,4.206E-12,3.932E-10,58,"MHC class II, IL-1 alpha, Calcineurin A (catalytic), NF-AT1(NFATC2), ICAM1, CD44, CD28, MSK1/2 (RPS6KA5/4), HDAC7, CaMK IV, PI3K cat class IB (p110-gamma), IP3 receptor, I-kB, PI3K reg class IA (p85), PKC-theta, MyD88, ZAP70, IKK-alpha, PLC-gamma 1, NR2, ITK, Caspase-3, CREB1, G-protein beta/gamma, CD83, NF-kB, AKT(PKB), HSP70, CXCR4, MEKK4(MAP3K4), RhoA, Pyk2(FAK2), PI3K cat class IA, Lck, CD45, Slp76, HIP1, TRAF6, MEK3(MAP2K3), c-Jun, PSMC2, MEF2, NIK(MAP3K14), LAT, NR2A, RhoGDI alpha, MEK4(MAP2K4), ROCK, Calmodulin, PKC-alpha, CD3, PSD-95, IRAK1/2, JNK(MAPK8-10), PI3K reg class IB (p101), Calcineurin B (regulatory), p38 MAPK, TLR2",7.753E-09,1.994E-07,50,"MHC class II, IL-1 alpha, Calcineurin A (catalytic), ICAM1, CD44, CD28, MSK1/2 (RPS6KA5/4), HDAC7, CaMK IV, PI3K cat class IB (p110-gamma), IP3 receptor, I-kB, PI3K reg class IA (p85), PKC-theta, PLC-gamma 1, NR2, Caspase-3, CREB1, G-protein beta/gamma, CD83, NF-kB, AKT(PKB), HSP70, CXCR4, RhoA, Pyk2(FAK2), CD80, PI3K cat class IA, Lck, CD45, Slp76, HIP1, TRAF6, MEK3(MAP2K3), PSMC2, MEF2, NIK(MAP3K14), NR2A, RhoGDI alpha, MEK4(MAP2K4), ROCK, Calmodulin, PKC-alpha, CD3, PSD-95, IRAK1/2, JNK(MAPK8-10), Calcineurin B (regulatory), p38 MAPK, TLR2",
23,Development_YAP/TAZ-mediated co-regulation of transcription,56,4.955E-12,4.360E-10,4.955E-12,4.360E-10,45,"PML, TBX5, SOD2, Oct-3/4, Lef-1, TEF-1, ID3, ID1, Beta-catenin, VEGF-A, SMAD4, SMAD2, p63, p73, Survivin, Endothelin-1, Endothelin-2, FKHR, Neurotractin, SIP1 (ZFHX1B), Cyr61, HBP17, TAZ, TWIST1, Catalase, c-Myc, SOX9, UCA1, ITGB2, HIF1A, KLF5, Osteocalcin, CDX2, FOXM1, ErbB4(ICD), CDK6, TEF-4, RUNX2, RHAMM, UFO, SLUG, SMAD1, SNAIL1, SMAD3, CTGF",3.532E-11,2.296E-09,42,"PML, SOD2, Oct-3/4, TEF-1, ID3, ID1, Beta-catenin, VEGF-A, SMAD4, SMAD2, YAP1 (YAp65), p63, p73, Survivin, Endothelin-1, Endothelin-2, FKHR, Neurotractin, SIP1 (ZFHX1B), Cyr61, HBP17, TAZ, TWIST1, Catalase, SOX9, UCA1, ITGB2, HIF1A, KLF5, Osteocalcin, CDX2, FOXM1, ErbB4(ICD), CDK6, TEF-4, RUNX2, RHAMM, UFO, SLUG, SNAIL1, SMAD3, CTGF",
24,TGF-beta signaling via kinase cascades in breast cancer,58,6.816E-12,5.366E-10,6.816E-12,5.366E-10,46,"TGF-beta 1, ITGAV, ADAM12, ERK1/2, Rac1, ATF-2/c-Jun, Ubiquitin, Shc, p38beta (MAPK11), Survivin, IKK-alpha, alpha-V/beta-3 integrin, MMP-2, TGF-alpha, TWIST1, AKT(PKB), TIMP2, c-Src, TAK1(MAP3K7), TNF-alpha, TGF-beta 2, ITGB1, MLK3(MAP3K11), RelA (p65 NF-kB subunit), MMP-13, NF-kB1 (p50), ITGB3, IL-8, TGF-beta receptor type II, EGFR, XIAP, TRAF6, MEK3(MAP2K3), c-Jun, SOS1, TAB3, COX-2 (PTGS2), AP-1, ATF-2, TAB1, JNK(MAPK8-10), ADAM17, p38 MAPK, MMP-9, PAI1, TGF-beta receptor type I",2.336E-10,1.127E-08,42,"p38alpha (MAPK14), TGF-beta 1, ITGAV, ADAM12, Neuregulin 1, ERK1/2, Ubiquitin, Shc, Survivin, alpha-V/beta-3 integrin, MMP-2, TGF-alpha, TWIST1, AKT(PKB), TIMP2, c-Src, TAK1(MAP3K7), TNF-alpha, MEK1(MAP2K1), TGF-beta 2, ITGB1, MLK3(MAP3K11), RelA (p65 NF-kB subunit), MMP-13, NF-kB1 (p50), ITGB3, IL-8, TGF-beta receptor type II, EGFR, XIAP, TRAF6, MEK3(MAP2K3), SOS1, TAB3, COX-2 (PTGS2), ATF-2, JNK(MAPK8-10), ADAM17, p38 MAPK, MMP-9, PAI1, TGF-beta receptor type I",
25,Development_Positive regulation of WNT/Beta-catenin signaling in the cytoplasm,76,7.723E-12,5.769E-10,7.723E-12,5.769E-10,56,"Casein kinase II, alpha chains, Bcl-9, TGF-beta 1, IRS-2, NKD1, IRS-1, UBE2B, PP1-cat, RIPK4, APC protein, 14-3-3, Beta-catenin, TGIF, SMAD4, Makorin-1, Dsh, USP47, ZBED3, Rac1, Beta-arrestin2, CDK1 (p34), PPP2R2A, SIAH1, USP25, PR130, GSK3 alpha/beta, TBLR1, ERK2 (MAPK1), AKT(PKB), RNF146, Axin, HECTD1, ITGB1, LRP5/LRP6, HIPK2, Tcf(Lef), 14-3-3 zeta/delta, c-Jun, TGT, PP2A catalytic, RNF220, DOCK4, COX-2 (PTGS2), Trabid, Tankyrases, Miz-1, USP9X, WNT, Jouberin, JNK(MAPK8-10), SMAD3, NKD2, MITF, PKA-cat (cAMP-dependent), Frizzled, DACT1",2.161E-07,2.761E-06,46,"Casein kinase II, alpha chains, Bcl-9, TGF-beta 1, IRS-2, PP1-cat, RIPK4, APC protein, 14-3-3, Beta-catenin, TGIF, SMAD4, Dsh, Beta-arrestin2, YAP1 (YAp65), CDK1 (p34), PPP2R2A, SIAH1, USP25, PR130, GSK3 alpha/beta, TBLR1, ERK2 (MAPK1), AKT(PKB), RNF146, Axin, ITGB1, HIPK2, Tcf(Lef), 14-3-3 zeta/delta, TGT, PP2A catalytic, RNF220, DOCK4, COX-2 (PTGS2), Tankyrases, Miz-1, USP9X, WNT, Jouberin, JNK(MAPK8-10), SMAD3, NKD2, MITF, PKA-cat (cAMP-dependent), Frizzled, DACT1",
26,Immune response_Induction of the antigen presentation machinery by IFN-gamma,53,8.098E-12,5.769E-10,8.098E-12,5.769E-10,43,"CBP, MHC class II, HLA-B, JAK1, HLA-A, HLA-DMA, HLA-DPA1, HLA-DOA, HLA-DQB1, HLA-DRA1, IRF1, HLA-DQA1, Cathepsin S, STAT1, TAP1 (PSF1), PSME2, Nucleophosmin, PCAF, MHC class I, RFXANK, RFX5, HLA-DPB1, IFNGR1, JAK2, HLA-DRB1, PSMB8(LMP7), NLRC5, PSMB9, HLA-F, IFNGR2, Tapasin, HLA-DMB, RFX, Beta-2-microglobulin, CARM1, HLA-E, CD74, PSMB10, TAP2 (PSF2), CIITA, NCOA1 (SRC1), HLA-C, ERAP1",7.470E-11,4.295E-09,40,"CBP, MHC class II, HLA-B, JAK1, HLA-A, IFN-gamma, HLA-DMA, HLA-DPA1, HLA-DOA, HLA-DQB1, HLA-DRA1, IRF1, HLA-DQA1, Cathepsin S, STAT1, TAP1 (PSF1), PCAF, MHC class I, RFXANK, HLA-DPB1, IFNGR1, JAK2, HLA-DRB1, PSMB8(LMP7), NLRC5, PSMB9, HLA-F, IFNGR2, Tapasin, HLA-DMB, Beta-2-microglobulin, CARM1, HLA-E, CD74, PSMB10, TAP2 (PSF2), CIITA, NCOA1 (SRC1), HLA-C, ERAP1",
27,WNT signaling in HCC,40,9.935E-12,6.756E-10,9.935E-12,6.756E-10,35,"NOTUM, p14ARF, DVL-3, WNT3A, FZD6, SFRP2, APC protein, TCF7L2 (TCF4), DKK1, Beta-catenin, Dsh, GSK3 beta, Glypican-3, LRP5, c-Myc, FZD7, DVL-2, Axin, Ep-CAM, Prickle-1, Tcf(Lef), EGFR, WNT3, FZD3, SFRP5, WNT1, SFRP4, WNT5A, WNT7B, WNT, LGR5, SFRP1, p53, Frizzled, DACT1",7.654E-07,6.614E-06,28,"NOTUM, p14ARF, FZD6, SFRP2, APC protein, TCF7L2 (TCF4), DKK1, Beta-catenin, Dsh, GSK3 beta, Glypican-3, FZD7, DVL-2, Axin, Ep-CAM, Prickle-1, Tcf(Lef), EGFR, WNT3, SFRP5, WNT5A, WNT7B, WNT, LGR5, SFRP1, p53, Frizzled, DACT1",
28,Stellate cells activation and liver fibrosis,70,1.033E-11,1.030E-09,6.459E-10,1.896E-08,50,"COL1A1, GRO-2, Biglycan, TNF-R2, TGF-beta 1, ICAM1, WNT3A, CCL2, Beta-catenin, SMAD4, PDGF-R-alpha, SMAD2, Dsh, Smoothened, IL-1 beta, I-kB, Shc, PI3K reg class IA (p85), GSK3 beta, MyD88, RIPK1, MEK2(MAP2K2), MMP-2, COL1A2, ERK2 (MAPK1), AKT(PKB), PDGF receptor, NF-kB p50/p65, TNF-R1, TNF-alpha, PI3K cat class IA, PTCH1, Tcf(Lef), TGF-beta receptor type II, TRAF6, IL1RAP, KLF6, SOS, NIK(MAP3K14), TIMP1, TRAF1, ACTA2, IRAK1/2, GLI-1, SMAD3, Elk-1, Frizzled, TLR2, TGF-beta receptor type I, PDGF-R-beta",1.033E-11,1.030E-09,50,"COL1A1, GRO-2, Biglycan, TNF-R2, TGF-beta 1, ICAM1, CCL2, Beta-catenin, c-Raf-1, SMAD4, PDGF-R-alpha, SMAD2, Dsh, Smoothened, IL-1 beta, I-kB, Shc, PI3K reg class IA (p85), GSK3 beta, RIPK1, MEK2(MAP2K2), MMP-2, COL1A2, ERK2 (MAPK1), AKT(PKB), PDGF receptor, NF-kB p50/p65, TNF-R1, TNF-alpha, MEK1(MAP2K1), PI3K cat class IA, PTCH1, Tcf(Lef), TGF-beta receptor type II, TRAF6, IL1RAP, KLF6, SOS, NIK(MAP3K14), TIMP1, TRAF1, ACTA2, IRAK1/2, GLI-1, SMAD3, Elk-1, Frizzled, TLR2, TGF-beta receptor type I, PDGF-R-beta",
29,"Immune response_T cell co-signaling receptors, schema",55,1.275E-11,1.191E-09,7.919E-11,3.590E-09,43,"OX40L(TNFSF4), BPAG2, MHC class II, PD-L2, CD28, TIM-4, DR3(TNFRSF12), OX40(TNFRSF4), SLAM, DPP4, CD48, TR2(TNFRSF14), CD30(TNFRSF8), CTLA-4, ICOS, Collagen VI, NTB-A, GITR, CD70(TNFSF7), DNAM1, Collagen XXIII, Collagen V, CD137(TNFRSF9), BTLA, Galectin-9, LFA-3, Collagen III, TIM-1, Collagen XIII, PP2135, CD30L (TNFSF8), TIM-3, LAIR1, CD244, GITRL, Nectin-3, PD-1, CD137 ligand(TNFSF9), PVR, LIGHT(TNFSF14), CD86, Collagen I, PD-L1",1.275E-11,1.191E-09,42,"OX40L(TNFSF4), BPAG2, MHC class II, TIGIT, PD-L2, CD28, DR3(TNFRSF12), OX40(TNFRSF4), SLAM, DPP4, CD48, TR2(TNFRSF14), CD30(TNFRSF8), CTLA-4, Collagen VI, CD40L(TNFSF5), CD80, NTB-A, GITR, CD70(TNFSF7), DNAM1, Collagen XXIII, Collagen V, CD137(TNFRSF9), BTLA, Galectin-9, LFA-3, Collagen III, Collagen XIII, PP2135, LAIR1, CD244, CD2, GITRL, Nectin-3, PD-1, CD137 ligand(TNFSF9), PVR, LIGHT(TNFSF14), CD86, Collagen I, PD-L1",
30,TGF-beta 1-induced transactivation of membrane receptors signaling in HCC,50,1.297E-11,8.087E-10,1.297E-11,8.087E-10,41,"Laminin 5, TGF-beta 1, alpha-6/beta-1 integrin, Lef-1, Beta-catenin, CRK, PDGF-R-alpha, LIMK1, Fibronectin, Actin, Rac1, GSK3 beta, PI3K reg class IA, CDK4, AKT(PKB), PDGF receptor, c-Src, c-Myc, Axin, alpha-3/beta-1 integrin, ITGB1, PI3K cat class IA, TGF-beta receptor type II, DOCK1, PDGF-A, alpha-5/beta-1 integrin, TGF-beta, ITGA6, CDK2, p130CAS, ITGA2, Cyclin E, SLUG, c-Abl, alpha-2/beta-1 integrin, Cyclin A, SNAIL1, ITGA5, Cofilin, TGF-beta receptor type I, PDGF-R-beta",1.571E-10,8.099E-09,38,"Laminin 5, TGF-beta 1, alpha-6/beta-1 integrin, Beta-catenin, CRK, PDGF-R-alpha, LIMK1, Fibronectin, Actin, GSK3 beta, PI3K reg class IA, CDK4, AKT(PKB), PDGF receptor, c-Src, Axin, alpha-3/beta-1 integrin, ITGB1, PI3K cat class IA, TGF-beta receptor type II, DOCK1, PDGF-A, alpha-5/beta-1 integrin, TGF-beta, ITGA6, CDK2, p130CAS, ITGA2, Cyclin E, SLUG, c-Abl, alpha-2/beta-1 integrin, Cyclin A, SNAIL1, ITGA5, Cofilin, TGF-beta receptor type I, PDGF-R-beta",
31,Role of Th17 cells in asthma,28,1.953E-11,1.661E-09,4.151E-09,8.746E-08,25,"GRO-2, TGF-beta 1, ICAM1, ERK1/2, ALOX5AP, HB-EGF, IL-17 receptor, IL-22, GRO-3, MLCP (reg), GRO-1, IL-17F, NF-kB, MLCP (cat), RhoA, VCAM1, ROCK2, IL-8, EGFR, ALOX5, Myosin II, IL-22 receptor, MRLC, p38 MAPK, IL-11",1.953E-11,1.661E-09,26,"GRO-2, TGF-beta 1, ICAM1, ERK1/2, ALOX5AP, HB-EGF, IL-17, IL-17 receptor, IL-22, GRO-3, MLCP (reg), GRO-1, IL-17F, NF-kB, MLCP (cat), RhoA, VCAM1, ROCK2, IL-8, EGFR, ALOX5, Myosin II, IL-22 receptor, MRLC, p38 MAPK, IL-11",
32,Vascular endothelial cell damage in SLE,63,2.000E-11,1.661E-09,1.839E-10,7.054E-09,47,"TGF-beta 1, IL-1 alpha, PD-L2, alpha-4/beta-1 integrin, HMGB1, ICAM1, CCL2, IL-10, MSR1, C5a, ERK1/2, VEGF-A, IL1RN, Fibronectin, FN14(TNFRSF12A), IL-1 beta, IL1R2, Endothelin-1, IFN-alpha, GM-CSF, Caspase-3, VEGF-B, IL-6, NF-kB, NF-kB p50/p65, Caspase-1, P-selectin, TNF-alpha, HGF, VCAM1, RelA (p65 NF-kB subunit), iNOS, IL-18, IL-8, alpha-5/beta-1 integrin, CSF1, Tissue factor, AML1 (RUNX1), RAGE, Caspase-7, PD-1, JNK(MAPK8-10), TWEAK(TNFSF12), C3a, p38 MAPK, PAI1, PD-L1",2.000E-11,1.661E-09,46,"TGF-beta 1, IL-1 alpha, PD-L2, alpha-4/beta-1 integrin, HMGB1, ICAM1, CCL2, IL-10, MSR1, C5a, ERK1/2, VEGF-A, IL1RN, Fibronectin, FN14(TNFRSF12A), IL-1 beta, IL1R2, Endothelin-1, IFN-alpha, GM-CSF, Caspase-3, VEGF-B, IL-6, NF-kB, NF-kB p50/p65, Caspase-1, P-selectin, TNF-alpha, HGF, VCAM1, RelA (p65 NF-kB subunit), iNOS, IL-18, IL-8, alpha-5/beta-1 integrin, CSF1, Tissue factor, AML1 (RUNX1), RAGE, PD-1, JNK(MAPK8-10), TWEAK(TNFSF12), C3a, p38 MAPK, PAI1, PD-L1",
33,Immune response_IFN-gamma in macrophages activation,50,2.194E-11,1.726E-09,2.255E-06,1.486E-05,34,"CBP, IP10, JAK1, c-Rel (NF-kB subunit), CCL2, IL-10, gp91-phox, IRF1, STAT1, IL-6, PAI2, EZH2, TLR9, Caspase-1, PPAR-gamma, Pleiotrophin (OSF1), TNF-alpha, JAK2, RelA (p65 NF-kB subunit), iNOS, IL-18, C/EBPbeta, IFN-gamma receptor, MER, p300, Thrombospondin 1, CLIC5, RANK(TNFRSF11A), COX-2 (PTGS2), CYP27B1, c-Maf, BATF2, TLR4, IL-12 beta",2.194E-11,1.726E-09,39,"IRF8, MIG, CBP, IP10, JAK1, c-Rel (NF-kB subunit), CCL2, IL-10, IFN-gamma, gp91-phox, IRF1, C1qb, STAT1, IL-6, PAI2, EZH2, TLR9, Caspase-1, PPAR-gamma, Pleiotrophin (OSF1), TNF-alpha, JAK2, RelA (p65 NF-kB subunit), iNOS, IL-18, C/EBPbeta, IFN-gamma receptor, p67-phox, MER, p300, Thrombospondin 1, CLIC5, RANK(TNFRSF11A), COX-2 (PTGS2), CYP27B1, c-Maf, BATF2, TLR4, IL-12 beta",
34,Immune response_M-CSF-receptor signaling pathway,81,2.419E-11,1.808E-09,4.601E-10,1.496E-08,56,"STAT5A, ERK5 (MAPK7), JAK1, Tyk2, MSR1, M-CSF receptor, ERK1/2, Beta-catenin, CRK, Rac2, STAT5B, VAV-1, STAT1, Rac1, IP3 receptor, Syk, Cyclin D2, Shc, PI3K reg class IA (p85), p120GAP, MAP3K2 (MEKK2), MAP2K5 (MEK5), MEK2(MAP2K2), CDC42, Fyn, NF-kB, AKT(PKB), c-Src, c-Myc, TSAD, GAB2, RhoA, Pyk2(FAK2), PI3K cat class IA, c-Cbl, FMIP, Tcf(Lef), ETS1, PRIM2A, c-Jun, YES, ETS2, CSF1, SOS1, GRAP2, GAB3, PLD2, PLAU (UPA), AP-1, DAP12, Calmodulin, PKC, IL-34, PLC-gamma, Elk-1, SRF",2.419E-11,1.808E-09,55,"STAT5A, ERK5 (MAPK7), JAK1, Tyk2, MSR1, M-CSF receptor, ERK1/2, Beta-catenin, CRK, c-Raf-1, Rac2, STAT5B, VAV-1, STAT1, IP3 receptor, Syk, Cyclin D2, Shc, PI3K reg class IA (p85), p120GAP, MAP3K2 (MEKK2), MAP2K5 (MEK5), MEK2(MAP2K2), CDC42, Fyn, NF-kB, AKT(PKB), c-Src, TSAD, GAB2, MEK1(MAP2K1), RhoA, Pyk2(FAK2), PI3K cat class IA, c-Cbl, FMIP, Tcf(Lef), ETS1, PRIM2A, YES, ETS2, CSF1, SOS1, GRAP2, GAB3, PLD2, PLAU (UPA), STAT3, DAP12, Calmodulin, PKC, IL-34, PLC-gamma, Elk-1, SRF",
35,Immune response_Fc epsilon RI pathway: Lyn-mediated cytokine production,87,3.015E-11,1.769E-09,3.015E-11,1.769E-09,61,"ERK5 (MAPK7), Calcineurin A (catalytic), NF-AT1(NFATC2), CCL2, ERK1/2, MEF2C, BFL1, EGR1, TSLP, VAV-1, Rac1, IP3 receptor, Fc epsilon RI alpha, Syk, IL-1 beta, Shc, MAP3K2 (MEKK2), MAP2K5 (MEK5), IL-13, IL-6, MEK1/2, CDC42, NF-kB, NF-kB p50/p65, TAK1(MAP3K7), NF-AT2(NFATC1), IL-2, SH3BP-2, TNF-alpha, Slp76, PKC-delta, Lyn, MIST, TRAF6, MEK3(MAP2K3), IL-5, Fer, c-Jun, SOS, MKK7 (MAP2K7), LAT, GRAP2, SKAP55, NF-AT, MEK4(MAP2K4), PKC-beta, AP-1, PKC-beta1, Calmodulin, PKC, MEKK1(MAP3K1), PKC-alpha, ATF-2, MALT1, IL-33, PLC-gamma, JNK(MAPK8-10), Bcl-10, FYB1, p38 MAPK, Elk-1",5.440E-09,1.479E-07,54,"ERK5 (MAPK7), Calcineurin A (catalytic), CCL2, ERK1/2, MEF2C, BFL1, c-Raf-1, GATA-1, TSLP, VAV-1, IP3 receptor, Fc epsilon RI alpha, Syk, IL-1 beta, Shc, MAP3K2 (MEKK2), MAP2K5 (MEK5), IL-6, MEK1/2, CDC42, NF-kB, NF-kB p50/p65, TAK1(MAP3K7), NF-AT2(NFATC1), IL-2, SH3BP-2, TNF-alpha, Slp76, Lyn, MIST, TRAF6, IL-5, MEK3(MAP2K3), Fer, SOS, Fc epsilon RI beta, GRAP2, SKAP55, NF-AT, MEK4(MAP2K4), PKC-beta, PKC-beta1, Calmodulin, PKC, PKC-alpha, ATF-2, MALT1, IL-33, PLC-gamma, JNK(MAPK8-10), Bcl-10, FYB1, p38 MAPK, Elk-1",
36,Inhibition of remyelination in multiple sclerosis: regulation of cytoskeleton proteins,44,3.075E-11,1.769E-09,3.075E-11,1.769E-09,37,"NGFR(TNFRSF16), CDK5, alpha-V/beta-1 integrin, Lingo1, chTOG, HDAC6, KLHL2, LIMK1, Fibronectin, VAV-1, Rac1, MLCP (reg), PCBP-1, CDC42, Actin cytoskeletal, Fyn, WASF1(WAVE1), TNF-alpha, Tubulin (in microtubules), MLCP (cat), Tubulin beta, RhoA, ROCK2, Stathmin, Myosin II, TGF-beta, Sirtuin2, hnRNP A2, Paxillin, Myelin basic protein, Tubulin alpha, PKC-alpha, MRLC, Tubulin beta 4, MELC, WASF2, Cofilin",4.639E-09,1.309E-07,33,"NGFR(TNFRSF16), CDK5, alpha-V/beta-1 integrin, chTOG, HDAC6, KLHL2, LIMK1, Fibronectin, VAV-1, MLCP (reg), CDC42, Actin cytoskeletal, Fyn, WASF1(WAVE1), Tubulin (in microtubules), TNF-alpha, MLCP (cat), Tubulin beta, RhoA, ROCK2, Stathmin, Myosin II, TGF-beta, Sirtuin2, hnRNP A2, Myelin basic protein, Tubulin alpha, PKC-alpha, MRLC, Tubulin beta 4, MELC, WASF2, Cofilin",
37,Role of TGF-beta 1 in fibrosis development after myocardial infarction,38,3.284E-11,2.296E-09,6.465E-10,1.896E-08,32,"COL1A1, Biglycan, TGF-beta 1, SMAD4, Angiotensin II, SMAD2, Fibronectin, TMSB4X, Endothelin-1, AGTR2, Tenascin-C, MMP-2, COL1A2, TIMP2, Prolyl endopeptidase, SMAD7, TGF-beta receptor type II, Ac-SDKP, Thymosin beta-4, Thrombospondin 1, TIMP1, Collagen III, Collagen Prolyl 4-Hydroxylase, EDNRB, ACTA2, SMAD3, CTGF, MMP-9, PAI1, EDNRA, Collagen I, TGF-beta receptor type I",3.284E-11,2.296E-09,32,"COL1A1, Biglycan, TGF-beta 1, SMAD4, Angiotensin II, SMAD2, Fibronectin, TMSB4X, Endothelin-1, AGTR2, Tenascin-C, MMP-2, COL1A2, TIMP2, Prolyl endopeptidase, SMAD7, TGF-beta receptor type II, Ac-SDKP, Thymosin beta-4, Thrombospondin 1, TIMP1, Collagen III, Collagen Prolyl 4-Hydroxylase, EDNRB, ACTA2, SMAD3, CTGF, MMP-9, PAI1, EDNRA, Collagen I, TGF-beta receptor type I",
38,Immune response_IFN-gamma signaling via PI3K and NF-kB,56,3.513E-11,1.946E-09,3.513E-11,1.946E-09,44,"Casein kinase II, alpha chains, Rictor, CYP1B1, IP10, RUNX3, JAK1, SOD2, ERK1/2, DKK1, Beta-catenin, IRF1, PKC-epsilon, HBZ, HLA-B7, STAT1, I-kB, GSK3 beta, IKK-alpha, MEK1/2, Fyn, NF-kB, AKT(PKB), NF-kB p50/p65, GAB2, IFNGR1, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), iNOS, PKR, PKC-delta, c-Jun, IFNGR2, Alpha1-globin, CX3CL1, MICA, SHP-2, TGM2, STAT5, TLR3, LPL, mTOR, PD-L1",3.532E-11,2.296E-09,42,"Casein kinase II, alpha chains, Rictor, CYP1B1, IP10, RUNX3, JAK1, SOD2, IFN-gamma, ERK1/2, DKK1, Beta-catenin, c-Raf-1, IRF1, PKC-epsilon, HBZ, HLA-B7, STAT1, I-kB, GSK3 beta, MEK1/2, Fyn, NF-kB, AKT(PKB), NF-kB p50/p65, GAB2, IFNGR1, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), iNOS, PKR, IFNGR2, Alpha1-globin, CX3CL1, MICA, TGM2, STAT5, TLR3, LPL, mTOR, PD-L1",
39,Glomerular injury in Lupus Nephritis,92,4.036E-11,2.514E-09,1.340E-08,2.343E-07,59,"OX40L(TNFSF4), GRO-2, IP10, HMGB1, ICAM1, CCL2, NGAL, C5a, ERK1/2, ATF-4, IRF1, Fibronectin, CaMK IV, PKC-epsilon, GRO-3, IFN-beta, FN14(TNFRSF12A), STAT1, IL-1 beta, Bax, GRO-1, Decorin, MDA-5, IFN-alpha, HAS2, GM-CSF, RIPK1, IL-6, MEK1/2, FasL(TNFSF6), NF-kB, AKT(PKB), NF-kB p50/p65, RIG-I, IFI56, TNF-alpha, VCAM1, RelA (p65 NF-kB subunit), iNOS, p22-phox, HIF1A, IL-8, TRAF6, TGF-beta, CSF1, A20, PKC-beta2, CX3CL1, PKC-beta1, PKC-alpha, Annexin II, FasR(CD95), JNK(MAPK8-10), TLR3, TWEAK(TNFSF12), C3a, p38 MAPK, MMP-9, PDGF-R-beta",4.036E-11,2.514E-09,60,"OX40L(TNFSF4), GRO-2, IP10, HMGB1, ICAM1, CCL2, NGAL, C5a, IFN-gamma, ERK1/2, IL-17, c-Raf-1, IRF1, Fibronectin, CaMK IV, PKC-epsilon, GRO-3, IFN-beta, FN14(TNFRSF12A), STAT1, IL-1 beta, Bax, GRO-1, Decorin, MDA-5, IFN-alpha, HAS2, GM-CSF, RIPK1, IL-6, MEK1/2, NF-kB, AKT(PKB), NF-kB p50/p65, RIG-I, IFI56, TNF-alpha, VCAM1, RelA (p65 NF-kB subunit), iNOS, p22-phox, HIF1A, IL-8, TRAF6, TGF-beta, CSF1, A20, PKC-beta2, CX3CL1, PKC-beta1, PKC-alpha, Annexin II, FasR(CD95), JNK(MAPK8-10), TLR3, TWEAK(TNFSF12), C3a, p38 MAPK, MMP-9, PDGF-R-beta",
40,Signal transduction_Angiotensin II/ AGTR1 signaling via RhoA and JNK,78,4.349E-11,2.243E-09,4.349E-11,2.243E-09,56,"COL1A1, STIM1, LBC, RECK, NCK1, CCL2, LARG, ERK1/2, ARHGEF1 (p115RhoGEF), VEGF-A, CRK, G-protein alpha-q/11, Angiotensin II, BNP, PLC-beta1, Rac1, IP3 receptor, MLCP (reg), Endothelin-1, PLC-gamma 1, MMP-2, G-protein beta/gamma, c-Src, PLK1, MLCK, MLCP (cat), RhoA, Pyk2(FAK2), JAK2, GEFT, G-protein alpha-12 family, ROCK2, PKC-delta, G-protein alpha-12, c-Jun, MKK7 (MAP2K7), Paxillin, MEK4(MAP2K4), Collagen III, p130CAS, ROCK, AP-1, PDZ-RhoGEF, Calmodulin, MEKK1(MAP3K1), Vinculin, ATF-2, TLR4, MRLC, JNK(MAPK8-10), CTGF, RacGAP1, ECT2, MMP-9, PAI1, SRF",1.935E-07,2.515E-06,47,"COL1A1, STIM1, LBC, RECK, NCK1, CCL2, ERK1/2, ARHGEF1 (p115RhoGEF), VEGF-A, CRK, G-protein alpha-q/11, Angiotensin II, BNP, IP3 receptor, MLCP (reg), Endothelin-1, PLC-gamma 1, MMP-2, G-protein beta/gamma, c-Src, PLK1, MLCK, MLCP (cat), RhoA, Pyk2(FAK2), JAK2, GEFT, G-protein alpha-12 family, ROCK2, G-protein alpha-12, MEK4(MAP2K4), Collagen III, p130CAS, ROCK, PDZ-RhoGEF, Calmodulin, Vinculin, ATF-2, TLR4, MRLC, JNK(MAPK8-10), CTGF, RacGAP1, ECT2, MMP-9, PAI1, SRF",
41,Cytoskeleton remodeling_Regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases,58,4.560E-11,2.274E-09,4.560E-11,2.274E-09,45,"WRCH-1, Spectrin, PRK1, Caldesmon, Alpha-actinin, Rac2, RhoC, LIMK1, Rac1, Talin, MLCP (reg), Cdc42 subfamily, MSN (moesin), ERM proteins, ARPC1B, RhoA-related, CDC42, Actin cytoskeletal, MLCK, MLCP (cat), BETA-PIX, RhoA, Citron, RhoJ, Destrin, F-Actin cytoskeleton, Myosin II, CPI-17, Alpha adducin, MyHC, LIMK, Paxillin, MRCK, RhoGDI alpha, ROCK, Actomyosin, MRCKalpha, PAK, Cofilin, non-muscle, Rac1-related, Vinculin, MRLC, Filamin A, TC10, Cofilin",1.917E-06,1.358E-05,36,"Spectrin, PRK1, Caldesmon, Alpha-actinin, Rac2, LIMK1, Talin, MLCP (reg), Cdc42 subfamily, MSN (moesin), ERM proteins, ARPC1B, RhoA-related, CDC42, Actin cytoskeletal, MLCK, MLCP (cat), RhoA, Citron, RhoJ, F-Actin cytoskeleton, Myosin II, CPI-17, Alpha adducin, MyHC, LIMK, RhoGDI alpha, ROCK, Actomyosin, PAK, Rac1-related, Vinculin, MRLC, Filamin A, TC10, Cofilin",
42,SLE genetic marker-specific pathways in antigen-presenting cells (APC),84,5.671E-11,2.737E-09,5.671E-11,2.737E-09,59,"IL-1 alpha, GRP78, Separase, JAK1, ICAM1, IL-10, Tyk2, UBCH7, ATF-6 alpha (90kDa), VISA, PI3K cat class III (Vps34), WDFY4, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, Ubiquitin, IL-1 beta, I-kB, MyD88, STAT4, MDA-5, IKK-alpha, IFN-alpha, RFP, NF-kB, IL-23, TLR9, YY1, ATF-6 beta, MICB, TAK1(MAP3K7), ATF-6 alpha (50kDa), TNF-alpha, TNIP1, TRAF6, IRF9, IFN-gamma receptor, NIK(MAP3K14), Fc gamma RII alpha, KLRK1 (NKG2D), A20, S1P, Securin, Mitotic cohesin complex, TIP27, APG5, TLR4, IRAK1, SLC15A4, Beclin 1, IRF7, TLR7, iC3b, TRIF (TICAM1), TR4, IL-12 beta, LRRC18, JIK",8.446E-10,3.413E-08,54,"IRF8, IL-1 alpha, GRP78, JAK1, ICAM1, IL-10, Tyk2, IFN-gamma, UBCH7, ATF-6 alpha (90kDa), VISA, PI3K cat class III (Vps34), WDFY4, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, Ubiquitin, IL-1 beta, I-kB, STAT4, MDA-5, IFN-alpha, RFP, NF-kB, IL-23, TLR9, MICB, TAK1(MAP3K7), ATF-6 alpha (50kDa), CD40L(TNFSF5), TNF-alpha, TNIP1, TRAF6, IRF9, IFN-gamma receptor, NIK(MAP3K14), Fc gamma RII alpha, KLRK1 (NKG2D), A20, S1P, Securin, Mitotic cohesin complex, TIP27, APG5, TLR4, IRAK1, SLC15A4, IRF7, TLR7, iC3b, TR4, IL-12 beta, LRRC18",
43,Immune response_IFN-alpha/beta signaling via PI3K and NF-kB pathways,94,7.442E-11,3.479E-09,7.442E-11,3.479E-09,64,"Cyclin D3, ISG15, JAK1, IRS-2, IL-10, Tyk2, IRS-1, RPS6, DHFR, NMI, eIF4E, ERK1/2, CDC25A, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IFNAR1, PKC-epsilon, IFN-beta, CDK1 (p34), I-kB, PI3K reg class IA (p85), GSK3 beta, NF-kB2 (p100), CDK4, IKK-alpha, IFN-alpha, p19, ISG54, CREB1, MEK1/2, RSAD2, b-Myb, NF-kB, AKT(PKB), p16INK4, p107, c-Myc, SLFN5, IFI17, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB2 (p52), PKC-delta, I-TAC, p107/E2F4, IFNAR2, eIF4G1/3, NIK(MAP3K14), MNK1, CDK2, PCNA, 4E-BP1, GBP1, IFIT1, E2F4, PKC-alpha, Cyclin E, eIF4A, FOXO3A, IRF7, p15, Cyclin A, c-FLIP, IL-12 beta",5.689E-10,2.430E-08,59,"ISG15, JAK1, IRS-2, IL-10, Tyk2, RPS6, DHFR, NMI, ERK1/2, c-Raf-1, CDC25A, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IFNAR1, PKC-epsilon, IFN-beta, CDK1 (p34), I-kB, PI3K reg class IA (p85), GSK3 beta, NF-kB2 (p100), CDK4, IFN-alpha, p19, ISG54, CREB1, MEK1/2, RSAD2, b-Myb, NF-kB, AKT(PKB), p16INK4, p107, SLFN5, IFI17, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB2 (p52), I-TAC, p107/E2F4, IFNAR2, p90RSK1, eIF4G1/3, NIK(MAP3K14), MNK1, CDK2, STAT3, PCNA, GBP1, IFIT1, E2F4, PKC-alpha, Cyclin E, eIF4A, IRF7, p15, Cyclin A, c-FLIP, IL-12 beta",
44,Canonical WNT signaling pathway in colorectal cancer,66,1.009E-10,4.438E-09,1.009E-10,4.438E-09,49,"DVL-3, PLD1, CD44, SFRP2, BMP4, APC protein, Lef-1, TCF7L2 (TCF4), DKK1, Beta-catenin, Matrilysin (MMP-7), VEGF-A, Dsh, Rac1, PI3K reg class IA (p85), GSK3 beta, FZD2, Survivin, Axin2, CAS-L, Carbonic anhydrase II, c-Myc, FZD7, DVL-2, Axin, TCF7 (TCF1), PI3K cat class IA, iNOS, IAP, ENC1, Leptin receptor, SFRP5, PLD2, WNT1, SFRP4, WNT5A, Miz-1, I-FABP, FZD10, WNT, SLUG, WNT2, LRP6, FZD1, SFRP1, HGF receptor (Met), DACT3, Frizzled, WNT6",2.457E-08,5.324E-07,43,"PLD1, CD44, SFRP2, BMP4, APC protein, TCF7L2 (TCF4), DKK1, Beta-catenin, Matrilysin (MMP-7), VEGF-A, Dsh, PI3K reg class IA (p85), GSK3 beta, FZD2, Survivin, Axin2, CAS-L, Carbonic anhydrase II, FZD7, DVL-2, Axin, TCF7 (TCF1), PI3K cat class IA, iNOS, IAP, ENC1, Leptin receptor, SFRP5, PLD2, WNT5A, Miz-1, I-FABP, FZD10, WNT, SLUG, WNT2, LRP6, FZD1, SFRP1, HGF receptor (Met), DACT3, Frizzled, WNT6",
45,Development_Negative regulation of WNT/Beta-catenin signaling in the nucleus,89,1.352E-10,5.779E-09,1.352E-10,5.779E-09,61,"Casein kinase I delta, Calcineurin A (catalytic), RUNX3, BACH1, HBP1, Oct-3/4, VHL, APC protein, Lef-1, TCF7L2 (TCF4), 14-3-3, Jade-1, Casein kinase I epsilon, Beta-catenin, PAX7, VEGF-A, BCL9/B9L, PC1-CTT, TLE, CBP/P300, Dsh, NF-AT5, GSK3 beta, Nephrocystin-4, HDAC2, ICAT, HIC1, LATS2, SENP1, P15RS, RANBP3, CtBP, TBLR1, PJA2, HIC5, PPAR-gamma, Axin, TAK1(MAP3K7), SOX9, TCF7 (TCF1), LRP5/LRP6, TRRAP, NARF, c-Cbl, PKC-delta, Tcf(Lef), CDX2, SOX17, GLI-3R, SENP2, Kaiso, Cul1/Rbx1 E3 ligase, RNF43, WNT5A, WNT, FOXO3A, CHIBBY, HDAC1, CDX1, Frizzled, DACT1",4.384E-06,2.697E-05,49,"Calcineurin A (catalytic), RUNX3, BACH1, HBP1, Oct-3/4, VHL, APC protein, TCF7L2 (TCF4), 14-3-3, Jade-1, Casein kinase I epsilon, Beta-catenin, VEGF-A, BCL9/B9L, TLE, CBP/P300, Dsh, NF-AT5, GSK3 beta, Nephrocystin-4, HDAC2, ICAT, HIC1, LATS2, SENP1, P15RS, CtBP, TBLR1, HIC5, PPAR-gamma, Axin, TAK1(MAP3K7), SOX9, TCF7 (TCF1), TRRAP, NARF, c-Cbl, Tcf(Lef), CDX2, SOX17, GLI-3R, Kaiso, Cul1/Rbx1 E3 ligase, WNT5A, WNT, HDAC1, CDX1, Frizzled, DACT1",
46,Neurogenesis_NGF/ TrkA MAPK-mediated signaling,105,1.603E-10,6.662E-09,1.603E-10,6.662E-09,69,"SPHK1, CDK5R1 (p35), TrkA, ERK5 (MAPK7), CDK5, APS, Fra-1, ERK1/2, MEF2C, HB-EGF, PKC-zeta, CrkL, EGR1, SGK1, PP2A regulatory, PKA-reg (cAMP-dependent), CRK, VGF, PKC-epsilon, Ephrin-A receptor 2, IP3 receptor, RAP-1A, Shc, PLC-gamma 1, N-Ras, SNX26 (TCGAP), MAP2K5 (MEK5), KIDINS220, CREB1, MEK1/2, PLAUR (uPAR), Flotillin-1, M-Ras, RGS2, p107, Stromelysin-1, c-Src, KCTD11, GAB2, Sequestosome 1(p62), SHPS-1, B-Raf, NF-kB1 (p50), PKC-delta, MEK3(MAP2K3), c-Jun, SOS, PP2A catalytic, C3G, SH2B, p90Rsk, p130CAS, NGF, AP-1, Calmodulin, MAGI-2, PKC-lambda/iota, SHP-2, RASGRF1, SORBS1, MMP-10, PVR, SHB, PDZ-GEF1, RIT, p38 MAPK, Elk-1, PKA-cat (cAMP-dependent), SRF",5.142E-07,5.160E-06,58,"SPHK1, CDK5R1 (p35), ERK5 (MAPK7), CDK5, APS, Fra-1, ERK1/2, MEF2C, HB-EGF, CrkL, SGK1, PP2A regulatory, CRK, c-Raf-1, PKC-epsilon, Ephrin-A receptor 2, IP3 receptor, RAP-1A, Shc, PLC-gamma 1, N-Ras, MAP2K5 (MEK5), KIDINS220, CREB1, MEK1/2, PLAUR (uPAR), Flotillin-1, M-Ras, RGS2, p107, Stromelysin-1, c-Src, KCTD11, GAB2, Sequestosome 1(p62), SHPS-1, B-Raf, NF-kB1 (p50), MEK3(MAP2K3), SOS, PP2A catalytic, p90Rsk, p130CAS, NGF, Calmodulin, MAGI-2, PKC-lambda/iota, RASGRF1, SORBS1, MMP-10, PVR, SHB, PDZ-GEF1, RIT, p38 MAPK, Elk-1, PKA-cat (cAMP-dependent), SRF",
47,Inhibition of apoptosis in gastric cancer,42,1.777E-10,6.995E-09,1.777E-10,6.995E-09,35,"Gastrin 17-Gly, TGF-beta 1, DR5(TNFRSF10B), RUNX3, Apaf-1, Apo-2L(TNFSF10), Caspase-8, BAD, Bax, c-IAP1, Caspase-3, NF-kB, AKT(PKB), DR4(TNFRSF10A), Gastrin 17, Progastrin, Mcl-1, XAF1, HGF, c-IAP2, CCKBR, TGF-beta receptor type II, XIAP, Caspase-9, ROCK, Caspase-10, Caspase-7, Gasdermin, tBid, HtrA2, c-FLIP(Short), HGF receptor (Met), Bim, TGF-beta receptor type I, Bid",4.072E-09,1.194E-07,32,"Gastrin 17-Gly, TGF-beta 1, DR5(TNFRSF10B), RUNX3, Apaf-1, Apo-2L(TNFSF10), Caspase-8, Bax, c-IAP1, Caspase-3, NF-kB, AKT(PKB), DR4(TNFRSF10A), Gastrin 17, Progastrin, Mcl-1, XAF1, HGF, c-IAP2, TGF-beta receptor type II, XIAP, Caspase-9, ROCK, Caspase-10, Gasdermin, tBid, HtrA2, c-FLIP(Short), HGF receptor (Met), Bim, TGF-beta receptor type I, Bid",
48,Signal transduction_WNT/Beta-catenin signaling in tissue homeostasis,42,1.777E-10,6.995E-09,1.777E-10,6.995E-09,35,"BACE1, Lef-1, TCF7L2 (TCF4), Versican, Beta-catenin, ACADL, Cyclin D2, MENA, Survivin, Cyclin A2, Eomesodermin, FKHR, MMP-2, NeuroD1, c-Myc, TCF7 (TCF1), TERT, LRP5/LRP6, iNOS, CDC25C, Tcf(Lef), IL-8, CACNA1G, COX-2 (PTGS2), PPCKC, FGF18, WNT, SLUG, Pitx2, SNAIL1, BDNF, MMP-9, PAI1, CDX1, Frizzled",4.072E-09,1.194E-07,32,"BACE1, TCF7L2 (TCF4), Versican, Beta-catenin, ACADL, Cyclin D2, MENA, Survivin, Cyclin A2, Eomesodermin, FKHR, MMP-2, NeuroD1, TCF7 (TCF1), TERT, iNOS, CDC25C, Tcf(Lef), IL-8, CACNA1G, COX-2 (PTGS2), PPCKC, WNT, SLUG, Pitx2, Connexin 43, SNAIL1, BDNF, MMP-9, PAI1, CDX1, Frizzled",
49,Immune response_IFN-gamma signaling via JAK/STAT and PLC-gamma,54,1.997E-10,9.952E-09,3.049E-08,4.472E-07,39,"STIM1, MCM5, JAK1, MVP, BRG1, PKA-reg (cAMP-dependent), IRF1, CBP/P300, CaMK IV, STAT1, Rac1, IP3 receptor, GSK3 beta, TRPC1, SOCS3, CREB1, Fyn, FANCC, c-Src, XAF1, IFNGR1, Pyk2(FAK2), JAK2, CDK8, MEF2A, IBRDC3, IFNGR2, p300, Karyopherin alpha 1, MEF2B, CX3CL1, Calmodulin, SOD3 (EC-SOD), PKC-alpha, PLC-gamma, NOXA, PKA-cat (cAMP-dependent), Aquaporin 1, C/EBPdelta",1.997E-10,9.952E-09,40,"IRF8, STIM1, MCM5, JAK1, MVP, IFN-gamma, BRG1, IRF1, CBP/P300, CaMK IV, STAT1, IP3 receptor, GSK3 beta, TRPC1, SOCS3, CREB1, Fyn, FANCC, c-Src, XAF1, IFNGR1, Pyk2(FAK2), JAK2, CDK8, MEF2A, IBRDC3, IFNGR2, p300, Karyopherin alpha 1, MEF2B, STAT3, CX3CL1, Calmodulin, SOD3 (EC-SOD), PKC-alpha, PLC-gamma, NOXA, PKA-cat (cAMP-dependent), Aquaporin 1, C/EBPdelta",
50,Immune response_TLR2 and TLR4 signaling pathways,69,2.801E-10,1.022E-08,2.801E-10,1.022E-08,50,"TLR1, TLR10, IL-10, ERK1/2, MD-2, MSK1/2 (RPS6KA5/4), VAV-1, Rac1, Ubiquitin, IL-1 beta, I-kB, PI3K reg class IA (p85), IRAK4, CD14, MyD88, IKK-alpha, CREB1, IL-6, MEK1/2, TPL2(MAP3K8), NF-kB, AKT(PKB), UEV1A, TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, iNOS, NF-kB1 (p105), IL-8, TLR6, Lyn, TRAF6, MEK3(MAP2K3), c-Jun, IRAK2, NIK(MAP3K14), p90Rsk, TAB3, MEK4(MAP2K4), COX-2 (PTGS2), AP-1, Pellino 1, Pellino 2, TLR4, IRAK1, TAB1, JNK(MAPK8-10), p38 MAPK, IL-12 beta, TLR2",1.651E-07,2.224E-06,43,"TLR1, TLR10, IL-10, ERK1/2, MD-2, MSK1/2 (RPS6KA5/4), VAV-1, Ubiquitin, IL-1 beta, I-kB, PI3K reg class IA (p85), IRAK4, CD14, CREB1, IL-6, MEK1/2, TPL2(MAP3K8), NF-kB, AKT(PKB), TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, iNOS, NF-kB1 (p105), IL-8, TLR6, Lyn, TRAF6, MEK3(MAP2K3), IRAK2, NIK(MAP3K14), p90Rsk, TAB3, MEK4(MAP2K4), COX-2 (PTGS2), Pellino 1, Pellino 2, TLR4, IRAK1, JNK(MAPK8-10), p38 MAPK, IL-12 beta, TLR2",
51,Development_Positive regulation of WNT/Beta-catenin signaling in the nucleus,69,2.801E-10,1.022E-08,2.801E-10,1.022E-08,50,"Casein kinase II, alpha chains, SMYD2, CBP, DP1, Lef-1, TCF7L2 (TCF4), Jade-1, Beta-catenin, BCL9/B9L, FOXK1, TLE, CBP/P300, Dsh, UBR5, GSK3 beta, NRARP, HDAC2, UCHL5, PCAF, RUNX, FOXK2, ICAT, TBLR1, SOX4, ERK2 (MAPK1), SOX9, TCF7 (TCF1), TERT, JRK, LRP5/LRP6, Tcf(Lef), XIAP, FOXM1, Pin1, BARX2, p300, NCOA2 (GRIP1/TIF2), FAM53B, DLL4, Cul1/Rbx1 E3 ligase, Kindlin-2, CARF, FHL2, WNT, FOXO3A, HMGB2, HDAC1, APPL, LRRFIP2, Frizzled",4.412E-08,7.947E-07,44,"Casein kinase II, alpha chains, SMYD2, CBP, DP1, TCF7L2 (TCF4), Jade-1, Beta-catenin, BCL9/B9L, FOXK1, TLE, CBP/P300, Dsh, UBR5, YAP1 (YAp65), GSK3 beta, NRARP, HDAC2, PCAF, RUNX, FOXK2, ICAT, TBLR1, SOX4, ERK2 (MAPK1), SOX9, TCF7 (TCF1), TERT, JRK, Tcf(Lef), XIAP, FOXM1, Pin1, BARX2, p300, NCOA2 (GRIP1/TIF2), Cul1/Rbx1 E3 ligase, Kindlin-2, FHL2, WNT, HMGB2, HDAC1, APPL, LRRFIP2, Frizzled",
52,"Signal transduction_Angiotensin II/ AGTR1 signaling via p38, ERK and PI3K",98,2.999E-10,1.068E-08,2.999E-10,1.068E-08,65,"RECK, ERK5 (MAPK7), CCL2, eIF4E, ERK1/2, MEF2C, HB-EGF, PKC-zeta, EGR1, HDAC4, Angiotensin II, PI3K cat class IB (p110-gamma), p47-phox, Syk, Shc, FKHR, cPLA2, MAP2K5 (MEK5), MMP-2, CMYA3, PDGF-C, CREB1, IL-6, MEK1/2, G-protein beta/gamma, PPARGC1 (PGC1-alpha), Fyn, AKT(PKB), Catalase, OSF-2, c-Src, PDGF-D, MEKK4(MAP3K4), Pyk2(FAK2), Osteopontin, PI3K cat class IA, PI3K reg class IA (p85-alpha), PKC-delta, KLF5, ETS1, EGFR, SP3, PDGF-A, MEF2A, SOS, MNK1, PLD2, CaMK II delta, COX-2 (PTGS2), ELAVL1 (HuR), 4E-BP1, p130CAS, Calmodulin, SOD3 (EC-SOD), WISP1, TLR4, MMP-14, G-protein alpha-q, ADAM17, p38 MAPK, Elk-1, PAI1, PKA-cat (cAMP-dependent), PDGF-R-beta, ATP7A",1.685E-09,5.997E-08,60,"RECK, ERK5 (MAPK7), CCL2, ERK1/2, MEF2C, HB-EGF, c-Raf-1, HDAC4, Angiotensin II, PI3K cat class IB (p110-gamma), p47-phox, Syk, Shc, FKHR, cPLA2, MAP2K5 (MEK5), MMP-2, CMYA3, PDGF-C, CREB1, IL-6, MEK1/2, G-protein beta/gamma, PPARGC1 (PGC1-alpha), Fyn, AKT(PKB), Catalase, OSF-2, c-Src, PDGF-D, Pyk2(FAK2), Osteopontin, PI3K cat class IA, PI3K reg class IA (p85-alpha), KLF5, ETS1, EGFR, SP3, PDGF-A, MEF2A, SOS, MNK1, PLD2, CaMK II delta, COX-2 (PTGS2), ELAVL1 (HuR), p130CAS, Calmodulin, ALOX12, SOD3 (EC-SOD), WISP1, TLR4, MMP-14, ADAM17, p38 MAPK, Elk-1, PAI1, PKA-cat (cAMP-dependent), PDGF-R-beta, ATP7A",
53,WNT signaling in gastric cancer,36,3.822E-10,1.330E-08,3.822E-10,1.330E-08,31,"CD44, WNT3A, SFRP2, APC protein, TCF7L2 (TCF4), Beta-catenin, Matrilysin (MMP-7), Dsh, Ubiquitin, GSK3 beta, SIAH1, DKK3, WNT7A, Skp2/TrCP/FBXW, Axin, FBXW11, TNF-alpha, Tcf(Lef), WNT3, WNT10A, CRCM, Cul1/Rbx1 E3 ligase, WNT1, WNT2B, WNT5A, WNT, WNT 8A, WNT10B, WNT2, SFRP1, Frizzled",2.204E-09,7.487E-08,29,"CD44, SFRP2, APC protein, TCF7L2 (TCF4), IFN-gamma, Beta-catenin, Matrilysin (MMP-7), Dsh, Ubiquitin, GSK3 beta, SIAH1, DKK3, WNT7A, Skp2/TrCP/FBXW, Axin, FBXW11, TNF-alpha, Tcf(Lef), WNT3, WNT10A, CRCM, Cul1/Rbx1 E3 ligase, WNT2B, WNT5A, WNT, WNT 8A, WNT2, SFRP1, Frizzled",
54,"Immune response_IL-4-induced regulators of cell growth, survival, differentiation and metabolism",62,3.940E-10,1.339E-08,3.940E-10,1.339E-08,46,"ATP6V1B2, RARbeta, ATP6V0D2, DHA2, MCM5, IL-4R type I, PPAR-alpha, SOCS1, CDC25A, ACADL, ATP6V0A1, STAT1, Filaggrin, EGR2 (Krox20), Bax, CDK4, FKHR, SOCS3, ACADM, FasL(TNFSF6), Osteoprotegerin, AKT(PKB), c-Myc, PPAR-gamma, GFI-1, MMP-13, PLEKHF1, MCM4, IL-4R type II, Cyclin D, CYP2E1, IL4RA, Bcl-6, SK4/IK1, Cathepsin V, CDK2, CDK6, AP-1, Cyclin E, HSD3B1, FOXO3A, MCM6, PERC, STAT5, Cyclin A, LPL",1.308E-09,4.769E-08,43,"ATP6V1B2, RARbeta, ATP6V0D2, DHA2, MCM5, IL-4R type I, PPAR-alpha, SOCS1, CDC25A, ACADL, ATP6V0A1, STAT1, Filaggrin, EGR2 (Krox20), Bax, CDK4, FKHR, SOCS3, ACADM, Osteoprotegerin, AKT(PKB), PPAR-gamma, GFI-1, A-FABP, MMP-13, PLEKHF1, MCM4, IL-4R type II, Cyclin D, IL4RA, Bcl-6, SK4/IK1, Cathepsin V, CDK2, CDK6, STAT3, Cyclin E, HSD3B1, MCM6, PERC, STAT5, Cyclin A, LPL",
55,Development_Endothelial differentiation during embryonic development,51,4.274E-10,1.936E-08,1.942E-09,4.763E-08,39,"TIE2, Ephrin-B receptor 4, NOTCH1 receptor, LYVE-1, BMP4, SOX18, Neuropilin-1, ERK1/2, FOXC2, Beta-catenin, VEGF-A, VEGFR-2, GLI-2, Survivin, PI3K reg class IA, FKHR, PLC-gamma 1, MEK2(MAP2K2), AKT(PKB), RBP-J kappa (CBF1), FOXC1, FOXF1, HEY1, PI3K cat class IA, ETS1, Angiopoietin 1, Angiopoietin 2, Ihh, CSX (Nkx2.5), DLL4, VEGFR-3, PROX1, VEGF-C, PKC, WNT, NOTCH1 precursor, COUP-TFII, SMAD1, Ephrin-B2",4.274E-10,1.936E-08,38,"TIE2, Ephrin-B receptor 4, NOTCH1 receptor, LYVE-1, BMP4, SOX18, Neuropilin-1, ERK1/2, FOXC2, Beta-catenin, VEGF-A, c-Raf-1, VEGFR-2, GLI-2, Survivin, PI3K reg class IA, FKHR, PLC-gamma 1, MEK2(MAP2K2), AKT(PKB), RBP-J kappa (CBF1), FOXC1, FOXF1, MEK1(MAP2K1), PI3K cat class IA, ETS1, Angiopoietin 1, Angiopoietin 2, Ihh, CSX (Nkx2.5), VEGFR-3, PROX1, VEGF-C, PKC, WNT, NOTCH1 precursor, COUP-TFII, Ephrin-B2",
56,Chemotaxis_SDF-1/ CXCR4-induced chemotaxis of immune cells,79,4.342E-10,1.444E-08,4.342E-10,1.444E-08,55,"NCK1, PLD1, alpha-4/beta-1 integrin, ICAM1, ROCK1, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), CRK, LIMK1, VAV-1, PI3K cat class IB (p110-gamma), Rac1, Talin, RAP-1A, Shc, PI3K reg class IA (p85), PLC-beta, PLEKHG2, ZAP70, ITK, MEK1/2, G-protein beta/gamma, CDC42, Fyn, AKT(PKB), SFK, TSAD, CXCR4, BETA-PIX, RhoA, Pyk2(FAK2), ITGB1, JAK2, PI3K cat class IA, VCAM1, Lck, CD45, CALDAG-GEFI, ITGB2, PKA-cat alpha, G-protein alpha-i family, F-Actin cytoskeleton, Csk, JAK3, Paxillin, 4E-BP1, p130CAS, PAK, Vinculin, CD3, CD3 zeta, PI3K reg class IB (p101), PLC-gamma 2, Cofilin",3.133E-06,2.149E-05,45,"NCK1, PLD1, alpha-4/beta-1 integrin, ICAM1, ROCK1, ERK1/2, CRK, LIMK1, VAV-1, PI3K cat class IB (p110-gamma), Talin, RAP-1A, Shc, PI3K reg class IA (p85), PLC-beta, PLEKHG2, MEK1/2, G-protein beta/gamma, CDC42, Fyn, AKT(PKB), SFK, TSAD, CXCR4, RhoA, Pyk2(FAK2), ITGB1, JAK2, PI3K cat class IA, VCAM1, Lck, CD45, ITGB2, PKA-cat alpha, G-protein alpha-i family, F-Actin cytoskeleton, Csk, JAK3, p130CAS, PAK, Vinculin, CD3, CD3 zeta, PLC-gamma 2, Cofilin",
57,IFN-gamma and Th2 cytokines-induced inflammatory signaling in normal and asthmatic airway epithelium,40,4.411E-10,1.939E-08,5.319E-08,6.979E-07,31,"IP10, ICAM1, CCL2, IL-4R type I, ERK1/2, SOCS1, IRF1, TSLP, Fibronectin, STAT1, IFN-alpha, SOCS3, IL-13, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, JAK2, I-TAC, IL-8, IL-4R type II, Eotaxin-3, CXCL16, IFN-gamma receptor, IL4RA, CXCR3, ST2(L), IL-2R gamma chain, JNK(MAPK8-10), p38 MAPK, TSLPR",4.411E-10,1.939E-08,32,"MIG, IP10, ICAM1, CCL2, IL-4R type I, IFN-gamma, ERK1/2, SOCS1, IRF1, TSLP, Fibronectin, STAT1, IFN-alpha, SOCS3, IL-6, IL13RA2, NF-kB, Eotaxin, NF-kB p50/p65, JAK2, I-TAC, IL-8, IL-4R type II, Eotaxin-3, CXCL16, IFN-gamma receptor, IL4RA, ST2(L), IL-2R gamma chain, JNK(MAPK8-10), p38 MAPK, TSLPR",
58,Immune response_Immunological synapse formation,55,4.957E-10,1.578E-08,4.957E-10,1.578E-08,42,"MHC class II, NCK1, PLD1, PREL1, alpha-4/beta-1 integrin, ICAM1, CrkL, CD28, VAV-1, Rac1, Talin, RAP-1A, PI3K reg class IA (p85), PKC-theta, NCK2, STK4, ZAP70, PLC-gamma 1, ITK, MHC class I, CDC42, Fyn, Cytohesin1, WaspIP, ITGB1, PI3K cat class IA, VCAM1, Slp76, CALDAG-GEFI, ITGB2, C3G, LAT, GRAP2, SKAP55, Vinculin, PKC-alpha, CD3, c-Abl, FYB1, PDZ-GEF1, WASF2, CD86",6.617E-08,1.064E-06,37,"MHC class II, NCK1, PLD1, PREL1, alpha-4/beta-1 integrin, ICAM1, CrkL, CD28, VAV-1, Talin, RAP-1A, PI3K reg class IA (p85), PKC-theta, NCK2, STK4, PLC-gamma 1, MHC class I, CDC42, Fyn, Cytohesin1, WaspIP, ITGB1, CD80, PI3K cat class IA, VCAM1, Slp76, ITGB2, GRAP2, SKAP55, Vinculin, PKC-alpha, CD3, c-Abl, FYB1, PDZ-GEF1, WASF2, CD86",
59,Development_BMP signaling,33,5.134E-10,1.600E-08,5.134E-10,1.600E-08,29,"SMAD5, CBP, BMP receptor 2, BMP4, SMAD4, BMP6, BMPR1B, Follistatin, CREB1, TAK1(MAP3K7), Cerberus, Gremlin, SMURF1, SMAD7, Ski, SMURF2, XIAP, MEK3(MAP2K3), ALK-2, SMAD9 (SMAD8), p300, Noggin, SMAD6, ATF-2, TAB1, BMPR1A, SMAD1, p38 MAPK, BMP2",4.232E-09,1.217E-07,27,"SMAD5, CBP, BMP receptor 2, BMP4, SMAD4, BMP6, BMPR1B, Follistatin, CREB1, TAK1(MAP3K7), Cerberus, Gremlin, SMURF1, SMAD7, Ski, SMURF2, XIAP, MEK3(MAP2K3), ALK-2, SMAD9 (SMAD8), p300, Noggin, SMAD6, ATF-2, BMPR1A, p38 MAPK, BMP2",
60,Immune response_Role of PKR in stress-induced antiviral cell response,57,6.039E-10,1.844E-08,6.039E-10,1.844E-08,43,"JAK1, IL-10, Tyk2, ERK1/2, IFN-alpha/beta receptor, IRF1, Caspase-8, IFN-beta, STAT1, ATF-2/c-Jun, IL-1 beta, I-kB, MyD88, IKK-alpha, IFN-alpha, Caspase-3, NFKBIB, IL-6, NF-kB, MSK2, NF-kB p50/p65, TNF-R1, c-Myc, TAK1(MAP3K7), BAFF(TNFSF13B), TNF-alpha, RelA (p65 NF-kB subunit), TRAF3, PKR, IL-8, TRAF6, c-Jun, IFN-gamma receptor, MEK4(MAP2K4), PACT, Caspase-7, ATF-2, TLR4, IRF7, JNK(MAPK8-10), TRIF (TICAM1), TLR3, TLR2",6.374E-08,1.047E-06,38,"p38alpha (MAPK14), JAK1, IL-10, Tyk2, IFN-gamma, ERK1/2, IFN-alpha/beta receptor, IRF1, Caspase-8, IFN-beta, STAT1, IL-1 beta, I-kB, IFN-alpha, Caspase-3, NFKBIB, IL-6, NF-kB, MSK2, NF-kB p50/p65, TNF-R1, TAK1(MAP3K7), BAFF(TNFSF13B), TNF-alpha, RelA (p65 NF-kB subunit), TRAF3, PKR, IL-8, TRAF6, IFN-gamma receptor, MEK4(MAP2K4), PACT, ATF-2, TLR4, IRF7, JNK(MAPK8-10), TLR3, TLR2",
61,Immune response_Lysophosphatidic acid signaling via NF-kB,52,8.799E-10,2.531E-08,8.799E-10,2.531E-08,40,"CCL20, ICAM1, CCL2, CARD10, ERK1/2, CYLD, VEGF-A, TSLP, TRIP6, GRO-3, Beta-arrestin2, LPAR2, Bax, Caspase-3, MMP-2, IL-6, NF-kB, NF-kB p50/p65, c-Src, PLC-epsilon, PKD, VCAM1, RelA (p65 NF-kB subunit), ROCK2, LPAR1, PKC-delta, IL-8, TRAF6, CARD10/BCL10/MALT1, MKK7 (MAP2K7), A20, p90Rsk, PRKD2, COX-2 (PTGS2), Caspase-7, PKC, MAP3K3, JNK(MAPK8-10), p38 MAPK, MMP-9",1.101E-09,4.133E-08,38,"CCL20, ICAM1, CCL2, CARD10, ERK1/2, CYLD, VEGF-A, TSLP, TRIP6, GRO-3, Beta-arrestin2, LPAR2, Bax, Caspase-3, MMP-2, IL-6, NF-kB, NF-kB p50/p65, c-Src, PLC-epsilon, PKD, VCAM1, RelA (p65 NF-kB subunit), ROCK2, LPAR1, IL-8, TRAF6, CARD10/BCL10/MALT1, A20, p90Rsk, PRKD2, COX-2 (PTGS2), PKC, MAP3K3, PEA15, JNK(MAPK8-10), p38 MAPK, MMP-9",
62,Stimulation of TGF-beta signaling in lung cancer,48,9.109E-10,3.584E-08,3.447E-09,7.473E-08,37,"Arkadia, TGF-beta 1, EGR1, VEGF-A, SMAD4, SMAD2, Fibronectin, Vimentin, IL-1 beta, I-kB, IKK-alpha, MMP-2, Fyn, AKT(PKB), N-cadherin, TGF-beta 2, ITGB1, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), TGF-beta receptor type II, Ski, IRAKM, TGF-beta, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), Vinculin, SLUG, IRAK1, ACTA2, Tropomyosin-1, SNAIL1, SMAD3, Furin, MMP-9, PAI1, TGF-beta receptor type I, Tropomyosin-2",9.109E-10,3.584E-08,36,"p38alpha (MAPK14), Arkadia, TGF-beta 1, VEGF-A, SMAD4, SMAD2, Fibronectin, Vimentin, IL-1 beta, I-kB, MMP-2, Fyn, AKT(PKB), N-cadherin, TGF-beta 2, ITGB1, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), TGF-beta receptor type II, Ski, IRAKM, TGF-beta, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), Vinculin, SLUG, IRAK1, ACTA2, Tropomyosin-1, SNAIL1, SMAD3, Furin, MMP-9, PAI1, TGF-beta receptor type I, Tropomyosin-2",
63,Role of osteoblasts in bone lesions formation in multiple myeloma,35,9.421E-10,2.647E-08,9.421E-10,2.647E-08,30,"SMAD5, DR5(TNFRSF10B), IL-7, alpha-4/beta-1 integrin, WNT3A, RANKL(TNFSF11), SFRP2, DKK1, Beta-catenin, Apo-2L(TNFSF10), LRP5, TAZ, FasL(TNFSF6), Osteoprotegerin, DR4(TNFRSF10A), TCF7 (TCF1), TNF-alpha, HGF, VCAM1, Osteocalcin, ALPL, RANK(TNFRSF11A), RUNX2, WNT, FasR(CD95), LRP6, SMAD1, BMP2, Frizzled, Collagen I",2.895E-07,3.408E-06,26,"SMAD5, DR5(TNFRSF10B), IL-7, alpha-4/beta-1 integrin, RANKL(TNFSF11), SFRP2, DKK1, Beta-catenin, Apo-2L(TNFSF10), TAZ, Osteoprotegerin, DR4(TNFRSF10A), TCF7 (TCF1), TNF-alpha, HGF, VCAM1, Osteocalcin, ALPL, RANK(TNFRSF11A), RUNX2, WNT, FasR(CD95), LRP6, BMP2, Frizzled, Collagen I",
64,Development_Negative regulation of WNT/Beta-catenin signaling in the cytoplasm,82,9.554E-10,2.647E-08,9.554E-10,2.647E-08,56,"Casein kinase I delta, NOTCH1 receptor, VHL, DP1, NKD1, PP1-cat, RIPK4, APC protein, Laforin, FAF1, Casein kinase I epsilon, Beta-catenin, CYLD, PI3K cat class III (Vps34), Nucleoredoxin, Dsh, Rac1, STK4, SIAH1, Itch, GSK3 alpha/beta, LATS2, G-protein beta/gamma, Skp2/TrCP/FBXW, TAZ, Axin, KCTD1, RACK1, HECTD1, LRP5/LRP6, Prickle-1, c-Cbl, HIPK2, STK3, Tcf(Lef), Amer1, PP2A catalytic, PR72, SENP2, JNK1(MAPK8), A20, Cul1/Rbx1 E3 ligase, YAP1/TAZ, MAP1LC3A, CDK6, ELAVL1 (HuR), WNT5A, PKC-alpha, WNT, Beclin 1, NEDD4L, p53, NKD2, DACT3, Frizzled, DACT1",4.600E-08,8.090E-07,50,"NOTCH1 receptor, VHL, DP1, PP1-cat, RIPK4, APC protein, Laforin, FAF1, Casein kinase I epsilon, Beta-catenin, CYLD, PI3K cat class III (Vps34), Nucleoredoxin, Dsh, YAP1 (YAp65), STK4, SIAH1, Itch, GSK3 alpha/beta, LATS2, G-protein beta/gamma, Skp2/TrCP/FBXW, TAZ, Axin, KCTD1, RACK1, Prickle-1, c-Cbl, HIPK2, STK3, Tcf(Lef), Amer1, PP2A catalytic, PR72, JNK1(MAPK8), A20, Cul1/Rbx1 E3 ligase, YAP1/TAZ, MAP1LC3A, CDK6, ELAVL1 (HuR), WNT5A, PKC-alpha, WNT, NEDD4L, p53, NKD2, DACT3, Frizzled, DACT1",
65,The role of UV radiation in melanoma development,40,1.008E-09,2.741E-08,1.008E-09,2.741E-08,33,"ERK1/2, HB-EGF, XPF, XRCC3, ADAM9, N-Ras, XPG, TGF-alpha, FasL(TNFSF6), NF-kB, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, alpha-MSH, MC1R, p16INK4, TNF-alpha, POMC, PARP-1, B-Raf, EGFR, ASK1 (MAP3K5), c-Jun, MKK7 (MAP2K7), GCK(MAP4K2), MEKK1(MAP3K1), ATF-2, FasR(CD95), JNK(MAPK8-10), ADAM17, p38 MAPK, MITF, XPD",1.571E-05,8.242E-05,26,"ERK1/2, HB-EGF, XPF, ADAM9, N-Ras, XPG, TGF-alpha, NF-kB, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, alpha-MSH, MC1R, p16INK4, TNF-alpha, POMC, B-Raf, EGFR, ASK1 (MAP3K5), GCK(MAP4K2), ATF-2, FasR(CD95), JNK(MAPK8-10), ADAM17, p38 MAPK, MITF",
66,Neurophysiological process_Dynein-dynactin motor complex in axonal transport in neurons,54,1.086E-09,2.851E-08,1.086E-09,2.851E-08,41,"TrkA, CDK5, NudE, ERK1/2, DCTN1(p150Glued), Importin (karyopherin)-alpha, HDAC6, APP, Piccolo, DYNC1I1, Vimentin, Ubiquitin, Hap-1, TMEM108, Centractins, DYNLL, ORP1, Rab-7, Dynein 1, cytoplasmic, heavy chain, DYNLT, PRNP, AKT(PKB), PAFAH alpha (LIS1), MAPRPE1(EB1), DYI2, NT-3, Tubulin (in microtubules), Importin (karyopherin)-beta, TrkC, Sortilin, BPAG1, TrkB, NGF, Rab-5A, RILP (Rab interacting lysosomal protein), Kinesin heavy chain, Bassoon, Kinesin light chain, Dynein 1, cytoplasmic, intermediate chains, BDNF, NUDEL",8.306E-06,4.616E-05,33,"CDK5, NudE, ERK1/2, DCTN1(p150Glued), Importin (karyopherin)-alpha, HDAC6, APP, Piccolo, NEFM, DYNC1I1, Vimentin, Ubiquitin, ORP1, Dynein 1, cytoplasmic, heavy chain, DYNLT, PRNP, AKT(PKB), PAFAH alpha (LIS1), MAPRPE1(EB1), DYI2, Tubulin (in microtubules), Importin (karyopherin)-beta, Sortilin, BPAG1, TrkB, NGF, Rab-5A, RILP (Rab interacting lysosomal protein), Kinesin heavy chain, Kinesin light chain, Dynein 1, cytoplasmic, intermediate chains, BDNF, NUDEL",
67,Immune response_HSP60 and HSP70/ TLR signaling pathway,54,1.086E-09,2.851E-08,1.086E-09,2.851E-08,41,"MHC class II, ICAM1, IL-10, ERK1/2, MD-2, Ubiquitin, IL-1 beta, I-kB, IRAK4, CD14, MyD88, IKK-alpha, MHC class I, IL-6, MEK1/2, TPL2(MAP3K8), CD83, NF-kB, UEV1A, HSP70, TAK1(MAP3K7), TNF-alpha, iNOS, NF-kB1 (p105), IL-8, TRAF6, MEK3(MAP2K3), c-Jun, TAB3, MEK4(MAP2K4), CD69, AP-1, UBE1, TLR4, TAB1, IRAK1/2, JNK(MAPK8-10), p38 MAPK, IL-12 beta, CD86, TLR2",5.950E-07,5.630E-06,35,"MHC class II, ICAM1, IL-10, ERK1/2, MD-2, Ubiquitin, IL-1 beta, I-kB, IRAK4, CD14, MHC class I, IL-6, MEK1/2, TPL2(MAP3K8), CD83, NF-kB, HSP70, TAK1(MAP3K7), TNF-alpha, CD80, iNOS, NF-kB1 (p105), IL-8, TRAF6, MEK3(MAP2K3), TAB3, MEK4(MAP2K4), CD69, TLR4, IRAK1/2, JNK(MAPK8-10), p38 MAPK, IL-12 beta, CD86, TLR2",
68,DNA damage_ATM/ATR regulation of G1/S checkpoint,32,1.106E-09,3.330E-08,1.291E-09,3.330E-08,28,"NFBD1, SMC1, BLM, GADD45 beta, CDC25A, FANCL, Ubiquitin, I-kB, Chk1, CDK4, FANCD2, GADD45 alpha, NF-kB, Bard1, c-Myc, Nibrin, Brca1, Cyclin D, ATR, RAD9, CDK2, PCNA, Cyclin E, ATM, Cyclin A, p53, Claspin, USP1",1.106E-09,4.133E-08,27,"NFBD1, SMC1, BLM, GADD45 beta, CDC25A, FANCL, Ubiquitin, I-kB, Chk1, CDK4, FANCD2, GADD45 alpha, NF-kB, Bard1, Chk2, Brca1, Cyclin D, ATR, RAD9, CDK2, PCNA, Cyclin E, ATM, Cyclin A, p53, Claspin, USP1",
69,Immune response_IL-6 signaling pathway via JAK/STAT,71,1.439E-09,3.648E-08,1.439E-09,3.648E-08,50,"CBP, JAK1, ICAM1, CCL2, RANKL(TNFSF11), Tyk2, IRS-1, Mucin 13, SOCS1, VEGF-A, Rac2, IRF1, TEC, VAV-1, STAT1, Rac1, CDK4, FKHR, p19, SOCS3, IL-6, Mucin 4, AKT(PKB), ICOS, ADAM10, Mcl-1, JAK2, iNOS, PKC-delta, Osteocalcin, C/EBPbeta, c-Jun, ALPL, p300, JAK3, MEK4(MAP2K4), CDK2, CDK6, COX-2 (PTGS2), p18, AP-1, RUNX2, MEKK1(MAP3K1), SHP-2, FOXO3A, STAT5, RacGAP1, ADAM17, mTOR, C/EBPdelta",5.224E-07,5.172E-06,43,"CBP, JAK1, ICAM1, CCL2, RANKL(TNFSF11), Tyk2, Mucin 13, SOCS1, VEGF-A, Rac2, IRF1, TEC, VAV-1, STAT1, CDK4, FKHR, p19, SOCS3, IL-6, Mucin 4, AKT(PKB), ADAM10, Mcl-1, JAK2, iNOS, Osteocalcin, C/EBPbeta, ALPL, p300, JAK3, MEK4(MAP2K4), CDK2, CDK6, STAT3, COX-2 (PTGS2), p18, RUNX2, STAT5, RacGAP1, IL-21, ADAM17, mTOR, C/EBPdelta",
70,Signal transduction_NF-kB activation pathways,51,1.942E-09,4.763E-08,1.942E-09,4.763E-08,39,"IL-1 alpha, Ubiquitin, IL-1 beta, I-kB, NF-kB2 (p100), IRAK4, MyD88, IKK-alpha, c-IAP1, NF-kB p52/RelB, RIPK1, NF-kB, NF-kB p50/p65, TNF-R1, ZFP91, TAK1(MAP3K7), BAFF(TNFSF13B), TNF-alpha, c-IAP2, RelA (p65 NF-kB subunit), NF-kB1 (p105), TRAF3, NF-kB1 (p50), SUMO-1, NF-kB2 (p52), BAFF-R, TRAF6, IRAK2, RelB (NF-kB subunit), NIK(MAP3K14), Cul1/Rbx1 E3 ligase, TAB3, Pellino 1, Pellino 2, MALT1, TLR4, IRAK1, TAB1, TLR2",1.394E-08,3.261E-07,36,"IL-1 alpha, Ubiquitin, IL-1 beta, I-kB, NF-kB2 (p100), IRAK4, c-IAP1, NF-kB p52/RelB, RIPK1, NF-kB, NF-kB p50/p65, TNF-R1, ZFP91, TAK1(MAP3K7), BAFF(TNFSF13B), TNF-alpha, c-IAP2, RelA (p65 NF-kB subunit), NF-kB1 (p105), TRAF3, NF-kB1 (p50), SUMO-1, NF-kB2 (p52), BAFF-R, TRAF6, IRAK2, RelB (NF-kB subunit), NIK(MAP3K14), Cul1/Rbx1 E3 ligase, TAB3, Pellino 1, Pellino 2, MALT1, TLR4, IRAK1, TLR2",
71,Development_Negative regulation of STK3/4 (Hippo) pathway and positive regulation of YAP/TAZ function,62,2.019E-09,4.871E-08,2.019E-09,4.871E-08,45,"TGF-beta 1, LPAR3, CD44, LARG, ERK1/2, ARHGEF1 (p115RhoGEF), G-protein alpha-q/11, Angiotensin II, ZO-2, LPAR2, MLCP (reg), ARHGEF2, Nephrocystin-4, Thrombin, FRMD4A, STK4, Itch, LATS2, Actin cytoskeletal, TAZ, PJA2, MLCP (cat), RhoA, G-protein alpha-12 family, PARD3, Citron, LPAR1, HIPK2, LIMD1, STK3, EGFR, ASPP2, RASSF6, RhoGAP5, S1P2 receptor, NEDD4, MOBKL1A, WW45, PDZ-RhoGEF, Schwannomin (NF2), WTIP, Mol1b, JNK(MAPK8-10), PAR1, Angiomotin (AMOT)",1.130E-07,1.706E-06,40,"TGF-beta 1, LPAR3, CD44, ERK1/2, ARHGEF1 (p115RhoGEF), G-protein alpha-q/11, Angiotensin II, YAP1 (YAp65), ZO-2, LPAR2, MLCP (reg), ARHGEF2, Nephrocystin-4, FRMD4A, STK4, Itch, LATS2, Actin cytoskeletal, TAZ, MLCP (cat), RhoA, G-protein alpha-12 family, PARD3, Citron, LPAR1, HIPK2, STK3, EGFR, ASPP2, RhoGAP5, S1P2 receptor, MOBKL1A, WW45, PDZ-RhoGEF, Schwannomin (NF2), WTIP, Mol1b, JNK(MAPK8-10), PAR1, Angiomotin (AMOT)",
72,"Immune response_IL-3 signaling via JAK/STAT, p38, JNK and NF-kB",93,2.059E-09,4.889E-08,2.059E-09,4.889E-08,61,"STAT5A, MHC class II, DHA2, Cyclin D3, JAK1, ICAM1, Tyk2, SOCS1, ID1, Fibronectin, Pim-1, SPECC1, STAT1, Rac1, BAD, Cyclin D2, I-kB, SRP9, Survivin, Cyclin A2, IKK-alpha, SOCS3, IL-6, NOTCH4, IL3RA, NF-kB, AKT(PKB), NF-kB p50/p65, Cyclin B1, c-Src, c-Myc, Mcl-1, P-selectin, IL-2R alpha chain, C3aR, PKM2, Ephrin-B1, ARNT, ITGB1, JAK2, PI3K cat class IA, C/EBPbeta, Lyn, TRAF6, MEK3(MAP2K3), 14-3-3 gamma, Bcl-6, MKK7 (MAP2K7), JNK1(MAPK8), JAK3, MEK4(MAP2K4), CD69, NOTCH1 precursor, KSR1, Oncostatin M, TACI(TNFRSF13B), STAT5, HDAC1, Ephrin-B2, p38 MAPK, BMP2",4.183E-07,4.373E-06,53,"STAT5A, MHC class II, DHA2, JAK1, ICAM1, Tyk2, SOCS1, ID1, Fibronectin, Pim-1, SPECC1, STAT1, Cyclin D2, I-kB, SRP9, Survivin, Cyclin A2, SOCS3, IL-6, NOTCH4, IL3RA, NF-kB, AKT(PKB), NF-kB p50/p65, Cyclin B1, c-Src, Mcl-1, P-selectin, PKM2, Ephrin-B1, ITGB1, JAK2, PI3K cat class IA, C/EBPbeta, Lyn, TRAF6, MEK3(MAP2K3), 14-3-3 gamma, Bcl-6, JNK1(MAPK8), JAK3, MEK4(MAP2K4), CD69, STAT3, NOTCH1 precursor, KSR1, Oncostatin M, TACI(TNFRSF13B), STAT5, HDAC1, Ephrin-B2, p38 MAPK, BMP2",
73,TGF-beta signaling via SMADs in breast cancer,47,2.172E-09,7.487E-08,4.340E-08,5.902E-07,35,"TGF-beta 1, NOX4, CD44, ATF-3, ITGB5, VEGF-A, SMAD4, SMAD2, GLI-2, CXADR, Cyclin A1, CD44 soluble, TWIST1, TGF-beta 2, MMP-13, IL-8, ETS1, TGF-beta receptor type II, Ihh, FOXQ1 (HFH1), RUNX2, SLUG, Fascin, MMP-14, PTHrP, HMGA2, JNK2(MAPK9), SNAIL1, SMAD3, CTGF, p53, MMP-9, PAI1, IL-11, TGF-beta receptor type I",2.172E-09,7.487E-08,35,"TGF-beta 1, NOX4, CD44, ATF-3, VEGF-A, SMAD4, SMAD2, GLI-2, CXADR, Cyclin A1, CD44 soluble, TWIST1, TGF-beta 2, MMP-13, IL-8, ETS1, TGF-beta receptor type II, Ihh, FOXQ1 (HFH1), MTS1 (S100A4), RUNX2, SLUG, Fascin, MMP-14, PTHrP, HMGA2, JNK2(MAPK9), SNAIL1, SMAD3, CTGF, p53, MMP-9, PAI1, IL-11, TGF-beta receptor type I",
74,CHDI_Correlations from Replication data_Cytoskeleton and adhesion module,64,2.256E-09,5.273E-08,2.256E-09,5.273E-08,46,"MHC class II, ICAM1, CrkL, Alpha-actinin, Fibronectin, VAV-1, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, Plasminogen, Talin, RAP-1A, MLCP (reg), ZAP70, PLC-gamma 1, alpha-V/beta-3 integrin, G-protein beta/gamma, PLAUR (uPAR), CDC42, Actin cytoskeletal, Fyn, AKT(PKB), Collagen IV, Cytohesin1, CXCR4, MLCP (cat), RhoA, Slp76, CALDAG-GEFI, ITGB2, c-Cbl, Laminin 1, Plasmin, C3G, MyHC, Intersectin, PLAU (UPA), Paxillin, ROCK, Vinculin, CD3, Ephrin-B, MRLC, MELC, PI3K reg class IB (p101), Ephrin-B receptors",4.691E-06,2.851E-05,38,"MHC class II, ICAM1, CrkL, Alpha-actinin, Fibronectin, VAV-1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, MLCP (reg), PLC-gamma 1, alpha-V/beta-3 integrin, G-protein beta/gamma, PLAUR (uPAR), CDC42, Actin cytoskeletal, Fyn, AKT(PKB), Collagen IV, Cytohesin1, CXCR4, MLCP (cat), RhoA, Slp76, ITGB2, c-Cbl, Laminin 1, MyHC, Intersectin, PLAU (UPA), ROCK, Vinculin, CD3, Ephrin-B, MRLC, MELC, Ephrin-B receptors",
75,Apoptosis and survival_Role of PKR in stress-induced apoptosis,53,2.368E-09,5.319E-08,2.368E-09,5.319E-08,40,"TRAM, C/EBP zeta, JAK1, Tyk2, ATF-3, eIF4E, ERK1/2, ATF-4, PP2A regulatory, IFN-alpha/beta receptor, IRF1, Caspase-8, IFN-beta, I-kB, IKK-alpha, IFN-alpha, NFAT-90, Caspase-3, NFKBIB, FasL(TNFSF6), NF-kB, MSK2, NF-kB p50/p65, TNF-R1, c-Myc, TAK1(MAP3K7), TNF-alpha, TRAF3, PKR, TRAF6, IFN-gamma receptor, PP2A catalytic, PACT, 4E-BP1, Caspase-7, TLR4, FasR(CD95), TRIF (TICAM1), p53, TLR3",4.642E-06,2.832E-05,33,"TRAM, C/EBP zeta, JAK1, Tyk2, ATF-3, IFN-gamma, ERK1/2, PP2A regulatory, IFN-alpha/beta receptor, IRF1, Caspase-8, IFN-beta, I-kB, IFN-alpha, NFAT-90, Caspase-3, NFKBIB, NF-kB, MSK2, NF-kB p50/p65, TNF-R1, TAK1(MAP3K7), TNF-alpha, TRAF3, PKR, TRAF6, IFN-gamma receptor, PP2A catalytic, PACT, TLR4, FasR(CD95), p53, TLR3",
76,Immune response_HMGB1/RAGE signaling pathway,53,2.368E-09,5.319E-08,2.368E-09,5.319E-08,40,"IL-1 alpha, HMGB1, ICAM1, ERK1/2, MEF2C, p90RSK2(RPS6KA3), IL1RN, Rac1, IL-1 beta, I-kB, PI3K reg class IA (p85), PLAT (TPA), DIA1, NFKBIB, CREB1, IL-6, MEK1/2, CDC42, NF-kB, AKT(PKB), c-Src, Secretogranin II, TNF-alpha, Chromogranin A, PI3K cat class IA, VCAM1, PI3K reg class IA (p85-alpha), iNOS, IL-8, c-Jun, MEF2A, Tissue factor, Paxillin, RAGE, Secretogranin 1, TLR4, JNK(MAPK8-10), p38 MAPK, PAI1, TLR2",2.698E-09,8.582E-08,38,"IL-1 alpha, HMGB1, ICAM1, ERK1/2, MEF2C, p90RSK2(RPS6KA3), c-Raf-1, IL1RN, IL-1 beta, I-kB, PI3K reg class IA (p85), PLAT (TPA), DIA1, NFKBIB, CREB1, IL-6, MEK1/2, CDC42, NF-kB, AKT(PKB), c-Src, Secretogranin II, TNF-alpha, PI3K cat class IA, VCAM1, PI3K reg class IA (p85-alpha), iNOS, IL-8, MEF2A, p90RSK1, Tissue factor, RAGE, Secretogranin 1, TLR4, JNK(MAPK8-10), p38 MAPK, PAI1, TLR2",
77,Development_BMP7 in brown adipocyte differentiation,39,2.382E-09,5.319E-08,2.382E-09,5.319E-08,32,"NRF1, BMP receptor 2, PPAR-alpha, OTOP1, COL5A1, UCP1, Resistin, DIO2, PPARGC1 (PGC1-alpha), CtBP, PPAR-gamma, TAK1(MAP3K7), CIDE-A, TrkC, SERPINA3 (ACT), XIAP, WNT10A, TFAM, MEL1, Annexin I, PSAT, ENDOD1, EVA1, CtBP2, ATF-2, TAB1, PERC, Angiotensinogen, BMPR1A, CtBP1, EDNRA, Necdin",1.706E-06,1.226E-05,27,"p38alpha (MAPK14), NRF1, BMP receptor 2, PPAR-alpha, OTOP1, COL5A1, UCP1, DIO2, PPARGC1 (PGC1-alpha), CtBP, PPAR-gamma, TAK1(MAP3K7), DLK, CIDE-A, SERPINA3 (ACT), XIAP, WNT10A, Annexin I, PSAT, ENDOD1, EVA1, CtBP2, ATF-2, PERC, Angiotensinogen, BMPR1A, EDNRA",
78,Breakdown of CD4+ T cell peripheral tolerance in type 1 diabetes mellitus,49,2.382E-09,7.915E-08,1.090E-06,8.402E-06,34,"RAG1, MHC class II, JAK1, CD28, HLA-DQB1, PTPN22, HLA-DQA1, STAT4, ZAP70, CD4, CTLA-4, NF-kB, IL-23, ICOS, IL-2R alpha chain, IL-2, HLA-DRB1, IL-12 receptor, Lck, T-bet, PTPN2, Bcl-6, LAT, JAK3, NF-AT, AP-1, CD3, STAT5, Ku70, PD-1, c-FLIP, IL-12 beta, CD86, PD-L1",2.382E-09,7.915E-08,36,"RAG1, MHC class II, JAK1, IFN-gamma, CXCR5, CD28, HLA-DQB1, IL-17, PTPN22, HLA-DQA1, RAG2, STAT4, CD4, CTLA-4, NF-kB, IL-23, IL-2, CD40L(TNFSF5), HLA-DRB1, CD80, IL-12 receptor, Lck, T-bet, PTPN2, Bcl-6, JAK3, NF-AT, CD3, STAT5, Ku70, PD-1, c-FLIP, IL-21, IL-12 beta, CD86, PD-L1",
79,SLE genetic marker-specific pathways in T cells,101,2.654E-09,8.582E-08,1.911E-07,2.013E-06,61,"OX40L(TNFSF4), MHC class II, Calcineurin A (catalytic), TCR beta subunit, RUNX3, NF-AT1(NFATC2), IL-10, Tyk2, UBCH7, ERK1/2, OX40(TNFRSF4), PTPN22, IFN-alpha/beta receptor, IFN-beta, VAV-1, Rac1, Ubiquitin, I-kB, NF-AT4(NFATC3), PKC-theta, STAT4, ZAP70, IKK-alpha, IFN-alpha, PLC-gamma 1, RFP, MEK1/2, IL-10 receptor, NF-kB, IL-23, TMEM39A, MHC class II beta chain, MICB, NF-AT2(NFATC1), IL-2, Calcineurin A (alpha), HLA-DRB1, TNIP1, IL-12 receptor, Ikaros, Lck, Slp76, MeCP2, ETS1, T-bet, SOS, NIK(MAP3K14), Csk, LAT, KLRK1 (NKG2D), A20, Calmodulin, CalDAG-GEFIII, CD3, HLA-DRB, CD3 zeta, OR2H2, PD-1, DNMT1, IL-12 beta, Lnk",2.654E-09,8.582E-08,61,"OX40L(TNFSF4), MHC class II, Calcineurin A (catalytic), TCR beta subunit, RUNX3, IL-10, Tyk2, IFN-gamma, UBCH7, ERK1/2, OX40(TNFRSF4), IL-17, c-Raf-1, PTPN22, IFN-alpha/beta receptor, IFN-beta, VAV-1, Ubiquitin, I-kB, NF-AT4(NFATC3), HSD17B2, PKC-theta, STAT4, IFN-alpha, PLC-gamma 1, RFP, MEK1/2, IL-10 receptor, NF-kB, IL-23, TMEM39A, MHC class II beta chain, MICB, NF-AT2(NFATC1), IL-2, CD40L(TNFSF5), Calcineurin A (alpha), HLA-DRB1, TNIP1, IL-12 receptor, Lck, Slp76, MeCP2, ETS1, T-bet, SOS, NIK(MAP3K14), Csk, KLRK1 (NKG2D), A20, STAT3, Calmodulin, CalDAG-GEFIII, CD3, HLA-DRB, CD3 zeta, OR2H2, PD-1, DNMT1, IL-12 beta, Lnk",
80,TNF-alpha and IL-1 beta-mediated regulation of contraction and secretion of inflammatory factors in normal and asthmatic airway smooth muscle,65,2.797E-09,8.712E-08,2.219E-08,3.570E-07,45,"GRO-2, CCL2, gp91-phox, ERK1/2, HDAC4, GRO-3, p47-phox, IL-1 beta, PI3K reg class IA (p85), GRO-1, PLC-beta, MyD88, PCAF, GM-CSF, Ca-ATPase2, IL-6, PA24A, NF-kB, Eotaxin, AKT(PKB), NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, RhoA, VCAM1, RelA (p65 NF-kB subunit), Cytochrome b-558, CD38, IL-8, EGFR, c-Jun, PGES, p300, PKC-beta2, CCL7, COX-2 (PTGS2), Calmodulin, TRPC3, PKC-alpha, JNK(MAPK8-10), PLA2, p38 MAPK, MMP-9, PDGF-R-beta",2.797E-09,8.712E-08,44,"GRO-2, p38alpha (MAPK14), CCL2, gp91-phox, ERK1/2, HDAC4, GRO-3, p47-phox, IL-1 beta, PI3K reg class IA (p85), GRO-1, PLC-beta, PCAF, GM-CSF, Ca-ATPase2, IL-6, PA24A, NF-kB, Eotaxin, AKT(PKB), NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, RhoA, VCAM1, RelA (p65 NF-kB subunit), Cytochrome b-558, CD38, IL-8, EGFR, PGES, p300, PKC-beta2, CCL7, COX-2 (PTGS2), Calmodulin, TRPC3, PKC-alpha, JNK(MAPK8-10), PLA2, p38 MAPK, MMP-9, PDGF-R-beta",
81,Cell adhesion_ECM remodeling,55,2.816E-09,6.196E-08,2.816E-09,6.196E-08,41,"Laminin 5, CD44, SERPINE2, Caveolin-2, Versican, HB-EGF, Matrilysin (MMP-7), Fibronectin, Nidogen, Plasminogen, PLAT (TPA), MSN (moesin), IGF-2, MMP-2, PLAUR (uPAR), Actin cytoskeletal, Collagen IV, TIMP2, Stromelysin-1, MMP-13, IL-8, EGFR, Laminin 1, alpha-5/beta-1 integrin, ErbB4, alpha-1/beta-1 integrin, Plasmin, Flotillin-2, LAMA4, PLAU (UPA), TIMP1, Collagen III, MMP-16, MMP-14, MMP-10, Kallikrein 1, Osteonectin, MMP-9, PAI1, Syndecan-2, Collagen I",1.418E-08,3.261E-07,38,"Laminin 5, CD44, SERPINE2, Caveolin-2, Versican, HB-EGF, Matrilysin (MMP-7), Fibronectin, Nidogen, PLAT (TPA), MSN (moesin), IGF-2, MMP-2, PLAUR (uPAR), Actin cytoskeletal, Collagen IV, TIMP2, Stromelysin-1, MMP-13, IL-8, EGFR, Laminin 1, alpha-5/beta-1 integrin, ErbB4, alpha-1/beta-1 integrin, Flotillin-2, LAMA4, PLAU (UPA), TIMP1, Collagen III, MMP-16, MMP-14, MMP-10, Osteonectin, MMP-9, PAI1, Syndecan-2, Collagen I",
82,Apoptotic pathways and resistance to apoptosis in lung cancer cells,57,2.863E-09,8.736E-08,1.232E-06,8.896E-06,38,"DR5(TNFRSF10B), FGFR2, Apaf-1, ERK1/2, Caspase-4, CYLD, BFL1, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, PKC-epsilon, BAD, Bax, Survivin, c-IAP1, Caspase-3, RIPK1, MEK2(MAP2K2), FasL(TNFSF6), NF-kB, DR4(TNFRSF10A), TNF-R1, Caspase-1, Mcl-1, TNF-alpha, c-IAP2, B-Raf, DAPK1, XIAP, FGF2, Caspase-9, Caspase-10, PKC-alpha, tBid, FasR(CD95), HDAC1, p53, Bid",2.863E-09,8.736E-08,40,"DR5(TNFRSF10B), FGFR2, Apaf-1, miR-221-3p, ERK1/2, Caspase-4, CYLD, BFL1, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, PKC-epsilon, Bax, Survivin, c-IAP1, Caspase-3, RIPK1, MEK2(MAP2K2), NF-kB, DR4(TNFRSF10A), TNF-R1, Caspase-1, Mcl-1, TNF-alpha, MEK1(MAP2K1), c-IAP2, B-Raf, DAPK1, XIAP, FGF2, Caspase-9, Caspase-10, PKC-alpha, microRNA 221, PEA15, tBid, FasR(CD95), HDAC1, p53, Bid",
83,"Development_The role of GDNF ligand family/ RET receptor in cell survival, growth and proliferation",92,3.887E-09,8.308E-08,3.887E-09,8.308E-08,60,"NCK1, IRS-1, ATF-1, ERK1/2, GFRalpha3, EGR1, VEGF-A, p90RSK2(RPS6KA3), CRK, IRS5(DOK4), SHANK3, LIMK1, IL-22, Rac1, IP3 receptor, RAP-1A, Shc, PI3K reg class IA (p85), MLC2, CREM (activators), Cyclin A2, GFRalpha4, IKK-alpha, PLC-gamma 1, alpha-V/beta-3 integrin, N-Ras, CREB1, MEK1/2, DOK1, CDC42, NF-kB, AKT(PKB), c-Src, GAB2, RhoA, ITGB1, PI3K cat class IA, NRTN, B-Raf, HIF1A, XIAP, F-Actin cytoskeleton, c-Jun, SOS, C3G, JNK1(MAPK8), Paxillin, MEK4(MAP2K4), CDK2, GDNF, ROCK, Calmodulin, MEKK1(MAP3K1), SHP-2, CaMK II alpha, JNK2(MAPK9), c-FLIP, ARTN, Elk-1, Cofilin",7.619E-07,6.614E-06,52,"p38alpha (MAPK14), NCK1, ATF-1, ERK1/2, GFRalpha3, VEGF-A, p90RSK2(RPS6KA3), CRK, c-Raf-1, SHANK3, LIMK1, IL-22, IP3 receptor, RAP-1A, Shc, PI3K reg class IA (p85), MLC2, CREM (activators), Cyclin A2, PLC-gamma 1, alpha-V/beta-3 integrin, N-Ras, CREB1, MEK1/2, DOK1, CDC42, NF-kB, AKT(PKB), c-Src, GAB2, RhoA, ITGB1, PI3K cat class IA, NRTN, B-Raf, HIF1A, XIAP, F-Actin cytoskeleton, SOS, JNK1(MAPK8), MEK4(MAP2K4), CDK2, STAT3, GDNF, ROCK, Calmodulin, CaMK II alpha, JNK2(MAPK9), c-FLIP, ARTN, Elk-1, Cofilin",
84,Role of Tissue factor-induced Thrombin signaling in cancerogenesis,65,5.089E-09,1.057E-07,5.089E-09,1.057E-07,46,"PAR2, LARG, ERK1/2, VEGF-A, Coagulation factor X, G-protein alpha-q/11, IP3 receptor, MLCP (reg), GRO-1, Thrombin, IKK-alpha, MEK2(MAP2K2), MMP-2, Actin cytoskeletal, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, c-Src, P-selectin, MLCK, MLCP (cat), RhoA, G-protein alpha-12 family, RelA (p65 NF-kB subunit), MMP-13, PI3K reg class IA (p85-alpha), IL-8, EGFR, G-protein alpha-i family, c-Jun, Angiopoietin 1, Tissue factor, Coagulation factor V, alpha-V/beta-5 integrin, Paxillin, ROCK, PAR3, PI3K cat class IA (p110-alpha), Calmodulin, Fibrinogen alpha, PKC-alpha, MRLC, PAR1, MELC, Fibrinogen (fibrin), PLC-beta3",1.976E-07,2.546E-06,41,"PAR2, ERK1/2, VEGF-A, Coagulation factor X, c-Raf-1, G-protein alpha-q/11, IP3 receptor, MLCP (reg), GRO-1, MEK2(MAP2K2), MMP-2, Actin cytoskeletal, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, c-Src, P-selectin, MLCK, MLCP (cat), MEK1(MAP2K1), RhoA, G-protein alpha-12 family, RelA (p65 NF-kB subunit), MMP-13, PI3K reg class IA (p85-alpha), IL-8, EGFR, G-protein alpha-i family, Angiopoietin 1, Tissue factor, Coagulation factor V, ROCK, PAR3, PI3K cat class IA (p110-alpha), Calmodulin, Fibrinogen alpha, PKC-alpha, MRLC, PAR1, MELC, PLC-beta3",
85,DNA damage_ATM / ATR regulation of G2 / M checkpoint,28,5.143E-09,1.424E-07,4.503E-07,4.159E-06,23,"NFBD1, Cyclin B, Cyclin B2, BLM, GADD45 beta, FANCL, CDK1 (p34), Ubiquitin, Chk1, FANCD2, GADD45 alpha, Cyclin B1, PLK3 (CNK), Brca1, CDC25C, CDC25B, ATR, RAD9, ATM, Kinase MYT1, Cyclin A, p53, Claspin",5.143E-09,1.424E-07,24,"p38alpha (MAPK14), NFBD1, Cyclin B, Cyclin B2, BLM, GADD45 beta, FANCL, CDK1 (p34), Ubiquitin, Chk1, FANCD2, GADD45 alpha, Cyclin B1, PLK3 (CNK), Chk2, Brca1, CDC25C, CDC25B, ATR, RAD9, ATM, Cyclin A, p53, Claspin",
86,Immune response_CCL2 signaling,54,6.028E-09,1.219E-07,6.028E-09,1.219E-07,40,"VE-cadherin, IL-1 alpha, alpha-4/beta-1 integrin, ICAM1, CCL2, ERK1/2, PI3K class II (CII-alpha), PKC-zeta, VEGF-A, DARC, p47-phox, Rac1, ZO-2, IL-1 beta, PI3K reg class IA (p85), MMP-2, IL-6, G-protein beta/gamma, CDC42, Actin cytoskeletal, NF-kB, CDH19, TNF-alpha, RhoA, MCPIP, iNOS, HIF1A, ITGB3, ETS1, G-protein alpha-i family, ZO-1, c-Jun, alpha-5/beta-1 integrin, PI3K cat class IA (p110-delta), AP-1, PKC-alpha, MMP-14, Caveolin-1, CCBP2 (CCR9), p53",3.119E-08,6.088E-07,37,"VE-cadherin, IL-1 alpha, alpha-4/beta-1 integrin, ICAM1, CCL2, IFN-gamma, ERK1/2, PI3K class II (CII-alpha), VEGF-A, DARC, p47-phox, ZO-2, IL-1 beta, PI3K reg class IA (p85), MMP-2, IL-6, G-protein beta/gamma, CDC42, Actin cytoskeletal, NF-kB, CDH19, TNF-alpha, RhoA, MCPIP, iNOS, HIF1A, ITGB3, ETS1, G-protein alpha-i family, ZO-1, alpha-5/beta-1 integrin, PI3K cat class IA (p110-delta), PKC-alpha, MMP-14, Caveolin-1, CCBP2 (CCR9), p53",
87,Th17 cells in CF,54,6.317E-09,1.657E-07,2.840E-05,1.210E-04,34,"TGF-beta 1, MHC class II, CCL20, JAK1, ICAM1, ERK1/2, MD-2, CD28, SMAD2, IL-17 receptor, IL-1 beta, GRO-1, CD14, MyD88, IL-17F, GM-CSF, CD4, IL-6, NF-kB, IL-23, JAK2, VCAM1, LBP, IL-8, TGF-beta receptor type II, IRF4, JAK3, GCP2, IL23A, TLR4, IL-21 receptor, p38 MAPK, CD86, TGF-beta receptor type I",6.317E-09,1.657E-07,38,"TGF-beta 1, MHC class II, CCL20, JAK1, ICAM1, ERK1/2, MD-2, CD28, IL-17, SMAD2, IL-17 receptor, IL-1 beta, GRO-1, CD14, IL-17F, GM-CSF, CD4, IL-6, NF-kB, IL-23, JAK2, CD80, VCAM1, ROR-alpha, IL-8, TGF-beta receptor type II, CFTR, IRF4, JAK3, STAT3, GCP2, IL23A, TLR4, IL-21 receptor, IL-21, p38 MAPK, CD86, TGF-beta receptor type I",
88,Role of IL-23/ T17 pathogenic axis in psoriasis,54,6.317E-09,1.657E-07,8.488E-06,4.379E-05,35,"MHC class II, CCL20, NF-AT1(NFATC2), Calgranulin A, ERK1/2, CD28, IL-17 receptor, IL-22, IL-15, IL-1 beta, IL-15RA, IL-17F, CD4, MHC class I, IL-6, sIL-15RA, HLA-Cw6, NF-kB, IL-23, AKT(PKB), NF-AT2(NFATC1), IL-1F9, IL-8, IL-1F5, IL1R-rp2, IRF4, IL22RA1, IL23A, Calgranulin B, IL-2R gamma chain, HLA-C, ADAM17, IL-12 beta, CD86, ERAP1",6.317E-09,1.657E-07,38,"MHC class II, CCL20, Calgranulin A, ERK1/2, CD28, IL-17, IL-17 receptor, IL-22, IL-15, IL-1 beta, IL-15RA, IL-17F, CD4, MHC class I, IL-6, sIL-15RA, HLA-Cw6, NF-kB, IL-23, AKT(PKB), NF-AT2(NFATC1), CD40L(TNFSF5), IL-1F9, CD80, IL-8, IL-1F5, IL1R-rp2, IRF4, IL22RA1, STAT3, IL23A, Calgranulin B, IL-2R gamma chain, HLA-C, ADAM17, IL-12 beta, CD86, ERAP1",
89,Immune response_TCR alpha/beta signaling pathway,97,6.964E-09,1.389E-07,6.964E-09,1.389E-07,62,"STIM1, MHC class II, Calcineurin A (catalytic), STK39, NF-AT1(NFATC2), GLK(MAP4K3), ERK1/2, CD28, TRPM2, c-FLIP(Long), Caspase-8, 14-3-3 theta, CaMK IV, VAV-1, IP3 receptor, I-kB, PKC-theta, PAG, ZAP70, PLC-gamma 1, ITK, RIPK1, CD4, MHC class I, P2X7, MEK1/2, Fyn, AKT(PKB), NF-kB p50/p65, UEV1A, TAK1(MAP3K7), NF-AT2(NFATC1), IL-2, WaspIP, STIM2, Lck, B-Raf, CD45, Slp76, TRAF3, TRAF6, CABIN1, Ca(II)channel L-type, Csk, Pannexin-1, LAT, GRAP2, CARD11, AP-1, Calmodulin, TRPC3, CD8, PKC-alpha, CD3, MALT1, P2X1, CFLAR p43, TAB1, Bcl-10, FYB1, Calcineurin B (regulatory), CD86",3.524E-08,6.755E-07,57,"p38alpha (MAPK14), STIM1, MHC class II, Calcineurin A (catalytic), STK39, GLK(MAP4K3), ERK1/2, CD28, TRPM2, c-FLIP(Long), c-Raf-1, Caspase-8, 14-3-3 theta, CaMK IV, VAV-1, IP3 receptor, I-kB, PKC-theta, PAG, PLC-gamma 1, RIPK1, CD4, MHC class I, P2X7, MEK1/2, Fyn, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), NF-AT2(NFATC1), IL-2, WaspIP, CD80, STIM2, Lck, B-Raf, CD45, Slp76, TRAF3, TRAF6, CABIN1, Csk, Pannexin-1, GRAP2, CARD11, Calmodulin, TRPC3, CD8, PKC-alpha, CD3, MALT1, P2X1, CFLAR p43, Bcl-10, FYB1, Calcineurin B (regulatory), CD86",
90,Development_Role of BMP signaling in embryonic stem cell neural differentiation,30,7.868E-09,1.994E-07,6.314E-07,5.397E-06,24,"SMAD5, NCAM1, BMP receptor 2, Neurogenin 2, BMP4, ERK1/2, MSX1, SMAD4, DULLARD, BMPR1B, Follistatin, NeuroD1, ZIC2, IRX1, ALK-2, SMAD9 (SMAD8), Geminin, Noggin, SOX15, ZIC1, Tubulin beta 2B, BMPR1A, SMAD1, BMP2",7.868E-09,1.994E-07,25,"SMAD5, NCAM1, BMP receptor 2, Neurogenin 2, BMP4, ERK1/2, MSX1, SMAD4, DULLARD, BMPR1B, Follistatin, NeuroD1, MEK1(MAP2K1), ZIC2, IRX1, ALK-2, OTX2, SMAD9 (SMAD8), Geminin, Noggin, SOX15, ZIC1, Tubulin beta 2B, BMPR1A, BMP2",
91,Development_WNT/Beta-catenin and NOTCH in induction of osteogenesis,40,7.880E-09,1.551E-07,7.880E-09,1.551E-07,32,"COL1A1, NOTCH1 receptor, WNT3A, RANKL(TNFSF11), APC protein, Beta-catenin, SMAD4, Dsh, GSK3 beta, LRP5, Osteoprotegerin, RBP-J kappa (CBF1), PPAR-gamma, Axin, TCF7 (TCF1), NOTCH1 (NICD), HEY1, Osteopontin, Osteocalcin, MAML1, ALPL, WNT1, RUNX2, FHL2, HES1, WNT, WNT10B, SMAD1, NOTCH1 (NEXT), Jagged1, ADAM17, Frizzled",1.571E-05,8.242E-05,26,"COL1A1, NOTCH1 receptor, RANKL(TNFSF11), APC protein, Beta-catenin, SMAD4, Dsh, GSK3 beta, Osteoprotegerin, RBP-J kappa (CBF1), PPAR-gamma, Axin, TCF7 (TCF1), NOTCH1 (NICD), A-FABP, Osteopontin, Osteocalcin, ALPL, RUNX2, FHL2, HES1, WNT, NOTCH1 (NEXT), Jagged1, ADAM17, Frizzled",
92,Cooperative action of IFN-gamma and TNF-alpha on astrocytes in multiple sclerosis,39,8.517E-09,2.122E-07,6.752E-07,5.612E-06,29,"MHC class II, IP10, JAK1, ICAM1, CCL2, PKA-reg (cAMP-dependent), HLA-DRA1, IRF1, STAT1, I-kB, Adenylate cyclase, CREB1, MHC class I, NF-kB, TNF-R1, PPAR-gamma, TNF-alpha, JAK2, iNOS, PKR, PKA-cat alpha, C/EBPbeta, IFN-gamma receptor, HLA-E, CIITA, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent), CD86, C/EBPdelta",8.517E-09,2.122E-07,30,"MHC class II, IP10, JAK1, ICAM1, CCL2, IFN-gamma, HLA-DRA1, IRF1, STAT1, I-kB, Adenylate cyclase, CREB1, MHC class I, NF-kB, TNF-R1, PPAR-gamma, TNF-alpha, JAK2, CD80, iNOS, PKR, PKA-cat alpha, C/EBPbeta, IFN-gamma receptor, HLA-E, CIITA, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent), CD86, C/EBPdelta",
93,Cell adhesion_Plasmin signaling,35,8.931E-09,1.713E-07,8.931E-09,1.713E-07,29,"TGF-beta 1, VEGF-A, VEGFR-2, Plasma kallikrein, Fibronectin, Plasminogen, PI3K reg class IA, PLAT (TPA), C1 inhibitor, Collagen IV, TAK1(MAP3K7), TGF-beta 2, PI3K cat class IA, MMP-13, TFPI-2, TGF-beta receptor type II, XIAP, MEK3(MAP2K3), Laminin 1, Neuroserpin, FGF2, Plasmin, TGF-beta receptor type III (betaglycan), PZP, PLAU (UPA), TAB1, Fibrinogen (fibrin), p38 MAPK, TGF-beta receptor type I",3.765E-05,1.648E-04,23,"TGF-beta 1, VEGF-A, VEGFR-2, Plasma kallikrein, Fibronectin, PI3K reg class IA, PLAT (TPA), C1 inhibitor, Collagen IV, TAK1(MAP3K7), TGF-beta 2, PI3K cat class IA, MMP-13, TFPI-2, TGF-beta receptor type II, XIAP, MEK3(MAP2K3), Laminin 1, FGF2, TGF-beta receptor type III (betaglycan), PLAU (UPA), p38 MAPK, TGF-beta receptor type I",
94,Development_WNT and Notch signaling in early cardiac myogenesis,35,8.931E-09,1.713E-07,8.931E-09,1.713E-07,29,"NOTCH1 receptor, TBX5, WNT3A, MEF2C, DKK1, Beta-catenin, SMAD4, Dsh, GSK3 beta, WNT11, LRP5, RBP-J kappa (CBF1), FZD7, TCF7 (TCF1), NOTCH1 (NICD), CSX (Nkx2.5), HHEX (PRH), SFRP5, WNT1, Noggin, HES1, WNT, WNT 8A, CHIBBY, NOTCH1 (NEXT), Jagged1, ADAM17, BMP2, Frizzled",8.440E-06,4.673E-05,24,"NOTCH1 receptor, MEF2C, DKK1, Beta-catenin, SMAD4, Dsh, GSK3 beta, WNT11, RBP-J kappa (CBF1), FZD7, TCF7 (TCF1), NOTCH1 (NICD), CSX (Nkx2.5), HHEX (PRH), SFRP5, Noggin, HES1, WNT, WNT 8A, NOTCH1 (NEXT), Jagged1, ADAM17, BMP2, Frizzled",
95,Immune response_B cell antigen receptor (BCR) pathway,110,1.004E-08,1.901E-07,1.004E-08,1.901E-07,68,"STIM1, Calcineurin A (catalytic), NCK1, alpha-4/beta-1 integrin, ICAM1, c-Rel (NF-kB subunit), NF-kB p50/c-Rel, ERK1/2, EGR1, BCAP, Fibronectin, VAV-1, Rac1, IP3 receptor, BAD, Syk, Cyclin D2, Shc, PI3K reg class IA (p85), GSK3 beta, CDK4, FKHR, IKK-alpha, N-Ras, MEK2(MAP2K2), GSK3 alpha/beta, MEK1/2, CDC42, Actin cytoskeletal, NF-kB, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), NF-AT2(NFATC1), MEKK4(MAP3K4), VCAM1, RelA (p65 NF-kB subunit), LRRK1, B-Raf, NF-kB1 (p50), ETS1, Lyn, PIP5KIII, MEK3(MAP2K3), CIN85, PP2A catalytic, SOS1, PKC-beta2, PI3K cat class IA (p110-delta), CARD11, CDK6, HPK1(MAP4K1), PKC-beta, Calmodulin, CalDAG-GEFIII, CKLFSF7, MEKK1(MAP3K1), ATF-2, MALT1, PLC-gamma, CD79B, Bcl-10, DAPP1, Calcineurin B (regulatory), PLC-gamma 2, p38 MAPK, Elk-1, mTOR",2.686E-08,5.736E-07,63,"STIM1, Calcineurin A (catalytic), NCK1, alpha-4/beta-1 integrin, ICAM1, c-Rel (NF-kB subunit), NF-kB p50/c-Rel, ERK1/2, c-Raf-1, BCAP, Fibronectin, VAV-1, IP3 receptor, Syk, Cyclin D2, Shc, PI3K reg class IA (p85), GSK3 beta, CDK4, FKHR, N-Ras, MEK2(MAP2K2), GSK3 alpha/beta, MEK1/2, CDC42, Actin cytoskeletal, NF-kB, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), NF-AT2(NFATC1), MEK1(MAP2K1), VCAM1, RelA (p65 NF-kB subunit), LRRK1, B-Raf, NF-kB1 (p50), ETS1, Lyn, PIP5KIII, MEK3(MAP2K3), CIN85, PP2A catalytic, SOS1, PKC-beta2, PI3K cat class IA (p110-delta), CARD11, CDK6, HPK1(MAP4K1), PKC-beta, Calmodulin, CalDAG-GEFIII, CKLFSF7, ATF-2, MALT1, PLC-gamma, Bcl-10, DAPP1, Calcineurin B (regulatory), PLC-gamma 2, p38 MAPK, Elk-1, mTOR",
96,TGF-beta-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,64,1.035E-08,1.936E-07,1.035E-08,1.936E-07,45,"COL1A1, ITGA1, Biglycan, TGF-beta 1, ERK1/2, SMAD4, COL5A1, SMAD2, Fibronectin, Decorin, Endothelin-1, Tenascin-C, HAS2, MMP-2, COL1A2, AKT(PKB), Collagen IV, TIMP2, Stromelysin-1, TAK1(MAP3K7), TGF-beta 2, ITGB1, PI3K cat class IA, MMP-13, PKC-delta, TGF-beta receptor type II, c-Jun, TIMP1, MEK4(MAP2K4), Collagen III, AP-1, COL4A1, ITGA2, HAS1, ITGA3, TAB1, JNK(MAPK8-10), SMAD3, ITGA5, p38 MAPK, MMP-9, PAI1, Collagen I, TGF-beta receptor type I, Thrombospondin 2",1.051E-07,1.637E-06,41,"COL1A1, ITGA1, Biglycan, TGF-beta 1, ERK1/2, SMAD4, COL5A1, SMAD2, Fibronectin, Decorin, Endothelin-1, Tenascin-C, HAS2, MMP-2, COL1A2, AKT(PKB), Collagen IV, TIMP2, Stromelysin-1, TAK1(MAP3K7), TGF-beta 2, ITGB1, PI3K cat class IA, MMP-13, TGF-beta receptor type II, TIMP1, MEK4(MAP2K4), Collagen III, COL4A1, ITGA2, HAS1, ITGA3, JNK(MAPK8-10), SMAD3, ITGA5, p38 MAPK, MMP-9, PAI1, Collagen I, TGF-beta receptor type I, Thrombospondin 2",
97,Signal transduction_PDGF signaling via PI3K/AKT and NFkB pathways,70,1.230E-08,2.243E-07,1.230E-08,2.243E-07,48,"SOD2, CCL2, PI3K cat class IA (p110-beta), ERK1/2, Beta-catenin, SGK1, PDGF-R-alpha, Rac1, PI3K reg class IA (p85), p120GAP, GSK3 beta, FKHR, Tenascin-C, PLC-gamma 1, MMP-2, PDGF-C, Transgelin, Inversin, PDGFR-ab, NF-kB, AKT(PKB), PDGF receptor, NF-kB p50/p65, c-Src, c-Myc, PDGF-D, Phox1 (PRRX1), Myocardin, RelA (p65 NF-kB subunit), HIF1A, ETS1, c-Jun, PDGF-A, ETS2, c-Jun/Fra-1, SOS1, PI3K cat class IA (p110-alpha), Calmodulin, MYH11, c-Abl, ACTA2, MKL1, p53, Elk-1, MMP-9, SRF, mTOR, PDGF-R-beta",2.153E-08,4.733E-07,45,"PDK1, SOD2, CCL2, PI3K cat class IA (p110-beta), ERK1/2, Beta-catenin, YB-1, SGK1, PDGF-R-alpha, PI3K reg class IA (p85), p120GAP, GSK3 beta, FKHR, Tenascin-C, PLC-gamma 1, MMP-2, PDGF-C, Transgelin, Inversin, PDGFR-ab, NF-kB, AKT(PKB), PDGF receptor, NF-kB p50/p65, c-Src, PDGF-D, Phox1 (PRRX1), Myocardin, RelA (p65 NF-kB subunit), HIF1A, ETS1, PDGF-A, ETS2, SOS1, PI3K cat class IA (p110-alpha), Calmodulin, c-Abl, ACTA2, MKL1, p53, Elk-1, MMP-9, SRF, mTOR, PDGF-R-beta",
98,Mechanisms of drug resistance in SCLC,70,1.230E-08,2.243E-07,1.230E-08,2.243E-07,48,"alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, Apaf-1, alpha-V/beta-1 integrin, RPS6, ERK1/2, VEGF-A, Caspase-8, Fibronectin, c-Kit, Rad51, PKC-epsilon, MDR1, BAD, ABCC1, p73, Bax, GSK3 beta, Survivin, PI3K reg class IA, IKK-alpha, c-IAP1, alpha-V/beta-3 integrin, Caspase-3, AKT(PKB), Collagen IV, HSP70, TERT, alpha-3/beta-1 integrin, ITGB1, Osteopontin, PI3K cat class IA, VCAM1, RelA (p65 NF-kB subunit), B-Raf, ABCC10, XIAP, Laminin 1, alpha-5/beta-1 integrin, FGF2, Caspase-9, HSF1, tBid, TOP2 alpha, alpha-2/beta-1 integrin, ABCC4, mTOR, Bid",2.153E-08,4.733E-07,45,"alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, Apaf-1, alpha-V/beta-1 integrin, RPS6, ERK1/2, VEGF-A, Caspase-8, Fibronectin, c-Kit, PKC-epsilon, MDR1, ABCC1, p73, Bax, GSK3 beta, Survivin, PI3K reg class IA, c-IAP1, alpha-V/beta-3 integrin, Caspase-3, AKT(PKB), Collagen IV, HSP70, TERT, alpha-3/beta-1 integrin, ITGB1, Osteopontin, PI3K cat class IA, VCAM1, RelA (p65 NF-kB subunit), B-Raf, ABCC10, TERC, XIAP, Laminin 1, alpha-5/beta-1 integrin, FGF2, Caspase-9, tBid, TOP2 alpha, alpha-2/beta-1 integrin, ABCC4, mTOR, Bid",
99,Dysregulation of germinal center response in SLE,65,1.235E-08,3.027E-07,1.272E-05,6.300E-05,40,"alpha-4/beta-1 integrin, JAK1, ICAM1, IL-4R type I, IFN-alpha/beta receptor, IL-17 receptor, STAT1, IL-15, PI3K reg class IA (p85), IL-15RA, IFN-alpha, alpha-V/beta-3 integrin, Oct-1, FasL(TNFSF6), NF-kB, C3dg, NF-kB p50/p65, BAFF(TNFSF13B), MFGE8, VCAM1, APRIL(TNFSF13), BOB1, IRF9, MER, CD21, Bcl-6, IRF4, JAK3, PI3K cat class IA (p110-delta), Oct-2, RGS13, TC21, CD79B, FasR(CD95), CXCL13, TGM2, TACI(TNFRSF13B), TLR7, IL-21 receptor, DOCK8",1.235E-08,3.027E-07,43,"alpha-4/beta-1 integrin, JAK1, ICAM1, IL-4R type I, CXCR5, IL-17, IFN-alpha/beta receptor, IL-17 receptor, STAT1, IL-15, PI3K reg class IA (p85), IL-15RA, IFN-alpha, alpha-V/beta-3 integrin, Oct-1, NF-kB, C3dg, NF-kB p50/p65, CD40L(TNFSF5), BAFF(TNFSF13B), MFGE8, VCAM1, APRIL(TNFSF13), BOB1, IRF9, MER, CD21, Bcl-6, IRF4, JAK3, PI3K cat class IA (p110-delta), STAT3, Oct-2, RGS13, TC21, FasR(CD95), CXCL13, TGM2, TACI(TNFRSF13B), TLR7, IL-21 receptor, IL-21, DOCK8",
100,Notch signaling in breast cancer,53,1.282E-08,2.311E-07,1.282E-08,2.311E-07,39,"NOTCH1 receptor, HES5, CD44, HEYL, Beta-catenin, VEGF-A, Jagged2, NOTCH2 (2ICD), NOTCH4 (ICD4), Bax, Survivin, IKK-alpha, NOTCH4, RBP-J kappa (CBF1), Cyclin B1, c-Myc, Mcl-1, NUMB, NOTCH1 (NICD), HEY1, EGFR, MAML1, Pin1, HURP, p300, NOTCH2, DLL4, PLAU (UPA), CDK2, NOTCH3 (3ICD), HES1, SLUG, NOTCH1 precursor, NOXA, Cyclin A, NOTCH1 (NEXT), Jagged1, ADAM17, NOTCH3",1.230E-06,9.886E-06,34,"NOTCH1 receptor, HES5, CD44, HEYL, Beta-catenin, VEGF-A, Jagged2, NOTCH2 (2ICD), NOTCH4 (ICD4), Bax, Survivin, NOTCH4, RBP-J kappa (CBF1), Cyclin B1, Mcl-1, NUMB, NOTCH1 (NICD), EGFR, Pin1, HURP, p300, NOTCH2, PLAU (UPA), CDK2, NOTCH3 (3ICD), HES1, SLUG, NOTCH1 precursor, NOXA, Cyclin A, NOTCH1 (NEXT), Jagged1, ADAM17, NOTCH3",
101,Development_MAG-dependent inhibition of neurite outgrowth,37,1.309E-08,2.332E-07,1.309E-08,2.332E-07,30,"NGFR(TNFRSF16), TrkA, Lingo1, NT-4/5, LIMK1, Reticulon 4, MLCP (reg), NGFR (ICD), Actin cytoskeletal, NT-3, MLCP (cat), RhoA, TrkC, Destrin, Myosin II, TrkB, MyHC, RhoGDI alpha, NGF, ROCK, RTN4R, NGFR (CTF), MRLC, OMgp, MAG, RASGRF1, MELC, ADAM17, BDNF, Cofilin",3.520E-05,1.570E-04,24,"NGFR(TNFRSF16), NT-4/5, LIMK1, Reticulon 4, MLCP (reg), NGFR (ICD), Actin cytoskeletal, MLCP (cat), RhoA, Myosin II, TrkB, MyHC, RhoGDI alpha, NGF, ROCK, RTN4R, NGFR (CTF), MRLC, OMgp, RASGRF1, MELC, ADAM17, BDNF, Cofilin",
102,Apoptosis and survival_FAS signaling cascades,44,1.353E-08,2.343E-07,1.353E-08,2.343E-07,34,"ICAD, Caspase-6, Apaf-1, FasR(CD95) soluble, Lamin A/C, c-FLIP(Long), Caspase-8, Bax, BRE, c-IAP1, Caspase-3, RIPK1, DFF40 (CAD), Caspase-2, Lamin B, FasL(TNFSF6), PARP-1, SUMO-1, ASK1 (MAP3K5), XIAP, DAXX, Caspase-9, FLASH, BMF, MEK4(MAP2K4), Caspase-10, Caspase-7, MEKK1(MAP3K1), tBid, FasR(CD95), HtrA2, JNK(MAPK8-10), Bim, Bid",7.528E-07,6.614E-06,30,"ICAD, Caspase-6, Apaf-1, FasR(CD95) soluble, Lamin A/C, c-FLIP(Long), Caspase-8, Bax, BRE, c-IAP1, Caspase-3, RIPK1, DFF40 (CAD), Lamin B, Caspase-2, SUMO-1, ASK1 (MAP3K5), XIAP, DAXX, Caspase-9, FLASH, BMF, MEK4(MAP2K4), Caspase-10, tBid, FasR(CD95), HtrA2, JNK(MAPK8-10), Bim, Bid",
103,Proinflammatory cytokine production by Th17 cells in asthma,53,1.415E-08,3.261E-07,1.586E-05,7.462E-05,34,"TGF-beta 1, MHC class II, CCL20, JAK1, IL-10, C3, C5a, CD28, IL-22, IL-1 beta, IL-17F, CD4, IL-13, IL-6, NF-kB, IL-23, C3aR, CXCR4, TNF-alpha, JAK2, alpha-V/beta-8 integrin, IL-8, IL-5, c-Jun, IRF4, JAK3, COX-2 (PTGS2), IL23A, C5, JNK(MAPK8-10), IL-21 receptor, C3a, CCR4, CD86",1.415E-08,3.261E-07,37,"TGF-beta 1, MHC class II, CCL20, JAK1, IL-10, C3, C5a, CD28, IL-17, IL-22, IL-1 beta, IL-17F, CD4, IL-6, NF-kB, IL-23, CXCR4, TNF-alpha, JAK2, CD80, ROR-alpha, alpha-V/beta-8 integrin, CRTH2, IL-8, IL-5, IRF4, JAK3, STAT3, COX-2 (PTGS2), IL23A, C5, JNK(MAPK8-10), IL-21 receptor, IL-21, C3a, CCR4, CD86",
104,Immune response_Inhibitory PD-1 signaling in T cells,53,1.415E-08,3.261E-07,6.327E-08,8.160E-07,38,"MHC class II, PD-L2, ICAM1, ERK1/2, CD28, VAV-1, Syk, PI3K reg class IA (p85), GSK3 beta, PKC-theta, Eomesodermin, ZAP70, PLC-gamma 1, CD4, MHC class I, Skp2/TrCP/FBXW, SKP2, AKT(PKB), PI3K cat class IA, Lck, T-bet, CBL-B, Csk, CDK2, CD8 alpha, CD8, CD3, Cyclin E, SHP-2, CD3 zeta, p15, PD-1, SMAD3, FYB1, Elk-1, CD86, mTOR, PD-L1",1.415E-08,3.261E-07,37,"MHC class II, PD-L2, ICAM1, ERK1/2, CD28, VAV-1, Syk, PI3K reg class IA (p85), GSK3 beta, PKC-theta, Eomesodermin, PLC-gamma 1, CD4, MHC class I, Skp2/TrCP/FBXW, SKP2, AKT(PKB), CD80, PI3K cat class IA, Lck, T-bet, CBL-B, Csk, CDK2, CD8 alpha, CD8, CD3, Cyclin E, CD3 zeta, p15, PD-1, SMAD3, FYB1, Elk-1, CD86, mTOR, PD-L1",
105,Neurophysiological process_Receptor-mediated axon growth repulsion,46,1.676E-08,2.849E-07,1.676E-08,2.849E-07,35,"CDK5, Semaphorin 4D, Neuropilin-1, LARG, HB-EGF, LIMK1, Ephrin-A receptor 2, Rac1, RAP-1A, Plexin A1, CDC42, Actin cytoskeletal, Fyn, Ephexin, c-Src, Pleiotrophin (OSF1), Tubulin (in microtubules), RhoA, Tiam1, B-Raf, Plexin A2, ROCK2, EGFR, Destrin, F-Actin cytoskeleton, Fer, Ephrin-A receptors, CRMP2, ROCK, PDZ-RhoGEF, Semaphorin 3A, c-Fes, Ephrin-A, Cofilin, Syndecan-3",2.971E-08,6.088E-07,33,"CDK5, Semaphorin 4D, Neuropilin-1, HB-EGF, c-Raf-1, LIMK1, Ephrin-A receptor 2, RAP-1A, Plexin A1, CDC42, Actin cytoskeletal, Fyn, Ephexin, c-Src, Pleiotrophin (OSF1), Tubulin (in microtubules), RhoA, Tiam1, B-Raf, Plexin A2, ROCK2, EGFR, F-Actin cytoskeleton, Fer, Ephrin-A receptors, CRMP2, ROCK, PDZ-RhoGEF, Semaphorin 3A, c-Fes, Ephrin-A, Cofilin, Syndecan-3",
106,Th17 cytokines in COPD,36,1.764E-08,3.996E-07,1.161E-04,3.688E-04,24,"TGF-beta 1, MHC class II, CCL20, IP10, CCL2, CD28, IL-17 receptor, IL-22, AHR, IL-1 beta, GRO-1, IL-17F, GM-CSF, CD4, MHC class I, IL-6, NF-kB, IL-23, IL-8, CXCR3, CD8, p38 MAPK, MMP-9, CD86",1.764E-08,3.996E-07,28,"TGF-beta 1, MHC class II, CCL20, IP10, CCL2, CD28, IL-17, IL-17 receptor, IL-22, AHR, IL-1 beta, GRO-1, IL-17F, GM-CSF, CD4, MHC class I, IL-6, NF-kB, IL-23, CD80, ROR-alpha, IL-8, STAT3, CD8, IL-21, p38 MAPK, MMP-9, CD86",
107,Apoptosis and survival_p53-dependent apoptosis,29,1.997E-08,3.350E-07,1.997E-08,3.350E-07,25,"p14ARF, Apaf-1, GADD45 beta, 14-3-3 theta, CDK1 (p34), BAD, p73, Bax, Caspase-3, Oct-1, GADD45 alpha, Bard1, MEKK4(MAP3K4), Brca1, PKC-delta, c-Jun, Caspase-9, BMF, RAD9, MEK4(MAP2K4), 14-3-3 sigma, c-Abl, JNK(MAPK8-10), p53, Bim",1.342E-06,1.057E-05,22,"p38alpha (MAPK14), p14ARF, Apaf-1, GADD45 beta, 14-3-3 theta, CDK1 (p34), p73, Bax, Caspase-3, Oct-1, GADD45 alpha, Bard1, Brca1, Caspase-9, BMF, RAD9, MEK4(MAP2K4), 14-3-3 sigma, c-Abl, JNK(MAPK8-10), p53, Bim",
108,Cell adhesion_Integrin-mediated cell adhesion and migration,48,2.015E-08,3.350E-07,2.015E-08,3.350E-07,36,"ERK1/2, Alpha-actinin, CRK, LIMK1, Fibronectin, Rac1, Talin, MLCP (reg), Actin cytoskeletal, ERK2 (MAPK1), Collagen IV, MYLK1, c-Src, MLCK, MLCP (cat), RhoA, alpha-3/beta-1 integrin, alpha-11/beta-1 integrin, DOCK1, Laminin 1, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, MyHC, Paxillin, p130CAS, ROCK, Vinculin, N-WASP, Zyxin, MRLC, alpha-2/beta-1 integrin, RASGRF1, alpha-7/beta-1 integrin, MELC, Collagen I, Cofilin",1.541E-07,2.105E-06,33,"ERK1/2, Alpha-actinin, CRK, LIMK1, Fibronectin, Talin, MLCP (reg), Actin cytoskeletal, ERK2 (MAPK1), Collagen IV, MYLK1, c-Src, MLCK, MLCP (cat), RhoA, alpha-3/beta-1 integrin, alpha-11/beta-1 integrin, DOCK1, Laminin 1, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, MyHC, p130CAS, ROCK, Vinculin, Zyxin, MRLC, alpha-2/beta-1 integrin, RASGRF1, alpha-7/beta-1 integrin, MELC, Collagen I, Cofilin",
109,Immune response_IL-18 signaling,63,2.092E-08,3.440E-07,2.092E-08,3.440E-07,44,"IL-18R1, IL-1 alpha, TRAM, ICAM1, CCL2, ERK1/2, Fibronectin, p47-phox, Rac1, IL-1 beta, I-kB, Shc, IRAK4, PI3K reg class IA, MyD88, IKK-alpha, IL-6, MEK1/2, FasL(TNFSF6), NF-kB, AKT(PKB), c-Src, TAK1(MAP3K7), CD147, TNF-alpha, PI3K cat class IA, VCAM1, PI3K reg class IA (p85-alpha), iNOS, IL-18, IL-8, IL18RAP, TRAF6, MEK3(MAP2K3), c-Jun, CXCL16, SOS, COX-2 (PTGS2), AP-1, IRAK1, TAB1, JNK(MAPK8-10), p38 MAPK, MMP-9",7.928E-07,6.773E-06,39,"IL-18R1, IL-1 alpha, TRAM, ICAM1, CCL2, ERK1/2, c-Raf-1, Fibronectin, p47-phox, IL-1 beta, I-kB, Shc, IRAK4, PI3K reg class IA, IL-6, MEK1/2, NF-kB, AKT(PKB), c-Src, TAK1(MAP3K7), CD147, TNF-alpha, PI3K cat class IA, VCAM1, PI3K reg class IA (p85-alpha), iNOS, IL-18, IL-8, IL18RAP, TRAF6, MEK3(MAP2K3), CXCL16, SOS, p67-phox, COX-2 (PTGS2), IRAK1, JNK(MAPK8-10), p38 MAPK, MMP-9",
110,Development_Neurotrophin family signaling,41,2.376E-08,3.741E-07,2.376E-08,3.741E-07,32,"NGFR(TNFRSF16), TrkA, ERK1/2, CrkL, NT-4/5, Rac1, RAP-1A, Shc, PI3K reg class IA (p85), Bax, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), NT-3, GAB2, PI3K cat class IA, B-Raf, TrkC, XIAP, c-Jun, Sortilin, SOS, TrkB, C3G, SH2B, NGF, MEKK1(MAP3K1), SHP-2, JNK(MAPK8-10), p53, BDNF, Elk-1",1.089E-04,3.895E-04,25,"NGFR(TNFRSF16), ERK1/2, CrkL, c-Raf-1, NT-4/5, RAP-1A, Shc, PI3K reg class IA (p85), Bax, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), GAB2, MEK1(MAP2K1), PI3K cat class IA, B-Raf, XIAP, Sortilin, SOS, TrkB, NGF, JNK(MAPK8-10), p53, BDNF, Elk-1",
111,Fibroblast/ myofibroblast proliferation in asthmatic airways,41,2.376E-08,3.741E-07,2.376E-08,3.741E-07,32,"TGF-beta 1, FGFR2, PAR2, ERK1/2, SMAD4, PDGF-R-alpha, SMAD2, IL-1 beta, Thrombin, Endothelin-1, alpha-V/beta-3 integrin, IL-13, NF-kB, ECP (RNase 3), PI3K cat class IA, ITGB3, TGF-beta receptor type II, ASK1 (MAP3K5), c-Jun, PDGF-A, Tryptase, Tissue factor, Histamine H1 receptor, EDNRB, PKC, JNK(MAPK8-10), PAR1, SMAD3, CTGF, des-Arg10-kallidin, EDNRA, TGF-beta receptor type I",1.682E-06,1.226E-05,28,"TGF-beta 1, FGFR2, PAR2, ERK1/2, SMAD4, PDGF-R-alpha, SMAD2, IL-1 beta, Endothelin-1, alpha-V/beta-3 integrin, NF-kB, ECP (RNase 3), PI3K cat class IA, ITGB3, TGF-beta receptor type II, ASK1 (MAP3K5), PDGF-A, Tryptase, Tissue factor, Histamine H1 receptor, EDNRB, PKC, JNK(MAPK8-10), PAR1, SMAD3, CTGF, EDNRA, TGF-beta receptor type I",
112,Development_Positive regulation of STK3/4 (Hippo) pathway and negative regulation of YAP/TAZ function,71,2.503E-08,3.900E-07,2.503E-08,3.900E-07,48,"Willin, Casein kinase I delta, MPP5, Cullin 2, INADL, AMPK beta subunit, 14-3-3, Casein kinase I epsilon, AMPK gamma subunit, Beta-catenin, PKA-reg (cAMP-dependent), PP2A cat (alpha), ZO-2, RASSF2, STK4, RASSF1, Adenylate cyclase, Itch, LIF, LATS2, Actin cytoskeletal, Skp2/TrCP/FBXW, TAZ, LRR-1, AMOTL1 (Jeap), Axin, Ajuba, RhoA, GCGR, Glucagon, PKA-cat alpha, STK3, AMPK alpha subunit, MARKK, Cul1/Rbx1 E3 ligase, Alpha-catenin, RhoGDI alpha, MOBKL1A, WW45, MALS-3, Schwannomin (NF2), FasR(CD95), Mol1b, Beta-2 adrenergic receptor, PEZ, Angiomotin (AMOT), PKA-cat (cAMP-dependent), AMOTL2",5.224E-07,5.172E-06,43,"Willin, MPP5, Cullin 2, AMPK beta subunit, 14-3-3, Casein kinase I epsilon, AMPK gamma subunit, Beta-catenin, c-Raf-1, PP2A cat (alpha), YAP1 (YAp65), ZO-2, RASSF2, STK4, RASSF1, Adenylate cyclase, Itch, LIF, LATS2, Actin cytoskeletal, Skp2/TrCP/FBXW, TAZ, LRR-1, AMOTL1 (Jeap), Axin, Ajuba, RhoA, Glucagon, PKA-cat alpha, STK3, AMPK alpha subunit, Cul1/Rbx1 E3 ligase, RhoGDI alpha, MOBKL1A, WW45, Schwannomin (NF2), FasR(CD95), Mol1b, Beta-2 adrenergic receptor, PEZ, Angiomotin (AMOT), PKA-cat (cAMP-dependent), AMOTL2",
113,CHDI_Correlations from Discovery data_Causal network,73,2.564E-08,3.954E-07,2.564E-08,3.954E-07,49,"CDK5, RHEB2, CCL2, Kir3.4, TCF7L2 (TCF4), ERK1/2, Beta-catenin, SMAD4, PDGF-R-alpha, CaMK IV, Dsh, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, Shc, PI3K reg class IA (p85), GSK3 beta, PLC-beta, PLC-gamma 1, nAChR, TSC-22, CREB1, G-protein beta/gamma, AKT(PKB), Calpain 1(mu), c-Src, c-Myc, YY1, Axin, PI3K cat class IA, Sin3A, G-protein alpha-i family, Substance P receptor, PDGF-A, SOS, MEF2, HDAC5, p90Rsk, 4E-BP1, Calmodulin, WNT, p15, G-protein alpha-q, SMAD3, PI3K reg class IB (p101), Elk-1, Frizzled, mTOR, TGF-beta receptor type I",1.361E-07,2.015E-06,45,"CDK5, RHEB2, CCL2, Kir3.4, TCF7L2 (TCF4), ERK1/2, Beta-catenin, c-Raf-1, SMAD4, PDGF-R-alpha, CaMK IV, Dsh, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, Shc, PI3K reg class IA (p85), GSK3 beta, PLC-beta, PLC-gamma 1, TSC-22, CREB1, G-protein beta/gamma, AKT(PKB), Calpain 1(mu), c-Src, Axin, MEK1(MAP2K1), PI3K cat class IA, Sin3A, G-protein alpha-i family, Substance P receptor, PDGF-A, SOS, MEF2, HDAC5, p90Rsk, Calmodulin, WNT, p15, SMAD3, Elk-1, Frizzled, mTOR, TGF-beta receptor type I",
114,Apoptosis and survival_NGF/ TrkA PI3K-mediated signaling,77,2.637E-08,4.025E-07,2.637E-08,4.025E-07,51,"TRIO, TrkA, ELMO2, Calcineurin A (catalytic), CLCN4, APC protein, ERK1/2, PKC-zeta, SSH2L, LIMK1, Rac1, BAD, RAP-1A, MLCP (reg), Shc, PI3K reg class IA (p85), GSK3 beta, FKHR, MSN (moesin), PLC-gamma 1, KIDINS220, CREB1, CDC42, Actin cytoskeletal, AKT(PKB), c-Src, Tubulin (in microtubules), MLCP (cat), BETA-PIX, RhoA, Tiam1, PI3K cat class IA, PARD3, Destrin, DOCK1, Myosin II, SOS, 4E-BP1, NGF, ROCK, MRCKalpha, Cofilin, non-muscle, Calmodulin, N-WASP, MRLC, FOXO3A, Calcineurin B (regulatory), ARAP3, SSH1L, Cofilin, mTOR",4.255E-04,1.172E-03,39,"TRIO, Calcineurin A (catalytic), CLCN4, APC protein, ERK1/2, SSH2L, LIMK1, RAP-1A, MLCP (reg), Shc, PI3K reg class IA (p85), GSK3 beta, FKHR, MSN (moesin), PLC-gamma 1, KIDINS220, CREB1, CDC42, Actin cytoskeletal, AKT(PKB), c-Src, Tubulin (in microtubules), MLCP (cat), RhoA, Tiam1, PI3K cat class IA, PARD3, DOCK1, Myosin II, SOS, NGF, ROCK, Calmodulin, MRLC, Calcineurin B (regulatory), ARAP3, SSH1L, Cofilin, mTOR",
115,Development_TGF-beta receptor signaling,52,2.710E-08,4.095E-07,2.710E-08,4.095E-07,38,"CBP, TGF-beta 1, Sno-N, eIF4E, ERK1/2, GADD45 beta, FKBP12, SMAD4, SMAD2, Shc, IKK-alpha, MEK2(MAP2K2), TSC-22, NF-kB, YY1, TAK1(MAP3K7), MEKK4(MAP3K4), Importin (karyopherin)-beta, SMURF1, SMAD7, TGF-beta receptor type II, Ski, SMURF2, XIAP, MEK3(MAP2K3), SOS, MNK1, p300, TAB1, p15, SMAD3, Caveolin-1, TIEG1, ER81, p38 MAPK, Elk-1, PAI1, TGF-beta receptor type I",1.473E-07,2.097E-06,35,"CBP, TGF-beta 1, Sno-N, ERK1/2, GADD45 beta, FKBP12, c-Raf-1, SMAD4, SMAD2, Shc, MEK2(MAP2K2), TSC-22, NF-kB, TAK1(MAP3K7), MEK1(MAP2K1), Importin (karyopherin)-beta, SMURF1, SMAD7, TGF-beta receptor type II, Ski, SMURF2, XIAP, MEK3(MAP2K3), SOS, MNK1, p300, p15, SMAD3, Caveolin-1, TIEG1, ER81, p38 MAPK, Elk-1, PAI1, TGF-beta receptor type I",
116,Immune response_IL-17 signaling pathways,60,2.867E-08,6.038E-07,7.929E-06,4.221E-05,38,"CCL20, JAK1, ICAM1, CCL2, RANKL(TNFSF11), NGAL, ERK1/2, ENA-78, IL-17 receptor, IL-1 beta, I-kB, GSK3 beta, GRO-1, PI3K reg class IA, IL-17F, GM-CSF, MEK2(MAP2K2), IL-6, NF-kB, IL-23, AKT(PKB), Stromelysin-1, TAK1(MAP3K7), JAK2, PI3K cat class IA, iNOS, C/EBPbeta, IL-8, TRAF6, MEK3(MAP2K3), c-Jun, NIK(MAP3K14), CCL7, COX-2 (PTGS2), GCP2, p38 MAPK, MMP-9, C/EBPdelta",2.867E-08,6.038E-07,40,"CCL20, JAK1, ICAM1, CCL2, RANKL(TNFSF11), NGAL, ERK1/2, ENA-78, IL-17, IL-17 receptor, IL-1 beta, I-kB, GSK3 beta, GRO-1, PI3K reg class IA, IL-17F, GM-CSF, MEK2(MAP2K2), IL-6, NF-kB, IL-23, AKT(PKB), Stromelysin-1, TAK1(MAP3K7), MEK1(MAP2K1), JAK2, PI3K cat class IA, iNOS, C/EBPbeta, IL-8, TRAF6, MEK3(MAP2K3), NIK(MAP3K14), CCL7, COX-2 (PTGS2), GCP2, IL-21, p38 MAPK, MMP-9, C/EBPdelta",
117,Aberrant production of IL-2 and IL-17 in SLE T cells,58,2.976E-08,6.088E-07,1.590E-07,1.762E-06,40,"CBP, TGF-beta 1, MHC class II, NF-AT1(NFATC2), ERK1/2, PKA-reg (cAMP-dependent), PP2A cat (alpha), CaMK IV, Syk, IL-1 beta, I-kB, ZAP70, IL-17F, CD4, CREB1, IL-6, MEK1/2, IL-23, AKT(PKB), NF-kB p50/p65, IL-2, NOTCH1 (NICD), CD229, NTB-A, RelA (p65 NF-kB subunit), Lck, CREM (repressors), ETS1, PP2A cat (beta), SOS, p300, LAT, AP-1, Calmodulin, CD3, CD3 zeta, NOTCH1 precursor, HDAC1, PKA-cat (cAMP-dependent), mTOR",2.976E-08,6.088E-07,39,"CBP, TGF-beta 1, MHC class II, ERK1/2, IL-17, c-Raf-1, PP2A cat (alpha), CaMK IV, Syk, IL-1 beta, I-kB, IL-17F, CD4, CREB1, IL-6, MEK1/2, CD3 epsilon, IL-23, AKT(PKB), NF-kB p50/p65, IL-2, NOTCH1 (NICD), NTB-A, RelA (p65 NF-kB subunit), Lck, CREM (repressors), ETS1, PP2A cat (beta), SOS, p300, Calmodulin, CD3, CD3 zeta, NOTCH1 precursor, SAP, HDAC1, IL-21, PKA-cat (cAMP-dependent), mTOR",
118,Immune response_IFN-gamma actions on extracellular matrix and cell differentiation,54,3.049E-08,4.472E-07,3.049E-08,4.472E-07,39,"COL1A1, IP10, JAK1, ICAM1, TYRP2, IRF1, STAT1, OAS1, ACTA1, GSK3 beta, Troponin I, fast skeletal muscle, HDAC2, PSME2, EZH2, COL1A2, RFX5, Pyk2(FAK2), LMOD2, JAK2, iNOS, SMAD7, TRAF6, Sortilin, IFN-gamma receptor, 2'-5'-oligoadenylate synthetase, RANK(TNFRSF11A), OAS2, MYH11, Sin3B, PRC2 complex, SUZ12, CIITA, ACTA2, Casein kinase I, Involucrin, MYLPF, MMP-9, SRF, G9a",5.950E-07,5.630E-06,35,"COL1A1, IP10, JAK1, ICAM1, IFN-gamma, TYRP2, IRF1, STAT1, OAS1, GSK3 beta, Troponin I, fast skeletal muscle, HDAC2, EZH2, COL1A2, Pyk2(FAK2), JAK2, iNOS, SMAD7, TRAF6, Sortilin, IFN-gamma receptor, 2'-5'-oligoadenylate synthetase, RANK(TNFRSF11A), OAS2, Sin3B, PRC2 complex, SUZ12, CIITA, ACTA2, Casein kinase I, Involucrin, MYLPF, MMP-9, SRF, G9a",
119,NRF2 regulation of oxidative stress response,54,3.049E-08,4.472E-07,3.049E-08,4.472E-07,39,"Casein kinase II, alpha chains, CBP, NRF1, CRM1, BACH1, SMRT, SLC7A11, BRG1, Ubiquitin, GSK3 beta, UGT1A1, MAFG, SOD1, PI3K reg class IA, MafK, Actin cytoskeletal, Fyn, ERK2 (MAPK1), AKT(PKB), MafF, Casein kinase II, beta chain (Phosvitin), Thioredoxin, Heme oxygenase 1, PI3K cat class IA, KEAP1, GCL reg, DJ-1, GSTA2, ENC1, PRDX1, JNK1(MAPK8), MEK4(MAP2K4), GSTP1, PKC, GSTA1, GCL cat, p53, TXNRD1, NRF2",5.950E-07,5.630E-06,35,"Casein kinase II, alpha chains, CBP, NRF1, CRM1, BACH1, SMRT, SLC7A11, BRG1, c-Raf-1, Ubiquitin, GSK3 beta, UGT1A1, MAFG, PI3K reg class IA, Actin cytoskeletal, Fyn, ERK2 (MAPK1), AKT(PKB), MafF, MEK1(MAP2K1), Casein kinase II, beta chain (Phosvitin), Heme oxygenase 1, PI3K cat class IA, KEAP1, GCL reg, GSTA2, ENC1, JNK1(MAPK8), MEK4(MAP2K4), GSTP1, PKC, GCL cat, p53, TXNRD1, NRF2",
120,Development_Differentiation of white adipocytes ,54,3.119E-08,6.088E-07,8.488E-06,4.379E-05,35,"CBP, BMP receptor 2, BMP4, ERK1/2, FOXC2, HDAC3, SMAD4, PRKAR1A, UCP1, Shc, HIVEP2, Resistin, FTase-alpha, MEK2(MAP2K2), CREB1, MEK1/2, PPARGC1 (PGC1-alpha), INSIG1, p107, PPAR-gamma, TAK1(MAP3K7), CIDEC, C/EBPbeta, XIAP, SOS, p300, RIP140, PSAT, TAB1, Angiotensinogen, BMPR1A, SMAD1, BMP2, LPL, C/EBPdelta",3.119E-08,6.088E-07,37,"p38alpha (MAPK14), CBP, BMP receptor 2, BMP4, ERK1/2, FOXC2, c-Raf-1, HDAC3, SMAD4, UCP1, Shc, HIVEP2, FTase-alpha, MEK2(MAP2K2), CREB1, MEK1/2, PPARGC1 (PGC1-alpha), INSIG1, p107, PPAR-gamma, TAK1(MAP3K7), MEK1(MAP2K1), A-FABP, CIDEC, C/EBPbeta, XIAP, SOS, p90RSK1, p300, RIP140, PSAT, Angiotensinogen, LXR-alpha, BMPR1A, BMP2, LPL, C/EBPdelta",
121,Rheumatoid arthritis (general schema),50,3.131E-08,6.088E-07,9.745E-05,3.276E-04,31,"TNF-R2, MHC class II, alpha-4/beta-1 integrin, ICAM1, RANKL(TNFSF11), CD28, VEGF-A, PTPN22, IL-15, IL-1 beta, CD4, IL-6, MMP-8, IL-23, MHC class II beta chain, Stromelysin-1, IL-2R alpha chain, BAFF(TNFSF13B), TNF-alpha, HLA-DRB1, VCAM1, IL-18, TGF-beta, FGF2, CSF1, LFA-3, HLA-DRB, TLR4, MMP-9, CD86, TLR2",3.131E-08,6.088E-07,35,"TNF-R2, MHC class II, alpha-4/beta-1 integrin, ICAM1, RANKL(TNFSF11), IFN-gamma, CD28, VEGF-A, IL-17, PTPN22, IL-15, IL-1 beta, CD4, IL-6, MMP-8, IL-23, MHC class II beta chain, Stromelysin-1, CD40L(TNFSF5), BAFF(TNFSF13B), TNF-alpha, HLA-DRB1, CD80, VCAM1, IL-18, TGF-beta, FGF2, CSF1, LFA-3, HLA-DRB, CD2, TLR4, MMP-9, CD86, TLR2",
122,Role of inhibition of WNT signaling in the progression of lung cancer,31,3.313E-08,4.720E-07,3.313E-08,4.720E-07,26,"ERK5 (MAPK7), SMRT, APC protein, ROCK1, Beta-catenin, Vimentin, Dsh, Rac1, GSK3 beta, WNT7A, MAP2K5 (MEK5), FZD9, SPRY4, PPAR-gamma, Axin, RhoA, N-cadherin, CD82, c-Jun, MKK7 (MAP2K7), JNK1(MAPK8), TIMP1, MEKK1(MAP3K1), p53, MMP-9, Frizzled",1.780E-04,5.836E-04,20,"ERK5 (MAPK7), SMRT, APC protein, ROCK1, Beta-catenin, Vimentin, Dsh, GSK3 beta, WNT7A, MAP2K5 (MEK5), FZD9, PPAR-gamma, Axin, RhoA, N-cadherin, JNK1(MAPK8), TIMP1, p53, MMP-9, Frizzled",
123,Inhibition of TGF-beta signaling in lung cancer,31,3.313E-08,4.720E-07,3.313E-08,4.720E-07,26,"TGF-beta 1, SMAD4, SMAD2, HDAC2, CDK4, Caspase-3, CREB1, c-Myc, TAK1(MAP3K7), TERT, SMAD7, TGF-beta receptor type II, Ski, c-Jun, TGF-beta receptor type III (betaglycan), MKK7 (MAP2K7), MEK4(MAP2K4), DLX4 (BP1), SMAD6, ATF-2, Beta-fodrin, p15, JNK(MAPK8-10), SMAD3, PAI1, TGF-beta receptor type I",2.239E-07,2.813E-06,24,"p38alpha (MAPK14), TGF-beta 1, SMAD4, SMAD2, HDAC2, CDK4, Caspase-3, CREB1, TAK1(MAP3K7), TERT, SMAD7, TGF-beta receptor type II, Ski, TGF-beta receptor type III (betaglycan), MEK4(MAP2K4), DLX4 (BP1), SMAD6, ATF-2, Beta-fodrin, p15, JNK(MAPK8-10), SMAD3, PAI1, TGF-beta receptor type I",
124,Fibroblast differentiation to myofibroblasts in asthmatic airways,31,3.313E-08,4.720E-07,3.313E-08,4.720E-07,26,"TGF-beta 1, IL-4R type I, ERK1/2, SMAD4, SMAD2, Fibronectin, PI3K reg class IA, Endothelin-1, IL-13, AKT(PKB), ECP (RNase 3), TAK1(MAP3K7), ITGB1, PI3K cat class IA, TGF-beta receptor type II, IL-4R type II, c-Jun, alpha-5/beta-1 integrin, EDNRB, ACTA2, JNK(MAPK8-10), SMAD3, ITGA5, p38 MAPK, EDNRA, TGF-beta receptor type I",2.239E-07,2.813E-06,24,"TGF-beta 1, IL-4R type I, ERK1/2, SMAD4, SMAD2, Fibronectin, PI3K reg class IA, Endothelin-1, AKT(PKB), ECP (RNase 3), TAK1(MAP3K7), ITGB1, PI3K cat class IA, TGF-beta receptor type II, IL-4R type II, alpha-5/beta-1 integrin, EDNRB, ACTA2, JNK(MAPK8-10), SMAD3, ITGA5, p38 MAPK, EDNRA, TGF-beta receptor type I",
125,Immune response_IL-3 signaling via ERK and PI3K,102,3.648E-08,5.069E-07,3.648E-08,5.069E-07,63,"Calcineurin A (catalytic), PREL1, alpha-4/beta-1 integrin, NGAL, RPS6, ERK1/2, CrkL, EGR1, A-Raf-1, PKC-epsilon, TEC, VAV-1, Rac1, IP3 receptor, BAD, Syk, Cyclin D2, Talin, RAP-1A, Shc, PI3K reg class IA (p85), GSK3 beta, cPLA2, GSK3 alpha/beta, CREB1, MEK1/2, CDC42, IL3RA, E4BP4, AKT(PKB), Mcl-1, GAB2, ITGB1, JAK2, cPKC (conventional), PI3K cat class IA, B-Raf, Slp76, c-Cbl, Lyn, 14-3-3 zeta/delta, alpha-5/beta-1 integrin, SOS, C3G, PDE4, p90Rsk, PI3K cat class IA (p110-delta), Paxillin, PI3K cat class IA (p110-alpha), Calmodulin, SHP-2, FOXO3A, STAT5, Semaphorin 7A, R-Ras, p53, Calcineurin B (regulatory), PLC-gamma 2, Bim, Elk-1, PKA-cat (cAMP-dependent), LPCAT2, mTOR",3.822E-07,4.024E-06,57,"Calcineurin A (catalytic), PREL1, alpha-4/beta-1 integrin, NGAL, RPS6, ERK1/2, CrkL, c-Raf-1, GATA-1, PKC-epsilon, TEC, VAV-1, IP3 receptor, Syk, Cyclin D2, Talin, RAP-1A, Shc, PI3K reg class IA (p85), GSK3 beta, cPLA2, GSK3 alpha/beta, CREB1, MEK1/2, CDC42, IL3RA, E4BP4, AKT(PKB), Mcl-1, GAB2, ITGB1, JAK2, cPKC (conventional), PI3K cat class IA, B-Raf, Slp76, c-Cbl, Lyn, 14-3-3 zeta/delta, alpha-5/beta-1 integrin, SOS, PDE4, p90Rsk, PI3K cat class IA (p110-delta), PI3K cat class IA (p110-alpha), Calmodulin, STAT5, Semaphorin 7A, R-Ras, p53, Calcineurin B (regulatory), PLC-gamma 2, Bim, Elk-1, PKA-cat (cAMP-dependent), LPCAT2, mTOR",
126,Development_Negative regulation of WNT/Beta-catenin signaling at the receptor level,45,3.659E-08,5.069E-07,3.659E-08,5.069E-07,34,"DKK4, Sclerostin, NOTUM, AP complex 2 medium (mu) chain, DKK1, FZD4, SOSTDC1, CDON, Krm, Syndecans, Casein kinase II, GSK3 alpha/beta, SFRP, MESD, Amyloid beta, DKK2, c-Src, Axin, LRP1, LRP5/LRP6, SMURF1, Tcf(Lef), TIKI, APCDD1, RNF43, PEDF (serpinF1), FRMD8, LRP4, ZNRF3, WNT, LRP6, Glypican-6, AAK1, Frizzled",8.642E-05,3.296E-04,27,"NOTUM, AP complex 2 medium (mu) chain, DKK1, SOSTDC1, CDON, Krm, Syndecans, Casein kinase II, GSK3 alpha/beta, SFRP, MESD, Amyloid beta, c-Src, Axin, LRP1, SMURF1, Tcf(Lef), TIKI, APCDD1, PEDF (serpinF1), LRP4, ZNRF3, WNT, LRP6, Glypican-6, AAK1, Frizzled",
127,Immune response_TNF-R2 signaling pathways,45,3.659E-08,5.069E-07,3.659E-08,5.069E-07,34,"TNF-R2, AIP1 (DAB2ip), ERK1/2, VEGFR-2, ATF-2/c-Jun, I-kB, PI3K reg class IA (p85), NF-kB2 (p100), PI3K reg class IA, IKK-alpha, c-IAP1, NF-kB p52/RelB, NF-kB, AKT(PKB), NF-kB p50/p65, ZFP91, TNF-alpha, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), TRAF3, NF-kB2 (p52), ASK1 (MAP3K5), SMURF2, c-Jun, NIK(MAP3K14), BMF, MEK4(MAP2K4), BMX, AP-1, TRAF1, JNK(MAPK8-10), p38 MAPK, Bim",6.550E-06,3.810E-05,29,"TNF-R2, ERK1/2, VEGFR-2, I-kB, PI3K reg class IA (p85), NF-kB2 (p100), PI3K reg class IA, c-IAP1, NF-kB p52/RelB, NF-kB, AKT(PKB), NF-kB p50/p65, ZFP91, TNF-alpha, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), TRAF3, NF-kB2 (p52), ASK1 (MAP3K5), SMURF2, NIK(MAP3K14), BMF, MEK4(MAP2K4), BMX, TRAF1, JNK(MAPK8-10), p38 MAPK, Bim",
128,Signal transduction_JNK pathway,47,4.340E-08,5.902E-07,4.340E-08,5.902E-07,35,"GLK(MAP4K3), CRK, Elk-4, Rac1, ATF-2/c-Jun, NF-AT4(NFATC3), MAP3K2 (MEKK2), TPL2(MAP3K8), CDC42, FasL(TNFSF6), TNF-R1, TAK1(MAP3K7), NF-AT2(NFATC1), MEKK4(MAP3K4), TNF-alpha, MLK3(MAP3K11), HGK(MAP4K4), ASK1 (MAP3K5), c-Jun, DAXX, SOS, MKK7 (MAP2K7), JNK1(MAPK8), MEK4(MAP2K4), GCK(MAP4K2), HPK1(MAP4K1), AP-1, MEKK1(MAP3K1), MAP3K3, ATF-2, FasR(CD95), JNK(MAPK8-10), GCKR(MAP4K5), p53, Elk-1",7.661E-05,3.014E-04,28,"GLK(MAP4K3), CRK, c-Raf-1, Elk-4, NF-AT4(NFATC3), MAP3K2 (MEKK2), TPL2(MAP3K8), CDC42, TNF-R1, TAK1(MAP3K7), NF-AT2(NFATC1), TNF-alpha, HGK(MAP4K4), MLK3(MAP3K11), ASK1 (MAP3K5), DAXX, SOS, JNK1(MAPK8), MEK4(MAP2K4), GCK(MAP4K2), HPK1(MAP4K1), MAP3K3, ATF-2, FasR(CD95), JNK(MAPK8-10), GCKR(MAP4K5), p53, Elk-1",
129,Th2 cytokine- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,35,4.358E-08,7.946E-07,7.027E-08,8.688E-07,28,"TGF-beta 1, ICAM1, CCL2, IL-4R type I, ERK1/2, IL13RA1, GM-CSF, IL-13, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, TNF-R1, TNF-alpha, ITGB1, VCAM1, RelA (p65 NF-kB subunit), IL-8, IL-4R type II, c-Jun, Eotaxin-3, alpha-5/beta-1 integrin, IL4RA, COX-2 (PTGS2), Oncostatin M, JNK(MAPK8-10), ITGA5, Elk-1",4.358E-08,7.946E-07,27,"TGF-beta 1, ICAM1, CCL2, IL-4R type I, ERK1/2, IL13RA1, GM-CSF, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, TNF-R1, CD40L(TNFSF5), TNF-alpha, ITGB1, VCAM1, RelA (p65 NF-kB subunit), IL-8, IL-4R type II, Eotaxin-3, alpha-5/beta-1 integrin, IL4RA, COX-2 (PTGS2), Oncostatin M, JNK(MAPK8-10), ITGA5, Elk-1",
130,Immune response_Differentiation of natural regulatory T cells,35,4.358E-08,7.946E-07,2.678E-06,1.712E-05,26,"OX40L(TNFSF4), TGF-beta 1, MHC class II, JAK1, NF-AT1(NFATC2), CD28, OX40(TNFRSF4), TSLP, Ubiquitin, Itch, CD4, CTLA-4, IL-2R alpha chain, NF-AT2(NFATC1), IL-2, JAK2, GITR, TGF-beta receptor type II, JAK3, GITRL, STAT5, SMAD3, TIEG1, CD86, TGF-beta receptor type I, TSLPR",4.358E-08,7.946E-07,27,"OX40L(TNFSF4), TGF-beta 1, MHC class II, JAK1, CD28, OX40(TNFRSF4), TSLP, Ubiquitin, Itch, CD4, CTLA-4, NF-AT2(NFATC1), IL-2, CD40L(TNFSF5), JAK2, CD80, GITR, TGF-beta receptor type II, JAK3, STAT3, GITRL, STAT5, SMAD3, TIEG1, CD86, TGF-beta receptor type I, TSLPR",
131,Role of adhesion of SCLC cells in tumor progression,35,4.358E-08,7.946E-07,4.680E-07,4.167E-06,27,"NCAM1, alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, ICAM1, Bombesin receptor, alpha-V/beta-1 integrin, Fibronectin, Rac1, Tenascin-C, MMP-2, CDC42, Collagen IV, Stromelysin-1, P-selectin, CXCR4, RhoA, alpha-3/beta-1 integrin, N-cadherin, ITGB1, VCAM1, Laminin 1, alpha-5/beta-1 integrin, ACM3, MMP-14, alpha-2/beta-1 integrin, PTHrP, Caveolin-1",4.358E-08,7.946E-07,27,"NCAM1, alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, ICAM1, Bombesin receptor, alpha-V/beta-1 integrin, IFN-gamma, Fibronectin, Tenascin-C, MMP-2, CDC42, Collagen IV, Stromelysin-1, P-selectin, CXCR4, RhoA, alpha-3/beta-1 integrin, N-cadherin, ITGB1, VCAM1, Laminin 1, alpha-5/beta-1 integrin, ACM3, MMP-14, alpha-2/beta-1 integrin, PTHrP, Caveolin-1",
132,Immune response_Th17 cell differentiation,35,4.358E-08,7.946E-07,2.235E-04,6.399E-04,23,"TGF-beta 1, MHC class II, NF-AT1(NFATC2), CD28, IL-17 receptor, IL-22, IL-1 beta, IL-17F, CD4, IL-6, NF-kB, IL-23, NF-AT2(NFATC1), JAK2, TGF-beta receptor type II, IL-22 receptor, IRF4, JAK3, IL23A, IL-21 receptor, IL-12 beta, CD86, TGF-beta receptor type I",4.358E-08,7.946E-07,27,"TGF-beta 1, MHC class II, CD28, IL-17, IL-17 receptor, IL-22, IL-1 beta, IL-17F, CD4, IL-6, NF-kB, IL-23, NF-AT2(NFATC1), JAK2, CD80, ROR-alpha, TGF-beta receptor type II, IL-22 receptor, IRF4, JAK3, STAT3, IL23A, IL-21 receptor, IL-21, IL-12 beta, CD86, TGF-beta receptor type I",
133,Development_VEGF signaling via VEGFR2 - generic cascades,93,4.490E-08,7.991E-07,2.361E-07,2.386E-06,57,"SPHK1, Calcineurin A (catalytic), NCK1, CCL2, SHC2, TCF7L2 (TCF4), ROCK1, eIF4E, ERK1/2, Beta-catenin, VEGF-A, VEGFR-2, Rac1, IP3 receptor, I-kB, Shc, p120GAP, GSK3 beta, PI3K reg class IA, PLC-gamma 1, alpha-V/beta-3 integrin, MEK2(MAP2K2), CREB1, PLAUR (uPAR), CDC42, Actin cytoskeletal, Fyn, ERK2 (MAPK1), AKT(PKB), HSP90, NF-kB p50/p65, c-Src, TSAD, NF-AT2(NFATC1), MLCK, RhoA, Pyk2(FAK2), PI3K cat class IA, iNOS, MEK3(MAP2K3), c-Jun, SOS, MNK1, p90Rsk, PLAU (UPA), Paxillin, COX-2 (PTGS2), PKC-beta, Calmodulin, PKC, MEKK1(MAP3K1), Vinculin, PKC-alpha, Neurofibromin, SHB, Calcineurin B (regulatory), p38 MAPK",4.490E-08,7.991E-07,55,"SPHK1, Calcineurin A (catalytic), NCK1, CCL2, SHC2, TCF7L2 (TCF4), ROCK1, ERK1/2, Beta-catenin, VEGF-A, c-Raf-1, VEGFR-2, IP3 receptor, I-kB, Shc, COX-1 (PTGS1), p120GAP, GSK3 beta, PI3K reg class IA, PLC-gamma 1, alpha-V/beta-3 integrin, MEK2(MAP2K2), CREB1, PLAUR (uPAR), CDC42, Actin cytoskeletal, Fyn, ERK2 (MAPK1), AKT(PKB), HSP90, NF-kB p50/p65, c-Src, TSAD, NF-AT2(NFATC1), MLCK, MEK1(MAP2K1), RhoA, Pyk2(FAK2), PI3K cat class IA, iNOS, MEK3(MAP2K3), SOS, MNK1, p90Rsk, PLAU (UPA), COX-2 (PTGS2), PKC-beta, Calmodulin, PKC, Vinculin, PKC-alpha, Neurofibromin, SHB, Calcineurin B (regulatory), p38 MAPK",
134,Immune response_Gastrin in inflammatory response,68,4.751E-08,6.404E-07,4.751E-08,6.404E-07,46,"GRO-2, ERK5 (MAPK7), IRS-1, LARG, MEF2C, HB-EGF, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, ATF-2/c-Jun, I-kB, Shc, PI3K reg class IA (p85), IKK-alpha, PLC-gamma 1, MAP2K5 (MEK5), MEK2(MAP2K2), CREB1, PAI2, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, Gastrin 17, Stromelysin-1, c-Src, TAK1(MAP3K7), RhoA, PI3K cat class IA, PKC-delta, CCKBR, IL-8, EGFR, TRAF6, c-Jun, SOS, MEF2, NIK(MAP3K14), MEK4(MAP2K4), COX-2 (PTGS2), ELAVL1 (HuR), MEKK1(MAP3K1), PKC-alpha, ATF-2, G-protein alpha-q, JNK(MAPK8-10), Elk-1",3.675E-06,2.346E-05,40,"GRO-2, p38alpha (MAPK14), ERK5 (MAPK7), MEF2C, HB-EGF, c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, I-kB, Shc, PI3K reg class IA (p85), PLC-gamma 1, MAP2K5 (MEK5), MEK2(MAP2K2), CREB1, PAI2, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, Gastrin 17, Stromelysin-1, c-Src, TAK1(MAP3K7), MEK1(MAP2K1), RhoA, PI3K cat class IA, IL-8, EGFR, TRAF6, SOS, MEF2, NIK(MAP3K14), MEK4(MAP2K4), COX-2 (PTGS2), ELAVL1 (HuR), PKC-alpha, ATF-2, JNK(MAPK8-10), Elk-1",
135,Normal and pathological TGF-beta-mediated regulation of cell proliferation,33,5.002E-08,6.681E-07,5.002E-08,6.681E-07,27,"TGF-beta 1, ITGAV, Beta-catenin, SMAD4, PDGF-R-alpha, SMAD2, Rac1, Shc, GSK3 beta, PDGF receptor, c-Src, c-Myc, Axin, MLK3(MAP3K11), ITGB3, TGF-beta receptor type II, MEK3(MAP2K3), PDGF-A, FGF2, SOS, c-Abl, JNK(MAPK8-10), SMAD3, p53, p38 MAPK, TGF-beta receptor type I, PDGF-R-beta",2.596E-07,3.207E-06,25,"TGF-beta 1, ITGAV, Beta-catenin, SMAD4, PDGF-R-alpha, SMAD2, Shc, GSK3 beta, PDGF receptor, c-Src, Axin, MLK3(MAP3K11), ITGB3, TGF-beta receptor type II, MEK3(MAP2K3), PDGF-A, FGF2, SOS, c-Abl, JNK(MAPK8-10), SMAD3, p53, p38 MAPK, TGF-beta receptor type I, PDGF-R-beta",
136,Role of tumor-infiltrating B cells in anti-tumor immunity,91,5.058E-08,8.792E-07,2.069E-06,1.394E-05,54,"IL-18R1, MLANA, MHC class II, IP10, JAK1, DHFR, POLR2B, Apo-2L(TNFSF10), IFN-alpha/beta receptor, Dsk2 (ubiquilin-2), Perforin, STAT1, ADAM-TS9, MAGE-3, IFN-alpha, ACAT2, CD4, MHC class I, G-protein beta/gamma, Kappa chain (Ig light chain), FasL(TNFSF6), NF-kB, CXCR4, IL-2, G3P2, IL-12 receptor, IL-18, MAGEC1, CD38, I-TAC, T-bet, G-protein alpha-i family, IFN-gamma receptor, IL4RA, Bcl-6, IRF4, RGS1, JAK3, CXCR3, NY-ESO-1, CD8, CXorf61, ATF-2, RGS13, FasR(CD95), CXCL13, KTN1, JNK2(MAPK9), IL-21 receptor, MAGEC2, p53, IL-12 beta, MAGEA10, BLIMP1 (PRDI-BF1)",5.058E-08,8.792E-07,54,"MIG, IL-18R1, MLANA, MHC class II, IP10, JAK1, DHFR, IFN-gamma, CXCR5, POLR2B, Apo-2L(TNFSF10), IFN-alpha/beta receptor, Dsk2 (ubiquilin-2), STAT1, ADAM-TS9, MAGE-3, IFN-alpha, ACAT2, CD4, MHC class I, MAGE-4 antigen, G-protein beta/gamma, NF-kB, CXCR4, IL-2, CD40L(TNFSF5), IL-12 receptor, IL-18, MAGEC1, CD38, I-TAC, T-bet, G-protein alpha-i family, IFN-gamma receptor, IL4RA, Bcl-6, IRF4, RGS1, JAK3, STAT3, CD8, CXorf61, ATF-2, RGS13, FasR(CD95), CXCL13, KTN1, JNK2(MAPK9), IL-21 receptor, p53, IL-21, IL-12 beta, MAGEA10, BLIMP1 (PRDI-BF1)",
137,Stem cells_Response to hypoxia in glioblastoma stem cells,40,5.319E-08,6.979E-07,5.319E-08,6.979E-07,31,"SMAD5, NOTCH1 receptor, BMP receptor 2, HES5, VHL, BMP4, ID1, VEGF-A, SMAD4, Jagged2, Ubiquitin, Nucleophosmin, BMPR1B, RBP-J kappa (CBF1), NOTCH1 (NICD), ARNT, HEY1, HIF1A, HIF-1, SMAD9 (SMAD8), DLL4, Noggin, HES1, BMPR1A, SMAD1, HIF-prolyl hydroxylase, NOTCH1 (NEXT), p53, Jagged1, ADAM17, BMP2",6.079E-05,2.463E-04,25,"SMAD5, NOTCH1 receptor, BMP receptor 2, HES5, VHL, BMP4, ID1, VEGF-A, SMAD4, Jagged2, Ubiquitin, BMPR1B, RBP-J kappa (CBF1), NOTCH1 (NICD), HIF1A, SMAD9 (SMAD8), Noggin, HES1, BMPR1A, HIF-prolyl hydroxylase, NOTCH1 (NEXT), p53, Jagged1, ADAM17, BMP2",
138,Immune response_IFN-gamma actions on blood cells,28,5.458E-08,9.380E-07,3.296E-06,2.063E-05,22,"PD-L2, JAK1, SOCS1, IRF1, HBZ, HNF3-beta, STAT1, IL-15, Survivin, SOCS3, CREB1, IL-6, BAFF(TNFSF13B), JAK2, T-bet, c-Jun, Uteroglobin, IFN-gamma receptor, Bcl-6, K12, Alpha1-globin, PD-L1",5.458E-08,9.380E-07,23,"IRF8, PD-L2, JAK1, IFN-gamma, SOCS1, GATA-1, IRF1, HBZ, HNF3-beta, STAT1, IL-15, Survivin, SOCS3, CREB1, IL-6, BAFF(TNFSF13B), JAK2, T-bet, IFN-gamma receptor, Bcl-6, K12, Alpha1-globin, PD-L1",
139,HGF signaling in melanoma,39,5.648E-08,9.487E-07,6.752E-07,5.612E-06,29,"CD44, ERK1/2, Beta-catenin, EGR1, Fibronectin, PI3K reg class IA (p85), GSK3 beta, N-Ras, TWIST1, AKT(PKB), alpha-MSH, MC1R, HGF, N-cadherin, PI3K cat class IA, B-Raf, Desmoglein 1, NF-kB2 (p52), HIF1A, C/EBPbeta, PKC-beta2, PKC-alpha, ATF-2, SLUG, JNK(MAPK8-10), HGF receptor (Met), p38 MAPK, Elk-1, MITF",5.648E-08,9.487E-07,29,"CD44, ERK1/2, Beta-catenin, Fibronectin, PI3K reg class IA (p85), GSK3 beta, N-Ras, TWIST1, AKT(PKB), alpha-MSH, MC1R, HGF, MEK1(MAP2K1), N-cadherin, PI3K cat class IA, B-Raf, Desmoglein 1, NF-kB2 (p52), HIF1A, C/EBPbeta, PKC-beta2, PKC-alpha, ATF-2, SLUG, JNK(MAPK8-10), HGF receptor (Met), p38 MAPK, Elk-1, MITF",
140,Resistance of melanoma cells to Apo-2L(TNFSF10)-induced apoptosis,39,5.648E-08,9.487E-07,1.515E-05,7.193E-05,27,"DR5(TNFRSF10B), Apaf-1, ERK1/2, c-FLIP(Long), Apo-2L(TNFSF10), Bak, Caspase-8, PKC-epsilon, TRUNDD(TNFRSF10D), PI3K reg class IA (p85), Bax, Survivin, IFN-alpha, Caspase-3, DR4(TNFRSF10A), Mcl-1, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), B-Raf, XIAP, Caspase-9, IFNA2, tBid, c-FLIP(Short), p53, Bid",5.648E-08,9.487E-07,29,"DR5(TNFRSF10B), Apaf-1, ERK1/2, c-FLIP(Long), c-Raf-1, Apo-2L(TNFSF10), Caspase-8, PKC-epsilon, TRUNDD(TNFRSF10D), PI3K reg class IA (p85), Bax, Survivin, IFN-alpha, Caspase-3, DR4(TNFRSF10A), Mcl-1, MEK1(MAP2K1), JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), B-Raf, XIAP, Caspase-9, IFNA2, STAT3, tBid, c-FLIP(Short), p53, Bid",
141,Signal transduction_CXCR4 signaling via MAPKs cascades,53,6.327E-08,8.160E-07,6.327E-08,8.160E-07,38,"IL-10, IRS-1, ERK1/2, EGR1, p90RSK2(RPS6KA3), G-protein alpha-i2, Rac1, Beta-arrestin2, BAD, Ubiquitin, ZAP70, N-Ras, CREB1, IL-6, MEK1/2, G-protein beta/gamma, c-Src, CXCR4, IL-2, Plectin 1, RhoA, RelA (p65 NF-kB subunit), NF-kB1 (p50), G-protein alpha-i family, c-Jun, GAD1, CD69, ROCK, AP-1, PAK, MEKK1(MAP3K1), CD3, CD3 zeta, JNK(MAPK8-10), SMAD3, CTGF, p38 MAPK, Elk-1",1.622E-05,8.480E-05,32,"IL-10, ERK1/2, p90RSK2(RPS6KA3), c-Raf-1, G-protein alpha-i2, Beta-arrestin2, Ubiquitin, N-Ras, CREB1, IL-6, MEK1/2, G-protein beta/gamma, c-Src, CXCR4, IL-2, Plectin 1, MEK1(MAP2K1), RhoA, RelA (p65 NF-kB subunit), NF-kB1 (p50), G-protein alpha-i family, GAD1, CD69, ROCK, PAK, CD3, CD3 zeta, JNK(MAPK8-10), SMAD3, CTGF, p38 MAPK, Elk-1",
142,Gamma-Secretase regulation of neuronal cell development and function,57,6.374E-08,1.047E-06,1.232E-06,8.896E-06,38,"CBP, NGFR(TNFRSF16), GFAP, BACE1, Beta-catenin, APP-C99, N-cadherin (CTF1), TFCP2, APP, Tip60, NGFR (ICD), GSK3 beta, betaAPPs, CREB1, Transgelin, NRIF, N-cadherin (CTF2), N-CoR, Amyloid beta, ADAM10, Fe65, RhoA, N-cadherin, ErbB4(CTF), S100B, TRAF6, ErbB4, ErbB4(ICD), RhoGDI alpha, NGF, NGFR (CTF), ACTA2, MAG, Tropomyosin-1, Amyloid beta 40, ADAM17, BDNF, APP-C59 (AICD)",6.374E-08,1.047E-06,38,"CBP, NGFR(TNFRSF16), GFAP, BACE1, Neuregulin 1, Beta-catenin, APP-C99, N-cadherin (CTF1), TFCP2, APP, Tip60, NGFR (ICD), GSK3 beta, betaAPPs, CREB1, Transgelin, NRIF, N-cadherin (CTF2), N-CoR, Amyloid beta, ADAM10, Fe65, RhoA, N-cadherin, ErbB4(CTF), S100B, TRAF6, ErbB4, ErbB4(ICD), RhoGDI alpha, NGF, NGFR (CTF), ACTA2, Tropomyosin-1, Amyloid beta 40, ADAM17, BDNF, APP-C59 (AICD)",
143,Immune response_IL-7 signaling in B lymphocytes,43,6.519E-08,1.059E-06,1.729E-03,3.753E-03,25,"STAT5A, IL-7 receptor, RAG1, IL-7, JAK1, ERK1/2, STAT5B, Pim-1, STAT1, Cyclin D2, PAX5, FKHR, MEK2(MAP2K2), Oct-1, Fyn, AKT(PKB), IL7RA, PI3K reg class IA (p85-alpha), Lyn, SOS1, JAK3, PI3K cat class IA (p110-alpha), EBF, IL-2R gamma chain, STAT5",6.519E-08,1.059E-06,31,"STAT5A, IL-7 receptor, RAG1, IL-7, JAK1, ERK1/2, c-Raf-1, STAT5B, RAG2, Pim-1, STAT1, Cyclin D2, PAX5, FKHR, RAG1/2 complex, MEK2(MAP2K2), Oct-1, Fyn, AKT(PKB), MEK1(MAP2K1), IL7RA, PI3K reg class IA (p85-alpha), Lyn, SOS1, JAK3, STAT3, Ig heavy chain, PI3K cat class IA (p110-alpha), EBF, IL-2R gamma chain, STAT5",
144,Apoptosis and survival_Apoptotic TNF-family pathways,42,6.604E-08,8.302E-07,6.604E-08,8.302E-07,32,"TNF-R2, NGFR(TNFRSF16), DR5(TNFRSF10B), DR3(TNFRSF12), Apo-2L(TNFSF10), DR6(TNFRSF21), Caspase-8, Bax, c-IAP1, Caspase-3, RIPK1, Caspase-2, FasL(TNFSF6), DR4(TNFRSF10A), TNF-R1, TNF-alpha, LTBR(TNFRSF3), GITR, TRAF3, XIAP, CD70(TNFSF7), Caspase-9, NGF, Caspase-10, Caspase-7, tBid, GITRL, FasR(CD95), NADE(NGFRAP1), LIGHT(TNFSF14), TWEAK(TNFSF12), Bid",1.495E-07,2.097E-06,30,"TNF-R2, NGFR(TNFRSF16), DR5(TNFRSF10B), DR3(TNFRSF12), Apo-2L(TNFSF10), DR6(TNFRSF21), Caspase-8, Bax, c-IAP1, Caspase-3, RIPK1, Caspase-2, DR4(TNFRSF10A), TNF-R1, TNF-alpha, LTBR(TNFRSF3), GITR, TRAF3, XIAP, CD70(TNFSF7), Caspase-9, NGF, Caspase-10, tBid, GITRL, FasR(CD95), NADE(NGFRAP1), LIGHT(TNFSF14), TWEAK(TNFSF12), Bid",
145,Development_NOTCH in inhibition of WNT/Beta-catenin-induced osteogenesis,42,6.604E-08,8.302E-07,6.604E-08,8.302E-07,32,"COL1A1, STAT5A, NOTCH1 receptor, GCR, WNT3A, RANKL(TNFSF11), APC protein, Beta-catenin, Dsh, NOTCH2 (2ICD), GSK3 beta, LRP5, RBP-J kappa (CBF1), PPAR-gamma, Axin, TCF7 (TCF1), NOTCH1 (NICD), HEY1, Osteocalcin, MAML1, ALPL, NOTCH2, WNT1, RUNX2, HES1, WNT, WNT10B, NOTCH1 (NEXT), Jagged1, ADAM17, Frizzled, C/EBPdelta",1.460E-05,7.742E-05,27,"COL1A1, STAT5A, NOTCH1 receptor, GCR, RANKL(TNFSF11), APC protein, Beta-catenin, Dsh, NOTCH2 (2ICD), GSK3 beta, RBP-J kappa (CBF1), PPAR-gamma, Axin, TCF7 (TCF1), NOTCH1 (NICD), A-FABP, Osteocalcin, ALPL, NOTCH2, RUNX2, HES1, WNT, NOTCH1 (NEXT), Jagged1, ADAM17, Frizzled, C/EBPdelta",
146,Apoptosis and survival_Lymphotoxin-beta receptor signaling,42,6.604E-08,8.302E-07,6.604E-08,8.302E-07,32,"Apaf-1, I-kB, Bax, NF-kB2 (p100), IKK-alpha, c-IAP1, NF-kB p52/RelB, Caspase-3, NF-kB p50/p65, IL-2, LTBR(TNFRSF3), VCAM1, RelA (p65 NF-kB subunit), TRAF3, NF-kB1 (p50), NF-kB2 (p52), IL-8, ASK1 (MAP3K5), c-Jun, CCL19, RelB (NF-kB subunit), Caspase-9, NIK(MAP3K14), MKK7 (MAP2K7), MEK4(MAP2K4), Caspase-7, MEKK1(MAP3K1), TNF-beta, CXCL13, LTB, JNK(MAPK8-10), LIGHT(TNFSF14)",3.516E-06,2.317E-05,28,"CCL21, Apaf-1, I-kB, Bax, NF-kB2 (p100), c-IAP1, NF-kB p52/RelB, Caspase-3, NF-kB p50/p65, IL-2, LTBR(TNFRSF3), VCAM1, RelA (p65 NF-kB subunit), TRAF3, NF-kB1 (p50), NF-kB2 (p52), IL-8, ASK1 (MAP3K5), CCL19, RelB (NF-kB subunit), Caspase-9, NIK(MAP3K14), MEK4(MAP2K4), TNF-beta, CXCL13, LTB, JNK(MAPK8-10), LIGHT(TNFSF14)",
147,Inhibition of oligodendrocyte precursor cells differentiation by Wnt signaling in multiple sclerosis,25,6.815E-08,8.496E-07,6.815E-08,8.496E-07,22,"WNT3A, APC protein, Lef-1, TCF7L2 (TCF4), Beta-catenin, FZD4, Dsh, GLI-2, GSK3 beta, FZD2, LRP5, FZD7, Axin, GLI-3R, WNT1, WNT5A, GLI-3, WNT, OLIG2, FZD1, GLI-1, Frizzled",2.141E-04,6.667E-04,17,"APC protein, TCF7L2 (TCF4), Beta-catenin, Dsh, GLI-2, GSK3 beta, FZD2, FZD7, Axin, GLI-3R, WNT5A, GLI-3, WNT, OLIG2, FZD1, GLI-1, Frizzled",
148,Signal transduction_Soluble CXCL16 signaling,49,6.976E-08,1.110E-06,1.090E-06,8.402E-06,34,"RHEB2, CD44, IL-10, RANKL(TNFSF11), ERK1/2, VEGF-A, PI3K cat class IB (p110-gamma), I-kB, ARHGEF2, alpha-IIb/beta-3 integrin, IKK-alpha, MMP-2, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), Stromelysin-1, P-selectin, TNF-alpha, RhoA, JAK2, Osteopontin, HIF1A, IL-8, G-protein alpha-i family, F-Actin cytoskeleton, CXCL16, 4E-BP1, ROCK, JNK(MAPK8-10), p38 MAPK, MMP-9, Cofilin, mTOR",6.976E-08,1.110E-06,34,"RHEB2, CD44, IL-10, RANKL(TNFSF11), ERK1/2, VEGF-A, c-Raf-1, PI3K cat class IB (p110-gamma), I-kB, ARHGEF2, alpha-IIb/beta-3 integrin, MMP-2, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), Stromelysin-1, P-selectin, TNF-alpha, RhoA, JAK2, Osteopontin, HIF1A, IL-8, G-protein alpha-i family, F-Actin cytoskeleton, CXCL16, STAT3, ROCK, JNK(MAPK8-10), p38 MAPK, MMP-9, Cofilin, mTOR",
149,Inhibition of Ephrin receptors in colorectal cancer,30,7.957E-08,9.757E-07,7.957E-08,9.757E-07,25,"Ephrin-B receptor 4, c-Rel (NF-kB subunit), TCF7L2 (TCF4), Beta-catenin, Ephrin-A receptor 3, Ephrin-A receptor 2, Rac1, RAP-1A, CDC42, Ephrin-B1, RhoA, KLF5, Ephrin-A receptors, Ephrin-B receptor 3, Ephrin-B receptor 1, Paxillin, ROCK, Ephrin-B, WNT, Ephrin-B receptor 2, SMAD3, Ephrin-A, Ephrin-B2, Ephrin-B receptors, Frizzled",1.917E-05,9.273E-05,21,"Ephrin-B receptor 4, c-Rel (NF-kB subunit), TCF7L2 (TCF4), Beta-catenin, Ephrin-A receptor 2, RAP-1A, CDC42, Ephrin-B1, RhoA, KLF5, Ephrin-A receptors, Ephrin-B receptor 1, ROCK, Ephrin-B, WNT, Ephrin-B receptor 2, SMAD3, Ephrin-A, Ephrin-B2, Ephrin-B receptors, Frizzled",
150,Expression targets of Tissue factor signaling in cancer,22,8.400E-08,1.011E-06,8.400E-08,1.011E-06,20,"GFPT2, PAR2, Coagulation factor X, GRO-1, Thrombin, GM-CSF, NFKBIE, Cyr61, PLAUR (uPAR), PTX3, ITGB1, IL-8, CSF1, Tissue factor, Coagulation factor V, PLAU (UPA), VEGF-C, PAR1, CTGF, PAI1",1.769E-07,2.341E-06,19,"GFPT2, PAR2, Coagulation factor X, GRO-1, GM-CSF, NFKBIE, Cyr61, PLAUR (uPAR), PTX3, ITGB1, IL-8, CSF1, Tissue factor, Coagulation factor V, PLAU (UPA), VEGF-C, PAR1, CTGF, PAI1",
151,DKK1 signaling in multiple myeloma,19,8.447E-08,1.011E-06,8.447E-08,1.011E-06,18,"WNT3A, RANKL(TNFSF11), Krm1, DKK1, Beta-catenin, Dsh, GSK3 beta, LRP5, IL-6, Osteoprotegerin, Axin, RelA (p65 NF-kB subunit), Tcf(Lef), ALPL, LRP6, JNK(MAPK8-10), BMP2, Frizzled",3.544E-06,2.324E-05,16,"RANKL(TNFSF11), Krm1, DKK1, Beta-catenin, Dsh, GSK3 beta, IL-6, Osteoprotegerin, Axin, RelA (p65 NF-kB subunit), Tcf(Lef), ALPL, LRP6, JNK(MAPK8-10), BMP2, Frizzled",
152,Immune response_ETV3 affect on CSF1-promoted macrophage differentiation,19,8.447E-08,1.011E-06,8.447E-08,1.011E-06,18,"MSR1, SMRT, M-CSF receptor, MSK1/2 (RPS6KA5/4), CDK1 (p34), CREM (activators), HDAC2, CREB1, N-CoR, c-Myc, Sin3A, PRIM2A, ETS2, HDAC5, CSF1, PLAU (UPA), ETV3, p38 MAPK",2.812E-07,3.408E-06,17,"MSR1, SMRT, M-CSF receptor, MSK1/2 (RPS6KA5/4), CDK1 (p34), CREM (activators), HDAC2, CREB1, N-CoR, Sin3A, PRIM2A, ETS2, HDAC5, CSF1, PLAU (UPA), ETV3, p38 MAPK",
153,Neuroprotective action of lithium,63,8.736E-08,1.037E-06,8.736E-08,1.037E-06,43,"CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PP1-cat, Beta-catenin, VEGF-A, Dsh, Bax, GSK3 beta, NR2, Caspase-3, CREB1, Calpain 1(mu), HSP70, Amyloid beta, c-Src, Axin, Pyk2(FAK2), Thioredoxin, IPP-2, ASK1 (MAP3K5), MEK3(MAP2K3), c-Jun, CDK5R1 (p25), p300, MKK7 (MAP2K7), nNOS, NR2A, JNK1(MAPK8), NR2B, MEK4(MAP2K4), HSF1, ATF-2, WNT, FZD5, PSD-95, JNK2(MAPK9), p53, Calcineurin B (regulatory), p38 MAPK, Bim, BDNF, Frizzled",7.928E-07,6.773E-06,39,"p38alpha (MAPK14), CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PP1-cat, Beta-catenin, VEGF-A, Dsh, Bax, GSK3 beta, NR2, Caspase-3, CREB1, Calpain 1(mu), HSP70, Amyloid beta, c-Src, Axin, Pyk2(FAK2), ASK1 (MAP3K5), MEK3(MAP2K3), CDK5R1 (p25), p300, NR2A, nNOS, JNK1(MAPK8), NR2B, MEK4(MAP2K4), ATF-2, WNT, FZD5, PSD-95, JNK2(MAPK9), p53, Calcineurin B (regulatory), p38 MAPK, Bim, BDNF, Frizzled",
154,Attenuation of IFN type I signaling in melanoma cells,37,9.327E-08,1.099E-06,9.327E-08,1.099E-06,29,"IP10, JAK1, Tyk2, HLA-A, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IRF1, IFNAR1, TAP, IFN-beta, VAV-1, STAT1, Rac1, TAP1 (PSF1), IFN-alpha, MHC class I, c-Myc, PSMB8(LMP7), I-TAC, c-Jun, IFNAR2, PSMB9, IRF9, Tapasin, JNK1(MAPK8), MEK4(MAP2K4), PNPase(old-35), MEKK1(MAP3K1), TAP2 (PSF2)",3.129E-07,3.604E-06,27,"p38alpha (MAPK14), IP10, JAK1, Tyk2, HLA-A, Apo-2L(TNFSF10), IFN-alpha/beta receptor, IRF1, IFNAR1, TAP, IFN-beta, VAV-1, STAT1, TAP1 (PSF1), IFN-alpha, MHC class I, PSMB8(LMP7), I-TAC, IFNAR2, PSMB9, IRF9, Tapasin, JNK1(MAPK8), MEK4(MAP2K4), STAT3, PNPase(old-35), TAP2 (PSF2)",
155,Endothelin-1- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,20,9.872E-08,1.554E-06,6.480E-06,3.590E-05,17,"TGF-beta 1, ICAM1, IL-1 beta, Endothelin-1, IL-6, NF-kB, NF-kB p50/p65, TNF-R1, TNF-alpha, TGF-beta 2, RelA (p65 NF-kB subunit), ADAM33, COX-2 (PTGS2), NGF, IL-33, EDNRA, IL-11",9.872E-08,1.554E-06,18,"TGF-beta 1, ICAM1, IFN-gamma, IL-1 beta, Endothelin-1, IL-6, NF-kB, NF-kB p50/p65, TNF-R1, TNF-alpha, TGF-beta 2, RelA (p65 NF-kB subunit), ADAM33, COX-2 (PTGS2), NGF, IL-33, EDNRA, IL-11",
156,Role of IFN-beta in inhibition of Th1 cell differentiation in multiple sclerosis,34,1.068E-07,1.646E-06,2.737E-05,1.177E-04,24,"CBP, IL-18R1, MHC class II, JAK1, IL-10, CD28, IFN-alpha/beta receptor, IFN-beta, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, CREB1, IL-10 receptor, NF-kB, AKT(PKB), PI3K cat class IA, IL-12 receptor, IL-18, IFN-gamma receptor, TLR4, PD-1, IL-12 beta, CD86, PD-L1",1.068E-07,1.646E-06,26,"CBP, IL-18R1, MHC class II, JAK1, IL-10, IFN-gamma, CD28, IFN-alpha/beta receptor, IFN-beta, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, CREB1, IL-10 receptor, NF-kB, AKT(PKB), CD80, PI3K cat class IA, IL-12 receptor, IL-18, IFN-gamma receptor, TLR4, PD-1, IL-12 beta, CD86, PD-L1",
157,Immune response_IL-10 signaling pathway,62,1.130E-07,1.706E-06,2.314E-06,1.499E-05,40,"IKBZ, MHC class II, IL-1 alpha, JAK1, IL10RA, ICAM1, IRS-2, IL-10, Tyk2, ALOX5AP, STAT1, IL-1 beta, PCBP-1, CD14, PI3K reg class IA, p19, GM-CSF, SOCS3, IL-6, IL-10 receptor, NF-kB, SHIP, AKT(PKB), NF-kB p50/p65, TNF-alpha, Heme oxygenase 1, PI3K cat class IA, iNOS, NF-kB1 (p50), IL10RB, IL-8, CRP2, Fc gamma RII alpha, TIMP1, COX-2 (PTGS2), STAT5, HDAC1, IL-12 beta, MMP-9, CD86",1.130E-07,1.706E-06,40,"IKBZ, MHC class II, IL-1 alpha, JAK1, IL10RA, ICAM1, IRS-2, IL-10, Tyk2, ALOX5AP, STAT1, IL-1 beta, CD14, PI3K reg class IA, p19, GM-CSF, SOCS3, IL-6, IL-10 receptor, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-alpha, Heme oxygenase 1, CD80, PI3K cat class IA, iNOS, NF-kB1 (p50), IL10RB, IL-8, CRP2, Fc gamma RII alpha, TIMP1, STAT3, COX-2 (PTGS2), STAT5, HDAC1, IL-12 beta, MMP-9, CD86",
158,Cell cycle_Role of APC in cell cycle regulation,32,1.173E-07,1.360E-06,1.173E-07,1.360E-06,26,"Cyclin B, Nek2A, CDC20, MAD2a, MAD2b, Kid, CDC25A, BUB1, CDK1 (p34), CKS1, RASSF1, BUBR1, SKP2, Emi1, PLK1, ORC1L, BUB3, CDC14a, Geminin, Aurora-A, Securin, CDK2, Tome-1, Cyclin A, Aurora-B, PKA-cat (cAMP-dependent)",6.250E-07,5.877E-06,24,"Cyclin B, Nek2A, CDC20, MAD2a, MAD2b, CDC25A, BUB1, CDK1 (p34), CKS1, RASSF1, BUBR1, SKP2, Emi1, PLK1, ORC1L, BUB3, CDC14a, Geminin, Securin, CDK2, Tome-1, Cyclin A, Aurora-B, PKA-cat (cAMP-dependent)",
159,Cell cycle_Start of DNA replication in early S phase,32,1.173E-07,1.360E-06,1.173E-07,1.360E-06,26,"ORC2L, MCM5, DP1, MCM10, ORC6L, DNA polymerase alpha/primase, ORC4L, MCM4/6/7 complex, MCM2, CDC45L, MCM3, CDC7, ORC1L, MCM4, ORC3L, ASK (Dbf4), PP2A catalytic, Geminin, CDK2, Cyclin E, RPA1, ORC5L, Cdt1, HP1 alpha, DRF1, RPA2",3.703E-06,2.346E-05,23,"ORC2L, MCM5, DP1, MCM10, ORC6L, ORC4L, MCM4/6/7 complex, MCM2, CDC45L, MCM3, CDC7, ORC1L, MCM4, ASK (Dbf4), PP2A catalytic, Geminin, CDK2, Cyclin E, RPA1, Cdt1, HP1 alpha, DRF1, RPA2",
160,Pro-inflammatory action of Gastrin in gastric cancer,50,1.186E-07,1.365E-06,1.186E-07,1.365E-06,36,"GRO-2, IRS-1, LARG, ERK1/2, HB-EGF, G-protein alpha-q/11, I-kB, Shc, PI3K reg class IA (p85), IKK-alpha, MEK2(MAP2K2), CREB1, PAI2, AKT(PKB), NF-kB p50/p65, Gastrin 17, Progastrin, Stromelysin-1, c-Src, TAK1(MAP3K7), RhoA, PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-delta, CCKBR, IL-8, EGFR, TRAF6, c-Jun, SOS, NIK(MAP3K14), COX-2 (PTGS2), ELAVL1 (HuR), AP-1, MEKK1(MAP3K1), G-protein alpha-q",3.528E-05,1.570E-04,30,"GRO-2, p38alpha (MAPK14), ERK1/2, HB-EGF, c-Raf-1, G-protein alpha-q/11, I-kB, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), CREB1, PAI2, AKT(PKB), NF-kB p50/p65, Gastrin 17, Progastrin, Stromelysin-1, c-Src, TAK1(MAP3K7), MEK1(MAP2K1), RhoA, PI3K cat class IA, RelA (p65 NF-kB subunit), IL-8, EGFR, TRAF6, SOS, NIK(MAP3K14), COX-2 (PTGS2), ELAVL1 (HuR)",
161,Th2 cytokine- and TNF-alpha-induced profibrotic response in asthmatic airway fibroblasts/ myofibroblasts,52,1.304E-07,1.489E-06,1.304E-07,1.489E-06,37,"COL1A1, Biglycan, TGF-beta 1, TrkA, IL-4R type I, ERK1/2, PDGF-R-alpha, IL-1 beta, Decorin, Tenascin-C, HAS2, IL-13, MMP-2, MEK1/2, COL1A2, NF-kB, AKT(PKB), TNF-R1, TNF-alpha, FAN, ETS1, IL-4R type II, c-Jun, PDGF-A, TIMP1, Collagen III, COX-2 (PTGS2), NGF, AP-1, HAS1, ACTA2, JNK(MAPK8-10), SMAD3, p38 MAPK, des-Arg10-kallidin, MMP-9, Collagen I",1.473E-07,2.097E-06,35,"COL1A1, Biglycan, TGF-beta 1, IL-4R type I, ERK1/2, c-Raf-1, PDGF-R-alpha, IL-1 beta, COX-1 (PTGS1), Decorin, Tenascin-C, HAS2, MMP-2, MEK1/2, IL13RA2, COL1A2, NF-kB, AKT(PKB), TNF-R1, TNF-alpha, FAN, ETS1, IL-4R type II, PDGF-A, TIMP1, Collagen III, COX-2 (PTGS2), NGF, HAS1, ACTA2, JNK(MAPK8-10), SMAD3, p38 MAPK, MMP-9, Collagen I",
162,Immune response_IL-4 signaling pathway,94,1.328E-07,1.505E-06,1.328E-07,1.505E-06,58,"RHEB2, JAK1, c-Rel (NF-kB subunit), IRS-2, IL-4R type I, Tyk2, IRS-1, ERK1/2, PKC-zeta, PDE3A, STAT1, Rac1, IP3 receptor, BAD, Syk, Shc, p38beta (MAPK11), IL13RA1, FKHR, IKK-alpha, PLC-gamma 1, GSK3 alpha/beta, CREB1, MEK1/2, CDC42, SHIP, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, JAK2, PI3K reg class IA (p85-alpha), c-Cbl, PKC-delta, IL-4R type II, c-Jun, IL4RA, c-Jun/Fra-2, NF-kB p50/RelB, PDE4, Fra-2, JAK3, PI3K cat class IA (p110-delta), 4E-BP1, AP-1, Tubulin alpha, PKC, MEKK1(MAP3K1), ATF-2, PLC-gamma, FOXO3A, IL-2R gamma chain, STAT5, JNK(MAPK8-10), c-Fes, PLC-gamma 2, p38 MAPK, Elk-1, mTOR",7.507E-05,2.980E-04,48,"p38alpha (MAPK14), RHEB2, JAK1, c-Rel (NF-kB subunit), IRS-2, IL-4R type I, Tyk2, ERK1/2, c-Raf-1, PDE3A, STAT1, IP3 receptor, Syk, Shc, IL13RA1, FKHR, PLC-gamma 1, GSK3 alpha/beta, CREB1, MEK1/2, CDC42, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, JAK2, PI3K reg class IA (p85-alpha), c-Cbl, IL-4R type II, p90RSK1, IL4RA, NF-kB p50/RelB, PDE4, Fra-2, JAK3, PI3K cat class IA (p110-delta), STAT3, Tubulin alpha, PKC, ATF-2, PLC-gamma, IL-2R gamma chain, STAT5, JNK(MAPK8-10), c-Fes, PLC-gamma 2, p38 MAPK, Elk-1, mTOR",
163,Development_Neural stem cell lineage commitment (schema),38,1.335E-07,1.996E-06,1.442E-06,1.010E-05,28,"CNTN1 (F3), NOTCH1 receptor, BMP receptor 2, GFAP, BMP4, CNTF, PDGF-R-alpha, NeuN, Reticulon 4, Vimentin, Smoothened, WNT7A, MAP2, LIF, Nestin, Tubulin beta 3, MCT1 (SLC16A1), FZD9, GLAST1/EAAT1, MAP-1B, PTCH1, S100B, Myelin basic protein, CNP1, SLC6A11, CSPG4 (NG2), MAG, BMP2",1.335E-07,1.996E-06,28,"CNTN1 (F3), NOTCH1 receptor, BMP receptor 2, GFAP, BMP4, CNTF, PDGF-R-alpha, NeuN, Reticulon 4, Vimentin, Smoothened, WNT7A, MAP2, LIF, Nestin, Tubulin beta 3, MCT1 (SLC16A1), FZD9, GLAST1/EAAT1, MAP-1B, PTCH1, IGKV1D-37, S100B, Myelin basic protein, CNP1, SLC6A11, CSPG4 (NG2), BMP2",
164,Development_Astrocyte differentiation from adult stem cells,40,1.429E-07,2.095E-06,3.135E-07,3.026E-06,30,"SMAD5, SOX1, BMP receptor 2, GFAP, JAK1, CD44, BMP4, CNTF, ERK1/2, ID3, ID1, SMAD4, Vimentin, Shc, BMPR1B, LIF, MEK1/2, Nestin, Nkx2.2, JAK2, SMAD9 (SMAD8), SOS, p300, ID4, HES1, SHP-2, OLIG2, BMPR1A, SMAD1, BMP2",1.429E-07,2.095E-06,29,"SMAD5, SOX1, BMP receptor 2, GFAP, JAK1, CD44, BMP4, CNTF, ERK1/2, ID3, ID1, c-Raf-1, SMAD4, Vimentin, Shc, BMPR1B, LIF, MEK1/2, Nestin, JAK2, SMAD9 (SMAD8), SOS, p300, ID4, STAT3, HES1, OLIG2, BMPR1A, BMP2",
165,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway,42,1.495E-07,2.097E-06,3.653E-07,3.432E-06,31,"OX40L(TNFSF4), TNF-R2, NGFR(TNFRSF16), RANKL(TNFSF11), PKC-zeta, BFL1, OX40(TNFRSF4), FN14(TNFRSF12A), I-kB, NF-kB2 (p100), IKK-alpha, NF-kB p52/RelB, RIPK1, BCMA(TNFRSF17), NF-kB, TNF-R1, BAFF(TNFSF13B), TNF-alpha, Sequestosome 1(p62), RelA (p65 NF-kB subunit), APRIL(TNFSF13), TRAF3, NF-kB2 (p52), TRAF6, RelB (NF-kB subunit), NIK(MAP3K14), RANK(TNFRSF11A), NGF, TACI(TNFRSF13B), IRAK1/2, TWEAK(TNFSF12)",1.495E-07,2.097E-06,30,"OX40L(TNFSF4), TNF-R2, NGFR(TNFRSF16), RANKL(TNFSF11), BFL1, OX40(TNFRSF4), FN14(TNFRSF12A), I-kB, NF-kB2 (p100), NF-kB p52/RelB, RIPK1, BCMA(TNFRSF17), NF-kB, TNF-R1, CD40L(TNFSF5), BAFF(TNFSF13B), TNF-alpha, Sequestosome 1(p62), RelA (p65 NF-kB subunit), APRIL(TNFSF13), TRAF3, NF-kB2 (p52), TRAF6, RelB (NF-kB subunit), NIK(MAP3K14), RANK(TNFRSF11A), NGF, TACI(TNFRSF13B), IRAK1/2, TWEAK(TNFSF12)",
166,Angiogenesis in HCC,50,1.515E-07,2.097E-06,3.018E-05,1.245E-04,32,"TGF-beta 1, TIE2, CCL2, ID1, VEGF-A, VEGFR-2, FN14(TNFRSF12A), Heparanase 1, IGF-2, MMP-2, NF-kB, Ephrin-B1, NF-kB1 (p50), HIF1A, IL-8, TGF-beta receptor type II, EGFR, Angiopoietin 1, FGF2, PGES, Angiopoietin 2, Leptin receptor, Securin, COX-2 (PTGS2), PEDF (serpinF1), Ephrin-B, STAT5, TWEAK(TNFSF12), Ephrin-B receptors, MMP-9, Betacellulin, TGF-beta receptor type I",1.515E-07,2.097E-06,34,"TGF-beta 1, TIE2, CCL2, ID1, VEGF-A, VEGFR-2, TIE, FN14(TNFRSF12A), Heparanase 1, IGF-2, MMP-2, NF-kB, Ephrin-B1, NF-kB1 (p50), HIF1A, IL-8, TGF-beta receptor type II, EGFR, Angiopoietin 1, FGF2, PGES, Angiopoietin 2, Leptin receptor, Securin, STAT3, COX-2 (PTGS2), PEDF (serpinF1), Ephrin-B, STAT5, TWEAK(TNFSF12), Ephrin-B receptors, MMP-9, Betacellulin, TGF-beta receptor type I",
167,PDE4 regulation of cyto/chemokine expression in inflammatory skin diseases,50,1.515E-07,2.097E-06,8.606E-06,4.379E-05,33,"CBP, IP10, NF-AT1(NFATC2), CCL2, IL-10, ERK1/2, 14-3-3, PKA-reg (cAMP-dependent), IL-22, G-protein alpha-i2, NF-kB p50/p50, IL-1 beta, G-protein alpha-i1, Adenylate cyclase, IL-13, CREB1, IL-6, MEK1/2, NF-kB p50/p65, IL-2, TNF-alpha, MxA, RelA (p65 NF-kB subunit), iNOS, NF-kB1 (p50), PKA-cat alpha, IL-8, G-protein alpha-i family, PDE4, IL23A, p38 MAPK, IL-12 beta, PKA-cat (cAMP-dependent)",1.515E-07,2.097E-06,34,"MIG, CBP, IP10, CCL2, IL-10, IFN-gamma, ERK1/2, 14-3-3, IL-17, c-Raf-1, IL-22, G-protein alpha-i2, NF-kB p50/p50, IL-1 beta, G-protein alpha-i1, Adenylate cyclase, CREB1, IL-6, MEK1/2, NF-kB p50/p65, IL-2, TNF-alpha, MxA, RelA (p65 NF-kB subunit), iNOS, NF-kB1 (p50), PKA-cat alpha, IL-8, G-protein alpha-i family, PDE4, IL23A, p38 MAPK, IL-12 beta, PKA-cat (cAMP-dependent)",
168,Immune response_Naive CD4+ T cell differentiation,46,1.549E-07,2.105E-06,3.285E-04,9.016E-04,28,"TGF-beta 1, MHC class II, RUNX3, NF-AT1(NFATC2), IL-10, CD28, IL-22, STAT1, AHR, IL-1 beta, STAT4, IL-17F, CD4, IL-13, IL-6, NF-kB, IL-23, NF-AT2(NFATC1), IL-2, TNF-alpha, DEC2, IL-18, T-bet, IL-5, IRF4, c-Maf, AP-1, CD86",1.549E-07,2.105E-06,32,"TGF-beta 1, MHC class II, RUNX3, IL-10, IFN-gamma, CD28, IL-17, IL-22, STAT1, AHR, IL-1 beta, STAT4, IL-17F, CD4, IL-6, NF-kB, IL-23, NF-AT2(NFATC1), IL-2, CD40L(TNFSF5), TNF-alpha, CD80, DEC2, ROR-alpha, IL-18, T-bet, IL-5, IRF4, STAT3, c-Maf, IL-21, CD86",
169,"Immune response_TLR5, TLR7, TLR8 and TLR9 signaling pathways",58,1.590E-07,1.762E-06,1.590E-07,1.762E-06,40,"TLR5, ERK1/2, IRF1, IFN-beta, Ubiquitin, IL-1 beta, I-kB, PI3K reg class IA (p85), IRAK4, MyD88, IKK-alpha, IFN-alpha, IL-6, MEK1/2, TPL2(MAP3K8), NF-kB, AKT(PKB), TLR9, UEV1A, TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, NF-kB1 (p105), IL-8, TRAF6, MEK3(MAP2K3), c-Jun, IRAK2, NIK(MAP3K14), TAB3, MEK4(MAP2K4), AP-1, IRAK1, TAB1, IRF7, JNK(MAPK8-10), TLR7, TLR8, p38 MAPK, IL-12 beta",2.161E-05,1.026E-04,34,"ERK1/2, IRF1, IFN-beta, Ubiquitin, IL-1 beta, I-kB, PI3K reg class IA (p85), IRAK4, IFN-alpha, IL-6, MEK1/2, TPL2(MAP3K8), NF-kB, AKT(PKB), TLR9, TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, NF-kB1 (p105), IL-8, TRAF6, MEK3(MAP2K3), IRAK2, NIK(MAP3K14), TAB3, MEK4(MAP2K4), STAT3, IRAK1, IRF7, JNK(MAPK8-10), TLR7, TLR8, p38 MAPK, IL-12 beta",
170,Immune response_IL-33 signaling pathway,58,1.590E-07,1.762E-06,1.590E-07,1.762E-06,40,"ICAM1, CCL2, ERK1/2, Ubiquitin, I-kB, GRO-1, IRAK4, PI3K reg class IA, MyD88, IKK-alpha, IL-17F, GM-CSF, IL-13, IL-6, MEK1/2, NF-kB, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), TNF-alpha, JAK2, PI3K cat class IA, VCAM1, RelA (p65 NF-kB subunit), IL-8, TRAF6, MEK3(MAP2K3), IL-5, IL1RAP, c-Jun, ST2L, NIK(MAP3K14), MKK7 (MAP2K7), MEK4(MAP2K4), ST2(L), ATF-2, IL-33, IRAK1, TAB1, JNK(MAPK8-10)",6.662E-06,3.860E-05,35,"p38alpha (MAPK14), ICAM1, CCL2, ERK1/2, Ubiquitin, I-kB, GRO-1, IRAK4, PI3K reg class IA, IL-17F, GM-CSF, IL-6, MEK1/2, NF-kB, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), TNF-alpha, JAK2, PI3K cat class IA, VCAM1, RelA (p65 NF-kB subunit), IL-8, TRAF6, IL-5, MEK3(MAP2K3), IL1RAP, ST2L, NIK(MAP3K14), MEK4(MAP2K4), ST2(L), ATF-2, IL-33, IRAK1, JNK(MAPK8-10)",
171,Development_Epigenetic and transcriptional regulation of oligodendrocyte precursor cell differentiation and myelination,34,1.612E-07,1.773E-06,1.612E-07,1.773E-06,27,"UGT8, NOTCH1 receptor, HES5, WNT3A, SMRT, TCF7L2 (TCF4), MYT1, Beta-catenin, QKI, PPAR-beta(delta), HDAC2, RBP-J kappa (CBF1), Nkx2.2, YY1, SOX9, NOTCH1 (NICD), SOX17, C11orf9, ID4, SOX10, Myelin basic protein, SOX8, HES1, OLIG2, HDAC1, Jagged1, Frizzled",1.846E-05,9.228E-05,23,"UGT8, NOTCH1 receptor, HES5, SMRT, TCF7L2 (TCF4), Beta-catenin, QKI, PPAR-beta(delta), HDAC2, RBP-J kappa (CBF1), SOX9, NOTCH1 (NICD), SOX17, C11orf9, ID4, SOX10, Myelin basic protein, SOX8, HES1, OLIG2, HDAC1, Jagged1, Frizzled",
172,Epigenetic alterations in ovarian cancer,82,1.656E-07,1.799E-06,1.656E-07,1.799E-06,52,"Maspin, TrkA, HOXA10, RARbeta, ZIC4, APC protein, CDC20, HRK, HDAC3, CTCF, Ephrin-A receptor 2, GLI-2, STAR, Bax, OBCAM, HDAC2, CDK4, RASSF1, IGF-2, AL1A1, MMP-2, EZH2, SKP2, TWIST1, p16INK4, N-cadherin, Brca1, PARP-1, GATA-6, DAPK1, SF1, ErbB4, LSD1, Thrombospondin 1, Aurora-A, DOK2, CYP11A1, CDK6, GSTP1, ZIC1, PRC2 complex, SUZ12, p15, DNMT1, Aurora-B, SNAIL1, HDAC1, L1TD1, GLI-1, DACT3, MMP-9, Thrombospondin 2",4.916E-07,4.966E-06,48,"Maspin, HOXA10, RARbeta, ZIC4, APC protein, CDC20, HRK, HDAC3, Ephrin-A receptor 2, GLI-2, Bax, OBCAM, HDAC2, CDK4, RASSF1, IGF-2, AL1A1, MMP-2, EZH2, SKP2, TWIST1, p16INK4, N-cadherin, Brca1, GATA-6, DAPK1, SF1, ErbB4, LSD1, Thrombospondin 1, DOK2, CYP11A1, CDK6, GSTP1, ZIC1, PRC2 complex, SSTR1, SUZ12, p15, DNMT1, Aurora-B, SNAIL1, HDAC1, L1TD1, GLI-1, DACT3, MMP-9, Thrombospondin 2",
173,Oxidative stress_ROS-mediated MAPK activation via canonical pathways,60,1.659E-07,1.799E-06,1.659E-07,1.799E-06,41,"ERK5 (MAPK7), ERK1/2, HB-EGF, TRPM2, CRK, PKC-epsilon, Rac1, IP3 receptor, Shc, MAP3K2 (MEKK2), PLC-gamma 1, MAP2K5 (MEK5), RIPK1, MEK1/2, CDC42, Fyn, ERK2 (MAPK1), SFK, c-Src, TSAD, Pyk2(FAK2), JAK2, MLK3(MAP3K11), PKC-delta, EGFR, ASK1 (MAP3K5), MEK3(MAP2K3), SOS, JNK1(MAPK8), CaMK II delta, GSTP1, p130CAS, Calmodulin, MEKK1(MAP3K1), SHP-2, CaMK II alpha, JNK(MAPK8-10), JNK2(MAPK9), ADAM17, p38 MAPK, PDGF-R-beta",4.740E-07,4.820E-06,38,"ERK5 (MAPK7), ERK1/2, HB-EGF, TRPM2, CRK, c-Raf-1, PKC-epsilon, IP3 receptor, Shc, MAP3K2 (MEKK2), PLC-gamma 1, MAP2K5 (MEK5), RIPK1, MEK1/2, CDC42, Fyn, ERK2 (MAPK1), SFK, c-Src, TSAD, Pyk2(FAK2), JAK2, MLK3(MAP3K11), EGFR, ASK1 (MAP3K5), MEK3(MAP2K3), SOS, JNK1(MAPK8), CaMK II delta, GSTP1, p130CAS, Calmodulin, CaMK II alpha, JNK(MAPK8-10), JNK2(MAPK9), ADAM17, p38 MAPK, PDGF-R-beta",
174,"NF-kB-, AP-1- and MAPKs-mediated proinflammatory cytokine production by eosinophils in asthma",43,1.709E-07,1.813E-06,1.709E-07,1.813E-06,32,"CCL2, PAR2, C5a, ERK1/2, ENA-78, TSLP, IL17BR, IL-1 beta, GRO-1, IL-17F, GM-CSF, Chymase, IL-6, NF-kB, IL-23, ERK2 (MAPK1), Eotaxin, NF-kB p50/p65, PRG2, TNF-alpha, Cathepsin G, IL-8, IL-5, c-Jun, Leukocyte elastase, Tryptase, ST2(L), AP-1, IL-33, JNK(MAPK8-10), p38 MAPK, TSLPR",3.442E-07,3.675E-06,30,"CCL2, PAR2, C5a, ERK1/2, ENA-78, IL-17, TSLP, IL17BR, IL-1 beta, GRO-1, IL-17F, GM-CSF, IL-6, NF-kB, IL-23, ERK2 (MAPK1), Eotaxin, NF-kB p50/p65, PRG2, TNF-alpha, Cathepsin G, IL-8, IL-5, Leukocyte elastase, Tryptase, ST2(L), IL-33, JNK(MAPK8-10), p38 MAPK, TSLPR",
175,Development_WNT/Beta-catenin signaling in embryogenesis,43,1.709E-07,1.813E-06,1.709E-07,1.813E-06,32,"p14ARF, Oct-3/4, Lef-1, TCF7L2 (TCF4), Beta-catenin, FGF8, SMAD2, Cyclin D2, Sp8, Eomesodermin, Mixl1, p16INK4, TCF7 (TCF1), TERT, LRP5/LRP6, KLF5, Tcf(Lef), NODAL, CDX2, SOX17, T brachyury protein, SP5, WNT, Pitx2, LBH, p15, TCF7L1 (TCF3), SNAIL1, Esrrb, En1, CDX1, Frizzled",7.027E-06,3.994E-05,28,"p14ARF, Oct-3/4, TCF7L2 (TCF4), Beta-catenin, FGF8, SMAD2, Cyclin D2, Eomesodermin, Mesogenin 1, Mixl1, p16INK4, TCF7 (TCF1), TERT, KLF5, Tcf(Lef), NODAL, CDX2, SOX17, SP5, WNT, Pitx2, LBH, p15, TCF7L1 (TCF3), SNAIL1, En1, CDX1, Frizzled",
176,Apoptosis and survival_TNFR1 signaling pathway,43,1.709E-07,1.813E-06,1.709E-07,1.813E-06,32,"Caspase-6, Apaf-1, Caspase-8, I-kB, Bax, BRE, c-IAP1, Caspase-3, RIPK1, Caspase-2, NF-kB, TNF-R1, TNF-alpha, c-IAP2, XIAP, c-Jun, jBid, Caspase-9, MKK7 (MAP2K7), FLASH, MEK4(MAP2K4), GCK(MAP4K2), Caspase-10, Caspase-7, MEKK1(MAP3K1), tBid, SODD, HtrA2, c-FLIP(Short), JNK(MAPK8-10), ERAP1, Bid",7.027E-06,3.994E-05,28,"Caspase-6, Apaf-1, Caspase-8, I-kB, Bax, BRE, c-IAP1, Caspase-3, RIPK1, Caspase-2, NF-kB, TNF-R1, TNF-alpha, c-IAP2, XIAP, jBid, Caspase-9, FLASH, MEK4(MAP2K4), GCK(MAP4K2), Caspase-10, tBid, SODD, HtrA2, c-FLIP(Short), JNK(MAPK8-10), ERAP1, Bid",
177,Cell cycle_Role of 14-3-3 proteins in cell cycle regulation,22,1.769E-07,2.341E-06,1.068E-06,8.324E-06,19,"HUS1, CDC25A, 14-3-3 theta, CDK1 (p34), Chk1, AKT(PKB), TAK1(MAP3K7), 14-3-3 epsilon, CDC25C, 14-3-3 zeta/delta, CDC25B, 14-3-3 gamma, ATR, 14-3-3 beta/alpha, 14-3-3 sigma, ATM, 14-3-3 eta, p53, p38 MAPK",1.769E-07,2.341E-06,19,"HUS1, CDC25A, 14-3-3 theta, CDK1 (p34), Chk1, AKT(PKB), TAK1(MAP3K7), Chk2, 14-3-3 epsilon, CDC25C, 14-3-3 zeta/delta, CDC25B, 14-3-3 gamma, ATR, 14-3-3 sigma, ATM, 14-3-3 eta, p53, p38 MAPK",
178,Suppression of TGF-beta signaling in pancreatic cancer,29,1.841E-07,2.414E-06,1.449E-06,1.010E-05,23,"Biglycan, TGF-beta 1, GADD45 beta, VEGF-A, SMAD4, SMAD2, ERK2 (MAPK1), c-Myc, MEKK4(MAP3K4), KLF11 (TIEG2), SMAD7, ETS1, TGF-beta receptor type II, Ski, MEK3(MAP2K3), Thrombospondin 1, PLAU (UPA), SMAD6, p15, SMAD3, p38 MAPK, MMP-9, TGF-beta receptor type I",1.841E-07,2.414E-06,23,"Biglycan, TGF-beta 1, GADD45 beta, VEGF-A, c-Raf-1, SMAD4, SMAD2, ERK2 (MAPK1), KLF11 (TIEG2), MEK1(MAP2K1), SMAD7, ETS1, TGF-beta receptor type II, Ski, MEK3(MAP2K3), Thrombospondin 1, PLAU (UPA), SMAD6, p15, SMAD3, p38 MAPK, MMP-9, TGF-beta receptor type I",
179,Cell adhesion_Histamine H1 receptor signaling in the interruption of cell barrier integrity,45,1.970E-07,2.061E-06,1.970E-07,2.061E-06,33,"VE-cadherin, Beta-catenin, Alpha-actinin, G-protein alpha-q/11, LIMK1, IP3 receptor, Talin, MLCP (reg), PLC-beta, G-protein beta/gamma, Actin cytoskeletal, c-Src, MLCK, MLCP (cat), RhoA, Pyk2(FAK2), GEFT, PKC-delta, ZO-1, Myosin II, CPI-17, Alpha-catenin, Paxillin, Histamine H1 receptor, p130CAS, ROCK, Calmodulin, Vinculin, PKC-alpha, MRLC, MELC, p120-catenin, Cofilin",6.550E-06,3.810E-05,29,"VE-cadherin, Beta-catenin, Alpha-actinin, G-protein alpha-q/11, LIMK1, IP3 receptor, Talin, MLCP (reg), PLC-beta, G-protein beta/gamma, Actin cytoskeletal, c-Src, MLCK, MLCP (cat), RhoA, Pyk2(FAK2), GEFT, ZO-1, Myosin II, CPI-17, Histamine H1 receptor, p130CAS, ROCK, Calmodulin, Vinculin, PKC-alpha, MRLC, MELC, Cofilin",
180,Inhibition of apoptosis in multiple myeloma,36,2.097E-07,2.164E-06,2.097E-07,2.164E-06,28,"DR5(TNFRSF10B), NOTCH1 receptor, EGR1, c-FLIP(Long), Apo-2L(TNFSF10), Survivin, Caspase-3, BCMA(TNFRSF17), IL-6, FasL(TNFSF6), NF-kB, TLR9, DR4(TNFRSF10A), NF-kB p50/p65, Mcl-1, BAFF(TNFSF13B), c-IAP2, APRIL(TNFSF13), BAFF-R, XIAP, c-Jun, TLR4, FasR(CD95), TACI(TNFRSF13B), JNK2(MAPK9), p53, Jagged1, Bim",7.264E-07,6.614E-06,26,"DR5(TNFRSF10B), NOTCH1 receptor, c-FLIP(Long), Apo-2L(TNFSF10), Survivin, Caspase-3, BCMA(TNFRSF17), IL-6, NF-kB, TLR9, DR4(TNFRSF10A), NF-kB p50/p65, Mcl-1, BAFF(TNFSF13B), c-IAP2, APRIL(TNFSF13), BAFF-R, XIAP, STAT3, TLR4, FasR(CD95), TACI(TNFRSF13B), JNK2(MAPK9), p53, Jagged1, Bim",
181,CHDI_Correlations from Discovery data_Causal network (positive),36,2.097E-07,2.164E-06,2.097E-07,2.164E-06,28,"TIE2, JAK1, IFN-alpha/beta receptor, Actin, LAMA3 (Epiligrin), STAT1, Rac1, Talin, PI3K reg class IA (p85), GABA-A receptor, IFN-alpha, MMP-2, CDC42, Actin cytoskeletal, Collagen IV, alpha-3/beta-1 integrin, alpha-5/beta-1 integrin, Thrombospondin 1, Intersectin, Paxillin, Collagen III, Vinculin, SHP-2, Ephrin-B, N-WASP, alpha-2/beta-1 integrin, Ephrin-B receptors, CD47",3.814E-06,2.366E-05,25,"TIE2, JAK1, IFN-alpha/beta receptor, Actin, LAMA3 (Epiligrin), STAT1, Talin, PI3K reg class IA (p85), GABA-A receptor, IFN-alpha, MMP-2, CDC42, Actin cytoskeletal, Collagen IV, alpha-3/beta-1 integrin, alpha-5/beta-1 integrin, Thrombospondin 1, Intersectin, Collagen III, STAT3, Vinculin, Ephrin-B, alpha-2/beta-1 integrin, Ephrin-B receptors, CD47",
182,Immune response_Induction of apoptosis and inhibition of proliferation mediated by IFN-gamma,47,2.220E-07,2.259E-06,2.220E-07,2.259E-06,34,"IDO1, PML, JAK1, CrkL, Apo-2L(TNFSF10), IRF1, Caspase-8, IFN-beta, STAT1, IL-15, RAP-1A, OAS1, CDK4, IFN-alpha, Caspase-3, RIPK1, FasL(TNFSF6), Caspase-1, c-Myc, IFI17, JAK2, Brca1, c-Cbl, PKR, DAXX, IFN-gamma receptor, C3G, GBP1, Caspase-7, Caspase-12, Cyclin E, FasR(CD95), CTGF, p53",1.496E-06,1.159E-05,31,"IDO1, PML, JAK1, IFN-gamma, CrkL, Apo-2L(TNFSF10), IRF1, Caspase-8, IFN-beta, STAT1, IL-15, RAP-1A, OAS1, CDK4, IFN-alpha, Caspase-3, RIPK1, Caspase-1, IFI17, JAK2, Brca1, c-Cbl, PKR, DAXX, IFN-gamma receptor, GBP1, Caspase-12, Cyclin E, FasR(CD95), CTGF, p53",
183,Regulation of mast cell survival in asthma,47,2.220E-07,2.259E-06,2.220E-07,2.259E-06,34,"TNF-R2, DR5(TNFRSF10B), TrkA, IL-4R type I, ERK1/2, BFL1, c-FLIP(Long), Apo-2L(TNFSF10), Fibronectin, c-Kit, BAD, Syk, Bax, GSK3 beta, GM-CSF, Chymase, IL-6, MEK1/2, FasL(TNFSF6), AKT(PKB), DR4(TNFRSF10A), TNF-R1, Mcl-1, IL-2, TNF-alpha, Thy-1, alpha-5/beta-1 integrin, HSP90 beta, NGF, FOXO3A, FasR(CD95), STAT5, Bim, TSLC1",7.661E-05,3.014E-04,28,"TNF-R2, DR5(TNFRSF10B), IL-4R type I, ERK1/2, BFL1, c-FLIP(Long), Apo-2L(TNFSF10), Fibronectin, c-Kit, Syk, Bax, GSK3 beta, GM-CSF, IL-6, MEK1/2, AKT(PKB), DR4(TNFRSF10A), TNF-R1, Mcl-1, IL-2, TNF-alpha, Thy-1, alpha-5/beta-1 integrin, HSP90 beta, NGF, FasR(CD95), STAT5, Bim",
184,Influence of multiple myeloma cells on bone marrow stromal cells,33,2.596E-07,3.207E-06,5.565E-05,2.049E-04,23,"TGF-beta 1, NOTCH1 receptor, FGFR2, ICAM1, c-Rel (NF-kB subunit), RANKL(TNFSF11), VEGF-A, VEGFR-2, Jagged2, IL-1 beta, IL-6, NF-kB, Osteoprotegerin, TNF-alpha, VCAM1, RelA (p65 NF-kB subunit), NF-kB1 (p50), FGF2, RANK(TNFRSF11A), COX-2 (PTGS2), ITGA4, HES1, IL-11",2.596E-07,3.207E-06,25,"TGF-beta 1, NOTCH1 receptor, FGFR2, ICAM1, c-Rel (NF-kB subunit), RANKL(TNFSF11), VEGF-A, VEGFR-2, Jagged2, IL-1 beta, IL-6, NF-kB, Osteoprotegerin, CD40L(TNFSF5), TNF-alpha, CD80, VCAM1, RelA (p65 NF-kB subunit), NF-kB1 (p50), FGF2, RANK(TNFRSF11A), COX-2 (PTGS2), ITGA4, HES1, IL-11",
185,Development_Noncanonical WNT signaling in cardiac myogenesis,38,2.611E-07,2.604E-06,2.611E-07,2.604E-06,29,"ROCK1, SMAD4, beta-MHC, Dsh, Rac1, NF-AT4(NFATC3), PLC-beta, WNT11, ACTC, G-protein beta/gamma, CDC42, FZD7, RhoA, ROCK2, PKC-delta, ARHGEF19, c-Jun, c-Jun/Fra-2, MKK7 (MAP2K7), CSX (Nkx2.5), MEK4(MAP2K4), PKC, MEKK1(MAP3K1), ATF-2, G-protein alpha-q, SMAD1, JNK(MAPK8-10), SMAD3, SRF",2.268E-03,4.857E-03,21,"ROCK1, SMAD4, beta-MHC, Dsh, NF-AT4(NFATC3), PLC-beta, WNT11, ACTC, G-protein beta/gamma, CDC42, FZD7, RhoA, ROCK2, ARHGEF19, CSX (Nkx2.5), MEK4(MAP2K4), PKC, ATF-2, JNK(MAPK8-10), SMAD3, SRF",
186,WNT signaling in proliferative-type melanoma cells,38,2.611E-07,2.604E-06,2.611E-07,2.604E-06,29,"DVL-3, WNT3A, APC protein, Lef-1, ERK1/2, DKK1, TAJ(TNFRSF19), Beta-catenin, Fibronectin, Dsh, GSK3 beta, Survivin, DKK3, ICAT, Axin2, MEK1/2, c-Myc, Axin, SOX9, B-Raf, WNT5A, WNT7B, WNT, WNT10B, WNT2, LRP6, MITF, Frizzled, DACT1",6.682E-05,2.693E-04,24,"APC protein, ERK1/2, DKK1, TAJ(TNFRSF19), Beta-catenin, Fibronectin, Dsh, GSK3 beta, Survivin, DKK3, ICAT, Axin2, MEK1/2, Axin, SOX9, B-Raf, WNT5A, WNT7B, WNT, WNT2, LRP6, MITF, Frizzled, DACT1",
187,"Development_Hedgehog, BMP and Parathyroid hormone in osteogenesis",51,2.666E-07,2.607E-06,2.666E-07,2.607E-06,36,"COL1A1, SMAD5, RANKL(TNFSF11), ERK1/2, PKA-reg (cAMP-dependent), SMAD4, G-protein alpha-q/11, DLX5, Smoothened, GLI-2, RAP-1A, EGR2 (Krox20), PLC-beta, BMP6, Adenylate cyclase, BMPR1B, MEK2(MAP2K2), TAZ, Osteoprotegerin, PPAR-gamma, Osteopontin, B-Raf, PTCH1, PKC-delta, Osteocalcin, ALK-2, ALPL, SMAD9 (SMAD8), Ihh, RUNX2, BMPR1A, SMAD1, PTHrP, GLI-1, PKA-cat (cAMP-dependent), BMP2",3.158E-07,3.604E-06,34,"COL1A1, SMAD5, RANKL(TNFSF11), ERK1/2, SMAD4, G-protein alpha-q/11, DLX5, Smoothened, GLI-2, RAP-1A, EGR2 (Krox20), PLC-beta, BMP6, Adenylate cyclase, BMPR1B, MEK2(MAP2K2), TAZ, Osteoprotegerin, PPAR-gamma, MEK1(MAP2K1), Osteopontin, B-Raf, PTCH1, Osteocalcin, ALK-2, ALPL, SMAD9 (SMAD8), Ihh, RUNX2, BMPR1A, PTHrP, GLI-1, PKA-cat (cAMP-dependent), BMP2",
188,Immune response_BAFF-induced signaling,51,2.666E-07,2.607E-06,2.666E-07,2.607E-06,36,"RHEB2, RPS6, eIF4E, ERK1/2, BAD, Ubiquitin, PI3K reg class IA (p85), FKHR, GSK3 alpha/beta, BCMA(TNFRSF17), CREB1, MEK1/2, ERK2 (MAPK1), AKT(PKB), BAFF(TNFSF13B), PKC-delta, Pim-2, BAFF-R, MEK3(MAP2K3), c-Jun, TRIM2, MKK7 (MAP2K7), JNK1(MAPK8), Cul1/Rbx1 E3 ligase, PI3K cat class IA (p110-delta), MEK4(MAP2K4), 4E-BP1, PKC-beta, MEKK1(MAP3K1), FOXO3A, TACI(TNFRSF13B), JNK2(MAPK9), Bcl-10, p38 MAPK, Bim, mTOR",5.151E-04,1.344E-03,28,"RHEB2, RPS6, ERK1/2, c-Raf-1, Ubiquitin, PI3K reg class IA (p85), FKHR, GSK3 alpha/beta, BCMA(TNFRSF17), CREB1, MEK1/2, ERK2 (MAPK1), AKT(PKB), BAFF(TNFSF13B), BAFF-R, MEK3(MAP2K3), TRIM2, JNK1(MAPK8), Cul1/Rbx1 E3 ligase, PI3K cat class IA (p110-delta), MEK4(MAP2K4), PKC-beta, TACI(TNFRSF13B), JNK2(MAPK9), Bcl-10, p38 MAPK, Bim, mTOR",
189,Epithelial cell anoikis in COPD,51,2.666E-07,2.607E-06,2.666E-07,2.607E-06,36,"BPAG2, Laminin 5, IRS-2, IRS-1, ERK1/2, Alpha-actinin, alpha-6/beta-4 integrin, Bak, BAD, Talin, Shc, Bax, PI3K reg class IA, MEK1/2, Actin cytoskeletal, MMP-8, AKT(PKB), Plectin 1, alpha-3/beta-1 integrin, PI3K cat class IA, ASK1 (MAP3K5), MEK3(MAP2K3), Leukocyte elastase, BPAG1, SOS, Beta-parvin, MKK7 (MAP2K7), BMF, Paxillin, MEK4(MAP2K4), Vinculin, Alpha-parvin, JNK(MAPK8-10), p38 MAPK, Bim, MMP-9",5.099E-06,3.062E-05,32,"BPAG2, Laminin 5, IRS-2, ERK1/2, Alpha-actinin, c-Raf-1, alpha-6/beta-4 integrin, Talin, Shc, Bax, PI3K reg class IA, MEK1/2, Actin cytoskeletal, MMP-8, AKT(PKB), Plectin 1, alpha-3/beta-1 integrin, PI3K cat class IA, ASK1 (MAP3K5), MEK3(MAP2K3), Leukocyte elastase, BPAG1, SOS, Beta-parvin, BMF, MEK4(MAP2K4), Vinculin, Alpha-parvin, JNK(MAPK8-10), p38 MAPK, Bim, MMP-9",
190,Signal transduction_Angiotensin II signaling via Beta-arrestin,57,2.680E-07,3.284E-06,1.232E-06,8.896E-06,38,"GRK6, eIF4E, ERK1/2, 14-3-3, Angiotensin II, Beta-arrestin2, BAD, MLCP (reg), STAR, GSK3 beta, AP-2 alpha subunits, PLC-gamma 1, Itch, TRPV4, DGK, AKT(PKB), MYLK1, c-Src, MLCK, MLCP (cat), Casein kinase II, beta chain (Phosvitin), RhoA, GRAF2, EGFR, ASK1 (MAP3K5), SET, PP2A catalytic, MNK1, Casein kinase II, alpha' chain (CSNK2A2), p90Rsk, MEK4(MAP2K4), ROCK, TRPC3, GRK5, MRLC, Beta-adaptin 2, SSH1L, Cofilin",2.680E-07,3.284E-06,37,"GRK6, ERK1/2, 14-3-3, c-Raf-1, Angiotensin II, Beta-arrestin2, MLCP (reg), GSK3 beta, AP-2 alpha subunits, PLC-gamma 1, Itch, TRPV4, DGK, AKT(PKB), MYLK1, c-Src, MLCK, MLCP (cat), MEK1(MAP2K1), Casein kinase II, beta chain (Phosvitin), RhoA, GRAF2, EGFR, ASK1 (MAP3K5), SET, PP2A catalytic, MNK1, Casein kinase II, alpha' chain (CSNK2A2), p90Rsk, MEK4(MAP2K4), ROCK, TRPC3, GRK5, MRLC, Beta-adaptin 2, SSH1L, Cofilin",
191,Tau pathology in Alzheimer disease,55,2.851E-07,2.932E-06,3.018E-07,2.932E-06,38,"CDK5R1 (p35), Casein kinase I delta, CDK5, Calcineurin A (catalytic), Caspase-6, ERK1/2, Syndecan-4, PP2C, Caspase-8, Ubiquitin, GSK3 beta, p38beta (MAPK11), Glypican-3, NR2, MAP2, Caspase-3, GSK3 alpha/beta, ERK2 (MAPK1), Calpain 1(mu), Tubulin (in microtubules), DYRK1a, CDK5R1 (p25), Glypican-1, PP2A catalytic, Caspase-9, Calpain 2(m), NR2B, MAP1LC3A, Caspase-7, PKC, Agrin, JNK(MAPK8-10), OGT (GlcNAc transferase), p38gamma (MAPK12), Glypican-4, p38 MAPK, Syndecan-2, Syndecan-3",2.851E-07,3.408E-06,36,"p38alpha (MAPK14), CDK5R1 (p35), CDK5, Calcineurin A (catalytic), Caspase-6, ERK1/2, Syndecan-4, PP2C, Caspase-8, Ubiquitin, GSK3 beta, Glypican-3, NR2, MAP2, Caspase-3, GSK3 alpha/beta, ERK2 (MAPK1), Calpain 1(mu), Tubulin (in microtubules), DYRK1a, CDK5R1 (p25), Glypican-1, PP2A catalytic, Caspase-9, Calpain 2(m), NR2B, MAP1LC3A, PKC, Agrin, JNK(MAPK8-10), OGT (GlcNAc transferase), p38gamma (MAPK12), Glypican-4, p38 MAPK, Syndecan-2, Syndecan-3",
192,Interleukins-induced inflammatory response in asthmatic airway fibroblasts,35,2.895E-07,3.408E-06,1.331E-05,6.530E-05,25,"GRO-2, CBP, IL-1 alpha, ICAM1, CCL2, ERK1/2, IL-17 receptor, IL17BR, IL-1 beta, GRO-1, GM-CSF, IL-6, MEK1/2, NF-kB, Eotaxin, NF-kB p50/p65, VCAM1, RelA (p65 NF-kB subunit), IL-8, c-Jun, COX-2 (PTGS2), NGF, IL-33, p38 MAPK, IL-11",2.895E-07,3.408E-06,26,"GRO-2, p38alpha (MAPK14), CBP, IL-1 alpha, ICAM1, CCL2, ERK1/2, IL-17, IL-17 receptor, IL17BR, IL-1 beta, GRO-1, GM-CSF, IL-6, MEK1/2, NF-kB, Eotaxin, NF-kB p50/p65, VCAM1, RelA (p65 NF-kB subunit), IL-8, COX-2 (PTGS2), NGF, IL-33, p38 MAPK, IL-11",
193,Plasminogen activators signaling in pancreatic cancer,35,2.895E-07,3.408E-06,4.680E-07,4.167E-06,27,"TGF-beta 1, IL-1 alpha, Nek2A, Fra-1, ERK1/2, HB-EGF, Angiostatin, Plasminogen, Shc, PLAT (TPA), MEK2(MAP2K2), MMP-2, PLAUR (uPAR), PPAR-gamma, HGF, RelA (p65 NF-kB subunit), EGFR, FOXM1, Plasmin, SOS, PLAU (UPA), Annexin II, MMP-14, Galectin-1, HGF receptor (Met), MMP-9, PAI1",2.895E-07,3.408E-06,26,"TGF-beta 1, IL-1 alpha, Nek2A, Fra-1, ERK1/2, HB-EGF, c-Raf-1, Shc, PLAT (TPA), MEK2(MAP2K2), MMP-2, PLAUR (uPAR), PPAR-gamma, HGF, MEK1(MAP2K1), RelA (p65 NF-kB subunit), EGFR, FOXM1, SOS, PLAU (UPA), Annexin II, MMP-14, Galectin-1, HGF receptor (Met), MMP-9, PAI1",
194,Gamma-secretase regulation of osteogenesis,37,3.129E-07,3.604E-06,3.054E-06,1.920E-05,27,"COL1A1, NOTCH1 receptor, CD44, RANKL(TNFSF11), M-CSF receptor, CD44 (ICD), NOTCH2 (2ICD), CDK4, CD44 soluble, CD44 (EXT), NF-kB, Osteoprotegerin, RBP-J kappa (CBF1), NF-AT2(NFATC1), NOTCH1 (NICD), HEY1, RelA (p65 NF-kB subunit), Osteocalcin, ALPL, CSF1, NOTCH2, RANK(TNFRSF11A), RUNX2, HES1, NOTCH1 (NEXT), Jagged1, ADAM17",3.129E-07,3.604E-06,27,"COL1A1, NOTCH1 receptor, CD44, RANKL(TNFSF11), M-CSF receptor, CD44 (ICD), NOTCH2 (2ICD), CDK4, CD44 soluble, CD44 (EXT), NF-kB, Osteoprotegerin, RBP-J kappa (CBF1), NF-AT2(NFATC1), NOTCH1 (NICD), RelA (p65 NF-kB subunit), Osteocalcin, ALPL, CSF1, NOTCH2, RANK(TNFRSF11A), RUNX2, HES1, Collagen X, NOTCH1 (NEXT), Jagged1, ADAM17",
195,Development_Oligodendrocyte differentiation from adult stem cells,51,3.158E-07,3.604E-06,1.142E-06,8.627E-06,35,"SMAD5, CNTN1 (F3), NOTCH1 receptor, BMP receptor 2, BMP4, ERK1/2, OATP-F, SMAD4, PDGF-R-alpha, Smoothened, Endothelin-1, TAT1, BMPR1B, CREB1, NOTCH1 (NICD), PTCH1, SMAD7, PDGF-A, SMAD9 (SMAD8), FGF2, p90Rsk, Noggin, Myelin basic protein, EDNRB, SMAD6, CNP1, DTX1, CSPG4 (NG2), OLIG2, MAG, BMPR1A, SMAD1, p38 MAPK, BMP2, EDNRA",3.158E-07,3.604E-06,34,"SMAD5, CNTN1 (F3), NOTCH1 receptor, BMP receptor 2, BMP4, ERK1/2, OATP-F, SMAD4, PDGF-R-alpha, Smoothened, Endothelin-1, TAT1, BMPR1B, CREB1, NOTCH1 (NICD), PTCH1, IGKV1D-37, SMAD7, PDGF-A, SMAD9 (SMAD8), FGF2, p90Rsk, Noggin, Myelin basic protein, EDNRB, SMAD6, CNP1, DTX1, CSPG4 (NG2), OLIG2, BMPR1A, p38 MAPK, BMP2, EDNRA",
196,Activation of TNF-alpha-dependent pro-tumoral effect in colorectal cancer,49,3.281E-07,3.624E-06,4.414E-06,2.550E-05,33,"IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, ERK1/2, ALDR, Beta-catenin, I-kB, GRO-1, NF-kB p65/c-Rel, IKK-alpha, RIPK1, IL-6, MEK1/2, NF-kB, NF-kB p50/p65, TNF-R1, Axin, TAK1(MAP3K7), TNF-alpha, PGE2R2, c-IAP2, VCAM1, RelA (p65 NF-kB subunit), NF-kB1 (p50), IL-8, SOS, NIK(MAP3K14), PKC-beta2, COX-2 (PTGS2), TRAF1, ABCC4, p38 MAPK",3.281E-07,3.624E-06,33,"IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, ERK1/2, ALDR, Beta-catenin, c-Raf-1, I-kB, GRO-1, NF-kB p65/c-Rel, RIPK1, IL-6, MEK1/2, NF-kB, NF-kB p50/p65, TNF-R1, Axin, TAK1(MAP3K7), TNF-alpha, PGE2R2, c-IAP2, VCAM1, RelA (p65 NF-kB subunit), NF-kB1 (p50), IL-8, SOS, NIK(MAP3K14), PKC-beta2, COX-2 (PTGS2), TRAF1, ABCC4, p38 MAPK",
197,Glucocorticoids-mediated inhibition of pro-constrictory and pro-inflammatory signaling in airway smooth muscle cells,49,3.281E-07,3.624E-06,4.414E-06,2.550E-05,33,"GCR Beta, GCR, ERK1/2, IRF1, IL-1 beta, MLCP (reg), GRO-1, HDAC2, IL-6, PA24A, NF-kB, Eotaxin, NF-kB p50/p65, Neurokinin-2 receptor, TNF-alpha, MLCP (cat), RhoA, RelA (p65 NF-kB subunit), CD38, c-Jun, Myosin II, PGES, CPI-17, p300, NCOA2 (GRIP1/TIF2), COX-2 (PTGS2), GRK5, MRLC, GCR Alpha, JNK(MAPK8-10), Beta-2 adrenergic receptor, PLA2, p38 MAPK",3.281E-07,3.624E-06,33,"GCR Beta, GCR, IFN-gamma, ERK1/2, IRF1, IL-1 beta, MLCP (reg), GRO-1, HDAC2, IL-6, PA24A, NF-kB, Eotaxin, NF-kB p50/p65, Neurokinin-2 receptor, TNF-alpha, MLCP (cat), RhoA, RelA (p65 NF-kB subunit), CD38, Myosin II, PGES, CPI-17, p300, NCOA2 (GRIP1/TIF2), COX-2 (PTGS2), GRK5, MRLC, GCR Alpha, JNK(MAPK8-10), Beta-2 adrenergic receptor, PLA2, p38 MAPK",
198,Th17 cells in CF (mouse model),49,3.281E-07,3.624E-06,1.747E-04,5.343E-04,30,"TGF-beta 1, MHC class II, JAK1, ICAM1, MD-2, CD28, SMAD2, IL-17 receptor, IL-1 beta, GRO-1, CD14, MyD88, IL-17F, GM-CSF, CD4, IL-6, NF-kB, IL-23, JAK2, LBP, TGF-beta receptor type II, IRF4, JAK3, GCP2, IL23A, TLR4, SMAD3, IL-21 receptor, CD86, TGF-beta receptor type I",3.281E-07,3.624E-06,33,"TGF-beta 1, MHC class II, JAK1, ICAM1, MD-2, CD28, IL-17, SMAD2, IL-17 receptor, IL-1 beta, GRO-1, CD14, IL-17F, GM-CSF, CD4, IL-6, NF-kB, IL-23, JAK2, CD80, TGF-beta receptor type II, CFTR, IRF4, JAK3, STAT3, GCP2, IL23A, TLR4, SMAD3, IL-21 receptor, IL-21, CD86, TGF-beta receptor type I",
199,Signal transduction_Leptin signaling via JAK/STAT and MAPK cascade,39,3.297E-07,3.624E-06,6.752E-07,5.612E-06,29,"STAT5A, SOD2, Apaf-1, RPS6, ERK1/2, VEGF-A, STAT5B, NT/NN, STAT1, Endothelin-1, cPLA2, SOCS3, Caspase-3, MEK1/2, POMC, JAK2, c-Jun, AGRP, Caspase-9, Leptin receptor, p90Rsk, TIMP1, PPCKC, AP-1, SHP-2, STAT5, JNK(MAPK8-10), MMP-9, BMP2",3.297E-07,3.624E-06,28,"STAT5A, SOD2, Apaf-1, RPS6, ERK1/2, VEGF-A, STAT5B, NT/NN, STAT1, Endothelin-1, cPLA2, SOCS3, Caspase-3, MEK1/2, POMC, JAK2, G6PT, AGRP, Caspase-9, Leptin receptor, p90Rsk, TIMP1, STAT3, PPCKC, STAT5, JNK(MAPK8-10), MMP-9, BMP2",
200,FGF2 signaling in melanoma,39,3.297E-07,3.624E-06,3.395E-06,2.099E-05,28,"FGFR2, Fra-1, ERK1/2, Syndecan-4, VEGF-A, Fibronectin, Rac1, CDK1 (p34), Shc, Heparanase 1, N-Ras, MMP-2, MEK1/2, CDC42, Collagen IV, c-Src, RhoA, PI3K cat class IA, B-Raf, YES, FGF2, SOS, Perlecan, Caveolin-1, SPRY2, p38 MAPK, Syndecan-2, Collagen I",3.297E-07,3.624E-06,28,"FGFR2, Fra-1, ERK1/2, Syndecan-4, VEGF-A, Fibronectin, CDK1 (p34), Shc, Heparanase 1, N-Ras, MMP-2, MEK1/2, CDC42, Collagen IV, c-Src, RhoA, PI3K cat class IA, B-Raf, YES, FGF2, SOS, STAT3, Perlecan, Caveolin-1, SPRY2, p38 MAPK, Syndecan-2, Collagen I",
201,Development_c-Kit ligand signaling pathway during hemopoiesis,61,3.343E-07,3.206E-06,3.343E-07,3.206E-06,41,"PLD1, APS, PLGF, ERK1/2, SOCS1, CrkL, VEGF-A, c-Kit, TEC, VAV-1, STAT1, Rac1, IP3 receptor, BAD, Shc, PI3K reg class IA (p85), MEK1/2, DOK1, Fyn, AKT(PKB), CXCR4, GAB2, Pyk2(FAK2), JAK2, PI3K cat class IA, c-Cbl, Lyn, GRAP, SOS, GRAP2, p90Rsk, Paxillin, PKC-alpha, SHP-2, SLUG, PLC-gamma, FOXO3A, STAT5, Elk-1, MMP-9, mTOR",8.730E-07,7.332E-06,38,"PLD1, APS, PLGF, ERK1/2, SOCS1, CrkL, VEGF-A, c-Raf-1, c-Kit, TEC, VAV-1, STAT1, IP3 receptor, Shc, PI3K reg class IA (p85), MEK1/2, DOK1, Fyn, AKT(PKB), CXCR4, GAB2, Pyk2(FAK2), JAK2, PI3K cat class IA, c-Cbl, Lyn, GRAP, SOS, GRAP2, p90Rsk, STAT3, PKC-alpha, SLUG, PLC-gamma, STAT5, Elk-1, MMP-9, mTOR",
202,Development_Schema: FGF signaling in embryonic stem cell self-renewal and differentiation,47,3.375E-07,3.675E-06,5.746E-05,2.081E-04,30,"TGF-beta 1, SOX1, NCAM1, WNT3A, Nkx6.1, BMP4, FGF1, VEGF-A, VEGFR-2, HNF3-beta, PAX6, IGF-2, Mixl1, Nestin, SOX9, CXCR4, PTCH1, Activin A, Gremlin, Pdx-1 (IPF1), NODAL, SOX17, T brachyury protein, WNT3, FGF2, Noggin, SPRY2, HNF4-alpha, BMP2, NEFH",3.375E-07,3.675E-06,32,"TGF-beta 1, SOX1, NCAM1, Nkx6.1, BMP4, FGF1, VEGF-A, VEGFR-2, NEFM, HNF3-beta, PAX6, IGF-2, Mixl1, AFP, Nestin, TAL1, SOX9, CXCR4, PTF1-p48, PTCH1, Activin A, Gremlin, Pdx-1 (IPF1), NODAL, SOX17, WNT3, FGF2, Noggin, SPRY2, HNF4-alpha, BMP2, NEFH",
203,LKB1 signaling pathway in lung cancer cells,45,3.431E-07,3.675E-06,5.887E-05,2.102E-04,29,"TGF-beta 1, MO25, ERK1/2, BRG1, Beta-catenin, Fibronectin, Vimentin, p63, CDC42, NF-kB, PEA3, Collagen IV, p16INK4, c-Src, c-Myc, N-cadherin, TGF-beta 2, ITGB1, Lysyl oxidase, HIF1A, C/EBPbeta, AMPK alpha subunit, TCF8, NFYA, COX-2 (PTGS2), SIK, p53, Collagen I, mTOR",3.431E-07,3.675E-06,31,"TGF-beta 1, MO25, ERK1/2, BRG1, Beta-catenin, Fibronectin, Vimentin, p63, CDC42, NF-kB, PEA3, Collagen IV, p16INK4, c-Src, N-cadherin, TGF-beta 2, ITGB1, Lysyl oxidase, HIF1A, C/EBPbeta, microRNA 200a, AMPK alpha subunit, TCF8, NFYA, STAT3, COX-2 (PTGS2), SIK, miR-200a-3p, p53, Collagen I, mTOR",
204,Role of neuropeptides in pathogenesis of SCLC,67,3.437E-07,3.275E-06,3.437E-07,3.275E-06,44,"Neprilysin, CCKAR, PI3K cat class IA (p110-beta), ERK1/2, GRP precursor, Galanin, G-protein alpha-q/11, PKC-epsilon, PLC-beta1, IP3 receptor, Shc, OTR, NMB-R, PLC-beta, GALR2, MEK1/2, G-protein beta/gamma, Fyn, AKT(PKB), Gastrin 17, Pyk2(FAK2), cPKC (conventional), G-protein alpha-12 family, PKC-delta, V1a receptor, CCKBR, EGFR, Substance P receptor, c-Jun, FGR, OT, SOS, Neuromedin B, PKC-beta2, p90Rsk, Bradykinin, 4E-BP1, PI3K cat class IA (p110-alpha), PKC, GRP(1-27), PKC-alpha, NT, G-protein alpha-q, mTOR",6.910E-06,3.989E-05,39,"Neprilysin, CCKAR, PI3K cat class IA (p110-beta), ERK1/2, GRP precursor, c-Raf-1, Galanin, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, Shc, OTR, NMB-R, PLC-beta, GALR2, MEK1/2, G-protein beta/gamma, Fyn, AKT(PKB), Gastrin 17, Pyk2(FAK2), cPKC (conventional), G-protein alpha-12 family, V1a receptor, EGFR, Substance P receptor, FGR, AVP extracellular region, OT, SOS, Neuromedin B, PKC-beta2, p90Rsk, PI3K cat class IA (p110-alpha), PKC, GRP(1-27), PKC-alpha, NT, mTOR",
205,Regulation of proinflammatory cytokine production by Th2 cells in asthma,43,3.442E-07,3.675E-06,5.987E-05,2.118E-04,28,"IL-7 receptor, MHC class II, IL-7, Importin (karyopherin)-alpha, CD28, TSLP, IL17BR, IL-15, IRAK4, MyD88, CD4, IL-13, NF-kB p50/p65, IL-2, TNF-alpha, JAK2, IL-12 receptor, TRAF6, IL-5, IL1RAP, ST2(L), c-Maf, CD3, IL-33, IRAK1, STAT5, CD86, TSLPR",3.442E-07,3.675E-06,30,"p38alpha (MAPK14), IL-7 receptor, MHC class II, IL-7, IFN-gamma, Importin (karyopherin)-alpha, CD28, IL-17, TSLP, IL17BR, IL-15, IRAK4, CD4, NF-kB p50/p65, IL-2, TNF-alpha, JAK2, CD80, IL-12 receptor, TRAF6, IL-5, IL1RAP, ST2(L), c-Maf, CD3, IL-33, IRAK1, STAT5, CD86, TSLPR",
206,Stromal-epithelial interaction in Prostate Cancer,42,3.653E-07,3.432E-06,3.653E-07,3.432E-06,31,"TGF-beta 1, FGFR2, Versican, SMAD4, PDGF-R-alpha, SMAD2, Fibronectin, Vimentin, Keratin 17, Tenascin-C, MMP-2, IL-6, HIC5, TIMP2, PDGF-D, HGF, TGF-beta 2, TGF-beta receptor type II, c-Jun, PDGF-A, FGF2, TIMP1, FGF7, ACTA2, SNAIL1, SMAD3, HGF receptor (Met), MMP-9, Collagen I, TGF-beta receptor type I, PDGF-R-beta",7.646E-07,6.614E-06,29,"TGF-beta 1, FGFR2, Versican, SMAD4, PDGF-R-alpha, SMAD2, Fibronectin, Vimentin, Keratin 17, Tenascin-C, MMP-2, IL-6, HIC5, TIMP2, PDGF-D, HGF, TGF-beta 2, TGF-beta receptor type II, PDGF-A, FGF2, TIMP1, ACTA2, SNAIL1, SMAD3, HGF receptor (Met), MMP-9, Collagen I, TGF-beta receptor type I, PDGF-R-beta",
207,"IGF family, invasion and metastasis in colorectal cancer",33,3.671E-07,3.432E-06,3.671E-07,3.432E-06,26,"ITGAV, IRS-1, Beta-catenin, alpha-6/beta-4 integrin, IBP6, Fibronectin, Rac1, PI3K reg class IA, PLAT (TPA), IGF-2, PLAUR (uPAR), alpha-V/beta-6 integrin, Collagen IV, RhoA, alpha-3/beta-1 integrin, ITGB1, PI3K cat class IA, PKC-delta, Laminin 1, alpha-1/beta-1 integrin, alpha-V/beta-5 integrin, PLAU (UPA), ITGB4, p38 MAPK, PAI1, Collagen I",3.984E-05,1.726E-04,22,"ITGAV, Beta-catenin, alpha-6/beta-4 integrin, IBP6, Fibronectin, PI3K reg class IA, PLAT (TPA), IGF-2, PLAUR (uPAR), alpha-V/beta-6 integrin, Collagen IV, RhoA, alpha-3/beta-1 integrin, ITGB1, PI3K cat class IA, Laminin 1, alpha-1/beta-1 integrin, PLAU (UPA), ITGB4, p38 MAPK, PAI1, Collagen I",
208,Immune response_Role of HMGB1 in dendritic cell maturation and migration,26,3.678E-07,3.899E-06,4.189E-04,1.113E-03,18,"MHC class II, HMGB1, ERK1/2, IL-15, IL-1 beta, IL-6, NF-kB, CXCR4, IL-2, TNF-alpha, IL-18, IL-8, IL-5, CCL19, RAGE, p38 MAPK, IL-12 beta, CD86",3.678E-07,3.899E-06,21,"MHC class II, CCL21, HMGB1, IFN-gamma, ERK1/2, IL-15, IL-1 beta, IL-6, NF-kB, CXCR4, IL-2, TNF-alpha, CD80, IL-18, IL-8, IL-5, CCL19, RAGE, p38 MAPK, IL-12 beta, CD86",
209,Role of alpha-V/ beta-6 integrin in colorectal cancer,23,4.294E-07,3.990E-06,4.294E-07,3.990E-06,20,"TGF-beta 1, ITGAV, ERK1/2, Fibronectin, Plasminogen, Bax, Caspase-3, MMP-2, MEK1/2, alpha-V/beta-6 integrin, ERK2 (MAPK1), Collagen IV, ETS1, Plasmin, Caspase-9, PLAU (UPA), PKC, ITGB6, MMP-9, Collagen I",6.023E-06,3.587E-05,18,"TGF-beta 1, ITGAV, ERK1/2, Fibronectin, Bax, Caspase-3, MMP-2, MEK1/2, alpha-V/beta-6 integrin, ERK2 (MAPK1), Collagen IV, ETS1, Caspase-9, PLAU (UPA), PKC, ITGB6, MMP-9, Collagen I",
210,Signal transduction_Adenosine A1 receptor signaling pathway,62,4.350E-07,4.516E-06,2.314E-06,1.499E-05,40,"PI3K cat class IA (p110-beta), ERK1/2, HB-EGF, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PKC-epsilon, STAT1, IP3 receptor, BAD, I-kB, PI3K reg class IA (p85), PLC-beta, Glycine receptor, Adenylate cyclase, MMP-2, CREB1, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), SFK, c-Src, TTC1, G-protein alpha-15, EGFR, ASK1 (MAP3K5), G-protein alpha-i family, ADA, PP2A catalytic, CGRP, HB-EGF(mature), GlyRA1, Calmodulin, PKC, PKC-alpha, PLC-beta3, ADAM17, p38 MAPK, PKA-cat (cAMP-dependent), PLC-beta2",4.350E-07,4.516E-06,39,"PI3K cat class IA (p110-beta), ERK1/2, HB-EGF, c-Raf-1, G-protein alpha-q/11, PKC-epsilon, STAT1, IP3 receptor, I-kB, PI3K reg class IA (p85), PLC-beta, Glycine receptor, Adenylate cyclase, MMP-2, CREB1, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), SFK, c-Src, G-protein alpha-15, EGFR, ASK1 (MAP3K5), G-protein alpha-i family, ADA, PP2A catalytic, CGRP, HB-EGF(mature), GlyRA1, STAT3, Calmodulin, PKC, PKC-alpha, PLC-beta3, ADAM17, p38 MAPK, PKA-cat (cAMP-dependent), PLC-beta2",
211,High shear stress-induced platelet activation,46,4.615E-07,4.167E-06,4.615E-07,4.167E-06,33,"PI3K cat class IA (p110-beta), GP-IB beta, Alpha-actinin, Gas6, Fibronectin, Talin, PI3K reg class IA (p85), Thrombin, alpha-IIb/beta-3 integrin, Tyro3, L1CAM, G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), Collagen VI, P-selectin, Ephrin-B1, PI3K reg class IA (p85-alpha), ITGB3, RAP-1B, G-protein alpha-i family, 14-3-3 zeta/delta, Ephrin-B receptor 1, MER, TBXA2R, Collagen III, Vinculin, UFO, PAR1, Filamin A, Fibrinogen (fibrin), Ephrin-A receptor 4, Collagen I",3.148E-06,2.149E-05,30,"PI3K cat class IA (p110-beta), Alpha-actinin, Gas6, Fibronectin, sCD40L, Talin, PI3K reg class IA (p85), alpha-IIb/beta-3 integrin, L1CAM, G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), Collagen VI, P-selectin, Ephrin-B1, PI3K reg class IA (p85-alpha), ITGB3, RAP-1B, G-protein alpha-i family, 14-3-3 zeta/delta, Ephrin-B receptor 1, MER, TBXA2R, Collagen III, Vinculin, UFO, PAR1, Filamin A, Ephrin-A receptor 4, Collagen I",
212,"Development_TGF-beta-dependent induction of EMT via RhoA,  PI3K and ILK",46,4.615E-07,4.167E-06,4.615E-07,4.167E-06,33,"TGF-beta 1, Lef-1, ROCK1, Beta-catenin, Caldesmon, Fibronectin, Vimentin, Claudin-1, Actin, I-kB, PI3K reg class IA (p85), GSK3 beta, IKK-alpha, AKT(PKB), HIC5, ACTB, RhoA, TGF-beta 2, PI3K cat class IA, RelA (p65 NF-kB subunit), PINCH, SMURF1, TGF-beta receptor type II, ZO-1, SLUG, ACTA2, Tropomyosin-1, SNAIL1, SMAD3, MKL1, SRF, Cofilin, TGF-beta receptor type I",7.320E-07,6.614E-06,31,"TGF-beta 1, ROCK1, Beta-catenin, Caldesmon, Fibronectin, Vimentin, Claudin-1, Actin, I-kB, PI3K reg class IA (p85), GSK3 beta, AKT(PKB), HIC5, ACTB, RhoA, TGF-beta 2, PI3K cat class IA, RelA (p65 NF-kB subunit), PINCH, SMURF1, TGF-beta receptor type II, ZO-1, SLUG, ACTA2, Tropomyosin-1, SNAIL1, SMAD3, MKL1, SRF, Cofilin, TGF-beta receptor type I",
213,Release of pro-inflammatory mediators and elastolytic enzymes by alveolar macrophages in COPD,28,4.636E-07,4.748E-06,1.984E-05,9.022E-05,21,"IP10, CCL2, Matrilysin (MMP-7), Cathepsin S, STAT1, IL-1 beta, HDAC2, GM-CSF, MMP-2, IL-6, NF-kB p50/p65, TNF-alpha, CHI3L1, Cathepsin L, RelA (p65 NF-kB subunit), IL-8, Leukocyte elastase, TLR4, p38 MAPK, MMP-9, TLR2",4.636E-07,4.748E-06,22,"IP10, CCL2, IFN-gamma, Matrilysin (MMP-7), Cathepsin S, STAT1, IL-1 beta, HDAC2, GM-CSF, MMP-2, IL-6, NF-kB p50/p65, TNF-alpha, CHI3L1, Cathepsin L, RelA (p65 NF-kB subunit), IL-8, Leukocyte elastase, TLR4, p38 MAPK, MMP-9, TLR2",
214,Development_Astrocyte differentiation (general schema),28,4.636E-07,4.748E-06,1.984E-05,9.022E-05,21,"SOX1, NOTCH1 receptor, BMP receptor 2, GFAP, JAK1, CD44, BMP4, CNTF, Vimentin, BMPR1B, LIF, Nestin, MCT1 (SLC16A1), GLAST1/EAAT1, TERT, JAK2, p300, HES1, SLC6A11, BMPR1A, BMP2",4.636E-07,4.748E-06,22,"SOX1, NOTCH1 receptor, BMP receptor 2, GFAP, JAK1, CD44, BMP4, CNTF, Vimentin, BMPR1B, LIF, Nestin, MCT1 (SLC16A1), GLAST1/EAAT1, TERT, JAK2, p300, STAT3, HES1, SLC6A11, BMPR1A, BMP2",
215,Production and activation of TGF-beta in airway smooth muscle cells,35,4.680E-07,4.167E-06,4.680E-07,4.167E-06,27,"TGF-beta 1, PAR2, ERK1/2, EGR1, Angiotensin II, Plasminogen, MyD88, GM-CSF, MEK1/2, RhoA, TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta receptor type II, G-protein alpha-i family, c-Jun, Leukocyte elastase, TGF-beta, Plasmin, TGF-beta receptor type III (betaglycan), Tryptase, PLAU (UPA), ROCK, AP-1, TLR4, IRAK1, PAI1, TGF-beta receptor type I",5.267E-04,1.362E-03,21,"TGF-beta 1, PAR2, ERK1/2, Angiotensin II, GM-CSF, MEK1/2, RhoA, TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta receptor type II, G-protein alpha-i family, Leukocyte elastase, TGF-beta, TGF-beta receptor type III (betaglycan), Tryptase, PLAU (UPA), ROCK, TLR4, IRAK1, PAI1, TGF-beta receptor type I",
216,Development_TGF-beta-dependent induction of EMT via SMADs ,35,4.680E-07,4.167E-06,4.680E-07,4.167E-06,27,"TGF-beta 1, Lef-1, SMAD4, SMAD2, Fibronectin, Vimentin, Claudin-1, Endothelin-1, SIP1 (ZFHX1B), MMP-2, TWIST1, NOTCH1 (NICD), HEY1, N-cadherin, TGF-beta 2, ETS1, TGF-beta receptor type II, TGF-beta, TCF8, SLUG, HMGA2, SNAIL1, SMAD3, MKL1, Jagged1, PAI1, TGF-beta receptor type I",1.670E-06,1.226E-05,25,"TGF-beta 1, SMAD4, SMAD2, Fibronectin, Vimentin, Claudin-1, Endothelin-1, SIP1 (ZFHX1B), MMP-2, TWIST1, NOTCH1 (NICD), N-cadherin, TGF-beta 2, ETS1, TGF-beta receptor type II, TGF-beta, TCF8, SLUG, HMGA2, SNAIL1, SMAD3, MKL1, Jagged1, PAI1, TGF-beta receptor type I",
217,Immune response_Antigen presentation by MHC class II,118,4.816E-07,4.263E-06,4.816E-07,4.263E-06,68,"MHC class II alpha chain, MHC class II, Langerin, AP complex 2 medium (mu) chain, Endoplasmin, ERK1/2, DCTN1(p150Glued), PI3K cat class III (Vps34), Dynamin-2, Cathepsin S, TAP, Rac1, Syk, Cathepsin F, IP-30, Dynamin-1, ORP1, Rab-7, ARHGEF2, Dynein 1, cytoplasmic, heavy chain, Gie1, MyD88, Itch, LAMP2, CD209, CD4, SWAP-70, HLA-DO, CDC42, HSP90, MHC class II beta chain, LRP1, Tubulin (in microtubules), Cathepsin L, RhoA, Dectin-1, PI3K cat class IA, HSC70, MAP1LC3B, c-Cbl, PKC-delta, HLA-DM, MYO1E, LY75, PLEKHM2, ARL14, Cathepsin V, HSP90 beta, MAP1LC3A, 14-3-3 beta/alpha, CD74, PKC, SPPL2a, RILP (Rab interacting lysosomal protein), Kinesin heavy chain, PKC-alpha, TLR4, CD79B, Beclin 1, JNK(MAPK8-10), Legumain, TRIF (TICAM1), Kinesin light chain, R-Ras, Dynein 1, cytoplasmic, intermediate chains, p38 MAPK, TLR2, mTOR",5.878E-05,2.401E-04,58,"MHC class II alpha chain, MHC class II, Langerin, AP complex 2 medium (mu) chain, Endoplasmin, CLEC10A, ERK1/2, DCTN1(p150Glued), PI3K cat class III (Vps34), Dynamin-2, Cathepsin S, TAP, Syk, IP-30, Dynamin-1, ORP1, ARHGEF2, Dynein 1, cytoplasmic, heavy chain, Gie1, Itch, LAMP2, CD4, HLA-DO, CDC42, HSP90, MHC class II beta chain, LRP1, Tubulin (in microtubules), Cathepsin L, RhoA, Dectin-1, PI3K cat class IA, MAP1LC3B, c-Cbl, HLA-DM, CLEC9A, MYO1E, LY75, PLEKHM2, ARL14, Cathepsin V, HSP90 beta, MAP1LC3A, CD74, PKC, SPPL2a, RILP (Rab interacting lysosomal protein), Kinesin heavy chain, PKC-alpha, TLR4, JNK(MAPK8-10), Legumain, Kinesin light chain, R-Ras, Dynein 1, cytoplasmic, intermediate chains, p38 MAPK, TLR2, mTOR",
218,Inter-cellular relations in COPD (general schema),30,5.508E-07,5.418E-06,2.276E-05,1.012E-04,22,"IP10, GCR, CCL2, Perforin, IL-1 beta, GRO-1, HDAC2, GM-CSF, IL-6, TGF-alpha, IL-23, NF-kB p50/p65, TNF-alpha, RelA (p65 NF-kB subunit), I-TAC, IL-8, EGFR, Leukocyte elastase, TGF-beta, CXCR3, CTGF, MMP-9",5.508E-07,5.418E-06,23,"MIG, IP10, GCR, CCL2, IFN-gamma, IL-17, IL-1 beta, GRO-1, HDAC2, GM-CSF, IL-6, TGF-alpha, IL-23, NF-kB p50/p65, TNF-alpha, RelA (p65 NF-kB subunit), I-TAC, IL-8, EGFR, Leukocyte elastase, TGF-beta, CTGF, MMP-9",
219,Immune response_Generation of memory CD4+ T cells,37,5.719E-07,5.004E-06,5.719E-07,5.004E-06,28,"OX40L(TNFSF4), IL-7 receptor, MHC class II, IL-7, JAK1, NF-AT1(NFATC2), CD44, IL-4R type I, CD28, BFL1, OX40(TNFRSF4), IL-15, L-selectin, IL-15RA, GABP alpha, FKHR, CD4, NF-kB, Mcl-1, IL-2R alpha chain, NF-AT2(NFATC1), IL-2, IL7RA, IL4RA, JAK3, AP-1, STAT5, CD86",1.704E-06,1.226E-05,26,"OX40L(TNFSF4), IL-7 receptor, MHC class II, IL-7, JAK1, CD44, IL-4R type I, CD28, BFL1, OX40(TNFRSF4), IL-15, L-selectin, IL-15RA, GABP alpha, FKHR, CD4, NF-kB, Mcl-1, NF-AT2(NFATC1), IL-2, CD80, IL7RA, IL4RA, JAK3, STAT5, CD86",
220,G-protein signaling_Regulation of p38 and JNK signaling mediated by G-proteins,37,5.719E-07,5.004E-06,5.719E-07,5.004E-06,28,"LARG, ROCK1, MEF2C, PRK1, ARHGEF1 (p115RhoGEF), G-protein alpha-q/11, PKC-epsilon, PI3K cat class IB (p110-gamma), Rac1, PLC-beta, G-protein beta/gamma, CDC42, ZAK, c-Src, MEKK4(MAP3K4), RhoA, Pyk2(FAK2), G-protein alpha-12 family, G-protein alpha-i family, MEK3(MAP2K3), c-Jun, MKK7 (MAP2K7), MEK4(MAP2K4), MEKK1(MAP3K1), ATF-2, JNK(MAPK8-10), PI3K reg class IB (p101), p38 MAPK",1.443E-03,3.263E-03,21,"ROCK1, MEF2C, PRK1, ARHGEF1 (p115RhoGEF), G-protein alpha-q/11, PKC-epsilon, PI3K cat class IB (p110-gamma), PLC-beta, G-protein beta/gamma, CDC42, ZAK, c-Src, RhoA, Pyk2(FAK2), G-protein alpha-12 family, G-protein alpha-i family, MEK3(MAP2K3), MEK4(MAP2K4), ATF-2, JNK(MAPK8-10), p38 MAPK",
221,Chemotaxis_CXCR3-A signaling,69,5.822E-07,5.630E-06,1.172E-06,8.812E-06,44,"IP10, GRK6, ERK1/2, GRK3, G-protein alpha-i2, Perforin, PI3K cat class IB (p110-gamma), STAT1, Rac1, IP3 receptor, Beta-arrestin2, Shc, STAT4, ZAP70, PLC-gamma 1, MMP-2, CREB1, MEK1/2, G-protein beta/gamma, CDC42, AKT(PKB), Calpain 1(mu), c-Src, PF4V1, RhoA, Lck, I-TAC, IL-8, T-bet, ZO-1, SOS, LAT, Cathepsin B, CXCR3, Calmodulin, Vinculin, CD3, GRK5, STAT5, PF4, PI3K reg class IB (p101), PLC-beta3, MMP-9, PREX2",5.822E-07,5.630E-06,42,"MIG, IP10, GRK6, IFN-gamma, ERK1/2, c-Raf-1, GRK3, G-protein alpha-i2, PI3K cat class IB (p110-gamma), STAT1, IP3 receptor, Beta-arrestin2, Shc, STAT4, PLC-gamma 1, MMP-2, CREB1, MEK1/2, G-protein beta/gamma, CDC42, AKT(PKB), Calpain 1(mu), c-Src, PF4V1, RhoA, Lck, I-TAC, IL-8, T-bet, ZO-1, SOS, p90RSK1, Cathepsin B, Calmodulin, Vinculin, CD3, GRK5, STAT5, PF4, PLC-beta3, MMP-9, PREX2",
222,Immune response_OX40L/ OX40 signaling pathway,69,5.822E-07,5.630E-06,1.147E-05,5.799E-05,42,"OX40L(TNFSF4), Calcineurin A (catalytic), IL-10, BFL1, OX40(TNFRSF4), IL-22, Perforin, IP3 receptor, I-kB, PI3K reg class IA (p85), GSK3 beta, NF-kB2 (p100), PKC-theta, Survivin, FKHR, IKK-alpha, NF-kB p52/RelB, RIPK1, IL-13, NF-kB, AKT(PKB), NF-kB p50/p65, IL-2R alpha chain, NF-AT2(NFATC1), CXCR4, IL-2, PI3K cat class IA, NF-kB2 (p52), T-bet, TRAF6, IL-5, NIK(MAP3K14), Bcl-6, CARD11, Calmodulin, CD3, MALT1, PLC-gamma, Aurora-B, Bcl-10, mTOR, IL-12RB2",5.822E-07,5.630E-06,42,"OX40L(TNFSF4), Calcineurin A (catalytic), IL-10, IFN-gamma, CXCR5, BFL1, OX40(TNFRSF4), IL-17, IL-22, IP3 receptor, I-kB, PI3K reg class IA (p85), GSK3 beta, NF-kB2 (p100), PKC-theta, Survivin, FKHR, NF-kB p52/RelB, RIPK1, NF-kB, AKT(PKB), NF-kB p50/p65, NF-AT2(NFATC1), CXCR4, IL-2, PI3K cat class IA, NF-kB2 (p52), T-bet, TRAF6, IL-5, NIK(MAP3K14), Bcl-6, CARD11, Calmodulin, CD3, MALT1, PLC-gamma, Aurora-B, Bcl-10, IL-21, mTOR, IL-12RB2",
223,Eosinophil granule protein release in asthma,54,5.950E-07,5.630E-06,2.840E-05,1.210E-04,34,"PAR2, C5a, ERK1/2, RNS2, VEGF-A, TSLP, CD48, FPR, PI3K cat class IB (p110-gamma), GM-CSF, CRLF2, Eotaxin, PRG2, ECP (RNase 3), IL-2, NT-3, TNF-alpha, FPRL1, cPKC (conventional), Cathepsin G, IL-5, Leukocyte elastase, IFN-gamma receptor, Tryptase, NGF, ST2(L), PKC, PKC-alpha, CD244, IL-33, C3a, p38 MAPK, BDNF, TSLPR",5.950E-07,5.630E-06,35,"PAR2, C5a, IFN-gamma, ERK1/2, RNS2, VEGF-A, TSLP, CD48, FPR, PI3K cat class IB (p110-gamma), GM-CSF, CRLF2, Eotaxin, PRG2, ECP (RNase 3), IL-2, TNF-alpha, FPRL1, cPKC (conventional), Cathepsin G, CRTH2, IL-5, Leukocyte elastase, IFN-gamma receptor, Tryptase, NGF, ST2(L), PKC, PKC-alpha, CD244, IL-33, C3a, p38 MAPK, BDNF, TSLPR",
224,Development_WNT/Beta-catenin signaling in organogenesis,30,6.314E-07,5.397E-06,6.314E-07,5.397E-06,24,"Oct-3/4, Lef-1, TCF7L2 (TCF4), Neuropilin-1, FOXC2, Beta-catenin, PLA2G7, FGF8, Neuroligin 3, HESX1, LRP5/LRP6, PROP1, Myelin P0 protein, Tcf(Lef), IL-8, FAM19A5, PROX1, PIT1, PMP22, WNT, LBH, En1, BMP2, Frizzled",9.002E-05,3.381E-04,20,"Oct-3/4, TCF7L2 (TCF4), Neuropilin-1, FOXC2, Beta-catenin, PLA2G7, FGF8, Fam132a, Neuroligin 3, HESX1, Myelin P0 protein, Tcf(Lef), IL-8, PROX1, PMP22, WNT, LBH, En1, BMP2, Frizzled",
225,Development_WNT/Beta-catenin signaling in cell differentiation,30,6.314E-07,5.397E-06,6.314E-07,5.397E-06,24,"Lef-1, Beta-catenin, VEGFR-2, Eomesodermin, PAX8, Follistatin, NeuroD1, TCF7 (TCF1), CXCR4, LRP5/LRP6, TNR19 isoform 2, Tcf(Lef), BMP3, Kindlin-2, PROX1, FGF18, DSPP, WNT, EMX2, SLUG, ATH1, CDX1, BMP2, Frizzled",3.518E-06,2.317E-05,22,"Beta-catenin, VEGFR-2, Islet-1, Eomesodermin, PAX8, Follistatin, NeuroD1, TCF7 (TCF1), CXCR4, TNR19 isoform 2, Tcf(Lef), BMP3, Kindlin-2, PROX1, DSPP, WNT, EMX2, SLUG, ATH1, CDX1, BMP2, Frizzled",
226,Activation of TGF-beta signaling in advanced colorectal cancer,30,6.314E-07,5.397E-06,6.314E-07,5.397E-06,24,"TGF-beta 1, SMAD4, SMAD2, IBP3, PI3K reg class IA, CDK4, AKT(PKB), c-Myc, TAK1(MAP3K7), TGF-beta 2, PI3K cat class IA, IL-8, TGF-beta receptor type II, MKK7 (MAP2K7), JNK1(MAPK8), MEK4(MAP2K4), MEKK1(MAP3K1), SNAIL1, SMAD3, p38 MAPK, MMP-9, PAI1, mTOR, TGF-beta receptor type I",1.917E-05,9.273E-05,21,"TGF-beta 1, SMAD4, SMAD2, IBP3, PI3K reg class IA, CDK4, AKT(PKB), TAK1(MAP3K7), TGF-beta 2, PI3K cat class IA, IL-8, TGF-beta receptor type II, JNK1(MAPK8), MEK4(MAP2K4), SNAIL1, SMAD3, p38 MAPK, MMP-9, PAI1, mTOR, TGF-beta receptor type I",
227,Signal transduction_mTORC2 downstream signaling,68,6.431E-07,5.466E-06,6.431E-07,5.466E-06,44,"Rictor, RAG1, IRS-1, PKC-zeta, PRAS40, Beta-catenin, SGK1, PKA-reg (cAMP-dependent), GLUT4, Rac1, BAD, GSK3 beta, STK4, FKHR, IGF-2, GSK3 alpha/beta, CDC42, AKT(PKB), c-Myc, Mcl-1, RhoA, cPKC (conventional), OSR1, IL7RA, PKC-delta, F-Actin cytoskeleton, TBCD4, PKC-beta2, Paxillin, PPCKC, PKC, PKC-alpha, IMP1(ZBP1), TLR4, Rab-10, FOXO3A, NEDD4L, AKT2, HXK4, Filamin A, p53, Bim, PKA-cat (cAMP-dependent), mTOR",2.843E-03,5.823E-03,33,"Rictor, RAG1, Beta-catenin, SGK1, RAG2, GSK3 beta, STK4, FKHR, IGF-2, GSK3 alpha/beta, CDC42, AKT(PKB), Mcl-1, RhoA, cPKC (conventional), OSR1, IL7RA, G6PT, F-Actin cytoskeleton, TBCD4, PKC-beta2, PPCKC, PKC, PKC-alpha, IMP1(ZBP1), TLR4, NEDD4L, HXK4, Filamin A, p53, Bim, PKA-cat (cAMP-dependent), mTOR",
228,Development_WNT/Beta-catenin signaling in the nucleus,62,6.522E-07,5.512E-06,6.522E-07,5.512E-06,41,"PLD1, Lef-1, TCF7L2 (TCF4), BRG1, Beta-catenin, BCL9/B9L, TLE, p15(PAF), CBP/P300, Dsh, UBR5, RUNX, ICAT, Casein kinase II, EZH2, TCF7 (TCF1), RUVBL1, LRP5/LRP6, TRRAP, TNIK, BAF53, Tcf(Lef), AF-10, c-Jun, TBP, MEF2, Kaiso, PLD2, hSPT3, Mitotic cohesin complex, WNT, Pitx2, TCF7L1 (TCF3), JNK(MAPK8-10), SMARCA5, SNAIL1, HDAC1, NIPBL, p120-catenin, p38 MAPK, Frizzled",4.966E-05,2.074E-04,35,"PLD1, TCF7L2 (TCF4), BRG1, Beta-catenin, BCL9/B9L, TLE, CBP/P300, Dsh, UBR5, RUNX, ICAT, Casein kinase II, EZH2, TCF7 (TCF1), RUVBL1, TRRAP, TNIK, BAF53, Tcf(Lef), AF-10, MEF2, Kaiso, PLD2, hSPT3, Mitotic cohesin complex, WNT, Pitx2, TCF7L1 (TCF3), JNK(MAPK8-10), SMARCA5, SNAIL1, HDAC1, NIPBL, p38 MAPK, Frizzled",
229,Immune response_IL-12 signaling pathway,48,7.042E-07,6.580E-06,2.175E-06,1.459E-05,33,"IKBZ, STAT5A, Cyclin D3, RUNX3, Tyk2, SOCS1, GADD45 beta, STAT5B, Ubiquitin, PI3K reg class IA, STAT4, SOCS3, AKT(PKB), c-Myc, MEKK4(MAP3K4), JAK2, PI3K cat class IA, IL-12 receptor, Lck, iNOS, IL-18, T-bet, c-Jun, PIAS2, PDLIM2, ATF-2, STAT5, JNK(MAPK8-10), IL-12 beta, IL-12RB1, mTOR, IL-12RB2, ERM",7.042E-07,6.580E-06,32,"p38alpha (MAPK14), IKBZ, STAT5A, RUNX3, Tyk2, IFN-gamma, SOCS1, GADD45 beta, STAT5B, Ubiquitin, PI3K reg class IA, STAT4, SOCS3, AKT(PKB), JAK2, PI3K cat class IA, IL-12 receptor, Lck, iNOS, IL-18, T-bet, PIAS2, PDLIM2, STAT3, ATF-2, STAT5, JNK(MAPK8-10), IL-12 beta, IL-12RB1, mTOR, IL-12RB2, ERM",
230,Activation of pro-oncogenic TGF-beta potential in gastric cancer,25,7.143E-07,5.871E-06,7.143E-07,5.871E-06,21,"TGF-beta 1, NCK1, SMAD4, SMAD2, Fibronectin, MMP-2, c-Src, alpha-3/beta-1 integrin, TGF-beta 2, PKC-delta, TGF-beta receptor type II, Paxillin, GSTP1, p130CAS, Cofilin, non-muscle, ITGA2, ITGA3, alpha-2/beta-1 integrin, SMAD3, MMP-9, TGF-beta receptor type I",4.240E-05,1.791E-04,18,"TGF-beta 1, NCK1, SMAD4, SMAD2, Fibronectin, MMP-2, c-Src, alpha-3/beta-1 integrin, TGF-beta 2, TGF-beta receptor type II, GSTP1, p130CAS, ITGA2, ITGA3, alpha-2/beta-1 integrin, SMAD3, MMP-9, TGF-beta receptor type I",
231,Inhibition of TGF-beta signaling in gastric cancer,25,7.143E-07,5.871E-06,7.143E-07,5.871E-06,21,"CBP, TGF-beta 1, RUNX3, SMAD4, SMAD2, ELF3, Ubiquitin, TGF-beta 2, TGF-beta receptor type II, Ski, LMO1, p300, Thrombospondin 1, MEL1, Gasdermin, Beta-fodrin, Praja-1, HDAC1, SMAD3, Bim, TGF-beta receptor type I",4.240E-05,1.791E-04,18,"CBP, TGF-beta 1, RUNX3, SMAD4, SMAD2, Ubiquitin, TGF-beta 2, TGF-beta receptor type II, Ski, p300, Thrombospondin 1, Gasdermin, Beta-fodrin, Praja-1, HDAC1, SMAD3, Bim, TGF-beta receptor type I",
232,Immune response_CD40 signaling,65,7.175E-07,6.614E-06,4.065E-06,2.404E-05,41,"STAT5A, ICAM1, CCL2, c-FLIP(Long), IRF1, Cyclin D2, Acid sphingomyelinase, I-kB, PI3K reg class IA (p85), IKK-alpha, IL-6, FasL(TNFSF6), NF-kB, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), JAK2, PI3K cat class IA, TRAF3, c-Cbl, IL-8, Lyn, TRAF6, MEK3(MAP2K3), c-Jun, NIK(MAP3K14), JNK1(MAPK8), A20, JAK3, MEK4(MAP2K4), COX-2 (PTGS2), MEKK1(MAP3K1), ATF-2, TRAF1, TNF-beta, FasR(CD95), JNK2(MAPK9), p53, PLC-gamma 2, p38 MAPK, CD86",7.175E-07,6.614E-06,40,"STAT5A, ICAM1, CCL2, c-FLIP(Long), IRF1, Cyclin D2, Acid sphingomyelinase, I-kB, PI3K reg class IA (p85), IL-6, NF-kB, AKT(PKB), NF-kB p50/p65, TAK1(MAP3K7), CD40L(TNFSF5), JAK2, CD80, PI3K cat class IA, TRAF3, c-Cbl, IL-8, Lyn, TRAF6, MEK3(MAP2K3), NIK(MAP3K14), JNK1(MAPK8), A20, JAK3, MEK4(MAP2K4), STAT3, COX-2 (PTGS2), ATF-2, TRAF1, TNF-beta, FasR(CD95), JNK2(MAPK9), p53, PLC-gamma 2, p38 MAPK, CD86",
233,Beta-catenin-dependent transcription regulation in colorectal cancer,36,7.264E-07,6.614E-06,2.901E-05,1.226E-04,25,"LAMC2, CD44, Lef-1, TCF7L2 (TCF4), Lamin A/C, Beta-catenin, LAMC2 (100kDa), Claudin-1, MDR1, Tenascin-C, CD44 soluble, L1CAM, CD44 (EXT), PLAUR (uPAR), Progastrin, SOX9, LAMC2 (80kDa), IL-8, CDX2, PLAU (UPA), COX-2 (PTGS2), ELAVL1 (HuR), Calcyclin, Fascin, MMP-14",7.264E-07,6.614E-06,26,"LAMC2, CD44, TCF7L2 (TCF4), Lamin A/C, Beta-catenin, LAMC2 (100kDa), Claudin-1, MDR1, YAP1 (YAp65), Tenascin-C, CD44 soluble, L1CAM, CD44 (EXT), PLAUR (uPAR), Progastrin, SOX9, LAMC2 (80kDa), IL-8, CDX2, PLAU (UPA), COX-2 (PTGS2), ELAVL1 (HuR), MTS1 (S100A4), Calcyclin, Fascin, MMP-14",
234,Cell cycle_Regulation of G1/S transition (part 1),38,7.532E-07,6.614E-06,7.011E-06,3.856E-05,27,"TGF-beta 1, Cyclin D3, PP2A regulatory, CDC25A, SMAD4, SMAD2, Cyclin D2, Ubiquitin, GSK3 beta, CDK4, Skp2/TrCP/FBXW, p16INK4, PLK3 (CNK), TGF-beta 2, Brca1, TGF-beta receptor type II, Cyclin D, PP2A catalytic, Cul1/Rbx1 E3 ligase, CDK2, CDK6, Cyclin E, p15, Cyclin A, RING-box protein 1, SMAD3, TGF-beta receptor type I",7.532E-07,6.614E-06,27,"TGF-beta 1, PP2A regulatory, CDC25A, SMAD4, SMAD2, Cyclin D2, Ubiquitin, GSK3 beta, CDK4, Skp2/TrCP/FBXW, p16INK4, PLK3 (CNK), TGF-beta 2, Chk2, Brca1, TGF-beta receptor type II, Cyclin D, PP2A catalytic, Cul1/Rbx1 E3 ligase, CDK2, CDK6, Cyclin E, p15, Cyclin A, RING-box protein 1, SMAD3, TGF-beta receptor type I",
235,WNT signaling in invasive-type melanoma cells,38,7.532E-07,6.614E-06,1.442E-06,1.010E-05,28,"TGF-beta 1, MLANA, CD44, WNT3A, TCF7L2 (TCF4), Beta-catenin, Vimentin, FZD2, PDE6 reg, KiSS-1, MMP-2, Calpain 1(mu), cPKC (conventional), MKK7 (MAP2K7), MEK4(MAP2K4), WNT5A, SFRP3 (FRZB1), Calmodulin, PKC, G-protein alpha-t2, FZD5, Filamin-A (CTF), JNK(MAPK8-10), SNAIL1, Filamin A, PDE6 cat, TLR3, MITF",7.532E-07,6.614E-06,27,"TGF-beta 1, MLANA, CD44, TCF7L2 (TCF4), Beta-catenin, Vimentin, FZD2, PDE6 reg, KiSS-1, MMP-2, Calpain 1(mu), cPKC (conventional), MEK4(MAP2K4), STAT3, WNT5A, SFRP3 (FRZB1), Calmodulin, PKC, G-protein alpha-t2, FZD5, Filamin-A (CTF), JNK(MAPK8-10), SNAIL1, Filamin A, PDE6 cat, TLR3, MITF",
236,Eosinophil-derived cytokines in airway remodeling in asthma,38,7.532E-07,6.614E-06,7.011E-06,3.856E-05,27,"TGF-beta 1, CD44, C5a, ERK1/2, VEGF-A, PP2A cat (alpha), IL-17F, GM-CSF, TGF-alpha, NF-kB, IL-23, Stromelysin-1, TNF-alpha, TGF-beta 2, Osteopontin, AUF1, PKC-delta, IL-5, FGF2, Pin1, ELAVL1 (HuR), NGF, PKC-alpha, p38 MAPK, BDNF, MMP-9, IL-11",7.532E-07,6.614E-06,27,"TGF-beta 1, CD44, C5a, ERK1/2, VEGF-A, IL-17, PP2A cat (alpha), IL-17F, GM-CSF, TGF-alpha, NF-kB, IL-23, Stromelysin-1, TNF-alpha, TGF-beta 2, Osteopontin, AUF1, IL-5, FGF2, Pin1, ELAVL1 (HuR), NGF, PKC-alpha, p38 MAPK, BDNF, MMP-9, IL-11",
237,Immune response_Th1 and Th2 cell differentiation,40,7.654E-07,6.614E-06,7.516E-06,4.045E-05,28,"MHC class II, RUNX3, JAK1, NF-AT1(NFATC2), IL-4R type I, Tyk2, CD28, STAT1, STAT4, CD4, IL-13, NF-kB, NF-AT2(NFATC1), IL-2, JAK2, IL-12 receptor, IL-18, T-bet, IL-5, IFN-gamma receptor, CD137(TNFRSF9), c-Maf, AP-1, CD3, CD137 ligand(TNFSF9), IL-12 beta, CD86, IL-12RB2",7.654E-07,6.614E-06,28,"MHC class II, RUNX3, JAK1, IL-4R type I, Tyk2, IFN-gamma, CD28, STAT1, STAT4, CD4, NF-kB, NF-AT2(NFATC1), IL-2, CD40L(TNFSF5), JAK2, CD80, IL-12 receptor, IL-18, T-bet, IL-5, IFN-gamma receptor, CD137(TNFRSF9), c-Maf, CD3, CD137 ligand(TNFSF9), IL-12 beta, CD86, IL-12RB2",
238,IL-1 beta- and Endothelin-1-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,40,7.654E-07,6.614E-06,1.629E-06,1.118E-05,29,"COL1A1, IL-1 alpha, CCL2, ERK1/2, Versican, PDGF-R-alpha, Fibronectin, IL-1 beta, Decorin, Endothelin-1, HAS2, MMP-2, COL1A2, NF-kB, NF-kB p50/p65, Stromelysin-1, c-Jun, Thrombospondin 1, TIMP1, Collagen III, AP-1, COL4A1, EDNRB, HAS1, CTGF, PAI1, EDNRA, Collagen I, PDGF-R-beta",7.654E-07,6.614E-06,28,"COL1A1, IL-1 alpha, CCL2, IFN-gamma, ERK1/2, Versican, PDGF-R-alpha, Fibronectin, IL-1 beta, Decorin, Endothelin-1, HAS2, MMP-2, COL1A2, NF-kB, NF-kB p50/p65, Stromelysin-1, Thrombospondin 1, TIMP1, Collagen III, COL4A1, EDNRB, HAS1, CTGF, PAI1, EDNRA, Collagen I, PDGF-R-beta",
239,Cytoskeleton remodeling_PDGF signaling via calcium and Rho GTPases,83,8.083E-07,6.866E-06,9.028E-07,7.340E-06,51,"ABL2, STIM1, CDK5, NCK1, PLD1, F-Actin, Beta-catenin, Guanylate cyclase A (NPR1), TRPC6, PDGF-R-alpha, Dynamin-2, PKC-epsilon, Rac1, IP3 receptor, PI3K reg class IA (p85), PLC-gamma 1, PDGF-C, CDC42, Actin cytoskeletal, Fyn, PDGFR-ab, PDGF receptor, WASF1(WAVE1), c-Src, PDGF-D, ARPC2, WaspIP, Tiam1, Pyk2(FAK2), N-cadherin, Lysyl oxidase, DOCK1, PDGF-A, IQGAP1, WASF subunit, Paxillin, p130CAS, Schwannomin (NF2), Calmodulin, ARP2, PKC, Vinculin, PKC-alpha, N-WASP, c-Abl, ALPHA-PIX, PKA-cat (cAMP-dependent), WASF2, PDGF-R-beta, ATP7A, DOCK8",8.083E-07,6.866E-06,48,"ABL2, STIM1, CDK5, NCK1, PLD1, F-Actin, Beta-catenin, Guanylate cyclase A (NPR1), TRPC6, PDGF-R-alpha, Dynamin-2, PKC-epsilon, IP3 receptor, PI3K reg class IA (p85), PLC-gamma 1, PDGF-C, CDC42, Actin cytoskeletal, Fyn, PDGFR-ab, PDGF receptor, WASF1(WAVE1), c-Src, PDGF-D, ARPC2, WaspIP, Tiam1, Pyk2(FAK2), N-cadherin, Lysyl oxidase, DOCK1, PDGF-A, IQGAP1, WASF subunit, p130CAS, Schwannomin (NF2), Calmodulin, ARP2, PKC, Vinculin, PKC-alpha, c-Abl, ALPHA-PIX, PKA-cat (cAMP-dependent), WASF2, PDGF-R-beta, ATP7A, DOCK8",
240,The role of KEAP1/NRF2 pathway in skin sensitization,32,8.296E-07,6.782E-06,8.296E-07,6.782E-06,25,"TNF-R2, CBP, ERK1/2, Ubiquitin, IL-1 beta, MAFG, MyD88, MafK, NF-kB, ERK2 (MAPK1), MafF, HSP70, Caspase-1, TNF-alpha, Thioredoxin, Heme oxygenase 1, KEAP1, IL-18, IL-8, JNK1(MAPK8), TLR4, JNK(MAPK8-10), TXNRD1, NRF2, IL-12 beta",3.703E-06,2.346E-05,23,"TNF-R2, CBP, IFN-gamma, ERK1/2, Ubiquitin, IL-1 beta, MAFG, NF-kB, ERK2 (MAPK1), MafF, HSP70, Caspase-1, TNF-alpha, Heme oxygenase 1, KEAP1, IL-18, IL-8, JNK1(MAPK8), TLR4, JNK(MAPK8-10), TXNRD1, NRF2, IL-12 beta",
241,Effect of H. pylori infection on inflammation in gastric epithelial cells,61,8.730E-07,7.332E-06,1.392E-05,6.806E-05,38,"ERK1/2, Rac1, IP3 receptor, I-kB, MyD88, GM-CSF, MEK2(MAP2K2), CREB1, IL-6, TLR9, NF-kB p50/p65, c-Src, TAK1(MAP3K7), TNF-alpha, RhoA, iNOS, IL-18, RIPK2, C/EBPbeta, IL-8, TRAF6, MEK3(MAP2K3), c-Jun, SOS, NIK(MAP3K14), MEK4(MAP2K4), COX-2 (PTGS2), CD74, PKC-alpha, ATF-2, TLR4, PLC-gamma, IRAK1/2, JNK(MAPK8-10), Nod1, PLC-gamma 2, TLR2, C/EBPdelta",8.730E-07,7.332E-06,38,"p38alpha (MAPK14), ERK1/2, c-Raf-1, IP3 receptor, I-kB, GM-CSF, MEK2(MAP2K2), CREB1, IL-6, TLR9, NF-kB p50/p65, c-Src, TAK1(MAP3K7), TNF-alpha, MEK1(MAP2K1), RhoA, iNOS, IL-18, RIPK2, C/EBPbeta, IL-8, TRAF6, MEK3(MAP2K3), SOS, NIK(MAP3K14), MEK4(MAP2K4), COX-2 (PTGS2), CD74, PKC-alpha, ATF-2, TLR4, PLC-gamma, IRAK1/2, JNK(MAPK8-10), Nod1, PLC-gamma 2, TLR2, C/EBPdelta",
242,Role of epigenetic alterations in proliferation and differentiation of SCLC cells,72,8.999E-07,7.516E-06,2.310E-02,3.672E-02,34,"MYO18B, RARbeta, APC protein, CDC20, HAND1, Beta-catenin, CDC25A, HNF3-beta, Cyclin D2, RASSF2, MBD2, HDAC2, RASSF1, NRSF, SLC7A5, L1CAM, NeuroD1, c-Myc, TERT, MeCP2, USF2, ZNF423, DMRTA2, GlyRA1, CDK2, CDK6, HES1, L-Myc, SYP, AKT2, DNMT1, HDAC1, Caveolin-1, p53",8.999E-07,7.516E-06,43,"MYO18B, microRNA 34b, RARbeta, miR-34c-5p, APC protein, CDC20, HAND1, Beta-catenin, CDC25A, HNF3-beta, YAP1 (YAp65), Cyclin D2, RASSF2, microRNA 126, MBD2, microRNA 27a, HDAC2, RASSF1, SLC7A5, L1CAM, microRNA 375, NeuroD1, TERT, MeCP2, USF2, ZNF423, miR-126-3p, DMRTA2, miR-34b-3p, GlyRA1, CDK2, CDK6, HES1, miR-34c-3p, CCDC140, microRNA 34c, miR-375-3p, L-Myc, DNMT1, HDAC1, Caveolin-1, p53, miR-34b-5p",
243,Cytoskeleton remodeling_Neurofilaments,25,9.428E-07,7.831E-06,5.736E-06,3.214E-05,20,"CDK5R1 (p35), CDK5, GFAP, DCTN1(p150Glued), Vimentin, Tubulin gamma 1, Nestin, Actin cytoskeletal, Alpha-internexin, Tubulin (in microtubules), Plectin 1, Tubulin beta, Tubulin gamma, MUNC18, BPAG1, Desmuslin, Desmin, Tubulin alpha, Kinesin heavy chain, NEFH",9.428E-07,7.831E-06,20,"CDK5R1 (p35), CDK5, GFAP, DCTN1(p150Glued), NEFM, Vimentin, Tubulin gamma 1, Nestin, Actin cytoskeletal, Alpha-internexin, Tubulin (in microtubules), Plectin 1, Tubulin beta, Tubulin gamma, BPAG1, Desmuslin, Desmin, Tubulin alpha, Kinesin heavy chain, NEFH",
244,Apo-2L(TNFSF10)-induced apoptosis in melanoma,45,9.518E-07,7.697E-06,9.518E-07,7.697E-06,32,"DR5(TNFRSF10B), MITF (17kDa), ICAD, Apaf-1, Caspase-4, c-FLIP(Long), Apo-2L(TNFSF10), Bak, Caspase-8, Dynamin-2, IFN-beta, Bax, IFN-alpha, Caspase-3, RIPK1, NF-kB, DR4(TNFRSF10A), NF-kB p50/p65, ATF-6 alpha (50kDa), XAF1, RelA (p65 NF-kB subunit), PARP-1, NF-kB1 (p50), PKC-delta, IL-8, XIAP, Caspase-9, IFNA2, tBid, c-FLIP(Short), MITF, Bid",1.572E-06,1.212E-05,30,"DR5(TNFRSF10B), MITF (17kDa), ICAD, Apaf-1, IFN-gamma, Caspase-4, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, Dynamin-2, IFN-beta, Bax, IFN-alpha, Caspase-3, RIPK1, NF-kB, DR4(TNFRSF10A), NF-kB p50/p65, ATF-6 alpha (50kDa), XAF1, RelA (p65 NF-kB subunit), NF-kB1 (p50), IL-8, XIAP, Caspase-9, IFNA2, tBid, c-FLIP(Short), MITF, Bid",
245,Th9 cells in asthma,47,1.026E-06,8.202E-06,1.026E-06,8.202E-06,33,"OX40L(TNFSF4), TGF-beta 1, MHC class II, NF-AT1(NFATC2), IL-4R type I, PKA-reg (cAMP-dependent), OX40(TNFRSF4), TSLP, IL17BR, GSK3 beta, NF-kB2 (p100), IKK-alpha, NF-kB p52/RelB, Eotaxin, JAK2, RelA (p65 NF-kB subunit), Activin A, NF-kB2 (p52), RAMP1, TRAF6, IL-5, TGF-beta, CGRP, NIK(MAP3K14), p300, IRF4, CCL7, ST2(L), CRLR, IL-33, STAT5, PKA-cat (cAMP-dependent), TSLPR",6.062E-06,3.596E-05,30,"OX40L(TNFSF4), TGF-beta 1, MHC class II, IL-4R type I, OX40(TNFRSF4), TSLP, IL17BR, GSK3 beta, NF-kB2 (p100), NF-kB p52/RelB, Eotaxin, JAK2, RelA (p65 NF-kB subunit), Activin A, NF-kB2 (p52), RAMP1, TRAF6, IL-5, TGF-beta, CGRP, NIK(MAP3K14), p300, IRF4, CCL7, ST2(L), CRLR, IL-33, STAT5, PKA-cat (cAMP-dependent), TSLPR",
246,Inhibition of remyelination in multiple sclerosis: role of cell-cell and ECM-cell interactions,47,1.026E-06,8.202E-06,1.026E-06,8.202E-06,33,"NGFR(TNFRSF16), TrkA, NCAM1, CD44, Connexin 26, Connexin 32, alpha-V/beta-1 integrin, Lingo1, APC protein, Connexin 30.2/ 31.3, Connexin 47, Fibronectin, Claudin-11, MyD88, Connexin 30, Actin cytoskeletal, Fyn, ITGB1, CD82, Caspr1, Tetraspanin-2, Tenascin-R, Neurofascin, NGF, Myelin basic protein, HYAL3, PKC, RTN4R, HYAL2, MAG, Connexin 45, MMP-9, TLR2",6.934E-04,1.739E-03,26,"NGFR(TNFRSF16), NCAM1, CD44, Connexin 26, alpha-V/beta-1 integrin, APC protein, Connexin 30.2/ 31.3, Connexin 47, Fibronectin, Claudin-11, Connexin 30, Actin cytoskeletal, Fyn, ITGB1, Caspr1, Tetraspanin-2, NGF, Myelin basic protein, HYAL3, PKC, RTN4R, Connexin 43, HYAL2, Connexin 45, MMP-9, TLR2",
247,Development_Role of cell-cell and ECM-cell interactions in oligodendrocyte differentiation and myelination,34,1.036E-06,8.202E-06,1.036E-06,8.202E-06,26,"Plexin B3, NGFR(TNFRSF16), NCAM1, alpha-6/beta-1 integrin, Connexin 26, Connexin 32, Lingo1, APC protein, Connexin 30.2/ 31.3, Connexin 47, Reticulon 4, Claudin-11, Laminin 2, Connexin 30, Fyn, ITGB1, CD82, Caspr1, Tetraspanin-2, Tenascin-R, Neurofascin, Myelin basic protein, RTN4R, CNP1, MAG, Connexin 45",3.001E-04,8.840E-04,21,"Plexin B3, NGFR(TNFRSF16), NCAM1, alpha-6/beta-1 integrin, Connexin 26, APC protein, Connexin 30.2/ 31.3, Connexin 47, Reticulon 4, Claudin-11, Laminin 2, Connexin 30, Fyn, ITGB1, Caspr1, Tetraspanin-2, Myelin basic protein, RTN4R, CNP1, Connexin 43, Connexin 45",
248,"Apoptosis and survival_Cytoplasmic/mitochondrial transport of proapoptotic proteins Bid, Bmf and Bim",34,1.036E-06,8.202E-06,1.036E-06,8.202E-06,26,"N-myristoyltransferase, Apaf-1, Myosin Va, GLK(MAP4K3), Caspase-8, Bax, FasL(TNFSF6), TNF-R1, TNF-alpha, HGK(MAP4K4), ASK1 (MAP3K5), DAXX, Caspase-9, MKK7 (MAP2K7), FLASH, JNK1(MAPK8), BMF, MEK4(MAP2K4), Caspase-10, MEKK1(MAP3K1), tBid, DLC1 (Dynein LC8a), FasR(CD95), GCKR(MAP4K5), Bim, Bid",7.905E-05,3.086E-04,22,"N-myristoyltransferase, Apaf-1, Myosin Va, GLK(MAP4K3), Caspase-8, Bax, TNF-R1, TNF-alpha, HGK(MAP4K4), ASK1 (MAP3K5), DAXX, Caspase-9, FLASH, JNK1(MAPK8), BMF, MEK4(MAP2K4), Caspase-10, tBid, FasR(CD95), GCKR(MAP4K5), Bim, Bid",
249,Th2-cytokines and IFN-mediated regulation of airway smooth muscle contraction,27,1.060E-06,8.324E-06,1.060E-06,8.324E-06,22,"JAK1, IRS-2, IL-4R type I, Tyk2, IRS-1, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, PI3K reg class IA (p85), IL13RA1, Ca-ATPase2, IL-13, TNF-alpha, RhoA, RelA (p65 NF-kB subunit), CD38, IL-4R type II, IFN-gamma receptor, IL4RA, PI3K cat class IA (p110-delta), Histamine H1 receptor",1.157E-06,9.401E-06,21,"JAK1, IRS-2, IL-4R type I, Tyk2, IFN-gamma, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, PI3K reg class IA (p85), IL13RA1, Ca-ATPase2, TNF-alpha, RhoA, RelA (p65 NF-kB subunit), CD38, IL-4R type II, IFN-gamma receptor, IL4RA, PI3K cat class IA (p110-delta), Histamine H1 receptor",
250,Role of fibroblasts in the sensitization phase of allergic contact dermatitis,22,1.068E-06,8.324E-06,1.068E-06,8.324E-06,19,"Laminin 5, IL-1 alpha, IL-10, Elastin, alpha-6/beta-4 integrin, Fibronectin, IL-1 beta, MMP-2, IL-6, NF-kB, Collagen IV, TNF-R1, CXCR4, TNF-alpha, IL-8, Collagen III, AP-1, MMP-9, Collagen I",1.867E-06,1.329E-05,18,"Laminin 5, IL-1 alpha, IL-10, Elastin, alpha-6/beta-4 integrin, Fibronectin, IL-1 beta, MMP-2, IL-6, NF-kB, Collagen IV, TNF-R1, CXCR4, TNF-alpha, IL-8, Collagen III, MMP-9, Collagen I",
251,Regulation and signaling of HGF receptor (Met) and MSP receptor (RON) in lung cancer,73,1.107E-06,8.492E-06,1.107E-06,8.492E-06,46,"NCK1, ERK1/2, PKC-zeta, CrkL, Beta-catenin, VEGF-A, Rac1, ATF-2/c-Jun, CDK1 (p34), IL-1 beta, Shc, PI3K reg class IA (p85), PAX5, GSK3 beta, PLC-gamma 1, MMP-2, CREB1, IL-6, CDC42, AKT(PKB), c-Src, Gamma adducin, HGF, Tiam1, PI3K cat class IA, c-Cbl, HIF1A, PKC-delta, C/EBPbeta, MEK3(MAP2K3), c-Jun, PDGF-A, FGF2, SOS, Alpha adducin, Thrombospondin 1, PKC-beta2, p90Rsk, Paxillin, COX-2 (PTGS2), AP-1, MEKK1(MAP3K1), PKC-alpha, ATF-2, HGF receptor (Met), MMP-9",3.769E-05,1.648E-04,40,"p38alpha (MAPK14), NCK1, ERK1/2, CrkL, Beta-catenin, VEGF-A, CDK1 (p34), IL-1 beta, Shc, PI3K reg class IA (p85), PAX5, GSK3 beta, PLC-gamma 1, MMP-2, CREB1, IL-6, CDC42, AKT(PKB), c-Src, Gamma adducin, HGF, Tiam1, PI3K cat class IA, c-Cbl, HIF1A, C/EBPbeta, MEK3(MAP2K3), PDGF-A, FGF2, SOS, Alpha adducin, Thrombospondin 1, PKC-beta2, p90Rsk, STAT3, COX-2 (PTGS2), PKC-alpha, ATF-2, HGF receptor (Met), MMP-9",
252,Aberrant B-Raf signaling in melanoma progression,55,1.137E-06,8.896E-06,1.212E-06,8.896E-06,37,"Rictor, CBP, Raptor, RHEB2, ROCK1, ERK1/2, CDK1 (p34), BAD, MAP2, MEK1/2, ERK2 (MAPK1), AKT(PKB), Mcl-1, NOTCH1 (NICD), ITGB1, PDE5A, B-Raf, ITGB3, FOXM1, AMPK alpha subunit, ITGA6, Nicastrin, BMF, p90Rsk, ROCK, HES1, AKT3, FOXO3A, Kinase MYT1, RhoE, Aurora-B, JNK(MAPK8-10), SPRY2, RalA, Bim, MITF, mTOR",1.137E-06,9.394E-06,35,"Rictor, CBP, Raptor, RHEB2, ROCK1, ERK1/2, CDK1 (p34), MAP2, MEK1/2, ERK2 (MAPK1), AKT(PKB), Mcl-1, NOTCH1 (NICD), MEK1(MAP2K1), ITGB1, PDE5A, B-Raf, ITGB3, FOXM1, AMPK alpha subunit, ITGA6, p90RSK1, Nicastrin, BMF, p90Rsk, ROCK, HES1, AKT3, RhoE, Aurora-B, JNK(MAPK8-10), SPRY2, Bim, MITF, mTOR",
253,PI3K signaling in gastric cancer,51,1.142E-06,8.627E-06,1.142E-06,8.627E-06,35,"IRS-1, Beta-catenin, G-protein alpha-q/11, MDR1, BAD, I-kB, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, IKK-alpha, alpha-V/beta-3 integrin, Cyr61, PRNP, AKT(PKB), NF-kB p50/p65, Gastrin 17, Progastrin, c-Src, HGF, Osteopontin, PI3K cat class IA, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), HIF1A, CCKBR, IL-8, EGFR, c-Jun, CBL-B, ELAVL1 (HuR), PI3K cat class IA (p110-alpha), G-protein alpha-q, HGF receptor (Met), PAI1, BMP2",1.815E-05,9.198E-05,31,"Neuregulin 1, Beta-catenin, CCXCR1, G-protein alpha-q/11, MDR1, I-kB, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, alpha-V/beta-3 integrin, Cyr61, PRNP, AKT(PKB), NF-kB p50/p65, Gastrin 17, Progastrin, c-Src, HGF, Osteopontin, PI3K cat class IA, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), HIF1A, IL-8, EGFR, CBL-B, ELAVL1 (HuR), PI3K cat class IA (p110-alpha), HGF receptor (Met), PAI1, BMP2",
254,Immune response_IFN-gamma signaling via MAPK,51,1.142E-06,8.627E-06,1.142E-06,8.627E-06,35,"IP10, JAK1, eIF4E, ERK1/2, TREX1, UBCH8, IRF1, STAT1, MyD88, COL1A2, ERK2 (MAPK1), ATF-6 alpha (50kDa), MEKK4(MAP3K4), TNF-alpha, IFNGR1, Pyk2(FAK2), JAK2, MLK3(MAP3K11), iNOS, IL-18, IFI6, C/EBPbeta, DAPK1, MEK3(MAP2K3), c-Jun, IRF9, IFNGR2, IFN-gamma receptor, MNK1, p300, SP100, MEKK1(MAP3K1), IFI16, ATF-2, p38 MAPK",1.322E-06,1.057E-05,33,"IP10, JAK1, IFN-gamma, ERK1/2, c-Raf-1, UBCH8, IRF1, STAT1, COL1A2, ERK2 (MAPK1), ATF-6 alpha (50kDa), TNF-alpha, MEK1(MAP2K1), IFNGR1, Pyk2(FAK2), JAK2, MLK3(MAP3K11), iNOS, IL-18, IFI6, C/EBPbeta, DAPK1, MEK3(MAP2K3), IRF9, IFNGR2, IFN-gamma receptor, p90RSK1, MNK1, p300, SP100, IFI16, ATF-2, p38 MAPK",
255,Activation of TGF-beta signaling in pancreatic cancer,27,1.157E-06,9.401E-06,2.063E-04,6.098E-04,19,"TGF-beta 1, ICAM1, VEGF-A, SMAD4, SMAD2, GLI-2, Shc, L1CAM, ERK2 (MAPK1), TAK1(MAP3K7), TGF-beta receptor type II, PDGF-A, SOS, JNK1(MAPK8), MEK4(MAP2K4), SLUG, SMAD3, PAI1, TGF-beta receptor type I",1.157E-06,9.401E-06,21,"TGF-beta 1, ICAM1, VEGF-A, c-Raf-1, SMAD4, SMAD2, GLI-2, Shc, L1CAM, ERK2 (MAPK1), TAK1(MAP3K7), MEK1(MAP2K1), TGF-beta receptor type II, PDGF-A, SOS, JNK1(MAPK8), MEK4(MAP2K4), SLUG, SMAD3, PAI1, TGF-beta receptor type I",
256,Regulation of VEGF signaling in pancreatic cancer,27,1.157E-06,9.401E-06,8.441E-04,1.992E-03,18,"IL-1 alpha, Neuropilin-1, ERK1/2, VEGF-A, VEGFR-2, SP4, Shc, MEK2(MAP2K2), VEGF-B, IL-6, NF-kB p50/p65, HIF1A, SP3, SOS, VEGFR-3, Neuropilin-2, VEGF-C, Elk-1",1.157E-06,9.401E-06,21,"IL-1 alpha, Neuropilin-1, ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, SP4, Shc, MEK2(MAP2K2), VEGF-B, IL-6, NF-kB p50/p65, MEK1(MAP2K1), HIF1A, SP3, SOS, VEGFR-3, STAT3, Neuropilin-2, VEGF-C, Elk-1",
257,Development_Thrombopoietin signaling via ERK1/2 and PI3K,67,1.199E-06,8.896E-06,1.199E-06,8.896E-06,43,"Cyclin D3, IRS-2, BMP4, PP1-cat, NF-kB p50/c-Rel, ERK1/2, PKC-zeta, CrkL, EGR1, VEGF-A, RAP-1A, HOXB4, Shc, PI3K reg class IA (p85), NF-E2 (45 kDa), GSK3 beta, MEIS1, c-MPL, CREB1, MEK1/2, AKT(PKB), c-Myc, GAB2, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), B-Raf, ITGA2B, c-Cbl, HIF1A, IEX1, DNA-PK, HOXA9, PDHA (somatic), SOS1, C3G, AML1 (RUNX1), 4E-BP1, SHP-2, FOXO3A, FLI1, p38 MAPK, Elk-1",5.830E-05,2.388E-04,37,"PDK1, IRS-2, BMP4, PP1-cat, NF-kB p50/c-Rel, ERK1/2, CrkL, VEGF-A, c-Raf-1, GATA-1, RAP-1A, Shc, PI3K reg class IA (p85), NF-E2 (45 kDa), GSK3 beta, MEIS1, c-MPL, CREB1, MEK1/2, AKT(PKB), TAL1, GAB2, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), B-Raf, ITGA2B, c-Cbl, HIF1A, IEX1, DNA-PK, HOXA9, SOS1, AML1 (RUNX1), FLI1, p38 MAPK, Elk-1",
258,Immune response_Platelet activating factor/ PTAFR pathway signaling,55,1.212E-06,8.896E-06,1.212E-06,8.896E-06,37,"Calcineurin A (catalytic), NF-AT1(NFATC2), CCL2, Tyk2, HB-EGF, PKA-reg (cAMP-dependent), LSP1, STAT1, IP3 receptor, Beta-arrestin2, IL-1 beta, PI3K reg class IA, PLC-beta, IKK-alpha, Adenylate cyclase, G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, NF-AT2(NFATC1), JAK2, PTAFR, PI3K cat class IA, G-protein beta2/gamma2, ASK1 (MAP3K5), G-protein alpha-i family, F-Actin cytoskeleton, MEK3(MAP2K3), Arrestin 3, NF-AT, STAT5, G-protein alpha-q, Calcineurin B (regulatory), p38 MAPK, MMP-9, PKA-cat (cAMP-dependent)",4.207E-06,2.599E-05,34,"Calcineurin A (catalytic), CCL2, Tyk2, HB-EGF, LSP1, STAT1, IP3 receptor, Beta-arrestin2, IL-1 beta, PI3K reg class IA, PLC-beta, Adenylate cyclase, G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, NF-AT2(NFATC1), JAK2, PTAFR, PI3K cat class IA, G-protein beta2/gamma2, ASK1 (MAP3K5), G-protein alpha-i family, F-Actin cytoskeleton, MEK3(MAP2K3), Arrestin 3, NF-AT, STAT3, STAT5, Calcineurin B (regulatory), p38 MAPK, MMP-9, PKA-cat (cAMP-dependent)",
259,Ovarian cancer (main signaling cascades),65,1.220E-06,8.896E-06,1.220E-06,8.896E-06,42,"LPAR3, ERK1/2, Beta-catenin, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), LPAR2, I-kB, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, IKK-alpha, MMP-2, CREB1, IL-6, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), c-Src, c-Myc, TERT, LH receptor, HGF, PI3K cat class IA, Brca1, B-Raf, LPAR1, Tcf(Lef), EGFR, G-protein alpha-i family, SOS, PLAU (UPA), PI3K cat class IA (p110-alpha), MEKK1(MAP3K1), SNAIL1, HGF receptor (Met), PI3K reg class IB (p101), Elk-1, MMP-9, PKA-cat (cAMP-dependent), EDNRA",2.369E-05,1.110E-04,37,"LPAR3, ERK1/2, Beta-catenin, PI3K cat class IB (p110-gamma), LPAR2, I-kB, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, MMP-2, CREB1, IL-6, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), FSHR, c-Src, TERT, HGF, PI3K cat class IA, Brca1, B-Raf, LPAR1, Tcf(Lef), EGFR, G-protein alpha-i family, SOS, PLAU (UPA), PI3K cat class IA (p110-alpha), SNAIL1, HGF receptor (Met), Elk-1, MMP-9, PKA-cat (cAMP-dependent), EDNRA",
260,Cytoskeleton remodeling_FAK signaling,57,1.232E-06,8.896E-06,1.232E-06,8.896E-06,38,"Cyclin D3, ERK1/2, VEGF-A, CRK, VEGFR-2, G-protein alpha-q/11, Fibronectin, FARP2, Rac1, IP3 receptor, Talin, RAP-1A, Shc, GSK3 beta, PI3K reg class IA, PLC-beta, PLC-gamma 1, RIPK1, MEK2(MAP2K2), CDC42, AKT(PKB), c-Src, RhoA, PI3K cat class IA, TRAF3, DOCK1, SOS, C3G, MKK7 (MAP2K7), Calpain 2(m), JNK1(MAPK8), Paxillin, p130CAS, Calmodulin, GRP(1-27), MEKK1(MAP3K1), alpha-2/beta-1 integrin, Elk-1",1.285E-05,6.885E-05,34,"ERK1/2, VEGF-A, CRK, c-Raf-1, VEGFR-2, G-protein alpha-q/11, Fibronectin, FARP2, IP3 receptor, Talin, RAP-1A, Shc, GSK3 beta, PI3K reg class IA, PLC-beta, PLC-gamma 1, RIPK1, MEK2(MAP2K2), CDC42, AKT(PKB), c-Src, MEK1(MAP2K1), RhoA, PI3K cat class IA, TRAF3, DOCK1, SOS, Calpain 2(m), JNK1(MAPK8), p130CAS, Calmodulin, GRP(1-27), alpha-2/beta-1 integrin, Elk-1",
261,E-cadherin signaling and its regulation in gastric cancer,36,1.243E-06,8.896E-06,1.243E-06,8.896E-06,27,"FGFR2, FGF1, Beta-catenin, Alpha-actinin, Dsh, Actin, Ubiquitin, Shc, GSK3 beta, SIP1 (ZFHX1B), TWIST1, c-Src, HGF, RhoA, EGFR, IQGAP1, TCF8, Alpha-catenin, WNT, SLUG, DNMT1, SNAIL1, HAKAI, HGF receptor (Met), p120-catenin, BMP2, Frizzled",3.814E-06,2.366E-05,25,"FGFR2, FGF1, Beta-catenin, Alpha-actinin, Dsh, Actin, Ubiquitin, Shc, GSK3 beta, SIP1 (ZFHX1B), TWIST1, c-Src, HGF, RhoA, EGFR, IQGAP1, TCF8, WNT, SLUG, DNMT1, SNAIL1, HAKAI, HGF receptor (Met), BMP2, Frizzled",
262,Immune response_HMGB1/TLR signaling pathway,36,1.243E-06,8.896E-06,1.243E-06,8.896E-06,27,"HMGB1, IL1RN, IFN-beta, Ubiquitin, IL-1 beta, I-kB, IRAK4, MyD88, IKK-alpha, IFN-alpha, IL-6, TLR9, UEV1A, TAK1(MAP3K7), TNF-alpha, RelA (p65 NF-kB subunit), IL-8, TRAF6, MEK3(MAP2K3), TAB3, RAGE, UBE1, TLR4, TAB1, IRF7, IRAK1/2, TLR2",7.297E-05,2.909E-04,23,"p38alpha (MAPK14), HMGB1, IL1RN, IFN-beta, Ubiquitin, IL-1 beta, I-kB, IRAK4, IFN-alpha, IL-6, TLR9, TAK1(MAP3K7), TNF-alpha, RelA (p65 NF-kB subunit), IL-8, TRAF6, MEK3(MAP2K3), TAB3, RAGE, TLR4, IRF7, IRAK1/2, TLR2",
263,Hedgehog signaling in gastric cancer,29,1.342E-06,1.057E-05,4.804E-05,1.833E-04,21,"BMP4, MEF2C, KIF27, HNF3-beta, Smoothened, GLI-2, SIP1 (ZFHX1B), N-cadherin, PTCH1, ROBO1, CDX2, FOXM1, Ihh, WNT5A, SLUG, GLI-1, SFRP1, Elk-1, EDNRA, TWIST2, PDGF-R-beta",1.342E-06,1.057E-05,22,"BMP4, MEF2C, HNF3-beta, Smoothened, GLI-2, Islet-1, SIP1 (ZFHX1B), N-cadherin, PTCH1, ROBO1, CDX2, FOXM1, Ihh, WNT5A, SLUG, HIP, GLI-1, SFRP1, Elk-1, EDNRA, TWIST2, PDGF-R-beta",
264,EGFR family signaling in pancreatic cancer,75,1.343E-06,1.057E-05,9.643E-06,4.890E-05,45,"Neuropilin-1, gp91-phox, ERK1/2, HB-EGF, BFL1, VEGF-A, VAV-1, p47-phox, Rac1, I-kB, Shc, PI3K reg class IA (p85), Survivin, CDK4, IKK-alpha, N-Ras, MEK2(MAP2K2), MMP-2, Mucin 4, TGF-alpha, NF-kB, PEA3, AKT(PKB), c-Src, c-Myc, RhoA, JAK2, PI3K cat class IA, Cytochrome b-558, p22-phox, EGFR, c-Jun, ErbB4, SOS, MKK7 (MAP2K7), PLAU (UPA), MEK4(MAP2K4), CDK2, COX-2 (PTGS2), ATF-2, Cyclin E, JNK(MAPK8-10), p38 MAPK, MMP-9, mTOR",1.343E-06,1.057E-05,44,"Neuropilin-1, gp91-phox, ERK1/2, HB-EGF, BFL1, VEGF-A, c-Raf-1, VAV-1, p47-phox, I-kB, Shc, PI3K reg class IA (p85), Survivin, CDK4, N-Ras, MEK2(MAP2K2), MMP-2, Mucin 4, TGF-alpha, NF-kB, PEA3, AKT(PKB), c-Src, MEK1(MAP2K1), RhoA, JAK2, PI3K cat class IA, Cytochrome b-558, p22-phox, EGFR, ErbB4, SOS, p67-phox, PLAU (UPA), MEK4(MAP2K4), CDK2, STAT3, COX-2 (PTGS2), ATF-2, Cyclin E, JNK(MAPK8-10), p38 MAPK, MMP-9, mTOR",
265,G-protein signaling_G-Protein alpha-12 signaling pathway,38,1.442E-06,1.010E-05,1.442E-06,1.010E-05,28,"LBC, LARG, ERK1/2, ARHGEF1 (p115RhoGEF), LIMK1, Rac1, RAP-1A, PI3K reg class IA (p85), MEK2(MAP2K2), G-protein beta/gamma, CDC42, M-Ras, PLC-epsilon, RhoA, G-protein alpha-12 family, PI3K cat class IA, RASA2, MEK4(MAP2K4), 14-3-3 beta/alpha, ROCK, PDZ-RhoGEF, MEKK1(MAP3K1), TC21, PLC-gamma, JNK(MAPK8-10), R-Ras, p38 MAPK, PKA-cat (cAMP-dependent)",3.764E-06,2.364E-05,26,"LBC, ERK1/2, ARHGEF1 (p115RhoGEF), c-Raf-1, LIMK1, RAP-1A, PI3K reg class IA (p85), MEK2(MAP2K2), G-protein beta/gamma, CDC42, M-Ras, PLC-epsilon, MEK1(MAP2K1), RhoA, G-protein alpha-12 family, PI3K cat class IA, RASA2, MEK4(MAP2K4), ROCK, PDZ-RhoGEF, TC21, PLC-gamma, JNK(MAPK8-10), R-Ras, p38 MAPK, PKA-cat (cAMP-dependent)",
266,Proteolysis_Putative SUMO-1 pathway,29,1.449E-06,1.010E-05,1.449E-06,1.010E-05,23,"PML, GCR, RanGAP1, PIAS1, Ubiquitin, SENP1, HSF2, NF-kB, TOP2, SUMO-1, c-Jun, SAE1/2, SP3, DAXX, PIAS2, SP100, SAE1, RanBP2, HSF1, FasR(CD95), UBE2E3, SAE2, p53",1.918E-04,6.167E-04,19,"PML, GCR, RanGAP1, PIAS1, Ubiquitin, SENP1, HSF2, NF-kB, TOP2, SUMO-1, SP3, DAXX, PIAS2, SP100, RanBP2, FasR(CD95), UBE2E3, SAE2, p53",
267,DNA damage_NHEJ mechanisms of DSBs repair,19,1.452E-06,1.010E-05,1.452E-06,1.010E-05,17,"Casein kinase II, alpha chains, FEN1, WRN, MRN complex, Ku70/80, Nibrin, Casein kinase II, beta chain (Phosvitin), Sirtuin, Brca1, DNA-PK, Rad50, Ku80, MRE11, XRCC4, DNA ligase IV, Ku70, Artemis",2.134E-04,6.667E-04,14,"Casein kinase II, alpha chains, FEN1, WRN, Ku70/80, Casein kinase II, beta chain (Phosvitin), Sirtuin, Brca1, DNA-PK, Ku80, MRE11, XRCC4, DNA ligase IV, Ku70, Artemis",
268,Immune response_Histamine H1 receptor signaling in immune response,47,1.496E-06,1.159E-05,5.746E-05,2.081E-04,30,"Calcineurin A (catalytic), ICAM1, G-protein alpha-q/11, IP3 receptor, I-kB, PLC-beta, cPLA2, GM-CSF, MEK2(MAP2K2), IL-6, G-protein beta/gamma, ERK2 (MAPK1), NF-kB p50/p65, Stromelysin-1, NF-AT2(NFATC1), TNF-alpha, VCAM1, RelA (p65 NF-kB subunit), MMP-13, iNOS, IL-8, c-Jun, Tissue factor, Histamine H1 receptor, Calmodulin, PKC-alpha, JNK(MAPK8-10), Calcineurin B (regulatory), p38 MAPK, MMP-9",1.496E-06,1.159E-05,31,"Calcineurin A (catalytic), ICAM1, c-Raf-1, G-protein alpha-q/11, IP3 receptor, I-kB, PLC-beta, cPLA2, GM-CSF, MEK2(MAP2K2), IL-6, G-protein beta/gamma, ERK2 (MAPK1), NF-kB p50/p65, Stromelysin-1, NF-AT2(NFATC1), TNF-alpha, MEK1(MAP2K1), VCAM1, RelA (p65 NF-kB subunit), MMP-13, iNOS, IL-8, Tissue factor, Histamine H1 receptor, Calmodulin, PKC-alpha, JNK(MAPK8-10), Calcineurin B (regulatory), p38 MAPK, MMP-9",
269,Development_TGF-beta-dependent induction of EMT via MAPK ,47,1.496E-06,1.159E-05,4.304E-06,2.515E-05,32,"TGF-beta 1, NOX4, alpha-V/beta-1 integrin, ERK1/2, Fibronectin, Vimentin, Claudin-1, Rac1, Shc, Endothelin-1, MEK2(MAP2K2), MMP-2, c-Src, TAK1(MAP3K7), TGF-beta 2, ITGB1, MLK3(MAP3K11), ITGB3, TGF-beta receptor type II, MEK3(MAP2K3), c-Jun, TGF-beta, SOS, MKK7 (MAP2K7), MEK4(MAP2K4), AP-1, ATF-2, JNK(MAPK8-10), SNAIL1, p38 MAPK, PAI1, TGF-beta receptor type I",1.496E-06,1.159E-05,31,"p38alpha (MAPK14), TGF-beta 1, NOX4, alpha-V/beta-1 integrin, ERK1/2, c-Raf-1, Fibronectin, Vimentin, Claudin-1, Shc, Endothelin-1, MEK2(MAP2K2), MMP-2, c-Src, TAK1(MAP3K7), MEK1(MAP2K1), TGF-beta 2, ITGB1, MLK3(MAP3K11), ITGB3, TGF-beta receptor type II, MEK3(MAP2K3), TGF-beta, SOS, MEK4(MAP2K4), ATF-2, JNK(MAPK8-10), SNAIL1, p38 MAPK, PAI1, TGF-beta receptor type I",
270,Deficient alpha-MSH signaling in melanoma,33,1.600E-06,1.220E-05,1.209E-05,6.047E-05,24,"ROCK1, ERK1/2, PKA-reg (cAMP-dependent), TYRP2, TYRO, Rac1, GSK3 beta, PI3K reg class IA, N-Ras, CREB1, MEK1/2, AKT(PKB), alpha-MSH, MC1R, SOX9, RhoA, PI3K cat class IA, B-Raf, PKA-cat alpha, SOX10, p38 MAPK, MITF, PKA-cat (cAMP-dependent), Syndecan-2",1.600E-06,1.220E-05,24,"p38alpha (MAPK14), ROCK1, ERK1/2, c-Raf-1, TYRP2, TYRO, GSK3 beta, PI3K reg class IA, N-Ras, CREB1, MEK1/2, AKT(PKB), alpha-MSH, MC1R, SOX9, RhoA, PI3K cat class IA, B-Raf, PKA-cat alpha, SOX10, p38 MAPK, MITF, PKA-cat (cAMP-dependent), Syndecan-2",
271,Signal transduction_Activin A signaling regulation,33,1.600E-06,1.220E-05,5.565E-05,2.049E-04,23,"CBP, FKBP12, SMAD4, SMAD2, MED15, Ubiquitin, Follistatin, ActRIIA, N-CoR, MECOM, Sin3A, Activin A, SMURF1, SMAD7, Ski, TGF-beta receptor type III (betaglycan), p300, FKHL1, FSRP, DLX1, ActRIIB, HDAC1, SMAD3",1.600E-06,1.220E-05,24,"CBP, FKBP12, SMAD4, SMAD2, MED15, Ubiquitin, Follistatin, ActRIIA, N-CoR, MECOM, Sin3A, Activin A, SMURF1, SMAD7, Ski, TGF-beta receptor type III (betaglycan), p300, FKHL1, IGSF1, FSRP, DLX1, ActRIIB, HDAC1, SMAD3",
272,Stem cells_NOTCH1-induced self-renewal of glioblastoma stem cells,40,1.629E-06,1.118E-05,1.629E-06,1.118E-05,29,"SMAD5, NOTCH1 receptor, BMP receptor 2, HES5, GFAP, JAK1, BMP4, CNTF, ID1, SMAD4, Jagged2, BMPR1B, Nestin, EZH2, RBP-J kappa (CBF1), NOTCH1 (NICD), HEY1, JAK2, EGFR, SMAD9 (SMAD8), DLL4, HES1, BMPR1A, SMAD1, NOTCH1 (NEXT), p53, Jagged1, ADAM17, BMP2",3.660E-06,2.346E-05,27,"SMAD5, NOTCH1 receptor, BMP receptor 2, HES5, GFAP, JAK1, BMP4, CNTF, ID1, SMAD4, Jagged2, BMPR1B, Nestin, EZH2, RBP-J kappa (CBF1), NOTCH1 (NICD), JAK2, EGFR, SMAD9 (SMAD8), STAT3, HES1, BMPR1A, NOTCH1 (NEXT), p53, Jagged1, ADAM17, BMP2",
273,Development_SLIT-ROBO1 signaling,40,1.629E-06,1.118E-05,1.629E-06,1.118E-05,29,"Rictor, Calcineurin A (catalytic), NCK1, VEGFR-2, LSP1, Rac1, PI3K reg class IA (p85), MENA, NCK2, SLIT2, CDC42, Fyn, AKT(PKB), Cytohesin1, Endophilin A2, CXCR4, ACTB, RhoA, PI3K cat class IA, ROBO1, SRGAP1, F-Actin cytoskeleton, SLIT3, Myosin II, ROCK, Calmodulin, Cytohesin3, SSH1L, Cofilin",3.660E-06,2.346E-05,27,"Rictor, Calcineurin A (catalytic), NCK1, VEGFR-2, LSP1, PI3K reg class IA (p85), MENA, NCK2, SLIT2, CDC42, Fyn, AKT(PKB), Cytohesin1, CXCR4, ACTB, RhoA, PI3K cat class IA, ROBO1, SRGAP1, F-Actin cytoskeleton, SLIT3, Myosin II, ROCK, Calmodulin, Cytohesin3, SSH1L, Cofilin",
274,Mechanisms of CAM-DR in multiple myeloma,35,1.670E-06,1.226E-05,5.804E-05,2.082E-04,24,"alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, ICAM1, Fibronectin, Dsh, Talin, HMDH, HSP70, TOP2 beta, RhoA, ITGB1, c-IAP2, VCAM1, WNT3, alpha-5/beta-1 integrin, NF-kB p50/RelB, CDK2, ROCK, Vinculin, Cyclin E, TOP2 alpha, Cyclin A, Bim, Frizzled",1.670E-06,1.226E-05,25,"alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, ICAM1, Fibronectin, Dsh, Talin, HMDH, HSP70, TOP2 beta, RhoA, ITGB1, c-IAP2, VCAM1, WNT3, alpha-5/beta-1 integrin, NF-kB p50/RelB, CDK2, STAT3, ROCK, Vinculin, Cyclin E, TOP2 alpha, Cyclin A, Bim, Frizzled",
275,Role of Tissue factor in cancer independent of coagulation protease signaling,35,1.670E-06,1.226E-05,5.804E-05,2.082E-04,24,"Laminin 5, alpha-6/beta-1 integrin, ERK1/2, VEGF-A, Rac1, Shc, MEK2(MAP2K2), CDC42, Actin cytoskeletal, ERK2 (MAPK1), AKT(PKB), c-Src, alpha-3/beta-1 integrin, PI3K reg class IA (p85-alpha), Lyn, YES, SOS, Tissue factor, Thrombospondin 1, PI3K cat class IA (p110-alpha), PKC-alpha, ATF-2, Filamin A, p38 MAPK",1.670E-06,1.226E-05,25,"Laminin 5, alpha-6/beta-1 integrin, ERK1/2, VEGF-A, c-Raf-1, Shc, MEK2(MAP2K2), CDC42, Actin cytoskeletal, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), alpha-3/beta-1 integrin, PI3K reg class IA (p85-alpha), Lyn, YES, SOS, Tissue factor, Thrombospondin 1, PI3K cat class IA (p110-alpha), PKC-alpha, ATF-2, Filamin A, p38 MAPK",
276,Langerhans cell migration to lymph nodes in allergic contact dermatitis,35,1.670E-06,1.226E-05,5.804E-05,2.082E-04,24,"Laminin 5, TNF-R2, TGF-beta 1, CCL20, alpha-4/beta-1 integrin, ICAM1, CD44, IL-10, alpha-6/beta-4 integrin, Fibronectin, MDR1, IL-1 beta, L1CAM, Collagen IV, Stromelysin-1, CXCR4, TNF-alpha, GITR, Laminin 1, CCL19, GITRL, Oncostatin M, MMP-9, CD47",1.670E-06,1.226E-05,25,"Laminin 5, TNF-R2, TGF-beta 1, CCL20, CCL21, alpha-4/beta-1 integrin, ICAM1, CD44, IL-10, alpha-6/beta-4 integrin, Fibronectin, MDR1, IL-1 beta, L1CAM, Collagen IV, Stromelysin-1, CXCR4, TNF-alpha, GITR, Laminin 1, CCL19, GITRL, Oncostatin M, MMP-9, CD47",
277,IL-6 signaling in colorectal cancer,37,1.704E-06,1.226E-05,1.433E-05,6.873E-05,26,"TNF-R2, TGF-beta 1, Cyclin B, JAK1, ICAM1, IL-10, PAP, CDK1 (p34), Cyclin D2, Bax, Survivin, SOCS3, IL-6, Cyclin B1, HSP70, c-Myc, JAK2, TGF-beta receptor type II, Ku80, CRP, Cyclin E, Ku70, DNMT1, HDAC1, p53, ADAM17",1.704E-06,1.226E-05,26,"TNF-R2, TGF-beta 1, Cyclin B, JAK1, ICAM1, IL-10, PAP, CDK1 (p34), Cyclin D2, Bax, Survivin, SOCS3, IL-6, Cyclin B1, HSP70, JAK2, TGF-beta receptor type II, STAT3, Ku80, CRP, Cyclin E, Ku70, DNMT1, HDAC1, p53, ADAM17",
278,"Immune response_Th17, Th22 and Th9 cell differentiation ",39,1.706E-06,1.226E-05,2.021E-03,4.351E-03,23,"TGF-beta 1, MHC class II, NF-AT1(NFATC2), IL-4R type I, IL-10, CD28, IL-22, AHR, IL-1 beta, IL-17F, CD4, IL-6, NF-kB, IL-23, TNF-R1, NF-AT2(NFATC1), IL-2, TNF-alpha, TGF-beta receptor type II, IRF4, AP-1, CD86, TGF-beta receptor type I",1.706E-06,1.226E-05,27,"TGF-beta 1, MHC class II, IL-4R type I, IL-10, CD28, IL-17, IL-22, AHR, IL-1 beta, IL-17F, CD4, IL-6, NF-kB, IL-23, TNF-R1, NF-AT2(NFATC1), IL-2, CD40L(TNFSF5), TNF-alpha, CD80, ROR-alpha, TGF-beta receptor type II, IRF4, STAT3, IL-21, CD86, TGF-beta receptor type I",
279,Role of tumor microenvironment in plexiform neurofibroma formation in neurofibromatosis type 1,39,1.706E-06,1.226E-05,6.032E-05,2.118E-04,26,"TGF-beta 1, TrkA, alpha-4/beta-1 integrin, ERK1/2, VEGF-A, Rac2, Fibronectin, c-Kit, VAV-1, Shc, PI3K reg class IA (p85), Midkine, MMP-2, MEK1/2, AKT(PKB), PI3K cat class IA, Semaphorin 4F, VCAM1, PI3K reg class IA (p85-alpha), FGF2, SOS, Tryptase, NGF, Neurofibromin, p38 MAPK, PDGF-R-beta",1.706E-06,1.226E-05,27,"TGF-beta 1, alpha-4/beta-1 integrin, ERK1/2, VEGF-A, c-Raf-1, Rac2, Fibronectin, c-Kit, VAV-1, Shc, PI3K reg class IA (p85), Midkine, MMP-2, MEK1/2, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, Semaphorin 4F, VCAM1, PI3K reg class IA (p85-alpha), FGF2, SOS, Tryptase, NGF, Neurofibromin, p38 MAPK, PDGF-R-beta",
280,Cell adhesion_PLAU signaling,39,1.706E-06,1.226E-05,1.515E-05,7.193E-05,27,"Casein kinase II, alpha chains, JAK1, SERPINE2, ERK1/2, STAT1, Plasminogen, Shc, PI3K reg class IA, PLAT (TPA), MEK2(MAP2K2), PAI2, PLAUR (uPAR), AKT(PKB), c-Src, HGF, Casein kinase II, beta chain (Phosvitin), alpha-8/beta-1 integrin, PI3K cat class IA, EGFR, Plasmin, SOS, PLAU (UPA), p130CAS, Nucleolin, HGF receptor (Met), Elk-1, PAI1",1.706E-06,1.226E-05,27,"Casein kinase II, alpha chains, JAK1, SERPINE2, ERK1/2, c-Raf-1, STAT1, Shc, PI3K reg class IA, PLAT (TPA), MEK2(MAP2K2), PAI2, PLAUR (uPAR), AKT(PKB), c-Src, HGF, MEK1(MAP2K1), Casein kinase II, beta chain (Phosvitin), alpha-8/beta-1 integrin, PI3K cat class IA, EGFR, SOS, PLAU (UPA), p130CAS, Nucleolin, HGF receptor (Met), Elk-1, PAI1",
281,Immune response_Differentiation and clonal expansion of CD8+ T cells,39,1.706E-06,1.226E-05,6.032E-05,2.118E-04,26,"OX40L(TNFSF4), MHC class II, NF-AT1(NFATC2), ICAM1, CD28, OX40(TNFRSF4), IFN-alpha/beta receptor, IFN-beta, Perforin, STAT1, STAT4, IFN-alpha, CD4, MHC class I, FasL(TNFSF6), NF-kB, NF-AT2(NFATC1), IL-12 receptor, T-bet, CD70(TNFSF7), CD137(TNFRSF9), CD8, CD137 ligand(TNFSF9), CD86, mTOR, IL-12RB2",1.706E-06,1.226E-05,27,"OX40L(TNFSF4), MHC class II, ICAM1, IFN-gamma, CD28, OX40(TNFRSF4), IFN-alpha/beta receptor, IFN-beta, STAT1, STAT4, IFN-alpha, CD4, MHC class I, NF-kB, NF-AT2(NFATC1), CD40L(TNFSF5), CD80, IL-12 receptor, T-bet, CD70(TNFSF7), CD137(TNFRSF9), STAT3, CD8, CD137 ligand(TNFSF9), CD86, mTOR, IL-12RB2",
282,Development_EGFR signaling pathway,71,1.717E-06,1.228E-05,3.622E-06,2.203E-05,44,"NCK1, JAK1, ERK1/2, HB-EGF, PKC-epsilon, STAT1, Rac1, I-kB, Shc, PI3K reg class IA (p85), Bax, p120GAP, GSK3 beta, PKC-theta, PLC-gamma 1, MEK2(MAP2K2), MMP-2, TGF-alpha, NF-kB, ERK2 (MAPK1), AKT(PKB), c-Src, c-Myc, JAK2, PI3K cat class IA, PARP-1, c-Cbl, Epiregulin, EGFR, c-Jun, SOS, Caspase-9, MKK7 (MAP2K7), JNK1(MAPK8), DOK2, MEK4(MAP2K4), PKC-beta, Caspase-7, PKC-alpha, JNK2(MAPK9), p38 MAPK, Elk-1, MMP-9, Betacellulin",1.717E-06,1.228E-05,42,"p38alpha (MAPK14), NCK1, JAK1, ERK1/2, HB-EGF, c-Raf-1, PKC-epsilon, STAT1, I-kB, Shc, PI3K reg class IA (p85), Bax, p120GAP, GSK3 beta, PKC-theta, PLC-gamma 1, MEK2(MAP2K2), MMP-2, TGF-alpha, NF-kB, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), JAK2, PI3K cat class IA, c-Cbl, Epiregulin, EGFR, SOS, Caspase-9, JNK1(MAPK8), DOK2, MEK4(MAP2K4), STAT3, PKC-beta, PKC-alpha, JNK2(MAPK9), p38 MAPK, Elk-1, MMP-9, Betacellulin",
283,Cell adhesion_Endothelial cell contacts by non-junctional mechanisms,24,1.719E-06,1.174E-05,1.719E-06,1.174E-05,20,"alpha-6/beta-1 integrin, Beta-catenin, Alpha-actinin, alpha-6/beta-4 integrin, Fibronectin, MAGI-1(BAIAP1), alpha-V/beta-3 integrin, Laminin 8, Collagen IV, alpha-3/beta-1 integrin, N-cadherin, F-Actin cytoskeleton, Laminin 1, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, alpha-V/beta-5 integrin, Alpha-catenin, alpha-2/beta-1 integrin, p120-catenin, Collagen I",9.733E-05,3.506E-04,17,"alpha-6/beta-1 integrin, Beta-catenin, Alpha-actinin, alpha-6/beta-4 integrin, Fibronectin, MAGI-1(BAIAP1), alpha-V/beta-3 integrin, Laminin 8, Collagen IV, alpha-3/beta-1 integrin, N-cadherin, F-Actin cytoskeleton, Laminin 1, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, alpha-2/beta-1 integrin, Collagen I",
284,Deregulation of canonical WNT signaling in major depressive disorder,31,1.860E-06,1.265E-05,1.860E-06,1.265E-05,24,"WNT3A, APC protein, Lef-1, TCF7L2 (TCF4), FZD8, Casein kinase I epsilon, Beta-catenin, Dsh, GSK3 beta, WNT7A, LRP5, NeuroD1, FZD9, c-Myc, Axin, TCF7 (TCF1), MAP-1B, Tcf(Lef), FZD3, Casein kinase I gamma 1, WNT2B, WNT, LRP6, Frizzled",2.210E-03,4.762E-03,18,"APC protein, TCF7L2 (TCF4), FZD8, Casein kinase I epsilon, Beta-catenin, Dsh, GSK3 beta, WNT7A, NeuroD1, FZD9, Axin, TCF7 (TCF1), MAP-1B, Tcf(Lef), WNT2B, WNT, LRP6, Frizzled",
285,Development_Flt3 signaling,44,1.946E-06,1.318E-05,1.946E-06,1.318E-05,31,"STAT5A, ERK1/2, CrkL, CRK, VAV-1, Rac1, BAD, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), CDC42, Fyn, SHIP, AKT(PKB), c-Src, FLT3 ligand, MEKK4(MAP3K4), GAB2, PI3K cat class IA, c-Cbl, MEK3(MAP2K3), c-Jun, SOS, MKK7 (MAP2K7), JNK1(MAPK8), p90Rsk, MEK4(MAP2K4), MEKK1(MAP3K1), ATF-2, SHP-2, p38 MAPK",5.101E-04,1.333E-03,25,"STAT5A, ERK1/2, CrkL, CRK, c-Raf-1, VAV-1, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), CDC42, Fyn, AKT(PKB), c-Src, FLT3 ligand, GAB2, MEK1(MAP2K1), PI3K cat class IA, c-Cbl, MEK3(MAP2K3), SOS, JNK1(MAPK8), p90Rsk, MEK4(MAP2K4), ATF-2, p38 MAPK",
286,Immune response_IL-11 signaling pathway via MEK/ERK and PI3K/AKT cascades,67,2.179E-06,1.536E-05,3.926E-06,2.342E-05,42,"ICAM1, IL-10, RPS6, ATF-1, ERK1/2, IL-1 beta, IL11RA, I-kB, PI3K reg class IA (p85), GSK3 beta, IKK-alpha, Caspase-3, NFKBIB, CREB1, IL-6, MEK1/2, Fyn, AKT(PKB), ADAM10, SFK, c-Src, IL-2, TNF-alpha, JAK2, RelA (p65 NF-kB subunit), Osteocalcin, IL-8, c-Jun, YES, ALPL, Leukocyte elastase, SOS, Caspase-9, p90Rsk, PI3K cat class IA (p110-alpha), RUNX2, sIL11-RA, Cyclin E, SHP-2, SNAIL1, IL-12 beta, IL-11",2.179E-06,1.536E-05,40,"ICAM1, IL-10, RPS6, ATF-1, IFN-gamma, ERK1/2, c-Raf-1, YAP1 (YAp65), IL-1 beta, I-kB, PI3K reg class IA (p85), GSK3 beta, Caspase-3, NFKBIB, CREB1, IL-6, MEK1/2, Fyn, AKT(PKB), ADAM10, SFK, c-Src, IL-2, TNF-alpha, JAK2, RelA (p65 NF-kB subunit), Osteocalcin, IL-8, YES, ALPL, Leukocyte elastase, SOS, Caspase-9, p90Rsk, PI3K cat class IA (p110-alpha), RUNX2, Cyclin E, SNAIL1, IL-12 beta, IL-11",
287,Immune response_Function of MEF2 in T lymphocytes,50,2.255E-06,1.486E-05,2.255E-06,1.486E-05,34,"HDAC9, ERK5 (MAPK7), Calcineurin A (catalytic), NF-AT1(NFATC2), MEF2C, 14-3-3, CaMK I, HDAC4, HDAC7, CaMK IV, IP3 receptor, p38beta (MAPK11), MAP3K2 (MEKK2), HDAC2, ZAP70, PCAF, PLC-gamma 1, MAP2K5 (MEK5), IL-2, Lck, Sin3A, c-Jun, CABIN1, MEF2A, MEF2, HDAC5, p300, LAT, NCOA2 (GRIP1/TIF2), CARM1, Calmodulin, CD3, MAP3K3, HDAC1",3.528E-05,1.570E-04,30,"p38alpha (MAPK14), HDAC9, ERK5 (MAPK7), Calcineurin A (catalytic), MEF2C, 14-3-3, CaMK I, HDAC4, HDAC7, CaMK IV, IP3 receptor, MAP3K2 (MEKK2), HDAC2, PCAF, PLC-gamma 1, MAP2K5 (MEK5), IL-2, Lck, Sin3A, CABIN1, MEF2A, MEF2, HDAC5, p300, NCOA2 (GRIP1/TIF2), CARM1, Calmodulin, CD3, MAP3K3, HDAC1",
288,The role of PTEN and PI3K signaling in melanoma,50,2.255E-06,1.486E-05,2.255E-06,1.486E-05,34,"Apaf-1, Beta-catenin, RhoC, Caspase-8, Fibronectin, Rac1, BAD, PI3K reg class IA (p85), GSK3 beta, Survivin, alpha-V/beta-3 integrin, N-Ras, Caspase-3, FasL(TNFSF6), TWIST1, AKT(PKB), Mcl-1, TERT, N-cadherin, JAK2, MCAM, PI3K cat class IA, B-Raf, XIAP, alpha-5/beta-1 integrin, Caspase-9, PI3K cat class IA (p110-alpha), AKT3, FOXO3A, p15, AKT2, SNAIL1, Bim, mTOR",1.126E-04,3.969E-04,29,"Apaf-1, Beta-catenin, Caspase-8, Fibronectin, PI3K reg class IA (p85), GSK3 beta, Survivin, alpha-V/beta-3 integrin, N-Ras, Caspase-3, TWIST1, AKT(PKB), Mcl-1, TERT, N-cadherin, JAK2, MCAM, PI3K cat class IA, B-Raf, XIAP, alpha-5/beta-1 integrin, Caspase-9, STAT3, PI3K cat class IA (p110-alpha), AKT3, p15, SNAIL1, Bim, mTOR",
289,IgE- and MGF-induced Lyn-mediated production of cytokines and arachidonic acid metabolites in lung mast cells in asthma,50,2.255E-06,1.486E-05,2.255E-06,1.486E-05,34,"Calcineurin A (catalytic), NF-AT1(NFATC2), CCL2, IL-10, ERK1/2, c-Kit, IP3 receptor, Syk, I-kB, GSK3 beta, IKK-alpha, cPLA2, PLC-gamma 1, GM-CSF, IL-13, MEK1/2, Fyn, NF-kB, AKT(PKB), NF-AT2(NFATC1), TNF-alpha, Slp76, IL-8, Lyn, IL-5, c-Jun, SOS, LAT, GRAP2, JNK1(MAPK8), PKC-beta, PKC-alpha, Calcineurin B (regulatory), p38 MAPK",3.528E-05,1.570E-04,30,"Calcineurin A (catalytic), CCL2, IL-10, ERK1/2, c-Raf-1, c-Kit, IP3 receptor, Syk, I-kB, GSK3 beta, cPLA2, PLC-gamma 1, GM-CSF, MEK1/2, Fyn, NF-kB, AKT(PKB), NF-AT2(NFATC1), TNF-alpha, Slp76, IL-8, Lyn, IL-5, SOS, GRAP2, JNK1(MAPK8), PKC-beta, PKC-alpha, Calcineurin B (regulatory), p38 MAPK",
290,Cell cycle_Spindle assembly and chromosome separation,33,2.275E-06,1.493E-05,2.275E-06,1.493E-05,25,"Cyclin B, Separase, Nek2A, CDC20, MAD2a, Importin (karyopherin)-alpha, RCC1, Kid, CSE1L, CDK1 (p34), Ubiquitin, MAD1 (mitotic checkpoint), Dynein 1, cytoplasmic, heavy chain, TPX2, Tubulin (in microtubules), Importin (karyopherin)-beta, ZW10, Aurora-A, Securin, Mitotic cohesin complex, Tubulin alpha, KNSL1, Aurora-B, HEC, Dynein 1, cytoplasmic, intermediate chains",1.636E-04,5.435E-04,21,"Cyclin B, Nek2A, CDC20, MAD2a, Importin (karyopherin)-alpha, RCC1, CDK1 (p34), Ubiquitin, MAD1 (mitotic checkpoint), Dynein 1, cytoplasmic, heavy chain, TPX2, Tubulin (in microtubules), Importin (karyopherin)-beta, ZW10, Securin, Mitotic cohesin complex, Tubulin alpha, KNSL1, Aurora-B, HEC, Dynein 1, cytoplasmic, intermediate chains",
291,IGF signaling in HCC,52,2.312E-06,1.499E-05,2.312E-06,1.499E-05,35,"TGF-beta 1, NOTCH1 receptor, IRS-2, IRS-1, ERK1/2, EGR1, VEGF-A, IBP3, Shc, PI3K reg class IA (p85), GSK3 beta, IGF-2, MEK2(MAP2K2), MMP-2, TGF-alpha, AKT(PKB), HGF, Junctin, PI3K cat class IA, HIF1A, C/EBPbeta, EGFR, c-Jun, SOS, GSTA2, IGF-2 receptor, TIMP1, PKC, HES1, FOXO3A, HGF receptor (Met), Jagged1, ADAM17, Elk-1, MMP-9",2.517E-06,1.750E-05,33,"TGF-beta 1, NOTCH1 receptor, IRS-2, ERK1/2, VEGF-A, c-Raf-1, IBP3, Shc, PI3K reg class IA (p85), GSK3 beta, IGF-2, MEK2(MAP2K2), MMP-2, TGF-alpha, AKT(PKB), HGF, Junctin, MEK1(MAP2K1), PI3K cat class IA, HIF1A, C/EBPbeta, EGFR, SOS, GSTA2, IGF-2 receptor, TIMP1, PKC, HES1, HGF receptor (Met), Jagged1, ADAM17, Elk-1, MMP-9",
292,Signal transduction_MIF signaling pathway,60,2.345E-06,1.512E-05,2.345E-06,1.512E-05,39,"ICAM1, CD44, ERK1/2, PI3K cat class IB (p110-gamma), BAD, Syk, GSK3 beta, PI3K reg class IA, ZAP70, cPLA2, MIF, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), SFK, c-Src, CXCR4, Heme oxygenase 1, PI3K cat class IA, VCAM1, RelA (p65 NF-kB subunit), IL-8, Lyn, GCL reg, G-protein alpha-i family, c-Jun, PRDX1, CD74-ICD, COX-2 (PTGS2), AP-1, CD74, SPPL2a, TLR4, FOXO3A, JNK(MAPK8-10), p53, NRF2, PI3K reg class IB (p101)",1.605E-04,5.368E-04,33,"ICAM1, CD44, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), Syk, GSK3 beta, PI3K reg class IA, cPLA2, MIF, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), SFK, c-Src, CXCR4, Heme oxygenase 1, PI3K cat class IA, VCAM1, RelA (p65 NF-kB subunit), IL-8, Lyn, GCL reg, G-protein alpha-i family, CD74-ICD, COX-2 (PTGS2), CD74, SPPL2a, TLR4, JNK(MAPK8-10), p53, NRF2",
293,G-protein signaling_M-RAS regulation pathway,24,2.395E-06,1.681E-05,8.019E-05,2.764E-04,18,"ERK1/2, A-Raf-1, RAP-1A, p120GAP, MEK2(MAP2K2), DOK1, M-Ras, c-Src, G-protein alpha-12 family, Lck, B-Raf, BCR, SOS, RASA2, DOK2, CalDAG-GEFIII, Neurofibromin, RASGRF1",2.395E-06,1.681E-05,19,"ERK1/2, c-Raf-1, RAP-1A, p120GAP, MEK2(MAP2K2), DOK1, M-Ras, c-Src, MEK1(MAP2K1), G-protein alpha-12 family, Lck, B-Raf, BCR, SOS, RASA2, DOK2, CalDAG-GEFIII, Neurofibromin, RASGRF1",
294,Signal transduction_Activation of PKC via G-Protein coupled receptor,52,2.517E-06,1.750E-05,8.578E-06,4.379E-05,34,"Calcineurin A (catalytic), NF-AT1(NFATC2), ERK1/2, PKC-zeta, HDAC7, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, MLCP (reg), I-kB, NF-AT4(NFATC3), GSK3 beta, PKC-theta, PLC-beta, RIPK1, MEK2(MAP2K2), G-protein beta/gamma, NF-kB, c-Src, NF-AT2(NFATC1), MLCK, MLCP (cat), Sequestosome 1(p62), PKC-delta, MEF2, CPI-17, PKC-beta, Calmodulin, PKC-alpha, PKC-lambda/iota, c-Abl, MELC, Calcineurin B (regulatory), Elk-1",2.517E-06,1.750E-05,33,"Calcineurin A (catalytic), ERK1/2, c-Raf-1, HDAC7, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, MLCP (reg), I-kB, NF-AT4(NFATC3), GSK3 beta, PKC-theta, PLC-beta, RIPK1, MEK2(MAP2K2), G-protein beta/gamma, NF-kB, c-Src, NF-AT2(NFATC1), MLCK, MLCP (cat), MEK1(MAP2K1), Sequestosome 1(p62), MEF2, CPI-17, PKC-beta, Calmodulin, PKC-alpha, PKC-lambda/iota, c-Abl, MELC, Calcineurin B (regulatory), Elk-1",
295,Probable BMP4-mediated induction of EMT in airway epithelium,21,2.641E-06,1.695E-05,2.641E-06,1.695E-05,18,"COL1A1, SMAD5, BMP4, Beta-catenin, COL5A1, SIP1 (ZFHX1B), MMP-2, TWIST1, N-cadherin, ALK-2, SMAD9 (SMAD8), TCF8, Desmin, SLUG, BMPR1A, SMAD1, SNAIL1, MMP-9",4.847E-06,2.922E-05,17,"COL1A1, SMAD5, BMP4, Beta-catenin, COL5A1, SIP1 (ZFHX1B), MMP-2, TWIST1, N-cadherin, ALK-2, SMAD9 (SMAD8), TCF8, Desmin, SLUG, BMPR1A, SNAIL1, MMP-9",
296,VEGF signaling in multiple myeloma,50,2.729E-06,1.889E-05,2.905E-04,8.077E-04,30,"alpha-4/beta-1 integrin, ICAM1, Neuropilin-1, VEGF-A, VEGFR-2, Fibronectin, MDR1, IP3 receptor, Shc, Plexin A1, PI3K reg class IA, FKHR, IL-6, ERK2 (MAPK1), c-Src, c-Myc, Mcl-1, Pyk2(FAK2), ITGB1, PI3K cat class IA, VCAM1, alpha-5/beta-1 integrin, SOS, VEGFR-3, p130CAS, VEGF-C, PKC-alpha, Semaphorin 3A, PLC-gamma, Caveolin-1",2.729E-06,1.889E-05,32,"alpha-4/beta-1 integrin, ICAM1, Neuropilin-1, VEGF-A, c-Raf-1, VEGFR-2, Fibronectin, MDR1, IP3 receptor, Shc, Plexin A1, PI3K reg class IA, FKHR, IL-6, ERK2 (MAPK1), c-Src, Mcl-1, MEK1(MAP2K1), Pyk2(FAK2), ITGB1, PI3K cat class IA, VCAM1, alpha-5/beta-1 integrin, SOS, VEGFR-3, STAT3, p130CAS, VEGF-C, PKC-alpha, Semaphorin 3A, PLC-gamma, Caveolin-1",
297,"Chemokines in inflammation in adipose tissue and liver in obesity, type 2 diabetes and metabolic syndrome X",48,2.941E-06,2.026E-05,3.083E-05,1.260E-04,31,"MHC class II, LYVE-1, ICAM1, CD44, CCL2, TIG2, IL-1 beta, L-selectin, CD14, PSGL-1, IL-6, MIF, PLAUR (uPAR), P-selectin, CXCR4, TNF-alpha, VCAM1, CD68, CD45, IL-8, CD8 alpha, CX3CL1, ITGA4, CD8, CMKLR1, CD3, TLR4, EMR1, CD86, TLR2, CD1c",2.941E-06,2.026E-05,31,"MHC class II, LYVE-1, ICAM1, CD44, CCL2, TIG2, IL-1 beta, L-selectin, CD14, PSGL-1, IL-6, MIF, PLAUR (uPAR), P-selectin, CXCR4, TNF-alpha, VCAM1, CD68, CD45, IL-8, CD8 alpha, CX3CL1, ITGA4, CD8, CMKLR1, CD3, TLR4, EMR1, CD86, TLR2, CD1c",
298,Down-regulation of mast cell functions through ITIM-containing inhibitory receptors in asthma,37,3.054E-06,1.920E-05,3.054E-06,1.920E-05,27,"CCL2, Semaphorin 4D, ERK1/2, KLRG1, c-Kit, Fc epsilon RI alpha, Syk, Shc, OX-2 receptor 1, p120GAP, alpha-V/beta-3 integrin, MHC class I, DOK1, Fyn, SHIP, SHPS-1, Lyn, Fer, SOS1, Csk, PIRB, DOK2, CD72, LAIR1, SHP-2, CD200 (OX-2), CD47",8.209E-06,4.596E-05,25,"CCL2, Semaphorin 4D, ERK1/2, KLRG1, c-Kit, Fc epsilon RI alpha, Syk, Shc, p120GAP, alpha-V/beta-3 integrin, MHC class I, DOK1, Fyn, SHPS-1, Lyn, Fer, Fc epsilon RI beta, SOS1, Csk, PIRB, DOK2, CD72, LAIR1, CD200 (OX-2), CD47",
299,Development_Negative feedback regulation of WNT/Beta-catenin signaling,37,3.054E-06,1.920E-05,3.054E-06,1.920E-05,27,"NOTUM, NKD1, APC protein, TCF7L2 (TCF4), DKK1, Casein kinase I epsilon, Beta-catenin, Dsh, Casein kinase II, GSK3 alpha/beta, LATS2, Axin2, G-protein beta/gamma, EZH2, c-Src, Axin, LRP5/LRP6, TRRAP, PKC-delta, Tcf(Lef), G-protein alpha-i family, RNF43, WNT, G-protein alpha-q, AAK1, NKD2, Frizzled",4.649E-04,1.241E-03,22,"NOTUM, APC protein, TCF7L2 (TCF4), DKK1, Casein kinase I epsilon, Beta-catenin, Dsh, Casein kinase II, GSK3 alpha/beta, LATS2, Axin2, G-protein beta/gamma, EZH2, c-Src, Axin, TRRAP, Tcf(Lef), G-protein alpha-i family, WNT, AAK1, NKD2, Frizzled",
300,Immune response_Oncostatin M signaling via MAPK,37,3.054E-06,1.920E-05,3.054E-06,1.920E-05,27,"JAK1, CCL2, ERK1/2, EGR1, OSMR, STAT1, Rac1, Shc, LDLR, MEK2(MAP2K2), ERK2 (MAPK1), Stromelysin-1, PPAR-gamma, MMP-13, C/EBPbeta, MEK3(MAP2K3), c-Jun, SOS, TIMP1, MEK4(MAP2K4), AP-1, MEKK1(MAP3K1), SHP-2, LIFR, Oncostatin M, JNK(MAPK8-10), p38 MAPK",1.350E-04,4.608E-04,23,"JAK1, CCL2, ERK1/2, c-Raf-1, OSMR, STAT1, Shc, LDLR, MEK2(MAP2K2), ERK2 (MAPK1), Stromelysin-1, PPAR-gamma, MEK1(MAP2K1), MMP-13, C/EBPbeta, MEK3(MAP2K3), SOS, TIMP1, MEK4(MAP2K4), LIFR, Oncostatin M, JNK(MAPK8-10), p38 MAPK",
301,IL-17 and IL-17F-induced inflammatory signaling in normal and asthmatic airway epithelium,28,3.237E-06,2.200E-05,4.302E-04,1.120E-03,19,"IP10, ICAM1, ERK1/2, ENA-78, IL-17 receptor, I-kB, GRO-1, IL-17F, GM-CSF, MEK2(MAP2K2), CREB1, IL-6, NF-kB p50/p65, IL-8, p90Rsk, CXCR3, GCP2, p38 MAPK, IL-11",3.237E-06,2.200E-05,21,"IP10, ICAM1, ERK1/2, ENA-78, IL-17, c-Raf-1, IL-17 receptor, I-kB, GRO-1, IL-17F, GM-CSF, MEK2(MAP2K2), CREB1, IL-6, NF-kB p50/p65, MEK1(MAP2K1), IL-8, p90Rsk, GCP2, p38 MAPK, IL-11",
302,Role of CD8+ Tc1 cells in COPD,44,3.342E-06,2.251E-05,3.149E-05,1.260E-04,29,"IL-18R1, IP10, CCL2, Tyk2, Antileukoproteinase 1, Cathepsin S, Perforin, IL-15, STAT4, MHC class I, NF-kB, TNF-R1, TNF-alpha, JAK2, IL-12 receptor, IL-18, T-bet, c-Jun, Leukocyte elastase, CXCL16, Leptin receptor, KLRK1 (NKG2D), CXCR3, CD69, CX3CL1, MICA, CD8, ATF-2, MMP-9",3.342E-06,2.251E-05,29,"MIG, IL-18R1, IP10, CCL2, Tyk2, Antileukoproteinase 1, IFN-gamma, Cathepsin S, IL-15, STAT4, MHC class I, NF-kB, TNF-R1, TNF-alpha, JAK2, IL-12 receptor, IL-18, T-bet, Leukocyte elastase, CXCL16, Leptin receptor, KLRK1 (NKG2D), CD69, STAT3, CX3CL1, MICA, CD8, ATF-2, MMP-9",
303,Release of pro-inflammatory factors and proteases by alveolar macrophages in asthma,44,3.342E-06,2.251E-05,1.007E-03,2.344E-03,26,"GRO-2, IP10, CCL2, IRF1, STAT1, IL-1 beta, GRO-1, Endothelin-1, NF-kB p65/c-Rel, GM-CSF, IL-6, NF-kB, IL-23, NF-kB p50/p65, Stromelysin-1, TNF-alpha, iNOS, IL-8, TRAF6, CXCL16, IFN-gamma receptor, TIMP1, TLR4, ADAM17, MMP-9, TLR2",3.342E-06,2.251E-05,29,"GRO-2, MIG, IP10, CCL2, IFN-gamma, IL-17, IRF1, STAT1, IL-1 beta, GRO-1, Endothelin-1, NF-kB p65/c-Rel, GM-CSF, IL-6, NF-kB, IL-23, NF-kB p50/p65, Stromelysin-1, TNF-alpha, iNOS, IL-8, TRAF6, CXCL16, IFN-gamma receptor, TIMP1, TLR4, ADAM17, MMP-9, TLR2",
304,Role of neurotrophins in activation of p53 in major depressive disorder,39,3.395E-06,2.099E-05,3.395E-06,2.099E-05,28,"NGFR(TNFRSF16), TrkA, Apaf-1, NT-4/5, Rac1, Plasminogen, Shc, Bax, PI3K reg class IA, PLAT (TPA), NRIF, CDC42, NT-3, PI3K cat class IA, TrkC, ASK1 (MAP3K5), Sortilin, Plasmin, SOS, Caspase-9, TrkB, MKK7 (MAP2K7), NGF, MEKK1(MAP3K1), JNK(MAPK8-10), p53, BDNF, PAI1",8.716E-03,1.548E-02,20,"NGFR(TNFRSF16), Apaf-1, NT-4/5, Shc, Bax, PI3K reg class IA, PLAT (TPA), NRIF, CDC42, PI3K cat class IA, ASK1 (MAP3K5), Sortilin, SOS, Caspase-9, TrkB, NGF, JNK(MAPK8-10), p53, BDNF, PAI1",
305,Apoptosis and survival_APRIL and BAFF signaling,39,3.395E-06,2.099E-05,3.395E-06,2.099E-05,28,"Calcineurin A (catalytic), NF-AT1(NFATC2), IL-10, BFL1, NF-kB p50/p50, I-kB, NF-kB2 (p100), IKK-alpha, BCMA(TNFRSF17), Cyclophilin B, NF-kB p50/p65, NF-AT2(NFATC1), BAFF(TNFSF13B), RelA (p65 NF-kB subunit), APRIL(TNFSF13), TRAF3, NF-kB1 (p50), NF-kB2 (p52), BAFF-R, TRAF6, RelB (NF-kB subunit), NIK(MAP3K14), CD21, MEK4(MAP2K4), COX-2 (PTGS2), MEKK1(MAP3K1), TACI(TNFRSF13B), JNK(MAPK8-10)",3.261E-05,1.482E-04,25,"Calcineurin A (catalytic), IL-10, BFL1, NF-kB p50/p50, I-kB, NF-kB2 (p100), BCMA(TNFRSF17), Cyclophilin B, NF-kB p50/p65, NF-AT2(NFATC1), BAFF(TNFSF13B), RelA (p65 NF-kB subunit), APRIL(TNFSF13), TRAF3, NF-kB1 (p50), NF-kB2 (p52), BAFF-R, TRAF6, RelB (NF-kB subunit), NIK(MAP3K14), CD21, MEK4(MAP2K4), COX-2 (PTGS2), TACI(TNFRSF13B), JNK(MAPK8-10)",
306,"Immune response_IL-2 signaling via ERK, PI3K, and PLC-gamma",73,3.462E-06,2.131E-05,3.462E-06,2.131E-05,45,"Cyclin D3, JAK1, IRS-2, STAM1, IRS-1, RPS6, ERK1/2, CrkL, Rac1, CDK1 (p34), Syk, Cyclin D2, Shc, PI3K reg class IA (p85), PKC-theta, CDK4, PLC-gamma 1, DGK-alpha, MEK1/2, Fyn, NF-kB, ERK2 (MAPK1), AKT(PKB), c-Myc, IL-2R alpha chain, IL-2, GAB2, PI3K cat class IA, Lck, c-Cbl, Lyn, c-Jun, SOS1, JAK3, CDK2, 4E-BP1, Cyclin E, SHP-2, FOXO3A, IL-2R gamma chain, Cyclin A, ALPHA-PIX, Bim, Elk-1, mTOR",2.460E-04,7.445E-04,38,"JAK1, IRS-2, STAM1, RPS6, ERK1/2, CrkL, c-Raf-1, CDK1 (p34), Syk, Cyclin D2, Shc, PI3K reg class IA (p85), PKC-theta, CDK4, PLC-gamma 1, DGK-alpha, MEK1/2, Fyn, NF-kB, ERK2 (MAPK1), AKT(PKB), IL-2, GAB2, PI3K cat class IA, Lck, c-Cbl, Lyn, SOS1, JAK3, CDK2, STAT3, Cyclin E, IL-2R gamma chain, Cyclin A, ALPHA-PIX, Bim, Elk-1, mTOR",
307,Development_TGF-beta family mediated differentiation of embryonic stem cells,42,3.516E-06,2.317E-05,3.141E-05,1.260E-04,28,"TGF-beta 1, SOX1, Oct-3/4, Neurogenin 2, BMP4, CRIPTO, GBX2, VEGFR-2, SMAD4, SMAD2, HNF3-beta, PAX6, ActRIIA, Mixl1, Nestin, TAZ, Lefty-2, CXCR4, Activin A, NODAL, TGF-beta receptor type II, SOX17, T brachyury protein, Noggin, ActRIIB, HOXA1, SMAD3, TGF-beta receptor type I",3.516E-06,2.317E-05,28,"TGF-beta 1, SOX1, Oct-3/4, Neurogenin 2, BMP4, CRIPTO, GBX2, VEGFR-2, SMAD4, SMAD2, HNF3-beta, PAX6, ActRIIA, Mixl1, AFP, Nestin, TAZ, Lefty-2, CXCR4, Activin A, NODAL, TGF-beta receptor type II, SOX17, Noggin, ActRIIB, HOXA1, SMAD3, TGF-beta receptor type I",
308,Signal transduction_Angiotensin II/ AGTR1 signaling via TGF-beta 1 and SMADs,42,3.516E-06,2.317E-05,7.921E-06,4.221E-05,29,"COL1A1, TGF-beta 1, NOX4, ERK1/2, SMAD4, Angiotensin II, SPRY1, SMAD2, IL-1 beta, GSK3 beta, NF-kB, AKT(PKB), OSF-2, Caspase-1, TAK1(MAP3K7), SMAD7, TGF-beta receptor type II, SMURF2, TRAF6, Thrombospondin 1, AP-1, JNK(MAPK8-10), SMAD3, CTGF, HNF4-alpha, p38 MAPK, PAI1, TGF-beta receptor type I, NALP3",3.516E-06,2.317E-05,28,"COL1A1, TGF-beta 1, NOX4, ERK1/2, SMAD4, Angiotensin II, SPRY1, SMAD2, IL-1 beta, GSK3 beta, NF-kB, AKT(PKB), OSF-2, Caspase-1, TAK1(MAP3K7), SMAD7, TGF-beta receptor type II, SMURF2, TRAF6, Thrombospondin 1, JNK(MAPK8-10), SMAD3, CTGF, HNF4-alpha, p38 MAPK, PAI1, TGF-beta receptor type I, NALP3",
309,Role of adipose tissue hypoxia in obesity and type 2 diabetes,30,3.518E-06,2.317E-05,1.070E-04,3.526E-04,21,"TGF-beta 1, CCL2, VEGF-A, IBP3, IL-1 beta, IL-6, MIF, MCT1 (SLC16A1), PBEF, DEC1 (Stra13), PPAR-gamma, TNF-alpha, Heme oxygenase 1, RelA (p65 NF-kB subunit), Lysyl oxidase, HIF1A, Angiopoietin 1, FATP1, EPAS1, MMP-9, PAI1",3.518E-06,2.317E-05,22,"PDK1, TGF-beta 1, CCL2, VEGF-A, IBP3, IL-1 beta, IL-6, MIF, MCT1 (SLC16A1), PBEF, DEC1 (Stra13), PPAR-gamma, TNF-alpha, Heme oxygenase 1, RelA (p65 NF-kB subunit), Lysyl oxidase, HIF1A, Angiopoietin 1, FATP1, EPAS1, MMP-9, PAI1",
310,Immune response _CCR3 signaling in eosinophils,77,3.584E-06,2.340E-05,2.486E-05,1.097E-04,45,"gp91-phox, PKC-zeta, Rac2, PI3K cat class IB (p110-gamma), p47-phox, Rac1, IP3 receptor, MLCP (reg), Profilin, DIA1, CCL8, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, Actin cytoskeletal, ERK2 (MAPK1), Eotaxin, c-Src, MLCK, MLCP (cat), Profilin I, RhoA, Tiam1, iNOS, Eotaxin-2, ROCK2, Cytochrome b-558, p22-phox, G-protein alpha-i family, FGR, Eotaxin-3, Myosin II, MyHC, MEK4(MAP2K4), CCL7, ROCK, Calmodulin, MEKK1(MAP3K1), PKC-alpha, MRLC, MELC, PI3K reg class IB (p101), p38 MAPK, Cofilin, PLC-beta2",3.584E-06,2.340E-05,44,"gp91-phox, c-Raf-1, Rac2, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, MLCP (reg), Profilin, DIA1, CCL8, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, Actin cytoskeletal, ERK2 (MAPK1), Eotaxin, c-Src, MLCK, MLCP (cat), Profilin I, MEK1(MAP2K1), RhoA, Tiam1, iNOS, Eotaxin-2, ROCK2, Cytochrome b-558, p22-phox, G-protein alpha-i family, FGR, Eotaxin-3, Myosin II, p67-phox, MyHC, MEK4(MAP2K4), CCL7, ROCK, Calmodulin, PKC-alpha, MRLC, MELC, p38 MAPK, Cofilin, PLC-beta2",
311,Development_Stimulation of differentiation of mouse embryonic fibroblasts into adipocytes by extracellular factors,71,3.622E-06,2.203E-05,3.622E-06,2.203E-05,44,"CBP, BMP receptor 2, IRS-2, IRS-1, NGAL, ATF-1, ERK1/2, p90RSK2(RPS6KA3), PKA-reg (cAMP-dependent), SMAD4, GLUT4, Shc, EGR2 (Krox20), PI3K reg class IA (p85), HIVEP2, Prostacyclin receptor, FKHR, KLF15, Resistin, Adenylate cyclase, MEK2(MAP2K2), LIF, CREB1, ERK2 (MAPK1), PPAR-gamma, Lysyl oxidase, C/EBPbeta, XIAP, SOS, PPCKC, PI3K cat class IA (p110-alpha), ATF-2, SHP-2, TAB1, BMPR1A, AKT2, SMAD1, p38 MAPK, Elk-1, PKA-cat (cAMP-dependent), BMP2, LPL, mTOR, C/EBPdelta",1.149E-04,4.024E-04,38,"CBP, BMP receptor 2, IRS-2, NGAL, ATF-1, ERK1/2, p90RSK2(RPS6KA3), c-Raf-1, SMAD4, Shc, EGR2 (Krox20), PI3K reg class IA (p85), HIVEP2, FKHR, KLF15, Adenylate cyclase, MEK2(MAP2K2), LIF, CREB1, ERK2 (MAPK1), PPAR-gamma, MEK1(MAP2K1), A-FABP, Lysyl oxidase, C/EBPbeta, XIAP, SOS, PPCKC, PI3K cat class IA (p110-alpha), ATF-2, BMPR1A, p38 MAPK, Elk-1, PKA-cat (cAMP-dependent), BMP2, LPL, mTOR, C/EBPdelta",
312,Blood coagulation_GPCRs in platelet aggregation,71,3.622E-06,2.203E-05,3.622E-06,2.203E-05,44,"PREL1, PI3K cat class IA (p110-beta), LARG, HTR2A, ARHGEF1 (p115RhoGEF), PKA-reg (cAMP-dependent), LIMK1, G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, MLCP (reg), Prostacyclin receptor, Thrombin, alpha-IIb/beta-3 integrin, Adenylate cyclase, G-protein beta/gamma, Actin cytoskeletal, Syntaxin 4, MLCP (cat), RhoA, VAMP3, CALDAG-GEFI, ITGA2B, ITGB3, RAP-1B, G-protein alpha-i family, Myosin II, TBXA2R, NRIF3, ROCK, PKC-alpha, MRLC, P2Y1, G-protein alpha-q, PAR1, MELC, Fibrinogen (fibrin), PI3K reg class IB (p101), PLC-beta3, PKA-cat (cAMP-dependent), Cofilin, PLC-beta2",1.527E-03,3.429E-03,35,"PREL1, PI3K cat class IA (p110-beta), HTR2A, ARHGEF1 (p115RhoGEF), LIMK1, G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, MLCP (reg), alpha-IIb/beta-3 integrin, Adenylate cyclase, G-protein beta/gamma, Actin cytoskeletal, MLCP (cat), RhoA, VAMP3, ITGA2B, ITGB3, RAP-1B, G-protein alpha-i family, Myosin II, TBXA2R, NRIF3, ROCK, PKC-alpha, MRLC, P2Y1, PAR1, MELC, PLC-beta3, PKA-cat (cAMP-dependent), Cofilin, PLC-beta2",
313,Memory CD8+ T cells in allergic contact dermatitis,40,3.660E-06,2.346E-05,3.099E-05,1.260E-04,27,"IL-7 receptor, IL-7, alpha-4/beta-1 integrin, NF-AT1(NFATC2), ICAM1, IL-15, IL-1 beta, Eomesodermin, FKHR, PSGL-1, MHC class I, NF-kB, NF-kB p50/p65, TNF-R1, P-selectin, NF-AT2(NFATC1), IL-2, TNF-alpha, IL7RA, VCAM1, T-bet, CCL19, CCL27, AP-1, CD8, CCR10, CCR4",3.660E-06,2.346E-05,27,"IL-7 receptor, IL-7, CCL21, alpha-4/beta-1 integrin, ICAM1, IFN-gamma, IL-15, IL-1 beta, Eomesodermin, FKHR, PSGL-1, MHC class I, NF-kB, NF-kB p50/p65, TNF-R1, P-selectin, NF-AT2(NFATC1), IL-2, TNF-alpha, IL7RA, VCAM1, T-bet, CCL19, CCL27, CD8, CCR10, CCR4",
314,Pro-tumoral TNF-alpha signaling in melanoma,41,3.693E-06,2.228E-05,3.693E-06,2.228E-05,29,"Rictor, TNF-R2, alpha-4/beta-1 integrin, Fibronectin, TYRO, MMP-2, VEGF-B, MHC class I, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-R1, TNF-alpha, ITGB1, PI3K cat class IA, VCAM1, IL-8, c-Jun, alpha-5/beta-1 integrin, Angiopoietin 2, MEK4(MAP2K4), RhoGDI beta, ITGA4, ITGA3, MEKK1(MAP3K1), Filamin-A (CTF), AKT2, JNK(MAPK8-10), MMP-9",1.089E-04,3.895E-04,25,"Rictor, TNF-R2, alpha-4/beta-1 integrin, Fibronectin, TYRO, MMP-2, VEGF-B, MHC class I, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-R1, TNF-alpha, ITGB1, PI3K cat class IA, VCAM1, IL-8, alpha-5/beta-1 integrin, Angiopoietin 2, MEK4(MAP2K4), ITGA4, ITGA3, Filamin-A (CTF), JNK(MAPK8-10), MMP-9",
315,Cytoskeleton remodeling_Role of PKA in cytoskeleton reorganisation,41,3.693E-06,2.228E-05,3.693E-06,2.228E-05,29,"LBC, alpha-4/beta-1 integrin, PKA-reg (cAMP-dependent), LIMK1, Rac1, IP3 receptor, MLCP (reg), VASP, Adenylate cyclase, G-protein beta/gamma, CDC42, Actin cytoskeletal, Beta adducin, Fodrin (spectrin), MLCK, MLCP (cat), BETA-PIX, RhoA, F-Actin cytoskeleton, Alpha adducin, Paxillin, 14-3-3 beta/alpha, ROCK, Calmodulin, c-Abl, MELC, PLC-beta3, PKA-cat (cAMP-dependent), Cofilin",3.592E-04,1.017E-03,24,"LBC, alpha-4/beta-1 integrin, LIMK1, IP3 receptor, MLCP (reg), VASP, Adenylate cyclase, G-protein beta/gamma, CDC42, Actin cytoskeletal, Beta adducin, Fodrin (spectrin), MLCK, MLCP (cat), RhoA, F-Actin cytoskeleton, Alpha adducin, ROCK, Calmodulin, c-Abl, MELC, PLC-beta3, PKA-cat (cAMP-dependent), Cofilin",
316,Immunological synapse between dendritic and CD8+ T cells in allergic contact dermatitis,32,3.703E-06,2.346E-05,4.951E-06,2.827E-05,24,"OX40L(TNFSF4), PD-L2, NF-AT1(NFATC2), ICAM1, RANKL(TNFSF11), CD28, OX40(TNFRSF4), MHC class I, CTLA-4, NF-kB, ICOS, NF-AT2(NFATC1), IL-12 receptor, Lck, CD70(TNFSF7), CD137(TNFRSF9), LFA-3, RANK(TNFRSF11A), AP-1, CD8, PD-1, CD137 ligand(TNFSF9), CD86, PD-L1",3.703E-06,2.346E-05,23,"OX40L(TNFSF4), PD-L2, ICAM1, RANKL(TNFSF11), CD28, OX40(TNFRSF4), MHC class I, CTLA-4, NF-kB, NF-AT2(NFATC1), CD80, IL-12 receptor, Lck, CD70(TNFSF7), CD137(TNFRSF9), LFA-3, RANK(TNFRSF11A), CD8, CD2, PD-1, CD137 ligand(TNFSF9), CD86, PD-L1",
317,TNF-alpha-induced inflammatory signaling in normal and asthmatic airway epithelium,38,3.764E-06,2.364E-05,1.160E-04,3.688E-04,25,"IP10, ICAM1, CCL2, ERK1/2, IRF1, TSLP, FN14(TNFRSF12A), I-kB, GRO-1, GM-CSF, IL-13, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, TNF-R1, TNF-alpha, IL-8, IL-5, c-Jun, PP2A catalytic, JNK1(MAPK8), MEKK1(MAP3K1), TWEAK(TNFSF12), p38 MAPK",3.764E-06,2.364E-05,26,"IP10, ICAM1, CCL2, IFN-gamma, ERK1/2, IL-17, c-Raf-1, IRF1, TSLP, FN14(TNFRSF12A), I-kB, GRO-1, GM-CSF, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, TNF-R1, TNF-alpha, MEK1(MAP2K1), IL-8, IL-5, PP2A catalytic, JNK1(MAPK8), TWEAK(TNFSF12), p38 MAPK",
318,Transcription_Negative regulation of HIF1A function,69,3.778E-06,2.270E-05,3.778E-06,2.270E-05,43,"FHL3, p14ARF, Casein kinase I delta, MCM5, RUNX3, VHL, COMMD1 (MURR1), SART1, SKP1, UBXD7, Ubiquitin, GSK3 beta, MCM7, LAMP2, HSP40, MCM2, HSP90, Calpain 1(mu), HSP70, HSPA4, SAT2, EGLN1, RACK1, PLK3 (CNK), MCM3, DEC2, HSC70, PRDX2, HIF1A, ARD1, Sirtuin2, HSP90 beta, Cul1/Rbx1 E3 ligase, AML1 (RUNX1), HIF3A, FHL1 (SLIM1), FHL2, SSAT, Elongin C, HIF-prolyl hydroxylase, PRDX4, p53, CITED4",3.350E-04,9.521E-04,36,"FHL3, p14ARF, MCM5, RUNX3, VHL, SART1, SKP1, UBXD7, Ubiquitin, GSK3 beta, MCM7, LAMP2, MCM2, HSP90, Calpain 1(mu), HSP70, SAT2, EGLN1, RACK1, PLK3 (CNK), MCM3, DEC2, HIF1A, ARD1, Sirtuin2, HSP90 beta, Cul1/Rbx1 E3 ligase, AML1 (RUNX1), HIF3A, FHL1 (SLIM1), FHL2, SSAT, HIF-prolyl hydroxylase, PRDX4, p53, CITED4",
319,Immune response_IL-12-induced IFN-gamma production,36,3.814E-06,2.366E-05,1.161E-04,3.688E-04,24,"IL-18R1, Tyk2, GADD45 beta, I-kB, STAT4, NF-kB, MEKK4(MAP3K4), JAK2, IL-12 receptor, iNOS, IL-18, T-bet, TRAF6, MEK3(MAP2K3), c-Jun, NIK(MAP3K14), MEK4(MAP2K4), CD3, ATF-2, IRAK1, JNK(MAPK8-10), IL-12RB1, IL-12RB2, ERM",3.814E-06,2.366E-05,25,"p38alpha (MAPK14), IL-18R1, Tyk2, IFN-gamma, GADD45 beta, I-kB, STAT4, NF-kB, JAK2, IL-12 receptor, iNOS, IL-18, T-bet, TRAF6, MEK3(MAP2K3), NIK(MAP3K14), MEK4(MAP2K4), STAT3, CD3, ATF-2, IRAK1, JNK(MAPK8-10), IL-12RB1, IL-12RB2, ERM",
320,Role of cell adhesion in vaso-occlusion in Sickle cell disease,43,3.945E-06,2.342E-05,3.945E-06,2.342E-05,30,"GLG1, IL-1 alpha, alpha-4/beta-1 integrin, ICAM1, CD44, PKA-reg (cAMP-dependent), Fibronectin, PKC-epsilon, IL-1 beta, CD14, alpha-IIb/beta-3 integrin, PSGL-1, alpha-V/beta-3 integrin, GLPA, NF-kB p50/p65, JMJD6, P-selectin, TNF-alpha, ICAM4, VCAM1, CD45, ITGB2, IL-8, Fc gamma RII alpha, Thrombospondin 1, TfR1, CD3, iC3b, Fibrinogen (fibrin), PKA-cat (cAMP-dependent)",2.739E-05,1.272E-04,27,"GLG1, IL-1 alpha, alpha-4/beta-1 integrin, ICAM1, CD44, Fibronectin, PKC-epsilon, IL-1 beta, CD14, alpha-IIb/beta-3 integrin, PSGL-1, alpha-V/beta-3 integrin, GLPA, NF-kB p50/p65, JMJD6, P-selectin, TNF-alpha, VCAM1, CD45, ITGB2, IL-8, Fc gamma RII alpha, Thrombospondin 1, TfR1, CD3, iC3b, PKA-cat (cAMP-dependent)",
321,Development_Notch Signaling Pathway,43,3.945E-06,2.342E-05,3.945E-06,2.342E-05,30,"Core histone deacetylase I complex, NOTCH1 receptor, c-Rel (NF-kB subunit), CIR, SMRT, Jagged2, TLE, Ubiquitin, p63, p73, HDAC2, Radical fringe, PCAF, N-CoR, RBP-J kappa (CBF1), NOTCH1 (NICD), HEY1, MAML1, Manic fringe glycosyltransferase, p300, DLL4, SKIP (Ski-interacting protein), HES1, NOTCH1 precursor, HDAC1, SAP30, NOTCH1 (NEXT), Furin, Jagged1, ADAM17",9.718E-05,3.506E-04,26,"Core histone deacetylase I complex, NOTCH1 receptor, c-Rel (NF-kB subunit), CIR, SMRT, Jagged2, TLE, Ubiquitin, p63, p73, HDAC2, PCAF, N-CoR, RBP-J kappa (CBF1), NOTCH1 (NICD), Manic fringe glycosyltransferase, p300, SKIP (Ski-interacting protein), HES1, NOTCH1 precursor, HDAC1, SAP30, NOTCH1 (NEXT), Furin, Jagged1, ADAM17",
322,Development_NODAL signaling in early mesendoderm formation,23,4.103E-06,2.417E-05,4.103E-06,2.417E-05,19,"BMP4, CRIPTO, HDAC3, SMAD4, SMAD2, HNF3-beta, ActRIIA, Mixl1, CFC1, Lefty-2, PACE4, Cerberus, Lefty-1, NODAL, T brachyury protein, WNT3, ActRIIB, HDAC1, Furin",4.036E-05,1.744E-04,17,"BMP4, CRIPTO, HDAC3, SMAD4, SMAD2, HNF3-beta, ActRIIA, Mixl1, CFC1, Lefty-2, PACE4, Cerberus, NODAL, WNT3, ActRIIB, HDAC1, Furin",
323,DNA damage_Role of Brca1 and Brca2 in DNA repair,30,4.133E-06,2.425E-05,4.133E-06,2.425E-05,23,"NFBD1, Brca2, ATF-1, XPC, FANCL, Rad51, MSH6, p53BP1, MRN complex, FANCD2, Bard1, Nibrin, Brca1, MSH3, Rad50, DNA polymerase beta, ATR, PCNA, MRE11, MSH2, ATM, Brca1/Bard1, p53",1.315E-03,3.001E-03,18,"NFBD1, Brca2, ATF-1, FANCL, MSH6, p53BP1, FANCD2, Bard1, Chk2, Brca1, DNA polymerase beta, ATR, PCNA, MRE11, MSH2, ATM, Brca1/Bard1, p53",
324,Mechanisms of drug resistance in multiple myeloma,49,4.414E-06,2.550E-05,4.414E-06,2.550E-05,33,"NOTCH1 receptor, CD44, WNT3A, TCF7L2 (TCF4), ERK1/2, PKC-zeta, Beta-catenin, FZD4, MDR1, BAD, ABCC1, Bax, CKS1, FANCD2, IKK-alpha, GSK3 alpha/beta, IL-6, MEK1/2, NF-kB p50/p65, RBP-J kappa (CBF1), c-Src, c-Myc, Mcl-1, FANCE, IL-8, NF-kB p50/RelB, RHAMM, HAS1, HES1, NOXA, GCR Alpha, Jagged1, Frizzled",2.093E-04,6.600E-04,28,"NOTCH1 receptor, CD44, TCF7L2 (TCF4), ERK1/2, Beta-catenin, MDR1, ABCC1, Bax, CKS1, FANCD2, GSK3 alpha/beta, IL-6, MEK1/2, NF-kB p50/p65, RBP-J kappa (CBF1), c-Src, Mcl-1, FANCE, IL-8, NF-kB p50/RelB, STAT3, RHAMM, HAS1, HES1, NOXA, GCR Alpha, Jagged1, Frizzled",
325,Some pathways of EMT in cancer cells,51,4.481E-06,2.578E-05,4.481E-06,2.578E-05,34,"TGF-beta 1, JAK1, Lef-1, Beta-catenin, PDGF-R-alpha, STAT1, I-kB, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, IKK-alpha, TWIST1, AKT(PKB), PDGF receptor, TNF-R1, c-Src, Axin, TAK1(MAP3K7), PDGF-D, TNF-alpha, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, PDGF-A, SOS, 4E-BP1, TAB1, c-Abl, SNAIL1, EDNRA, mTOR, PDGF-R-beta",1.815E-05,9.198E-05,31,"TGF-beta 1, JAK1, Beta-catenin, PDGF-R-alpha, STAT1, I-kB, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, TWIST1, AKT(PKB), PDGF receptor, TNF-R1, c-Src, Axin, TAK1(MAP3K7), PDGF-D, TNF-alpha, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, PDGF-A, SOS, STAT3, c-Abl, SNAIL1, EDNRA, mTOR, PDGF-R-beta",
326,Regulation of VEGF expression in lung cancer,53,4.642E-06,2.832E-05,4.357E-04,1.120E-03,31,"IL-7 receptor, IL-7, JAK1, VHL, ERK1/2, PGE2R1, PTP4A3, VEGF-A, RhoC, IL-17 receptor, c-Kit, IL-1 beta, PI3K reg class IA (p85), PI3K reg class IA, alpha-V/beta-3 integrin, MMP-2, IL-6, NF-kB, AKT(PKB), HSP90, c-Src, RhoA, JAK2, PI3K cat class IA, HIF1A, c-Jun, COX-2 (PTGS2), ROCK, VEGF-C, EPAS1, mTOR",4.642E-06,2.832E-05,33,"IL-7 receptor, IL-7, JAK1, VHL, ERK1/2, PGE2R1, PTP4A3, VEGF-A, IL-17, IL-17 receptor, c-Kit, IL-1 beta, microRNA 126, PI3K reg class IA (p85), PI3K reg class IA, alpha-V/beta-3 integrin, MMP-2, IL-6, NF-kB, AKT(PKB), HSP90, c-Src, RhoA, JAK2, PI3K cat class IA, HIF1A, miR-126-3p, STAT3, COX-2 (PTGS2), ROCK, VEGF-C, EPAS1, mTOR",
327,Cell cycle_Cell cycle (generic schema),21,4.847E-06,2.922E-05,2.280E-05,1.012E-04,17,"Cyclin B, DP1, E2F6, CDC25A, E2F3, CDK1 (p34), E2F2, CDK4, p107, CDC25C, CDC25B, Cyclin D, CDK2, CDK6, E2F4, Cyclin E, Cyclin A",4.847E-06,2.922E-05,17,"Cyclin B, DP1, E2F6, CDC25A, E2F3, CDK1 (p34), E2F2, CDK4, p107, CDC25C, CDC25B, Cyclin D, CDK2, CDK6, E2F4, Cyclin E, Cyclin A",
328,Interleukins-induced inflammatory signaling in normal and asthmatic airway epithelium,32,4.951E-06,2.827E-05,4.951E-06,2.827E-05,24,"IL-1 alpha, IP10, ERK1/2, TSLP, Fibronectin, IL-1 beta, IRAK4, MyD88, IFN-alpha, GM-CSF, IL-13, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, IL-8, TRAF6, c-Jun, CXCR3, ST2(L), IL-33, IRAK1, IL-16, p38 MAPK",3.333E-04,9.509E-04,20,"IL-1 alpha, IP10, IFN-gamma, ERK1/2, TSLP, Fibronectin, IL-1 beta, IRAK4, IFN-alpha, GM-CSF, IL-6, NF-kB, Eotaxin, NF-kB p50/p65, IL-8, TRAF6, ST2(L), IL-33, IRAK1, p38 MAPK",
329,Disruption of epithelial layer restitution in asthma,34,5.716E-06,3.214E-05,5.716E-06,3.214E-05,25,"TGF-beta 1, IL-1 alpha, alpha-V/beta-1 integrin, SMAD4, SMAD2, Fibronectin, Plasminogen, IL-1 beta, Endothelin-1, PLAUR (uPAR), TNF-alpha, HGF, TGF-beta 2, ITGB1, SMAD7, EGFR, alpha-5/beta-1 integrin, Plasmin, PLAU (UPA), SMAD3, HGF receptor (Met), MMP-9, PAI1, EDNRA, TGF-beta receptor type I",1.846E-05,9.228E-05,23,"TGF-beta 1, IL-1 alpha, alpha-V/beta-1 integrin, SMAD4, SMAD2, Fibronectin, IL-1 beta, Endothelin-1, PLAUR (uPAR), TNF-alpha, HGF, TGF-beta 2, ITGB1, SMAD7, EGFR, alpha-5/beta-1 integrin, PLAU (UPA), SMAD3, HGF receptor (Met), MMP-9, PAI1, EDNRA, TGF-beta receptor type I",
330,Apoptosis and survival_Caspase cascade,34,5.716E-06,3.214E-05,5.716E-06,3.214E-05,25,"ICAD, Caspase-6, Apaf-1, IRS-1, Caspase-4, Lamin A/C, Caspase-8, Bax, Caspase-3, RIPK1, DFF40 (CAD), Caspase-2, Lamin B, FasL(TNFSF6), AKT(PKB), TNF-R1, TNF-alpha, PARP-1, XIAP, Caspase-9, Caspase-10, Caspase-7, tBid, FasR(CD95), Bid",3.001E-04,8.840E-04,21,"ICAD, Caspase-6, Apaf-1, Caspase-4, Lamin A/C, Caspase-8, Bax, Caspase-3, RIPK1, DFF40 (CAD), Lamin B, Caspase-2, AKT(PKB), TNF-R1, TNF-alpha, XIAP, Caspase-9, Caspase-10, tBid, FasR(CD95), Bid",
331,Development_BMP signaling in cardiac myogenesis,34,5.716E-06,3.214E-05,5.716E-06,3.214E-05,25,"SMAD5, BMP5, BMP receptor 2, p57, BMP4, MEF2C, BMP10, SMAD4, beta-MHC, BNP, ACTA1, MLC2, BMP6, ACTC, TAK1(MAP3K7), XIAP, MEK3(MAP2K3), CSX (Nkx2.5), Noggin, ATF-2, TAB1, BMPR1A, SMAD1, p38 MAPK, BMP2",7.905E-05,3.086E-04,22,"SMAD5, BMP5, BMP receptor 2, p57, BMP4, MEF2C, BMP10, SMAD4, beta-MHC, BNP, MLC2, BMP6, ACTC, TAK1(MAP3K7), XIAP, MEK3(MAP2K3), CSX (Nkx2.5), Noggin, ATF-2, BMPR1A, p38 MAPK, BMP2",
332,"Development_ROBO2, ROBO3 and ROBO4 signaling pathways",25,5.736E-06,3.214E-05,5.736E-06,3.214E-05,20,"P-cadherin, NCK1, Rac1, MYH9, MENA, Nephrin, SLIT2, CDC42, HIC5, ROBO4, ROBO2, ROBO1, SRGAP1, MYRL2, SLIT3, Myosin II, alpha-5/beta-1 integrin, Paxillin, ROBO3, N-WASP",2.141E-04,6.667E-04,17,"P-cadherin, NCK1, MYH9, MENA, Nephrin, SLIT2, CDC42, HIC5, ROBO4, ROBO2, ROBO1, SRGAP1, MYRL2, SLIT3, Myosin II, alpha-5/beta-1 integrin, ROBO3",
333,Putative roles of SETDB1 and PLU-1 in melanoma,23,6.023E-06,3.587E-05,2.992E-05,1.245E-04,18,"HOXA13, p14ARF, HOXA10, ATF7IP, LMO2, TAJ(TNFRSF19), TSLP, HOXA6, HOXA2, HOXA7, p16INK4, HOXA4, HOXA9, HOXA11, CDK6, HOXA3, HOXA5, Jagged1",6.023E-06,3.587E-05,18,"HOXA13, p14ARF, HOXA10, ATF7IP, LMO2, TAJ(TNFRSF19), TSLP, HOXA6, HOXA2, HOXA7, p16INK4, HOXA4, HOXA9, HOXA11, CDK6, HOXA3, HOXA5, Jagged1",
334,Cytoskeleton remodeling_Substance P mediated membrane blebbing,16,6.263E-06,3.701E-05,2.383E-05,1.055E-04,14,"ROCK1, MLCP (reg), Dynamin-1, MLCK, Tubulin (in microtubules), MLCP (cat), RhoA, G-protein alpha-12 family, ROCK2, Substance P receptor, Myosin II, Tubulin alpha, MRLC, Dynamin",6.263E-06,3.701E-05,14,"ROCK1, MLCP (reg), Dynamin-1, MLCK, Tubulin (in microtubules), MLCP (cat), RhoA, G-protein alpha-12 family, ROCK2, Substance P receptor, Myosin II, Tubulin alpha, MRLC, Dynamin",
335,G-protein signaling_Regulation of RAC1 activity,36,6.408E-06,3.577E-05,6.408E-06,3.577E-05,26,"SRGAP2(WRP), ABR, VAV-1, Rac1, ARHGEF4, ARHGAP24, ARHGEF2, ZAP70, Rap1GDS1, DEF6, Caspase-3, Caspase-1, Tiam1, ARCGAP22, Slp76, BCR, ARHGAP9, ARHGAP12, B-chimaerin, RhoGDI alpha, KAP3, RhoGDI beta, CD3, RacGAP1, RalBP1, ECT2",8.877E-04,2.162E-03,21,"ABR, VAV-1, ARHGEF4, ARHGAP24, ARHGEF2, Rap1GDS1, DEF6, Caspase-3, Caspase-1, Tiam1, ARCGAP22, Slp76, BCR, ARHGAP9, ARHGAP12, RhoGDI alpha, KAP3, CD3, RacGAP1, RalBP1, ECT2",
336,Cytoskeleton remodeling_Role of Activin A in cytoskeleton remodeling,20,6.480E-06,3.590E-05,6.480E-06,3.590E-05,17,"ROCK1, SMAD4, SMAD2, Fibronectin, FTase-alpha, ActRIIA, RhoA, Activin A, c-Jun, MKK7 (MAP2K7), JNK1(MAPK8), Paxillin, MEK4(MAP2K4), MEKK1(MAP3K1), ActRIIB, ACTA2, SMAD3",2.285E-03,4.880E-03,13,"ROCK1, SMAD4, SMAD2, Fibronectin, FTase-alpha, ActRIIA, RhoA, Activin A, JNK1(MAPK8), MEK4(MAP2K4), ActRIIB, ACTA2, SMAD3",
337,Role of DNA methylation in progression of multiple myeloma,45,6.550E-06,3.810E-05,1.639E-05,7.572E-05,30,"p14ARF, RARbeta, NOTCH1 receptor, JAK1, SOD2, SFRP2, APC protein, SOCS1, Beta-catenin, EGR1, Jagged2, CDK4, DKK3, IL-6, NF-kB, p16INK4, JAK2, DAPK1, SFRP5, CDK6, SFRP4, AP-1, WNT, p15, RHG7, DNMT1, SFRP1, p53, Bim, Frizzled",6.550E-06,3.810E-05,29,"IRF8, p14ARF, RARbeta, NOTCH1 receptor, JAK1, SOD2, SFRP2, APC protein, SOCS1, Beta-catenin, Jagged2, CDK4, DKK3, IL-6, NF-kB, p16INK4, JAK2, DAPK1, SFRP5, CDK6, STAT3, WNT, p15, RHG7, DNMT1, SFRP1, p53, Bim, Frizzled",
338,"Role of TNF-alpha, IL-1beta and IL-6 in development of obesity and type 2 diabetes in liver",45,6.550E-06,3.810E-05,5.887E-05,2.102E-04,29,"TNF-R2, JAK1, IRS-1, HNF3-beta, p47-phox, IL-1 beta, FKHR, SOCS3, APOB, IL-6, N-CoR, TNF-R1, TNF-alpha, JAK2, RelA (p65 NF-kB subunit), p22-phox, C/EBPbeta, ASK1 (MAP3K5), MTP, PTP-1B, JNK1(MAPK8), MEK4(MAP2K4), APOA1, CRP, PERC, HXK4, ADAM17, PAI1, mTOR",6.550E-06,3.810E-05,29,"TNF-R2, JAK1, HNF3-beta, p47-phox, IL-1 beta, FKHR, SOCS3, APOB, IL-6, N-CoR, TNF-R1, TNF-alpha, JAK2, RelA (p65 NF-kB subunit), p22-phox, C/EBPbeta, ASK1 (MAP3K5), G6PT, MTP, JNK1(MAPK8), MEK4(MAP2K4), STAT3, APOA1, CRP, PERC, HXK4, ADAM17, PAI1, mTOR",
339,Development_Glucocorticoid receptor signaling,25,6.993E-06,3.994E-05,3.669E-05,1.456E-04,19,"CBP, GCR Beta, GCR, Oct-1, NF-kB, HSP90, HSP70, MMP-13, SUMO-1, C/EBPbeta, p300, NCOA2 (GRIP1/TIF2), Oct-2, STAT5, GCR Alpha, NCOA1 (SRC1), SMAD3, PAI1, TGF-beta receptor type I",6.993E-06,3.994E-05,19,"CBP, GCR Beta, GCR, Oct-1, NF-kB, HSP90, HSP70, MMP-13, SUMO-1, C/EBPbeta, p300, NCOA2 (GRIP1/TIF2), Oct-2, STAT5, GCR Alpha, NCOA1 (SRC1), SMAD3, PAI1, TGF-beta receptor type I",
340,HGF receptor (Met) and MSP receptor (RON) signaling pathways in SCLC,43,7.027E-06,3.994E-05,2.015E-04,5.992E-04,27,"ERK1/2, CrkL, VEGF-A, CDK1 (p34), PI3K reg class IA (p85), PAX5, CDK4, CREB1, MEK1/2, AKT(PKB), c-Src, Gamma adducin, HGF, GAB2, Pyk2(FAK2), PI3K cat class IA, PKR, MEK3(MAP2K3), PDGF-A, FGF2, Alpha adducin, Thrombospondin 1, Paxillin, CDK2, JNK(MAPK8-10), HGF receptor (Met), mTOR",7.027E-06,3.994E-05,28,"p38alpha (MAPK14), ERK1/2, CrkL, VEGF-A, CDK1 (p34), PI3K reg class IA (p85), PAX5, CDK4, CREB1, MEK1/2, AKT(PKB), c-Src, Gamma adducin, HGF, GAB2, Pyk2(FAK2), PI3K cat class IA, PKR, MEK3(MAP2K3), PDGF-A, FGF2, Alpha adducin, Thrombospondin 1, CDK2, STAT3, JNK(MAPK8-10), HGF receptor (Met), mTOR",
341,Notch signaling in oligodendrocyte precursor cell differentiation in multiple sclerosis,27,7.432E-06,4.045E-05,7.432E-06,4.045E-05,21,"CNTN1 (F3), TIP30, TGF-beta 1, NOTCH1 receptor, HES5, NUP153, NOTCH2 (2ICD), RBP-J kappa (CBF1), NOTCH1 (NICD), Importin (karyopherin)-beta, MAML1, NOTCH2, SOX10, Myelin basic protein, HES1, DTX1, Lamin B1, MAG, NOTCH1 (NEXT), Jagged1, ADAM17",4.312E-05,1.806E-04,19,"CNTN1 (F3), TIP30, TGF-beta 1, NOTCH1 receptor, HES5, NUP153, NOTCH2 (2ICD), RBP-J kappa (CBF1), NOTCH1 (NICD), Importin (karyopherin)-beta, NOTCH2, SOX10, Myelin basic protein, HES1, DTX1, Lamin B1, NOTCH1 (NEXT), Jagged1, ADAM17",
342,Inhibition of TGF-beta 1 signaling in early colorectal cancer,27,7.432E-06,4.045E-05,7.432E-06,4.045E-05,21,"TGF-beta 1, Sno-N, SMAD4, SMAD2, Survivin, PI3K reg class IA, CDK4, MAP2, MMP-2, AKT(PKB), c-Myc, PI3K cat class IA, SMAD7, TGF-beta receptor type II, Ski, Thrombospondin 1, SMAD6, Beta-fodrin, SMAD3, MMP-9, TGF-beta receptor type I",7.724E-06,4.341E-05,20,"TGF-beta 1, Sno-N, SMAD4, SMAD2, Survivin, PI3K reg class IA, CDK4, MAP2, MMP-2, AKT(PKB), PI3K cat class IA, SMAD7, TGF-beta receptor type II, Ski, Thrombospondin 1, SMAD6, Beta-fodrin, SMAD3, MMP-9, TGF-beta receptor type I",
343,Noise-induced hair cell death and spiral ganglion neuron degeneration,96,7.449E-06,4.045E-05,7.449E-06,4.045E-05,55,"TrkA, Calcineurin A (catalytic), CCL2, Apaf-1, AMPK beta subunit, AMPK gamma subunit, HDAC4, HDAC3, Bak, Syntaxin 1A, Caspase-8, Actin, E2F3, Rac1, BAD, IL-1 beta, Bax, TMC1, HDAC2, ERM proteins, DIA1, Caspase-3, RIPK1, IL-6, Synaptotagmin IV, Ca(II)channel T-type, Calpain 1(mu), c-Src, NT-3, TNF-alpha, RhoA, PI3K reg class IA (p85-alpha), Otoferlin, iNOS, ROCK2, TrkC, CACNA1G, F-Actin cytoskeleton, AMPK alpha subunit, Ca(II)channel L-type, Caspase-9, Isoform p66 Shc, TrkB, COX-2 (PTGS2), GDNF, ROCK, PI3K cat class IA (p110-alpha), TMC2, FasR(CD95), Alpha-fodrin, JNK(MAPK8-10), HDAC1, p53, Calcineurin B (regulatory), BDNF",1.104E-05,6.000E-05,51,"p38alpha (MAPK14), Calcineurin A (catalytic), CCL2, Apaf-1, SNAP-25, AMPK beta subunit, AMPK gamma subunit, HDAC4, HDAC3, Caspase-8, Actin, E2F3, IL-1 beta, Bax, TMC1, HDAC2, ERM proteins, DIA1, Caspase-3, RIPK1, IL-6, Synaptotagmin IV, Ca(II)channel T-type, Calpain 1(mu), c-Src, TNF-alpha, RhoA, PI3K reg class IA (p85-alpha), Otoferlin, iNOS, ROCK2, CACNA1G, F-Actin cytoskeleton, AMPK alpha subunit, Caspase-9, p67-phox, Isoform p66 Shc, TrkB, STAT3, COX-2 (PTGS2), GDNF, ROCK, PI3K cat class IA (p110-alpha), TMC2, FasR(CD95), Alpha-fodrin, JNK(MAPK8-10), HDAC1, p53, Calcineurin B (regulatory), BDNF",
344,MAPK-mediated proliferation of normal and asthmatic smooth muscle cells,56,7.450E-06,4.218E-05,8.332E-05,2.865E-04,34,"TGF-beta 1, LPAR3, ERK1/2, HB-EGF, PDGF-R-alpha, IP3 receptor, LPAR2, Shc, Thrombin, PLC-beta, Endothelin-1, PLAT (TPA), N-Ras, IL-13, PDGF-C, CREB1, MEK1/2, G-protein beta/gamma, PDGF receptor, c-Src, LPAR1, EGFR, G-protein alpha-i family, PDGF-A, FGF2, SOS, p90Rsk, EDNRB, PKC-alpha, Elk-1, PAI1, EDNRA, TGF-beta receptor type I, PDGF-R-beta",7.450E-06,4.218E-05,34,"p38alpha (MAPK14), TGF-beta 1, LPAR3, ERK1/2, HB-EGF, c-Raf-1, PDGF-R-alpha, IP3 receptor, LPAR2, Shc, PLC-beta, Endothelin-1, PLAT (TPA), N-Ras, PDGF-C, CREB1, MEK1/2, G-protein beta/gamma, PDGF receptor, c-Src, LPAR1, EGFR, G-protein alpha-i family, PDGF-A, FGF2, SOS, p90Rsk, EDNRB, PKC-alpha, Elk-1, PAI1, EDNRA, TGF-beta receptor type I, PDGF-R-beta",
345,Maturation and migration of dendritic cells in skin sensitization,41,7.476E-06,4.218E-05,1.575E-05,7.433E-05,28,"MHC class II alpha chain, TNF-R2, MHC class II, ICAM1, ERK1/2, HLA-DRA1, IL-1 beta, I-kB, IL-6, CD83, NF-kB, HLA-DRB5, MHC class II beta chain, TNF-R1, TNF-alpha, HLA-DRB1, IL-8, ASK1 (MAP3K5), MEK3(MAP2K3), c-Jun, CCL19, GCK(MAP4K2), MEKK1(MAP3K1), HLA-DRB, JNK(MAPK8-10), p38 MAPK, IL-12 beta, CD86",7.476E-06,4.218E-05,27,"MHC class II alpha chain, TNF-R2, MHC class II, ICAM1, ERK1/2, HLA-DRA1, IL-1 beta, I-kB, IL-6, CD83, NF-kB, HLA-DRB5, MHC class II beta chain, TNF-R1, TNF-alpha, HLA-DRB1, CD80, IL-8, ASK1 (MAP3K5), MEK3(MAP2K3), CCL19, GCK(MAP4K2), HLA-DRB, JNK(MAPK8-10), p38 MAPK, IL-12 beta, CD86",
346,CHDI_Correlations from Replication data_Causal network (negative correlations),40,7.516E-06,4.045E-05,7.516E-06,4.045E-05,28,"CBP, PLD1, TCF7L2 (TCF4), Beta-catenin, Fibronectin, Dsh, PLC-beta1, Plasminogen, GSK3 beta, alpha-V/beta-3 integrin, LRP5, CREB1, PLAUR (uPAR), CtBP, AKT(PKB), Collagen IV, Axin, LPP3, RhoA, Laminin 1, Plasmin, PLAU (UPA), ACM3, PKC, WNT, G-protein alpha-q, Frizzled, PLC-beta2",6.751E-04,1.702E-03,23,"CBP, PLD1, TCF7L2 (TCF4), Beta-catenin, Fibronectin, Dsh, GSK3 beta, alpha-V/beta-3 integrin, CREB1, PLAUR (uPAR), CtBP, AKT(PKB), Collagen IV, Axin, LPP3, RhoA, Laminin 1, PLAU (UPA), ACM3, PKC, WNT, Frizzled, PLC-beta2",
347,Stem cells_Pancreatic cancer stem cells in tumor metastasis,40,7.516E-06,4.045E-05,7.516E-06,4.045E-05,28,"LARG, ARHGEF1 (p115RhoGEF), VAV-1, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, MLCP (reg), G-protein beta/gamma, CDC42, Fyn, c-Src, MLCK, CXCR4, MLCP (cat), RhoA, Pyk2(FAK2), CD133, G-protein alpha-i family, F-Actin cytoskeleton, Myosin II, MyHC, ROCK, PDZ-RhoGEF, Calmodulin, MRLC, PLC-gamma, MELC, PI3K reg class IB (p101)",6.079E-05,2.463E-04,25,"ARHGEF1 (p115RhoGEF), VAV-1, PI3K cat class IB (p110-gamma), IP3 receptor, MLCP (reg), G-protein beta/gamma, CDC42, Fyn, c-Src, MLCK, CXCR4, MLCP (cat), RhoA, Pyk2(FAK2), CD133, G-protein alpha-i family, F-Actin cytoskeleton, Myosin II, MyHC, ROCK, PDZ-RhoGEF, Calmodulin, MRLC, PLC-gamma, MELC",
348,IL-1 signaling in melanoma,42,7.921E-06,4.221E-05,7.921E-06,4.221E-05,29,"GRO-2, MLANA, IL-1 alpha, PD-L2, alpha-4/beta-1 integrin, ICAM1, SOD2, CCL2, VEGF-A, GRO-3, TYRO, IL-1 beta, I-kB, GRO-1, MyD88, IL-6, NF-kB, VCAM1, iNOS, IL-18, IL-8, c-Jun, COX-2 (PTGS2), AP-1, JNK(MAPK8-10), p53, MITF, MMP-9, PD-L1",5.498E-05,2.265E-04,26,"GRO-2, MLANA, IL-1 alpha, PD-L2, alpha-4/beta-1 integrin, ICAM1, SOD2, CCL2, VEGF-A, GRO-3, TYRO, IL-1 beta, I-kB, GRO-1, IL-6, NF-kB, VCAM1, iNOS, IL-18, IL-8, COX-2 (PTGS2), JNK(MAPK8-10), p53, MITF, MMP-9, PD-L1",
349,CHDI_DEGs from Replication data_Causal network,81,7.956E-06,4.221E-05,7.956E-06,4.221E-05,48,"CBP, CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PLD1, PP1-cat, TCF7L2 (TCF4), ERK1/2, Casein kinase I epsilon, Beta-catenin, EGR1, APP, Dsh, PLC-beta1, IP3 receptor, I-kB, Shc, GSK3 beta, ADAM9, IKK-alpha, cPLA2, LRP5, CREB1, CtBP, AKT(PKB), GABA-A receptor beta-2 subunit, Axin, LPP3, RhoA, LTBR(TNFRSF3), NF-kB1 (p50), PKC-delta, c-Jun, SOS, NIK(MAP3K14), ACM3, MEK4(MAP2K4), Calmodulin, PKC, MEKK1(MAP3K1), WNT, LTB, alpha-2/beta-1 integrin, G-protein alpha-q, p53, Calcineurin B (regulatory), Frizzled, Collagen I",1.329E-04,4.599E-04,42,"CBP, CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PLD1, PP1-cat, TCF7L2 (TCF4), ERK1/2, Casein kinase I epsilon, Beta-catenin, c-Raf-1, APP, NEFM, Dsh, IP3 receptor, I-kB, Shc, GSK3 beta, ADAM9, cPLA2, CREB1, CtBP, AKT(PKB), Axin, LPP3, MEK1(MAP2K1), RhoA, LTBR(TNFRSF3), NF-kB1 (p50), SOS, NIK(MAP3K14), ACM3, MEK4(MAP2K4), Calmodulin, PKC, WNT, LTB, alpha-2/beta-1 integrin, p53, Calcineurin B (regulatory), Frizzled, Collagen I",
350,"Immune response_Antigen presentation by MHC class I, classical pathway",54,8.306E-06,4.616E-05,8.810E-05,3.023E-04,33,"MIC2, GANAB, UGCGL1, Endoplasmin, Bleomycin hydrolase, TAP, TAP1 (PSF1), PC7, PSME2, Calreticulin, PSMB2, MHC class I, Sec23, HSP70, PDIA3, PSMB8(LMP7), PSMB9, TPP2, Tapasin, MHC Class I alpha chain, Beta-2-microglobulin, Sec24, CD8, Nardilysin, PSMB10, PSMB11, TAP2 (PSF2), Calnexin, TAPBPL, ERAP2, Furin, BCAP31, ERAP1",8.306E-06,4.616E-05,33,"MIC2, GANAB, UGCGL1, Endoplasmin, IFN-gamma, Bleomycin hydrolase, TAP, TAP1 (PSF1), PC7, Calreticulin, PSMB2, MHC class I, Sec23, HSP70, PDIA3, PSMB8(LMP7), PSMB9, TPP2, Tapasin, MHC Class I alpha chain, Beta-2-microglobulin, Sec24, CD8, Nardilysin, PSMB10, PSMB11, TAP2 (PSF2), Calnexin, TAPBPL, ERAP2, Furin, BCAP31, ERAP1",
351,Role of FSH and Lutropin in ovarian cancer,56,8.344E-06,4.379E-05,8.344E-06,4.379E-05,36,"DR5(TNFRSF10B), ITGAV, CD44, ERK1/2, VEGF-A, PKA-reg (cAMP-dependent), APPL1, RAP-1A, Survivin, FKHR, Adenylate cyclase, SLIT2, MMP-2, CREB1, IL-6, MEK1/2, AKT(PKB), c-Myc, LH receptor, B-Raf, HIF1A, PKC-delta, EGFR, HIF-1, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), TRPC3, PKC-alpha, Cyclin E, NOTCH1 precursor, AKT2, JNK(MAPK8-10), NRF2, MMP-9, PKA-cat (cAMP-dependent), mTOR",7.515E-05,2.980E-04,32,"DR5(TNFRSF10B), ITGAV, CD44, ERK1/2, VEGF-A, APPL1, RAP-1A, COX-1 (PTGS1), Survivin, FKHR, Adenylate cyclase, SLIT2, MMP-2, CREB1, IL-6, MEK1/2, AKT(PKB), FSHR, B-Raf, HIF1A, EGFR, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), TRPC3, PKC-alpha, Cyclin E, NOTCH1 precursor, JNK(MAPK8-10), NRF2, MMP-9, PKA-cat (cAMP-dependent), mTOR",
352,SHH signaling in colorectal cancer,31,8.475E-06,4.675E-05,2.218E-04,6.399E-04,21,"DR5(TNFRSF10B), TCF7L2 (TCF4), FOXC2, Beta-catenin, PDGF-R-alpha, Vimentin, Smoothened, GLI-2, SIP1 (ZFHX1B), c-Myc, B-Raf, PTCH1, FOXM1, GLI-3R, GLI-3, WNT, IMP1(ZBP1), SNAIL1, GLI-1, p53, Frizzled",8.475E-06,4.675E-05,22,"DR5(TNFRSF10B), TCF7L2 (TCF4), FOXC2, Beta-catenin, PDGF-R-alpha, Vimentin, Smoothened, GLI-2, SIP1 (ZFHX1B), MEK1(MAP2K1), B-Raf, PTCH1, FOXM1, GLI-3R, GLI-3, WNT, IMP1(ZBP1), HIP, SNAIL1, GLI-1, p53, Frizzled",
353,Translation_Regulation of EIF4F activity,54,8.488E-06,4.379E-05,8.488E-06,4.379E-05,35,"TGF-beta 1, RHEB2, IRS-1, eIF4E, ERK1/2, PKC-zeta, Rac1, Shc, PI3K reg class IA, eIF4G2, MEK2(MAP2K2), CDC42, AKT(PKB), TAK1(MAP3K7), Tiam1, MLK3(MAP3K11), PI3K cat class IA, TGF-beta receptor type II, EGFR, MEK3(MAP2K3), eIF4H, SOS, PP2A catalytic, eIF4G1/3, MNK1, eIF4G1, Hamartin, MEK4(MAP2K4), 4E-BP1, MEKK1(MAP3K1), eIF4A, TAB1, p38 MAPK, mTOR, TGF-beta receptor type I",1.683E-03,3.733E-03,28,"TGF-beta 1, RHEB2, ERK1/2, c-Raf-1, Shc, PI3K reg class IA, MEK2(MAP2K2), CDC42, AKT(PKB), TAK1(MAP3K7), MEK1(MAP2K1), Tiam1, MLK3(MAP3K11), PI3K cat class IA, TGF-beta receptor type II, EGFR, MEK3(MAP2K3), eIF4H, SOS, PP2A catalytic, eIF4G1/3, MNK1, eIF4G1, MEK4(MAP2K4), eIF4A, p38 MAPK, mTOR, TGF-beta receptor type I",
354,Role of metalloproteases and heparanase in progression of pancreatic cancer,33,8.540E-06,4.694E-05,2.241E-04,6.399E-04,22,"CD44, HB-EGF, Matrilysin (MMP-7), VEGF-A, VEGFR-2, Shc, Heparanase 1, CD44 soluble, MEK2(MAP2K2), MMP-2, CD44 (EXT), FasL(TNFSF6), Collagen IV, TIMP2, CD147, EGFR, ZO-1, SOS, TIMP1, MMP-14, MMP-11, MMP-9",8.540E-06,4.694E-05,23,"CD44, HB-EGF, Matrilysin (MMP-7), VEGF-A, c-Raf-1, VEGFR-2, Shc, Heparanase 1, CD44 soluble, MEK2(MAP2K2), MMP-2, CD44 (EXT), Collagen IV, TIMP2, CD147, MEK1(MAP2K1), EGFR, ZO-1, SOS, TIMP1, MMP-14, MMP-11, MMP-9",
355,Immune response_C3a signaling,48,8.563E-06,4.379E-05,8.563E-06,4.379E-05,32,"TGF-beta 1, MHC class II, CCL2, ROCK1, ERK1/2, VEGF-A, PI3K cat class IB (p110-gamma), IP3 receptor, IL-1 beta, PLC-beta, FKHR, IKK-alpha, Adenylate cyclase, IL-6, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, C3aR, TERT, TNF-alpha, RhoA, RelA (p65 NF-kB subunit), KLF5, IL-8, G-protein alpha-i family, NGF, FOXO3A, C3a, PI3K reg class IB (p101), p38 MAPK, CD86",1.284E-04,4.453E-04,28,"TGF-beta 1, MHC class II, CCL2, ROCK1, ERK1/2, VEGF-A, PI3K cat class IB (p110-gamma), IP3 receptor, IL-1 beta, PLC-beta, FKHR, Adenylate cyclase, IL-6, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, TERT, TNF-alpha, RhoA, RelA (p65 NF-kB subunit), KLF5, IL-8, G-protein alpha-i family, NGF, C3a, p38 MAPK, CD86",
356,GLP-1 in beta cell apoptosis in type 2 diabetes,48,8.563E-06,4.379E-05,8.563E-06,4.379E-05,32,"IRS-2, Apaf-1, IRS-1, ERK1/2, GLP-1 (7-36) amide, PKA-reg (cAMP-dependent), GLP-1 receptor, BAD, IL-1 beta, I-kB, Bax, GSK3 beta, FKHR, IKK-alpha, IGF-2, Caspase-3, CREB1, GLP-1 (7-37), NF-kB, TNF-R1, JIP-1, TNF-alpha, Thioredoxin, c-IAP2, cAMP-GEFII, c-Jun, Caspase-9, p300, MKK7 (MAP2K7), JNK1(MAPK8), p53, PKA-cat (cAMP-dependent)",1.059E-03,2.486E-03,26,"IRS-2, Apaf-1, ERK1/2, GLP-1 (7-36) amide, GLP-1 receptor, IL-1 beta, I-kB, Bax, GSK3 beta, FKHR, IGF-2, Caspase-3, CREB1, GLP-1 (7-37), NF-kB, TNF-R1, JIP-1, TNF-alpha, c-IAP2, cAMP-GEFII, p90RSK1, Caspase-9, p300, JNK1(MAPK8), p53, PKA-cat (cAMP-dependent)",
357,Cell adhesion_Integrin inside-out signaling in T cells,52,8.578E-06,4.379E-05,8.578E-06,4.379E-05,34,"CCL20, TMEM102, PLD1, PREL1, alpha-4/beta-1 integrin, ICAM1, VAV-1, Rac1, Talin, RAP-1A, Shc, STK4, ZAP70, G-protein beta/gamma, CXCR4, RhoA, ITGB1, JAK2, VCAM1, Lck, CALDAG-GEFI, ITGB2, PKA-cat alpha, G-protein alpha-i family, CCL19, Csk, SKAP55, JAK3, Vinculin, CD3, CD3 zeta, FYB1, PLC-beta3, PLC-beta2",9.230E-06,5.055E-05,32,"CCL20, TMEM102, CCL21, PLD1, PREL1, alpha-4/beta-1 integrin, ICAM1, VAV-1, Talin, RAP-1A, Shc, STK4, G-protein beta/gamma, CXCR4, RhoA, ITGB1, JAK2, VCAM1, Lck, ITGB2, PKA-cat alpha, G-protein alpha-i family, CCL19, Csk, SKAP55, JAK3, Vinculin, CD3, CD3 zeta, FYB1, PLC-beta3, PLC-beta2",
358,Signal transduction_Additional pathways of NF-kB activation (in the cytoplasm),52,8.578E-06,4.379E-05,8.578E-06,4.379E-05,34,"ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), PKC-epsilon, Pim-1, PI3K cat class IB (p110-gamma), I-kB, PKC-theta, MAP3K2 (MEKK2), PI3K reg class IA, IKK-alpha, Adenylate cyclase, Casein kinase II, alpha chain (CSNK2A1), TPL2(MAP3K8), AKT(PKB), NF-kB p50/p65, c-Src, TAK1(MAP3K7), PI3K cat class IA, RelA (p65 NF-kB subunit), Lck, NF-kB1 (p50), PKA-cat alpha, PKC-delta, Pin1, NIK(MAP3K14), CDK6, PKC-beta, MEKK1(MAP3K1), PKC-alpha, PKC-lambda/iota, MAP3K3, AKT2, PI3K reg class IB (p101)",2.876E-04,8.566E-04,29,"ERK1/2, c-Raf-1, PKC-epsilon, Pim-1, PI3K cat class IB (p110-gamma), I-kB, PKC-theta, MAP3K2 (MEKK2), PI3K reg class IA, Adenylate cyclase, Casein kinase II, alpha chain (CSNK2A1), TPL2(MAP3K8), AKT(PKB), NF-kB p50/p65, c-Src, TAK1(MAP3K7), PI3K cat class IA, RelA (p65 NF-kB subunit), Lck, NF-kB1 (p50), PKA-cat alpha, Pin1, p90RSK1, NIK(MAP3K14), CDK6, PKC-beta, PKC-alpha, PKC-lambda/iota, MAP3K3",
359,Signal transduction_Adenosine A2A receptor signaling pathway,52,8.578E-06,4.379E-05,8.578E-06,4.379E-05,34,"TrkA, IL-10, gp91-phox, ERK1/2, PKA-reg (cAMP-dependent), I-kB, GSK3 beta, Adenylate cyclase, CREB1, MEK1/2, AKT(PKB), SFK, c-Src, Dopamine D2 receptor, IL-2, Osteopontin, RelA (p65 NF-kB subunit), Kif2a, NF-kB1 (p50), Cytochrome b-558, C/EBPbeta, DNA-PK, Ca(II)channel L-type, SOS, TSNAX, TrkB, SK4/IK1, G-protein alpha-olf, Collagen III, ATM, p38 MAPK, IL-12 beta, PKA-cat (cAMP-dependent), Collagen I",3.132E-05,1.441E-04,31,"IL-10, gp91-phox, ERK1/2, I-kB, GSK3 beta, Adenylate cyclase, CREB1, MEK1/2, AKT(PKB), SFK, c-Src, Dopamine D2 receptor, IL-2, Osteopontin, RelA (p65 NF-kB subunit), Kif2a, NF-kB1 (p50), Cytochrome b-558, C/EBPbeta, DNA-PK, SOS, TSNAX, TrkB, SK4/IK1, G-protein alpha-olf, Collagen III, ATM, p38 MAPK, IL-12 beta, PKA-cat (cAMP-dependent), Collagen I",
360,IGF-1 signaling in multiple myeloma,50,8.606E-06,4.379E-05,8.606E-06,4.379E-05,33,"IRS-2, RANKL(TNFSF11), IRS-1, ERK1/2, BFL1, VEGF-A, c-FLIP(Long), Fibronectin, CDK1 (p34), BAD, I-kB, Shc, Survivin, PI3K reg class IA, FKHR, IKK-alpha, GSK3 alpha/beta, MEK1/2, CDC42, NF-kB, ERK2 (MAPK1), AKT(PKB), RhoA, ITGB1, c-IAP2, PI3K cat class IA, HIF1A, XIAP, SOS, Paxillin, FOXO3A, Bim, mTOR",1.126E-04,3.969E-04,29,"IRS-2, RANKL(TNFSF11), ERK1/2, BFL1, VEGF-A, c-FLIP(Long), c-Raf-1, Fibronectin, CDK1 (p34), I-kB, Shc, Survivin, PI3K reg class IA, FKHR, GSK3 alpha/beta, MEK1/2, CDC42, NF-kB, ERK2 (MAPK1), AKT(PKB), RhoA, ITGB1, c-IAP2, PI3K cat class IA, HIF1A, XIAP, SOS, Bim, mTOR",
361,HBV-dependent NF-kB and PI3K/AKT pathways leading to HCC,50,1.022E-05,5.575E-05,3.018E-05,1.245E-04,32,"TGF-beta 1, JAK1, VHL, VBP-1, BAD, I-kB, Shc, PI3K reg class IA (p85), GSK3 beta, NF-kB p65/c-Rel, A2M, IKK-alpha, NF-kB p52/p65, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, Pyk2(FAK2), PI3K cat class IA, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), iNOS, NF-kB1 (p105), NF-kB2 (p52), SOS, Pin1, PLAU (UPA), CDK2, PKC-alpha, Cyclin E, p53, MMP-9",1.022E-05,5.575E-05,31,"TGF-beta 1, JAK1, VHL, c-Raf-1, VBP-1, I-kB, Shc, PI3K reg class IA (p85), GSK3 beta, NF-kB p65/c-Rel, A2M, NF-kB p52/p65, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, Pyk2(FAK2), PI3K cat class IA, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), iNOS, NF-kB1 (p105), NF-kB2 (p52), SOS, Pin1, PLAU (UPA), CDK2, PKC-alpha, Cyclin E, p53, MMP-9",
362,The innate immune response to contact allergens,33,1.209E-05,6.047E-05,1.209E-05,6.047E-05,24,"Biglycan, IL-1 alpha, CCL2, CARD8, IL-1 beta, CD14, MyD88, IL-6, P2X7, NF-kB, HSP70, Caspase-1, TNF-alpha, Thioredoxin, KEAP1, IL-18, IL-8, Pannexin-1, AP-1, TLR4, NRF2, IL-12 beta, TLR2, NALP3",5.944E-04,1.514E-03,20,"Biglycan, IL-1 alpha, CCL2, IL-1 beta, CD14, IL-6, P2X7, NF-kB, HSP70, Caspase-1, TNF-alpha, KEAP1, IL-18, IL-8, Pannexin-1, TLR4, NRF2, IL-12 beta, TLR2, NALP3",
363,Resistance of pancreatic cancer cells to death receptor signaling,33,1.209E-05,6.047E-05,1.209E-05,6.047E-05,24,"DR5(TNFRSF10B), Caspase-6, Apaf-1, Casein kinase I epsilon, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, TRUNDD(TNFRSF10D), Bax, Survivin, FAP-1, c-IAP1, Caspase-3, FasL(TNFSF6), DR4(TNFRSF10A), c-IAP2, RelA (p65 NF-kB subunit), XIAP, Caspase-9, Caspase-7, tBid, FasR(CD95), c-FLIP(Short), Bid",3.984E-05,1.726E-04,22,"DR5(TNFRSF10B), Caspase-6, Apaf-1, Casein kinase I epsilon, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, TRUNDD(TNFRSF10D), Bax, Survivin, FAP-1, c-IAP1, Caspase-3, DR4(TNFRSF10A), c-IAP2, RelA (p65 NF-kB subunit), XIAP, Caspase-9, tBid, FasR(CD95), c-FLIP(Short), Bid",
364,Apoptosis and survival_IL-17-induced CIKS-independent signaling pathways,46,1.235E-05,6.667E-05,9.352E-04,2.186E-03,27,"JAK1, Fra-1, Tyk2, ERK1/2, IL-17 receptor, STAT1, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, STAT4, MEK2(MAP2K2), TPL2(MAP3K8), NF-kB, NF-kB p50/p65, JAK2, PI3K cat class IA, C/EBPbeta, c-Jun, c-Jun/Fra-1, JAK3, p90Rsk, PI3K cat class IA (p110-alpha), AP-1, JNK(MAPK8-10), p38 MAPK, Elk-1, C/EBPdelta",1.235E-05,6.667E-05,29,"p38alpha (MAPK14), JAK1, Fra-1, Tyk2, ERK1/2, IL-17, c-Raf-1, IL-17 receptor, STAT1, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, STAT4, MEK2(MAP2K2), TPL2(MAP3K8), NF-kB, NF-kB p50/p65, MEK1(MAP2K1), JAK2, PI3K cat class IA, C/EBPbeta, JAK3, p90Rsk, STAT3, PI3K cat class IA (p110-alpha), JNK(MAPK8-10), p38 MAPK, Elk-1, C/EBPdelta",
365,Transcription_Androgen Receptor nuclear signaling,46,1.235E-05,6.667E-05,2.450E-03,5.147E-03,26,"TGF-beta 1, Beta-catenin, Dsh, Shc, GSK3 beta, MMP-2, IL-6, N-CoR, ERK2 (MAPK1), PAK6, AKT(PKB), HIC5, Pyk2(FAK2), TGF-beta receptor type II, EGFR, SOS, p300, NCOA2 (GRIP1/TIF2), RAD9, WNT, NCOA1 (SRC1), SMAD3, SRD5A1, PKA-cat (cAMP-dependent), Frizzled, TGF-beta receptor type I",1.235E-05,6.667E-05,29,"TGF-beta 1, Beta-catenin, c-Raf-1, Dsh, Shc, GSK3 beta, MMP-2, IL-6, N-CoR, ERK2 (MAPK1), PAK6, AKT(PKB), HIC5, MEK1(MAP2K1), Pyk2(FAK2), TGF-beta receptor type II, EGFR, SOS, p300, NCOA2 (GRIP1/TIF2), RAD9, STAT3, WNT, NCOA1 (SRC1), SMAD3, SRD5A1, PKA-cat (cAMP-dependent), Frizzled, TGF-beta receptor type I",
366,Neurophysiological process_Constitutive and regulated NMDA receptor trafficking,65,1.272E-05,6.300E-05,1.272E-05,6.300E-05,40,"Casein kinase II, alpha chains, CDK5R1 (p35), CDK5, Calcineurin A (catalytic), mGluR5, PP1-cat, Sec8, PKA-reg (cAMP-dependent), Syntaxin 1A, IP3 receptor, Neuroligin 1, PLC-beta, CASK, NR2, Adenylate cyclase, MALS, Fyn, KIF17, Calpain 1(mu), c-Src, VAMP2, SAP97 (DLG1), RACK1, Pyk2(FAK2), X11, cPKC (conventional), G-protein alpha-i family, DARPP-32, NR2A, NR2B, PACAP receptor 1, Calmodulin, PKC, PACAP, PSD-95, G-protein alpha-q, STEP, Calcineurin B (regulatory), PKA-cat (cAMP-dependent), LGN",6.736E-05,2.700E-04,36,"Casein kinase II, alpha chains, CDK5R1 (p35), CDK5, Calcineurin A (catalytic), mGluR5, SNAP-25, PP1-cat, Sec8, IP3 receptor, Neuroligin 1, PLC-beta, CASK, NR2, Adenylate cyclase, Fyn, KIF17, Calpain 1(mu), c-Src, VAMP2, SAP97 (DLG1), RACK1, Pyk2(FAK2), X11, cPKC (conventional), G-protein alpha-i family, DARPP-32, NR2A, NR2B, PACAP receptor 1, Calmodulin, PKC, PACAP, PSD-95, Calcineurin B (regulatory), PKA-cat (cAMP-dependent), LGN",
367,Signal transduction_PDGF signaling via MAPK cascades,65,1.272E-05,6.300E-05,1.272E-05,6.300E-05,40,"SPHK1, Fra-1, ERK1/2, EGR1, TRPC6, PDGF-R-alpha, Rac1, Shc, PLC-gamma 1, MMP-2, PDGF-C, CREB1, IL-6, MEK1/2, PDGFR-ab, ERK2 (MAPK1), PDGF receptor, Stromelysin-1, c-Src, c-Myc, PDGF-D, Phox1 (PRRX1), Osteopontin, MMP-13, PKC-delta, MEK3(MAP2K3), c-Jun, PDGF-A, SOS1, Tissue factor, p90Rsk, COX-2 (PTGS2), AP-1, SHP-2, c-Abl, JNK(MAPK8-10), p38 MAPK, Elk-1, MMP-9, PDGF-R-beta",4.563E-04,1.225E-03,34,"SPHK1, Fra-1, ERK1/2, c-Raf-1, TRPC6, PDGF-R-alpha, Shc, PLC-gamma 1, MMP-2, PDGF-C, CREB1, IL-6, MEK1/2, PDGFR-ab, ERK2 (MAPK1), PDGF receptor, Stromelysin-1, c-Src, PDGF-D, Phox1 (PRRX1), Osteopontin, MMP-13, MEK3(MAP2K3), PDGF-A, SOS1, Tissue factor, p90Rsk, COX-2 (PTGS2), c-Abl, JNK(MAPK8-10), p38 MAPK, Elk-1, MMP-9, PDGF-R-beta",
368,CCR7 signaling pathways in dendritic cells in allergic contact dermatitis,57,1.285E-05,6.885E-05,4.697E-05,1.811E-04,35,"alpha-4/beta-1 integrin, ICAM1, ERK1/2, Rac2, LIMK1, Fibronectin, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, RAP-1A, Shc, Profilin, MEK2(MAP2K2), G-protein beta/gamma, CDC42, Actin cytoskeletal, AKT(PKB), c-Src, RhoA, Pyk2(FAK2), CALDAG-GEFI, G-protein alpha-i family, Myosin II, CCL19, SOS, JNK1(MAPK8), Paxillin, MEK4(MAP2K4), ROCK, JNK(MAPK8-10), PI3K reg class IB (p101), PLC-gamma 2, p38 MAPK, Cofilin, PLC-beta2",1.285E-05,6.885E-05,34,"CCL21, alpha-4/beta-1 integrin, ICAM1, ERK1/2, c-Raf-1, Rac2, LIMK1, Fibronectin, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, Profilin, MEK2(MAP2K2), G-protein beta/gamma, CDC42, Actin cytoskeletal, AKT(PKB), c-Src, MEK1(MAP2K1), RhoA, Pyk2(FAK2), G-protein alpha-i family, Myosin II, CCL19, SOS, JNK1(MAPK8), MEK4(MAP2K4), ROCK, JNK(MAPK8-10), PLC-gamma 2, p38 MAPK, Cofilin, PLC-beta2",
369,Development_Extraembryonic differentiation of embryonic stem cells,35,1.331E-05,6.530E-05,1.331E-05,6.530E-05,25,"SMAD5, TGF-beta 1, SOX1, NCAM1, BMP receptor 2, BMP4, ID3, ID1, SMAD4, PAX6, CGB3, MAP2, GCMA, Nestin, HEY1, HNF4, Gremlin, GATA-6, SMAD9 (SMAD8), ID4, Noggin, Transferrin, BMPR1A, SMAD1, BMP2",3.765E-05,1.648E-04,23,"SMAD5, TGF-beta 1, SOX1, NCAM1, BMP receptor 2, BMP4, ID3, ID1, SMAD4, PAX6, CGB3, MAP2, AFP, Nestin, HNF4, Gremlin, GATA-6, SMAD9 (SMAD8), ID4, Noggin, Transferrin, BMPR1A, BMP2",
370,Anti-apoptotic action of Gastrin in pancreatic cancer,35,1.331E-05,6.530E-05,1.331E-05,6.530E-05,25,"Apaf-1, IRS-1, LARG, BAD, PI3K reg class IA (p85), Bax, FKHR, IKK-alpha, Caspase-3, AKT(PKB), Gastrin 17, Progastrin, c-Src, PPAR-gamma, MEKK4(MAP3K4), RhoA, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), CCKBR, MEK3(MAP2K3), Caspase-9, Annexin II, FOXO3A, G-protein alpha-q",1.211E-02,2.079E-02,18,"p38alpha (MAPK14), Apaf-1, PI3K reg class IA (p85), Bax, FKHR, Caspase-3, AKT(PKB), Gastrin 17, Progastrin, c-Src, PPAR-gamma, RhoA, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), MEK3(MAP2K3), Caspase-9, Annexin II",
371,IGF signaling in lung cancer,44,1.347E-05,7.195E-05,3.149E-05,1.260E-04,29,"ERK5 (MAPK7), RHEB2, IRS-2, IRS-1, ERK1/2, VEGF-A, MSK1/2 (RPS6KA5/4), IBP3, BAD, Shc, Survivin, PI3K reg class IA, IGF-2, MAP2K5 (MEK5), MEK2(MAP2K2), MMP-2, CREB1, AKT(PKB), IBP, PI3K cat class IA, SOS, ATR, p90Rsk, PLAU (UPA), 4E-BP1, ATM, p38 MAPK, MMP-9, mTOR",1.347E-05,7.195E-05,28,"ERK5 (MAPK7), RHEB2, IRS-2, ERK1/2, VEGF-A, MSK1/2 (RPS6KA5/4), c-Raf-1, IBP3, Shc, Survivin, PI3K reg class IA, IGF-2, MAP2K5 (MEK5), MEK2(MAP2K2), MMP-2, CREB1, AKT(PKB), IBP, MEK1(MAP2K1), PI3K cat class IA, SOS, ATR, p90Rsk, PLAU (UPA), ATM, p38 MAPK, MMP-9, mTOR",
372,Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion,37,1.433E-05,6.873E-05,1.433E-05,6.873E-05,26,"TRIO, Laminin 5, alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, LIMK1, Fibronectin, Actin, Rac1, Talin, Laminin 2, CDC42, Actin cytoskeletal, c-Src, RhoA, alpha-3/beta-1 integrin, ITGB1, CD82, Laminin 1, alpha-5/beta-1 integrin, CD53, ROCK, Vinculin, PKC-alpha, N-WASP, Filamin A, Cofilin",1.350E-04,4.608E-04,23,"TRIO, Laminin 5, alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, LIMK1, Fibronectin, Actin, Talin, Laminin 2, CDC42, Actin cytoskeletal, c-Src, RhoA, alpha-3/beta-1 integrin, ITGB1, Laminin 1, alpha-5/beta-1 integrin, CD53, ROCK, Vinculin, PKC-alpha, Filamin A, Cofilin",
373,Immune response_Regulation of T cell function by CTLA-4,37,1.433E-05,6.873E-05,1.433E-05,6.873E-05,26,"NF-AT1(NFATC2), AP complex 2 medium (mu) chain, CD28, PP2A cat (alpha), Shc, PI3K reg class IA (p85), ZAP70, CTLA-4, Fyn, NF-kB, AKT(PKB), IL-2, AP-1 beta subunit, PI3K cat class IA, Lck, Lyn, c-Jun, SOS, PP2A catalytic, LAT, CD3, SHP-2, CD3 zeta, Beta-adaptin 2, AP1M1, CD86",4.649E-04,1.241E-03,22,"AP complex 2 medium (mu) chain, CD28, PP2A cat (alpha), Shc, PI3K reg class IA (p85), CTLA-4, Fyn, NF-kB, AKT(PKB), IL-2, AP-1 beta subunit, CD80, PI3K cat class IA, Lck, Lyn, SOS, PP2A catalytic, CD3, CD3 zeta, Beta-adaptin 2, AP1M1, CD86",
374,Role of alveolar cell senescence in COPD,37,1.433E-05,6.873E-05,1.433E-05,6.873E-05,26,"alpha-6/beta-1 integrin, IRS-1, ERK1/2, VISA, PP2A cat (alpha), WRN, Rac1, IBP3, I-kB, Cyr61, IL-6, AKT(PKB), NF-kB p50/p65, RIG-I, p16INK4, IGFBP7, RelA (p65 NF-kB subunit), IL-8, PP2A catalytic, ATM, FOXO3A, GALC, CTGF, Caveolin-1, p53, p38 MAPK",3.520E-05,1.570E-04,24,"alpha-6/beta-1 integrin, ERK1/2, VISA, PP2A cat (alpha), WRN, IBP3, I-kB, Cyr61, IL-6, AKT(PKB), NF-kB p50/p65, RIG-I, p16INK4, MEK1(MAP2K1), IGFBP7, RelA (p65 NF-kB subunit), IL-8, PP2A catalytic, ATM, GALC, CTGF, Caveolin-1, p53, p38 MAPK",
375,Role of red blood cell adhesion to endothelium in vaso-occlusion in Sickle cell disease,37,1.433E-05,6.873E-05,1.433E-05,6.873E-05,26,"alpha-4/beta-1 integrin, CD44, ERK1/2, PKA-reg (cAMP-dependent), DARC, Fibronectin, RAP-1A, alpha-IIb/beta-3 integrin, alpha-V/beta-3 integrin, GLPA, MEK1/2, JMJD6, c-Src, P-selectin, CD147, ICAM4, VCAM1, IL-8, RAP-1B, G-protein alpha-i family, Thrombospondin 1, TfR1, ITGA4, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent), CD47",3.520E-05,1.570E-04,24,"alpha-4/beta-1 integrin, CD44, ERK1/2, DARC, Fibronectin, RAP-1A, alpha-IIb/beta-3 integrin, alpha-V/beta-3 integrin, GLPA, MEK1/2, JMJD6, c-Src, P-selectin, CD147, VCAM1, IL-8, RAP-1B, G-protein alpha-i family, Thrombospondin 1, TfR1, ITGA4, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent), CD47",
376,Development_Early embryonal hypaxial myogenesis,37,1.433E-05,6.873E-05,1.433E-05,6.873E-05,26,"BMP4, Lef-1, MSX1, Beta-catenin, PKA-reg (cAMP-dependent), MYF6, KIF27, Dsh, Smoothened, GLI-2, Paraxis, GSK3 beta, WNT7A, Adenylate cyclase, WNT11, CREB1, FZD7, PTCH1, Noggin, PKC, GLI-3, GLI-1, SMAD3, PKA-cat (cAMP-dependent), Frizzled, WNT6",1.350E-04,4.608E-04,23,"BMP4, MSX1, Beta-catenin, MYF6, Dsh, Smoothened, GLI-2, Paraxis, GSK3 beta, WNT7A, Adenylate cyclase, WNT11, CREB1, FZD7, PTCH1, Noggin, PKC, GLI-3, GLI-1, SMAD3, PKA-cat (cAMP-dependent), Frizzled, WNT6",
377,Apoptosis and survival_NO synthesis and signaling,55,1.446E-05,7.691E-05,2.496E-03,5.207E-03,30,"TGF-beta 1, Calcineurin A (catalytic), PI3K cat class IA (p110-beta), ERK1/2, CaMK I, CaMK IV, NF-kB p50/p50, IL-1 beta, IFN-alpha, GM-CSF, MEK2(MAP2K2), CREB1, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, TNF-alpha, PDE5A, PI3K reg class IA (p85-alpha), iNOS, Guanylate cyclase (alpha-1/beta-1), nNOS, JAK3, PI3K cat class IA (p110-delta), NF-kB p65/p65, COX-2 (PTGS2), Calmodulin, CaMK II alpha, PSD-95, Elk-1",1.446E-05,7.691E-05,33,"TGF-beta 1, Calcineurin A (catalytic), PI3K cat class IA (p110-beta), IFN-gamma, ERK1/2, CaMK I, c-Raf-1, CaMK IV, NF-kB p50/p50, IL-1 beta, IFN-alpha, GM-CSF, MEK2(MAP2K2), CREB1, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, TNF-alpha, MEK1(MAP2K1), PDE5A, PI3K reg class IA (p85-alpha), iNOS, Guanylate cyclase (alpha-1/beta-1), nNOS, JAK3, PI3K cat class IA (p110-delta), NF-kB p65/p65, COX-2 (PTGS2), Calmodulin, CaMK II alpha, PSD-95, Elk-1",
378,Blood coagulation_Blood coagulation,39,1.515E-05,7.193E-05,1.515E-05,7.193E-05,27,"SERPINE2, Protein C, Fibrinogen beta, TFPI, Coagulation factor X, Plasma kallikrein, Plasminogen, Thrombin, PLAT (TPA), A2M, PAI2, Coagulation factor XIII A, Plasmin, Tissue factor, Coagulation factor V, Coagulation factor VIII, PLAU (UPA), Bradykinin, KNG, Fibrinogen alpha, SERPINF2, Coagulation factor XI, Fibrinogen gamma, CPB2, Fibrinogen (fibrin), Protein S, PAI1",2.004E-02,3.246E-02,19,"SERPINE2, Protein C, TFPI, Coagulation factor X, Plasma kallikrein, PLAT (TPA), A2M, PAI2, Coagulation factor XIII A, Tissue factor, Coagulation factor V, Coagulation factor VIII, PLAU (UPA), Fibrinogen alpha, SERPINF2, Coagulation factor XI, CPB2, Protein S, PAI1",
379,G protein-coupled receptors signaling in lung cancer,76,1.563E-05,7.398E-05,1.563E-05,7.398E-05,45,"CD44, ERK1/2, CNR2, PGE2R1, HB-EGF, VEGF-A, PKA-reg (cAMP-dependent), Galanin, G-protein alpha-q/11, I-kB, Endothelin-1, IKK-alpha, alpha-V/beta-3 integrin, GALR2, MMP-2, G-protein beta/gamma, Galpha(i)-specific peptide GPCRs, VIP, TGF-alpha, Galpha(i)-specific cannabis GPSRs, AKT(PKB), c-Src, CXCR4, RhoA, Pyk2(FAK2), PGE2R4, G-protein alpha-12 family, RelA (p65 NF-kB subunit), LPAR1, IL-8, G-protein alpha-12, EGFR, G-protein alpha-i family, Galpha(q)-specific peptide GPCRs, HB-EGF(mature), Bradykinin, EDNRB, Calmodulin, GRP(1-27), Somatostatin, NT, SSTR5, ADAM17, PKA-cat (cAMP-dependent), EDNRA",1.248E-04,4.340E-04,40,"CD44, ERK1/2, CNR2, PGE2R1, HB-EGF, VEGF-A, Galanin, G-protein alpha-q/11, I-kB, Endothelin-1, alpha-V/beta-3 integrin, GALR2, MMP-2, G-protein beta/gamma, Galpha(i)-specific peptide GPCRs, TGF-alpha, Galpha(i)-specific cannabis GPSRs, AKT(PKB), c-Src, CXCR4, RhoA, Pyk2(FAK2), PGE2R4, G-protein alpha-12 family, RelA (p65 NF-kB subunit), LPAR1, IL-8, G-protein alpha-12, EGFR, G-protein alpha-i family, Galpha(q)-specific peptide GPCRs, HB-EGF(mature), STAT3, EDNRB, Calmodulin, GRP(1-27), NT, ADAM17, PKA-cat (cAMP-dependent), EDNRA",
380,Reproduction_Progesterone-mediated oocyte maturation,40,1.571E-05,8.242E-05,1.160E-03,2.674E-03,24,"CDC20, PKA-reg (cAMP-dependent), Wee1B, BUB1, CDK1 (p34), Shc, GSK3 beta, Adenylate cyclase, ERK2 (MAPK1), Cyclin B1, c-Src, PLK1, CPEB1, CDC25C, PKA-cat alpha, G-protein alpha-i family, CDC25B, SOS, Aurora-A, p90Rsk, Kinase MYT1, PAQR7, PKA-cat (cAMP-dependent), PAQR8",1.571E-05,8.242E-05,26,"CDC20, c-Raf-1, Wee1B, BUB1, CDK1 (p34), Shc, GSK3 beta, Adenylate cyclase, SPDY1, ERK2 (MAPK1), Cyclin B1, c-Src, PLK1, MEK1(MAP2K1), CPEB1, c-Mos, CDC25C, PKA-cat alpha, G-protein alpha-i family, CDC25B, SOS, p90RSK1, p90Rsk, PAQR7, PKA-cat (cAMP-dependent), PAQR8",
381,Effect of H. pylori infection on gastric epithelial cells motility,43,1.616E-05,7.572E-05,1.616E-05,7.572E-05,29,"Connexin 32, ERK1/2, CrkL, Beta-catenin, Alpha-actinin, CRK, Claudin-1, Actin, Rac1, Actin cytoskeletal, WASF1(WAVE1), c-Src, PTPR-zeta, ITGB1, Lyn, ZO-1, DOCK1, alpha-5/beta-1 integrin, Csk, Alpha-catenin, Paxillin, PTPR-alpha, Vinculin, PKC-alpha, SHP-2, c-Abl, JNK(MAPK8-10), ALPHA-PIX, p120-catenin",9.315E-04,2.232E-03,24,"ERK1/2, CrkL, Beta-catenin, Alpha-actinin, CRK, Claudin-1, Actin, Actin cytoskeletal, WASF1(WAVE1), c-Src, PTPR-zeta, ITGB1, Lyn, ZO-1, DOCK1, alpha-5/beta-1 integrin, Csk, PTPR-alpha, Vinculin, PKC-alpha, Connexin 43, c-Abl, JNK(MAPK8-10), ALPHA-PIX",
382,Retinal ganglion cell damage in glaucoma,45,1.639E-05,7.572E-05,1.639E-05,7.572E-05,30,"NGFR(TNFRSF16), TrkA, Calcineurin A (catalytic), C3, Rab-8, BAD, Bax, Endothelin-1, A2M, Factor H, P2X7, Optineurin, NF-kB, Calpain 1(mu), TNF-R1, TNF-alpha, iNOS, MAP1LC3B, TrkC, c-Jun, Sortilin, TrkB, TfR1, NGF, EDNRB, JNK(MAPK8-10), Rab12, Calcineurin B (regulatory), BDNF, EDNRA",2.751E-04,8.208E-04,26,"NGFR(TNFRSF16), Calcineurin A (catalytic), C3, Rab-8, Bax, Endothelin-1, A2M, Factor H, P2X7, Optineurin, NF-kB, Calpain 1(mu), TNF-R1, TNF-alpha, iNOS, MAP1LC3B, Sortilin, TrkB, TfR1, NGF, EDNRB, JNK(MAPK8-10), Rab12, Calcineurin B (regulatory), BDNF, EDNRA",
383,Signal transduction_Angiotensin II/ AGTR1 signaling via JAK/STAT,45,1.639E-05,7.572E-05,1.639E-05,7.572E-05,30,"COL1A1, IL-18R1, HMGB1, Tyk2, IRS-1, ERK1/2, beta-MHC, Angiotensin II, STAT5B, BNP, STAT1, Rac1, I-kB, SOCS3, IL-6, MEK1/2, Fyn, RGS2, JAK2, Osteopontin, c-Jun, AMPK alpha subunit, PTP-1B, p300, TIMP1, PKC, SHP-2, Angiotensinogen, p53, PKA-cat (cAMP-dependent)",8.642E-05,3.296E-04,27,"COL1A1, IL-18R1, HMGB1, Tyk2, ERK1/2, c-Raf-1, beta-MHC, Angiotensin II, STAT5B, BNP, STAT1, I-kB, SOCS3, IL-6, MEK1/2, Fyn, RGS2, JAK2, Osteopontin, AMPK alpha subunit, p300, TIMP1, STAT3, PKC, Angiotensinogen, p53, PKA-cat (cAMP-dependent)",
384,Development_Hedgehog signaling,47,1.645E-05,7.572E-05,1.645E-05,7.572E-05,31,"GAS1, CDK11, Beta-catenin, KIF27, Smoothened, Beta-arrestin2, GLI-2, Ubiquitin, CDON, BOC, GSK3 beta, Itch, Skp2/TrCP/FBXW, DHH, HSP90, Cyclin B1, NUMB, Sin3A, PTCH1, GLI-3R, Ihh, Cul1/Rbx1 E3 ligase, DYRK2, Cullin 1, GLI-3, SAP18, Casein kinase I, GLI-1, CDC37, PKA-cat (cAMP-dependent), DISP1",2.249E-05,1.057E-04,29,"GAS1, CDK11, Beta-catenin, Smoothened, Beta-arrestin2, GLI-2, Ubiquitin, CDON, GSK3 beta, Itch, Skp2/TrCP/FBXW, DHH, HSP90, Cyclin B1, NUMB, Sin3A, PTCH1, GLI-3R, Ihh, Cul1/Rbx1 E3 ligase, DYRK2, Cullin 1, GLI-3, Casein kinase I, HIP, GLI-1, CDC37, PKA-cat (cAMP-dependent), DISP1",
385,Canonical Notch signaling pathway in colorectal cancer,47,1.645E-05,7.572E-05,1.645E-05,7.572E-05,31,"NOTCH1 receptor, HES5, CD44, Lef-1, TCF7L2 (TCF4), Beta-catenin, Jagged2, NOTCH2 (2ICD), Survivin, Radical fringe, AKT(PKB), RBP-J kappa (CBF1), SOX9, NUMB, NOTCH1 (NICD), KLF5, MAML1, DNA-PK, Ephrin-B receptor 3, NOTCH2, DLL4, 4E-BP1, HES1, WNT, HES6, ATH1, HES4, NOTCH1 (NEXT), Jagged1, ADAM17, mTOR",4.554E-03,8.795E-03,24,"NOTCH1 receptor, HES5, CD44, TCF7L2 (TCF4), Beta-catenin, Jagged2, NOTCH2 (2ICD), Survivin, AKT(PKB), RBP-J kappa (CBF1), SOX9, NUMB, NOTCH1 (NICD), KLF5, DNA-PK, NOTCH2, HES1, WNT, ATH1, HES4, NOTCH1 (NEXT), Jagged1, ADAM17, mTOR",
386,Development_HGF signaling pathway,47,1.645E-05,7.572E-05,1.645E-05,7.572E-05,31,"TCF7L2 (TCF4), ERK1/2, CrkL, Beta-catenin, EGR1, CRK, Rac1, RAP-1A, Shc, GSK3 beta, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), AKT(PKB), HGF, PI3K cat class IA, HGFA, c-Jun, SOS, C3G, MKK7 (MAP2K7), PLAU (UPA), MEK4(MAP2K4), COX-2 (PTGS2), MEKK1(MAP3K1), DOCK2, FasR(CD95), JNK(MAPK8-10), SNAIL1, HGF receptor (Met), Elk-1",2.401E-04,7.280E-04,27,"TCF7L2 (TCF4), ERK1/2, CrkL, Beta-catenin, CRK, c-Raf-1, RAP-1A, Shc, GSK3 beta, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), AKT(PKB), HGF, MEK1(MAP2K1), PI3K cat class IA, SOS, PLAU (UPA), MEK4(MAP2K4), STAT3, COX-2 (PTGS2), DOCK2, FasR(CD95), JNK(MAPK8-10), SNAIL1, HGF receptor (Met), Elk-1",
387,Cell adhesion_Cell-matrix glycoconjugates,38,1.676E-05,8.729E-05,3.020E-05,1.245E-04,26,"NCAM1, LYVE-1, CD44, Elastin, Versican, Fibulin-2, ITIH3, Aggrecan, L-selectin, Neurocan, Tenascin-C, CCL8, TIMP2, ITIH, Stromelysin-1, alpha-3/beta-1 integrin, Tenascin-R, Laminin 1, Leukocyte elastase, Fibulin-1, Plasmin, CRTL1, Galectin-4, CSPG4 (NG2), BCAN, MMP-9",1.676E-05,8.729E-05,25,"NCAM1, LYVE-1, CD44, Elastin, Versican, ITIH3, Lymphotactin, Aggrecan, L-selectin, Neurocan, Tenascin-C, CCL8, TIMP2, ITIH, Stromelysin-1, alpha-3/beta-1 integrin, Laminin 1, Leukocyte elastase, Fibulin-1, CRTL1, Galectin-4, ECM1, CSPG4 (NG2), BCAN, MMP-9",
388,Immune response_IL-27 signaling pathway,24,1.691E-05,8.776E-05,3.988E-04,1.071E-03,17,"JAK1, ICAM1, IL-10, Tyk2, IL27RA, CD28, Pim-1, STAT1, SOCS3, NF-kB, c-Myc, IL-2, JAK2, IL-12 receptor, T-bet, IFN-gamma receptor, IL-12RB2",1.691E-05,8.776E-05,18,"JAK1, ICAM1, IL-10, Tyk2, IFN-gamma, IL27RA, CD28, Pim-1, STAT1, SOCS3, NF-kB, IL-2, JAK2, IL-12 receptor, T-bet, IFN-gamma receptor, STAT3, IL-12RB2",
389,Immune response_IL-22 signaling pathway,36,1.769E-05,9.059E-05,2.901E-05,1.226E-04,25,"MHC class II, JAK1, Tyk2, ERK1/2, CD28, IL-22, STAT1, STAT4, SOCS3, CD4, c-Myc, Mcl-1, IL-2, JAK2, IL-12 receptor, IL10RB, c-Jun, IL-22 receptor, JAK3, IL22RA1, IL-22RA2, STAT5, JNK(MAPK8-10), p38 MAPK, CD86",1.769E-05,9.059E-05,24,"MHC class II, JAK1, Tyk2, ERK1/2, CD28, IL-22, STAT1, STAT4, SOCS3, CD4, Mcl-1, IL-2, JAK2, IL-12 receptor, IL10RB, IL-22 receptor, JAK3, IL22RA1, STAT3, IL-22RA2, STAT5, JNK(MAPK8-10), p38 MAPK, CD86",
390,Cigarette smoke-induced inflammatory signaling in airway epithelial cells,36,1.769E-05,9.059E-05,4.136E-04,1.101E-03,23,"ICAM1, MSR1, C5a, ERK1/2, HB-EGF, PKA-reg (cAMP-dependent), IL-1 beta, GM-CSF, IL-6, MEK1/2, TGF-alpha, NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, RelA (p65 NF-kB subunit), c-Cbl, IL-8, EGFR, COX-2 (PTGS2), PKC-alpha, sICAM1, PKA-cat (cAMP-dependent)",1.769E-05,9.059E-05,24,"p38alpha (MAPK14), ICAM1, MSR1, C5a, ERK1/2, HB-EGF, c-Raf-1, IL-1 beta, GM-CSF, IL-6, MEK1/2, TGF-alpha, NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, RelA (p65 NF-kB subunit), c-Cbl, IL-8, EGFR, COX-2 (PTGS2), PKC-alpha, sICAM1, PKA-cat (cAMP-dependent)",
391,Development_EPO-induced Jak-STAT pathway,36,1.769E-05,9.059E-05,4.136E-04,1.101E-03,23,"STAT5A, APS, ERK1/2, SOCS1, CrkL, Pim-1, STAT1, Shc, p120GAP, SOCS3, MEK2(MAP2K2), ERK2 (MAPK1), c-Src, c-Myc, JAK2, c-Cbl, Lyn, XIAP, SOS, Calmodulin, SHP-2, STAT5, c-Fes",1.769E-05,9.059E-05,24,"STAT5A, APS, ERK1/2, SOCS1, CrkL, c-Raf-1, Pim-1, STAT1, Shc, p120GAP, SOCS3, MEK2(MAP2K2), ERK2 (MAPK1), c-Src, MEK1(MAP2K1), JAK2, c-Cbl, Lyn, XIAP, SOS, STAT3, Calmodulin, STAT5, c-Fes",
392,Role of IL-8 in melanoma,36,1.769E-05,9.059E-05,4.136E-04,1.101E-03,23,"TGF-beta 1, ICAM1, ERK1/2, Beta-catenin, VEGF-A, IL-1 beta, alpha-V/beta-3 integrin, MMP-2, IL-6, NF-kB, AKT(PKB), TNF-alpha, RelA (p65 NF-kB subunit), B-Raf, NF-kB1 (p50), ITGB2, IL-8, G-protein alpha-i family, SNAIL1, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, p38 MAPK, PKA-cat (cAMP-dependent)",1.769E-05,9.059E-05,24,"TGF-beta 1, ICAM1, ERK1/2, Beta-catenin, VEGF-A, IL-1 beta, alpha-V/beta-3 integrin, MMP-2, IL-6, NF-kB, AKT(PKB), TNF-alpha, MEK1(MAP2K1), RelA (p65 NF-kB subunit), B-Raf, NF-kB1 (p50), ITGB2, IL-8, G-protein alpha-i family, SNAIL1, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, p38 MAPK, PKA-cat (cAMP-dependent)",
393,IL-6 signaling in multiple myeloma,51,1.815E-05,9.198E-05,1.652E-04,5.094E-04,31,"SPHK1, JAK1, Tyk2, ERK1/2, VEGF-A, VEGFR-2, STAT1, BAD, Cyclin D2, Shc, PI3K reg class IA (p85), GSK3 beta, CDK4, FKHR, N-Ras, MEK2(MAP2K2), IL-6, AKT(PKB), Mcl-1, JAK2, PI3K cat class IA, Lyn, c-Jun, FGF2, SOS, Caspase-9, Bcl-6, CDK6, SHP-2, JNK2(MAPK9), p53",1.815E-05,9.198E-05,31,"SPHK1, JAK1, Tyk2, ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, STAT1, Cyclin D2, Shc, PI3K reg class IA (p85), GSK3 beta, CDK4, FKHR, N-Ras, MEK2(MAP2K2), IL-6, AKT(PKB), Mcl-1, MEK1(MAP2K1), JAK2, PI3K cat class IA, Lyn, FGF2, SOS, Caspase-9, Bcl-6, CDK6, STAT3, JNK2(MAPK9), p53",
394,Development_S1P2 and S1P3 receptors in cell proliferation and differentiation,26,1.821E-05,9.199E-05,9.123E-05,3.088E-04,19,"ERK1/2, ARHGEF1 (p115RhoGEF), LIMK1, Actin, G-protein alpha-i2, MEK2(MAP2K2), Transgelin, G-protein beta/gamma, RhoA, ROCK2, G-protein alpha-12, S1P2 receptor, MYH11, ACTA2, G-protein alpha-q, MKL1, Elk-1, SRF, Cofilin",1.821E-05,9.199E-05,19,"ERK1/2, ARHGEF1 (p115RhoGEF), c-Raf-1, LIMK1, Actin, G-protein alpha-i2, MEK2(MAP2K2), Transgelin, G-protein beta/gamma, MEK1(MAP2K1), RhoA, ROCK2, G-protein alpha-12, S1P2 receptor, ACTA2, MKL1, Elk-1, SRF, Cofilin",
395,Development_Role of CDK5 in neuronal development,34,1.846E-05,9.228E-05,1.148E-04,3.688E-04,23,"CDK5R1 (p35), CDK5, DCTN1(p150Glued), Beta-catenin, PI3K reg class IA (p85), GSK3 beta, Dynein 1, cytoplasmic, heavy chain, Actin cytoskeletal, Fyn, DAB1, AKT(PKB), WASF1(WAVE1), PAFAH alpha (LIS1), Tubulin (in microtubules), PI3K cat class IA, PI3K reg class IA (p85-alpha), VLDLR, Reelin, Pin1, APOER2, Dynein 1, cytoplasmic, intermediate chains, NUDEL, NEFH",1.846E-05,9.228E-05,23,"CDK5R1 (p35), CDK5, DCTN1(p150Glued), Beta-catenin, NEFM, PI3K reg class IA (p85), GSK3 beta, Dynein 1, cytoplasmic, heavy chain, Actin cytoskeletal, Fyn, AKT(PKB), WASF1(WAVE1), PAFAH alpha (LIS1), Tubulin (in microtubules), PI3K cat class IA, PI3K reg class IA (p85-alpha), VLDLR, Reelin, Pin1, APOER2, Dynein 1, cytoplasmic, intermediate chains, NUDEL, NEFH",
396,Impaired inhibition of Th17 cell differentiation by IFN-beta in multiple sclerosis,28,1.894E-05,9.273E-05,1.426E-02,2.394E-02,16,"TGF-beta 1, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, IL-1 beta, SOCS3, IL-6, IL-23, JAK2, Osteopontin, TGF-beta receptor type II, IRF4, JAK3, IL-21 receptor, TGF-beta receptor type I",1.894E-05,9.273E-05,20,"TGF-beta 1, IL-17, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, IL-1 beta, SOCS3, IL-6, IL-23, JAK2, Osteopontin, ROR-alpha, TGF-beta receptor type II, IRF4, JAK3, STAT3, IL-21 receptor, IL-21, TGF-beta receptor type I",
397,Rho-dependent regulation of normal and asthmatic smooth muscle contraction,28,1.894E-05,9.022E-05,1.984E-05,9.022E-05,21,"LPAR3, G-protein alpha-q/11, LPAR2, MLCP (reg), PLC-beta, Endothelin-1, MLCP (cat), RACK1, RhoA, GEFT, LPAR1, ACM2, G-protein alpha-i family, Myosin II, CPI-17, ACM3, Histamine H1 receptor, ROCK, PKC, MRLC, EDNRA",1.894E-05,9.273E-05,20,"LPAR3, G-protein alpha-q/11, LPAR2, MLCP (reg), PLC-beta, Endothelin-1, MLCP (cat), RACK1, RhoA, GEFT, LPAR1, G-protein alpha-i family, Myosin II, CPI-17, ACM3, Histamine H1 receptor, ROCK, PKC, MRLC, EDNRA",
398,Regulation of Beta-catenin activity  in melanoma,28,1.894E-05,9.022E-05,1.984E-05,9.022E-05,21,"Beta-catenin, VEGF-A, PKA-reg (cAMP-dependent), GSK3 beta, N-Ras, MMP-2, CREB1, AKT(PKB), alpha-MSH, MC1R, p16INK4, Mcl-1, PPAR-gamma, Osteopontin, Ski, FHL2, WISP1, IMP1(ZBP1), MITF, MMP-9, PKA-cat (cAMP-dependent)",1.894E-05,9.273E-05,20,"Beta-catenin, VEGF-A, GSK3 beta, N-Ras, MMP-2, CREB1, AKT(PKB), alpha-MSH, MC1R, p16INK4, Mcl-1, PPAR-gamma, Osteopontin, Ski, FHL2, WISP1, IMP1(ZBP1), MITF, MMP-9, PKA-cat (cAMP-dependent)",
399,Hedgehog signaling in pancreatic cancer,32,1.897E-05,9.273E-05,4.318E-04,1.120E-03,21,"TGF-beta 1, ERK1/2, SMAD4, KIF27, Smoothened, GLI-2, Cyclin D2, IL-1 beta, IGF-2, MEK2(MAP2K2), TNF-alpha, RelA (p65 NF-kB subunit), B-Raf, PTCH1, Ihh, Cathepsin B, SIL, SNAIL1, GLI-1, SMAD3, MMP-9",1.897E-05,9.273E-05,22,"TGF-beta 1, ERK1/2, SMAD4, Smoothened, GLI-2, Cyclin D2, IL-1 beta, IGF-2, MEK2(MAP2K2), TNF-alpha, MEK1(MAP2K1), RelA (p65 NF-kB subunit), B-Raf, PTCH1, Ihh, Cathepsin B, SIL, HIP, SNAIL1, GLI-1, SMAD3, MMP-9",
400,Activation of ACTH production in pituitary gland in major depressive disorder,32,1.897E-05,9.273E-05,1.467E-03,3.256E-03,20,"TNF-R2, JAK1, V1b receptor, IL-1 beta, I-kB, IRAK4, MyD88, RIPK1, IL-6, NF-kB p50/p65, TNF-R1, TNF-alpha, POMC, JAK2, TRAF6, NIK(MAP3K14), ACTH, TRAF1, Corticoliberin, IRAK1/2",1.897E-05,9.273E-05,22,"TNF-R2, JAK1, IL-1 beta, I-kB, IRAK4, RIPK1, IL-6, NF-kB p50/p65, TNF-R1, TNF-alpha, POMC, JAK2, TRAF6, AVP extracellular region, NIK(MAP3K14), ACTH, STAT3, AVP-NPII, TRAF1, Corticoliberin, CRHR1, IRAK1/2",
401,Neutrophil resistance to apoptosis in COPD and proresolving impact of lipid mediators,60,1.902E-05,9.273E-05,7.386E-05,2.582E-04,36,"SAA1, TNF-R2 soluble, TNF-R1 soluble, Apaf-1, FasR(CD95) soluble, gp91-phox, ERK1/2, 14-3-3, Bak, Caspase-8, p47-phox, BAD, Bax, PI3K reg class IA, Calpastatin, c-IAP1, Caspase-3, RIPK1, FasL(TNFSF6), AKT(PKB), Calpain 1(mu), TNF-R1, Mcl-1, TNF-alpha, FPRL1, PI3K cat class IA, Cytochrome b-558, p22-phox, XIAP, MEK3(MAP2K3), Caspase-9, MAP3K3, tBid, FasR(CD95), p38 MAPK, Bid",1.902E-05,9.273E-05,35,"SAA1, TNF-R2 soluble, TNF-R1 soluble, Apaf-1, FasR(CD95) soluble, gp91-phox, ERK1/2, 14-3-3, Caspase-8, p47-phox, Bax, PI3K reg class IA, Calpastatin, c-IAP1, Caspase-3, RIPK1, AKT(PKB), Calpain 1(mu), TNF-R1, Mcl-1, TNF-alpha, FPRL1, PI3K cat class IA, Cytochrome b-558, p22-phox, XIAP, MEK3(MAP2K3), p90RSK1, Caspase-9, p67-phox, MAP3K3, tBid, FasR(CD95), p38 MAPK, Bid",
402,Role of CNTF and LIF in regulation of oligodendrocyte development in multiple sclerosis,30,1.917E-05,9.273E-05,4.341E-04,1.120E-03,20,"IMPA1, JAK1, CNTF, SOCS1, 14-3-3, STAT1, Nkx6-2, PI3K reg class IA, IKK-alpha, Caspase-3, LIF, AKT(PKB), JAK2, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), Annexin V, IFN-gamma receptor, RhoGDI alpha, CLIC4",1.917E-05,9.273E-05,21,"IMPA1, JAK1, IFN-gamma, CNTF, SOCS1, 14-3-3, STAT1, Nkx6-2, PI3K reg class IA, Caspase-3, LIF, AKT(PKB), JAK2, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), Annexin V, IFN-gamma receptor, RhoGDI alpha, STAT3, CLIC4",
403,Putative role of Tregs in COPD,30,1.917E-05,9.273E-05,2.276E-05,1.012E-04,22,"STK39, JAK1, NF-AT1(NFATC2), IL-10, ERK1/2, L-selectin, ZAP70, SOCS3, CD4, CTLA-4, IL-2R alpha chain, NF-AT2(NFATC1), IL-2, JAK2, IL7RA, CD45, GITR, LAT, CD8, CD3, CD3 zeta, STAT5",1.917E-05,9.273E-05,21,"STK39, JAK1, IL-10, ERK1/2, IL-17, L-selectin, SOCS3, CD4, CTLA-4, NF-AT2(NFATC1), IL-2, MEK1(MAP2K1), JAK2, IL7RA, CD45, GITR, STAT3, CD8, CD3, CD3 zeta, STAT5",
404,Cytoskeleton remodeling_Integrin outside-in signaling,49,2.024E-05,9.699E-05,5.574E-05,2.049E-04,31,"TRIO, ERK1/2, Beta-catenin, Alpha-actinin, Fibronectin, Rac1, Talin, GSK3 beta, NCK2, alpha-V/beta-3 integrin, MEK2(MAP2K2), Actin cytoskeletal, AKT(PKB), Collagen IV, c-Src, alpha-3/beta-1 integrin, alpha-8/beta-1 integrin, alpha-11/beta-1 integrin, PINCH, Tcf(Lef), c-Jun, Laminin 1, alpha-5/beta-1 integrin, SOS, Beta-parvin, Paxillin, Vinculin, alpha-2/beta-1 integrin, Alpha-parvin, Filamin A, Collagen I",2.024E-05,9.699E-05,30,"TRIO, ERK1/2, Beta-catenin, Alpha-actinin, c-Raf-1, Fibronectin, Talin, GSK3 beta, NCK2, alpha-V/beta-3 integrin, MEK2(MAP2K2), Actin cytoskeletal, AKT(PKB), Collagen IV, c-Src, MEK1(MAP2K1), alpha-3/beta-1 integrin, alpha-8/beta-1 integrin, alpha-11/beta-1 integrin, PINCH, Tcf(Lef), Laminin 1, alpha-5/beta-1 integrin, SOS, Beta-parvin, Vinculin, alpha-2/beta-1 integrin, Alpha-parvin, Filamin A, Collagen I",
405,PDE4 regulation of cyto/chemokine expression in arthritis,49,2.024E-05,9.699E-05,1.747E-04,5.343E-04,30,"CBP, IL-1 alpha, IP10, CCL2, IL-10, ENA-78, CD28, PKA-reg (cAMP-dependent), CARD8, NF-kB p50/p50, IL-1 beta, RAP-1A, I-kB, GM-CSF, GSK3 alpha/beta, CREB1, IL-6, AKT(PKB), NF-kB p50/p65, TNF-alpha, PGE2R2, PGE2R4, PI3K cat class IA, RelA (p65 NF-kB subunit), Lck, NF-kB1 (p50), IL-8, PDE4, IL-12 beta, PKA-cat (cAMP-dependent)",2.024E-05,9.699E-05,30,"CBP, IL-1 alpha, IP10, CCL2, IL-10, IFN-gamma, ENA-78, CD28, IL-17, NF-kB p50/p50, IL-1 beta, RAP-1A, I-kB, GM-CSF, GSK3 alpha/beta, CREB1, IL-6, AKT(PKB), NF-kB p50/p65, TNF-alpha, PGE2R2, PGE2R4, PI3K cat class IA, RelA (p65 NF-kB subunit), Lck, NF-kB1 (p50), IL-8, PDE4, IL-12 beta, PKA-cat (cAMP-dependent)",
406,Development_G-CSF signaling,49,2.024E-05,9.699E-05,5.574E-05,2.049E-04,31,"ERK5 (MAPK7), Cyclin D3, JAK1, Tyk2, ERK1/2, BFL1, p47-phox, STAT1, Shc, PI3K reg class IA (p85), Survivin, MAP2K5 (MEK5), MEK2(MAP2K2), SHIP, AKT(PKB), c-Myc, CXCR4, GFI-1, GAB2, ITGA9, JAK2, c-IAP2, PI3K cat class IA, c-Cbl, C/EBPbeta, Lyn, SOS, SHP-2, STAT5, JNK(MAPK8-10), p38 MAPK",2.024E-05,9.699E-05,30,"ERK5 (MAPK7), JAK1, Tyk2, ERK1/2, BFL1, c-Raf-1, p47-phox, STAT1, Shc, PI3K reg class IA (p85), Survivin, MAP2K5 (MEK5), MEK2(MAP2K2), AKT(PKB), CXCR4, GFI-1, GAB2, MEK1(MAP2K1), ITGA9, JAK2, c-IAP2, PI3K cat class IA, c-Cbl, C/EBPbeta, Lyn, SOS, STAT3, STAT5, JNK(MAPK8-10), p38 MAPK",
407,Inflammatory mechanisms of pancreatic cancerogenesis,67,2.066E-05,9.869E-05,9.600E-05,3.242E-04,39,"TNF-R2, CCL20, IL-1 alpha, ICAM1, CCL2, ENA-78, VEGF-A, IRF1, Angiotensin II, STAT1, IL-1 beta, GRO-1, MyD88, IKK-alpha, MMP-2, IL-6, Mucin 4, TGF-alpha, NF-kB, NF-kB p50/p65, TNF-R1, Mcl-1, CXCR4, TNF-alpha, IFNGR1, JAK2, RelA (p65 NF-kB subunit), iNOS, IL-8, EGFR, G-protein alpha-i family, c-Jun, PLAU (UPA), COX-2 (PTGS2), AP-1, TLR4, IL-32 (NK4), C/EBP, MMP-9",2.066E-05,9.869E-05,38,"TNF-R2, CCL20, IL-1 alpha, ICAM1, CCL2, IFN-gamma, ENA-78, VEGF-A, IRF1, Angiotensin II, STAT1, IL-1 beta, GRO-1, MMP-2, IL-6, Mucin 4, TGF-alpha, NF-kB, NF-kB p50/p65, TNF-R1, Mcl-1, CXCR4, CD40L(TNFSF5), TNF-alpha, IFNGR1, JAK2, RelA (p65 NF-kB subunit), iNOS, IL-8, EGFR, G-protein alpha-i family, PLAU (UPA), STAT3, COX-2 (PTGS2), TLR4, IL-32 (NK4), C/EBP, MMP-9",
408,Development_Prolactin receptor signaling,58,2.161E-05,1.026E-04,2.621E-05,1.140E-04,36,"STAT5A, CBP, GCR, IRS-1, NMI, ERK1/2, SOCS1, IRF1, TEC, VAV-1, STAT1, Rac1, OAS1, Shc, PI3K reg class IA (p85), SOCS3, MEK2(MAP2K2), Fyn, AKT(PKB), NF-kB p50/p65, c-Src, c-Myc, RhoA, JAK2, PI3K cat class IA, c-Cbl, PKC-delta, C/EBPbeta, c-Jun, SOS, p300, NEK3, SHP-2, PLC-gamma, STAT5, Prolactin",2.161E-05,1.026E-04,34,"STAT5A, CBP, Somatotropin, GCR, NMI, ERK1/2, SOCS1, c-Raf-1, IRF1, TEC, VAV-1, STAT1, OAS1, Shc, PI3K reg class IA (p85), SOCS3, MEK2(MAP2K2), Fyn, AKT(PKB), NF-kB p50/p65, c-Src, MEK1(MAP2K1), RhoA, JAK2, PI3K cat class IA, c-Cbl, C/EBPbeta, SOS, p300, NEK3, STAT3, PLC-gamma, STAT5, Prolactin",
409,Androgen receptor activation and downstream signaling in Prostate cancer,110,2.197E-05,1.039E-04,1.145E-04,3.688E-04,58,"TGF-beta 1, FGFR2, JAK1, GCR, TMPRSS2, PI3K cat class IA (p110-beta), STEAP1, IRS-1, FGF1, Versican, Matrilysin (MMP-7), SGK1, VEGF-A, FEN1, APP, Bak, FGF8, SPRY1, Elk-4, IBP3, Shc, ADAM9, N-Ras, PELP1, MEK2(MAP2K2), Caspase-2, IL-6, SKP2, ERK2 (MAPK1), AKT(PKB), ADAM10, c-Src, c-Myc, TERT, Prosaposin, N-cadherin, B-Raf, c-Cbl, PKC-delta, KLF5, IL-8, EGFR, FOLH1 (GCP2), FGF2, SOS, NCOA2 (GRIP1/TIF2), FRS2beta, SHP-2, NCOA1 (SRC1), PAR1, c-FLIP, SRD5A1, Caveolin-1, SPRY2, p53, ER81, ADAM17, TLR2",2.197E-05,1.039E-04,56,"TGF-beta 1, FGFR2, JAK1, GCR, TMPRSS2, PI3K cat class IA (p110-beta), STEAP1, Kallikrein 4, FGF1, Versican, Matrilysin (MMP-7), SGK1, VEGF-A, c-Raf-1, FEN1, APP, FGF8, SPRY1, Elk-4, IBP3, Shc, ADAM9, N-Ras, PELP1, MEK2(MAP2K2), Caspase-2, IL-6, SKP2, ERK2 (MAPK1), AKT(PKB), ADAM10, c-Src, TERT, Prosaposin, MEK1(MAP2K1), N-cadherin, B-Raf, c-Cbl, KLF5, IL-8, EGFR, FGF2, SOS, NCOA2 (GRIP1/TIF2), STAT3, FRS2beta, NCOA1 (SRC1), PAR1, c-FLIP, SRD5A1, Caveolin-1, SPRY2, p53, ER81, ADAM17, TLR2",
410,Immune response_Role of DPP4 (CD26) in immune regulation,47,2.249E-05,1.057E-04,5.746E-05,2.081E-04,30,"TGF-beta 1, MHC class II, IL-10, CD28, DPP4, Ubiquitin, I-kB, ZAP70, MHC class I, IL-6, Fyn, FasL(TNFSF6), NF-kB, NF-kB p50/p65, c-Src, IL-2, TNF-alpha, Lck, CD45, ADA, IGF-2 receptor, CARD11, CD3, MALT1, CD3 zeta, IRAK1, Bcl-10, Caveolin-1, IL-12 beta, CD86",2.249E-05,1.057E-04,29,"TGF-beta 1, MHC class II, IL-10, IFN-gamma, CD28, DPP4, Ubiquitin, I-kB, MHC class I, IL-6, Fyn, NF-kB, NF-kB p50/p65, c-Src, IL-2, TNF-alpha, Lck, CD45, ADA, IGF-2 receptor, CARD11, CD3, MALT1, CD3 zeta, IRAK1, Bcl-10, Caveolin-1, IL-12 beta, CD86",
411,HGF signaling in colorectal cancer,64,2.259E-05,1.012E-04,2.259E-05,1.012E-04,39,"Laminin 5, LAMC2, CD44, TCF7L2 (TCF4), ERK1/2, Beta-catenin, VEGF-A, Matriptase, LAMA3 (Epiligrin), Rac1, Shc, GSK3 beta, PI3K reg class IA, Thrombin, MMP-2, MEK1/2, PLAUR (uPAR), Actin cytoskeletal, AKT(PKB), TIMP2, ADAM10, c-Src, c-Myc, HGF, PI3K cat class IA, HGFA, EGFR, XIAP, SOS, Thrombospondin 1, TIMP1, COX-2 (PTGS2), SHP-2, AKT2, JNK(MAPK8-10), LAMB3, HGF receptor (Met), MMP-9, mTOR",3.121E-04,9.094E-04,34,"Laminin 5, LAMC2, CD44, TCF7L2 (TCF4), ERK1/2, Beta-catenin, VEGF-A, c-Raf-1, Matriptase, LAMA3 (Epiligrin), Shc, GSK3 beta, PI3K reg class IA, MMP-2, MEK1/2, PLAUR (uPAR), Actin cytoskeletal, AKT(PKB), TIMP2, ADAM10, c-Src, HGF, PI3K cat class IA, EGFR, XIAP, SOS, Thrombospondin 1, TIMP1, COX-2 (PTGS2), JNK(MAPK8-10), LAMB3, HGF receptor (Met), MMP-9, mTOR",
412,MAPK-independent proliferation of normal and asthmatic smooth muscle cells,64,2.259E-05,1.012E-04,2.259E-05,1.012E-04,39,"TGF-beta 1, Cyclin D3, HB-EGF, PDGF-R-alpha, G-protein alpha-q/11, PI3K cat class IB (p110-gamma), Rac1, IBP3, I-kB, PI3K reg class IA (p85), PI3K reg class IA, Thrombin, Endothelin-1, CDK4, PLAT (TPA), IKK-alpha, IL-13, PDGF-C, G-protein beta/gamma, NF-kB, AKT(PKB), PDGF receptor, c-Src, c-Myc, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), EGFR, G-protein alpha-i family, PDGF-A, FGF2, Tryptase, TBXA2R, Histamine H1 receptor, EDNRB, EDNRA, mTOR, TGF-beta receptor type I, PDGF-R-beta",3.121E-04,9.094E-04,34,"TGF-beta 1, HB-EGF, PDGF-R-alpha, G-protein alpha-q/11, PI3K cat class IB (p110-gamma), IBP3, I-kB, PI3K reg class IA (p85), PI3K reg class IA, Endothelin-1, CDK4, PLAT (TPA), PDGF-C, G-protein beta/gamma, NF-kB, AKT(PKB), PDGF receptor, c-Src, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), EGFR, G-protein alpha-i family, PDGF-A, FGF2, Tryptase, TBXA2R, STAT3, Histamine H1 receptor, EDNRB, EDNRA, mTOR, TGF-beta receptor type I, PDGF-R-beta",
413,Role of SHH and Notch in SCLC,30,2.276E-05,1.012E-04,2.276E-05,1.012E-04,22,"NOTCH1 receptor, BMP4, Jagged2, Smoothened, GLI-2, NOTCH2 (2ICD), AL1A1, Nestin, RBP-J kappa (CBF1), NOTCH1 (NICD), CD133, PTCH1, MAML1, NOTCH2, ENO2, HES1, SYP, GLI-1, MMP-10, NOTCH1 (NEXT), Jagged1, ADAM17",9.002E-05,3.381E-04,20,"NOTCH1 receptor, BMP4, Jagged2, Smoothened, GLI-2, NOTCH2 (2ICD), AL1A1, Nestin, RBP-J kappa (CBF1), NOTCH1 (NICD), CD133, PTCH1, NOTCH2, ENO2, HES1, GLI-1, MMP-10, NOTCH1 (NEXT), Jagged1, ADAM17",
414,Development_Beta-catenin destruction complex signaling,21,2.280E-05,1.012E-04,2.280E-05,1.012E-04,17,"Casein kinase I delta, APC protein, Lef-1, TCF7L2 (TCF4), Casein kinase I epsilon, Beta-catenin, Ubiquitin, Casein kinase II, GSK3 alpha/beta, CtBP, Skp2/TrCP/FBXW, Axin, TCF7 (TCF1), Tcf(Lef), PP2A catalytic, Cul1/Rbx1 E3 ligase, LRP6",2.205E-04,6.783E-04,15,"APC protein, TCF7L2 (TCF4), Casein kinase I epsilon, Beta-catenin, Ubiquitin, Casein kinase II, GSK3 alpha/beta, CtBP, Skp2/TrCP/FBXW, Axin, TCF7 (TCF1), Tcf(Lef), PP2A catalytic, Cul1/Rbx1 E3 ligase, LRP6",
415,Cell cycle_Chromosome condensation in prometaphase,21,2.280E-05,1.012E-04,2.280E-05,1.012E-04,17,"Cyclin B, CAP-G/G2, CAP-D2/D3, AKAP8, CDK1 (p34), Condensin, TOP2, BRRN1, CAP-G, INCENP, CAP-C, Aurora-A, CAP-E, CAP-H/H2, Cyclin A, CNAP1, Aurora-B",3.682E-05,1.629E-04,16,"Cyclin B, CAP-G/G2, CAP-D2/D3, AKAP8, CDK1 (p34), Condensin, TOP2, BRRN1, CAP-G, INCENP, CAP-C, CAP-E, CAP-H/H2, Cyclin A, CNAP1, Aurora-B",
416,Cell adhesion_Ephrin signaling,45,2.488E-05,1.162E-04,1.930E-04,5.798E-04,28,"NCK1, Ephrin-A receptor 2, PI3K cat class IB (p110-gamma), Rac1, RAP-1A, p120GAP, NCK2, FAP-1, Ephrin-A5, CDC42, Fyn, Ephexin, ADAM10, c-Src, TAK1(MAP3K7), Ephrin-A2, RhoA, Tiam1, HGK(MAP4K4), G-protein alpha-i family, Ephrin-A receptors, Ephrin-B receptor 1, JNK1(MAPK8), Intersectin, Paxillin, Ephrin-B, Ephrin-A, Ephrin-B receptors",2.488E-05,1.162E-04,28,"NCK1, c-Raf-1, Ephrin-A receptor 2, PI3K cat class IB (p110-gamma), RAP-1A, p120GAP, NCK2, FAP-1, Ephrin-A5, CDC42, Fyn, Ephexin, ADAM10, SLAP, c-Src, TAK1(MAP3K7), Ephrin-A2, RhoA, Tiam1, HGK(MAP4K4), G-protein alpha-i family, Ephrin-A receptors, Ephrin-B receptor 1, JNK1(MAPK8), Intersectin, Ephrin-B, Ephrin-A, Ephrin-B receptors",
417,IGF family signaling in colorectal cancer,60,2.503E-05,1.101E-04,2.503E-05,1.101E-04,37,"IRS-2, IRS-1, eIF4E, ERK1/2, Beta-catenin, VEGF-A, Apo-2L(TNFSF10), Rad51, IBP3, GIPC, I-kB, Shc, GSK3 beta, MAFG, IKK-alpha, IGF-2, GSK3 alpha/beta, MEK1/2, NF-kB, ERK2 (MAPK1), AKT(PKB), IBP, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), CDC25C, HIF1A, IL-8, c-Jun, SOS, IGF-2 receptor, MNK1, COX-2 (PTGS2), 4E-BP1, PI3K cat class IA (p110-alpha), ZNF143, MAT2A, mTOR",5.358E-03,1.009E-02,29,"IRS-2, ERK1/2, Beta-catenin, VEGF-A, c-Raf-1, Apo-2L(TNFSF10), IBP3, I-kB, Shc, GSK3 beta, MAFG, IGF-2, GSK3 alpha/beta, MEK1/2, NF-kB, ERK2 (MAPK1), AKT(PKB), IBP, RelA (p65 NF-kB subunit), PI3K reg class IA (p85-alpha), CDC25C, HIF1A, IL-8, SOS, IGF-2 receptor, MNK1, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), mTOR",
418,Cytoskeleton remodeling_Fibronectin-binding integrins in cell motility,32,2.529E-05,1.103E-04,2.529E-05,1.103E-04,23,"ITGAV, Alpha-actinin, LIMK1, Fibronectin, VAV-1, Rac1, Talin, PI3K reg class IA (p85), alpha-V/beta-3 integrin, CDC42, Actin cytoskeletal, Fyn, c-Src, RhoA, PI3K cat class IA, alpha-5/beta-1 integrin, ROCK, Vinculin, N-WASP, IRAS, Caveolin-1, ITGA5, Cofilin",8.484E-05,3.269E-04,21,"ITGAV, Alpha-actinin, LIMK1, Fibronectin, VAV-1, Talin, PI3K reg class IA (p85), alpha-V/beta-3 integrin, CDC42, Actin cytoskeletal, Fyn, c-Src, RhoA, PI3K cat class IA, alpha-5/beta-1 integrin, ROCK, Vinculin, IRAS, Caveolin-1, ITGA5, Cofilin",
419,Immune response_BAFF-induced non-canonical NF-kB signaling,32,2.529E-05,1.103E-04,2.529E-05,1.103E-04,23,"IL-17 receptor, Ubiquitin, NF-kB2 (p100), IKK-alpha, c-IAP1, NF-kB p52/RelB, UBE1C, Skp2/TrCP/FBXW, UEV1A, ZFP91, BAFF(TNFSF13B), c-IAP2, TRAF3, SUMO-1, NF-kB2 (p52), BAFF-R, RelB (NF-kB subunit), NIK(MAP3K14), Cul1/Rbx1 E3 ligase, Cullin 1, UBE1, MALT1, Furin",8.484E-05,3.269E-04,21,"IL-17, IL-17 receptor, Ubiquitin, NF-kB2 (p100), c-IAP1, NF-kB p52/RelB, UBE1C, Skp2/TrCP/FBXW, ZFP91, BAFF(TNFSF13B), c-IAP2, TRAF3, SUMO-1, NF-kB2 (p52), BAFF-R, RelB (NF-kB subunit), NIK(MAP3K14), Cul1/Rbx1 E3 ligase, Cullin 1, MALT1, Furin",
420,DNA damage_Mismatch repair,32,2.529E-05,1.103E-04,2.529E-05,1.103E-04,23,"USP10, Rad9-Hus1-Rad1, HMGB1, PKC-zeta, EXO1, MSH6, WDHD1, HYPB, Casein kinase II, RFC complex, MutSalpha complex, MSH3, DNA-PK, HDAC10, RFX, MutSbeta complex, PCNA, MRE11, MSH2, MTMR15, MCM9, DNMT1, Artemis",2.401E-02,3.832E-02,16,"USP10, Rad9-Hus1-Rad1, HMGB1, EXO1, MSH6, WDHD1, HYPB, Casein kinase II, MutSalpha complex, DNA-PK, HDAC10, PCNA, MRE11, MSH2, DNMT1, Artemis",
421,Apoptosis and survival_Endoplasmic reticulum stress response pathway,56,2.734E-05,1.177E-04,2.734E-05,1.177E-04,35,"GRP78, C/EBP zeta, SOD2, Apaf-1, PP1-cat, Endoplasmin, ATF-4, S2P, GADD34, ATF-6 alpha (90kDa), Bak, Derlin-3, I-kB, Bax, Calpain 1(mu), NF-kB p50/p65, ATF-6 alpha (50kDa), Derlin-2, EDEM, ASK1 (MAP3K5), MEK3(MAP2K3), c-Jun, Caspase-9, Calpain 2(m), S1P, MEK4(MAP2K4), Caspase-7, Caspase-12, tBid, JNK(MAPK8-10), DNAJC3, Bim, JIK, Bid, ERP5",5.750E-04,1.480E-03,30,"p38alpha (MAPK14), GRP78, C/EBP zeta, SOD2, Apaf-1, PP1-cat, Endoplasmin, S2P, GADD34, ATF-6 alpha (90kDa), Derlin-3, I-kB, Bax, Calpain 1(mu), NF-kB p50/p65, ATF-6 alpha (50kDa), Derlin-2, EDEM, ASK1 (MAP3K5), MEK3(MAP2K3), Caspase-9, Calpain 2(m), S1P, MEK4(MAP2K4), Caspase-12, tBid, JNK(MAPK8-10), Bim, Bid, ERP5",
422,Immune response_IL-5 signaling via JAK/STAT,56,2.734E-05,1.177E-04,2.734E-05,1.177E-04,35,"Cyclin D3, JAK1, NF-AT1(NFATC2), SOCS1, RNS2, VEGF-A, Pim-1, EGOT, STAT1, IL-1 beta, HIG1, NF-AT4(NFATC3), Survivin, IL-13, SOX4, E4BP4, LPPL, PRG2, ECP (RNase 3), c-Myc, Mcl-1, JAK2, c-IAP2, Slp76, Syntenin 1, NF-kB1 (p105), IL-8, IL-5, c-Jun, Calgizzarin, IgJ, Bcl-6, IL5RA, STAT5, BLIMP1 (PRDI-BF1)",5.750E-04,1.480E-03,30,"JAK1, SOCS1, RNS2, VEGF-A, GATA-1, Pim-1, EGOT, STAT1, IL-1 beta, HIG1, NF-AT4(NFATC3), Survivin, SOX4, E4BP4, PRG2, ECP (RNase 3), Mcl-1, JAK2, c-IAP2, Slp76, Syntenin 1, NF-kB1 (p105), IL-8, IL-5, Calgizzarin, IgJ, Bcl-6, STAT3, STAT5, BLIMP1 (PRDI-BF1)",
423,G-protein signaling_RhoA regulation pathway,34,2.737E-05,1.177E-04,2.737E-05,1.177E-04,24,"PLD1, LARG, GRAF, PRK1, ARHGEF1 (p115RhoGEF), G-protein alpha-q/11, Myosin IXb, Rac1, ARHGEF2, DIA1, Rap1GDS1, Fyn, Ephexin, RhoA, G-protein alpha-12 family, RhoGDI gamma, Ephrin-A receptors, RhoGDI alpha, KAP3, RhoGDI beta, ROCK, BMX, Ephrin-A, ECT2",1.015E-03,2.401E-03,20,"PLD1, GRAF, PRK1, ARHGEF1 (p115RhoGEF), G-protein alpha-q/11, Myosin IXb, ARHGEF2, DIA1, Rap1GDS1, Fyn, Ephexin, RhoA, G-protein alpha-12 family, Ephrin-A receptors, RhoGDI alpha, KAP3, ROCK, BMX, Ephrin-A, ECT2",
424,Th2-cytokines-induced expression of mucins in asthma ,43,2.739E-05,1.272E-04,2.255E-02,3.597E-02,22,"SPHK1, GRO-2, JAK1, Tyk2, Pendrin, ERK1/2, SMAD4, HNF3-beta, STAT1, GRO-1, IL13RA1, IL-13, CREB1, IL-6, TGF-beta 2, JAK2, HIF1A, IL-8, TGF-beta receptor type II, IL-4R type II, IL4RA, TGF-beta receptor type I",2.739E-05,1.272E-04,27,"SPHK1, GRO-2, p38alpha (MAPK14), JAK1, Tyk2, Pendrin, ERK1/2, c-Raf-1, SMAD4, HNF3-beta, STAT1, GRO-1, IL13RA1, CREB1, IL-6, IL13RA2, MEK1(MAP2K1), TGF-beta 2, JAK2, HIF1A, IL-8, TGF-beta receptor type II, IL-4R type II, p90RSK1, IL4RA, STAT3, TGF-beta receptor type I",
425,"Disruption of apoptosis, proliferation and shedding of epithelial cells in asthma",54,2.774E-05,1.210E-04,2.840E-05,1.210E-04,34,"TNF-R2, TGF-beta 1, IL-1 alpha, ICAM1, ERK1/2, SMAD4, TSLP, SMAD2, STAT1, IL-1 beta, IL13RA1, Endothelin-1, Caspase-3, IL-13, TGF-alpha, NF-kB, TNF-R1, TNF-alpha, IFNGR1, TGF-beta 2, SMAD7, EGFR, IL-4R type II, Paxillin, EDNRB, Desmocollin 3, p15, SMAD3, p53, CLCN3, ADAM17, MMP-9, TGF-beta receptor type I, TSLPR",2.774E-05,1.284E-04,32,"TNF-R2, TGF-beta 1, IL-1 alpha, ICAM1, IFN-gamma, ERK1/2, SMAD4, TSLP, SMAD2, STAT1, IL-1 beta, IL13RA1, Endothelin-1, Caspase-3, TGF-alpha, NF-kB, TNF-R1, TNF-alpha, IFNGR1, TGF-beta 2, SMAD7, EGFR, IL-4R type II, EDNRB, Desmocollin 3, p15, SMAD3, p53, ADAM17, MMP-9, TGF-beta receptor type I, TSLPR",
426,Microsatellite instability in colorectal cancer,36,2.901E-05,1.226E-04,2.901E-05,1.226E-04,25,"MBD4, MTB-Zf, EXO1, HLA-DRA1, MSH6, Bax, ActRIIA, MHC class I, Axin2, RFX5, RFC complex, MutSalpha complex, Dicer, MSH3, TGF-beta receptor type II, EGFR, TFAM, IGF-2 receptor, p300, MutSbeta complex, PCNA, Beta-2-microglobulin, MSH2, Ephrin-B receptor 2, p53",7.074E-03,1.293E-02,19,"MBD4, MTB-Zf, EXO1, HLA-DRA1, MSH6, Bax, ActRIIA, MHC class I, Axin2, MutSalpha complex, TGF-beta receptor type II, EGFR, IGF-2 receptor, p300, PCNA, Beta-2-microglobulin, MSH2, Ephrin-B receptor 2, p53",
427,Proteolysis_Putative ubiquitin pathway,23,2.992E-05,1.245E-04,2.992E-05,1.245E-04,18,"UBCH7, UBCH8, SKP1, Ubiquitin, UBCH6, UBE2D1, SKP2, UEV1A, HSP70, GPR37, TRAF6, Septin 5 (CDC-REL1), Cul1/Rbx1 E3 ligase, Cullin 1, UBE1, MJD (ataxin-3), RING-box protein 1, Synphilin 1",2.201E-04,6.783E-04,16,"UBCH7, UBCH8, SKP1, Ubiquitin, UBCH6, UBE2D1, SKP2, HSP70, GPR37, TRAF6, Septin 5 (CDC-REL1), Cul1/Rbx1 E3 ligase, Cullin 1, MJD (ataxin-3), RING-box protein 1, Synphilin 1",
428,Development_ERK5 in cell proliferation and neuronal survival,23,2.992E-05,1.245E-04,2.992E-05,1.245E-04,18,"TrkA, ERK5 (MAPK7), MEF2C, PKC-zeta, p90RSK2(RPS6KA3), Elk-4, RAP-1A, MAP3K2 (MEKK2), MAP2K5 (MEK5), CREB1, TSAD, Sequestosome 1(p62), Lck, c-Jun, NGF, PKC-lambda/iota, MAP3K3, BDNF",2.201E-04,6.783E-04,16,"ERK5 (MAPK7), MEF2C, p90RSK2(RPS6KA3), c-Raf-1, Elk-4, RAP-1A, MAP3K2 (MEKK2), MAP2K5 (MEK5), CREB1, TSAD, Sequestosome 1(p62), Lck, NGF, PKC-lambda/iota, MAP3K3, BDNF",
429,Role of Bregs in attenuation of T and NK cells mediated anti-tumor immune responses,41,2.999E-05,1.384E-04,1.871E-03,4.051E-03,24,"TGF-beta 1, IP10, IL-10, CD28, 5'-NTD, PI3K reg class IA (p85), L-selectin, CTLA-4, IL-10 receptor, FasL(TNFSF6), IL-2R alpha chain, Lck, CD1d, TGF-beta receptor type II, CXCR3, ITGA2, CD3, CD3 zeta, FasR(CD95), PD-1, SMAD3, CD86, TGF-beta receptor type I, PD-L1",2.999E-05,1.384E-04,26,"MIG, TGF-beta 1, IP10, IL-10, IFN-gamma, CD28, 5'-NTD, IL-17, PI3K reg class IA (p85), L-selectin, CTLA-4, IL-10 receptor, CD80, Lck, CD1d, TGF-beta receptor type II, STAT3, ITGA2, CD3, CD3 zeta, FasR(CD95), PD-1, SMAD3, CD86, TGF-beta receptor type I, PD-L1",
430,Development_GM-CSF signaling,50,3.018E-05,1.245E-04,3.018E-05,1.245E-04,32,"STAT5A, Cyclin D3, CCL2, CSF2RA, ERK1/2, EGR1, Pim-1, BAD, I-kB, Shc, PI3K reg class IA (p85), IKK-alpha, GM-CSF, Caspase-3, MEK2(MAP2K2), CREB1, NF-kB, AKT(PKB), c-Myc, Mcl-1, RACK1, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), Lyn, 14-3-3 zeta/delta, SOS, Caspase-9, PKC-beta, SHP-2, STAT5, Elk-1",1.126E-04,3.969E-04,29,"STAT5A, CCL2, CSF2RA, ERK1/2, c-Raf-1, Pim-1, I-kB, Shc, PI3K reg class IA (p85), GM-CSF, Caspase-3, MEK2(MAP2K2), CREB1, NF-kB, AKT(PKB), Mcl-1, MEK1(MAP2K1), RACK1, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), Lyn, 14-3-3 zeta/delta, SOS, Caspase-9, STAT3, PKC-beta, STAT5, Elk-1",
431,Transcription_Role of AP-1 in regulation of cellular metabolism,38,3.020E-05,1.245E-04,3.020E-05,1.245E-04,26,"ERK1/2, FXYD2, POLA1, TSG-6, IFN-beta, CGB3, PLAUR (uPAR), FasL(TNFSF6), IL-2, HBB, GCL reg, IL-5, c-Jun, AP-1, PIT1, Alpha1-globin, ITGA2, IL5RA, FasR(CD95), c-Abl, ITGB4, JNK(MAPK8-10), HMBS, GCL cat, ITGA5, Prolactin",7.749E-04,1.921E-03,22,"IFN-gamma, ERK1/2, POLA1, TSG-6, IFN-beta, CGB3, PLAUR (uPAR), IL-2, HBB, GCL reg, IL-5, Alpha1-globin, ITGA2, FasR(CD95), c-Abl, ITGB4, JNK(MAPK8-10), HBE, HMBS, GCL cat, ITGA5, Prolactin",
432,Development_Oligodendrocyte differentiation (general schema),38,3.020E-05,1.245E-04,3.020E-05,1.245E-04,26,"BMP receptor 2, BMP4, APC protein, HB-EGF, PDGF-R-alpha, Endothelin-1, BMPR1B, TGF-alpha, Nkx2.2, CD82, SMAD7, EGFR, PDGF-A, FGF2, SOX10, Noggin, Myelin basic protein, EDNRB, SMAD6, CNP1, CSPG4 (NG2), OLIG2, BMPR1A, SMAD1, BMP2, EDNRA",2.396E-04,7.280E-04,23,"BMP receptor 2, BMP4, APC protein, HB-EGF, PDGF-R-alpha, Endothelin-1, BMPR1B, TGF-alpha, SMAD7, EGFR, PDGF-A, FGF2, SOX10, Noggin, Myelin basic protein, EDNRB, SMAD6, CNP1, CSPG4 (NG2), OLIG2, BMPR1A, BMP2, EDNRA",
433,Apoptosis and survival_NGF activation of NF-kB,40,3.099E-05,1.260E-04,3.099E-05,1.260E-04,27,"NGFR(TNFRSF16), TrkA, HES5, PKC-zeta, c-FLIP(Long), I-kB, Shc, PI3K reg class IA, MyD88, IKK-alpha, NF-kB, AKT(PKB), c-Src, Sequestosome 1(p62), PI3K cat class IA, iNOS, RIPK2, TRAF6, FAIM, PTP-1B, GSTP1, NGF, PKC-lambda/iota, HES1, IRAK1, TGM2, Synapsin II",6.751E-04,1.702E-03,23,"Neuromodulin, NGFR(TNFRSF16), HES5, c-FLIP(Long), I-kB, Shc, PI3K reg class IA, NF-kB, AKT(PKB), c-Src, Sequestosome 1(p62), PI3K cat class IA, iNOS, RIPK2, TRAF6, FAIM, GSTP1, NGF, PKC-lambda/iota, HES1, IRAK1, TGM2, Synapsin II",
434,Regulation of GSK3 beta in bipolar disorder,46,3.128E-05,1.260E-04,3.128E-05,1.260E-04,30,"TrkA, IRS-1, PP1-cat, APC protein, ERK1/2, PP2A regulatory, Nucleoredoxin, Dsh, Beta-arrestin2, IL-1 beta, Shc, GSK3 beta, LRP5, CREB1, MEK1/2, AKT(PKB), Axin, Dopamine D2 receptor, NT-3, IPP-2, TrkC, FGF2, SOS, PP2A catalytic, TrkB, NGF, WNT, LRP6, BDNF, Frizzled",4.426E-04,1.193E-03,26,"PP1-cat, APC protein, ERK1/2, PP2A regulatory, c-Raf-1, Nucleoredoxin, Dsh, Beta-arrestin2, IL-1 beta, Shc, GSK3 beta, CREB1, MEK1/2, AKT(PKB), Axin, Dopamine D2 receptor, FGF2, SOS, PP2A catalytic, p90RSK1, TrkB, NGF, WNT, LRP6, BDNF, Frizzled",
435,Chemoresistance pathways mediated by constitutive activation of PI3K pathway and BCL-2 in small cell lung cancer,42,3.141E-05,1.260E-04,3.141E-05,1.260E-04,28,"Laminin 5, LAMC2, alpha-6/beta-1 integrin, IRS-1, RPS6, Fibronectin, c-Kit, PI3K reg class IA (p85), Bax, Survivin, PI3K reg class IA, FKHR, Caspase-3, AKT(PKB), Collagen IV, alpha-3/beta-1 integrin, PI3K cat class IA, PARP-1, alpha-5/beta-1 integrin, FGF2, Caspase-9, 4E-BP1, BMX, Caspase-7, alpha-2/beta-1 integrin, p53, Collagen I, mTOR",5.872E-04,1.503E-03,24,"Laminin 5, LAMC2, alpha-6/beta-1 integrin, RPS6, Fibronectin, c-Kit, PI3K reg class IA (p85), Bax, Survivin, PI3K reg class IA, FKHR, Caspase-3, AKT(PKB), Collagen IV, alpha-3/beta-1 integrin, PI3K cat class IA, alpha-5/beta-1 integrin, FGF2, Caspase-9, BMX, alpha-2/beta-1 integrin, p53, Collagen I, mTOR",
436,K-RAS signaling in pancreatic cancer,44,3.149E-05,1.260E-04,3.149E-05,1.260E-04,29,"HNF1-alpha, ERK1/2, VEGF-A, Sec5, Rac1, Bax, IKK-alpha, MEK2(MAP2K2), GSK3 alpha/beta, AKT(PKB), NF-kB p50/p65, c-Myc, Tiam1, RelA (p65 NF-kB subunit), B-Raf, IL-8, MEK3(MAP2K3), Caspase-9, ATR, Thrombospondin 1, PLAU (UPA), PI3K cat class IA (p110-alpha), MEKK1(MAP3K1), MIRK, AKT2, SNAIL1, p53, RalA, RalBP1",1.437E-03,3.257E-03,24,"ERK1/2, VEGF-A, c-Raf-1, Sec5, Bax, MEK2(MAP2K2), GSK3 alpha/beta, AKT(PKB), NF-kB p50/p65, MEK1(MAP2K1), Tiam1, RelA (p65 NF-kB subunit), B-Raf, IL-8, MEK3(MAP2K3), Caspase-9, ATR, Thrombospondin 1, PLAU (UPA), PI3K cat class IA (p110-alpha), MIRK, SNAIL1, p53, RalBP1",
437,Role of TLR signaling in skin sensitization,44,3.149E-05,1.260E-04,3.149E-05,1.260E-04,29,"TRAM, IFN-beta, IL-1 beta, I-kB, IRAK4, CD14, MyD88, IKK-alpha, RIPK1, IL-6, NF-kB p50/p65, HSP70, TAK1(MAP3K7), TNF-alpha, TRAF3, TRAF6, MEK3(MAP2K3), MEK4(MAP2K4), AP-1, MAP3K3, TLR4, TAB1, IRAK1/2, JNK(MAPK8-10), TRIF (TICAM1), p38 MAPK, IL-12 beta, CD86, TLR2",5.101E-04,1.333E-03,25,"TRAM, IFN-gamma, IFN-beta, IL-1 beta, I-kB, IRAK4, CD14, RIPK1, IL-6, NF-kB p50/p65, HSP70, TAK1(MAP3K7), TNF-alpha, TRAF3, TRAF6, MEK3(MAP2K3), MEK4(MAP2K4), MAP3K3, TLR4, IRAK1/2, JNK(MAPK8-10), p38 MAPK, IL-12 beta, CD86, TLR2",
438,Leptin signaling in colorectal cancer,44,3.149E-05,1.260E-04,3.149E-05,1.260E-04,29,"TCF7L2 (TCF4), ERK1/2, Beta-catenin, Matrilysin (MMP-7), VEGF-A, Rac1, CDK1 (p34), GSK3 beta, Survivin, PI3K reg class IA, IKK-alpha, IL-6, MEK1/2, CDC42, AKT(PKB), Cyclin B1, c-Src, c-Myc, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-delta, IL-8, c-Jun, Leptin receptor, Cyclin E, JNK(MAPK8-10), ADAM17, mTOR",5.101E-04,1.333E-03,25,"TCF7L2 (TCF4), ERK1/2, Beta-catenin, Matrilysin (MMP-7), VEGF-A, CDK1 (p34), GSK3 beta, Survivin, PI3K reg class IA, IL-6, MEK1/2, CDC42, AKT(PKB), Cyclin B1, c-Src, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), IL-8, Leptin receptor, STAT3, Cyclin E, JNK(MAPK8-10), ADAM17, mTOR",
439,Development_Schema: Adult neurogenesis in the Subventricular Zone,19,3.167E-05,1.452E-04,7.087E-04,1.721E-03,14,"NCAM1, GFAP, Vimentin, MAP2, Nestin, Tubulin beta 3, CRMP4, GLAST1/EAAT1, TERT, SLC6A11, CSPG4 (NG2), OLIG2, DLX2, NEFH",3.167E-05,1.452E-04,15,"NCAM1, GFAP, NEFM, Vimentin, MAP2, Nestin, Tubulin beta 3, CRMP4, GLAST1/EAAT1, TERT, SLC6A11, CSPG4 (NG2), OLIG2, DLX2, NEFH",
440,Immune response_HMGB1 release from the cell,39,3.261E-05,1.482E-04,6.032E-05,2.118E-04,26,"TNF-R2, CBP, CRM1, HMGB1, CaMK IV, IP3 receptor, IL-1 beta, PI3K reg class IA (p85), PI3K reg class IA, MyD88, PCAF, MEK1/2, NF-kB, TNF-R1, TNF-alpha, IFNGR1, PI3K cat class IA, PARP-1, p300, Karyopherin alpha 1, PKC-beta, Calmodulin, PKC-alpha, TLR4, JNK(MAPK8-10), TLR2",3.261E-05,1.482E-04,25,"TNF-R2, CBP, CRM1, HMGB1, IFN-gamma, CaMK IV, IP3 receptor, IL-1 beta, PI3K reg class IA (p85), PI3K reg class IA, PCAF, MEK1/2, NF-kB, TNF-R1, TNF-alpha, IFNGR1, PI3K cat class IA, p300, Karyopherin alpha 1, PKC-beta, Calmodulin, PKC-alpha, TLR4, JNK(MAPK8-10), TLR2",
441,Immune response_TSLP signalling,39,3.261E-05,1.482E-04,6.032E-05,2.118E-04,26,"OX40L(TNFSF4), JAK1, CCL2, ERK1/2, TSLP, STAT1, PI3K reg class IA, STAT4, IKK-alpha, Claudin-7, IL-6, MEK1/2, CRLF2, NF-kB, Eotaxin, AKT(PKB), c-Myc, JAK2, PI3K cat class IA, IL7RA, IL-8, NF-kB p50/RelB, STAT5, JNK(MAPK8-10), p38 MAPK, TSLPR",3.261E-05,1.482E-04,25,"OX40L(TNFSF4), JAK1, CCL2, ERK1/2, c-Raf-1, TSLP, STAT1, PI3K reg class IA, STAT4, IL-6, MEK1/2, CRLF2, NF-kB, Eotaxin, AKT(PKB), JAK2, PI3K cat class IA, IL7RA, IL-8, NF-kB p50/RelB, STAT3, STAT5, JNK(MAPK8-10), p38 MAPK, TSLPR",
442,DNA damage_DNA-damage-induced responses,9,3.279E-05,1.486E-04,1.446E-03,3.244E-03,8,"NFBD1, Chk1, Brca1, DNA-PK, ATR, ATM, c-Abl, p53",3.279E-05,1.486E-04,9,"NFBD1, Chk1, Chk2, Brca1, DNA-PK, ATR, ATM, c-Abl, p53",
443,Eosinophil survival in asthma,67,3.510E-05,1.400E-04,3.510E-05,1.400E-04,40,"TrkA, IL-7, ICAM1, PGD2R, ERK1/2, Apo-2L(TNFSF10), NT-4/5, TSLP, Fibronectin, TRUNDD(TNFRSF10D), Syk, IL-15, Bax, Survivin, GM-CSF, IL-13, CRLF2, Guanylate Cyclase 1, soluble, Eotaxin, NT-3, TNF-alpha, PGE2R2, JAK2, c-IAP2, iNOS, Eotaxin-2, Lyn, IL-5, Eotaxin-3, Pin1, TrkB, NGF, ST2(L), IL5RA, SHP-2, IL-33, STAT5, p38 MAPK, BDNF, TSLPR",1.553E-04,5.253E-04,36,"IL-7, ICAM1, PGD2R, ERK1/2, Apo-2L(TNFSF10), NT-4/5, TSLP, Fibronectin, TRUNDD(TNFRSF10D), Syk, IL-15, Bax, Survivin, GM-CSF, CRLF2, Guanylate Cyclase 1, soluble, Eotaxin, CD40L(TNFSF5), TNF-alpha, PGE2R2, JAK2, c-IAP2, iNOS, Eotaxin-2, Lyn, IL-5, Eotaxin-3, Pin1, TrkB, NGF, ST2(L), IL-33, STAT5, p38 MAPK, BDNF, TSLPR",
444,Development_Trophectoderm differentiation,25,3.669E-05,1.456E-04,3.669E-05,1.456E-04,19,"P-cadherin, FGFR2, Oct-3/4, BMP4, CRIPTO, HAND1, SMAD4, SMAD2, Eomesodermin, ITGA7, ActRIIA, PACE4, NODAL, CDX2, ETS2, ActRIIB, SMAD3, Esrrb, Furin",4.240E-05,1.791E-04,18,"P-cadherin, FGFR2, Oct-3/4, BMP4, CRIPTO, HAND1, SMAD4, SMAD2, Eomesodermin, ITGA7, ActRIIA, PACE4, NODAL, CDX2, ETS2, ActRIIB, SMAD3, Furin",
445,Multiple sclerosis (general schema),21,3.682E-05,1.629E-04,1.495E-04,4.649E-04,16,"TGF-beta 1, ICAM1, CNTF, Apo-2L(TNFSF10), Fibronectin, IFN-beta, LIF, CTLA-4, FasL(TNFSF6), IL-2, TNF-alpha, VCAM1, FGF2, NGF, WNT5A, Jagged1",3.682E-05,1.629E-04,16,"TGF-beta 1, ICAM1, IFN-gamma, CNTF, Apo-2L(TNFSF10), Fibronectin, IFN-beta, LIF, CTLA-4, IL-2, TNF-alpha, VCAM1, FGF2, NGF, WNT5A, Jagged1",
446,Development_Transcriptional regulation of megakaryopoiesis,35,3.765E-05,1.648E-04,2.338E-03,4.940E-03,21,"NOTCH1 receptor, LMO2, NF-E2 (45 kDa), alpha-IIb/beta-3 integrin, ETS, c-MPL, RBP-J kappa (CBF1), CD45, ITGA2B, CD38, ETS1, ZFPM1 (FOG), Fc gamma RII alpha, p300, AML1 (RUNX1), ITGA2, THAS, FLI1, Jagged1, PF4, CBF beta",3.765E-05,1.648E-04,23,"NOTCH1 receptor, LMO2, GATA-1, NF-E2 (45 kDa), alpha-IIb/beta-3 integrin, ETS, c-MPL, RBP-J kappa (CBF1), TAL1, CD45, ITGA2B, CD38, ETS1, ZFPM1 (FOG), Fc gamma RII alpha, p300, AML1 (RUNX1), ITGA2, THAS, FLI1, Jagged1, PF4, CBF beta",
447,Transcription_Assembly of RNA Polymerase II preinitiation complex on TATA-less promoters ,18,3.807E-05,1.503E-04,3.807E-05,1.503E-04,15,"DHFR, VEGFR-2, APP, IGFRB, MDR1, AMH, TFIID, PTAFR, TBP, POLR2A, TFIIB, AML1 (RUNX1), PCNA, Mxi1, p15",3.123E-02,4.833E-02,10,"DHFR, VEGFR-2, APP, MDR1, PTAFR, POLR2A, TFIIB, AML1 (RUNX1), PCNA, p15",
448,Transport_RAN regulation pathway,18,3.807E-05,1.503E-04,3.807E-05,1.503E-04,15,"CRM1, NUP153, Importin (karyopherin)-alpha, RCC1, RanGAP1, NUP62, CHC1L, NUP58, RANBP3, Importin (karyopherin)-beta, NTF2, SUMO-1, RanBP1, NUP54, RanBP2",5.018E-04,1.329E-03,13,"CRM1, NUP153, Importin (karyopherin)-alpha, RCC1, RanGAP1, CHC1L, NUP58, Importin (karyopherin)-beta, NTF2, SUMO-1, RanBP1, NUP54, RanBP2",
449,Neuroendocrine transdifferentiation in Prostate Cancer,48,3.963E-05,1.726E-04,1.018E-04,3.393E-04,30,"Oct-3/4, TCF7L2 (TCF4), HB-EGF, Beta-catenin, PKA-reg (cAMP-dependent), PCDH11Y, Shc, MEK2(MAP2K2), CREB1, IL-6, NeuroD1, ERK2 (MAPK1), AKT(PKB), Progastrin, c-Src, Chromogranin A, Tcf(Lef), IL-8, EGFR, PTP-1B, SOS, BMX, Secretogranin 1, ENO2, GRP(1-27), PTPR-alpha, NT, PTHrP, PKA-cat (cAMP-dependent), mTOR",3.963E-05,1.726E-04,29,"Oct-3/4, TCF7L2 (TCF4), HB-EGF, Beta-catenin, c-Raf-1, Shc, MEK2(MAP2K2), CREB1, IL-6, NeuroD1, ERK2 (MAPK1), AKT(PKB), Progastrin, c-Src, MEK1(MAP2K1), Tcf(Lef), IL-8, EGFR, SOS, STAT3, BMX, Secretogranin 1, ENO2, GRP(1-27), PTPR-alpha, NT, PTHrP, PKA-cat (cAMP-dependent), mTOR",
450,Apoptosis and survival_CXCR3-B signaling,63,3.975E-05,1.561E-04,3.975E-05,1.561E-04,38,"MPTP complex, IP10, BACH1, IL-10, Apaf-1, ERK1/2, PKA-reg (cAMP-dependent), MCU, GRK3, IP3 receptor, Beta-arrestin2, AHR, Bax, Survivin, IDO2, Adenylate cyclase, Caspase-3, IL-13, Ryanodine receptor 1, G-protein beta/gamma, Calpain 1(mu), PF4V1, Heme oxygenase 1, PARP-1, I-TAC, ITGB3, IL-5, Caspase-9, Calpain 2(m), CXCR3, c-Maf, Beclin 1, p53, NRF2, PF4, PLC-beta3, p38 MAPK, PKA-cat (cAMP-dependent)",2.098E-04,6.604E-04,34,"MIG, IP10, BACH1, IL-10, Apaf-1, ERK1/2, MCU, GRK3, IP3 receptor, Beta-arrestin2, AHR, Bax, Survivin, IDO2, Adenylate cyclase, Caspase-3, Ryanodine receptor 1, G-protein beta/gamma, Calpain 1(mu), PF4V1, Heme oxygenase 1, I-TAC, ITGB3, IL-5, Caspase-9, Calpain 2(m), STAT3, c-Maf, p53, NRF2, PF4, PLC-beta3, p38 MAPK, PKA-cat (cAMP-dependent)",
451,Transport_Macropinocytosis regulation by growth factors,63,3.975E-05,1.561E-04,3.975E-05,1.561E-04,38,"TrkA, ERK5 (MAPK7), IRS-2, IRS-1, AMPK beta subunit, M-CSF receptor, AMPK gamma subunit, PDGF-R-alpha, LIMK1, VAV-1, PLC-beta1, Rac1, Shc, Profilin, CDC42, Actin cytoskeletal, AKT(PKB), PDGF receptor, WaspIP, HGF, Profilin I, Tiam1, JAK2, PI3K reg class IA (p85-alpha), EGFR, Destrin, AMPK alpha subunit, SOS, CSF1, Leptin receptor, NGF, PI3K cat class IA (p110-alpha), PLC-delta 1, HGF receptor (Met), CtBP1, WASF2, Cofilin, PDGF-R-beta",1.274E-03,2.918E-03,32,"ERK5 (MAPK7), IRS-2, AMPK beta subunit, M-CSF receptor, AMPK gamma subunit, PDGF-R-alpha, LIMK1, VAV-1, Shc, Profilin, CDC42, Actin cytoskeletal, AKT(PKB), PDGF receptor, WaspIP, HGF, Profilin I, Tiam1, JAK2, PI3K reg class IA (p85-alpha), EGFR, AMPK alpha subunit, SOS, CSF1, Leptin receptor, NGF, PI3K cat class IA (p110-alpha), PLC-delta 1, HGF receptor (Met), WASF2, Cofilin, PDGF-R-beta",
452,Development_Cytokine-mediated regulation of megakaryopoiesis,57,4.054E-05,1.747E-04,4.697E-05,1.811E-04,35,"IL-1 alpha, Cyclin D3, MYCT1, JAK1, PP1-cat, ERK1/2, IRF1, STAT1, IL-1 beta, Shc, PI3K reg class IA (p85), NF-E2 (45 kDa), GSK3 beta, PI3K reg class IA, alpha-IIb/beta-3 integrin, LIF, c-MPL, IL-6, NF-kB, AKT(PKB), c-Myc, FLT3 ligand, CXCR4, GAB2, JAK2, PI3K cat class IA, ITGA2B, 14-3-3 zeta/delta, IFN-gamma receptor, 4E-BP1, SHP-2, FOXO3A, STAT5, IL-11, mTOR",4.054E-05,1.747E-04,33,"IL-1 alpha, MYCT1, JAK1, PP1-cat, IFN-gamma, ERK1/2, GATA-1, IRF1, STAT1, IL-1 beta, Shc, PI3K reg class IA (p85), NF-E2 (45 kDa), GSK3 beta, PI3K reg class IA, alpha-IIb/beta-3 integrin, LIF, c-MPL, IL-6, NF-kB, AKT(PKB), FLT3 ligand, CXCR4, GAB2, JAK2, PI3K cat class IA, ITGA2B, 14-3-3 zeta/delta, IFN-gamma receptor, STAT3, STAT5, IL-11, mTOR",
453,Autocrine production of eosinophil pro-survival cytokines in asthma,31,4.162E-05,1.783E-04,5.233E-05,1.957E-04,22,"IL-7 receptor, IL-7, alpha-4/beta-1 integrin, ICAM1, CD44, C5a, ERK1/2, hnRNP C, Fibronectin, IL-15, GM-CSF, IL-13, NF-kB, NF-kB p50/p65, TNF-alpha, PI3K cat class IA, AUF1, VCAM1, IL-5, Pin1, ELAVL1 (HuR), p38 MAPK",4.162E-05,1.783E-04,21,"IL-7 receptor, IL-7, alpha-4/beta-1 integrin, ICAM1, CD44, C5a, ERK1/2, YB-1, Fibronectin, IL-15, GM-CSF, NF-kB, NF-kB p50/p65, TNF-alpha, PI3K cat class IA, AUF1, VCAM1, IL-5, Pin1, ELAVL1 (HuR), p38 MAPK",
454,Immune response_IL-23 signaling pathway,31,4.162E-05,1.783E-04,8.201E-04,1.947E-03,20,"RANKL(TNFSF11), Tyk2, SOCS1, STAT1, Ubiquitin, PI3K reg class IA, STAT4, IKK-alpha, SOCS3, NF-kB, IL-23, AKT(PKB), NF-kB p50/p65, JAK2, PI3K cat class IA, Cul1/Rbx1 E3 ligase, IL23A, STAT5, IL-12 beta, IL-12RB1",4.162E-05,1.783E-04,21,"RANKL(TNFSF11), Tyk2, SOCS1, IL-17, STAT1, Ubiquitin, PI3K reg class IA, STAT4, SOCS3, NF-kB, IL-23, AKT(PKB), NF-kB p50/p65, JAK2, PI3K cat class IA, Cul1/Rbx1 E3 ligase, STAT3, IL23A, STAT5, IL-12 beta, IL-12RB1",
455,Nociception_Nociceptin receptor signaling,76,4.198E-05,1.640E-04,4.198E-05,1.640E-04,44,"JAK1, Kir3.4, ERK1/2, PKA-reg (cAMP-dependent), GRK3, LIMK1, AP-2, Actin, Rac1, IP3 receptor, PLC-beta, cPLA2, Adenylate cyclase, CREB1, MEK1/2, G-protein beta/gamma, Ca(II)channel T-type, NF-kB p50/p65, c-Src, JAK2, cPKC (conventional), G-protein alpha-15, G-protein alpha-12, G-protein alpha-i family, c-Jun, Ca(II)channel N-type, Nociceptin receptor, Ca(II)channel R-type, Ca(II)channel L-type, PDXP, p90Rsk, ROCK, PKC, Oct-2, PKC-alpha, ATF-2, Nociceptin, Prepronociceptin, JNK(MAPK8-10), Ca(II)channel P/Q-type, N-type Ca(II) channel alpha1B, p38 MAPK, PKA-cat (cAMP-dependent), Cofilin",3.016E-04,8.840E-04,39,"JAK1, Kir3.4, ERK1/2, c-Raf-1, GRK3, LIMK1, AP-2, Actin, IP3 receptor, PLC-beta, cPLA2, Adenylate cyclase, CREB1, MEK1/2, G-protein beta/gamma, Ca(II)channel T-type, NF-kB p50/p65, c-Src, JAK2, cPKC (conventional), G-protein alpha-15, G-protein alpha-12, G-protein alpha-i family, Nociceptin receptor, Ca(II)channel R-type, PDXP, p90Rsk, STAT3, ROCK, PKC, Oct-2, Mu-type opioid receptor, PKC-alpha, ATF-2, JNK(MAPK8-10), Ca(II)channel P/Q-type, p38 MAPK, PKA-cat (cAMP-dependent), Cofilin",
456,"Immune response_IL-5 signaling via PI3K, MAPK and NF-kB",76,4.198E-05,1.640E-04,4.198E-05,1.640E-04,44,"ICAM1, ERK1/2, Beta-catenin, PP2A cat (alpha), p47-phox, Syk, Shc, PI3K reg class IA (p85), Bax, GSK3 beta, HVCN1, Calpastatin, cPLA2, MMP-2, MEK1/2, Fyn, NF-kB, AKT(PKB), Calpain 1(mu), NF-kB p50/p65, Mcl-1, PTAFR, PI3K cat class IA, Syntenin 1, ITGB2, PKC-delta, Lyn, TRAF6, IL-5, c-Jun, SOS, Pin1, Fc gamma RII alpha, MEK4(MAP2K4), AP-1, IL5RA, ATF-2, SHP-2, FOXO3A, JNK(MAPK8-10), p38 MAPK, Bim, MMP-9, LPCAT2",3.016E-04,8.840E-04,39,"ICAM1, ERK1/2, Beta-catenin, c-Raf-1, PP2A cat (alpha), p47-phox, Syk, Shc, PI3K reg class IA (p85), Bax, GSK3 beta, HVCN1, Calpastatin, cPLA2, MMP-2, MEK1/2, Fyn, NF-kB, AKT(PKB), Calpain 1(mu), NF-kB p50/p65, Mcl-1, PTAFR, PI3K cat class IA, Syntenin 1, ITGB2, Lyn, TRAF6, IL-5, SOS, Pin1, Fc gamma RII alpha, MEK4(MAP2K4), ATF-2, JNK(MAPK8-10), p38 MAPK, Bim, MMP-9, LPCAT2",
457,T cell generation in COPD,25,4.240E-05,1.791E-04,9.754E-03,1.715E-02,15,"MHC class II, CCL20, Langerin, ICAM1, CCL2, CD28, CCL8, CD4, MHC class I, CTLA-4, CCL19, CCL7, CD8, CD86, CD1c",4.240E-05,1.791E-04,18,"CD1a, MHC class II, CCL20, Langerin, CCL21, ICAM1, CCL2, CD28, CCL8, CD4, MHC class I, CTLA-4, CD80, CCL19, CCL7, CD8, CD86, CD1c",
458,G-protein signaling_TC21 regulation pathway,25,4.240E-05,1.791E-04,1.920E-04,5.792E-04,18,"ERK1/2, RAP-1A, p120GAP, MEK2(MAP2K2), DOK1, c-Src, G-protein alpha-12 family, Lck, B-Raf, CALDAG-GEFI, BCR, C3G, RASA2, DOK2, CalDAG-GEFIII, TC21, Neurofibromin, RASGRF1",4.240E-05,1.791E-04,18,"ERK1/2, c-Raf-1, RAP-1A, p120GAP, MEK2(MAP2K2), DOK1, c-Src, MEK1(MAP2K1), G-protein alpha-12 family, Lck, B-Raf, BCR, RASA2, DOK2, CalDAG-GEFIII, TC21, Neurofibromin, RASGRF1",
459,Bone metastases in Prostate Cancer,29,4.278E-05,1.802E-04,4.804E-05,1.833E-04,21,"CCL2, RANKL(TNFSF11), DKK1, VEGF-A, IBP3, Endothelin-1, LRP5, Osteoprotegerin, c-Src, CXCR4, Osteopontin, Osteocalcin, G-protein alpha-i family, RANK(TNFRSF11A), RUNX2, WNT7B, WNT, PTHrP, MMP-9, Frizzled, EDNRA",4.278E-05,1.802E-04,20,"CCL2, RANKL(TNFSF11), DKK1, VEGF-A, IBP3, Endothelin-1, Osteoprotegerin, c-Src, CXCR4, Osteopontin, Osteocalcin, G-protein alpha-i family, RANK(TNFRSF11A), RUNX2, WNT7B, WNT, PTHrP, MMP-9, Frizzled, EDNRA",
460,Role of IFN-beta in the improvement of blood-brain barrier integrity in multiple sclerosis,27,4.279E-05,1.659E-04,4.279E-05,1.659E-04,20,"TNF-R2, alpha-4/beta-1 integrin, ICAM1, 5'-NTD, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, NF-kB, TNF-R1, TNF-alpha, VCAM1, c-Jun, TIMP1, sVCAM1, AP-1, ITGA4, sICAM1, JNK(MAPK8-10), MMP-9",2.042E-04,6.481E-04,18,"TNF-R2, alpha-4/beta-1 integrin, ICAM1, 5'-NTD, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, NF-kB, TNF-R1, TNF-alpha, VCAM1, TIMP1, sVCAM1, ITGA4, sICAM1, JNK(MAPK8-10), MMP-9",
461,Brca1 in ovarian cancer,27,4.279E-05,1.659E-04,4.279E-05,1.659E-04,20,"Maspin, PML, ICAD, BACH1, Ubiquitin, Bax, c-IAP1, Caspase-3, AKT(PKB), RBBP8 (CtIP), Bard1, RAP80, Brca1, PARP-1, NF-kB1 (p105), XIAP, c-Jun, GPR56, Brca1/Bard1, p53",2.042E-04,6.481E-04,18,"Maspin, PML, ICAD, BACH1, Ubiquitin, Bax, c-IAP1, Caspase-3, AKT(PKB), RBBP8 (CtIP), Bard1, RAP80, Brca1, NF-kB1 (p105), XIAP, GPR56, Brca1/Bard1, p53",
462,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/IAP pathway,27,4.279E-05,1.659E-04,4.279E-05,1.659E-04,20,"TNF-R2, DR3(TNFRSF12), I-kB, Survivin, IKK-alpha, c-IAP1, CD30(TNFRSF8), RIPK1, BCMA(TNFRSF17), NF-kB, TNF-R1, TNF-alpha, c-IAP2, RelA (p65 NF-kB subunit), APRIL(TNFSF13), TRAF3, XIAP, NIK(MAP3K14), CD30L (TNFSF8), TACI(TNFRSF13B)",2.042E-04,6.481E-04,18,"TNF-R2, DR3(TNFRSF12), I-kB, Survivin, c-IAP1, CD30(TNFRSF8), RIPK1, BCMA(TNFRSF17), NF-kB, TNF-R1, TNF-alpha, c-IAP2, RelA (p65 NF-kB subunit), APRIL(TNFSF13), TRAF3, XIAP, NIK(MAP3K14), TACI(TNFRSF13B)",
463,HCV-dependent regulation of membrane receptors signaling in HCC,27,4.312E-05,1.806E-04,8.441E-04,1.992E-03,18,"ERK1/2, IL-1 beta, I-kB, Shc, TGF-alpha, ERK2 (MAPK1), NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, LTBR(TNFRSF3), EGFR, c-Jun, SOS, ATF-2, TNF-beta, LTB, Elk-1",4.312E-05,1.806E-04,19,"ERK1/2, c-Raf-1, IL-1 beta, I-kB, Shc, TGF-alpha, ERK2 (MAPK1), NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, MEK1(MAP2K1), LTBR(TNFRSF3), EGFR, SOS, ATF-2, TNF-beta, LTB, Elk-1",
464,Immune response_CD137 signaling in immune cell,29,4.804E-05,1.833E-04,4.804E-05,1.833E-04,21,"ERK1/2, BFL1, ATF-2/c-Jun, Cyclin D2, IKK-alpha, NF-kB, IL-2, ASK1 (MAP3K5), MEK3(MAP2K3), c-Jun, NIK(MAP3K14), CD137(TNFRSF9), JNK1(MAPK8), MEK4(MAP2K4), MEKK1(MAP3K1), ATF-2, TRAF1, Cyclin E, CD137 ligand(TNFSF9), p38 MAPK, Bim",1.918E-04,6.167E-04,19,"IFN-gamma, ERK1/2, BFL1, Cyclin D2, NF-kB, IL-2, MEK1(MAP2K1), ASK1 (MAP3K5), MEK3(MAP2K3), NIK(MAP3K14), CD137(TNFRSF9), JNK1(MAPK8), MEK4(MAP2K4), ATF-2, TRAF1, Cyclin E, CD137 ligand(TNFSF9), p38 MAPK, Bim",
465,Role of IFN-beta in activation of T cell apoptosis in multiple sclerosis,29,4.804E-05,1.833E-04,4.804E-05,1.833E-04,21,"DR5(TNFRSF10B), c-FLIP(Long), 5'-NTD, Apo-2L(TNFSF10), IFN-alpha/beta receptor, PP2A cat (alpha), IFN-beta, Survivin, c-IAP1, Caspase-3, CTLA-4, FasL(TNFSF6), AKT(PKB), DR4(TNFRSF10A), c-IAP2, XIAP, PP2A catalytic, Caspase-9, Caspase-7, FasR(CD95), c-FLIP(Short)",1.918E-04,6.167E-04,19,"DR5(TNFRSF10B), c-FLIP(Long), 5'-NTD, Apo-2L(TNFSF10), IFN-alpha/beta receptor, PP2A cat (alpha), IFN-beta, Survivin, c-IAP1, Caspase-3, CTLA-4, AKT(PKB), DR4(TNFRSF10A), c-IAP2, XIAP, PP2A catalytic, Caspase-9, FasR(CD95), c-FLIP(Short)",
466,Immune response_CD28 signaling,55,4.933E-05,1.873E-04,4.933E-05,1.873E-04,34,"Calcineurin A (catalytic), NF-AT1(NFATC2), CD28, VAV-1, Rac1, IP3 receptor, BAD, I-kB, PI3K reg class IA (p85), GSK3 beta, PKC-theta, ZAP70, IKK-alpha, PLC-gamma 1, ITK, Fyn, NF-kB, AKT(PKB), NF-AT2(NFATC1), PI3K cat class IA, Lck, Slp76, c-Jun, MKK7 (MAP2K7), LAT, GRAP2, NF-AT, MEK4(MAP2K4), Calmodulin, MEKK1(MAP3K1), CD3, JNK(MAPK8-10), p38 MAPK, CD86",2.291E-02,3.681E-02,25,"Calcineurin A (catalytic), CD28, VAV-1, IP3 receptor, I-kB, PI3K reg class IA (p85), GSK3 beta, PKC-theta, PLC-gamma 1, Fyn, NF-kB, AKT(PKB), NF-AT2(NFATC1), CD80, PI3K cat class IA, Lck, Slp76, GRAP2, NF-AT, MEK4(MAP2K4), Calmodulin, CD3, JNK(MAPK8-10), p38 MAPK, CD86",
467,Oxidative stress_Role of ASK1 under oxidative stress,55,4.933E-05,1.873E-04,4.933E-05,1.873E-04,34,"PLD1, SOD2, 14-3-3, SOK-1, SOD1, Gemin5, JKAP, MEKK6(MAP3K6), c-Src, KLD10, Thioredoxin, PKC-delta, MT-TRX, ASK1 (MAP3K5), DAPK1, 14-3-3 zeta/delta, TRAF6, MEK3(MAP2K3), DYRK1a, DAXX, 14-3-3 gamma, PP2A catalytic, MKK7 (MAP2K7), PRDX1, JNK1(MAPK8), MEK4(MAP2K4), USP9X, c-Abl, ZPR9, MAPK8/9, JNK(MAPK8-10), JNK2(MAPK9), HPK38, p38 MAPK",2.401E-03,5.055E-03,28,"PLD1, SOD2, 14-3-3, SOK-1, JKAP, MEKK6(MAP3K6), c-Src, KLD10, ASK1 (MAP3K5), DAPK1, 14-3-3 zeta/delta, TRAF6, MEK3(MAP2K3), DYRK1a, DAXX, 14-3-3 gamma, PP2A catalytic, JNK1(MAPK8), MEK4(MAP2K4), USP9X, Glutaredoxin, c-Abl, ZPR9, MAPK8/9, JNK(MAPK8-10), JNK2(MAPK9), HPK38, p38 MAPK",
468,Effect of H. pylori infection on apoptosis in gastric epithelial cells,53,5.161E-05,1.945E-04,5.161E-05,1.945E-04,33,"MHC class II, ICAD, Caspase-6, Apaf-1, Lamin A/C, Bak, Caspase-8, I-kB, p73, Bax, c-IAP1, Caspase-3, DFF40 (CAD), Lamin B, FasL(TNFSF6), NF-kB, TNF-R1, Caspase-1, Mcl-1, PPAR-gamma, PTPR-zeta, TNF-alpha, c-IAP2, PARP-1, PGES, Caspase-9, COX-2 (PTGS2), PTPR-alpha, tBid, FasR(CD95), c-Abl, NOXA, Bid",1.584E-04,5.334E-04,30,"MHC class II, ICAD, Caspase-6, Apaf-1, Lamin A/C, Caspase-8, I-kB, p73, Bax, c-IAP1, Caspase-3, DFF40 (CAD), Lamin B, NF-kB, TNF-R1, Caspase-1, Mcl-1, PPAR-gamma, PTPR-zeta, TNF-alpha, c-IAP2, PGES, Caspase-9, COX-2 (PTGS2), PTPR-alpha, tBid, FasR(CD95), c-Abl, NOXA, Bid",
469,IL-6 signaling in breast cancer cells,53,5.161E-05,1.945E-04,5.161E-05,1.945E-04,33,"IP10, JAK1, ERK1/2, Vimentin, Carbonic anhydrase IX, MDR1, STAT1, Shc, Survivin, PI3K reg class IA, CYP19, IL-6, MEK1/2, TWIST1, AKT(PKB), c-Myc, Mcl-1, N-cadherin, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB1 (p50), C/EBPbeta, SOS, SHP-2, Fascin, S100A7, AKT2, SNAIL1, Jagged1, Tensin 4, NOTCH3, C/EBPdelta",5.259E-05,2.184E-04,31,"IP10, JAK1, ERK1/2, c-Raf-1, Vimentin, Carbonic anhydrase IX, MDR1, STAT1, Shc, Survivin, PI3K reg class IA, IL-6, MEK1/2, TWIST1, AKT(PKB), Mcl-1, N-cadherin, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB1 (p50), C/EBPbeta, SOS, STAT3, Fascin, S100A7, SNAIL1, Jagged1, Tensin 4, NOTCH3, C/EBPdelta",
470,TLRs-mediated IFN-alpha production by plasmacytoid dendritic cells in SLE,53,5.161E-05,1.945E-04,5.161E-05,1.945E-04,33,"HMGB1, La protein, Ro60, Pim-1, Ro52, IRAK4, MyD88, TIAF1, IKK-alpha, IFN-alpha, AKT(PKB), TLR9, TAK1(MAP3K7), SNRPB (Sm-B), PI3K reg class IA (p85-alpha), TRAF6, IRAK2, NIK(MAP3K14), Fc gamma RII alpha, SNRPD1 (SMD1), A20, PI3K cat class IA (p110-delta), TAB3, RAGE, 4E-BP1, IRAK1, SLC15A4, TAB1, IRF7, TLR7, CDC37, Alpha-defensin, mTOR",4.438E-04,1.193E-03,29,"HMGB1, La protein, Ro60, Pim-1, RNU1-1, Ro52, IRAK4, IFN-alpha, AKT(PKB), TLR9, TAK1(MAP3K7), SNRPB (Sm-B), PI3K reg class IA (p85-alpha), TRAF6, IRAK2, NIK(MAP3K14), Fc gamma RII alpha, SNRPD1 (SMD1), A20, PI3K cat class IA (p110-delta), TAB3, RAGE, IRAK1, SLC15A4, IRF7, TLR7, CDC37, Alpha-defensin, mTOR",
471,Apoptosis and survival_Role of IAP-proteins in apoptosis,31,5.233E-05,1.957E-04,5.233E-05,1.957E-04,22,"Caspase-6, Apaf-1, Caspase-8, CDK1 (p34), Ubiquitin, Bax, Survivin, c-IAP1, Caspase-3, FasL(TNFSF6), Cyclin B1, HSP70, TNF-R1, TNF-alpha, c-IAP2, XIAP, Caspase-9, Caspase-7, tBid, FasR(CD95), HtrA2, Bid",1.780E-04,5.836E-04,20,"Caspase-6, Apaf-1, Caspase-8, CDK1 (p34), Ubiquitin, Bax, Survivin, c-IAP1, Caspase-3, Cyclin B1, HSP70, TNF-R1, TNF-alpha, c-IAP2, XIAP, Caspase-9, tBid, FasR(CD95), HtrA2, Bid",
472,Development_Embryonal epaxial myogenesis,31,5.233E-05,1.957E-04,5.233E-05,1.957E-04,22,"NOTCH1 receptor, WNT3A, FZD6, BMP4, Lef-1, Beta-catenin, MYF6, KIF27, Smoothened, WNT11, PTCH1, WNT1, Noggin, GLI-3, HES1, WNT, Pitx2, FZD1, GLI-1, SMAD3, Frizzled, WNT6",2.210E-03,4.762E-03,18,"NOTCH1 receptor, FZD6, BMP4, Beta-catenin, MYF6, Smoothened, WNT11, PTCH1, Noggin, GLI-3, HES1, WNT, Pitx2, FZD1, GLI-1, SMAD3, Frizzled, WNT6",
473,Development_Role of growth factors in the maintenance of embryonic stem cell pluripotency,53,5.259E-05,2.184E-04,1.134E-03,2.623E-03,30,"TGF-beta 1, FGFR2, Oct-3/4, IRS-1, ROCK1, ERK1/2, SMAD4, SMAD2, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, IGF-2, Caspase-3, MEK2(MAP2K2), ActRIIA, AKT(PKB), PI3K cat class IA, Activin A, NODAL, TGF-beta receptor type II, Myosin II, FGF2, SOS, Caspase-9, ROCK, SHP-2, ActRIIB, SMAD3, Bim, TGF-beta receptor type I",5.259E-05,2.184E-04,31,"TGF-beta 1, FGFR2, Oct-3/4, Neuregulin 1, ROCK1, ERK1/2, c-Raf-1, SMAD4, SMAD2, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, IGF-2, Caspase-3, MEK2(MAP2K2), ActRIIA, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, Activin A, NODAL, TGF-beta receptor type II, Myosin II, FGF2, SOS, Caspase-9, ROCK, ActRIIB, SMAD3, Bim, TGF-beta receptor type I",
474,GLP-1 in inhibition of beta cell proliferation and function in type 2 diabetes,42,5.498E-05,2.265E-04,1.126E-04,3.660E-04,27,"GLUT2, IRS-2, TCF7L2 (TCF4), ERK1/2, GLP-1 (7-36) amide, PKC-zeta, Beta-catenin, EGR1, PKA-reg (cAMP-dependent), GLP-1 receptor, HNF3-beta, RAP-1A, Cyclin A2, FKHR, IGF-2, CREB1, MEK1/2, GLP-1 (7-37), ADAM10, c-Src, B-Raf, Pdx-1 (IPF1), EGFR, HXK4, PKA-cat (cAMP-dependent), SRF, Betacellulin",5.498E-05,2.265E-04,26,"GLUT2, IRS-2, TCF7L2 (TCF4), ERK1/2, GLP-1 (7-36) amide, Beta-catenin, c-Raf-1, GLP-1 receptor, HNF3-beta, RAP-1A, Cyclin A2, FKHR, IGF-2, CREB1, MEK1/2, GLP-1 (7-37), ADAM10, c-Src, B-Raf, Pdx-1 (IPF1), EGFR, p90RSK1, HXK4, PKA-cat (cAMP-dependent), SRF, Betacellulin",
475,Growth factors in regulation of oligodendrocyte precursor cells survival in multiple sclerosis,42,5.498E-05,2.265E-04,1.126E-04,3.660E-04,27,"NGFR(TNFRSF16), IRS-1, PDGF-R-alpha, BAD, PI3K reg class IA (p85), Bax, PI3K reg class IA, IKK-alpha, Caspase-3, Fyn, AKT(PKB), IBP, TNF-alpha, 14-3-3 epsilon, PI3K cat class IA, RelA (p65 NF-kB subunit), Lyn, 14-3-3 zeta/delta, PDGF-A, ErbB4, Caspase-9, p90Rsk, 4E-BP1, NGF, 14-3-3 beta/alpha, JNK(MAPK8-10), mTOR",5.498E-05,2.265E-04,26,"NGFR(TNFRSF16), Neuregulin 1, IFN-gamma, c-Raf-1, PDGF-R-alpha, PI3K reg class IA (p85), Bax, PI3K reg class IA, Caspase-3, Fyn, AKT(PKB), IBP, TNF-alpha, 14-3-3 epsilon, CD80, PI3K cat class IA, RelA (p65 NF-kB subunit), Lyn, 14-3-3 zeta/delta, PDGF-A, ErbB4, Caspase-9, p90Rsk, NGF, JNK(MAPK8-10), mTOR",
476,G-protein signaling_Regulation of CDC42 activity,33,5.565E-05,2.049E-04,5.565E-05,2.049E-04,23,"Zizimin 1, Rich1, ABR, FGD1, NIP2, p120GAP, DEF6, Caspase-3, CDC42, Fyn, Caspase-1, DOCK11, BCR, RhoGDI gamma, Frabin, CDGAP, RhoGAP5, B-chimaerin, RhoGDI alpha, RhoGDI beta, RHG7, RalBP1, ECT2",5.538E-03,1.038E-02,18,"Rich1, ABR, FGD1, NIP2, p120GAP, DEF6, Caspase-3, CDC42, Fyn, Caspase-1, DOCK11, BCR, CDGAP, RhoGAP5, RhoGDI alpha, RHG7, RalBP1, ECT2",
477,Apoptosis and survival_Granzyme B signaling,33,5.565E-05,2.049E-04,5.565E-05,2.049E-04,23,"ICAD, Caspase-6, Apaf-1, Lamin A/C, Caspase-8, Perforin, Caspase-3, LAMP2, DFF40 (CAD), Caspase-2, Mcl-1, Rab-27A, PARP-1, ROCK2, Caspase-9, LAMP1, Caspase-10, Caspase-7, Tubulin alpha, tBid, Lamin B1, NOTCH1 (NEXT), Bid",5.944E-04,1.514E-03,20,"ICAD, Caspase-6, Apaf-1, Lamin A/C, Caspase-8, Caspase-3, LAMP2, DFF40 (CAD), Caspase-2, Mcl-1, Rab-27A, ROCK2, Caspase-9, LAMP1, Caspase-10, Tubulin alpha, tBid, Lamin B1, NOTCH1 (NEXT), Bid",
478,Tissue Factor signaling in cancer via PAR1 and PAR2,49,5.574E-05,2.049E-04,5.574E-05,2.049E-04,31,"STAT5A, PAR2, ERK1/2, EGR1, VEGF-A, Coagulation factor X, G-protein alpha-q/11, STAT5B, PLC-beta1, IP3 receptor, Beta-arrestin2, Shc, PI3K reg class IA, MEK2(MAP2K2), TGF-alpha, AKT(PKB), Pyk2(FAK2), JAK2, G-protein alpha-12 family, PI3K cat class IA, IL-8, EGFR, c-Jun, YES, SOS, Tissue factor, PKC-alpha, SHP-2, PAR1, ADAM17, mTOR",6.773E-05,2.708E-04,29,"STAT5A, PAR2, ERK1/2, VEGF-A, Coagulation factor X, c-Raf-1, G-protein alpha-q/11, STAT5B, IP3 receptor, Beta-arrestin2, Shc, PI3K reg class IA, MEK2(MAP2K2), TGF-alpha, AKT(PKB), MEK1(MAP2K1), Pyk2(FAK2), JAK2, G-protein alpha-12 family, PI3K cat class IA, IL-8, EGFR, YES, SOS, Tissue factor, PKC-alpha, PAR1, ADAM17, mTOR",
479,Immune response_TREM1 signaling pathway,60,5.707E-05,2.344E-04,5.287E-04,1.332E-03,34,"Calcineurin A (catalytic), NF-AT1(NFATC2), CCL2, ERK1/2, IP3 receptor, BAD, Syk, Ubiquitin, IL-1 beta, I-kB, Bax, PI3K reg class IA, IKK-alpha, GM-CSF, MEK2(MAP2K2), IL-6, AKT(PKB), NF-kB p50/p65, IL-2, TNF-alpha, PI3K cat class IA, c-Cbl, IL-8, SOS1, DAP12, MALT1, TLR4, PLC-gamma, Bcl-10, Calcineurin B (regulatory), IL-12 beta, Elk-1, TLR2, WBSCR5(NTAL)",5.707E-05,2.344E-04,34,"Calcineurin A (catalytic), CCL2, ERK1/2, c-Raf-1, IP3 receptor, Syk, Ubiquitin, IL-1 beta, I-kB, Bax, PI3K reg class IA, GM-CSF, MEK2(MAP2K2), IL-6, AKT(PKB), NF-kB p50/p65, IL-2, TNF-alpha, MEK1(MAP2K1), PI3K cat class IA, c-Cbl, IL-8, p90RSK1, SOS1, DAP12, MALT1, TLR4, PLC-gamma, Bcl-10, Calcineurin B (regulatory), IL-12 beta, Elk-1, TLR2, WBSCR5(NTAL)",
480,Canonical Leptin pathways in breast cancer,47,5.746E-05,2.081E-04,5.746E-05,2.081E-04,30,"IL-1 alpha, IRS-2, IRS-1, ERK1/2, Beta-catenin, VEGF-A, VEGFR-2, IL-1 beta, I-kB, GSK3 beta, Survivin, PI3K reg class IA, CYP19, MEK1/2, NF-kB, AKT(PKB), NF-kB p50/p65, c-Myc, Axin, TERT, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), HIF1A, Tcf(Lef), c-Jun, SOS, Leptin receptor, SHP-2, mTOR",2.401E-04,7.280E-04,27,"IL-1 alpha, IRS-2, ERK1/2, Beta-catenin, VEGF-A, c-Raf-1, VEGFR-2, IL-1 beta, I-kB, GSK3 beta, Survivin, PI3K reg class IA, MEK1/2, NF-kB, AKT(PKB), NF-kB p50/p65, Axin, TERT, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), HIF1A, Tcf(Lef), SOS, Leptin receptor, STAT3, mTOR",
481,"Development_TNF-alpha, IL-1 alpha and WNT5A-dependent regulation of osteogenesis and adipogenesis in mesenchymal stem cells",47,5.746E-05,2.081E-04,5.746E-05,2.081E-04,30,"IL-1 alpha, RANKL(TNFSF11), 14-3-3, HDAC3, IP3 receptor, FZD2, PLC-beta, IKK-alpha, G-protein beta/gamma, TAZ, TNF-R1, PPAR-gamma, TAK1(MAP3K7), TNF-alpha, RhoA, Osteopontin, ROCK2, Osteocalcin, TRAF6, c-Jun, ALPL, NIK(MAP3K14), 14-3-3 beta/alpha, WNT5A, Calmodulin, RUNX2, TAB1, IRAK1/2, JNK(MAPK8-10), Filamin A",2.401E-04,7.280E-04,27,"IL-1 alpha, RANKL(TNFSF11), 14-3-3, HDAC3, IP3 receptor, FZD2, PLC-beta, G-protein beta/gamma, TAZ, TNF-R1, PPAR-gamma, TAK1(MAP3K7), TNF-alpha, RhoA, Osteopontin, ROCK2, Osteocalcin, TRAF6, ALPL, NIK(MAP3K14), WNT5A, Calmodulin, RUNX2, LXR-alpha, IRAK1/2, JNK(MAPK8-10), Filamin A",
482,Development_WNT5A signaling,47,5.746E-05,2.081E-04,5.746E-05,2.081E-04,30,"Calcineurin A (catalytic), NF-AT1(NFATC2), Beta-catenin, FZD4, Dsh, PI3K reg class IA (p85), GSK3 beta, FZD2, PDE6 reg, PLC-beta, LRP5, G-protein beta/gamma, CDC42, Axin, TAK1(MAP3K7), MLK3(MAP3K11), Tcf(Lef), c-Jun, MKK7 (MAP2K7), MEK4(MAP2K4), WNT5A, Calmodulin, PKC-alpha, ATF-2, G-protein alpha-t2, FZD5, JNK(MAPK8-10), Filamin A, PDE6 cat, Calcineurin B (regulatory)",6.934E-04,1.739E-03,26,"Calcineurin A (catalytic), Beta-catenin, Dsh, PI3K reg class IA (p85), GSK3 beta, FZD2, PDE6 reg, PLC-beta, G-protein beta/gamma, CDC42, Axin, TAK1(MAP3K7), MLK3(MAP3K11), Tcf(Lef), MEK4(MAP2K4), WNT5A, Calmodulin, PKC-alpha, ATF-2, G-protein alpha-t2, FZD5, JNK(MAPK8-10), Filamin A, PDE6 cat, Calcineurin B (regulatory), IRAG",
483,NALP3 inflammasome activation in age-related macular degeneration (AMD),35,5.804E-05,2.082E-04,5.804E-05,2.082E-04,24,"IL-18R1, CCL20, IL-1 alpha, Caspase-8, CARD8, Ubiquitin, IL-1 beta, Caspase-3, IL-6, P2X7, VDAC 1, FasL(TNFSF6), NF-kB, BRCC36, Caspase-1, TNF-alpha, Thioredoxin, Dicer, RelA (p65 NF-kB subunit), IL-18, Cathepsin B, Amyloid beta 40, TLR2, NALP3",1.666E-03,3.717E-03,20,"IL-18R1, CCL20, IL-1 alpha, Caspase-8, Ubiquitin, IL-1 beta, Caspase-3, IL-6, P2X7, VDAC 1, NF-kB, BRCC36, Caspase-1, TNF-alpha, RelA (p65 NF-kB subunit), IL-18, Cathepsin B, Amyloid beta 40, TLR2, NALP3",
484,Immune response_Histamine signaling in dendritic cells,51,5.975E-05,2.434E-04,4.695E-04,1.201E-03,30,"Histamine H4 receptor, NF-AT1(NFATC2), CCL2, IL-10, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, IL-1 beta, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, IL-6, G-protein beta/gamma, IL-23, ERK2 (MAPK1), NF-kB p50/p65, NF-AT2(NFATC1), TNF-alpha, RelA (p65 NF-kB subunit), CREM (repressors), PKA-cat alpha, IL-8, G-protein alpha-i family, Histamine H2 receptor, Histamine H1 receptor, PKC-alpha, IL-12 beta, PKA-cat (cAMP-dependent), CD86",5.975E-05,2.434E-04,30,"IRF8, CCL2, IL-10, c-Raf-1, G-protein alpha-q/11, IP3 receptor, IL-1 beta, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, IL-6, G-protein beta/gamma, IL-23, ERK2 (MAPK1), NF-kB p50/p65, NF-AT2(NFATC1), TNF-alpha, MEK1(MAP2K1), RelA (p65 NF-kB subunit), CREM (repressors), PKA-cat alpha, IL-8, G-protein alpha-i family, Histamine H2 receptor, Histamine H1 receptor, PKC-alpha, IL-12 beta, PKA-cat (cAMP-dependent), CD86",
485,Development_WNT/Beta-catenin signaling pathway. Signalosome,43,5.987E-05,2.118E-04,5.987E-05,2.118E-04,28,"Casein kinase I delta, CDK14, GRK6, Casein kinase I epsilon, DAAM2, Dsh, Cyclin Y, Caprin-2, GSK3 beta, Tmem198, PI4KII, GSK3 alpha/beta, Axin, LRP5/LRP6, G-protein alpha-i family, Amer1, Casein kinase I gamma 1, PP2A catalytic, G-protein beta1/gamma2, PPP2R5E, Schwannomin (NF2), GRK5, WNT, DDX3X, LRP6, G-protein alpha-q, p120-catenin, Frizzled",6.292E-03,1.161E-02,22,"CDK14, GRK6, Casein kinase I epsilon, DAAM2, Dsh, Cyclin Y, Caprin-2, GSK3 beta, Tmem198, PI4KII, GSK3 alpha/beta, Axin, G-protein alpha-i family, Amer1, PP2A catalytic, G-protein beta1/gamma2, Schwannomin (NF2), GRK5, WNT, DDX3X, LRP6, Frizzled",
486,Transcription_p53 signaling pathway,39,6.032E-05,2.118E-04,6.032E-05,2.118E-04,26,"Core histone deacetylase I complex, CBP, p14ARF, Beta-catenin, VEGF-A, XPC, VEGFR-2, PIAS1, PCAF, MMP-2, NF-kB, SUMO-1, PIAS2, ATR, p300, RanBP2, MTA2, MEK4(MAP2K4), CDK2, MAP4, FHL2, MEKK1(MAP3K1), ATM, JNK(MAPK8-10), p53, APEX",4.092E-04,1.131E-03,23,"Core histone deacetylase I complex, CBP, p14ARF, Beta-catenin, VEGF-A, VEGFR-2, PIAS1, PCAF, MMP-2, NF-kB, SUMO-1, PIAS2, ATR, p300, RanBP2, MEK4(MAP2K4), CDK2, MAP4, FHL2, ATM, JNK(MAPK8-10), p53, APEX",
487,Neurophysiological process_Activity-dependent synaptic AMPA receptor removal,64,6.483E-05,2.271E-04,6.483E-05,2.271E-04,38,"mGluR1, NSF, Calcineurin A (catalytic), AP complex 2 medium (mu) chain, mGluR5, PP1-cat, ATAD1, AKAP5, DRD1IP, Dynamin-2, NPTX1, IP3 receptor, PLC-beta, AP-2 alpha subunits, Actin cytoskeletal, NAPB, Endophilin A3, cPKC (conventional), MAP-1B, FMR1, NPTX2, eEF2K, PP2A catalytic, Clathrin light chain, GRIP, Calmodulin, PKC, PKC-alpha, GluR1, Beta-adaptin 2, PSD-95, G-protein alpha-q, RalA, RalBP1, Calcineurin B (regulatory), ADAM17, Neuronal pentraxin receptor, Nesprin 1",3.900E-03,7.672E-03,31,"mGluR1, Calcineurin A (catalytic), AP complex 2 medium (mu) chain, mGluR5, PP1-cat, ATAD1, AKAP5, Dynamin-2, NPTX1, IP3 receptor, PLC-beta, AP-2 alpha subunits, Actin cytoskeletal, NAPB, cPKC (conventional), MAP-1B, FMR1, NPTX2, PP2A catalytic, Clathrin light chain, Calmodulin, PKC, PKC-alpha, Beta-adaptin 2, HPCA, PSD-95, RalBP1, Calcineurin B (regulatory), ADAM17, Neuronal pentraxin receptor, Nesprin 1",
488,Cell adhesion_Integrin inside-out signaling,58,6.552E-05,2.647E-04,7.855E-05,2.733E-04,35,"ERK1/2, G-protein alpha-q/11, Angiotensin II, Fibronectin, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, Thrombin, PLC-beta, alpha-IIb/beta-3 integrin, alpha-V/beta-3 integrin, G-protein beta/gamma, Actin cytoskeletal, ERK2 (MAPK1), Cytohesin1, c-Src, CXCR4, ITGB1, G-protein alpha-12 family, ITGB2, ITGA2B, ITGB3, G-protein alpha-i family, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, TBXA2R, NRIF3, Calmodulin, alpha-2/beta-1 integrin, PAR1, Cytohesin3, Fibrinogen (fibrin), ICAP-1, Collagen I",6.552E-05,2.647E-04,33,"ERK1/2, G-protein alpha-q/11, Angiotensin II, Fibronectin, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, PLC-beta, alpha-IIb/beta-3 integrin, alpha-V/beta-3 integrin, G-protein beta/gamma, Actin cytoskeletal, ERK2 (MAPK1), Cytohesin1, c-Src, CXCR4, ITGB1, G-protein alpha-12 family, ITGB2, ITGA2B, ITGB3, G-protein alpha-i family, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, TBXA2R, NRIF3, Calmodulin, alpha-2/beta-1 integrin, PAR1, Cytohesin3, ICAP-1, Collagen I",
489,Development_Role of IL-8 in angiogenesis,65,6.736E-05,2.700E-04,2.695E-04,7.621E-04,37,"VE-cadherin, ERK1/2, HB-EGF, S2P, VEGF-A, VEGFR-2, PI3K cat class IB (p110-gamma), Rac1, Ubiquitin, I-kB, PI3K reg class IA (p85), LDLR, HMDH, G-protein beta/gamma, NF-kB, AKT(PKB), c-Src, RhoA, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), IL-8, EGFR, G-protein alpha-i family, SREBP2 (nuclear), SREBP2 precursor, S1P, Cathepsin B, Paxillin, CARD11, MALT1, SREBP2 (Golgi membrane), MMP-14, Bcl-10, Caveolin-1, PI3K reg class IB (p101), Elk-1",6.736E-05,2.700E-04,36,"VE-cadherin, ERK1/2, HB-EGF, S2P, VEGF-A, VEGFR-2, PI3K cat class IB (p110-gamma), Ubiquitin, I-kB, PI3K reg class IA (p85), LDLR, HMDH, G-protein beta/gamma, NF-kB, AKT(PKB), c-Src, MEK1(MAP2K1), RhoA, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), IL-8, EGFR, G-protein alpha-i family, SREBP2 (nuclear), SREBP2 precursor, S1P, Cathepsin B, CARD11, STAT3, MALT1, SREBP2 (Golgi membrane), MMP-14, Bcl-10, Caveolin-1, Elk-1",
490,Mitogenic action of ESR1 (membrane) in breast cancer,47,7.661E-05,3.014E-04,5.414E-04,1.361E-03,28,"CRM1, ERK1/2, HB-EGF, SGK1, TOPBP1, STAT5B, Shc, Chk1, p120GAP, GSK3 beta, MMP-2, MEK1/2, ERK2 (MAPK1), AKT(PKB), c-Src, c-Myc, PI3K reg class IA (p85-alpha), EGFR, SOS, ATR, Calpain 2(m), p130CAS, PI3K cat class IA (p110-alpha), Cyclin E, Claspin, Elk-1, MMP-9, SRF",7.661E-05,3.014E-04,28,"CRM1, ERK1/2, HB-EGF, SGK1, c-Raf-1, TOPBP1, STAT5B, Shc, Chk1, p120GAP, GSK3 beta, MMP-2, MEK1/2, ERK2 (MAPK1), AKT(PKB), c-Src, PI3K reg class IA (p85-alpha), EGFR, SOS, ATR, Calpain 2(m), p130CAS, PI3K cat class IA (p110-alpha), Cyclin E, Claspin, Elk-1, MMP-9, SRF",
491,Transcription_Sirtuin6 regulation and functions ,63,7.780E-05,3.053E-04,1.113E-04,3.659E-04,37,"NRF1, USP10, ICAM1, SOD2, AMPK beta subunit, ATF-4, AMPK gamma subunit, S2P, KPYR, GPIAP1, Ubiquitin, HMGCS1, FKHR, LDLR, PDK4, HMDH, PPARGC1 (PGC1-alpha), ALDOC, c-IAP2, RelA (p65 NF-kB subunit), PARP-1, HIF1A, DNA-PK, AMPK alpha subunit, ELOVL6, G3BP1 (hdhVIII), LDHB, Ihh, SREBP2 (nuclear), SREBP2 precursor, S1P, PPCKC, SREBP2 (Golgi membrane), FOXO3A, SMARCA5, HXK4, LDHA",7.780E-05,3.053E-04,35,"NRF1, USP10, ICAM1, SOD2, AMPK beta subunit, AMPK gamma subunit, S2P, KPYR, GPIAP1, Ubiquitin, FKHR, LDLR, PDK4, HMDH, PPARGC1 (PGC1-alpha), ALDOC, c-IAP2, RelA (p65 NF-kB subunit), HIF1A, G6PT, DNA-PK, AMPK alpha subunit, ELOVL6, G3BP1 (hdhVIII), LDHB, Ihh, SREBP2 (nuclear), SREBP2 precursor, S1P, PPCKC, SREBP2 (Golgi membrane), SMARCA5, HXK4, LDHA, miR-33b-5p",
492,Effect of H. pylori infection on gastric epithelial cell proliferation,58,7.855E-05,2.733E-04,7.855E-05,2.733E-04,35,"Calcineurin A (catalytic), ERK1/2, HB-EGF, CrkL, EGR1, CRK, Rac1, IP3 receptor, RAP-1A, NF-AT4(NFATC3), MEK2(MAP2K2), CREB1, Skp2/TrCP/FBXW, SKP2, c-Src, c-Myc, MEKK4(MAP3K4), B-Raf, Lyn, EGFR, c-Jun, SOS1, Csk, C3G, Cul1/Rbx1 E3 ligase, MEK4(MAP2K4), AP-1, SHP-2, TLR4, PLC-gamma, c-Abl, HDAC1, p53, HGF receptor (Met), Calcineurin B (regulatory)",1.228E-03,2.834E-03,30,"p38alpha (MAPK14), Calcineurin A (catalytic), ERK1/2, HB-EGF, CrkL, CRK, c-Raf-1, IP3 receptor, RAP-1A, NF-AT4(NFATC3), MEK2(MAP2K2), CREB1, Skp2/TrCP/FBXW, SKP2, c-Src, MEK1(MAP2K1), B-Raf, Lyn, EGFR, SOS1, Csk, Cul1/Rbx1 E3 ligase, MEK4(MAP2K4), TLR4, PLC-gamma, c-Abl, HDAC1, p53, HGF receptor (Met), Calcineurin B (regulatory)",
493,Development_Role of proteases in hematopoietic stem cell mobilization,18,7.950E-05,3.095E-04,2.761E-04,7.765E-04,14,"alpha-4/beta-1 integrin, CD44, DPP4, Fibronectin, c-Kit, MMP-2, CXCR4, Cathepsin G, VCAM1, Leukocyte elastase, alpha-5/beta-1 integrin, Carboxypeptidase M, MMP-14, MMP-9",7.950E-05,3.095E-04,14,"alpha-4/beta-1 integrin, CD44, DPP4, Fibronectin, c-Kit, MMP-2, CXCR4, Cathepsin G, VCAM1, Leukocyte elastase, alpha-5/beta-1 integrin, Carboxypeptidase M, MMP-14, MMP-9",
494,Hedgehog signaling in breast cancer,24,8.019E-05,2.764E-04,8.019E-05,2.764E-04,18,"Cyclin D3, VEGF-A, Smoothened, MDR1, GLI-2, Cyr61, MMP-2, DHH, Osteopontin, PTCH1, XIAP, Ihh, Cyclin E, PTHrP, MMP-11, GLI-1, p53, MMP-9",9.733E-05,3.506E-04,17,"VEGF-A, Smoothened, MDR1, GLI-2, Cyr61, MMP-2, DHH, Osteopontin, PTCH1, XIAP, Ihh, Cyclin E, PTHrP, MMP-11, GLI-1, p53, MMP-9",
495,Proteolysis_Role of Parkin in the Ubiquitin-Proteasomal Pathway,24,8.019E-05,2.764E-04,8.019E-05,2.764E-04,18,"UBCH7, UBCH8, Caspase-8, SIAH1, CASK, HSP70, Caspase-1, UBC6, Tubulin beta, Alpha-synuclein, GPR37, Septin 5 (CDC-REL1), Cullin 1, UBE1, Tubulin alpha, Cyclin E, UBC7, Synphilin 1",9.733E-05,3.506E-04,17,"UBCH7, UBCH8, Caspase-8, SIAH1, CASK, HSP70, Caspase-1, UBC6, Tubulin beta, Alpha-synuclein, GPR37, Septin 5 (CDC-REL1), Cullin 1, Tubulin alpha, Cyclin E, UBC7, Synphilin 1",
496,Development_Schema: SMAD-dependent TGF-beta family signaling in embryonic stem cells,24,8.019E-05,2.764E-04,8.019E-05,2.764E-04,18,"SMAD5, TGF-beta 1, Oct-3/4, BMP4, ID3, ID1, SMAD2, Lefty-2, Activin A, Gremlin, NODAL, SOX17, SMAD9 (SMAD8), FGF2, Noggin, SMAD1, SMAD3, BMP2",9.733E-05,3.506E-04,17,"SMAD5, TGF-beta 1, Oct-3/4, BMP4, ID3, ID1, SMAD2, Lefty-2, Activin A, Gremlin, NODAL, SOX17, SMAD9 (SMAD8), FGF2, Noggin, SMAD3, BMP2",
497,Signal transduction_ERK1/2 signaling pathway,32,8.484E-05,3.269E-04,1.118E-04,3.660E-04,22,"SHC2, ERK1/2, A-Raf-1, PKC-epsilon, RAP-1A, Shc, SHC4, SOS2, SHC3, N-Ras, MEK2(MAP2K2), MEK1/2, M-Ras, ERK2 (MAPK1), B-Raf, PKC-delta, cAMP-GEFII, SOS, SOS1, PKC-beta, PKC-alpha, PDZ-GEF1",8.484E-05,3.269E-04,21,"SHC2, ERK1/2, c-Raf-1, PKC-epsilon, RAP-1A, Shc, SOS2, SHC3, N-Ras, MEK2(MAP2K2), MEK1/2, M-Ras, ERK2 (MAPK1), MEK1(MAP2K1), B-Raf, cAMP-GEFII, SOS, SOS1, PKC-beta, PKC-alpha, PDZ-GEF1",
498,Upregulation of IL-8 expression in colorectal cancer,32,8.484E-05,3.269E-04,4.318E-04,1.120E-03,21,"TGF-beta 1, APC protein, TCF7L2 (TCF4), Beta-catenin, IL-1 beta, NF-kB p50/p65, TNF-R1, TNF-alpha, RelA (p65 NF-kB subunit), NF-kB1 (p50), IL-8, TGF-beta receptor type II, WNT1, WNT5A, WNT, NT, WNT2, SNAIL1, Frizzled, TGF-beta receptor type I, WNT6",8.484E-05,3.269E-04,21,"TGF-beta 1, APC protein, TCF7L2 (TCF4), IFN-gamma, Beta-catenin, IL-1 beta, NF-kB p50/p65, TNF-R1, TNF-alpha, RelA (p65 NF-kB subunit), NF-kB1 (p50), IL-8, TGF-beta receptor type II, WNT5A, WNT, NT, WNT2, SNAIL1, Frizzled, TGF-beta receptor type I, WNT6",
499,ERBB family and HGF signaling in gastric cancer,54,8.610E-05,3.296E-04,2.539E-04,7.194E-04,32,"STAT5A, TCF7L2 (TCF4), Neuropilin-1, ERK1/2, HB-EGF, Beta-catenin, EGR1, VEGF-A, BAD, Shc, GSK3 beta, PI3K reg class IA, MEK1/2, TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Myc, HGF, JAK2, PI3K cat class IA, HIF1A, IL-8, Epiregulin, EGFR, MEK3(MAP2K3), c-Jun, ErbB4, SOS, COX-2 (PTGS2), MEKK1(MAP3K1), HGF receptor (Met), p38 MAPK",8.610E-05,3.296E-04,31,"STAT5A, Neuregulin 1, HDC, TCF7L2 (TCF4), Neuropilin-1, ERK1/2, HB-EGF, Beta-catenin, VEGF-A, c-Raf-1, Shc, GSK3 beta, PI3K reg class IA, MEK1/2, TGF-alpha, ERK2 (MAPK1), AKT(PKB), HGF, JAK2, PI3K cat class IA, HIF1A, IL-8, Epiregulin, EGFR, MEK3(MAP2K3), ErbB4, SOS, STAT3, COX-2 (PTGS2), HGF receptor (Met), p38 MAPK",
500,Role of cell adhesion molecules in progression of pancreatic cancer,45,8.642E-05,3.296E-04,1.930E-04,5.798E-04,28,"NCAM1, alpha-6/beta-1 integrin, ERK1/2, Beta-catenin, Fibronectin, IL-1 beta, Shc, alpha-V/beta-3 integrin, Caspase-3, L1CAM, MEK2(MAP2K2), Collagen IV, c-Src, c-Myc, alpha-3/beta-1 integrin, ITGB1, iNOS, Tcf(Lef), Laminin 1, alpha-5/beta-1 integrin, SOS, Alpha-catenin, p130CAS, Caspase-7, alpha-2/beta-1 integrin, ITGA5, SIAT8B, Collagen I",8.642E-05,3.296E-04,27,"NCAM1, alpha-6/beta-1 integrin, ERK1/2, Beta-catenin, c-Raf-1, Fibronectin, IL-1 beta, Shc, alpha-V/beta-3 integrin, Caspase-3, L1CAM, MEK2(MAP2K2), Collagen IV, c-Src, MEK1(MAP2K1), alpha-3/beta-1 integrin, ITGB1, iNOS, Tcf(Lef), Laminin 1, alpha-5/beta-1 integrin, SOS, p130CAS, alpha-2/beta-1 integrin, ITGA5, SIAT8B, Collagen I",
501,Immune response_Sublytic effects of membrane attack complex,68,8.900E-05,3.381E-04,1.492E-04,4.649E-04,39,"TGF-beta 1, GRP78, Endoplasmin, ERK1/2, c-FLIP(Long), MCU, IRF1, Caspase-8, PI3K cat class IB (p110-gamma), IP3 receptor, CDK1 (p34), BAD, ARHGEF2, cPLA2, PLC-gamma 1, IL-6, MEK1/2, G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), Cyclin B1, RGC32, TAK1(MAP3K7), ATF-6 alpha (50kDa), XAF1, RhoA, C/EBPbeta, EGFR, G-protein alpha-i family, TRAF6, MEK3(MAP2K3), SOS, MNK1, p300, PKC, C9, Pnpla8, PI3K reg class IB (p101), p38 MAPK",8.900E-05,3.381E-04,37,"TGF-beta 1, GRP78, Endoplasmin, ERK1/2, c-FLIP(Long), c-Raf-1, MCU, IRF1, Caspase-8, PI3K cat class IB (p110-gamma), IP3 receptor, CDK1 (p34), ARHGEF2, cPLA2, PLC-gamma 1, IL-6, MEK1/2, G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), Cyclin B1, RGC32, TAK1(MAP3K7), ATF-6 alpha (50kDa), XAF1, RhoA, C/EBPbeta, EGFR, G-protein alpha-i family, TRAF6, MEK3(MAP2K3), SOS, MNK1, p300, PKC, Pnpla8, p38 MAPK",
502,HBV mediates angiogenesis in HCC,20,8.930E-05,3.381E-04,2.035E-02,3.288E-02,12,"CBP, JAK1, VHL, ERK1/2, VEGF-A, Shc, MEK2(MAP2K2), c-Src, Pyk2(FAK2), HIF1A, SOS, HDAC1",8.930E-05,3.381E-04,15,"CBP, JAK1, VHL, ERK1/2, VEGF-A, c-Raf-1, Shc, MEK2(MAP2K2), c-Src, MEK1(MAP2K1), Pyk2(FAK2), HIF1A, SOS, STAT3, HDAC1",
503,Gamma-secretase regulation of angiogenesis,30,9.002E-05,3.381E-04,1.070E-04,3.526E-04,21,"TIE2, Ephrin-B receptor 4, NOTCH1 receptor, VEGF-A, VEGFR-2, NOTCH4 (ICD4), NCK2, NOTCH4, RBP-J kappa (CBF1), c-Src, NOTCH1 (NICD), HEY1, Angiopoietin 1, Csk, DLL4, PEDF (serpinF1), Ephrin-B2 (CTF2), Ephrin-B receptor 2, NOTCH1 (NEXT), Ephrin-B2, ADAM17",9.002E-05,3.381E-04,20,"TIE2, Ephrin-B receptor 4, NOTCH1 receptor, VEGF-A, VEGFR-2, TIE, NOTCH4 (ICD4), NCK2, NOTCH4, RBP-J kappa (CBF1), c-Src, NOTCH1 (NICD), Angiopoietin 1, Csk, PEDF (serpinF1), Ephrin-B2 (CTF2), Ephrin-B receptor 2, NOTCH1 (NEXT), Ephrin-B2, ADAM17",
504,Colorectal cancer (general schema),30,9.002E-05,3.381E-04,4.341E-04,1.120E-03,20,"TGF-beta 1, NOTCH1 receptor, Beta-catenin, FZD2, IL-6, alpha-V/beta-6 integrin, TNF-R1, TNF-alpha, HGF, PTCH1, IL-8, TGF-beta receptor type II, EGFR, Leptin receptor, WNT5A, Ephrin-B, WNT, HGF receptor (Met), Ephrin-B receptors, Frizzled",9.002E-05,3.381E-04,20,"TGF-beta 1, NOTCH1 receptor, Beta-catenin, FZD2, IL-6, alpha-V/beta-6 integrin, TNF-R1, TNF-alpha, HGF, PTCH1, IL-8, TGF-beta receptor type II, EGFR, Leptin receptor, WNT5A, Ephrin-B, WNT, HGF receptor (Met), Ephrin-B receptors, Frizzled",
505,Macrophage-induced immunosuppression in the tumor microenvironment,97,9.031E-05,3.384E-04,3.166E-04,8.771E-04,51,"IDO1, TGF-beta 1, TIE2, CCL20, PD-L2, Calcineurin A (catalytic), CD44, CCL2, IL-4R type I, IL-10, MSR1, M-CSF receptor, ERK1/2, TIM-4, 5'-NTD, STAT1, NF-kB p50/p50, ILT2, B7-H4, GM-CSF, IL-13, IL-6, IL-10 receptor, CD94, AMPK alpha 1 subunit, PPAR-gamma, TAK1(MAP3K7), NF-AT2(NFATC1), CXCR4, S1P1 receptor, CD68, Adenosine A2b receptor, NF-kB1 (p50), HIF1A, C/EBPbeta, IL-4R type II, c-Jun, Angiopoietin 2, HLA-G, Calcipressin 1, CSF1, COX-2 (PTGS2), HLA-E, WNT5A, Calmodulin, IL-34, TAB1, EPAS1, p38 MAPK, CCR4, PD-L1",9.031E-05,3.384E-04,49,"IDO1, TGF-beta 1, TIE2, CCL20, PD-L2, Calcineurin A (catalytic), CD44, CCL2, IL-4R type I, IL-10, MSR1, M-CSF receptor, ERK1/2, 5'-NTD, IL-17, STAT1, NF-kB p50/p50, ILT2, B7-H4, GM-CSF, IL-6, IL-10 receptor, CD94, AMPK alpha 1 subunit, PPAR-gamma, TAK1(MAP3K7), NF-AT2(NFATC1), CXCR4, S1P1 receptor, CD68, Adenosine A2b receptor, NF-kB1 (p50), HIF1A, C/EBPbeta, IL-4R type II, Angiopoietin 2, HLA-G, Calcipressin 1, CSF1, STAT3, COX-2 (PTGS2), HLA-E, WNT5A, Calmodulin, IL-34, EPAS1, p38 MAPK, CCR4, PD-L1",
506,DNA damage_Role of SUMO in p53 regulation,17,9.098E-05,3.088E-04,9.098E-05,3.088E-04,14,"CBP, PML, PIAS1, Ubiquitin, AKT(PKB), SUMO-1, SAE1/2, DAXX, PIAS2, p300, SAE1, RanBP2, SAE2, p53",1.968E-04,6.287E-04,13,"CBP, PML, PIAS1, Ubiquitin, AKT(PKB), Chk2, SUMO-1, DAXX, PIAS2, p300, RanBP2, SAE2, p53",
507,G-protein signaling_Ras family GTPases in kinase cascades,26,9.123E-05,3.088E-04,9.123E-05,3.088E-04,19,"ERK1/2, Rac1, RAP-1A, p38beta (MAPK11), N-Ras, MEK2(MAP2K2), CDC42, MEKK4(MAP3K4), B-Raf, C/EBPbeta, MEK3(MAP2K3), c-Jun, MEK4(MAP2K4), MEKK1(MAP3K1), ATF-2, JNK(MAPK8-10), R-Ras, p38 MAPK, Elk-1",4.355E-04,1.188E-03,17,"p38alpha (MAPK14), ERK1/2, c-Raf-1, RAP-1A, N-Ras, MEK2(MAP2K2), CDC42, MEK1(MAP2K1), B-Raf, C/EBPbeta, MEK3(MAP2K3), MEK4(MAP2K4), ATF-2, JNK(MAPK8-10), R-Ras, p38 MAPK, Elk-1",
508,Development_NOTCH1-mediated pathway for NF-KB activity modulation,26,9.123E-05,3.088E-04,9.123E-05,3.088E-04,19,"Core histone deacetylase I complex, NOTCH1 receptor, c-Rel (NF-kB subunit), CIR, SMRT, HDAC2, PCAF, N-CoR, NF-kB, RBP-J kappa (CBF1), NOTCH1 (NICD), MAML1, p300, SKIP (Ski-interacting protein), HDAC1, SAP30, NOTCH1 (NEXT), Jagged1, ADAM17",9.681E-05,3.506E-04,18,"Core histone deacetylase I complex, NOTCH1 receptor, c-Rel (NF-kB subunit), CIR, SMRT, HDAC2, PCAF, N-CoR, NF-kB, RBP-J kappa (CBF1), NOTCH1 (NICD), p300, SKIP (Ski-interacting protein), HDAC1, SAP30, NOTCH1 (NEXT), Jagged1, ADAM17",
509,Cell adhesion_Classical cadherin-mediated cell adhesion,26,9.123E-05,3.088E-04,9.123E-05,3.088E-04,19,"TRIO, VE-cadherin, F-Actin, Beta-catenin, Alpha-actinin, Rac1, RAP-1A, MAGI-1(BAIAP1), CDC42, Actin cytoskeletal, Tiam1, N-cadherin, F-Actin cytoskeleton, Alpha-catenin, Vinculin, N-WASP, p120-catenin, PDZ-GEF1, WASF2",5.560E-03,1.038E-02,15,"TRIO, VE-cadherin, F-Actin, Beta-catenin, Alpha-actinin, RAP-1A, MAGI-1(BAIAP1), CDC42, Actin cytoskeletal, Tiam1, N-cadherin, F-Actin cytoskeleton, Vinculin, PDZ-GEF1, WASF2",
510,Cell cycle_Transition and termination of DNA replication,26,9.123E-05,3.088E-04,9.123E-05,3.088E-04,19,"FEN1, DNA polymerase alpha/primase, WRN, CDK1 (p34), Ubiquitin, POLD reg (p68), MCM2, TOP2, RFC complex, Bard1, Brca1, POLD cat (p125), CDK2, PCNA, TOP2 alpha, Ribonuclease H1, RFC1, Cyclin A, Brca1/Bard1",4.355E-04,1.188E-03,17,"FEN1, WRN, CDK1 (p34), Ubiquitin, POLD reg (p68), MCM2, TOP2, Bard1, Brca1, POLD cat (p125), CDK2, PCNA, TOP2 alpha, Ribonuclease H1, RFC1, Cyclin A, Brca1/Bard1",
511,Development_Role of CNTF and LIF in regulation of oligodendrocyte development,28,9.417E-05,3.494E-04,4.302E-04,1.120E-03,19,"IMPA1, JAK1, CNTF, 14-3-3, STAT1, Nkx6-2, PI3K reg class IA, IKK-alpha, SOCS3, Caspase-3, LIF, AKT(PKB), JAK2, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), Annexin V, RhoGDI alpha, CLIC4",9.417E-05,3.494E-04,19,"IMPA1, JAK1, CNTF, 14-3-3, STAT1, Nkx6-2, PI3K reg class IA, SOCS3, Caspase-3, LIF, AKT(PKB), JAK2, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), Annexin V, RhoGDI alpha, STAT3, CLIC4",
512,Tumor-stroma interactions in pancreatic cancer,28,9.417E-05,3.353E-04,1.002E-04,3.353E-04,20,"TGF-beta 1, VEGF-A, KIF27, Fibronectin, Smoothened, MMP-2, COL1A2, OSF-2, CD147, HGF, PTCH1, HIF1A, alpha-5/beta-1 integrin, FGF2, alpha-2/beta-1 integrin, GLI-1, HGF receptor (Met), Collagen I, PDGF-R-beta, Thrombospondin 2",9.417E-05,3.494E-04,19,"TGF-beta 1, VEGF-A, Fibronectin, Smoothened, MMP-2, COL1A2, OSF-2, CD147, HGF, PTCH1, HIF1A, alpha-5/beta-1 integrin, FGF2, alpha-2/beta-1 integrin, GLI-1, HGF receptor (Met), Collagen I, PDGF-R-beta, Thrombospondin 2",
513,The role of aberrations in CDKN2 locus and CDK4 in familial melanoma,28,9.417E-05,3.494E-04,4.302E-04,1.120E-03,19,"p14ARF, DP1, FLRT3, E2F3, E2F3/DP1 complex, E2F2, CDK4, b-Myb, p16INK4, p107, EGFR, CDK6, MIG6, E2F4/DP1 complex, E2F4, RUNX2, E2F2/DP1 complex, p15, p53",9.417E-05,3.494E-04,19,"p14ARF, DP1, FLRT3, E2F3, E2F3/DP1 complex, E2F2, CDK4, b-Myb, p16INK4, p107, EGFR, CDK6, MIG6, E2F4/DP1 complex, E2F4, RUNX2, E2F2/DP1 complex, p15, p53",
514,Th1 and Th17 cells in an autoimmune mechanism of emphysema formation in smokers,28,9.417E-05,3.494E-04,7.627E-02,1.070E-01,14,"MHC class II, CCL20, IP10, CD44, Elastin, CD28, IL-17 receptor, CD4, Osteopontin, Leukocyte elastase, CXCR3, IRF7, CCR4, MMP-9",9.417E-05,3.494E-04,19,"MIG, CD1a, MHC class II, CCL20, IP10, CD44, Elastin, IFN-gamma, CD28, IL-17, IL-17 receptor, CD4, CD80, Osteopontin, ROR-alpha, Leukocyte elastase, IRF7, CCR4, MMP-9",
515,Immune response_Oncostatin M signaling via JAK-Stat,22,9.506E-05,3.506E-04,1.642E-03,3.580E-03,15,"JAK1, CCL2, Tyk2, VEGF-A, OSMR, STAT1, SOCS3, Eotaxin, JAK2, SERPINA3 (ACT), TIMP1, LIFR, Oncostatin M, ACTA2, STAT5",9.506E-05,3.506E-04,16,"JAK1, CCL2, Tyk2, VEGF-A, OSMR, STAT1, SOCS3, Eotaxin, JAK2, SERPINA3 (ACT), TIMP1, STAT3, LIFR, Oncostatin M, ACTA2, STAT5",
516,Origin of Langerhans cells in the steady-state and under inflammatory conditions,22,9.506E-05,3.506E-04,3.687E-04,9.974E-04,16,"TGF-beta 1, CCL20, RUNX3, CCL2, M-CSF receptor, SMAD4, SMAD2, IL-1 beta, PSGL-1, P-selectin, TNF-alpha, TGF-beta receptor type II, CSF1, IL-34, SMAD3, TGF-beta receptor type I",9.506E-05,3.506E-04,16,"TGF-beta 1, CCL20, RUNX3, CCL2, M-CSF receptor, SMAD4, SMAD2, IL-1 beta, PSGL-1, P-selectin, TNF-alpha, TGF-beta receptor type II, CSF1, IL-34, SMAD3, TGF-beta receptor type I",
517,Cytoskeleton remodeling_Hyaluronic acid/ CD44 signaling pathways,43,9.718E-05,3.506E-04,2.015E-04,5.992E-04,27,"CD44, LARG, ERK1/2, ARHGEF1 (p115RhoGEF), Dynamin-2, Actin, Rac1, MSN (moesin), PLC-gamma 1, MEK1/2, CDC42, Actin cytoskeletal, Fyn, c-Src, MLCK, HGF, Ankyrin 1, RhoA, Tiam1, PRK2, Lck, SOS, RDX (radixin), RhoGDI alpha, ROCK, Calmodulin, HGF receptor (Met)",9.718E-05,3.506E-04,26,"CD44, ERK1/2, ARHGEF1 (p115RhoGEF), c-Raf-1, Dynamin-2, Actin, MSN (moesin), PLC-gamma 1, MEK1/2, CDC42, Actin cytoskeletal, Fyn, c-Src, MLCK, HGF, Ankyrin 1, RhoA, Tiam1, PRK2, Lck, SOS, RDX (radixin), RhoGDI alpha, ROCK, Calmodulin, HGF receptor (Met)",
518,Immune response_Antimicrobial actions of IFN-gamma,43,9.718E-05,3.506E-04,6.175E-04,1.516E-03,26,"IDO1, Factor B, JAK1, NGAL, Caspase-4, MD-2, IRF1, STAT1, IP-30, SLC26A6, LRG-47, RIG-I, Sequestosome 1(p62), JAK2, GBP7, p22-phox, C/EBPbeta, Staf-50, IFP 35, IFN-gamma receptor, GBP2, GBP1, ACON, PERC, TLR3, Nod1",9.718E-05,3.506E-04,26,"IDO1, Factor B, JAK1, NGAL, IFN-gamma, Caspase-4, MD-2, IRF1, STAT1, IP-30, LRG-47, RIG-I, Sequestosome 1(p62), JAK2, GBP7, p22-phox, C/EBPbeta, Staf-50, IFP 35, IFN-gamma receptor, p67-phox, GBP2, GBP1, PERC, TLR3, Nod1",
519,Role of epigenetic alterations in survival and migration of SCLC cells,43,9.718E-05,3.506E-04,4.495E-02,6.632E-02,21,"Laminin 5, AIP1 (DAB2ip), LAMC2, Connexin 26, Caspase-8, LAMA3 (Epiligrin), RASSF2, Bax, HDAC2, STK4, RASSF1, SLIT2, DR4(TNFRSF10A), ROBO1, DAPK1, FasR(CD95), DNMT1, HDAC1, LAMB3, HTRA3, HGF receptor (Met)",9.718E-05,3.506E-04,26,"Laminin 5, microRNA 34b, LAMC2, miR-34c-5p, Connexin 26, Caspase-8, LAMA3 (Epiligrin), RASSF2, Bax, miR-574-5p, HDAC2, STK4, RASSF1, SLIT2, DR4(TNFRSF10A), ROBO1, DAPK1, miR-34b-3p, FasR(CD95), microRNA 34c, DNMT1, HDAC1, LAMB3, HTRA3, HGF receptor (Met), miR-34b-5p",
520,Regulation of immune cell differentiation by Notch signaling,43,9.718E-05,3.506E-04,1.729E-03,3.753E-03,25,"NOTCH1 receptor, IL-10, CD28, NOTCH2 (2ICD), NOTCH4 (ICD4), PI3K reg class IA (p85), NOTCH4, AKT(PKB), RBP-J kappa (CBF1), NOTCH1 (NICD), PI3K cat class IA, Lck, PI3K reg class IA (p85-alpha), T-bet, NOTCH2, DLL4, NOTCH3 (3ICD), IFI16, DTX1, SMAD3, NOTCH1 (NEXT), Jagged1, ADAM17, ADAM19, NOTCH3",9.718E-05,3.506E-04,26,"NOTCH1 receptor, IL-10, PTCRA, IFN-gamma, CD28, NOTCH2 (2ICD), NOTCH4 (ICD4), PI3K reg class IA (p85), NOTCH4, AKT(PKB), RBP-J kappa (CBF1), NOTCH1 (NICD), PI3K cat class IA, Lck, PI3K reg class IA (p85-alpha), T-bet, NOTCH2, NOTCH3 (3ICD), IFI16, DTX1, SMAD3, NOTCH1 (NEXT), Jagged1, ADAM17, ADAM19, NOTCH3",
521,Development_IGF-1 receptor signaling,50,9.745E-05,3.276E-04,9.745E-05,3.276E-04,31,"IRS-2, IRS-1, RPS6, eIF4E, ERK1/2, PKC-zeta, BAD, I-kB, Shc, PI3K reg class IA, IKK-alpha, IGF-2, MEK2(MAP2K2), GSK3 alpha/beta, CREB1, NF-kB, AKT(PKB), c-Myc, 14-3-3 epsilon, PI3K cat class IA, ASK1 (MAP3K5), 14-3-3 zeta/delta, Cyclin D, SOS, Caspase-9, MNK1, p90Rsk, 4E-BP1, 14-3-3 beta/alpha, FOXO3A, Elk-1",1.194E-02,2.059E-02,24,"IRS-2, RPS6, ERK1/2, c-Raf-1, I-kB, Shc, PI3K reg class IA, IGF-2, MEK2(MAP2K2), GSK3 alpha/beta, CREB1, NF-kB, AKT(PKB), MEK1(MAP2K1), 14-3-3 epsilon, PI3K cat class IA, ASK1 (MAP3K5), 14-3-3 zeta/delta, Cyclin D, SOS, Caspase-9, MNK1, p90Rsk, Elk-1",
522,Development_Endothelin-1/EDNRA signaling,52,9.851E-05,3.540E-04,2.719E-04,7.660E-04,31,"TCF7L2 (TCF4), ERK1/2, Beta-catenin, G-protein alpha-q/11, FARP2, PKC-epsilon, BNP, Rac1, IP3 receptor, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, Adenylate cyclase, MEK2(MAP2K2), CDC42, AKT(PKB), c-Src, MEKK4(MAP3K4), Pyk2(FAK2), PI3K cat class IA, PKC-delta, G-protein alpha-i family, SOS, MEK4(MAP2K4), Calmodulin, MEKK1(MAP3K1), JNK(MAPK8-10), PLC-beta3, Elk-1, EDNRA",9.851E-05,3.540E-04,30,"p38alpha (MAPK14), TCF7L2 (TCF4), ERK1/2, Beta-catenin, c-Raf-1, G-protein alpha-q/11, FARP2, PKC-epsilon, BNP, IP3 receptor, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, Adenylate cyclase, MEK2(MAP2K2), CDC42, AKT(PKB), c-Src, MEK1(MAP2K1), Pyk2(FAK2), PI3K cat class IA, G-protein alpha-i family, SOS, MEK4(MAP2K4), Calmodulin, JNK(MAPK8-10), PLC-beta3, Elk-1, EDNRA",
523,Cell cycle_Regulation of G1/S transition (part 2),28,1.002E-04,3.353E-04,1.002E-04,3.353E-04,20,"Cyclin D3, DP1, ERK1/2, Cyclin D2, Cyclin A1, GSK3 beta, CDK4, Cyclin A2, IKK-alpha, AKT(PKB), p107, RelA (p65 NF-kB subunit), c-Jun, Cyclin D, CDK2, CDK6, E2F4/DP1 complex, E2F4, Cyclin E, Cyclin A",1.488E-03,3.361E-03,17,"DP1, ERK1/2, Cyclin D2, Cyclin A1, GSK3 beta, CDK4, Cyclin A2, AKT(PKB), p107, RelA (p65 NF-kB subunit), Cyclin D, CDK2, CDK6, E2F4/DP1 complex, E2F4, Cyclin E, Cyclin A",
524,Neurophysiological process_ACM regulation of nerve impulse,48,1.018E-04,3.393E-04,1.018E-04,3.393E-04,30,"TRPC5, Calcineurin A (catalytic), ROCK1, FKBP12, PKA-reg (cAMP-dependent), TRPC6, G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, PLC-beta, ACM4, G-protein beta/gamma, ACM5, RhoA, cPKC (conventional), ROCK2, ACM2, CACNA1G, G-protein alpha-i family, G-protein alpha-o, ACM3, Calmodulin, TRPC3, PKC, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, G-protein alpha-q, N-type Ca(II) channel alpha1B, Calcineurin B (regulatory), PKA-cat (cAMP-dependent)",1.059E-03,2.486E-03,26,"TRPC5, Calcineurin A (catalytic), ROCK1, FKBP12, TRPC6, G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, PLC-beta, ACM4, G-protein beta/gamma, ACM5, RhoA, cPKC (conventional), ROCK2, CACNA1G, G-protein alpha-i family, G-protein alpha-o, ACM3, Calmodulin, TRPC3, PKC, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, Calcineurin B (regulatory), PKA-cat (cAMP-dependent)",
525,NF-AT signaling in cardiac hypertrophy,65,1.034E-04,3.439E-04,1.034E-04,3.439E-04,38,"HDAC9, CBP, ERK5 (MAPK7), Calcineurin A (catalytic), Cardiotrophin-1, IRS-1, MEF2C, HAND1, HDAC4, HDAC7, G-protein alpha-q/11, beta-MHC, Angiotensin II, CaMK IV, PKC-epsilon, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, MAP2K5 (MEK5), LIF, IL-6, ACTC, G-protein beta/gamma, AKT(PKB), c-Src, PI3K cat class IA, G-protein alpha-i family, MEF2A, HDAC5, p300, HAND2, CSX (Nkx2.5), Calmodulin, PKC-alpha, SHP-2, NCX1, Beta-1 adrenergic receptor",1.805E-04,5.906E-04,35,"HDAC9, CBP, ERK5 (MAPK7), Calcineurin A (catalytic), MEF2C, HAND1, HDAC4, HDAC7, G-protein alpha-q/11, beta-MHC, Angiotensin II, CaMK IV, PKC-epsilon, Shc, GSK3 beta, PI3K reg class IA, Endothelin-1, MAP2K5 (MEK5), LIF, IL-6, ACTC, G-protein beta/gamma, AKT(PKB), c-Src, PI3K cat class IA, G-protein alpha-i family, MEF2A, HDAC5, p300, HAND2, CSX (Nkx2.5), Calmodulin, PKC-alpha, NCX1, Beta-1 adrenergic receptor",
526,Signal transduction_CXCR4 signaling via PI3K cascade,46,1.059E-04,3.506E-04,1.059E-04,3.506E-04,29,"TCF7L2 (TCF4), Beta-catenin, SGK1, VEGF-A, PI3K cat class IB (p110-gamma), Rac1, BAD, Ubiquitin, PI3K reg class IA (p85), GSK3 beta, FKHR, Caspase-3, IL-6, G-protein beta/gamma, AKT(PKB), CXCR4, PI3K cat class IA, RelA (p65 NF-kB subunit), PARP-1, NF-kB1 (p50), G-protein alpha-i family, c-Jun, PPCKC, 4E-BP1, FOXO3A, AKT2, PI3K reg class IB (p101), Bim, mTOR",1.652E-02,2.738E-02,22,"TCF7L2 (TCF4), Beta-catenin, SGK1, VEGF-A, PI3K cat class IB (p110-gamma), Ubiquitin, PI3K reg class IA (p85), GSK3 beta, FKHR, Caspase-3, IL-6, G-protein beta/gamma, AKT(PKB), CXCR4, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB1 (p50), G-protein alpha-i family, G6PT, PPCKC, Bim, mTOR",
527,Cytoskeleton remodeling_Regulation of actin cytoskeleton nucleation and polymerization by Rho GTPases,46,1.059E-04,3.506E-04,1.059E-04,3.506E-04,29,"RhoF (Rif), HDIA2, FMNL3, FMNL1, Rac2, mDIA2(DIAPH3), RhoC, Gelsolin, Rac1, DRF, MENA, Profilin, Cdc42 subfamily, DIA1, VASP, RhoA-related, CDC42, Actin cytoskeletal, WASF1(WAVE1), RhoA, F-Actin cytoskeleton, IQGAP1, WASF subunit, FNBP1, Rac1-related, N-WASP, FMNL2, TC10, WASF2",4.426E-04,1.193E-03,26,"RhoF (Rif), HDIA2, FMNL3, FMNL1, Rac2, mDIA2(DIAPH3), Gelsolin, DRF, MENA, Profilin, Cdc42 subfamily, DIA1, VASP, RhoA-related, CDC42, Actin cytoskeletal, WASF1(WAVE1), RhoA, F-Actin cytoskeleton, IQGAP1, WASF subunit, FNBP1, Rac1-related, FMNL2, TC10, WASF2",
528,Selective Insulin resistance in type 2 diabetes in liver,32,1.118E-04,3.660E-04,1.118E-04,3.660E-04,22,"IRS-2, GYS2, IRS-1, SOCS1, KPYR, PKC-epsilon, HNF3-beta, PKC-theta, FKHR, SOCS3, GSK3 alpha/beta, PPARGC1 (PGC1-alpha), AKT(PKB), PI3K reg class IA (p85-alpha), MTP, PTP-1B, JNK1(MAPK8), PPCKC, PI3K cat class IA (p110-alpha), AKT2, JNK2(MAPK9), HXK4",3.333E-04,9.509E-04,20,"IRS-2, SOCS1, KPYR, PKC-epsilon, HNF3-beta, PKC-theta, FKHR, SOCS3, GSK3 alpha/beta, PPARGC1 (PGC1-alpha), AKT(PKB), PI3K reg class IA (p85-alpha), G6PT, MTP, JNK1(MAPK8), SHP, PPCKC, PI3K cat class IA (p110-alpha), JNK2(MAPK9), HXK4",
529,"Oxidative stress_Activation of NOX1, NOX5, DUOX1 and DUOX2 NADPH Oxidases",42,1.126E-04,3.660E-04,1.126E-04,3.660E-04,27,"PKA-reg (cAMP-dependent), Rac2, FISH, p47-phox, Rac1, NOXO1, MEK1/2, ERK2 (MAPK1), c-Src, NOX5, BETA-PIX, Tiam1, cPKC (conventional), p22-phox, PKA-cat alpha, SH3PXD2B, DUOXA2, DUOX2, DUOX1, PKC-beta, Calmodulin, PKC, PKC-alpha, CaMK II alpha, c-Abl, DUOXA1, PKA-cat (cAMP-dependent)",1.674E-03,3.723E-03,23,"Rac2, FISH, p47-phox, MEK1/2, ERK2 (MAPK1), c-Src, NOX5, Tiam1, cPKC (conventional), p22-phox, PKA-cat alpha, SH3PXD2B, DUOXA2, DUOX2, DUOX1, PKC-beta, Calmodulin, PKC, PKC-alpha, CaMK II alpha, c-Abl, DUOXA1, PKA-cat (cAMP-dependent)",
530,Development_Thromboxane A2 signaling pathway,50,1.126E-04,3.969E-04,2.905E-04,8.077E-04,30,"ERK1/2, ARHGEF1 (p115RhoGEF), Beta-catenin, MSK1/2 (RPS6KA5/4), PKA-reg (cAMP-dependent), IP3 receptor, PI3K reg class IA (p85), PI3K reg class IA, PLC-beta, Adenylate cyclase, GSK3 alpha/beta, CREB1, IL-6, MEK1/2, AKT(PKB), c-Src, RhoA, cPKC (conventional), G-protein alpha-12 family, PI3K cat class IA, B-Raf, Tcf(Lef), EGFR, RAP-1B, G-protein alpha-i family, TBXA2R, PKC, G-protein alpha-q, p38 MAPK, PKA-cat (cAMP-dependent)",1.126E-04,3.969E-04,29,"ERK1/2, ARHGEF1 (p115RhoGEF), Beta-catenin, MSK1/2 (RPS6KA5/4), c-Raf-1, IP3 receptor, PI3K reg class IA (p85), PI3K reg class IA, PLC-beta, Adenylate cyclase, GSK3 alpha/beta, CREB1, IL-6, MEK1/2, AKT(PKB), c-Src, RhoA, cPKC (conventional), G-protein alpha-12 family, PI3K cat class IA, B-Raf, Tcf(Lef), EGFR, RAP-1B, G-protein alpha-i family, TBXA2R, PKC, p38 MAPK, PKA-cat (cAMP-dependent)",
531,Immune response_Lectin induced complement pathway,50,1.126E-04,3.969E-04,2.905E-04,8.077E-04,30,"C3, C3b, C5a, C5 convertase (C2aC4bC3b), C3c, MASP2, C1 inhibitor, Factor I, C4b, C2, C7, C3dg, C2b, C3aR, C4a, C3 convertase (C2aC4b), MASP1, CD21, CR1, C4BP, C6, C5, DAF, C9, C5b, iC3b, C3a, C4, CD59, C2a",1.126E-04,3.969E-04,29,"C3, C3b, C5a, C5 convertase (C2aC4bC3b), C3c, MASP2, C1 inhibitor, Factor I, C4b, C2, C7, C3dg, C2b, C4a, C3 convertase (C2aC4b), MASP1, CD21, CR1, C6, C8alpha, C5, DAF, C5b, iC3b, C3a, C4, CD59, C2a, H-Ficolin",
532,Survival pathways in Prostate Cancer,50,1.126E-04,3.969E-04,2.045E-03,4.376E-03,28,"DR5(TNFRSF10B), CCL2, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, BAD, TRUNDD(TNFRSF10D), I-kB, Bax, GSK3 beta, Survivin, PI3K reg class IA, IKK-alpha, MEK2(MAP2K2), IL-6, NF-kB, ERK2 (MAPK1), AKT(PKB), DR4(TNFRSF10A), Mcl-1, PI3K cat class IA, XIAP, Caspase-9, Caspase-10, tBid, p53, mTOR, Bid",1.126E-04,3.969E-04,29,"DR5(TNFRSF10B), CCL2, c-FLIP(Long), c-Raf-1, Apo-2L(TNFSF10), Caspase-8, TRUNDD(TNFRSF10D), I-kB, Bax, GSK3 beta, Survivin, PI3K reg class IA, MEK2(MAP2K2), IL-6, NF-kB, ERK2 (MAPK1), AKT(PKB), DR4(TNFRSF10A), Mcl-1, MEK1(MAP2K1), PI3K cat class IA, XIAP, Caspase-9, STAT3, Caspase-10, tBid, p53, mTOR, Bid",
533,Muscle contraction_GPCRs in the regulation of smooth muscle tone,83,1.139E-04,4.008E-04,2.852E-04,8.006E-04,45,"TRPC5, LARG, HTR2A, ARHGEF1 (p115RhoGEF), PKA-reg (cAMP-dependent), TRPC6, G-protein alpha-q/11, Angiotensin II, IP3 receptor, MLCP (reg), OTR, Prostacyclin receptor, TRPC1, PLC-beta, Endothelin-1, Adenylate cyclase, MLCK, MLCP (cat), PGE2R2, RhoA, GEFT, G-protein alpha-12 family, Adenosine A2b receptor, V1a receptor, ACM2, G-protein alpha-i family, Myosin II, OT, TBXA2R, MyHC, ACM3, Histamine H1 receptor, ROCK, PDZ-RhoGEF, Calmodulin, TRPC3, PKC-alpha, NCX1, MRLC, Telokin, G-protein alpha-q, Beta-2 adrenergic receptor, MELC, PKA-cat (cAMP-dependent), EDNRA",1.139E-04,4.008E-04,43,"TRPC5, TRPC4, HTR2A, ARHGEF1 (p115RhoGEF), TRPC6, G-protein alpha-q/11, Angiotensin II, IP3 receptor, MLCP (reg), OTR, TRPC1, PLC-beta, Endothelin-1, Adenylate cyclase, MLCK, MLCP (cat), PGE2R2, RhoA, GEFT, G-protein alpha-12 family, Adenosine A2b receptor, V1a receptor, G-protein alpha-i family, AVP extracellular region, Myosin II, OT, TBXA2R, MyHC, ACM3, Histamine H1 receptor, ROCK, PDZ-RhoGEF, Calmodulin, TRPC3, PKC-alpha, NCX1, MRLC, Telokin, TRPC7, Beta-2 adrenergic receptor, MELC, PKA-cat (cAMP-dependent), EDNRA",
534,Role of Apo-2L(TNFSF10) in Prostate Cancer cell apoptosis,34,1.148E-04,3.688E-04,1.148E-04,3.688E-04,23,"DR5(TNFRSF10B), Apaf-1, c-FLIP(Long), Apo-2L(TNFSF10), Bak, Caspase-8, TRUNDD(TNFRSF10D), I-kB, Bax, Survivin, c-IAP1, Caspase-3, RIPK1, NF-kB, Osteoprotegerin, DR4(TNFRSF10A), c-IAP2, XIAP, Caspase-9, Caspase-10, Caspase-7, tBid, Bid",3.001E-04,8.840E-04,21,"DR5(TNFRSF10B), Apaf-1, c-FLIP(Long), Apo-2L(TNFSF10), Caspase-8, TRUNDD(TNFRSF10D), I-kB, Bax, Survivin, c-IAP1, Caspase-3, RIPK1, NF-kB, Osteoprotegerin, DR4(TNFRSF10A), c-IAP2, XIAP, Caspase-9, Caspase-10, tBid, Bid",
535,Role of IGH translocations in multiple myeloma,40,1.148E-04,3.688E-04,1.148E-04,3.688E-04,26,"NCAM1, Cyclin D3, ID1, VEGF-A, Cyclin D2, HDAC2, CDK4, ITGAE, p107, c-Myc, N-cadherin, Sin3A, IL-5, WHSC1, LSD1, IRF4, NOTCH2, CDK6, c-Maf, E2F4, HES1, RhoE, HDAC1, ITGA5, MRF-1, BLIMP1 (PRDI-BF1)",2.127E-04,6.667E-04,24,"NCAM1, ID1, VEGF-A, Cyclin D2, HDAC2, CDK4, ITGAE, p107, N-cadherin, Sin3A, IL-5, WHSC1, LSD1, IRF4, NOTCH2, CDK6, c-Maf, E2F4, HES1, RhoE, HDAC1, ITGA5, MRF-1, BLIMP1 (PRDI-BF1)",
536,Signal transduction_Adenosine A2B receptor signaling pathway,71,1.149E-04,4.024E-04,5.014E-04,1.273E-03,39,"Calcineurin A (catalytic), IL-10, ERK1/2, VEGF-A, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, Ubiquitin, RAP-1A, PI3K reg class IA (p85), Bax, GSK3 beta, PLC-beta, SLC26A6, VASP, Adenylate cyclase, CREB1, IL-6, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, NF-AT2(NFATC1), PKM2, TNF-alpha, PI3K cat class IA, B-Raf, CALDAG-GEFI, NF-kB1 (p105), Adenosine A2b receptor, HIF1A, cAMP-GEFII, RAP-1B, Cullin 1, PKC, LDHA, Calcineurin B (regulatory), p38 MAPK, PKA-cat (cAMP-dependent)",1.149E-04,4.024E-04,38,"PDK1, Calcineurin A (catalytic), IL-10, ERK1/2, VEGF-A, G-protein alpha-q/11, IP3 receptor, Ubiquitin, RAP-1A, PI3K reg class IA (p85), Bax, GSK3 beta, PLC-beta, VASP, Adenylate cyclase, CREB1, IL-6, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, NF-AT2(NFATC1), PKM2, TNF-alpha, PI3K cat class IA, B-Raf, NF-kB1 (p105), Adenosine A2b receptor, HIF1A, cAMP-GEFII, RAP-1B, CFTR, Cullin 1, PKC, LDHA, Calcineurin B (regulatory), p38 MAPK, PKA-cat (cAMP-dependent)",
537,Immune response_Role of integrins in NK cells cytotoxicity,38,1.160E-04,3.688E-04,1.160E-04,3.688E-04,25,"alpha-4/beta-1 integrin, ICAM1, Fibronectin, PKC-epsilon, VAV-1, Rac1, Shc, MEK2(MAP2K2), CD94, FasL(TNFSF6), ERK2 (MAPK1), RACK1, Pyk2(FAK2), VCAM1, IL-8, Lyn, MEK3(MAP2K3), SOS, Paxillin, HLA-E, MEKK1(MAP3K1), ATF-2, SHP-2, ICAM2, p38 MAPK",2.396E-04,7.280E-04,23,"alpha-4/beta-1 integrin, ICAM1, IFN-gamma, c-Raf-1, Fibronectin, PKC-epsilon, VAV-1, Shc, MEK2(MAP2K2), CD94, ERK2 (MAPK1), MEK1(MAP2K1), RACK1, Pyk2(FAK2), VCAM1, IL-8, Lyn, MEK3(MAP2K3), SOS, HLA-E, ATF-2, ICAM2, p38 MAPK",
538,Development_SDF-1 signaling in hematopoietic stem cell homing,38,1.160E-04,3.688E-04,1.160E-04,3.688E-04,25,"alpha-4/beta-1 integrin, ERK1/2, PKC-zeta, CrkL, CRK, G-protein alpha-i2, VAV-1, Rac1, RAP-1A, PI3K reg class IA (p85), MEK1/2, G-protein beta/gamma, CDC42, CXCR4, RhoA, Tiam1, Pyk2(FAK2), JAK2, PI3K cat class IA, Lyn, C3G, Paxillin, p130CAS, PLC-gamma, MMP-9",7.749E-04,1.921E-03,22,"alpha-4/beta-1 integrin, ERK1/2, CrkL, CRK, c-Raf-1, G-protein alpha-i2, VAV-1, RAP-1A, PI3K reg class IA (p85), MEK1/2, G-protein beta/gamma, CDC42, CXCR4, RhoA, Tiam1, Pyk2(FAK2), JAK2, PI3K cat class IA, Lyn, p130CAS, PLC-gamma, MMP-9",
539,Cell adhesion_Tight junctions,38,1.160E-04,3.688E-04,1.160E-04,3.688E-04,25,"JAM2, MUPP1, F-Actin, Claudin-16, Nectin-1, Claudin-1, Actin, ZO-2, Claudin-18, Claudin-11, LYRIC, Claudin-7, Claudin-14, ITGB1, Claudin-19, Tcf(Lef), CDX2, ZO-1, Myosin II, Claudin-8, Actomyosin, SNAIL1, CSDA, Caveolin-1, CDX1",2.268E-03,4.857E-03,21,"MUPP1, F-Actin, Claudin-16, Claudin-1, Actin, ZO-2, Claudin-18, Claudin-11, Claudin-14, ITGB1, Claudin-19, Tcf(Lef), CDX2, ZO-1, Myosin II, Claudin-8, Actomyosin, SNAIL1, CSDA, Caveolin-1, CDX1",
540,Immune response_IL-6-induced acute-phase response in hepatocytes,36,1.161E-04,3.688E-04,1.161E-04,3.688E-04,24,"SAA1, SAA2, C3, HNF1-alpha, Fibrinogen beta, PPAR-alpha, STAT1, GRO-1, HOPS, FKHR, HP, A2M, IL-6, AGP1 (ORM1), Heme oxygenase 1, C/EBPbeta, c-Jun, IBP1, Fibrinogen alpha, CRP, Angiotensinogen, Fibrinogen gamma, PAI1, C/EBPdelta",2.688E-04,8.052E-04,22,"SAA1, SAA2, C3, PPAR-alpha, STAT1, GRO-1, HOPS, FKHR, HP, A2M, IL-6, APCS, Heme oxygenase 1, C/EBPbeta, G6PT, IBP1, STAT3, Fibrinogen alpha, CRP, Angiotensinogen, PAI1, C/EBPdelta",
541,Immune response_IL-6 signaling pathway via MEK/ERK and PI3K/AKT cascades,74,1.165E-04,3.693E-04,1.165E-04,3.693E-04,42,"RHEB2, JAK1, RPS6, eIF4E, ERK1/2, EGR1, TEC, VAV-1, PLC-beta1, IP3 receptor, BAD, Shc, PI3K reg class IA (p85), Bax, GSK3 beta, PI3K reg class IA, FKHR, PLC-gamma 1, N-Ras, CREB1, IL-6, MEK1/2, AKT(PKB), ADAM10, Mcl-1, GAB2, JAK2, PI3K cat class IA, PKC-delta, C/EBPbeta, XIAP, c-Jun, SOS, Caspase-9, MNK1, 4E-BP1, Proepithelin, SHP-2, ADAM17, Elk-1, SRF, mTOR",8.106E-04,1.987E-03,37,"RHEB2, JAK1, RPS6, ERK1/2, c-Raf-1, TEC, VAV-1, IP3 receptor, Shc, PI3K reg class IA (p85), Bax, GSK3 beta, PI3K reg class IA, FKHR, PLC-gamma 1, N-Ras, CREB1, IL-6, MEK1/2, AKT(PKB), ADAM10, Mcl-1, GAB2, JAK2, PI3K cat class IA, C/EBPbeta, XIAP, SOS, p90RSK1, Caspase-9, MNK1, STAT3, Proepithelin, ADAM17, Elk-1, SRF, mTOR",
542,Cell cycle progression in Prostate Cancer,39,1.215E-04,4.236E-04,2.155E-04,6.312E-04,25,"STAT5A, Cyclin B, ERK1/2, Beta-catenin, CDC25A, STAT5B, CDK1 (p34), Cyclin A1, GSK3 beta, CDK4, IL-6, AKT(PKB), JAK2, Tcf(Lef), CDC25B, c-Jun, MNK1, CDK2, CDK6, 4E-BP1, WNT, p38 MAPK, Frizzled, Prolactin, mTOR",1.215E-04,4.236E-04,24,"STAT5A, Cyclin B, ERK1/2, Beta-catenin, CDC25A, STAT5B, CDK1 (p34), Cyclin A1, GSK3 beta, CDK4, IL-6, AKT(PKB), JAK2, Tcf(Lef), CDC25B, MNK1, CDK2, CDK6, STAT3, WNT, p38 MAPK, Frizzled, Prolactin, mTOR",
543,Development_ERBB-family signaling,39,1.215E-04,4.236E-04,5.340E-03,1.025E-02,22,"ERK1/2, HB-EGF, I-kB, Shc, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), TGF-alpha, NF-kB, AKT(PKB), c-Myc, Neuregulin 4, PI3K cat class IA, c-Cbl, Epiregulin, EGFR, ErbB4, SOS, NIK(MAP3K14), Neuregulin 2, Elk-1, Betacellulin",1.215E-04,4.236E-04,24,"Neuregulin 1, ERK1/2, HB-EGF, c-Raf-1, I-kB, Shc, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), TGF-alpha, NF-kB, AKT(PKB), MEK1(MAP2K1), Neuregulin 4, PI3K cat class IA, c-Cbl, Epiregulin, EGFR, ErbB4, SOS, NIK(MAP3K14), Neuregulin 2, Elk-1, Betacellulin",
544,Development_NOTCH-induced EMT,19,1.217E-04,3.848E-04,1.217E-04,3.848E-04,15,"VE-cadherin, TGF-beta 1, NOTCH1 receptor, Fibronectin, NOTCH4, RBP-J kappa (CBF1), NOTCH1 (NICD), HEY1, DLL4, SLUG, SNAIL1, SMAD3, NOTCH1 (NEXT), Jagged1, ADAM17",1.127E-03,2.628E-03,13,"VE-cadherin, TGF-beta 1, NOTCH1 receptor, Fibronectin, NOTCH4, RBP-J kappa (CBF1), NOTCH1 (NICD), SLUG, SNAIL1, SMAD3, NOTCH1 (NEXT), Jagged1, ADAM17",
545,Immune response_Antigen presentation by MHC class I: cross-presentation,99,1.328E-04,4.183E-04,1.328E-04,4.183E-04,53,"MSR1, Endoplasmin, gp91-phox, Rab-3B, SREC-I, Rac2, Cathepsin S, TAP, Rab-3C, VAV-1, p47-phox, Syk, Rab-6, IP-30, Adipophilin, HYOU1, Rab-7, IRAK4, IRAP, MyD88, cPLA2, Calreticulin, CD209, MHC class I, TLR9, HSP90, Syntaxin 4, HSP70, Rab8B, LRP1, EHD1, Cathepsin L, Dectin-1, Rab-27A, SEC61 complex, Cytochrome b-558, LY75, Rab-32, Fc gamma RII alpha, Rab-33A, Cathepsin B, TIM-3, DAP12, CD74, CD8, UFO, TLR4, Rab-10, TLR7, TRIF (TICAM1), TLR3, Rab-34, TLR2",7.638E-04,1.900E-03,47,"MSR1, Endoplasmin, gp91-phox, Rab-3B, SREC-I, Rac2, CLEC4C, Cathepsin S, TAP, VAV-1, p47-phox, Syk, Rab-6, IP-30, Adipophilin, HYOU1, IRAK4, cPLA2, Calreticulin, MHC class I, TLR9, HSP90, HSP70, Rab8B, LRP1, Cathepsin L, Dectin-1, Rab-27A, SEC61 complex, Cytochrome b-558, CLEC9A, LY75, Rab-32, p67-phox, Fc gamma RII alpha, Rab-33A, Cathepsin B, DAP12, CD74, CD8, UFO, TLR4, Connexin 43, TLR7, TLR3, Rab-34, TLR2",
546,SLE genetic marker-specific pathways in B cells,99,1.328E-04,4.183E-04,1.328E-04,4.183E-04,53,"GRP78, Cyclin D3, NOX4, Tyk2, ERK1/2, ATF-6 alpha (90kDa), IFN-alpha/beta receptor, Bak, PXK, IFN-beta, VAV-1, STAT1, Rac1, IP3 receptor, Syk, Shc, PAX5, SOD1, IFN-alpha, BCMA(TNFRSF17), MEK1/2, CD22, NF-kB, TMEM39A, TLR9, TNF-R1, c-Myc, ATF-6 beta, ATF-6 alpha (50kDa), IL-2, BAFF(TNFSF13B), TNF-alpha, Ikaros, p22-phox, CD38, PKC-delta, ETS1, Lyn, BAFF-R, IL-5, IRF9, SOS, Bcl-6, S1P, NOX4/p22-phox, BLK, CalDAG-GEFIII, TLR4, PLC-gamma, TACI(TNFRSF13B), TLR7, BLIMP1 (PRDI-BF1), JIK",1.518E-03,3.418E-03,46,"IRF8, GRP78, NOX4, Tyk2, ERK1/2, ATF-6 alpha (90kDa), c-Raf-1, IFN-alpha/beta receptor, PXK, IFN-beta, VAV-1, STAT1, IP3 receptor, Syk, Shc, PAX5, IFN-alpha, BCMA(TNFRSF17), MEK1/2, NF-kB, TMEM39A, TLR9, TNF-R1, ATF-6 alpha (50kDa), IL-2, BAFF(TNFSF13B), TNF-alpha, p22-phox, CD38, ETS1, Lyn, BAFF-R, IL-5, IRF9, SOS, p67-phox, Bcl-6, S1P, NOX4/p22-phox, BLK, CalDAG-GEFIII, TLR4, PLC-gamma, TACI(TNFRSF13B), TLR7, BLIMP1 (PRDI-BF1)",
547,FGFR3 signaling in multiple myeloma,37,1.350E-04,4.608E-04,1.424E-02,2.394E-02,20,"ERK1/2, FGF1, VEGF-A, p90RSK2(RPS6KA3), FGF8, STAT5B, FGF9, STAT1, Shc, PLC-gamma 1, N-Ras, ERK2 (MAPK1), AKT(PKB), Mcl-1, Pyk2(FAK2), JAK2, PI3K reg class IA (p85-alpha), FGF2, SOS, PI3K cat class IA (p110-alpha)",1.350E-04,4.608E-04,23,"ERK1/2, FGF1, VEGF-A, p90RSK2(RPS6KA3), c-Raf-1, FGF8, STAT5B, FGF9, STAT1, Shc, PLC-gamma 1, N-Ras, ERK2 (MAPK1), AKT(PKB), Mcl-1, MEK1(MAP2K1), Pyk2(FAK2), JAK2, PI3K reg class IA (p85-alpha), FGF2, SOS, STAT3, PI3K cat class IA (p110-alpha)",
548,Immune response_IL-7 signaling in T lymphocytes,37,1.350E-04,4.608E-04,2.177E-03,4.646E-03,22,"STAT5A, IL-7 receptor, CBP, RAG1, IL-7, JAK1, IRS-2, IRS-1, SOCS1, STAT5B, STAT1, FKHR, Fyn, AKT(PKB), Pyk2(FAK2), Lck, PI3K reg class IA (p85-alpha), p300, JAK3, PI3K cat class IA (p110-alpha), FOXO3A, STAT5",1.350E-04,4.608E-04,23,"STAT5A, IL-7 receptor, CBP, RAG1, IL-7, JAK1, IRS-2, SOCS1, STAT5B, RAG2, STAT1, FKHR, RAG1/2 complex, Fyn, AKT(PKB), Pyk2(FAK2), Lck, PI3K reg class IA (p85-alpha), p300, JAK3, STAT3, PI3K cat class IA (p110-alpha), STAT5",
549,G-protein signaling_H-RAS regulation pathway,37,1.350E-04,4.608E-04,7.308E-04,1.769E-03,23,"TIE2, RASA3, RASGRF2, GIPC, MAGI-1(BAIAP1), Shc, p120GAP, DOK1, c-Src, Tiam1, PI3K cat class IA, Lck, BCR, Angiopoietin 1, SOS, DOK2, GDNF, ICMT, CalDAG-GEFIII, RASGRF1, Beta-1 adrenergic receptor, PDZ-GEF1, PDGF-R-beta",1.350E-04,4.608E-04,23,"TIE2, RASA3, c-Raf-1, RASGRF2, MAGI-1(BAIAP1), Shc, p120GAP, DOK1, c-Src, Tiam1, PI3K cat class IA, Lck, BCR, Angiopoietin 1, SOS, DOK2, GDNF, ICMT, CalDAG-GEFIII, RASGRF1, Beta-1 adrenergic receptor, PDZ-GEF1, PDGF-R-beta",
550,Skeletal muscle atrophy in COPD,57,1.370E-04,4.307E-04,1.370E-04,4.307E-04,34,"KCRM, RHEB2, UBE2B, REDD1, ERK1/2, 14-3-3, beta-MHC, SMAD2, Vimentin, I-kB, GSK3 beta, MLC2, FKHR, Beta TnTF, PPARGC1 (PGC1-alpha), ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, TNF-alpha, RelA (p65 NF-kB subunit), iNOS, eIF3S5, MyHC, NEDD4, ELAVL1 (HuR), 4E-BP1, Desmin, MAFbx, FOXO3A, ActRIIB, SMAD3, p38 MAPK, mTOR, TGF-beta receptor type I",3.291E-04,9.479E-04,31,"p38alpha (MAPK14), KCRM, RHEB2, REDD1, ERK1/2, 14-3-3, beta-MHC, SMAD2, Vimentin, I-kB, GSK3 beta, MLC2, FKHR, Beta TnTF, PPARGC1 (PGC1-alpha), ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, TNF-alpha, RelA (p65 NF-kB subunit), iNOS, MLC1F, MyHC, ELAVL1 (HuR), Desmin, MAFbx, ActRIIB, SMAD3, p38 MAPK, mTOR, TGF-beta receptor type I",
551,Signal transduction_Calcium signaling,46,1.462E-04,4.978E-04,3.285E-04,9.016E-04,28,"Calcineurin A (catalytic), NF-AT1(NFATC2), CD44, PP1-cat, CaMK I, FKBP12, HDAC4, HDAC7, CaMK IV, IP3 receptor, PLC-beta, Ca-ATPase2, Ryanodine receptor 1, CREB1, G-protein beta/gamma, RhoA, cPKC (conventional), AKAP6, MEF2, PP2A catalytic, Calcipressin 1, HDAC5, RhoGDI alpha, 14-3-3 beta/alpha, ROCK, Calmodulin, NCX1, PKA-cat (cAMP-dependent)",1.462E-04,4.978E-04,27,"Calcineurin A (catalytic), CD44, PP1-cat, CaMK I, FKBP12, HDAC4, HDAC7, CaMK IV, IP3 receptor, PLC-beta, Ca-ATPase2, Ryanodine receptor 1, CREB1, G-protein beta/gamma, RhoA, Phospholamban, cPKC (conventional), AKAP6, MEF2, PP2A catalytic, Calcipressin 1, HDAC5, RhoGDI alpha, ROCK, Calmodulin, NCX1, PKA-cat (cAMP-dependent)",
552,PGE2 pathways in cancer,55,1.462E-04,4.587E-04,1.462E-04,4.587E-04,33,"PI3K cat class IA (p110-beta), Lef-1, TCF7L2 (TCF4), SLC21A2, Beta-catenin, EGR1, VEGF-A, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), GSK3 beta, PPAR-beta(delta), Adenylate cyclase, CREB1, G-protein beta/gamma, TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Src, c-Myc, Axin, TNF-alpha, PGE2R2, PGE2R4, HIF1A, Tcf(Lef), EGFR, G-protein alpha-i family, PGES, G-protein beta1/gamma2, COX-2 (PTGS2), ABCC4, Elk-1, PKA-cat (cAMP-dependent)",3.822E-04,1.070E-03,30,"PI3K cat class IA (p110-beta), TCF7L2 (TCF4), SLC21A2, Beta-catenin, VEGF-A, PI3K cat class IB (p110-gamma), COX-1 (PTGS1), GSK3 beta, PPAR-beta(delta), Adenylate cyclase, CREB1, G-protein beta/gamma, TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Src, Axin, TNF-alpha, PGE2R2, PGE2R4, HIF1A, Tcf(Lef), EGFR, G-protein alpha-i family, PGES, G-protein beta1/gamma2, COX-2 (PTGS2), ABCC4, Elk-1, PKA-cat (cAMP-dependent)",
553,Cell cycle_Nucleocytoplasmic transport of CDK/Cyclins,14,1.481E-04,4.636E-04,1.481E-04,4.636E-04,12,"CRM1, Cyclin D3, Importin (karyopherin)-alpha, CDK1 (p34), GSK3 beta, CDK4, Cyclin B1, Cyclin D, Karyopherin beta 1, CDK2, Cyclin E, Cyclin A",4.301E-04,1.182E-03,11,"CRM1, Importin (karyopherin)-alpha, CDK1 (p34), GSK3 beta, CDK4, Cyclin B1, Cyclin D, Karyopherin beta 1, CDK2, Cyclin E, Cyclin A",
554,NF-kB pathway in multiple myeloma,35,1.491E-04,5.055E-04,2.235E-04,6.399E-04,23,"CYLD, c-FLIP(Long), I-kB, NF-kB2 (p100), Survivin, IKK-alpha, c-IAP1, NF-kB p52/RelB, IL-6, NF-kB, NF-kB p50/p65, c-Myc, BAFF(TNFSF13B), c-IAP2, LTBR(TNFRSF3), APRIL(TNFSF13), TRAF3, NF-kB1 (p50), NF-kB2 (p52), BAFF-R, XIAP, NIK(MAP3K14), TACI(TNFRSF13B)",1.491E-04,5.055E-04,22,"CYLD, c-FLIP(Long), I-kB, NF-kB2 (p100), Survivin, c-IAP1, NF-kB p52/RelB, IL-6, NF-kB, NF-kB p50/p65, CD40L(TNFSF5), BAFF(TNFSF13B), c-IAP2, LTBR(TNFRSF3), APRIL(TNFSF13), TRAF3, NF-kB1 (p50), NF-kB2 (p52), BAFF-R, XIAP, NIK(MAP3K14), TACI(TNFRSF13B)",
555,IL-6 signaling pathway in lung cancer,35,1.491E-04,5.055E-04,2.235E-04,6.399E-04,23,"JAK1, ERK1/2, VEGF-A, STAT1, I-kB, Survivin, PI3K reg class IA, IKK-alpha, IL-6, NF-kB, AKT(PKB), c-Src, JAK2, PI3K cat class IA, HIF1A, EGFR, MEK3(MAP2K3), COX-2 (PTGS2), ENO2, ATF-2, SHP-2, MMP-10, p38 MAPK",1.491E-04,5.055E-04,22,"JAK1, ERK1/2, VEGF-A, STAT1, I-kB, Survivin, PI3K reg class IA, IL-6, NF-kB, AKT(PKB), c-Src, JAK2, PI3K cat class IA, HIF1A, EGFR, MEK3(MAP2K3), STAT3, COX-2 (PTGS2), ENO2, ATF-2, MMP-10, p38 MAPK",
556,Eosinophil adhesion and transendothelial migration in asthma,68,1.492E-04,4.649E-04,1.492E-04,4.649E-04,39,"Histamine H4 receptor, alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, ICAM1, CD44, C5a, ERK1/2, HTR2A, Fibronectin, c-Kit, PI3K cat class IB (p110-gamma), PSGL-1, GM-CSF, PLAUR (uPAR), Eotaxin, Collagen IV, Oxoeicosanoid receptor 1, P-selectin, C3aR, PTAFR, Osteopontin, VCAM1, Eotaxin-2, PKC-delta, IL-5, Laminin 1, Eotaxin-3, alpha-1/beta-1 integrin, CD67, PLAU (UPA), CCL7, ROCK, Calmodulin, PKC, alpha-2/beta-1 integrin, Fibrinogen (fibrin), C3a, p38 MAPK, MMP-9",5.617E-04,1.450E-03,35,"alpha-6/beta-1 integrin, alpha-4/beta-1 integrin, ICAM1, CD44, C5a, ERK1/2, HTR2A, Fibronectin, c-Kit, PI3K cat class IB (p110-gamma), PSGL-1, GM-CSF, PLAUR (uPAR), Eotaxin, Collagen IV, Oxoeicosanoid receptor 1, P-selectin, PTAFR, Osteopontin, VCAM1, Eotaxin-2, CRTH2, IL-5, Laminin 1, Eotaxin-3, alpha-1/beta-1 integrin, PLAU (UPA), CCL7, ROCK, Calmodulin, PKC, alpha-2/beta-1 integrin, C3a, p38 MAPK, MMP-9",
557,Cell cycle_Influence of Ras and Rho proteins on G1/S Transition,53,1.584E-04,5.334E-04,4.357E-04,1.120E-03,31,"ERK1/2, Rac1, MLCP (reg), GSK3 beta, PI3K reg class IA, CDK4, Cyclin A2, DIA1, IKK-alpha, MEK2(MAP2K2), CDC42, SKP2, AKT(PKB), NF-kB p50/p65, c-Myc, MLCK, MLCP (cat), RhoA, MLK3(MAP3K11), PI3K cat class IA, RelA (p65 NF-kB subunit), ROCK2, alpha-5/beta-1 integrin, JNK1(MAPK8), MEK4(MAP2K4), CDK2, CDK6, ATF-2, Cyclin E, MRLC, RalA",1.584E-04,5.334E-04,30,"ERK1/2, c-Raf-1, MLCP (reg), GSK3 beta, PI3K reg class IA, CDK4, Cyclin A2, DIA1, MEK2(MAP2K2), CDC42, SKP2, AKT(PKB), NF-kB p50/p65, MLCK, MLCP (cat), MEK1(MAP2K1), RhoA, MLK3(MAP3K11), PI3K cat class IA, RelA (p65 NF-kB subunit), ROCK2, alpha-5/beta-1 integrin, JNK1(MAPK8), MEK4(MAP2K4), CDK2, CDK6, STAT3, ATF-2, Cyclin E, MRLC",
558,Immune response_ICOS signaling pathway in T-helper cell,60,1.605E-04,5.368E-04,2.041E-04,6.046E-04,35,"MHC class II, Calcineurin A (catalytic), NF-AT1(NFATC2), IL-10, CD28, VAV-1, Rac1, IP3 receptor, PI3K reg class IA (p85), PI3K reg class IA, FKHR, IL-17F, PLC-gamma 1, ITK, CD4, IL-13, CDC42, AKT(PKB), ICOS, NF-AT2(NFATC1), TNF-alpha, RhoA, Tiam1, Osteopontin, PI3K cat class IA, PI3K reg class IA (p85-alpha), T-bet, IL-5, Bcl-6, 4E-BP1, ROCK, c-Maf, AP-1, Calmodulin, CD3",1.605E-04,5.368E-04,33,"MHC class II, Calcineurin A (catalytic), IL-10, IFN-gamma, CXCR5, CD28, IL-17, VAV-1, IP3 receptor, PI3K reg class IA (p85), PI3K reg class IA, FKHR, IL-17F, PLC-gamma 1, CD4, CDC42, AKT(PKB), NF-AT2(NFATC1), CD40L(TNFSF5), TNF-alpha, RhoA, Tiam1, Osteopontin, PI3K cat class IA, PI3K reg class IA (p85-alpha), T-bet, IL-5, Bcl-6, ROCK, c-Maf, Calmodulin, CD3, IL-21",
559,Pro-oncogenic action of Estradiol/ Estrogen receptors in ovarian cancer,60,1.605E-04,5.368E-04,2.041E-04,6.046E-04,35,"GnRH1, CD44, Fra-1, Caspase-4, Fibronectin, 14-3-3 theta, IBP3, I-kB, BETA-IG-H3, MALL, Survivin, PI3K reg class IA, Cyclin A2, IKK-alpha, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, c-Src, c-Myc, TERT, Keratin 7, PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, ASK1 (MAP3K5), IQGAP1, Fibulin-1, Leptin receptor, MKK7 (MAP2K7), PLAU (UPA), MEK4(MAP2K4), Cyclin E, JNK(MAPK8-10), Elk-1, MMP-9",1.605E-04,5.368E-04,33,"GnRH1, CD44, Fra-1, Caspase-4, Fibronectin, 14-3-3 theta, IBP3, I-kB, BETA-IG-H3, MALL, Survivin, PI3K reg class IA, Cyclin A2, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, c-Src, TERT, PI3K cat class IA, RelA (p65 NF-kB subunit), TERC, EGFR, ASK1 (MAP3K5), IQGAP1, Fibulin-1, Leptin receptor, PLAU (UPA), MEK4(MAP2K4), STAT3, Cyclin E, JNK(MAPK8-10), Elk-1, MMP-9",
560,Cell adhesion_Integrin inside-out signaling in neutrophils,77,1.606E-04,4.985E-04,1.606E-04,4.985E-04,43,"PREL1, ICAM1, CD44, PKC-zeta, G-protein alpha-i2, FPR, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, Syk, Talin, RAP-1A, L-selectin, GRO-1, VASP, PSGL-1, MEK1/2, G-protein beta/gamma, ERK2 (MAPK1), Cytohesin1, P-selectin, PTAFR, iNOS, Slp76, CALDAG-GEFI, ITGB2, PKC-delta, IL-8, Lyn, G-protein alpha-i family, Protein kinase G, FGR, C3G, PLD2, RAGE, DAP12, Talin-1, FYB1, PI3K reg class IB (p101), PLC-beta3, PLC-gamma 2, p38 MAPK, PLC-beta2",9.539E-04,2.282E-03,38,"PREL1, ICAM1, CD44, G-protein alpha-i2, FPR, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, Talin, RAP-1A, L-selectin, GRO-1, VASP, PSGL-1, MEK1/2, G-protein beta/gamma, ERK2 (MAPK1), Cytohesin1, P-selectin, MEK1(MAP2K1), PTAFR, iNOS, Slp76, ITGB2, IL-8, Lyn, G-protein alpha-i family, Protein kinase G, FGR, PLD2, RAGE, DAP12, Talin-1, FYB1, PLC-beta3, PLC-gamma 2, p38 MAPK, PLC-beta2",
561,Signal transduction_PDGF signaling via JAK-STAT and reactive oxygen species (ROS),66,1.617E-04,5.007E-04,1.617E-04,5.007E-04,38,"Cyclin D3, IP10, JAK1, SOD2, CCL2, Tyk2, ERK1/2, EGR1, PKA-reg (cAMP-dependent), PDGF-R-alpha, STAT1, Rac1, VASP, cPLA2, PLC-gamma 1, PDGF-C, PDGFR-ab, PDGF receptor, c-Src, c-Myc, NOX5, NF-AT2(NFATC1), PDGF-D, JAK2, PKR, HIF1A, I-TAC, PDGF-A, 14-3-3 gamma, CCL7, NOX4/p22-phox, c-Abl, SSH1L, Elk-1, PKA-cat (cAMP-dependent), SRF, Cofilin, PDGF-R-beta",2.679E-04,8.052E-04,35,"MIG, IP10, JAK1, SOD2, CCL2, Tyk2, ERK1/2, PDGF-R-alpha, STAT1, VASP, cPLA2, PLC-gamma 1, PDGF-C, PDGFR-ab, PDGF receptor, c-Src, NOX5, NF-AT2(NFATC1), PDGF-D, JAK2, PKR, HIF1A, I-TAC, PDGF-A, 14-3-3 gamma, CCL7, NOX4/p22-phox, STAT3, c-Abl, SSH1L, Elk-1, PKA-cat (cAMP-dependent), SRF, Cofilin, PDGF-R-beta",
562,Development_EGF-induced proliferation of Type C cells in SVZ of adult brain,33,1.636E-04,5.435E-04,7.002E-03,1.281E-02,19,"alphaAPPs, ERK1/2, APP, Smoothened, GLI-2, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), Fyn, TGF-alpha, AKT(PKB), PI3K cat class IA, PTCH1, EGFR, SOS, DLX2, GLI-1, APLP2 active fragment, Prolactin",1.636E-04,5.435E-04,21,"alphaAPPs, ERK1/2, c-Raf-1, APP, Smoothened, GLI-2, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), Fyn, TGF-alpha, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, PTCH1, EGFR, SOS, DLX2, GLI-1, APLP2 active fragment, Prolactin",
563,SHH signaling in melanoma,33,1.636E-04,5.435E-04,7.953E-04,1.898E-03,21,"TGF-beta 1, PDGF-R-alpha, KIF27, Vimentin, Smoothened, GLI-2, N-Ras, MMP-2, CREB1, N-cadherin, Osteopontin, B-Raf, PTCH1, FOXM1, PI3K cat class IA (p110-alpha), SLUG, GLI-1, SMAD3, MITF, MMP-9, PKA-cat (cAMP-dependent)",1.636E-04,5.435E-04,21,"TGF-beta 1, PDGF-R-alpha, Vimentin, Smoothened, GLI-2, N-Ras, MMP-2, CREB1, MEK1(MAP2K1), N-cadherin, Osteopontin, B-Raf, PTCH1, FOXM1, PI3K cat class IA (p110-alpha), SLUG, GLI-1, SMAD3, MITF, MMP-9, PKA-cat (cAMP-dependent)",
564,Signal transduction_PKA signaling,51,1.652E-04,5.094E-04,1.652E-04,5.094E-04,31,"LBC, AKAP3, AKAP11, AKAP82, KDELR, PP2A regulatory, PKA-reg (cAMP-dependent), SMAD4, PDE3A, AKAP8, BAD, PDE4A, Adenylate cyclase, Ryanodine receptor 1, GSK3 alpha/beta, NFKBIB, CREB1, WASF1(WAVE1), GABA-A receptor beta-2 subunit, PKI, G-protein alpha-12 family, PKA-cat alpha, G-protein alpha-i family, GABA-A receptor beta-1 subunit, PHK gamma, DARPP-32, AKAP7 gamma, AKAP12, PCTK1, SMAD3, PKA-cat (cAMP-dependent)",1.822E-04,5.946E-04,29,"LBC, AKAP3, AKAP11, AKAP82, KDELR, PP2A regulatory, SMAD4, PDE3A, Meprin A, beta, AKAP8, PDE4A, Adenylate cyclase, Ryanodine receptor 1, GSK3 alpha/beta, NFKBIB, CREB1, WASF1(WAVE1), PKI, G-protein alpha-12 family, PKA-cat alpha, G-protein alpha-i family, PHK gamma, p90RSK1, DARPP-32, AKAP7 gamma, AKAP12, PCTK1, SMAD3, PKA-cat (cAMP-dependent)",
565,Transition of HCC cells to invasive and migratory phenotype,44,1.661E-04,5.505E-04,3.474E-04,9.519E-04,27,"TIP30, JAK1, Beta-catenin, Matrilysin (MMP-7), EGR1, Caspase-8, Vimentin, STAT5B, GSK3 beta, SIAH1, SIP1 (ZFHX1B), MMP-2, TWIST1, AKT(PKB), c-Src, Pyk2(FAK2), N-cadherin, PI3K cat class IA, p130CAS, MMP-14, DNMT1, SNAIL1, HDAC1, p53, ADAM17, MMP-9, SRF",1.661E-04,5.505E-04,26,"TIP30, JAK1, Beta-catenin, Matrilysin (MMP-7), Caspase-8, Vimentin, STAT5B, GSK3 beta, SIAH1, SIP1 (ZFHX1B), MMP-2, TWIST1, AKT(PKB), c-Src, Pyk2(FAK2), N-cadherin, PI3K cat class IA, p130CAS, MMP-14, DNMT1, SNAIL1, HDAC1, p53, ADAM17, MMP-9, SRF",
566,Apoptosis and survival_DNA-damage-induced apoptosis,15,1.690E-04,5.589E-04,5.019E-04,1.273E-03,12,"BLM, FANCL, Chk1, FANCD2, Nibrin, Brca1, DNA-PK, ATR, RAD9, ATM, c-Abl, p53",1.690E-04,5.589E-04,12,"BLM, FANCL, Chk1, FANCD2, Chk2, Brca1, DNA-PK, ATR, RAD9, ATM, c-Abl, p53",
567,Stem cells_Aberrant Wnt signaling in medulloblastoma stem cells,23,1.731E-04,5.318E-04,1.731E-04,5.318E-04,17,"Casein kinase II, alpha chains, CD44, APC protein, Lef-1, TCF7L2 (TCF4), DKK1, Casein kinase I epsilon, Beta-catenin, Matrilysin (MMP-7), Dsh, GSK3 beta, LRP5, AKT(PKB), c-Myc, Axin, WNT, Frizzled",3.772E-03,7.449E-03,14,"Casein kinase II, alpha chains, CD44, APC protein, TCF7L2 (TCF4), DKK1, Casein kinase I epsilon, Beta-catenin, Matrilysin (MMP-7), Dsh, GSK3 beta, AKT(PKB), Axin, WNT, Frizzled",
568,Action of GSK3 beta in bipolar disorder,23,1.731E-04,5.318E-04,1.731E-04,5.318E-04,17,"APC protein, Lef-1, TCF7L2 (TCF4), Beta-catenin, Bax, GSK3 beta, CREB1, NeuroD1, c-Myc, REV-ERBalpha, Heme oxygenase 1, MAP-1B, Tcf(Lef), HDAC1, KCNQ2, p53, NRF2",1.214E-02,2.079E-02,13,"APC protein, TCF7L2 (TCF4), Beta-catenin, Bax, GSK3 beta, CREB1, NeuroD1, Heme oxygenase 1, MAP-1B, Tcf(Lef), HDAC1, p53, NRF2",
569,Neutrophil adhesion and transendothelial migration in asthma,31,1.780E-04,5.836E-04,7.638E-03,1.387E-02,18,"GLG1, alpha-4/beta-1 integrin, HMGB1, ICAM1, alpha-9/beta-1 integrin, C5a, ERK1/2, L-selectin, PSGL-1, cPLA2, MEK1/2, P-selectin, TNF-alpha, PTAFR, VCAM1, IL-8, Substance P receptor, RAGE",1.780E-04,5.836E-04,20,"GLG1, alpha-4/beta-1 integrin, HMGB1, ICAM1, alpha-9/beta-1 integrin, C5a, ERK1/2, IL-17, c-Raf-1, L-selectin, PSGL-1, cPLA2, MEK1/2, P-selectin, TNF-alpha, PTAFR, VCAM1, IL-8, Substance P receptor, RAGE",
570,Development_Dopamine-induced transactivation of EGFR in SVZ neural stem cells,31,1.780E-04,5.836E-04,7.638E-03,1.387E-02,18,"ADAM12, ERK1/2, HB-EGF, PAX6, Shc, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, TGF-alpha, c-Src, Dopamine D2 receptor, EGFR, G-protein alpha-i family, c-Jun, SOS, PKC, ADAM17, Elk-1",1.780E-04,5.836E-04,20,"ADAM12, ERK1/2, HB-EGF, c-Raf-1, PAX6, Shc, PLC-beta, Dopamine D3 receptor, MEK2(MAP2K2), G-protein beta/gamma, TGF-alpha, c-Src, Dopamine D2 receptor, MEK1(MAP2K1), EGFR, G-protein alpha-i family, SOS, PKC, ADAM17, Elk-1",
571,Development_PIP3 signaling in cardiac myocytes,47,1.840E-04,5.618E-04,1.840E-04,5.618E-04,29,"RHEB2, IRS-1, RPS6, 14-3-3, PKC-zeta, PI3K cat class IB (p110-gamma), BAD, Shc, PI3K reg class IA, GSK3 alpha/beta, CREB1, G-protein beta/gamma, CDC42, AKT(PKB), c-Myc, HGF, G-protein alpha-12 family, PI3K cat class IA, PARD3, Cyclin D, PTP-1B, SOS, Hamartin, p90Rsk, 4E-BP1, FOXO3A, HGF receptor (Met), PI3K reg class IB (p101), mTOR",7.815E-02,1.102E-01,20,"RHEB2, RPS6, 14-3-3, PI3K cat class IB (p110-gamma), Shc, PI3K reg class IA, GSK3 alpha/beta, CREB1, G-protein beta/gamma, CDC42, AKT(PKB), HGF, G-protein alpha-12 family, PI3K cat class IA, PARD3, Cyclin D, SOS, p90Rsk, HGF receptor (Met), mTOR",
572,Role of B cells in SLE,58,1.858E-04,6.053E-04,5.758E-04,1.437E-03,33,"OX40L(TNFSF4), MHC class II, ICAM1, CD28, OX40(TNFRSF4), IFN-alpha/beta receptor, Bak, Syk, NF-kB p50/p50, PI3K reg class IA, IFN-alpha, BCMA(TNFRSF17), MHC class I, IL-6, CD22, NF-kB, SHIP, AKT(PKB), ICOS, BAFF(TNFSF13B), TNF-alpha, PI3K cat class IA, CD45, APRIL(TNFSF13), NF-kB1 (p50), c-Cbl, Lyn, BAFF-R, RelB (NF-kB subunit), NF-kB p50/RelB, TNF-beta, TACI(TNFRSF13B), CD86",1.858E-04,6.053E-04,32,"OX40L(TNFSF4), MHC class II, ICAM1, IFN-gamma, CD28, OX40(TNFRSF4), IFN-alpha/beta receptor, Syk, NF-kB p50/p50, PI3K reg class IA, IFN-alpha, BCMA(TNFRSF17), MHC class I, IL-6, NF-kB, AKT(PKB), CD40L(TNFSF5), BAFF(TNFSF13B), TNF-alpha, CD80, PI3K cat class IA, CD45, APRIL(TNFSF13), NF-kB1 (p50), c-Cbl, Lyn, BAFF-R, RelB (NF-kB subunit), NF-kB p50/RelB, TNF-beta, TACI(TNFRSF13B), CD86",
573,Transcription targets of Androgen receptor involved in Prostate Cancer,42,1.882E-04,6.117E-04,3.659E-04,9.971E-04,26,"TGF-beta 1, TMPRSS2, Versican, Matrilysin (MMP-7), VEGF-A, APP, FGF8, Elk-4, IBP3, ADAM9, Caspase-2, IL-6, ADAM10, c-Myc, TERT, Prosaposin, N-cadherin, PKC-delta, KLF5, IL-8, NCOA2 (GRIP1/TIF2), PAR1, c-FLIP, ER81, ADAM17, TLR2",1.882E-04,6.117E-04,25,"TGF-beta 1, TMPRSS2, Kallikrein 4, Versican, Matrilysin (MMP-7), VEGF-A, APP, FGF8, Elk-4, IBP3, ADAM9, Caspase-2, IL-6, ADAM10, TERT, Prosaposin, N-cadherin, KLF5, IL-8, NCOA2 (GRIP1/TIF2), PAR1, c-FLIP, ER81, ADAM17, TLR2",
574,Abnormalities in cell cycle in SCLC,29,1.918E-04,6.167E-04,2.160E-04,6.312E-04,20,"p14ARF, E2F3, CDK1 (p34), E2F2, CKS1, CDK4, SKP2, Cyclin B1, p16INK4, c-Myc, Cyclin E2, CDK2, CDK6, PCNA, Miz-1, Cyclin E, p15, Cyclin A, Aurora-B, p53",1.918E-04,6.167E-04,19,"p14ARF, E2F3, CDK1 (p34), E2F2, CKS1, CDK4, SKP2, Cyclin B1, p16INK4, Cyclin E2, CDK2, CDK6, PCNA, Miz-1, Cyclin E, p15, Cyclin A, Aurora-B, p53",
575,Histone deacetylases in Prostate Cancer,29,1.918E-04,6.167E-04,8.372E-04,1.984E-03,19,"HDAC9, TMPRSS2, HDAC4, HDAC7, HDAC3, HDAC6, Bax, HDAC2, FKHR, HSP90, HIF1A, HDAC10, HDAC5, Sirtuin2, Tubulin alpha, Sirtuin5, HDAC8, HDAC1, p53",1.918E-04,6.167E-04,19,"HDAC9, TMPRSS2, HDAC4, HDAC7, HDAC3, HDAC6, Bax, HDAC2, FKHR, HSP90, HIF1A, HDAC10, HDAC5, Sirtuin2, Tubulin alpha, Sirtuin5, HDAC8, HDAC1, p53",
576,A proinflammatory phenotype of senescent alveolar epithelial cells in COPD,25,1.920E-04,5.792E-04,1.920E-04,5.792E-04,18,"Casein kinase II, alpha chains, CBP, I-kB, HDAC2, IKK-alpha, IL-6, NF-kB p50/p65, TNF-R1, p16INK4, TERT, TNF-alpha, RelA (p65 NF-kB subunit), IL-8, NIK(MAP3K14), p300, PI3K cat class IA (p110-delta), FOXO3A, p53",9.126E-04,2.190E-03,16,"Casein kinase II, alpha chains, CBP, I-kB, HDAC2, IL-6, NF-kB p50/p65, TNF-R1, p16INK4, TERT, TNF-alpha, RelA (p65 NF-kB subunit), IL-8, NIK(MAP3K14), p300, PI3K cat class IA (p110-delta), p53",
577,Transcription_Transcription regulation of aminoacid metabolism,25,1.920E-04,5.792E-04,1.920E-04,5.792E-04,18,"DCOR, ERK1/2, FECH, NF-E2 (45 kDa), MAFG, MafK, c-Myc, ZNF148, ALAS2, KEAP1, GCL reg, c-Maf, AP-1, PKC, ASSY, HMBS, GCL cat, NRF2",9.126E-04,2.190E-03,16,"p38alpha (MAPK14), DCOR, ERK1/2, GATA-1, NF-E2 (45 kDa), MAFG, ZNF148, ALAS2, KEAP1, GCL reg, c-Maf, PKC, ASSY, HMBS, GCL cat, NRF2",
578,Role of keratinocytes and Langerhans cells in skin sensitization,25,1.920E-04,5.792E-04,1.920E-04,5.792E-04,18,"TNF-R2, IL-18R1, MHC class II, CARD8, IL-1 beta, I-kB, MyD88, MHC class I, NF-kB p50/p65, Caspase-1, TNF-alpha, IL-18, TRAF6, c-Jun, CCL19, NIK(MAP3K14), IRAK1, NALP3",9.126E-04,2.190E-03,16,"TNF-R2, IL-18R1, MHC class II, CCL21, IL-1 beta, I-kB, MHC class I, NF-kB p50/p65, Caspase-1, TNF-alpha, IL-18, TRAF6, CCL19, NIK(MAP3K14), IRAK1, NALP3",
579,Transport_RAB5A regulation pathway,25,1.920E-04,5.792E-04,1.920E-04,5.792E-04,18,"PI3K cat class IA (p110-beta), ALS2, APPL1, p120GAP, RABGEF1, EPS8, RNTRE, Syntaxin 4, PI3K reg class III (p150), Rab5ip, EGFR, RUFY2, INPP4A, ANKRD27(Varp), Rab-5A, Rabenosyn-5, RIN1, I5P2",1.038E-02,1.803E-02,14,"PI3K cat class IA (p110-beta), ALS2, APPL1, p120GAP, EPS8, RNTRE, PI3K reg class III (p150), EGFR, INPP4A, ANKRD27(Varp), Rab-5A, Rabenosyn-5, RIN1, I5P2",
580,Dual role of BMP signaling in gastric cancer,25,1.920E-04,5.792E-04,1.920E-04,5.792E-04,18,"SMAD5, BMP receptor 2, BMP4, SMAD4, I-kB, PI3K reg class IA (p85), IKK-alpha, BMPR1B, AKT(PKB), LI-cadherin, PI3K cat class IA, RelA (p65 NF-kB subunit), CDX2, SMAD9 (SMAD8), BMPR1A, SMAD1, SNAIL1, BMP2",9.126E-04,2.190E-03,16,"SMAD5, BMP receptor 2, BMP4, SMAD4, I-kB, PI3K reg class IA (p85), BMPR1B, AKT(PKB), LI-cadherin, PI3K cat class IA, RelA (p65 NF-kB subunit), CDX2, SMAD9 (SMAD8), BMPR1A, SNAIL1, BMP2",
581,IL-1 production in melanoma,17,1.968E-04,6.287E-04,6.182E-04,1.516E-03,13,"IL-1 alpha, ERK1/2, BGAL, IL-1 beta, I-kB, N-Ras, MEK1/2, NF-kB, NF-kB p50/p65, Caspase-1, RelA (p65 NF-kB subunit), B-Raf, NALP3",1.968E-04,6.287E-04,13,"IL-1 alpha, ERK1/2, BGAL, IL-1 beta, I-kB, N-Ras, MEK1/2, NF-kB, NF-kB p50/p65, Caspase-1, RelA (p65 NF-kB subunit), B-Raf, NALP3",
582,Involvement of VEGF signaling in the progression of lung cancer,17,1.968E-04,6.287E-04,6.182E-04,1.516E-03,13,"CNTN1 (F3), ERK1/2, VEGF-A, VEGFR-2, VEGF-B, Fyn, AKT(PKB), c-Src, RhoA, C/EBPbeta, VEGFR-3, VEGF-C, p38 MAPK",1.968E-04,6.287E-04,13,"CNTN1 (F3), ERK1/2, VEGF-A, VEGFR-2, VEGF-B, Fyn, AKT(PKB), c-Src, RhoA, C/EBPbeta, VEGFR-3, VEGF-C, p38 MAPK",
583,Immune response_BAFF-induced canonical NF-kB signaling,43,2.015E-04,5.992E-04,2.015E-04,5.992E-04,27,"c-Rel (NF-kB subunit), NF-kB p50/c-Rel, IP3 receptor, Ubiquitin, NF-kB2 (p100), IRAK4, MyD88, IKK-alpha, BCMA(TNFRSF17), NF-kB p50/p65, UEV1A, TAK1(MAP3K7), BAFF(TNFSF13B), NF-kB1 (p105), NF-kB1 (p50), BAFF-R, TRAF6, NIK(MAP3K14), Cul1/Rbx1 E3 ligase, CARD11, PKC-beta, UBE1, MALT1, IRAK1, TACI(TNFRSF13B), Bcl-10, PLC-gamma 2",2.527E-03,5.269E-03,23,"c-Rel (NF-kB subunit), NF-kB p50/c-Rel, IP3 receptor, Ubiquitin, NF-kB2 (p100), IRAK4, BCMA(TNFRSF17), NF-kB p50/p65, TAK1(MAP3K7), BAFF(TNFSF13B), NF-kB1 (p105), NF-kB1 (p50), BAFF-R, TRAF6, NIK(MAP3K14), Cul1/Rbx1 E3 ligase, CARD11, PKC-beta, MALT1, IRAK1, TACI(TNFRSF13B), Bcl-10, PLC-gamma 2",
584,Signal transduction_AKT signaling,43,2.015E-04,5.992E-04,2.015E-04,5.992E-04,27,"RHEB2, Cyclin D3, IRS-1, RPS6, BAD, I-kB, Bax, PI3K reg class IA, IKK-alpha, GSK3 alpha/beta, FasL(TNFSF6), NF-kB, AKT(PKB), HSP90, c-Myc, PI3K cat class IA, Cyclin D, PP2A catalytic, Caspase-9, Hamartin, PCNA, 4E-BP1, FOXO3A, p53, HGF receptor (Met), Bim, mTOR",1.056E-01,1.445E-01,18,"RHEB2, RPS6, I-kB, Bax, PI3K reg class IA, GSK3 alpha/beta, NF-kB, AKT(PKB), HSP90, PI3K cat class IA, Cyclin D, PP2A catalytic, Caspase-9, PCNA, p53, HGF receptor (Met), Bim, mTOR",
585,Apoptosis and survival_TNF-alpha-induced Caspase-8 signaling,43,2.015E-04,5.992E-04,2.015E-04,5.992E-04,27,"Caspase-6, Apaf-1, CYLD, PP2A regulatory, Caspase-8, Acid sphingomyelinase, Bax, PP2A structural, Caspase-3, RIPK1, Caspase-2, AKT(PKB), HSP90, TNF-R1, TNF-alpha, c-Cbl, FAN, PP2A catalytic, Caspase-9, Cathepsin B, Caspase-7, CLIP3, tBid, AKT2, c-FLIP(Short), ADAM17, Bid",3.146E-04,9.098E-04,25,"Caspase-6, Apaf-1, CYLD, PP2A regulatory, Caspase-8, Acid sphingomyelinase, Bax, PP2A structural, Caspase-3, RIPK1, Caspase-2, AKT(PKB), HSP90, TNF-R1, TNF-alpha, c-Cbl, FAN, PP2A catalytic, Caspase-9, Cathepsin B, CLIP3, tBid, c-FLIP(Short), ADAM17, Bid",
586,Transport_Clathrin-coated vesicle cycle,71,2.087E-04,6.157E-04,2.087E-04,6.157E-04,40,"NSF, AP180, Myosin I, Rab-8, Eps15, PICALM, PI3K cat class III (Vps34), Dynamin-2, Actin, YKT6, RABGEF1, Rab-7, Epsin 1, Syntaxin 5, Syntaxin 12, BIN1 (Amphiphysin II), TIP47, GDI2, Actin cytoskeletal, Optineurin, RABGDIA, VAMP2, Syntaxin 6, PI3K reg class III (p150), VAMP7, HIP1, PIP5KIII, GOS-28, SNX9, VAMP4, Syntaxin 8, Syntaxin 7, Rab-5A, Rabenosyn-5, Endophilin B1, RILP (Rab interacting lysosomal protein), Rab-9, Rab11-FIP2, PREB, Rip11",6.799E-04,1.711E-03,36,"AP180, Myosin I, SNAP-25, Rab-8, Eps15, PICALM, PI3K cat class III (Vps34), Dynamin-2, Actin, YKT6, Epsin 1, Syntaxin 5, Syntaxin 12, BIN1 (Amphiphysin II), TIP47, GDI2, Actin cytoskeletal, Optineurin, RABGDIA, VAMP2, Syntaxin 6, PI3K reg class III (p150), VAMP7, HIP1, PIP5KIII, SNX9, Syntaxin 8, Syntaxin 7, Rab-5A, Rabenosyn-5, Endophilin B1, RILP (Rab interacting lysosomal protein), Rab-9, Rab11-FIP2, PREB, Rip11",
587,Transcription_Sin3 and NuRD in transcription regulation,41,2.091E-04,6.157E-04,2.091E-04,6.157E-04,26,"RARbeta, SMRT, SAP130, PPAR-alpha, RBBP4 (RbAp48), ARID4A, MBD2, HDAC2, Mi-2 beta, NRSF, Mi-2 alpha, N-CoR, ARID4B, p66beta, PSF, Mi-2, Sin3A, MTA2, SAP18, RBBP7 (RbAp46), Sin3B, HDAC1, SAP30, MBD3, NRB54, p66alpha",6.902E-02,9.809E-02,18,"RARbeta, SMRT, SAP130, PPAR-alpha, RBBP4 (RbAp48), MBD2, HDAC2, Mi-2 alpha, N-CoR, PSF, Mi-2, Sin3A, RBBP7 (RbAp46), Sin3B, HDAC1, SAP30, NRB54, p66alpha",
588,Neutrophil-derived granule proteins and cytokines in asthma,49,2.093E-04,6.600E-04,5.047E-04,1.273E-03,29,"TGF-beta 1, IP10, PAR2, C5a, ERK1/2, RNS2, Rac2, TSLP, PI3K cat class IB (p110-gamma), Syk, GM-CSF, IL-13, MEK1/2, MMP-8, PRG2, TNF-alpha, CHI3L1, TGF-beta 2, PTAFR, IL-8, FGR, Leukocyte elastase, Tryptase, DAP12, PKC, Oncostatin M, Fibrinogen (fibrin), Alpha-defensin, MMP-9",2.093E-04,6.600E-04,28,"TGF-beta 1, IP10, PAR2, C5a, ERK1/2, RNS2, IL-17, Rac2, TSLP, PI3K cat class IB (p110-gamma), Syk, GM-CSF, MEK1/2, MMP-8, PRG2, TNF-alpha, CHI3L1, TGF-beta 2, PTAFR, IL-8, FGR, Leukocyte elastase, Tryptase, DAP12, PKC, Oncostatin M, Alpha-defensin, MMP-9",
589,Development_PEDF signaling,49,2.093E-04,6.600E-04,5.047E-04,1.273E-03,29,"Fra-1, SOD2, ERK1/2, BFL1, VEGF-A, p90RSK2(RPS6KA3), c-FLIP(Long), VEGFR-2, NF-kB p50/p50, IL-1 beta, PI3K reg class IA, IKK-alpha, c-IAP1, CREB1, IL-6, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-alpha, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB1 (p50), Fra-2, NGF, GDNF, PEDF (serpinF1), c-FLIP(Short), BDNF",2.093E-04,6.600E-04,28,"Fra-1, SOD2, ERK1/2, BFL1, VEGF-A, p90RSK2(RPS6KA3), c-FLIP(Long), VEGFR-2, NF-kB p50/p50, IL-1 beta, PI3K reg class IA, c-IAP1, CREB1, IL-6, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-alpha, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), NF-kB1 (p50), Fra-2, NGF, GDNF, PEDF (serpinF1), c-FLIP(Short), BDNF",
590,Role of IL-8 in colorectal cancer,19,2.134E-04,6.667E-04,3.238E-03,6.463E-03,13,"ICAM1, CD44, ERK1/2, HB-EGF, IL-1 beta, MMP-2, MEK1/2, TNF-alpha, HGF, PI3K cat class IA, IL-8, EGFR, HGF receptor (Met)",2.134E-04,6.667E-04,14,"ICAM1, CD44, IFN-gamma, ERK1/2, HB-EGF, IL-1 beta, MMP-2, MEK1/2, TNF-alpha, HGF, PI3K cat class IA, IL-8, EGFR, HGF receptor (Met)",
591,Airway smooth muscle contraction in asthma,56,2.151E-04,6.685E-04,2.365E-04,6.727E-04,33,"LARG, ARHGEF1 (p115RhoGEF), PKA-reg (cAMP-dependent), TRPC6, G-protein alpha-q/11, IP3 receptor, MLCP (reg), PLC-beta, Adenylate cyclase, Ca-ATPase2, MLCK, MLCP (cat), PGE2R2, RhoA, GEFT, G-protein alpha-i family, PGF2aR, Myosin II, CPI-17, MyHC, Bradykinin, ACM3, Histamine H1 receptor, ROCK, PDZ-RhoGEF, Calmodulin, TRPC3, PKC-alpha, MRLC, Telokin, Beta-2 adrenergic receptor, MELC, PKA-cat (cAMP-dependent)",2.151E-04,6.685E-04,31,"ARHGEF1 (p115RhoGEF), TRPC6, G-protein alpha-q/11, IP3 receptor, MLCP (reg), PLC-beta, Adenylate cyclase, Ca-ATPase2, MLCK, MLCP (cat), PGE2R2, RhoA, Phospholamban, GEFT, G-protein alpha-i family, PGF2aR, Myosin II, CPI-17, MyHC, ACM3, Histamine H1 receptor, ROCK, PDZ-RhoGEF, Calmodulin, TRPC3, PKC-alpha, MRLC, Telokin, Beta-2 adrenergic receptor, MELC, PKA-cat (cAMP-dependent)",
592,Cell cycle_Role of SCF complex in cell cycle regulation,29,2.160E-04,6.312E-04,2.160E-04,6.312E-04,20,"CDC25A, SKP1, CDK1 (p34), Ubiquitin, Chk1, CKS1, CDK4, CDC34, Skp2/TrCP/FBXW, SKP2, Emi1, PLK1, Cul1/Rbx1 E3 ligase, CDK2, Cullin 1, UBE1, Cyclin E, RING-box protein 1, SMAD3, Cdt1",7.465E-04,1.860E-03,18,"CDC25A, SKP1, CDK1 (p34), Ubiquitin, Chk1, CKS1, CDK4, Skp2/TrCP/FBXW, SKP2, Emi1, PLK1, Cul1/Rbx1 E3 ligase, CDK2, Cullin 1, Cyclin E, RING-box protein 1, SMAD3, Cdt1",
593,Immune response_Delta-type opioid receptor signaling in T-cells,29,2.160E-04,6.312E-04,2.160E-04,6.312E-04,20,"PI3K cat class IB (p110-gamma), Rac1, G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, IL-2, Metenkefalin, Delta-type opioid receptor, PKC-delta, G-protein alpha-i family, c-Jun, MKK7 (MAP2K7), MEK4(MAP2K4), MEKK1(MAP3K1), ATF-2, JNK(MAPK8-10), PI3K reg class IB (p101), Elk-1, SRF",2.000E-02,3.246E-02,15,"c-Raf-1, PI3K cat class IB (p110-gamma), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, IL-2, MEK1(MAP2K1), Metenkefalin, G-protein alpha-i family, MEK4(MAP2K4), ATF-2, JNK(MAPK8-10), Elk-1, SRF",
594,Role of IL-17-producing T cells in allergic contact dermatitis,23,2.201E-04,6.783E-04,1.050E-02,1.835E-02,14,"MHC class II, ICAM1, CD28, IL-17 receptor, GRO-1, GM-CSF, CD4, IL-6, FasL(TNFSF6), IL-23, IL-8, IFN-gamma receptor, FasR(CD95), CD86",2.201E-04,6.783E-04,16,"MHC class II, ICAM1, IFN-gamma, CD28, IL-17, IL-17 receptor, GRO-1, GM-CSF, CD4, IL-6, IL-23, CD80, IL-8, IFN-gamma receptor, FasR(CD95), CD86",
595,Inflammatory response in ischemia-reperfusion injury during myocardial infarction,21,2.205E-04,6.783E-04,7.737E-04,1.855E-03,15,"HMGB1, ICAM1, CCL2, C5a, IL-1 beta, PSGL-1, IL-6, NF-kB, HSP70, P-selectin, TNF-alpha, IL-8, TLR4, C3a, TLR2",2.205E-04,6.783E-04,15,"HMGB1, ICAM1, CCL2, C5a, IL-1 beta, PSGL-1, IL-6, NF-kB, HSP70, P-selectin, TNF-alpha, IL-8, TLR4, C3a, TLR2",
596,Autophagy_Autophagy,35,2.235E-04,6.399E-04,2.235E-04,6.399E-04,23,"APG3, Raptor, APG10, PI3K cat class III (Vps34), BAD, WIPI2, MyD88, AMBRA1, PI3K reg class III (p150), MAP1LC3B, GATE-16, GABARAP, DAPK1, Barkor, APG7, MAP1LC3A, Endophilin B1, APG5, ATG13, Beclin 1, APG12, mTOR, FIP200",2.800E-02,4.406E-02,17,"APG3, Raptor, APG10, PI3K cat class III (Vps34), WIPI2, PI3K reg class III (p150), MAP1LC3B, GATE-16, GABARAP, DAPK1, Barkor, APG7, MAP1LC3A, Endophilin B1, APG5, mTOR, FIP200",
597,Role of growth factor receptors transactivation by Hyaluronic acid / CD44 signaling in tumor progression,35,2.235E-04,6.399E-04,2.235E-04,6.399E-04,23,"TGF-beta 1, CD44, LARG, ERK1/2, MDR1, p47-phox, Rac1, MMP-2, MEK1/2, HGF, Ankyrin 1, PI3K cat class IA, PKC-delta, EGFR, c-Jun, JNK1(MAPK8), RhoGDI alpha, PKC-alpha, PTHrP, SMAD3, HGF receptor (Met), MMP-9, TGF-beta receptor type I",5.267E-04,1.362E-03,21,"TGF-beta 1, CD44, ERK1/2, c-Raf-1, MDR1, p47-phox, MMP-2, MEK1/2, HGF, Ankyrin 1, PI3K cat class IA, EGFR, p67-phox, JNK1(MAPK8), RhoGDI alpha, PKC-alpha, PTHrP, SMAD3, HGF receptor (Met), MMP-9, TGF-beta receptor type I",
598,TNF-alpha and IL-1 beta induce hyperglycemia in obesity and type 2 diabetes in adipocytes,35,2.235E-04,6.399E-04,2.235E-04,6.399E-04,23,"TNF-R2, GPX3, IRS-1, NGAL, PKC-zeta, GLUT4, APP, IL-1 beta, SOCS3, MEK2(MAP2K2), TPL2(MAP3K8), NF-kB, ERK2 (MAPK1), TNF-R1, TNF-alpha, Sequestosome 1(p62), RelA (p65 NF-kB subunit), Sortilin, PTP-1B, JNK1(MAPK8), IRAK1, AKT2, p38 MAPK",4.733E-03,9.071E-03,19,"TNF-R2, NGAL, APP, GRB14, IL-1 beta, SOCS3, MEK2(MAP2K2), TPL2(MAP3K8), NF-kB, ERK2 (MAPK1), TNF-R1, TNF-alpha, MEK1(MAP2K1), Sequestosome 1(p62), RelA (p65 NF-kB subunit), Sortilin, JNK1(MAPK8), IRAK1, p38 MAPK",
599,Development_Growth hormone signaling via STATs and PLC/IP3,35,2.235E-04,6.399E-04,2.235E-04,6.399E-04,23,"Tensin, STAT5A, Fibrinogen beta, SOCS1, CRK, IRF1, STAT5B, STAT1, RAP-1A, PLC-gamma 1, SOCS3, Fyn, c-Src, JAK2, PKC-delta, c-Jun, PTP-1B, C3G, JNK1(MAPK8), Paxillin, p130CAS, PLC-gamma, ADAM17",4.733E-03,9.071E-03,19,"Tensin, STAT5A, Somatotropin, SOCS1, CRK, IRF1, STAT5B, STAT1, RAP-1A, PLC-gamma 1, SOCS3, Fyn, c-Src, JAK2, JNK1(MAPK8), STAT3, p130CAS, PLC-gamma, ADAM17",
600,Role of GSK3 beta in cardioprotection against myocardial infarction,33,2.241E-04,6.399E-04,2.241E-04,6.399E-04,22,"TOM20, MPTP complex, RAMP2, Enkephalin A, AM-R, Intermedin, Plasma kallikrein, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, Caspase-3, VDAC 1, MMP-8, AKT(PKB), ANT, PI3K cat class IA, Metenkefalin, Adrenomedullin, Delta-type opioid receptor, EGFR, Bradykinin, CRLR",3.316E-02,5.089E-02,16,"RAMP2, Enkephalin A, Intermedin, Plasma kallikrein, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, Caspase-3, VDAC 1, MMP-8, AKT(PKB), PI3K cat class IA, Metenkefalin, Adrenomedullin, EGFR, CRLR",
601,Interaction of deficient alpha-MSH signaling with TNF-alpha in melanoma,33,2.241E-04,6.399E-04,2.241E-04,6.399E-04,22,"ICAM1, PKA-reg (cAMP-dependent), Fibronectin, Vimentin, TMSB4X, IKK-alpha, SIP1 (ZFHX1B), NF-kB, Catalase, NF-kB p50/p65, alpha-MSH, MC1R, TNF-alpha, N-cadherin, ITGB1, RelA (p65 NF-kB subunit), NF-kB1 (p50), COX-2 (PTGS2), GPX1, SLUG, MMP-9, PKA-cat (cAMP-dependent)",5.944E-04,1.514E-03,20,"ICAM1, Fibronectin, Vimentin, TMSB4X, SIP1 (ZFHX1B), NF-kB, Catalase, NF-kB p50/p65, alpha-MSH, MC1R, TNF-alpha, N-cadherin, ITGB1, RelA (p65 NF-kB subunit), NF-kB1 (p50), COX-2 (PTGS2), GPX1, SLUG, MMP-9, PKA-cat (cAMP-dependent)",
602,LRRK2 in neurons in Parkinson's disease,33,2.241E-04,6.399E-04,2.241E-04,6.399E-04,22,"NSF, ERK1/2, 14-3-3, PKC-zeta, Rac1, Ubiquitin, GSK3 beta, AP-2 alpha subunits, MSN (moesin), MEK1/2, Actin cytoskeletal, HSP90, ACTB, Tubulin (in microtubules), Alpha-synuclein, MARKK, Actin cytoplasmic 2, RDX (radixin), AP2A2, Beta-adaptin 2, PKA-cat (cAMP-dependent), eEF1A",1.430E-02,2.413E-02,17,"ERK1/2, AP2A1, 14-3-3, Ubiquitin, GSK3 beta, AP-2 alpha subunits, MSN (moesin), MEK1/2, Actin cytoskeletal, HSP90, ACTB, Tubulin (in microtubules), Alpha-synuclein, Actin cytoplasmic 2, RDX (radixin), Beta-adaptin 2, PKA-cat (cAMP-dependent)",
603,Development_Schema: Embryonal cardiomyogenesis,8,2.337E-04,6.659E-04,2.337E-04,6.659E-04,8,"WNT3A, DKK1, WNT11, SFRP5, WNT1, WNT 8A, Jagged1, BMP2",1.527E-02,2.551E-02,6,"DKK1, WNT11, SFRP5, WNT 8A, Jagged1, BMP2",
604,Role of type 2 innate lymphoid cells in airway allergic inflammation and tissue repair,38,2.396E-04,7.280E-04,1.239E-03,2.833E-03,23,"IL-7 receptor, IL-7, JAK1, RPS6, TSLP, IL17BR, IL-13, CRLF2, IL-2R alpha chain, IL-2, JAK2, IL7RA, ETS1, EGFR, IL-5, JAK3, PI3K cat class IA (p110-delta), ST2(L), IL-33, IL-2R gamma chain, STAT5, mTOR, TSLPR",2.396E-04,7.280E-04,23,"IL-7 receptor, IL-7, JAK1, RPS6, TSLP, IL17BR, CRLF2, IL-2, JAK2, IL7RA, ROR-alpha, CRTH2, ETS1, EGFR, IL-5, JAK3, PI3K cat class IA (p110-delta), ST2(L), IL-33, IL-2R gamma chain, STAT5, mTOR, TSLPR",
605,Role of type 2 innate lymphoid cells in asthma,38,2.396E-04,7.280E-04,1.239E-03,2.833E-03,23,"IL-7 receptor, IL-7, JAK1, RPS6, TSLP, IL17BR, IL-13, CRLF2, IL-2R alpha chain, IL-2, FPRL1, JAK2, IL7RA, ETS1, IL-5, JAK3, PI3K cat class IA (p110-delta), ST2(L), IL-33, IL-2R gamma chain, STAT5, mTOR, TSLPR",2.396E-04,7.280E-04,23,"IL-7 receptor, IL-7, JAK1, RPS6, TSLP, IL17BR, CRLF2, IL-2, FPRL1, JAK2, IL7RA, ROR-alpha, CRTH2, ETS1, IL-5, JAK3, PI3K cat class IA (p110-delta), ST2(L), IL-33, IL-2R gamma chain, STAT5, mTOR, TSLPR",
606,Development_FGFR signaling pathway,54,2.539E-04,7.194E-04,2.539E-04,7.194E-04,32,"ERK1/2, Syndecan-4, CRK, Rac1, IP3 receptor, Ubiquitin, Shc, EPS8, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), CREB1, AKT(PKB), E3b1(ABI-1), MLK3(MAP3K11), PI3K cat class IA, c-Cbl, PKC-delta, DOCK1, c-Jun, FGF2, SOS, MEK4(MAP2K4), MEKK1(MAP3K1), ATF-2, SHP-2, Perlecan, JNK(MAPK8-10), SHB, p38 MAPK, Elk-1, Syndecan-2",6.700E-04,1.695E-03,29,"ERK1/2, Syndecan-4, CRK, c-Raf-1, IP3 receptor, Ubiquitin, Shc, EPS8, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), CREB1, AKT(PKB), E3b1(ABI-1), MEK1(MAP2K1), MLK3(MAP3K11), PI3K cat class IA, c-Cbl, DOCK1, FGF2, SOS, MEK4(MAP2K4), ATF-2, Perlecan, JNK(MAPK8-10), SHB, p38 MAPK, Elk-1, Syndecan-2",
607,Cytoskeleton remodeling_Keratin filaments,36,2.688E-04,8.052E-04,1.317E-03,2.986E-03,22,"Keratin 5, Keratin 6C, Plakophilin 1, Plakophilin 2, Vimentin, CDK1 (p34), Keratin 17, Keratin 14, Tubulin gamma 1, Desmoplakin, Actin cytoskeletal, Tubulin (in microtubules), Plectin 1, Tubulin beta, Keratin 7, 14-3-3 gamma, BPAG1, Keratin 5/14, Tubulin alpha, Keratin 16, Keratin 6A, JNK(MAPK8-10)",2.688E-04,8.052E-04,22,"Keratin 5, Keratin 6C, Plakophilin 1, Plakophilin 2, Vimentin, CDK1 (p34), Keratin 17, Keratin 14, Tubulin gamma 1, Desmoplakin, Actin cytoskeletal, Tubulin (in microtubules), Plectin 1, Tubulin beta, 14-3-3 gamma, BPAG1, Keratin 5/14, Keratin 13, Tubulin alpha, Keratin 16, Keratin 6A, JNK(MAPK8-10)",
608,IGF-1 signaling in pancreatic cancer,36,2.688E-04,8.052E-04,1.317E-03,2.986E-03,22,"JAK1, IRS-2, IRS-1, ERK1/2, PKC-zeta, VEGF-A, Shc, NUAK1, PI3K reg class IA, MEK2(MAP2K2), MMP-2, AMPK alpha 1 subunit, JAK2, PI3K cat class IA, HIF1A, HIF-1, SOS, COX-2 (PTGS2), ATM, MMP-14, MMP-9, mTOR",2.688E-04,8.052E-04,22,"JAK1, IRS-2, ERK1/2, VEGF-A, c-Raf-1, Shc, NUAK1, PI3K reg class IA, MEK2(MAP2K2), MMP-2, AMPK alpha 1 subunit, MEK1(MAP2K1), JAK2, PI3K cat class IA, HIF1A, SOS, STAT3, COX-2 (PTGS2), ATM, MMP-14, MMP-9, mTOR",
609,Development_Thrombospondin 1 signaling,36,2.688E-04,8.052E-04,4.136E-04,1.101E-03,23,"TGF-beta 1, alpha-4/beta-1 integrin, alpha-9/beta-1 integrin, VEGF-A, PKA-reg (cAMP-dependent), VEGFR-2, Caspase-8, MLCP (reg), Adenylate cyclase, Caspase-3, G-protein beta/gamma, Fyn, Guanylate Cyclase 1, soluble, MLCP (cat), alpha-3/beta-1 integrin, VLDLR, ITGB3, G-protein alpha-i family, FGF2, Thrombospondin 1, p38 MAPK, PKA-cat (cAMP-dependent), CD47",2.688E-04,8.052E-04,22,"TGF-beta 1, alpha-4/beta-1 integrin, alpha-9/beta-1 integrin, VEGF-A, VEGFR-2, Caspase-8, MLCP (reg), Adenylate cyclase, Caspase-3, G-protein beta/gamma, Fyn, Guanylate Cyclase 1, soluble, MLCP (cat), alpha-3/beta-1 integrin, VLDLR, ITGB3, G-protein alpha-i family, FGF2, Thrombospondin 1, p38 MAPK, PKA-cat (cAMP-dependent), CD47",
610,Development_Self-renewal of adult neural stem cells,52,2.719E-04,7.660E-04,2.719E-04,7.660E-04,31,"p14ARF, NOTCH1 receptor, HES5, GFAP, HDAC3, Smoothened, GLI-2, Cyclin D2, HDAC2, WNT7A, NRSF, Nestin, NeuroD1, RBP-J kappa (CBF1), p16INK4, NOTCH1 (NICD), MeCP2, Sin3A, PTCH1, MAML1, TBP, HDAC5, FKHL1, DLL4, HES1, TLX, HDAC1, GLI-1, ATH1, NOTCH1 (NEXT), ADAM17",7.806E-04,1.929E-03,28,"p14ARF, NOTCH1 receptor, HES5, GFAP, HDAC3, Smoothened, GLI-2, Cyclin D2, HDAC2, WNT7A, Nestin, NeuroD1, RBP-J kappa (CBF1), p16INK4, NOTCH1 (NICD), MeCP2, Sin3A, PTCH1, HDAC5, NeuroD4, FKHL1, HES1, TLX, HDAC1, GLI-1, ATH1, NOTCH1 (NEXT), ADAM17",
611,Differentiation of Th2 cells in asthma,45,2.751E-04,8.208E-04,5.791E-04,1.437E-03,27,"OX40L(TNFSF4), MHC class II, CCL20, NOTCH1 receptor, IP10, JAK1, CCL2, IL-4R type I, CD28, OX40(TNFRSF4), TSLP, PI3K reg class IA, IKK-alpha, GM-CSF, CD4, AKT(PKB), JAK2, PI3K cat class IA, NF-kB p50/RelB, Histamine H2 receptor, CXCR3, Histamine H1 receptor, CD3, Jagged1, CCR4, CD86, TSLPR",2.751E-04,8.208E-04,26,"OX40L(TNFSF4), MHC class II, CCL20, NOTCH1 receptor, IP10, JAK1, CCL2, IL-4R type I, CD28, OX40(TNFRSF4), TSLP, PI3K reg class IA, GM-CSF, CD4, AKT(PKB), JAK2, CD80, PI3K cat class IA, NF-kB p50/RelB, Histamine H2 receptor, Histamine H1 receptor, CD3, Jagged1, CCR4, CD86, TSLPR",
612,Modulation of tumor response to cytotoxic T cells by hypoxia in tumors,50,2.905E-04,8.077E-04,2.905E-04,8.077E-04,30,"NIX, VHL, ERK1/2, CD28, VEGF-A, 5'-NTD, VEGFR-2, Perforin, Ubiquitin, MHC class I, CTLA-4, FasL(TNFSF6), AKT(PKB), c-Src, ARNT, Sequestosome 1(p62), JAK2, HIF1A, HIF-1, PTP-1B, CD137(TNFRSF9), CD8, FasR(CD95), Beclin 1, PD-1, CD137 ligand(TNFSF9), HOXA1, HIF-prolyl hydroxylase, CD86, PD-L1",2.309E-03,4.889E-03,26,"NIX, VHL, ERK1/2, CD28, VEGF-A, 5'-NTD, VEGFR-2, Ubiquitin, MHC class I, CTLA-4, AKT(PKB), c-Src, Sequestosome 1(p62), JAK2, CD80, HIF1A, CD137(TNFRSF9), STAT3, CD8, FasR(CD95), PD-1, CD137 ligand(TNFSF9), HOXA1, HIF-prolyl hydroxylase, CD86, PD-L1",
613,Immune response_C5a signaling,50,2.905E-04,8.077E-04,2.905E-04,8.077E-04,30,"SPHK1, PLD1, C5a, ERK1/2, Rac2, PI3K cat class IB (p110-gamma), p47-phox, Rac1, BAD, IL-1 beta, I-kB, PLC-beta, CREB1, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-alpha, B-Raf, IL-8, G-protein alpha-i family, c-Jun, p90Rsk, AP-1, PKC, Oncostatin M, JNK(MAPK8-10), p38 MAPK, PAI1",3.323E-04,9.509E-04,28,"SPHK1, PLD1, C5a, ERK1/2, c-Raf-1, Rac2, PI3K cat class IB (p110-gamma), p47-phox, IL-1 beta, I-kB, PLC-beta, CREB1, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, TNF-alpha, B-Raf, IL-8, G-protein alpha-i family, p67-phox, p90Rsk, PKC, Oncostatin M, JNK(MAPK8-10), p38 MAPK, PAI1",
614,Development_HGF-dependent inhibition of TGF-beta-induced EMT,34,3.001E-04,8.840E-04,4.081E-03,7.992E-03,20,"Arkadia, TGF-beta 1, Sno-N, ERK1/2, TGIF, SMAD2, MEK2(MAP2K2), CREB1, SMURF, HGF, SMAD7, TGF-beta receptor type II, c-Jun, PGES, SOS, p90Rsk, COX-2 (PTGS2), HGF receptor (Met), Elk-1, TGF-beta receptor type I",3.001E-04,8.840E-04,21,"Arkadia, TGF-beta 1, Sno-N, ERK1/2, TGIF, c-Raf-1, SMAD2, MEK2(MAP2K2), CREB1, SMURF, HGF, MEK1(MAP2K1), SMAD7, TGF-beta receptor type II, PGES, SOS, p90Rsk, COX-2 (PTGS2), HGF receptor (Met), Elk-1, TGF-beta receptor type I",
615,NK cells in allergic contact dermatitis,34,3.001E-04,8.840E-04,1.394E-03,3.136E-03,21,"MHC class II, CCL20, NCAM1, IP10, ICAM1, CCL2, HLA-DRA1, IRF1, Perforin, STAT1, FasL(TNFSF6), NF-kB, TNF-R1, IL-2, TNF-alpha, IFN-gamma receptor, KLRK1 (NKG2D), CXCR3, FasR(CD95), CIITA, STAT5",3.001E-04,8.840E-04,21,"MIG, MHC class II, CCL20, NCAM1, IP10, ICAM1, CCL2, IFN-gamma, HLA-DRA1, IRF1, STAT1, NF-kB, TNF-R1, NKp44, IL-2, TNF-alpha, IFN-gamma receptor, KLRK1 (NKG2D), FasR(CD95), CIITA, STAT5",
616,Gamma-secretase proteolytic targets,76,3.016E-04,8.840E-04,2.746E-03,5.650E-03,39,"NGFR(TNFRSF16), NOTCH1 receptor, CD44, alphaAPPs, BACE1, APP-C99, N-cadherin (CTF1), CD44 (ICD), Jagged2, APP, NOTCH2 (2ICD), NOTCH4 (ICD4), NGFR (ICD), ADAM9, CD44 soluble, Jagged2 (CTF2), CD44 (EXT), BACE2, NOTCH4, APP-C83 (CTF), N-cadherin (CTF2), ADAM10, NOTCH1 (NICD), N-cadherin, ErbB4(CTF), ErbB4, NOTCH2, ErbB4(ICD), Jagged2 (CTF1), NOTCH3 (3ICD), NGFR (CTF), Ephrin-B2 (CTF2), Amyloid beta 40, NOTCH1 (NEXT), Ephrin-B2, ADAM17, APP-C59 (AICD), NOTCH3, Amyloid beta 42",3.016E-04,8.840E-04,39,"NGFR(TNFRSF16), NOTCH1 receptor, CD44, alphaAPPs, BACE1, APP-C99, N-cadherin (CTF1), CD44 (ICD), Jagged2, APP, NOTCH2 (2ICD), NOTCH4 (ICD4), NGFR (ICD), ADAM9, CD44 soluble, Jagged2 (CTF2), CD44 (EXT), BACE2, NOTCH4, APP-C83 (CTF), N-cadherin (CTF2), ADAM10, NOTCH1 (NICD), N-cadherin, ErbB4(CTF), ErbB4, NOTCH2, ErbB4(ICD), Jagged2 (CTF1), NOTCH3 (3ICD), NGFR (CTF), Ephrin-B2 (CTF2), Amyloid beta 40, NOTCH1 (NEXT), Ephrin-B2, ADAM17, APP-C59 (AICD), NOTCH3, Amyloid beta 42",
617,Signal transduction_Adenosine A3 receptor signaling pathway,48,3.094E-04,8.587E-04,3.094E-04,8.587E-04,29,"MPTP complex, ERK1/2, VEGF-A, G-protein alpha-q/11, G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, BAD, IL-1 beta, PI3K reg class IA (p85), GSK3 beta, PLC-beta, Adenylate cyclase, CREB1, MEK1/2, G-protein beta/gamma, AKT(PKB), TNF-alpha, PI3K cat class IA, RelA (p65 NF-kB subunit), HIF1A, PKC-delta, G-protein alpha-i family, G-protein alpha-i3, PKC, Rho GTPase, PI3K reg class IB (p101), p38 MAPK, IL-12 beta",1.059E-03,2.486E-03,26,"ERK1/2, VEGF-A, G-protein alpha-q/11, G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, IL-1 beta, PI3K reg class IA (p85), GSK3 beta, PLC-beta, Adenylate cyclase, CREB1, MEK1/2, G-protein beta/gamma, AKT(PKB), TNF-alpha, PI3K cat class IA, RelA (p65 NF-kB subunit), HIF1A, G-protein alpha-i family, G-protein alpha-i3, STAT3, PKC, Rho GTPase, p38 MAPK, IL-12 beta",
618,Myeloid-derived suppressor cells and M2 macrophages in cancer,64,3.121E-04,9.094E-04,1.029E-02,1.806E-02,32,"IDO1, TGF-beta 1, Calgranulin A, HMGB1, IL-10, M-CSF receptor, C5a, SLC7A11, ID1, VEGF-A, STAT1, IL-1 beta, GM-CSF, IL-13, IL-6, NF-kB, PPAR-gamma, PGE2R2, PGE2R4, iNOS, HIF1A, C/EBPbeta, IL4RA, CSF1, PKC-beta2, RAGE, COX-2 (PTGS2), Calgranulin B, TLR4, EPAS1, STAT5, PD-L1",3.121E-04,9.094E-04,34,"IRF8, IDO1, TGF-beta 1, Calgranulin A, HMGB1, IL-10, M-CSF receptor, C5a, SLC7A11, ID1, VEGF-A, IL-17, STAT1, IL-1 beta, GM-CSF, IL-6, NF-kB, PPAR-gamma, PGE2R2, PGE2R4, iNOS, HIF1A, C/EBPbeta, IL4RA, CSF1, PKC-beta2, RAGE, STAT3, COX-2 (PTGS2), Calgranulin B, TLR4, EPAS1, STAT5, PD-L1",
619,Development_ACM2 and ACM4 activation of ERK,43,3.146E-04,9.098E-04,1.729E-03,3.753E-03,25,"ERK1/2, EGR1, Caldesmon, PKC-epsilon, G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, PLC-beta, MEK2(MAP2K2), ACM4, CREB1, G-protein beta/gamma, Fyn, Pyk2(FAK2), PKC-delta, ACM2, EGFR, G-protein alpha-i family, G-protein alpha-o, SOS, Calmodulin, PKC-alpha, Elk-1",3.146E-04,9.098E-04,25,"ERK1/2, Caldesmon, c-Raf-1, PKC-epsilon, G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, PLC-beta, MEK2(MAP2K2), ACM4, CREB1, G-protein beta/gamma, Fyn, MEK1(MAP2K1), Pyk2(FAK2), EGFR, G-protein alpha-i family, G-protein alpha-o, SOS, p90RSK1, Calmodulin, PKC-alpha, Elk-1",
620,Nicotine / nAChR alpha-7 signaling in NSCLC,43,3.146E-04,9.098E-04,1.043E-02,1.826E-02,23,"RHEB2, ERK1/2, VEGF-A, Fibronectin, PI3K reg class IA (p85), PPAR-beta(delta), CDK4, MEK2(MAP2K2), CREB1, AKT(PKB), Calpain 1(mu), c-Src, nAChR alpha-7, PI3K cat class IA, HIF1A, Calpain 2(m), p90Rsk, CDK2, Calmodulin, PKC-alpha, PKC-lambda/iota, Cyclin E, mTOR",3.146E-04,9.098E-04,25,"RHEB2, ERK1/2, VEGF-A, c-Raf-1, Fibronectin, PI3K reg class IA (p85), PPAR-beta(delta), CDK4, MEK2(MAP2K2), CREB1, AKT(PKB), Calpain 1(mu), c-Src, MEK1(MAP2K1), nAChR alpha-7, PI3K cat class IA, HIF1A, Calpain 2(m), p90Rsk, CDK2, Calmodulin, PKC-alpha, PKC-lambda/iota, Cyclin E, mTOR",
621,Regulation of Tissue factor signaling in cancer,43,3.146E-04,9.098E-04,6.175E-04,1.516E-03,26,"TNF-R2, ERK1/2, EGR1, VEGF-A, VEGFR-2, Heparanase 1, NF-kB p65/c-Rel, PSGL-1, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), TNF-R1, P-selectin, TNF-alpha, EGFR, c-Jun, Tissue factor, JNK1(MAPK8), PI3K cat class IA (p110-alpha), AP-1, c-Jun/c-Jun, EPAS1, p53, Elk-1, SRF, mTOR",3.146E-04,9.098E-04,25,"TNF-R2, ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, Heparanase 1, NF-kB p65/c-Rel, PSGL-1, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), TNF-R1, P-selectin, CD40L(TNFSF5), TNF-alpha, MEK1(MAP2K1), EGFR, Tissue factor, JNK1(MAPK8), PI3K cat class IA (p110-alpha), EPAS1, p53, Elk-1, SRF, mTOR",
622,Immune response_IL-9 signaling pathway,61,3.179E-04,8.792E-04,3.179E-04,8.792E-04,35,"TGF-beta 1, Scinderin, JAK1, IRS-2, CCL2, IRS-1, ERK1/2, VEGF-A, IL-22, Pim-1, STAT1, Fc epsilon RI alpha, Shc, PI3K reg class IA (p85), SOCS3, Chymase, IL-13, MEK1/2, Eotaxin, AKT(PKB), c-Myc, PI3K cat class IA, MC-CPA, VCAM1, 14-3-3 zeta/delta, IL-5, Granzyme A, JAK3, p90Rsk, CCL7, IL5RA, IL-2R gamma chain, STAT5, IL-12 beta, mTOR",6.220E-04,1.576E-03,32,"TGF-beta 1, JAK1, IRS-2, CCL2, IFN-gamma, ERK1/2, VEGF-A, c-Raf-1, IL-22, Pim-1, STAT1, Fc epsilon RI alpha, Shc, PI3K reg class IA (p85), SOCS3, MEK1/2, Eotaxin, AKT(PKB), PI3K cat class IA, MC-CPA, VCAM1, 14-3-3 zeta/delta, IL-5, Granzyme A, JAK3, p90Rsk, CCL7, STAT3, IL-2R gamma chain, STAT5, IL-12 beta, mTOR",
623,Role of GIP in pathogenesis of type 2 diabetes,46,3.285E-04,9.016E-04,3.285E-04,9.016E-04,28,"Apaf-1, ERK1/2, PKA-reg (cAMP-dependent), BAD, Ubiquitin, RAP-1A, Bax, FKHR, Caspase-3, CREB1, MEK1/2, Kv1.4, AMPK alpha 1 subunit, AKT(PKB), B-Raf, cAMP-GEFII, ASK1 (MAP3K5), MEK3(MAP2K3), AMPK alpha subunit, GIP, PP2A catalytic, Caspase-9, MKK7 (MAP2K7), MEK4(MAP2K4), Adenylate cyclase type VIII, JNK(MAPK8-10), p38 MAPK, PKA-cat (cAMP-dependent)",1.234E-03,2.838E-03,25,"p38alpha (MAPK14), Apaf-1, ERK1/2, Ubiquitin, RAP-1A, Bax, FKHR, Caspase-3, CREB1, MEK1/2, AMPK alpha 1 subunit, AKT(PKB), B-Raf, cAMP-GEFII, ASK1 (MAP3K5), MEK3(MAP2K3), AMPK alpha subunit, GIP, PP2A catalytic, Caspase-9, MEK4(MAP2K4), Adenylate cyclase type VIII, JNK(MAPK8-10), p38 MAPK, PKA-cat (cAMP-dependent)",
624,Transcription_Hypoxia- and receptor-mediated HIF-1 activation,46,3.285E-04,9.016E-04,3.285E-04,9.016E-04,28,"CBP, VHL, RPS6, eIF4E, ERK1/2, HB-EGF, GPNMB (Osteoactivin), IL-1 beta, GSK3 beta, FKHR, IGF-2, MEK1/2, AKT(PKB), HGF, ARNT, PI3K cat class IA, HIF1A, EGFR, HIF-1, LINC01139, MNK1, p300, NCOA2 (GRIP1/TIF2), 4E-BP1, HIF-prolyl hydroxylase, NCOA1 (SRC1), p38 MAPK, APEX",4.426E-04,1.193E-03,26,"CBP, VHL, Neuregulin 1, RPS6, ERK1/2, HB-EGF, GPNMB (Osteoactivin), IL-1 beta, GSK3 beta, FKHR, IGF-2, MEK1/2, AKT(PKB), HGF, PI3K cat class IA, HIF1A, EGFR, LINC01139, MNK1, p300, NCOA2 (GRIP1/TIF2), STAT3, HIF-prolyl hydroxylase, NCOA1 (SRC1), p38 MAPK, APEX",
625,Lysophospholipid mediators-induced inflammatory signaling in normal and asthmatic airway epithelium,57,3.291E-04,9.479E-04,9.506E-04,2.218E-03,32,"SPHK1, CCL20, LPAR3, PLD1, PI3K cat class IA (p110-beta), CARD10, ERK1/2, IRF1, TSLP, G-protein alpha-i2, LPAR2, I-kB, PLC-beta, IL-13, MEK1/2, G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, RhoA, G-protein alpha-12 family, LPAR1, PKC-delta, IL-8, Lyn, G-protein alpha-i family, c-Jun, PLD2, COX-2 (PTGS2), JNK(MAPK8-10), p38 MAPK, MMP-9",3.291E-04,9.479E-04,31,"SPHK1, CCL20, LPAR3, PLD1, PI3K cat class IA (p110-beta), CARD10, ERK1/2, c-Raf-1, IRF1, TSLP, G-protein alpha-i2, LPAR2, I-kB, PLC-beta, MEK1/2, G-protein beta/gamma, IL13RA2, NF-kB, AKT(PKB), NF-kB p50/p65, RhoA, G-protein alpha-12 family, LPAR1, IL-8, Lyn, G-protein alpha-i family, PLD2, COX-2 (PTGS2), JNK(MAPK8-10), p38 MAPK, MMP-9",
626,Development_EDNRB signaling,50,3.323E-04,9.509E-04,2.045E-03,4.376E-03,28,"ATF-1, ERK1/2, p90RSK2(RPS6KA3), G-protein alpha-q/11, Endothelin-3, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, PLC-beta, Endothelin-1, MEK2(MAP2K2), CREB1, G-protein beta/gamma, Guanylate Cyclase 1, soluble, AKT(PKB), c-Src, B-Raf, CALDAG-GEFI, G-protein alpha-i family, Protein kinase G, SOS, EDNRB, p90RSK3(RPS6KA2), Caveolin-1, PI3K reg class IB (p101), Elk-1",3.323E-04,9.509E-04,28,"ATF-1, ERK1/2, p90RSK2(RPS6KA3), c-Raf-1, G-protein alpha-q/11, Endothelin-3, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, PLC-beta, Endothelin-1, MEK2(MAP2K2), CREB1, G-protein beta/gamma, Guanylate Cyclase 1, soluble, AKT(PKB), c-Src, MEK1(MAP2K1), B-Raf, G-protein alpha-i family, Protein kinase G, SOS, EDNRB, p90RSK3(RPS6KA2), Caveolin-1, Elk-1",
627,Cytoskeleton remodeling_Reverse signaling by Ephrin-B,32,3.333E-04,9.509E-04,4.318E-04,1.120E-03,21,"F-Actin, Beta-catenin, GSK3 beta, NCK2, FAP-1, G-protein beta/gamma, Actin cytoskeletal, c-Src, Axin, CXCR4, WaspIP, Tubulin (in microtubules), PINCH, G-protein alpha-i family, SOS, Paxillin, Tubulin alpha, Ephrin-B, N-WASP, PINCH-2, Ephrin-B receptors",3.333E-04,9.509E-04,20,"F-Actin, Beta-catenin, c-Raf-1, GSK3 beta, NCK2, FAP-1, G-protein beta/gamma, Actin cytoskeletal, c-Src, Axin, CXCR4, WaspIP, Tubulin (in microtubules), PINCH, G-protein alpha-i family, SOS, Tubulin alpha, Ephrin-B, PINCH-2, Ephrin-B receptors",
628,Mucin expression in CF airways,69,3.350E-04,9.521E-04,5.616E-03,1.067E-02,35,"ERK1/2, G-protein alpha-q/11, IP3 receptor, IL-1 beta, I-kB, Shc, PKC-theta, PLC-beta, CREB1, MEK1/2, TGF-alpha, AKT(PKB), NF-kB p50/p65, c-Src, PGE2R2, PGE2R4, PI3K cat class IA, PKC-delta, EGFR, MEK3(MAP2K3), c-Jun, PGF2aR, Leukocyte elastase, SOS, MKK7 (MAP2K7), JNK1(MAPK8), p90Rsk, MEK4(MAP2K4), COX-2 (PTGS2), MEKK1(MAP3K1), PKC-alpha, JNK(MAPK8-10), ADAM17, p38 MAPK, PKA-cat (cAMP-dependent)",3.350E-04,9.521E-04,36,"p38alpha (MAPK14), Neuregulin 1, ERK1/2, c-Raf-1, G-protein alpha-q/11, IP3 receptor, IL-1 beta, I-kB, Shc, PKC-theta, PLC-beta, CREB1, MEK1/2, TGF-alpha, AKT(PKB), NF-kB p50/p65, c-Src, PGE2R2, PGE2R4, PI3K cat class IA, EGFR, MEK3(MAP2K3), PGF2aR, Leukocyte elastase, CFTR, SOS, p90RSK1, JNK1(MAPK8), p90Rsk, MEK4(MAP2K4), COX-2 (PTGS2), PKC-alpha, JNK(MAPK8-10), ADAM17, p38 MAPK, PKA-cat (cAMP-dependent)",
629,Development_VEGF-family signaling,41,3.592E-04,1.017E-03,4.867E-03,9.407E-03,23,"PLGF, Neuropilin-1, ERK1/2, VEGF-A, VEGFR-2, Fibronectin, IP3 receptor, Shc, PI3K reg class IA, alpha-V/beta-3 integrin, L1CAM, MEK2(MAP2K2), VEGF-B, AKT(PKB), PI3K cat class IA, c-Jun, alpha-5/beta-1 integrin, SOS, VEGFR-3, Neuropilin-2, VEGF-C, PKC-alpha, PLC-gamma",3.592E-04,1.017E-03,24,"PLGF, Neuropilin-1, ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, Fibronectin, IP3 receptor, Shc, PI3K reg class IA, alpha-V/beta-3 integrin, L1CAM, MEK2(MAP2K2), VEGF-B, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, alpha-5/beta-1 integrin, SOS, VEGFR-3, Neuropilin-2, VEGF-C, PKC-alpha, PLC-gamma",
630,Hypoxia-induced EMT in cancer and fibrosis,13,3.639E-04,9.954E-04,3.639E-04,9.954E-04,11,"SIP1 (ZFHX1B), TWIST1, NOTCH1 (NICD), Lysyl oxidase, HIF1A, ETS1, HIF-1, TCF8, SLUG, LOXL2, SNAIL1",1.077E-03,2.519E-03,10,"SIP1 (ZFHX1B), TWIST1, NOTCH1 (NICD), Lysyl oxidase, HIF1A, ETS1, TCF8, SLUG, LOXL2, SNAIL1",
631,Development_Growth hormone signaling via PI3K/AKT and MAPK cascades,42,3.659E-04,9.971E-04,3.659E-04,9.971E-04,26,"C/EBP zeta, RHEB2, IRS-2, IRS-1, EGR1, Elk-4, Shc, GSK3 beta, ERK2 (MAPK1), AKT(PKB), c-Src, MEKK4(MAP3K4), Pyk2(FAK2), JAK2, PI3K reg class IA (p85-alpha), C/EBPbeta, MEK3(MAP2K3), c-Jun, SOS, 4E-BP1, PI3K cat class IA (p110-alpha), ATF-2, SHP-2, ADAM17, Elk-1, mTOR",5.872E-04,1.503E-03,24,"p38alpha (MAPK14), C/EBP zeta, Somatotropin, RHEB2, IRS-2, c-Raf-1, Elk-4, Shc, GSK3 beta, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), Pyk2(FAK2), JAK2, PI3K reg class IA (p85-alpha), C/EBPbeta, MEK3(MAP2K3), SOS, PI3K cat class IA (p110-alpha), ATF-2, ADAM17, Elk-1, mTOR",
632,Protein folding and maturation_POMC processing,30,3.677E-04,1.035E-03,1.533E-03,3.378E-03,19,"proACTH, gamma-LPH, Joining peptide (JP), gamma-MSH, beta-MSH, PAM, beta-Endorphin extracellular region, ACTH 1-17, PC1, N-POC, alpha-MSH, CLIP, POMC, N-POMC, gamma3-MSH, ACTH, DA-alphaMSH, beta-LPH, gamma2-MSH",3.677E-04,1.035E-03,19,"proACTH, gamma-LPH, Joining peptide (JP), gamma-MSH, beta-MSH, PAM, beta-Endorphin extracellular region, ACTH 1-17, PC1, N-POC, alpha-MSH, CLIP, POMC, N-POMC, gamma3-MSH, ACTH, DA-alphaMSH, beta-LPH, gamma2-MSH",
633,Role of histone modificators in progression of multiple myeloma,30,3.677E-04,1.035E-03,4.341E-04,1.120E-03,20,"UTX, SMRT, HDAC7, HDAC3, HDAC6, Jagged2, Cyclin D2, HDAC2, CDK4, N-Ras, Caspase-3, IL-6, EZH2, Suv39H1, WHSC1, CDK6, Tubulin alpha, HDAC8, HDAC1, Dynein 1, cytoplasmic, intermediate chains",3.677E-04,1.035E-03,19,"UTX, SMRT, HDAC7, HDAC3, HDAC6, Jagged2, Cyclin D2, HDAC2, CDK4, N-Ras, Caspase-3, IL-6, EZH2, WHSC1, CDK6, Tubulin alpha, HDAC8, HDAC1, Dynein 1, cytoplasmic, intermediate chains",
634,T regulatory cells in asthma,30,3.677E-04,1.035E-03,4.749E-03,9.239E-03,18,"TGF-beta 1, MHC class II, NOTCH1 receptor, IL-10, CD28, PI3K reg class IA (p85), CTLA-4, IL-10 receptor, RBP-J kappa (CBF1), ICOS, NOTCH1 (NICD), TGF-beta receptor type II, DLL4, CD3, HES1, PD-1, SMAD3, CD86",3.677E-04,1.035E-03,19,"TGF-beta 1, MHC class II, NOTCH1 receptor, IL-10, CD28, IL-17, PI3K reg class IA (p85), CTLA-4, IL-10 receptor, RBP-J kappa (CBF1), NOTCH1 (NICD), CD80, TGF-beta receptor type II, STAT3, CD3, HES1, PD-1, SMAD3, CD86",
635,TLR and EGFR-induced inflammatory signaling in normal and asthmatic airway epithelium,22,3.687E-04,9.974E-04,3.687E-04,9.974E-04,16,"TLR5, ERK1/2, HB-EGF, TSLP, TGF-alpha, TLR9, NF-kB p50/p65, IL-8, TLR6, EGFR, DUOX1, TLR8, TLR3, ADAM17, MMP-9, TLR2",4.893E-04,1.299E-03,15,"ERK1/2, HB-EGF, TSLP, TGF-alpha, TLR9, NF-kB p50/p65, IL-8, TLR6, EGFR, DUOX1, TLR8, TLR3, ADAM17, MMP-9, TLR2",
636,Inhibition of RUNX3 signaling in gastric cancer,22,3.687E-04,9.974E-04,3.687E-04,9.974E-04,16,"RUNX3, VEGF-A, Caspase-8, MDR1, ABCC1, Caspase-3, EZH2, LMO1, TIMP1, Caspase-7, Gasdermin, FOXO3A, HDAC1, Bim, MMP-9, G9a",7.411E-03,1.337E-02,13,"RUNX3, VEGF-A, Caspase-8, MDR1, ABCC1, Caspase-3, EZH2, TIMP1, Gasdermin, HDAC1, Bim, MMP-9, G9a",
637,LRRK2 and immune function in Parkinson's disease,22,3.687E-04,9.974E-04,3.687E-04,9.974E-04,16,"MHC class II, JAK1, NF-AT1(NFATC2), CSE1L, IFN-beta, STAT1, I-kB, CD14, NF-kB, TNF-alpha, JAK2, PSMD11, IQGAP1, IFN-gamma receptor, HSP90 beta, Karyopherin beta 2",4.893E-04,1.299E-03,15,"MHC class II, JAK1, IFN-gamma, IFN-beta, STAT1, I-kB, CD14, NF-kB, TNF-alpha, JAK2, PSMD11, IQGAP1, IFN-gamma receptor, HSP90 beta, Karyopherin beta 2",
638,Basophil migration in asthma,55,3.822E-04,1.070E-03,2.496E-03,5.207E-03,30,"Secretoneurin, alpha-4/beta-1 integrin, ICAM1, CCL2, C5a, VEGF-A, VEGFR-2, Fibronectin, PI3K cat class IB (p110-gamma), PSGL-1, CCL8, GM-CSF, G-protein beta/gamma, PLAUR (uPAR), Eotaxin, Oxoeicosanoid receptor 1, P-selectin, FPRL1, VCAM1, Eotaxin-2, IL-8, G-protein alpha-i family, IL-5, Eotaxin-3, PLAU (UPA), CCL7, ST2(L), IL-33, PI3K reg class IB (p101), MMP-9",3.822E-04,1.070E-03,30,"Secretoneurin, alpha-4/beta-1 integrin, ICAM1, CCL2, C5a, VEGF-A, VEGFR-2, Fibronectin, PI3K cat class IB (p110-gamma), PSGL-1, CCL8, GM-CSF, G-protein beta/gamma, PLAUR (uPAR), Eotaxin, Oxoeicosanoid receptor 1, P-selectin, FPRL1, VCAM1, Eotaxin-2, CRTH2, IL-8, G-protein alpha-i family, IL-5, Eotaxin-3, PLAU (UPA), CCL7, ST2(L), IL-33, MMP-9",
639,Immune response_Role of DAP12 receptors in NK cells,55,3.822E-04,1.070E-03,2.496E-03,5.207E-03,30,"HLA-B, ERK1/2, CrkL, Rac1, Syk, Shc, PKC-theta, PI3K reg class IA, ZAP70, PLC-gamma 1, MEK2(MAP2K2), MHC class I, Actin cytoskeletal, Fyn, CD94, WaspIP, PI3K cat class IA, Lck, SOS, HLA-G, LAT, KIR2DL1, HLA-E, KLRC3, DAP12, KLRA1, SHP-2, NKG2C, HLA-C, PLC-gamma 2",3.822E-04,1.070E-03,30,"HLA-B, ERK1/2, CrkL, c-Raf-1, Syk, Shc, PKC-theta, PI3K reg class IA, KIR3DL1, PLC-gamma 1, MEK2(MAP2K2), MHC class I, Actin cytoskeletal, Fyn, CD94, NKp44, WaspIP, MEK1(MAP2K1), PI3K cat class IA, Lck, SOS, HLA-G, KIR2DL3, KIR2DL1, HLA-E, KLRC3, DAP12, NKG2C, HLA-C, PLC-gamma 2",
640,Apoptosis and survival_Ceramides signaling pathway,40,3.835E-04,1.034E-03,3.835E-04,1.034E-03,25,"ERK1/2, PKC-zeta, Caspase-8, BAD, Acid sphingomyelinase, PI3K reg class IA (p85), Bax, Caspase-3, FasL(TNFSF6), AKT(PKB), TNF-R1, TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, PI3K reg class IA (p85-alpha), FAN, c-Jun, PP2A catalytic, JNK1(MAPK8), MEK4(MAP2K4), MEKK1(MAP3K1), tBid, FasR(CD95), KSR1, Bid",1.948E-03,4.265E-03,22,"ERK1/2, c-Raf-1, Caspase-8, Acid sphingomyelinase, PI3K reg class IA (p85), Bax, Caspase-3, AKT(PKB), TNF-R1, TAK1(MAP3K7), TNF-alpha, MEK1(MAP2K1), PI3K cat class IA, PI3K reg class IA (p85-alpha), FAN, PP2A catalytic, JNK1(MAPK8), MEK4(MAP2K4), tBid, FasR(CD95), KSR1, Bid",
641,Development_H3K27 demethylases in differentiation of stem cells,40,3.835E-04,1.034E-03,3.835E-04,1.034E-03,25,"HOXA13, SOX1, UTX, BMP4, SMAD4, DLX5, SMAD2, EED, PAX6, RING1, RING2, Nestin, EZH2, HOXA7, YY1, RelA (p65 NF-kB subunit), NODAL, T brachyury protein, HOXA11, PRC2 complex, SMAD1, HOXA1, HOXA3, SMAD3, BMP2",1.948E-03,4.265E-03,22,"HOXA13, SOX1, UTX, BMP4, SMAD4, DLX5, SMAD2, EED, PAX6, RING1, RING2, Nestin, EZH2, HOXA7, RelA (p65 NF-kB subunit), NODAL, HOXA11, PRC2 complex, HOXA1, HOXA3, SMAD3, BMP2",
642,Neuropeptide signaling in pancreatic cancer,48,3.837E-04,1.072E-03,8.661E-04,2.041E-03,28,"Neuromedin U receptor 2, CCL2, ERK1/2, VEGF-A, G-protein alpha-q/11, Angiotensin II, PKC-epsilon, IP3 receptor, PLC-beta, IKK-alpha, MEK2(MAP2K2), Neuromedin U, HMGI/Y, NF-kB, c-Myc, HGF, V1a receptor, CCKBR, Substance P receptor, PKC-beta2, NF-kB p65/p65, PKC-beta, GRP(1-27), PKC-alpha, NT, G-protein alpha-q, HGF receptor (Met), Elk-1",3.837E-04,1.072E-03,27,"Neuromedin U receptor 2, CCL2, ERK1/2, VEGF-A, c-Raf-1, G-protein alpha-q/11, Angiotensin II, PKC-epsilon, IP3 receptor, PLC-beta, MEK2(MAP2K2), Neuromedin U, HMGI/Y, NF-kB, HGF, MEK1(MAP2K1), V1a receptor, Substance P receptor, AVP extracellular region, PKC-beta2, NF-kB p65/p65, PKC-beta, GRP(1-27), PKC-alpha, NT, HGF receptor (Met), Elk-1",
643,ErbB2-induced breast cancer cell invasion,67,3.909E-04,1.088E-03,6.035E-04,1.495E-03,37,"NGAL, ERK1/2, VEGF-A, Rac1, IP3 receptor, I-kB, Shc, PI3K reg class IA (p85), IKK-alpha, PLC-gamma 1, MMP-2, MEK1/2, PLAUR (uPAR), CDC42, Actin cytoskeletal, NF-kB, AKT(PKB), Calpain 1(mu), c-Src, MLK3(MAP3K11), PI3K cat class IA, MMP-13, ETS1, EGFR, MEK3(MAP2K3), SOS, PLAU (UPA), Cofilin, non-muscle, ITGA4, PKC-alpha, MMP-14, p120-catenin, ER81, p38 MAPK, MMP-9, WASF2, Cofilin",3.909E-04,1.088E-03,35,"Neuregulin 1, NGAL, ERK1/2, VEGF-A, c-Raf-1, IP3 receptor, I-kB, Shc, PI3K reg class IA (p85), PLC-gamma 1, MMP-2, MEK1/2, PLAUR (uPAR), CDC42, Actin cytoskeletal, NF-kB, AKT(PKB), Calpain 1(mu), c-Src, MLK3(MAP3K11), PI3K cat class IA, MMP-13, ETS1, EGFR, MEK3(MAP2K3), SOS, PLAU (UPA), ITGA4, PKC-alpha, MMP-14, ER81, p38 MAPK, MMP-9, WASF2, Cofilin",
644,Ligand-independent activation of Androgen receptor in Prostate Cancer,67,3.909E-04,1.088E-03,6.237E-03,1.167E-02,34,"STAT5A, FGFR2, WNT3A, IRS-1, FGF1, Beta-catenin, PP2A regulatory, STAT5B, IBP3, Tip60, Shc, GSK3 beta, PI3K reg class IA, N-Ras, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), c-Myc, JAK2, PI3K cat class IA, B-Raf, Tcf(Lef), EGFR, FGF2, SOS, PP2A catalytic, NCOA2 (GRIP1/TIF2), FRS2beta, c-Abl, NCOA1 (SRC1), HDAC1, SRD5A1, Frizzled, Prolactin",3.909E-04,1.088E-03,35,"STAT5A, FGFR2, Neuregulin 1, FGF1, Beta-catenin, PP2A regulatory, c-Raf-1, STAT5B, IBP3, Tip60, Shc, GSK3 beta, PI3K reg class IA, N-Ras, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), MEK1(MAP2K1), JAK2, PI3K cat class IA, B-Raf, Tcf(Lef), EGFR, FGF2, SOS, PP2A catalytic, NCOA2 (GRIP1/TIF2), STAT3, FRS2beta, c-Abl, NCOA1 (SRC1), HDAC1, SRD5A1, Frizzled, Prolactin",
645,Dual role of TGF-beta 1 in HCC ,24,3.988E-04,1.071E-03,3.988E-04,1.071E-03,17,"TGF-beta 1, VEGF-A, SMAD4, SMAD2, CDK4, IKK-alpha, NF-kB, TAK1(MAP3K7), SMAD7, TGF-beta receptor type II, XIAP, CDK2, TAB1, p15, SMAD3, PAI1, TGF-beta receptor type I",1.875E-03,4.141E-03,15,"TGF-beta 1, VEGF-A, SMAD4, SMAD2, CDK4, NF-kB, TAK1(MAP3K7), SMAD7, TGF-beta receptor type II, XIAP, CDK2, p15, SMAD3, PAI1, TGF-beta receptor type I",
646,Defective efferocytosis in COPD,38,3.996E-04,1.071E-03,3.996E-04,1.071E-03,24,"Stabilin-2, TIM-4, CRK, Gas6, VAV-1, Rac1, CD14, alpha-V/beta-3 integrin, Calreticulin, LRP1, MFGE8, CED-6, DOCK1, Leukocyte elastase, MER, Thrombospondin 1, alpha-V/beta-5 integrin, TIM-1, p130CAS, TIM-3, CX3CL1, BAI1, Protein S, Beta-2-glycoprotein I (APOH)",6.398E-02,9.170E-02,17,"CRK, Gas6, VAV-1, CD14, alpha-V/beta-3 integrin, Calreticulin, LRP1, MFGE8, CED-6, DOCK1, Leukocyte elastase, MER, Thrombospondin 1, p130CAS, CX3CL1, Protein S, Beta-2-glycoprotein I (APOH)",
647,HGF signaling in pancreatic cancer,28,4.022E-04,1.114E-03,4.302E-04,1.120E-03,19,"Neuropilin-1, ERK1/2, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), MMP-2, c-Src, c-Myc, HGF, PI3K cat class IA, HGFA, HIF1A, c-Jun, SOS, PLAU (UPA), p53, HGF receptor (Met), Elk-1, MMP-9",4.022E-04,1.114E-03,18,"Neuropilin-1, ERK1/2, c-Raf-1, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), MMP-2, c-Src, HGF, MEK1(MAP2K1), PI3K cat class IA, HIF1A, SOS, PLAU (UPA), p53, HGF receptor (Met), Elk-1, MMP-9",
648,Development_Mu-type opioid receptor regulation of proliferation,28,4.022E-04,1.114E-03,1.426E-02,2.394E-02,16,"ADAM12, ERK1/2, HB-EGF, PKC-epsilon, PLC-beta1, Shc, beta-Endorphin extracellular region, MEK2(MAP2K2), G-protein beta/gamma, EGFR, G-protein alpha-i family, SOS, Calmodulin, PLC-beta3, Elk-1, SRF",4.022E-04,1.114E-03,18,"ADAM12, ERK1/2, HB-EGF, c-Raf-1, PKC-epsilon, Shc, beta-Endorphin extracellular region, MEK2(MAP2K2), G-protein beta/gamma, MEK1(MAP2K1), EGFR, G-protein alpha-i family, SOS, Calmodulin, Mu-type opioid receptor, PLC-beta3, Elk-1, SRF",
649,Putative pathways of activation of classical complement system in major depressive disorder,28,4.022E-04,1.114E-03,5.093E-03,9.806E-03,17,"C3, C3b, C5 convertase (C2aC4bC3b), IL-1 beta, C4b, IL-6, C7, C4A protein, TNF-alpha, C4B protein, C3 convertase (C2aC4b), CR1, C6, C5, C9, C5b, C4",4.022E-04,1.114E-03,18,"C3, C3b, IFN-gamma, C5 convertase (C2aC4bC3b), C1qb, IL-1 beta, C4b, IL-6, C7, C4A protein, TNF-alpha, C4B protein, C3 convertase (C2aC4b), CR1, C6, C5, C5b, C4",
650,A shift from oxidative to glycolytic muscle fiber phenotype in quadriceps muscles in COPD,60,4.236E-04,1.168E-03,6.301E-03,1.167E-02,31,"NRF1, H-FABP, Troponin I, slow skeletal, PPAR-alpha, HDAC4, beta-MHC, ALAS1, MLC2, PPAR-beta(delta), GABP alpha, FKHR, Troponin C, cardiac, PDK4, Fatty acid-binding protein, Ryanodine receptor 1, PPARGC1 (PGC1-alpha), PBEF, ACADM, NF-kB, UCP3, ERK2 (MAPK1), TNF-alpha, AMPK alpha subunit, TFAM, MEF2, Ca-ATPase1, ATP5O, EPAS1, Mitofusin 2, MKL1, SRF",4.236E-04,1.168E-03,32,"NRF1, H-FABP, Troponin I, slow skeletal, PPAR-alpha, HDAC4, beta-MHC, miR-1-3p, ALAS1, MLC2, PPAR-beta(delta), GABP alpha, FKHR, Troponin C, cardiac, PDK4, Fatty acid-binding protein, Ryanodine receptor 1, PPARGC1 (PGC1-alpha), PBEF, ACADM, NF-kB, UCP3, ERK2 (MAPK1), TNF-alpha, microRNA 1-1, AMPK alpha subunit, MEF2, Ca-ATPase1, ATP5O, EPAS1, Mitofusin 2, MKL1, SRF",
651,Oxidative stress_ROS-mediated activation of MAPK via inhibition of phosphatases,34,4.246E-04,1.120E-03,4.246E-04,1.120E-03,22,"SOD2, PP1-cat, VHR, ERK1/2, PP2A regulatory, MKP-5, SOD1, PP2A structural, MEK1/2, MKP-3, EGFR, ASK1 (MAP3K5), MEK3(MAP2K3), PTP-1B, PP2A catalytic, IL4RA, MKK7 (MAP2K7), MEK4(MAP2K4), SHP-2, JNK(MAPK8-10), p38 MAPK, PDGF-R-beta",8.318E-03,1.484E-02,18,"SOD2, PP1-cat, ERK1/2, PP2A regulatory, c-Raf-1, MKP-5, PP2A structural, MEK1/2, MKP-3, EGFR, ASK1 (MAP3K5), MEK3(MAP2K3), PP2A catalytic, IL4RA, MEK4(MAP2K4), JNK(MAPK8-10), p38 MAPK, PDGF-R-beta",
652,Epithelial cell apoptosis in COPD,32,4.318E-04,1.120E-03,4.318E-04,1.120E-03,21,"DR5(TNFRSF10B), Apo-2L(TNFSF10), BAD, I-kB, Bax, NF-kB, AKT(PKB), DR4(TNFRSF10A), Heme oxygenase 1, KEAP1, GCL reg, DJ-1, PSMD11, Leukocyte elastase, Caspase-9, PLAGL2, PSMB6, PAR1, GCL cat, p53, NRF2",1.157E-03,2.679E-03,19,"DR5(TNFRSF10B), Apo-2L(TNFSF10), I-kB, Bax, NF-kB, AKT(PKB), DR4(TNFRSF10A), Heme oxygenase 1, KEAP1, GCL reg, PSMD11, Leukocyte elastase, Caspase-9, PLAGL2, PSMB6, PAR1, GCL cat, p53, NRF2",
653,Muscle contraction_S1P2 receptor-mediated smooth muscle contraction,30,4.341E-04,1.120E-03,4.341E-04,1.120E-03,20,"ROCK1, ARHGEF1 (p115RhoGEF), PKC-zeta, G-protein alpha-i2, PLC-beta1, IP3 receptor, MLCP (reg), G-protein beta/gamma, MLCK, MLCP (cat), RhoA, ROCK2, G-protein alpha-12, CPI-17, S1P2 receptor, Calmodulin, PKC-alpha, MRLC, G-protein alpha-q, PLC-beta3",4.139E-03,8.058E-03,17,"ROCK1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, IP3 receptor, MLCP (reg), G-protein beta/gamma, MLCK, MLCP (cat), RhoA, ROCK2, G-protein alpha-12, CPI-17, S1P2 receptor, Calmodulin, PKC-alpha, MRLC, PLC-beta3",
654,Regulation of IGF family activity in colorectal cancer,30,4.341E-04,1.120E-03,4.341E-04,1.120E-03,20,"Matrilysin (MMP-7), IBP6, IBP3, Plasminogen, IL-1 beta, IGF-2, IL-6, PLAUR (uPAR), c-Src, IBP, Cystatin SN, Plasmin, NFYA, PLAU (UPA), COX-2 (PTGS2), ATM, PCSK5, Furin, p53, MMP-9",4.139E-03,8.058E-03,17,"Matrilysin (MMP-7), IBP6, IBP3, IL-1 beta, IGF-2, IL-6, PLAUR (uPAR), c-Src, IBP, NFYA, PLAU (UPA), COX-2 (PTGS2), ATM, PCSK5, Furin, p53, MMP-9",
655,Role of fibroblasts and keratinocytes in the elicitation phase of allergic contact dermatitis,26,4.355E-04,1.188E-03,5.433E-03,1.034E-02,16,"GRO-2, CCL20, IL-1 alpha, IP10, CCL2, IL-4R type I, IL-17 receptor, IL-1 beta, RAP-1A, GRO-1, TNF-R1, PLC-epsilon, TNF-alpha, IFNGR1, IL-8, CXCR3",4.355E-04,1.188E-03,17,"GRO-2, CCL20, IL-1 alpha, IP10, CCL2, IL-4R type I, IFN-gamma, IL-17, IL-17 receptor, IL-1 beta, RAP-1A, GRO-1, TNF-R1, PLC-epsilon, TNF-alpha, IFNGR1, IL-8",
656,Downregulation of MITF in melanoma,26,4.355E-04,1.188E-03,5.433E-03,1.034E-02,16,"TGF-beta 1, GLI-2, IL-1 beta, DIA1, CREB1, IL-6, SKP2, NF-kB, c-Src, RhoA, SOX10, ROCK, ATF-2, JNK(MAPK8-10), MITF, Cofilin",4.355E-04,1.188E-03,17,"TGF-beta 1, GLI-2, IL-1 beta, DIA1, CREB1, IL-6, SKP2, NF-kB, c-Src, RhoA, STAT3, SOX10, ROCK, ATF-2, JNK(MAPK8-10), MITF, Cofilin",
657,Immune response_Classical complement pathway,53,4.357E-04,1.120E-03,4.357E-04,1.120E-03,31,"C3, C3b, C5a, C5 convertase (C2aC4bC3b), C3c, C1r, C1 inhibitor, Factor I, C4b, C2, C7, C3dg, C2b, C3aR, C4a, C3 convertase (C2aC4b), CD21, CR1, C4BP, C6, CRP, C5, DAF, C9, C5b, iC3b, C3a, C4, C1s, CD59, C2a",4.438E-04,1.193E-03,29,"C3, C3b, C5a, C5 convertase (C2aC4bC3b), C3c, C1r, C1 inhibitor, Factor I, C4b, C2, C7, C3dg, C2b, C4a, C3 convertase (C2aC4b), CD21, CR1, C6, CRP, C8alpha, C5, DAF, C5b, iC3b, C3a, C4, C1s, CD59, C2a",
658,Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis,53,4.357E-04,1.120E-03,4.357E-04,1.120E-03,31,"HDAC9, ERK5 (MAPK7), Calcineurin A (catalytic), RHEB2, NF-AT1(NFATC2), IRS-1, MEF2C, 14-3-3, HDAC4, HDAC7, MYF6, CaMK IV, p38beta (MAPK11), MAP3K2 (MEKK2), PI3K reg class IA, PCAF, IGF-2, MAP2K5 (MEK5), AKT(PKB), PI3K cat class IA, c-Jun, MEF2A, MEF2, HDAC5, p300, NCOA2 (GRIP1/TIF2), CARM1, Calmodulin, MAP3K3, Calcineurin B (regulatory), mTOR",4.438E-04,1.193E-03,29,"p38alpha (MAPK14), HDAC9, ERK5 (MAPK7), Calcineurin A (catalytic), RHEB2, MEF2C, 14-3-3, HDAC4, HDAC7, MYF6, CaMK IV, AMP deaminase 1, MAP3K2 (MEKK2), PI3K reg class IA, PCAF, IGF-2, MAP2K5 (MEK5), AKT(PKB), PI3K cat class IA, MEF2A, MEF2, HDAC5, p300, NCOA2 (GRIP1/TIF2), CARM1, Calmodulin, MAP3K3, Calcineurin B (regulatory), mTOR",
659,Proliferative action of Gastrin in gastric cancer,53,4.357E-04,1.120E-03,4.357E-04,1.120E-03,31,"Gastrin 17-Gly, IRS-1, TCF7L2 (TCF4), ERK1/2, HB-EGF, Beta-catenin, G-protein alpha-q/11, ICRF, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), CREB1, Gastrin 17, Progastrin, Stromelysin-1, c-Src, c-Myc, JAK2, cPKC (conventional), PI3K cat class IA, CCKBR, EGFR, SP3, SOS, p90Rsk, PKC-beta, PKC, PKC-alpha, G-protein alpha-q",1.158E-03,2.679E-03,28,"Gastrin 17-Gly, TCF7L2 (TCF4), ERK1/2, HB-EGF, Beta-catenin, c-Raf-1, G-protein alpha-q/11, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), CREB1, Gastrin 17, Progastrin, Stromelysin-1, c-Src, MEK1(MAP2K1), JAK2, cPKC (conventional), PI3K cat class IA, EGFR, SP3, SOS, p90Rsk, PKC-beta, PKC, PKC-alpha",
660,Dual function of Treg cells in cancer development,46,4.426E-04,1.193E-03,9.352E-04,2.186E-03,27,"Helios, TGF-beta 1, IL-10, Neuropilin-1, Beta-catenin, 5'-NTD, OX40(TNFRSF4), IFNAR1, Perforin, STAT1, CD4, IL-6, CTLA-4, FasL(TNFSF6), ICOS, IL-2R alpha chain, IL-2, CD45, GITR, ETS1, COX-2 (PTGS2), TIM-3, c-Maf, WNT, STAT5, PD-1, DNMT1",4.426E-04,1.193E-03,26,"Helios, TGF-beta 1, IL-10, IFN-gamma, Neuropilin-1, Beta-catenin, 5'-NTD, OX40(TNFRSF4), IL-17, IFNAR1, STAT1, CD4, IL-6, CTLA-4, IL-2, CD45, GITR, ROR-alpha, ETS1, STAT3, COX-2 (PTGS2), c-Maf, WNT, STAT5, PD-1, DNMT1",
661,Immune response_Alternative complement pathway,53,4.438E-04,1.193E-03,2.749E-03,5.650E-03,29,"Factor B, C3, C3b, C5a, C3c, Factor I, Factor Bb, C7, Factor H, C3dg, C5 convertase (C3b2Bb), C3aR, PTX3, FHR-1, CD21, Factor Ba, C3 convertase (C3bBb), Properdin, CR1, C6, CRP, Annexin II, C5, DAF, C9, C5b, iC3b, C3a, CD59",4.438E-04,1.193E-03,29,"Factor B, C3, C3b, C5a, C3c, Factor I, Factor Bb, C7, Factor H, C3dg, FHR-2, C5 convertase (C3b2Bb), PTX3, FHR-1, CD21, Factor Ba, C3 convertase (C3bBb), Properdin, CR1, C6, CRP, Annexin II, C8alpha, C5, DAF, C5b, iC3b, C3a, CD59",
662,Development_Beta-adrenergic receptors transactivation of EGFR,37,4.649E-04,1.241E-03,2.177E-03,4.646E-03,22,"RHEB2, ADAM12, CD44, Beta-3 adrenergic receptor, ERK1/2, HB-EGF, Shc, PI3K reg class IA, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), MYLK1, c-Src, PI3K cat class IA, EGFR, G-protein alpha-i family, c-Jun, SOS, PP2A catalytic, AP-1, Beta-2 adrenergic receptor, mTOR",4.649E-04,1.241E-03,22,"RHEB2, ADAM12, CD44, Beta-3 adrenergic receptor, ERK1/2, HB-EGF, c-Raf-1, Shc, PI3K reg class IA, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), MYLK1, c-Src, MEK1(MAP2K1), PI3K cat class IA, EGFR, G-protein alpha-i family, SOS, PP2A catalytic, Beta-2 adrenergic receptor, mTOR",
663,Development_Dopamine D2 receptor transactivation of EGFR,24,4.655E-04,1.241E-03,1.713E-02,2.839E-02,14,"ADAM12, HB-EGF, Shc, PI3K reg class IA, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, Dopamine D2 receptor, PI3K cat class IA, EGFR, G-protein alpha-i family, SOS",4.655E-04,1.241E-03,16,"ADAM12, HB-EGF, c-Raf-1, Shc, PI3K reg class IA, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, Dopamine D2 receptor, MEK1(MAP2K1), PI3K cat class IA, EGFR, G-protein alpha-i family, SOS",
664,HIF-1 in gastric cancer,51,4.695E-04,1.201E-03,4.695E-04,1.201E-03,30,"F264, VHL, ERK1/2, VEGF-A, ENO1, MDR1, Rac1, Ubiquitin, ABCC1, Bax, F263, alpha-V/beta-3 integrin, Cyr61, CDC42, AKT(PKB), HSP90, c-Src, PGE2R2, ARNT, Osteopontin, CD133, PI3K reg class IA (p85-alpha), HIF1A, HIF-1, PGES, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), LDHA, p53, PAI1",1.353E-03,3.079E-03,27,"F264, VHL, ERK1/2, VEGF-A, ENO1, MDR1, Ubiquitin, ABCC1, Bax, F263, alpha-V/beta-3 integrin, Cyr61, CDC42, AKT(PKB), HSP90, c-Src, PGE2R2, Osteopontin, CD133, PI3K reg class IA (p85-alpha), HIF1A, PGES, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), LDHA, p53, PAI1",
665,Development_Signaling pathways in embryonic hepatocyte maturation,51,4.695E-04,1.201E-03,4.695E-04,1.201E-03,30,"ALDOB, APOA2, JAK1, HNF1-alpha, Beta-catenin, c-FLIP(Long), APOC2, OSMR, Caspase-8, HNF3-beta, Cyclin D2, Shc, PI3K reg class IA, RBP4, APOB, AKT(PKB), HGF, PI3K cat class IA, L-FABP, PAH, SOS, FXR, APOA1, Transferrin, APOC3, FasR(CD95), Oncostatin M, HGF receptor (Met), HNF4-alpha, p120-catenin",1.353E-03,3.079E-03,27,"ALDOB, APOA2, JAK1, Beta-catenin, c-FLIP(Long), OSMR, Caspase-8, HNF3-beta, Cyclin D2, Shc, PI3K reg class IA, RBP4, APOB, AKT(PKB), HGF, PI3K cat class IA, L-FABP, G6PT, SOS, FXR, STAT3, APOA1, Transferrin, FasR(CD95), Oncostatin M, HGF receptor (Met), HNF4-alpha",
666,Development_Gastrin in cell growth and proliferation,62,4.850E-04,1.238E-03,4.850E-04,1.238E-03,35,"Gastrin 17-Gly, IRS-1, TCF7L2 (TCF4), ERK1/2, HB-EGF, Beta-catenin, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), CREB1, ERK2 (MAPK1), Gastrin 17, Stromelysin-1, c-Src, c-Myc, JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), PKC-delta, CCKBR, EGFR, c-Jun, SOS, p90Rsk, MEK4(MAP2K4), PKC-beta, AP-1, MEKK1(MAP3K1), PKC-alpha, G-protein alpha-q, JNK(MAPK8-10)",2.087E-03,4.534E-03,31,"p38alpha (MAPK14), Gastrin 17-Gly, TCF7L2 (TCF4), ERK1/2, HB-EGF, Beta-catenin, c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), CREB1, ERK2 (MAPK1), Gastrin 17, Stromelysin-1, c-Src, MEK1(MAP2K1), JAK2, PI3K cat class IA, PI3K reg class IA (p85-alpha), EGFR, SOS, p90Rsk, MEK4(MAP2K4), STAT3, PKC-beta, PKC-alpha, JNK(MAPK8-10)",
667,B cell signaling in hematological malignancies,80,4.938E-04,1.259E-03,4.938E-04,1.259E-03,43,"PLD1, Semaphorin 4D, IP3 receptor, Syk, Cyclin D2, Ubiquitin, I-kB, PI3K reg class IA (p85), IRAK4, MyD88, ZAP70, IKK-alpha, BCMA(TNFRSF17), IL-6, CD22, NF-kB, AKT(PKB), LPP1, Mcl-1, TAK1(MAP3K7), BAFF(TNFSF13B), JAK2, APRIL(TNFSF13), TRAF3, c-Cbl, CD38, Lyn, BAFF-R, TRAF6, CD70(TNFSF7), NIK(MAP3K14), Bcl-6, PKC-beta2, PI3K cat class IA (p110-delta), CARD11, CD72, PKC-beta1, MALT1, IRAK1, CD79B, TACI(TNFRSF13B), Bcl-10, PLC-gamma 2",5.071E-04,1.333E-03,40,"PLD1, Semaphorin 4D, IP3 receptor, Syk, Cyclin D2, Ubiquitin, I-kB, PI3K reg class IA (p85), IRAK4, BCMA(TNFRSF17), IL-6, NF-kB, AKT(PKB), LPP1, Mcl-1, TAK1(MAP3K7), CD40L(TNFSF5), BAFF(TNFSF13B), JAK2, APRIL(TNFSF13), TRAF3, c-Cbl, CD38, Lyn, BAFF-R, TRAF6, CD70(TNFSF7), NIK(MAP3K14), Bcl-6, PKC-beta2, PI3K cat class IA (p110-delta), CARD11, STAT3, CD72, PKC-beta1, MALT1, IRAK1, TACI(TNFRSF13B), Bcl-10, PLC-gamma 2",
668,Development_Direct reprogramming of cardiac fibroblasts into cardiomyocytes,20,5.031E-04,1.329E-03,6.286E-03,1.167E-02,13,"TBX5, Troponin I, slow skeletal, MEF2C, beta-MHC, c-Kit, MLC2, Ca-ATPase2, ACTC, Myocardin, Thy-1, CSX (Nkx2.5), Tropomyosin-1, SRF",5.031E-04,1.329E-03,14,"Troponin I, slow skeletal, MEF2C, Alpha-actinin 2, beta-MHC, c-Kit, Islet-1, MLC2, Ca-ATPase2, ACTC, Myocardin, Thy-1, CSX (Nkx2.5), Tropomyosin-1, SRF",
669,wtCFTR and deltaF508-CFTR traffic / Clathrin coated vesicles formation (normal and CF),20,5.031E-04,1.329E-03,6.286E-03,1.167E-02,13,"AP180, Myosin I, Eps15, PICALM, Dynamin-2, Actin, Epsin 1, BIN1 (Amphiphysin II), Actin cytoskeletal, c-Cbl, HIP1, SNX9, Endophilin B1",5.031E-04,1.329E-03,14,"AP180, Myosin I, Eps15, PICALM, Dynamin-2, Actin, Epsin 1, BIN1 (Amphiphysin II), Actin cytoskeletal, c-Cbl, HIP1, CFTR, SNX9, Endophilin B1",
670,Immune response_Bacterial infections in normal airways,49,5.047E-04,1.273E-03,5.047E-04,1.273E-03,29,"TLR1, TLR5, JAK1, MD-2, IRF1, STAT1, IL-1 beta, I-kB, IRAK4, CD14, MyD88, IKK-alpha, IL-6, FasL(TNFSF6), NF-kB, TAK1(MAP3K7), JAK2, iNOS, LBP, IL-8, TRAF6, IL1RAP, IFN-gamma receptor, NIK(MAP3K14), TLR4, FasR(CD95), TAB1, IRAK1/2, TLR2",3.877E-03,7.637E-03,25,"TLR1, JAK1, IFN-gamma, MD-2, IRF1, STAT1, IL-1 beta, I-kB, IRAK4, CD14, IL-6, NF-kB, TAK1(MAP3K7), JAK2, iNOS, IL-8, TRAF6, IL1RAP, CFTR, IFN-gamma receptor, NIK(MAP3K14), TLR4, FasR(CD95), IRAK1/2, TLR2",
671,Neurophysiological process_HTR2A signaling in the nervous system,49,5.047E-04,1.273E-03,5.047E-04,1.273E-03,29,"MUPP1, Calcineurin A (catalytic), ERK1/2, HTR2A, EGR1, G-protein alpha-q/11, PLC-beta1, Rac1, IP3 receptor, Beta-arrestin2, GABA-A receptor, PLC-beta, CDC42, AKT(PKB), SFK, RACK1, Heme oxygenase 1, cPKC (conventional), iNOS, NR2B, Calmodulin, PKC, TGM2, PSD-95, SRD5A1, Caveolin-1, GCL cat, NRF2, Calcineurin B (regulatory)",1.581E-03,3.533E-03,26,"MUPP1, Calcineurin A (catalytic), ERK1/2, HTR2A, G-protein alpha-q/11, IP3 receptor, Beta-arrestin2, GABA-A receptor, PLC-beta, CDC42, AKT(PKB), SFK, RACK1, Heme oxygenase 1, cPKC (conventional), iNOS, NR2B, Calmodulin, PKC, TGM2, PSD-95, SRD5A1, Caveolin-1, GCL cat, NRF2, Calcineurin B (regulatory)",
672,Main pathways of Schwann cells transformation in neurofibromatosis type 1 ,80,5.071E-04,1.333E-03,8.406E-03,1.517E-02,39,"RHEB2, RPS6, ERK1/2, Beta-catenin, VEGF-A, Rac2, VAV-1, IP3 receptor, BAD, PI3K reg class IA (p85), GSK3 beta, PLC-gamma 1, N-Ras, IL-6, MEK1/2, CDC42, TGF-alpha, AKT(PKB), PDGF receptor, SOX9, CXCR4, ITGB1, PI3K cat class IA, HIF1A, S100B, EGFR, BRD4, ErbB4, Myelin basic protein, c-Maf, AP-1, Calmodulin, TC21, Neurofibromin, p38 MAPK, Bim, Elk-1, mTOR, PDGF-R-beta",5.071E-04,1.333E-03,40,"RHEB2, Neuregulin 1, RPS6, ERK1/2, Beta-catenin, VEGF-A, c-Raf-1, Rac2, VAV-1, IP3 receptor, PI3K reg class IA (p85), GSK3 beta, PLC-gamma 1, N-Ras, IL-6, MEK1/2, CDC42, TGF-alpha, AKT(PKB), PDGF receptor, SOX9, CXCR4, MEK1(MAP2K1), ITGB1, PI3K cat class IA, HIF1A, S100B, EGFR, BRD4, ErbB4, Myelin basic protein, c-Maf, Calmodulin, TC21, Neurofibromin, p38 MAPK, Bim, Elk-1, mTOR, PDGF-R-beta",
673,"Development_Activation of Erk by ACM1, ACM3 and ACM5",44,5.101E-04,1.333E-03,1.007E-03,2.344E-03,26,"ERK1/2, EGR1, PKC-epsilon, PLC-beta1, IP3 receptor, RAP-1A, Shc, p120GAP, cPLA2, MEK2(MAP2K2), Cyr61, CREB1, TGF-alpha, ACM5, c-Src, Pyk2(FAK2), B-Raf, CALDAG-GEFI, EGFR, SOS, ACM3, Calmodulin, ITGA2, PKC-alpha, G-protein alpha-q, ADAM17",5.101E-04,1.333E-03,25,"ERK1/2, c-Raf-1, PKC-epsilon, IP3 receptor, RAP-1A, Shc, p120GAP, cPLA2, MEK2(MAP2K2), Cyr61, CREB1, TGF-alpha, ACM5, c-Src, MEK1(MAP2K1), Pyk2(FAK2), B-Raf, EGFR, SOS, p90RSK1, ACM3, Calmodulin, ITGA2, PKC-alpha, ADAM17",
674,Th2-cytokines induced expression of Mucin 5AC and maintenance of mucous cell phenotype in normal airway epithelium,35,5.267E-04,1.362E-03,6.406E-03,1.182E-02,20,"SPHK1, Mucin 16, G6NT, Pendrin, ERK1/2, SMAD4, HNF3-beta, GCNT3, IL13RA1, IL-13, TGF-beta 2, JAK2, HIF1A, TGF-beta receptor type II, SOX17, IL-4R type II, Uteroglobin, IL4RA, JAK3, TGF-beta receptor type I",5.267E-04,1.362E-03,21,"SPHK1, p38alpha (MAPK14), Mucin 16, G6NT, Pendrin, ERK1/2, SMAD4, HNF3-beta, GCNT3, IL13RA1, IL13RA2, Centrin-1, TGF-beta 2, JAK2, HIF1A, TGF-beta receptor type II, SOX17, IL-4R type II, IL4RA, JAK3, TGF-beta receptor type I",
675,Development_Angiopoietin - Tie2 signaling,35,5.267E-04,1.362E-03,6.406E-03,1.182E-02,20,"TIE2, NCK1, CRK, STAT1, I-kB, p120GAP, Survivin, PI3K reg class IA, FKHR, RIPK1, Angiopoietin 4, NF-kB, AKT(PKB), PI3K cat class IA, Angiopoietin 1, Angiopoietin 2, EPAS1/ARNT, DOK2, SHP-2, STAT5",5.267E-04,1.362E-03,21,"TIE2, NCK1, CRK, GRB14, TIE, STAT1, I-kB, p120GAP, Survivin, PI3K reg class IA, FKHR, RIPK1, Angiopoietin 4, NF-kB, AKT(PKB), PI3K cat class IA, Angiopoietin 1, Angiopoietin 2, DOK2, STAT3, STAT5",
676,Anti-apoptotic action of Gastrin in gastric cancer,35,5.267E-04,1.362E-03,7.650E-04,1.840E-03,22,"Gastrin 17-Gly, Apaf-1, ERK1/2, Rac1, IP3 receptor, BAD, Bax, PLC-gamma 1, Caspase-3, MEK2(MAP2K2), CDC42, Gastrin 17, Progastrin, Mcl-1, RhoA, CCKBR, Caspase-9, PKC-beta, ROCK, PKC-alpha, Elk-1, SRF",5.267E-04,1.362E-03,21,"Gastrin 17-Gly, Apaf-1, ERK1/2, c-Raf-1, IP3 receptor, Bax, PLC-gamma 1, Caspase-3, MEK2(MAP2K2), CDC42, Gastrin 17, Progastrin, Mcl-1, MEK1(MAP2K1), RhoA, Caspase-9, PKC-beta, ROCK, PKC-alpha, Elk-1, SRF",
677,Immune response_CD16 signaling in NK cells,69,5.502E-04,1.379E-03,5.502E-04,1.379E-03,38,"Calcineurin A (catalytic), PLD1, NF-AT1(NFATC2), ERK1/2, VAV-1, Rac1, IP3 receptor, Syk, Shc, PKC-theta, PI3K reg class IA, ZAP70, PLC-gamma 1, GM-CSF, MEK2(MAP2K2), CDC42, Actin cytoskeletal, CD94, FasL(TNFSF6), SHIP, ERK2 (MAPK1), Cytohesin1, IL-2, WaspIP, TNF-alpha, PI3K cat class IA, Lck, c-Cbl, c-Jun, SOS, LAT, HLA-E, AP-1, Calmodulin, CD3 zeta, PLA2, Calcineurin B (regulatory), PLC-gamma 2",3.811E-03,7.515E-03,33,"Calcineurin A (catalytic), PLD1, IFN-gamma, ERK1/2, c-Raf-1, VAV-1, IP3 receptor, Syk, Shc, PKC-theta, PI3K reg class IA, PLC-gamma 1, GM-CSF, MEK2(MAP2K2), CDC42, Actin cytoskeletal, CD94, ERK2 (MAPK1), Cytohesin1, IL-2, WaspIP, TNF-alpha, MEK1(MAP2K1), PI3K cat class IA, Lck, c-Cbl, SOS, HLA-E, Calmodulin, CD3 zeta, PLA2, Calcineurin B (regulatory), PLC-gamma 2",
678,Calcium-dependent regulation of normal and asthmatic smooth muscle contraction,69,5.502E-04,1.379E-03,5.502E-04,1.379E-03,38,"STIM1, PAR2, TRPC6, Endothelin-3, IP3 receptor, TRPC1, Thrombin, PLC-beta, HTR2C (HTR1C), Endothelin-1, Endothelin-2, Ca-ATPase2, Ryanodine receptor 1, G-protein beta/gamma, MYLK1, MLCK, Neurokinin-2 receptor, CD38, ACM2, G-protein alpha-i family, Substance P receptor, Myosin II, Tryptase, TrkB, FKBP1B, Bradykinin, ACM3, Histamine H1 receptor, EDNRB, Calmodulin, TRPC3, NCX1, MRLC, G-protein alpha-q, PAR1, Ryanodine receptor 2, BDNF, EDNRA",7.952E-04,1.962E-03,35,"STIM1, TRPC4, PAR2, TRPC6, Ryanodine receptor 3, Endothelin-3, IP3 receptor, TRPC1, PLC-beta, Endothelin-1, Endothelin-2, Ca-ATPase2, Ryanodine receptor 1, G-protein beta/gamma, MYLK1, MLCK, Neurokinin-2 receptor, CD38, G-protein alpha-i family, Substance P receptor, Myosin II, Tryptase, TrkB, FKBP1B, ACM3, Histamine H1 receptor, EDNRB, Calmodulin, TRPC3, NCX1, MRLC, PAR1, Ryanodine receptor 2, BDNF, EDNRA",
679,Immune response_IL-15 signaling,58,5.758E-04,1.437E-03,5.758E-04,1.437E-03,33,"eIF4E, ERK1/2, PKC-epsilon, PLC-beta1, IL-15, I-kB, Shc, PI3K reg class IA (p85), IL-15RA, IL-6, MEK1/2, sIL-15RA, AKT(PKB), NF-kB p50/p65, c-Src, c-Myc, Mcl-1, GAB2, PI3K cat class IA, Lck, IL-8, ETS1, SOS, NIK(MAP3K14), MNK1, MEK4(MAP2K4), 4E-BP1, MEKK1(MAP3K1), UFO, IL-2R gamma chain, ADAM17, p38 MAPK, mTOR",2.868E-03,5.865E-03,29,"ERK1/2, c-Raf-1, PKC-epsilon, IL-15, I-kB, Shc, PI3K reg class IA (p85), IL-15RA, IL-6, MEK1/2, sIL-15RA, AKT(PKB), NF-kB p50/p65, c-Src, Mcl-1, GAB2, PI3K cat class IA, Lck, IL-8, ETS1, SOS, NIK(MAP3K14), MNK1, MEK4(MAP2K4), UFO, IL-2R gamma chain, ADAM17, p38 MAPK, mTOR",
680,Role of alpha-6/beta-4 integrins in carcinoma progression,45,5.791E-04,1.437E-03,5.791E-04,1.437E-03,27,"Laminin 5, IRS-2, IRS-1, eIF4E, VEGF-A, alpha-6/beta-4 integrin, LIMK1, 14-3-3 theta, Rac1, IP3 receptor, PI3K reg class IA (p85), PLC-gamma 1, Actin cytoskeletal, AKT(PKB), HGF, Plectin 1, PI3K cat class IA, EGFR, Laminin 1, 14-3-3 gamma, 4E-BP1, PKC-alpha, ITGB4, HGF receptor (Met), SSH1L, Cofilin, mTOR",2.161E-03,4.682E-03,24,"Laminin 5, IRS-2, Neuregulin 1, VEGF-A, alpha-6/beta-4 integrin, LIMK1, 14-3-3 theta, IP3 receptor, PI3K reg class IA (p85), PLC-gamma 1, Actin cytoskeletal, AKT(PKB), HGF, Plectin 1, PI3K cat class IA, EGFR, Laminin 1, 14-3-3 gamma, PKC-alpha, ITGB4, HGF receptor (Met), SSH1L, Cofilin, mTOR",
681,Development_EPO-induced MAPK pathway,45,5.791E-04,1.437E-03,5.791E-04,1.437E-03,27,"ERK1/2, CrkL, c-Kit, PKC-epsilon, VAV-1, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, Syk, RAP-1A, Shc, SOS2, PLC-gamma 1, N-Ras, MEK2(MAP2K2), G-protein beta/gamma, SHIP, JAK2, c-Cbl, Lyn, c-Jun, SOS, C3G, PKC-alpha, PLC-gamma, JNK(MAPK8-10), Elk-1",8.039E-04,1.973E-03,25,"ERK1/2, CrkL, c-Raf-1, c-Kit, PKC-epsilon, VAV-1, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, RAP-1A, Shc, SOS2, PLC-gamma 1, N-Ras, MEK2(MAP2K2), G-protein beta/gamma, MEK1(MAP2K1), JAK2, c-Cbl, Lyn, SOS, PKC-alpha, PLC-gamma, JNK(MAPK8-10), Elk-1",
682,Role of free fatty acids in obesity and type 2 diabetes,45,5.791E-04,1.437E-03,5.791E-04,1.437E-03,27,"HMGB1, CCL2, ATF-3, IRS-1, IFN-beta, IL-1 beta, PI3K reg class IA (p85), PKC-theta, PPAR-beta(delta), MyD88, IKK-alpha, PDK4, IL-6, AKT(PKB), NF-kB p50/p65, TNF-alpha, MLK3(MAP3K11), PI3K cat class IA, RelA (p65 NF-kB subunit), iNOS, NF-kB1 (p50), MKK7 (MAP2K7), JNK1(MAPK8), MEK4(MAP2K4), COX-2 (PTGS2), TLR4, TLR2",5.351E-03,1.009E-02,23,"HMGB1, CCL2, ATF-3, IFN-beta, IL-1 beta, PI3K reg class IA (p85), PKC-theta, PPAR-beta(delta), PDK4, IL-6, AKT(PKB), NF-kB p50/p65, TNF-alpha, MLK3(MAP3K11), PI3K cat class IA, RelA (p65 NF-kB subunit), iNOS, NF-kB1 (p50), JNK1(MAPK8), MEK4(MAP2K4), COX-2 (PTGS2), TLR4, TLR2",
683,Mast cell migration in asthma,73,5.814E-04,1.494E-03,2.227E-03,4.745E-03,38,"TGF-beta 1, IP10, CD44, CCL2, C5a, ERK1/2, VEGF-A, VEGFR-2, Fibronectin, c-Kit, PI3K cat class IB (p110-gamma), alpha-V/beta-3 integrin, G-protein beta/gamma, Eotaxin, PDGF receptor, C3aR, CXCR4, RhoA, TGF-beta 2, PTAFR, I-TAC, IL-8, TGF-beta receptor type II, G-protein alpha-i family, Laminin 1, alpha-5/beta-1 integrin, FGF2, CCL19, CXCL16, CXCR3, ROCK, P2Y1, C3a, PI3K reg class IB (p101), p38 MAPK, CCR4, Collagen I, TGF-beta receptor type I",5.814E-04,1.494E-03,37,"MIG, TGF-beta 1, CCL21, IP10, CD44, CCL2, C5a, ERK1/2, VEGF-A, VEGFR-2, Fibronectin, c-Kit, PI3K cat class IB (p110-gamma), alpha-V/beta-3 integrin, G-protein beta/gamma, Eotaxin, PDGF receptor, CXCR4, RhoA, TGF-beta 2, PTAFR, I-TAC, IL-8, TGF-beta receptor type II, G-protein alpha-i family, Laminin 1, alpha-5/beta-1 integrin, FGF2, CCL19, CXCL16, ROCK, P2Y1, C3a, p38 MAPK, CCR4, Collagen I, TGF-beta receptor type I",
684,Role and regulation of Prostaglandin E2 in gastric cancer,49,5.978E-04,1.517E-03,7.640E-03,1.387E-02,26,"NOTCH1 receptor, CCL2, ERK1/2, VEGF-A, PKA-reg (cAMP-dependent), IL-1 beta, Shc, Adenylate cyclase, MEK2(MAP2K2), CREB1, PLAUR (uPAR), TLR9, Gastrin 17, PGE2R2, PGE2R4, HIF1A, CCKBR, IL-8, EGFR, PGES, SOS, PLAU (UPA), COX-2 (PTGS2), Jagged1, PKA-cat (cAMP-dependent), TLR2",5.978E-04,1.517E-03,27,"NOTCH1 receptor, CCL2, ERK1/2, VEGF-A, c-Raf-1, IL-1 beta, Shc, Adenylate cyclase, MEK2(MAP2K2), CREB1, PLAUR (uPAR), TLR9, Gastrin 17, CD40L(TNFSF5), PGE2R2, MEK1(MAP2K1), PGE2R4, HIF1A, IL-8, EGFR, PGES, SOS, PLAU (UPA), COX-2 (PTGS2), Jagged1, PKA-cat (cAMP-dependent), TLR2",
685,Signal transduction_IP3 signaling,49,5.978E-04,1.517E-03,3.333E-03,6.612E-03,27,"ERK1/2, G-protein alpha-q/11, CaMK IV, PKC-epsilon, IP3 receptor, Syk, Shc, PI3K reg class IA, PLC-beta, ZAP70, PLC-gamma 1, MEK2(MAP2K2), CREB1, G-protein beta/gamma, AKT(PKB), PDGF receptor, PLC-epsilon, PI3K cat class IA, SOS, MEF2, HDAC5, LAT, Galpha(q)-specific nucleotide-like GPCRs, Calmodulin, CD3, HGF receptor (Met), Elk-1",5.978E-04,1.517E-03,27,"ERK1/2, c-Raf-1, G-protein alpha-q/11, CaMK IV, PKC-epsilon, IP3 receptor, Syk, Shc, PI3K reg class IA, PLC-beta, PLC-gamma 1, MEK2(MAP2K2), CREB1, G-protein beta/gamma, AKT(PKB), PDGF receptor, PLC-epsilon, MEK1(MAP2K1), PI3K cat class IA, SOS, MEF2, HDAC5, Galpha(q)-specific nucleotide-like GPCRs, Calmodulin, CD3, HGF receptor (Met), Elk-1",
686,Apoptosis and survival_Anti-apoptotic action of Gastrin,43,6.175E-04,1.516E-03,6.175E-04,1.516E-03,26,"Gastrin 17-Gly, IRS-1, ERK1/2, G-protein alpha-q/11, Rac1, IP3 receptor, BAD, PI3K reg class IA (p85), Bax, PLC-gamma 1, MEK2(MAP2K2), CDC42, AKT(PKB), Gastrin 17, c-Src, Mcl-1, RhoA, JAK2, PI3K cat class IA, CCKBR, PKC-beta, ROCK, PKC-alpha, G-protein alpha-q, Elk-1, SRF",2.527E-03,5.269E-03,23,"Gastrin 17-Gly, ERK1/2, c-Raf-1, G-protein alpha-q/11, IP3 receptor, PI3K reg class IA (p85), Bax, PLC-gamma 1, MEK2(MAP2K2), CDC42, AKT(PKB), Gastrin 17, c-Src, Mcl-1, MEK1(MAP2K1), RhoA, JAK2, PI3K cat class IA, PKC-beta, ROCK, PKC-alpha, Elk-1, SRF",
687,Immune response_Substance P-stimulated expression of proinflammatory cytokines via MAPKs,43,6.175E-04,1.516E-03,6.175E-04,1.516E-03,26,"GRO-2, CCL2, PI3K cat class IA (p110-beta), ERK1/2, PKC-epsilon, GRO-3, IP3 receptor, I-kB, PKC-theta, PLC-beta, IKK-alpha, IL-6, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, TNF-alpha, PKC-delta, IL-8, Substance P receptor, c-Jun, COX-2 (PTGS2), PKC-alpha, G-protein alpha-q, JNK(MAPK8-10), p38 MAPK",2.527E-03,5.269E-03,23,"GRO-2, CCL2, PI3K cat class IA (p110-beta), ERK1/2, c-Raf-1, PKC-epsilon, GRO-3, IP3 receptor, I-kB, PKC-theta, PLC-beta, IL-6, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, TNF-alpha, IL-8, Substance P receptor, COX-2 (PTGS2), PKC-alpha, JNK(MAPK8-10), p38 MAPK",
688,Mitogenic action of ErbB2 in breast cancer,56,6.265E-04,1.534E-03,6.265E-04,1.534E-03,32,"RHEB2, LMO4, TCF7L2 (TCF4), ERK1/2, Beta-catenin, Cyclin G2, Rac1, I-kB, Cyclin A1, Shc, PI3K reg class IA (p85), GSK3 beta, FKHR, IKK-alpha, MEK1/2, WT1, NF-kB, AKT(PKB), Cyclin B1, c-Src, c-Myc, NUMB, PI3K cat class IA, SMAD7, EGFR, ErbB4, SOS, Cyclin E, FOXO3A, HUNK, ER81, mTOR",1.438E-03,3.257E-03,29,"RHEB2, LMO4, Neuregulin 1, TCF7L2 (TCF4), ERK1/2, Beta-catenin, c-Raf-1, I-kB, Cyclin A1, Shc, PI3K reg class IA (p85), GSK3 beta, FKHR, MEK1/2, WT1, NF-kB, AKT(PKB), Cyclin B1, c-Src, NUMB, PI3K cat class IA, SMAD7, EGFR, ErbB4, SOS, Cyclin E, HUNK, ER81, mTOR",
689,Muscle contraction_Regulation of eNOS activity in endothelial cells,65,6.617E-04,1.617E-03,6.617E-04,1.617E-03,36,"VEGF-A, VEGFR-2, Dynamin-2, PI3K cat class IB (p110-gamma), IP3 receptor, PI3K reg class IA, PLC-beta, Endothelin-1, PLC-gamma 1, CREB1, G-protein beta/gamma, PEA3, AKT(PKB), HSP90, NF-kB p50/p65, c-Src, ARNT, CAT-1 (SLC7A1), NMT2, PI3K cat class IA, HIF1A, ETS1, G-protein alpha-i family, c-Jun, SP3, ETS2, Bradykinin, AP-1, EDNRB, Calmodulin, EPAS1, G-protein alpha-q, ZDHHC21, NMT1, Caveolin-1, Elk-1",5.220E-03,9.929E-03,31,"VEGF-A, VEGFR-2, Dynamin-2, PI3K cat class IB (p110-gamma), IP3 receptor, PI3K reg class IA, PLC-beta, Endothelin-1, PLC-gamma 1, CREB1, G-protein beta/gamma, PEA3, AKT(PKB), HSP90, NF-kB p50/p65, c-Src, CAT-1 (SLC7A1), NMT2, PI3K cat class IA, HIF1A, ETS1, G-protein alpha-i family, SP3, ETS2, EDNRB, Calmodulin, EPAS1, ZDHHC21, NMT1, Caveolin-1, Elk-1",
690,Blood coagulation_GPVI-dependent platelet activation,54,6.808E-04,1.662E-03,6.808E-04,1.662E-03,31,"PREL1, PI3K cat class IA (p110-beta), GP-IB beta, VAV-1, Rac1, IP3 receptor, Syk, Talin, RAP-1A, alpha-IIb/beta-3 integrin, CDC42, Fyn, Syntaxin 4, RhoA, VAMP3, PI3K reg class IA (p85-alpha), Slp76, CALDAG-GEFI, c-Cbl, ITGB3, Lyn, RAP-1B, LAT, GRAP2, PI3K cat class IA (p110-alpha), PKC-alpha, SHP-2, alpha-2/beta-1 integrin, Fibrinogen (fibrin), PLC-gamma 2, Collagen I",3.405E-02,5.194E-02,24,"PREL1, PI3K cat class IA (p110-beta), VAV-1, IP3 receptor, Syk, Talin, RAP-1A, alpha-IIb/beta-3 integrin, CDC42, Fyn, RhoA, VAMP3, PI3K reg class IA (p85-alpha), Slp76, c-Cbl, ITGB3, Lyn, RAP-1B, GRAP2, PI3K cat class IA (p110-alpha), PKC-alpha, alpha-2/beta-1 integrin, PLC-gamma 2, Collagen I",
691,Regulation of degradation of deltaF508-CFTR in CF,39,6.941E-04,1.688E-03,6.941E-04,1.688E-03,24,"NPL4, HDAC6, Sti1, Ubiquitin, Dynein 1, cytoplasmic, heavy chain, BAG-2, UBE2J1, UBE2D1, HSP90, HSP70, RNF5, SEC61 complex, HSC70, Hdj-2, SAE1, SUMO-3, USP19, Alpha crystallin A, UBE1, SUMO-2, UCHL1, HSPBP1, MJD (ataxin-3), Dynein 1, cytoplasmic, intermediate chains",4.209E-02,6.330E-02,18,"NPL4, HDAC6, Ubiquitin, Dynein 1, cytoplasmic, heavy chain, BAG-2, UBE2J1, UBE2D1, HSP90, HSP70, RNF5, SEC61 complex, CFTR, Hdj-2, SUMO-3, Alpha crystallin A, UCHL1, MJD (ataxin-3), Dynein 1, cytoplasmic, intermediate chains",
692,Role of iNKT and B cells in T cell recruitment in allergic contact dermatitis,39,6.941E-04,1.688E-03,6.941E-04,1.688E-03,24,"IP10, alpha-4/beta-1 integrin, JAK1, NF-AT1(NFATC2), ICAM1, IL-4R type I, C5a, IRF1, STAT1, ITK, NF-kB, CD5, TNF-R1, NF-AT2(NFATC1), TNF-alpha, IFNGR1, VCAM1, CD1d, Thy-1, T-bet, CD21, CXCR3, CD3, CXCL13",1.248E-03,2.862E-03,22,"IP10, alpha-4/beta-1 integrin, JAK1, ICAM1, IL-4R type I, C5a, IFN-gamma, CXCR5, IRF1, STAT1, NF-kB, TNF-R1, NF-AT2(NFATC1), TNF-alpha, IFNGR1, VCAM1, CD1d, Thy-1, T-bet, CD21, CD3, CXCL13",
693,Development_Growth factors in regulation of oligodendrocyte precursor cell survival,37,7.308E-04,1.769E-03,7.308E-04,1.769E-03,23,"IRS-1, PDGF-R-alpha, BAD, PI3K reg class IA (p85), Bax, GSK3 beta, PI3K reg class IA, IKK-alpha, Caspase-3, Fyn, AKT(PKB), 14-3-3 epsilon, PI3K cat class IA, RelA (p65 NF-kB subunit), Lyn, 14-3-3 zeta/delta, PDGF-A, ErbB4, Caspase-9, p90Rsk, 4E-BP1, 14-3-3 beta/alpha, mTOR",4.045E-03,7.915E-03,20,"Neuregulin 1, c-Raf-1, PDGF-R-alpha, PI3K reg class IA (p85), Bax, GSK3 beta, PI3K reg class IA, Caspase-3, Fyn, AKT(PKB), 14-3-3 epsilon, PI3K cat class IA, RelA (p65 NF-kB subunit), Lyn, 14-3-3 zeta/delta, PDGF-A, ErbB4, Caspase-9, p90Rsk, mTOR",
694,Neurophysiological process_Synaptic vesicle fusion and recycling in nerve terminals,52,7.389E-04,1.786E-03,7.389E-04,1.786E-03,30,"CADPS, NSF, Calcineurin A (catalytic), AP180, F-Actin, AP complex 2 medium (mu) chain, CaMK I, PICALM, Complexin, Syntaxin 1A, SLC17A7, SYNJ1, Dynamin-1, SV2A, VAMP2, CHL1, Alpha-synuclein, HSC70, MUNC18, HIP1, Calmodulin, BZRAP1, STN2, P/Q-type calcium channel alpha-1A subunit, RIM-bp2, Beta-adaptin 2, Synapsin II, SYP, Endophilin A1, N-type Ca(II) channel alpha1B",1.016E-02,1.775E-02,25,"CADPS, Calcineurin A (catalytic), AP180, F-Actin, AP complex 2 medium (mu) chain, SNAP-25, CaMK I, PICALM, MUNC13-1, SLC17A7, SYNJ1, Dynamin-1, SV2A, VAMP2, CHL1, Alpha-synuclein, HIP1, Calmodulin, BZRAP1, STN2, P/Q-type calcium channel alpha-1A subunit, RIM-bp2, Beta-adaptin 2, Synapsin II, Endophilin A1",
695,Role of Neuregulin 1 and Thymosin beta-4 in myocardium regeneration after infarction,29,7.465E-04,1.860E-03,2.820E-03,5.755E-03,18,"Fibronectin, PI3K reg class IA (p85), ACTA1, Endothelin-1, AKT(PKB), GAB2, alpha-3/beta-1 integrin, ITGB1, PI3K cat class IA, PINCH, Angiopoietin 1, alpha-5/beta-1 integrin, ErbB4, Thymosin beta-4, ITGA3, Alpha-parvin, ITGA5, ADAM17",7.465E-04,1.860E-03,18,"Neuregulin 1, Fibronectin, PI3K reg class IA (p85), Endothelin-1, AKT(PKB), GAB2, alpha-3/beta-1 integrin, ITGB1, PI3K cat class IA, PINCH, Angiopoietin 1, alpha-5/beta-1 integrin, ErbB4, Thymosin beta-4, ITGA3, Alpha-parvin, ITGA5, ADAM17",
696,Cigarette smoke-mediated attenuation of antibacterial and antivirus immune response,29,7.465E-04,1.860E-03,2.820E-03,5.755E-03,18,"IP10, ICAM1, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, IL-1 beta, GM-CSF, IL-6, TNF-R1, TNF-alpha, RelA (p65 NF-kB subunit), IL-8, IRF9, IFN-gamma receptor, AP-1, TLR4, sICAM1",7.465E-04,1.860E-03,18,"IP10, ICAM1, IFN-gamma, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, IL-1 beta, GM-CSF, IL-6, TNF-R1, TNF-alpha, RelA (p65 NF-kB subunit), IL-8, IRF9, IFN-gamma receptor, TLR4, sICAM1",
697,Prostate Cancer: candidate susceptibility genes in inflammatory pathways,29,7.465E-04,1.860E-03,2.820E-03,5.755E-03,18,"TLR1, TNF-R2, IL-1 alpha, TLR10, IL-10, MSR1, VEGF-A, IL1RN, IL-1 beta, IL-6, NF-kB, TNF-R1, TNF-alpha, IL-8, TLR6, 2'-5'-oligoadenylate synthetase, TLR4, p53",7.465E-04,1.860E-03,18,"TLR1, TNF-R2, IL-1 alpha, TLR10, IL-10, MSR1, VEGF-A, IL1RN, IL-1 beta, IL-6, NF-kB, TNF-R1, TNF-alpha, IL-8, TLR6, 2'-5'-oligoadenylate synthetase, TLR4, p53",
698,Cell adhesion_Alpha-4 integrins in cell migration and adhesion,35,7.650E-04,1.840E-03,7.650E-04,1.840E-03,22,"alpha-4/beta-1 integrin, CRK, LIMK1, Fibronectin, Rac1, PI3K reg class IA (p85), CDC42, Actin cytoskeletal, c-Src, BETA-PIX, ITGB1, PI3K cat class IA, VCAM1, F-Actin cytoskeleton, DOCK1, Paxillin, p130CAS, ITGA4, N-WASP, Filamin A, PKA-cat (cAMP-dependent), Cofilin",1.211E-02,2.079E-02,18,"alpha-4/beta-1 integrin, CRK, LIMK1, Fibronectin, PI3K reg class IA (p85), CDC42, Actin cytoskeletal, c-Src, ITGB1, PI3K cat class IA, VCAM1, F-Actin cytoskeleton, DOCK1, p130CAS, ITGA4, Filamin A, PKA-cat (cAMP-dependent), Cofilin",
699,Cell cycle_ESR1 regulation of G1/S transition,35,7.650E-04,1.840E-03,7.650E-04,1.840E-03,22,"CRM1, ERK1/2, CDC25A, ATF-2/c-Jun, Ubiquitin, CKS1, CDK4, Cyclin A2, Skp2/TrCP/FBXW, SKP2, ERK2 (MAPK1), c-Myc, c-Jun, Cul1/Rbx1 E3 ligase, CDK2, CDK6, Cullin 1, E2F4/DP1 complex, CARM1, E2F4, Cyclin E, Cyclin A",4.733E-03,9.071E-03,19,"CRM1, ERK1/2, CDC25A, Ubiquitin, CKS1, CDK4, Cyclin A2, Skp2/TrCP/FBXW, SKP2, ERK2 (MAPK1), Cul1/Rbx1 E3 ligase, CDK2, CDK6, Cullin 1, E2F4/DP1 complex, CARM1, E2F4, Cyclin E, Cyclin A",
700,Development_Schema: Osteogenic and adipogenic differentiation of mesenchymal stem cells,21,7.737E-04,1.855E-03,7.737E-04,1.855E-03,15,"IL-1 alpha, NOTCH1 receptor, WNT3A, BMP4, BMP6, Beta-adrenergic receptor, PPAR-gamma, TNF-alpha, Ihh, NOTCH2, WNT1, WNT5A, RUNX2, WNT10B, BMP2",1.419E-02,2.402E-02,12,"IL-1 alpha, NOTCH1 receptor, BMP4, BMP6, Beta-adrenergic receptor, PPAR-gamma, TNF-alpha, Ihh, NOTCH2, WNT5A, RUNX2, BMP2",
701,Immune response_T cell subsets: cell surface markers,52,7.806E-04,1.929E-03,9.596E-03,1.711E-02,27,"TGF-beta 1, TCR beta subunit, CD44, IL27RA, SLAM, IFN-alpha/beta receptor, IL17BR, L-selectin, IL-15RA, CD4, CTLA-4, CD94, IL-2R alpha chain, NTB-A, IL-12 receptor, IL7RA, GITR, IFN-gamma receptor, IL4RA, BTLA, CXCR3, ST2(L), CD8, CD3, CCR10, CCR4, IL-12RB2",7.806E-04,1.929E-03,28,"TGF-beta 1, TCR beta subunit, CD44, IL27RA, IL-17, SLAM, IFN-alpha/beta receptor, IL17BR, L-selectin, IL-15RA, CD4, CTLA-4, CD94, NTB-A, IL-12 receptor, IL7RA, GITR, CRTH2, IFN-gamma receptor, IL4RA, BTLA, ST2(L), TCR beta variable 11-1, CD8, CD3, CCR10, CCR4, IL-12RB2",
702,Immune response_Fc epsilon RI pathway: signaling through Fyn and PI3K,61,7.941E-04,1.898E-03,7.941E-04,1.898E-03,34,"SPHK1, Beta-hexosaminidase, PI3K class II (CII-alpha), SGK1, STAT5B, Fc epsilon RI alpha, Syk, I-kB, PI3K reg class IA (p85), PAG, N-Ras, IL-13, Fyn, NF-kB, AKT(PKB), Syntaxin 4, LAMP3, KIF5B, GAB2, c-Cbl, Lyn, MIST, FGR, NDRG1, Csk, SKAP55, NF-AT, PI3K cat class IA (p110-delta), AP-1, SHP-2, SYTL3, STAT5, FYB1, KLC1",1.492E-03,3.365E-03,31,"SPHK1, Beta-hexosaminidase, PI3K class II (CII-alpha), SGK1, STAT5B, Fc epsilon RI alpha, Syk, I-kB, PI3K reg class IA (p85), PAG, N-Ras, Fyn, NF-kB, AKT(PKB), LAMP3, KIF5B, GAB2, c-Cbl, Lyn, MIST, FGR, NDRG1, Fc epsilon RI beta, Csk, SKAP55, NF-AT, PI3K cat class IA (p110-delta), SYTL3, STAT5, FYB1, KLC1",
703,Development_EGFR signaling via small GTPases,33,7.953E-04,1.898E-03,7.953E-04,1.898E-03,21,"ERK1/2, Rac1, Shc, p120GAP, EPS8, PI3K reg class IA, N-Ras, RNTRE, MEK1/2, c-Myc, E3b1(ABI-1), PI3K cat class IA, c-Cbl, EGFR, SOS, MKK7 (MAP2K7), DOK2, MEK4(MAP2K4), Rab-5A, JNK(MAPK8-10), Elk-1",1.921E-03,4.222E-03,19,"ERK1/2, c-Raf-1, Shc, p120GAP, EPS8, PI3K reg class IA, N-Ras, RNTRE, MEK1/2, E3b1(ABI-1), PI3K cat class IA, c-Cbl, EGFR, SOS, DOK2, MEK4(MAP2K4), Rab-5A, JNK(MAPK8-10), Elk-1",
704,Hypertrophy of  asthmatic airway smooth muscle cells ,70,7.991E-04,1.904E-03,7.991E-04,1.904E-03,38,"TGF-beta 1, NOX4, Cardiotrophin-1, JAK1, eIF4E, PDGF-R-alpha, IFN-alpha/beta receptor, IFN-beta, Smooth muscle myosin, IL-1 beta, GSK3 beta, SOD1, Thrombin, Endothelin-1, IL-13, Transgelin, AKT(PKB), c-Myc, MLCK, TNF-alpha, IFNGR1, TGF-beta 2, TGF-beta receptor type II, EGFR, IL-4R type II, PDGF-A, NOX4/p22-phox, 4E-BP1, EDNRB, MYH11, Oncostatin M, ACTA2, SMAD3, EDNRA, Actin muscle, mTOR, TGF-beta receptor type I, PDGF-R-beta",2.429E-03,5.100E-03,34,"TGF-beta 1, NOX4, JAK1, IFN-gamma, PDGF-R-alpha, IFN-alpha/beta receptor, IFN-beta, Smooth muscle myosin, IL-1 beta, GSK3 beta, Endothelin-1, Transgelin, AKT(PKB), miR-25-3p, MLCK, TNF-alpha, IFNGR1, TGF-beta 2, TGF-beta receptor type II, EGFR, IL-4R type II, PDGF-A, NOX4/p22-phox, STAT3, EDNRB, Oncostatin M, ACTA2, SMAD3, microRNA 25, EDNRA, Actin muscle, mTOR, TGF-beta receptor type I, PDGF-R-beta",
705,Mechanisms of resistance to EGFR inhibitors in lung cancer,45,8.039E-04,1.973E-03,1.594E-03,3.491E-03,26,"IRS-1, Beta-catenin, Fibronectin, Vimentin, Shc, PI3K reg class IA (p85), Survivin, TACSTD2 (TROP2), Claudin-7, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), HSP90, c-Src, HGF, Ep-CAM, PI3K cat class IA, c-Cbl, EGFR, CIN85, SOS, TCF8, 4E-BP1, SNAIL1, HGF receptor (Met), mTOR",8.039E-04,1.973E-03,25,"Beta-catenin, c-Raf-1, Fibronectin, Vimentin, Shc, PI3K reg class IA (p85), Survivin, TACSTD2 (TROP2), MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), HSP90, c-Src, HGF, MEK1(MAP2K1), Ep-CAM, PI3K cat class IA, c-Cbl, EGFR, CIN85, SOS, TCF8, SNAIL1, HGF receptor (Met), mTOR",
706,Immune response_PGE2 signaling in immune response,45,8.039E-04,1.973E-03,2.021E-02,3.280E-02,23,"NF-AT1(NFATC2), IL-10, SLC21A2, PKA-reg (cAMP-dependent), CREM (activators), GM-CSF, Adenylate cyclase, CREB1, ERK2 (MAPK1), IL-2, TNF-alpha, HGF, PGE2R2, PGE2R4, CREM (repressors), PKA-cat alpha, C/EBPbeta, IL-8, IL-5, PGES, COX-2 (PTGS2), IL-12 beta, PKA-cat (cAMP-dependent)",8.039E-04,1.973E-03,25,"IL-10, IFN-gamma, SLC21A2, c-Raf-1, COX-1 (PTGS1), CREM (activators), GM-CSF, Adenylate cyclase, CREB1, ERK2 (MAPK1), IL-2, TNF-alpha, HGF, PGE2R2, MEK1(MAP2K1), PGE2R4, CREM (repressors), PKA-cat alpha, C/EBPbeta, IL-8, IL-5, PGES, COX-2 (PTGS2), IL-12 beta, PKA-cat (cAMP-dependent)",
707,Development_Delta- and kappa-type opioid receptors signaling via beta-arrestin,23,8.157E-04,1.940E-03,8.157E-04,1.940E-03,16,"GRK6, GRK3, Dynamin-2, Beta-arrestin2, Dynamin-1, CREB1, G-protein beta/gamma, Leu-enkephalin, Metenkefalin, Delta-type opioid receptor, G-protein alpha-i family, Dynorphin A(1-13), p300, Kappa-type opioid receptor, PKC, GRK5",9.942E-04,2.370E-03,15,"GRK6, GRK3, Dynamin-2, Beta-arrestin2, Dynamin-1, CREB1, G-protein beta/gamma, Leu-enkephalin, Metenkefalin, G-protein alpha-i family, Dynorphin A(1-13), p300, Kappa-type opioid receptor, PKC, GRK5",
708,Desensitization of Beta-2 adrenergic receptor signaling and reduction of relaxation,27,8.288E-04,2.028E-03,9.021E-03,1.616E-02,16,"ATF-1, ERK1/2, MSK1/2 (RPS6KA5/4), Beta-arrestin2, IL-1 beta, Shc, CREB1, MEK1/2, G-protein beta/gamma, c-Src, G-protein alpha-i family, SOS, p90Rsk, GRK5, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent)",8.288E-04,2.028E-03,17,"ATF-1, ERK1/2, MSK1/2 (RPS6KA5/4), c-Raf-1, Beta-arrestin2, IL-1 beta, Shc, CREB1, MEK1/2, G-protein beta/gamma, c-Src, G-protein alpha-i family, SOS, p90Rsk, GRK5, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent)",
709,Immune response_IL-2 signaling via JAK/ STAT,25,8.381E-04,1.984E-03,8.381E-04,1.984E-03,17,"STAT5A, JAK1, STAT5B, Perforin, STAT1, Syk, Cyclin D2, STAT4, c-Myc, IL-2R alpha chain, IL-2, JAK2, IL4RA, JAK3, TNF-beta, IL-2R gamma chain, STAT5",3.319E-03,6.652E-03,15,"STAT5A, JAK1, STAT5B, STAT1, Syk, Cyclin D2, STAT4, IL-2, JAK2, IL4RA, JAK3, STAT3, TNF-beta, IL-2R gamma chain, STAT5",
710,Oxidative stress_Activation of NADPH oxidase,59,8.691E-04,2.041E-03,8.691E-04,2.041E-03,33,"TRIO, PLD1, gp91-phox, ERK1/2, PKC-zeta, Rac2, VAV-1, PI3K cat class IB (p110-gamma), p47-phox, Rac1, IP3 receptor, IRAK4, PI3K reg class IA, PLC-beta, p114-RhoGEF, MEK1/2, G-protein beta/gamma, AKT(PKB), c-Src, BETA-PIX, Tiam1, cPKC (conventional), PI3K cat class IA, Cytochrome b-558, p22-phox, PKC-delta, Pin1, PKC-beta2, PKC, PKC-alpha, PLC-gamma, PI3K reg class IB (p101), p38 MAPK",3.950E-03,7.750E-03,29,"TRIO, PLD1, gp91-phox, ERK1/2, Rac2, VAV-1, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, IRAK4, PI3K reg class IA, PLC-beta, p114-RhoGEF, MEK1/2, G-protein beta/gamma, AKT(PKB), c-Src, Tiam1, cPKC (conventional), PI3K cat class IA, Cytochrome b-558, p22-phox, Pin1, p67-phox, PKC-beta2, PKC, PKC-alpha, PLC-gamma, p38 MAPK",
711,Neurophysiological process_Constitutive and activity-dependent synaptic AMPA receptor delivery,59,8.691E-04,2.041E-03,8.691E-04,2.041E-03,33,"NSF, Protein kinase G 2, Myosin Va, Homer 1, PKC-zeta, Sec8, Complexin, Dynamin-2, SHANK, NEEP21, Neuroligin 1, Hap-1, Syntaxin 12, 4.1N, Actin cytoskeletal, NAPB, Guanylate Cyclase 1, soluble, Syntaxin 4, VAMP2, SAP97 (DLG1), Sequestosome 1(p62), nNOS, GRIP, Calmodulin, PKC, Kinesin heavy chain, PKC-alpha, Rab11-FIP2, Dynamin-3, GluR1, PSD-95, DLGAP1 (GKAP), PKA-cat (cAMP-dependent)",3.151E-02,4.867E-02,26,"Protein kinase G 2, Myosin Va, Homer 1, Sec8, Dynamin-2, SHANK, NEEP21, Neuroligin 1, Syntaxin 12, Actin cytoskeletal, NAPB, Guanylate Cyclase 1, soluble, VAMP2, SAP97 (DLG1), Sequestosome 1(p62), Stargazin, nNOS, Calmodulin, PKC, Kinesin heavy chain, PKC-alpha, Rab11-FIP2, Dynamin-3, PSD-95, DLGAP1 (GKAP), PKA-cat (cAMP-dependent)",
712,iNKT cell-keratinocyte interactions in allergic contact dermatitis,36,8.877E-04,2.162E-03,1.317E-03,2.986E-03,22,"TCR beta subunit, IP10, JAK1, NF-AT1(NFATC2), ICAM1, ERK1/2, IRF1, STAT1, ITK, MHC class I, FasL(TNFSF6), NF-AT2(NFATC1), JAK2, CD1d, C/EBPbeta, T-bet, IFN-gamma receptor, CXCR3, Beta-2-microglobulin, MEKK1(MAP3K1), CD3, FasR(CD95)",8.877E-04,2.162E-03,21,"TCR beta subunit, IP10, JAK1, ICAM1, IFN-gamma, ERK1/2, IRF1, STAT1, MHC class I, CD3 epsilon, NF-AT2(NFATC1), MEK1(MAP2K1), JAK2, CD1d, C/EBPbeta, T-bet, IFN-gamma receptor, Beta-2-microglobulin, TCR beta variable 11-1, CD3, FasR(CD95)",
713,Upregulation of MITF in melanoma,36,8.877E-04,2.162E-03,3.767E-03,7.404E-03,21,"MLANA, TRPM1, ERK1/2, VEGF-A, TYRP2, c-Kit, TYRO, DIA1, Tyro3, SKP2, ERK2 (MAPK1), alpha-MSH, p16INK4, SUMO-1, HIF1A, CDK2, SOX10, IMP1(ZBP1), HDAC1, HGF receptor (Met), MITF",8.877E-04,2.162E-03,21,"MLANA, TRPM1, ERK1/2, VEGF-A, TYRP2, c-Kit, TYRO, DIA1, SKP2, ERK2 (MAPK1), alpha-MSH, p16INK4, SUMO-1, HIF1A, p90RSK1, CDK2, SOX10, IMP1(ZBP1), HDAC1, HGF receptor (Met), MITF",
714,Signal transduction_CXCR4 signaling via second messengers and JAK/STAT,50,9.094E-04,2.190E-03,2.045E-03,4.376E-03,28,"STIM1, alpha-1 Adrenergic receptor, JAK1, IL-10, SOCS1, STAT5B, IP3 receptor, Ubiquitin, Bax, Adenylate cyclase, SOCS3, G-protein beta/gamma, Alpha-1B adrenergic receptor, MLCK, CXCR4, Pyk2(FAK2), JAK2, G-protein alpha-i family, Ca(II)channel L-type, SK4/IK1, JAK3, Paxillin, p130CAS, Calmodulin, MRLC, Beta-2 adrenergic receptor, PLC-beta3, PLC-beta2",9.094E-04,2.190E-03,27,"STIM1, alpha-1 Adrenergic receptor, JAK1, IL-10, SOCS1, STAT5B, IP3 receptor, Ubiquitin, Bax, Adenylate cyclase, SOCS3, G-protein beta/gamma, Alpha-1B adrenergic receptor, MLCK, CXCR4, Pyk2(FAK2), JAK2, G-protein alpha-i family, SK4/IK1, JAK3, STAT3, p130CAS, Calmodulin, MRLC, Beta-2 adrenergic receptor, PLC-beta3, PLC-beta2",
715,Immune escape mechanisms in Prostate Cancer,25,9.126E-04,2.190E-03,9.754E-03,1.715E-02,15,"HMGB1, CCL2, IL-10, TAP, TAP1 (PSF1), MHC class I, IL-6, IL-2, TGF-beta, RAGE, CD8 alpha, Beta-2-microglobulin, CD8, TLR4, TAP2 (PSF2)",9.126E-04,2.190E-03,16,"HMGB1, CCL2, IL-10, IFN-gamma, TAP, TAP1 (PSF1), MHC class I, IL-6, IL-2, TGF-beta, RAGE, CD8 alpha, Beta-2-microglobulin, CD8, TLR4, TAP2 (PSF2)",
716,Generation of cytotoxic CD8+ T cells in COPD,25,9.126E-04,2.190E-03,9.754E-03,1.715E-02,15,"OX40L(TNFSF4), MHC class II, NF-AT1(NFATC2), ICAM1, OX40(TNFRSF4), Perforin, CD4, MHC class I, CTLA-4, NF-kB, NF-AT2(NFATC1), IL-12 receptor, CD137(TNFRSF9), CD8, CD137 ligand(TNFSF9)",9.126E-04,2.190E-03,16,"OX40L(TNFSF4), MHC class II, ICAM1, IFN-gamma, OX40(TNFRSF4), CD4, MHC class I, CTLA-4, NF-kB, NF-AT2(NFATC1), CD40L(TNFSF5), CD80, IL-12 receptor, CD137(TNFRSF9), CD8, CD137 ligand(TNFSF9)",
717,Immune response_T cell subsets: secreted signals,25,9.126E-04,2.190E-03,6.264E-02,8.941E-02,13,"CCL20, IL-1 alpha, IL-10, IL-22, IL-17F, GM-CSF, IL-13, IL-6, IL-2, TNF-alpha, IL-5, TGF-beta, TNF-beta",9.126E-04,2.190E-03,16,"CCL20, IL-1 alpha, IL-10, IFN-gamma, IL-17, IL-22, Lymphotactin, IL-17F, GM-CSF, IL-6, IL-2, TNF-alpha, IL-5, TGF-beta, TNF-beta, IL-21",
718,Resolution of inflammation in healing myocardial infarction,25,9.126E-04,2.190E-03,9.754E-03,1.715E-02,15,"TGF-beta 1, TIE2, ERK1/2, VEGF-A, VEGFR-2, MMP-2, NF-kB, AKT(PKB), CXCR4, HGF, JAK2, Angiopoietin 1, FGF2, HGF receptor (Met), MMP-9",9.126E-04,2.190E-03,16,"TGF-beta 1, TIE2, ERK1/2, VEGF-A, VEGFR-2, MMP-2, NF-kB, AKT(PKB), CXCR4, HGF, JAK2, Angiopoietin 1, FGF2, STAT3, HGF receptor (Met), MMP-9",
719,Signal transduction_PTEN pathway,46,9.352E-04,2.186E-03,9.352E-04,2.186E-03,27,"RHEB2, IRS-1, ERK1/2, Beta-catenin, BAD, Shc, GSK3 beta, PI3K reg class IA, Caspase-3, MEK2(MAP2K2), AKT(PKB), c-Src, PI3K cat class IA, c-Cbl, Tcf(Lef), EGFR, c-Jun, alpha-5/beta-1 integrin, SOS, Caspase-9, Paxillin, PCNA, p130CAS, MAGI-2, FOXO3A, p53, mTOR",3.172E-03,6.391E-03,24,"RHEB2, ERK1/2, Beta-catenin, c-Raf-1, Shc, GSK3 beta, PI3K reg class IA, Caspase-3, MEK2(MAP2K2), AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, c-Cbl, Tcf(Lef), EGFR, alpha-5/beta-1 integrin, SOS, Caspase-9, PCNA, p130CAS, MAGI-2, p53, mTOR",
720,Development_Thrombopoietin signaling via JAK-STAT pathway,23,9.942E-04,2.370E-03,3.190E-03,6.406E-03,15,"STAT5A, Tyk2, CrkL, STAT5B, Pim-1, STAT1, TAP1 (PSF1), SOCS3, Oct-1, c-MPL, JAK2, Pim-2, Bcl-6, STAT5, PAR1",9.942E-04,2.370E-03,15,"STAT5A, Tyk2, CrkL, STAT5B, Pim-1, STAT1, TAP1 (PSF1), SOCS3, Oct-1, c-MPL, JAK2, Bcl-6, STAT3, STAT5, PAR1",
721,Development_FGF2 signaling during embryonic stem cell differentiation,34,1.015E-03,2.401E-03,2.522E-02,3.963E-02,18,"SOX1, NCAM1, WNT3A, Nkx6.1, ERK1/2, PAX6, MEK2(MAP2K2), Nestin, SOX9, PTCH1, Activin A, Pdx-1 (IPF1), FGF2, SOS, Noggin, SHP-2, SPRY2, NEFH",1.015E-03,2.401E-03,20,"SOX1, NCAM1, Nkx6.1, ERK1/2, c-Raf-1, NEFM, PAX6, MEK2(MAP2K2), AFP, Nestin, SOX9, MEK1(MAP2K1), PTCH1, Activin A, Pdx-1 (IPF1), FGF2, SOS, Noggin, SPRY2, NEFH",
722,Nicotine / Beta-adrenergic signaling in lung cancer,34,1.015E-03,2.401E-03,1.394E-03,3.136E-03,21,"Beta-3 adrenergic receptor, ERK1/2, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), BAD, Shc, Bax, Adenylate cyclase, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), Beta-adrenergic receptor, c-Src, Mcl-1, G-protein alpha-i family, SOS, PKC-alpha, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PI3K reg class IB (p101), PKA-cat (cAMP-dependent)",1.015E-03,2.401E-03,20,"Beta-3 adrenergic receptor, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), Shc, Bax, Adenylate cyclase, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), Beta-adrenergic receptor, c-Src, Mcl-1, MEK1(MAP2K1), G-protein alpha-i family, SOS, PKC-alpha, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",
723,Development_S1P1 receptor signaling via beta-arrestin,34,1.015E-03,2.401E-03,2.522E-02,3.963E-02,18,"ERK1/2, Dynamin-2, G-protein alpha-i2, G-protein alpha-i1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), c-Src, S1P1 receptor, PI3K reg class IA (p85-alpha), G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, SOS, p90Rsk, PI3K cat class IA (p110-alpha), mTOR, PDGF-R-beta",1.015E-03,2.401E-03,20,"ERK1/2, c-Raf-1, Dynamin-2, G-protein alpha-i2, G-protein alpha-i1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), S1P1 receptor, PI3K reg class IA (p85-alpha), G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, SOS, p90Rsk, PI3K cat class IA (p110-alpha), mTOR, PDGF-R-beta",
724,Development_CNTF receptor signaling,34,1.015E-03,2.401E-03,1.070E-02,1.861E-02,19,"RHEB2, JAK1, CLF-1, CNTF, ERK1/2, BSF-3 (cardiotrophin-like cytokine), STAT1, Shc, PI3K reg class IA, SOCS3, MEK2(MAP2K2), AKT(PKB), JAK2, PI3K cat class IA, CNTFR alpha, SOS, SHP-2, LIFR, mTOR",1.015E-03,2.401E-03,20,"RHEB2, JAK1, CLF-1, CNTF, ERK1/2, c-Raf-1, BSF-3 (cardiotrophin-like cytokine), STAT1, Shc, PI3K reg class IA, SOCS3, MEK2(MAP2K2), AKT(PKB), MEK1(MAP2K1), JAK2, PI3K cat class IA, SOS, STAT3, LIFR, mTOR",
725,Reproduction_Gonadotropin-releasing hormone (GnRH) signaling,73,1.035E-03,2.404E-03,1.035E-03,2.404E-03,39,"GnRH1, LH-beta, ATF-3, ERK1/2, CaMK I, EGR1, PKA-reg (cAMP-dependent), HDAC4, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, Shc, Dynamin-1, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), Follistatin, CREB1, CDC42, c-Src, Secretogranin II, Pyk2(FAK2), PKC-delta, MEK3(MAP2K3), c-Jun, SOS, HDAC5, MKK7 (MAP2K7), p90Rsk, MEK4(MAP2K4), Secretogranin 1, AP-1, Calmodulin, MEKK1(MAP3K1), ATF-2, PACAP, JNK(MAPK8-10), Elk-1, PKA-cat (cAMP-dependent)",2.785E-03,5.719E-03,35,"p38alpha (MAPK14), GnRH1, LH-beta, ATF-3, ERK1/2, CaMK I, c-Raf-1, HDAC4, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, Shc, Dynamin-1, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), Follistatin, CREB1, CDC42, c-Src, Secretogranin II, MEK1(MAP2K1), Pyk2(FAK2), MEK3(MAP2K3), SOS, HDAC5, p90Rsk, MEK4(MAP2K4), Secretogranin 1, Calmodulin, ATF-2, PACAP, JNK(MAPK8-10), Elk-1, PKA-cat (cAMP-dependent)",
726,Immune response_IL-16 signaling pathway,55,1.039E-03,2.406E-03,1.039E-03,2.406E-03,31,"IL-16 mature, RAG1, HDAC3, IP3 receptor, IL-15, IL-1 beta, MLCP (reg), PPP1R12C, N-terminal IL16, FKHR, PLC-gamma 1, Caspase-3, CD4, IL-6, Skp2/TrCP/FBXW, SKP2, Eotaxin, AKT(PKB), IL-2R alpha chain, CXCR4, IL-2, TNF-alpha, MLCP (cat), cPKC (conventional), Lck, PI3K reg class IA (p85-alpha), HSC70, Cul1/Rbx1 E3 ligase, PI3K cat class IA (p110-alpha), PKC, IL-16",2.401E-03,5.055E-03,28,"RAG1, HDAC3, RAG2, IP3 receptor, IL-15, IL-1 beta, MLCP (reg), PPP1R12C, FKHR, PLC-gamma 1, RAG1/2 complex, Caspase-3, CD4, IL-6, Skp2/TrCP/FBXW, SKP2, Eotaxin, AKT(PKB), CXCR4, IL-2, TNF-alpha, MLCP (cat), cPKC (conventional), Lck, PI3K reg class IA (p85-alpha), Cul1/Rbx1 E3 ligase, PI3K cat class IA (p110-alpha), PKC",
727,Immune response_T regulatory cell-mediated modulation of effector T cell and NK cell functions,55,1.039E-03,2.406E-03,1.039E-03,2.406E-03,31,"TGF-beta 1, C/EBP zeta, NOTCH1 receptor, ATF-4, 5'-NTD, PKA-reg (cAMP-dependent), Perforin, Adenylate cyclase type VII, GCN2, STAT4, CREB1, FasL(TNFSF6), RBP-J kappa (CBF1), IL-2R alpha chain, NF-AT2(NFATC1), IL-2, NOTCH1 (NICD), PGE2R2, PGE2R4, CREM (repressors), TGF-beta receptor type II, T-bet, KLRK1 (NKG2D), DLL4, Granzyme A, COX-2 (PTGS2), HES1, Galectin-1, SMAD3, Jagged1, PKA-cat (cAMP-dependent)",2.401E-03,5.055E-03,28,"TGF-beta 1, C/EBP zeta, NOTCH1 receptor, IFN-gamma, 5'-NTD, Adenylate cyclase type VII, NKp30, GCN2, STAT4, CREB1, RBP-J kappa (CBF1), NF-AT2(NFATC1), IL-2, NOTCH1 (NICD), PGE2R2, PGE2R4, CREM (repressors), TGF-beta receptor type II, T-bet, KLRK1 (NKG2D), Granzyme A, COX-2 (PTGS2), HES1, Connexin 43, Galectin-1, SMAD3, Jagged1, PKA-cat (cAMP-dependent)",
728,Main genetic and epigenetic alterations in lung cancer,48,1.059E-03,2.486E-03,2.239E-03,4.745E-03,27,"TGF-beta 1, p14ARF, RECK, RARbeta, Neuropilin-1, VEGF-A, Caspase-8, IBP3, CDK4, RASSF1, IGF-2, MMP-2, TGF-alpha, p16INK4, c-Myc, IBP, HGF, TGF-beta receptor type II, EGFR, DAPK1, TGF-beta receptor type III (betaglycan), GSTP1, Neuropilin-2, DNMT1, HDAC1, p53, HGF receptor (Met)",1.059E-03,2.486E-03,26,"TGF-beta 1, p14ARF, RECK, RARbeta, Neuropilin-1, VEGF-A, Caspase-8, IBP3, CDK4, RASSF1, IGF-2, MMP-2, TGF-alpha, p16INK4, IBP, HGF, TGF-beta receptor type II, EGFR, DAPK1, TGF-beta receptor type III (betaglycan), GSTP1, Neuropilin-2, DNMT1, HDAC1, p53, HGF receptor (Met)",
729,IL-17-induced mucin expression in CF airways,48,1.059E-03,2.486E-03,4.659E-02,6.861E-02,23,"TLR5, TGF-beta 1, MHC class II, ERK1/2, CD28, IL-17 receptor, IL-1 beta, I-kB, CD4, CREB1, IL-6, NF-kB, IL-23, NF-kB p50/p65, TAK1(MAP3K7), JAK2, TRAF6, AP-1, IL23A, TLR4, p38 MAPK, CD86, TLR2",1.059E-03,2.486E-03,26,"TGF-beta 1, MHC class II, ERK1/2, CD28, IL-17, IL-17 receptor, IL-1 beta, I-kB, CD4, CREB1, IL-6, NF-kB, IL-23, NF-kB p50/p65, TAK1(MAP3K7), JAK2, CD80, ROR-alpha, TRAF6, CFTR, IL23A, TLR4, IL-21, p38 MAPK, CD86, TLR2",
730,Putative pathways of MHC class I-dependent postsynaptic long-term depression in major depressive disorder,21,1.068E-03,2.503E-03,3.244E-03,6.463E-03,14,"HLA-B, HLA-A, TAP, TAP1 (PSF1), MHC class I, TNF-R1, TNF-alpha, IFN-gamma receptor, PIRB, MHC Class I alpha chain, Beta-2-microglobulin, SHP-2, CD3 zeta, TAP2 (PSF2)",1.068E-03,2.503E-03,14,"HLA-B, HLA-A, IFN-gamma, TAP, TAP1 (PSF1), MHC class I, TNF-R1, TNF-alpha, IFN-gamma receptor, PIRB, MHC Class I alpha chain, Beta-2-microglobulin, CD3 zeta, TAP2 (PSF2)",
731,Breast cancer (general schema),41,1.079E-03,2.520E-03,1.157E-02,1.994E-02,22,"NOTCH1 receptor, Brca2, Jagged2, Smoothened, IL-6, NOTCH4, DHH, Brca1, PTCH1, TGF-beta receptor type II, EGFR, TGF-beta, ErbB4, Ihh, Leptin receptor, NOTCH2, DLL4, PTHrP, Jagged1, Prolactin, TGF-beta receptor type I, NOTCH3",1.079E-03,2.520E-03,23,"Somatotropin, NOTCH1 receptor, Brca2, Neuregulin 1, Jagged2, Smoothened, IL-6, NOTCH4, DHH, Brca1, PTCH1, TGF-beta receptor type II, EGFR, TGF-beta, ErbB4, Ihh, Leptin receptor, NOTCH2, PTHrP, Jagged1, Prolactin, TGF-beta receptor type I, NOTCH3",
732,Inhibition of neutrophil migration by proresolving lipid mediators in COPD,71,1.142E-03,2.636E-03,1.142E-03,2.636E-03,38,"TNF-R2, ICAM1, C5a, Alpha-actinin, Rac2, VAV-1, FPR, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, Talin, IL-1 beta, L-selectin, MSN (moesin), G-protein beta/gamma, Actin cytoskeletal, NF-kB, TNF-R1, TNF-alpha, FPRL1, cPKC (conventional), PTAFR, ITGB2, IL-8, G-protein alpha-i family, c-Jun, TLN2, Calmodulin, PKC, Vinculin, TLR4, c-Abl, ICAM2, PI3K reg class IB (p101), ADAM17, p38 MAPK, TLR2, PLC-beta2",1.527E-03,3.429E-03,35,"TNF-R2, ICAM1, C5a, Alpha-actinin, Rac2, VAV-1, FPR, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, IL-1 beta, L-selectin, MSN (moesin), G-protein beta/gamma, Actin cytoskeletal, NF-kB, TNF-R1, TNF-alpha, FPRL1, cPKC (conventional), PTAFR, ITGB2, IL-8, G-protein alpha-i family, TLN2, Calmodulin, PKC, Vinculin, TLR4, c-Abl, ICAM2, ADAM17, p38 MAPK, TLR2, PLC-beta2",
733,Role of GITR in skin sensitization,15,1.148E-03,2.674E-03,1.290E-02,2.186E-02,10,"TNF-R2, IL-1 alpha, IP10, IL-1 beta, TNF-R1, TNF-alpha, GITR, CCL19, GITRL, p38 MAPK",1.148E-03,2.674E-03,11,"TNF-R2, IL-1 alpha, CCL21, IP10, IL-1 beta, TNF-R1, TNF-alpha, GITR, CCL19, GITRL, p38 MAPK",
734,EML4/ALK fusion protein in nonsmoking-related lung cancer ,32,1.157E-03,2.679E-03,4.410E-03,8.613E-03,19,"IRS-2, IRS-1, ERK1/2, ALK, I-kB, Shc, PI3K reg class IA (p85), IKK-alpha, MEK2(MAP2K2), NF-kB, AKT(PKB), c-Src, c-Myc, PI3K cat class IA, B-Raf, EGFR, PI3K cat class IA (p110-alpha), EML4, p53",1.157E-03,2.679E-03,19,"IRS-2, ERK1/2, ALK, c-Raf-1, I-kB, Shc, PI3K reg class IA (p85), MEK2(MAP2K2), NF-kB, AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, B-Raf, EGFR, STAT3, PI3K cat class IA (p110-alpha), EML4, p53",
735,Immune response_Antiviral actions of Interferons,53,1.158E-03,2.679E-03,1.311E-02,2.213E-02,27,"CBP, IDO1, MHC class II, JAK1, Tyk2, HLA-A, HLA-DRA1, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, OAS1, IFN-alpha, MHC class I, OAS3, RLI, JAK2, MxA, iNOS, PKR, ADAR1, IRF9, IFN-gamma receptor, p300, 2'-5'-oligoadenylate synthetase, OAS2, CIITA",1.158E-03,2.679E-03,28,"CBP, IDO1, MHC class II, JAK1, Tyk2, HLA-A, IFN-gamma, HLA-DRA1, IFN-alpha/beta receptor, IRF1, IFN-beta, STAT1, OAS1, IFN-alpha, MHC class I, OAS3, RLI, JAK2, MxA, iNOS, PKR, ADAR1, IRF9, IFN-gamma receptor, p300, 2'-5'-oligoadenylate synthetase, OAS2, CIITA",
736,Role of integrins in eosinophil degranulation in asthma,58,1.228E-03,2.834E-03,3.244E-03,6.463E-03,31,"alpha-4/beta-1 integrin, ICAM1, C3b, C5a, ERK1/2, PKC-zeta, RNS2, Fibronectin, Plastin, PI3K cat class IB (p110-gamma), GM-CSF, MEK1/2, ERK2 (MAPK1), Eotaxin, PRG2, ECP (RNase 3), TNF-alpha, PI3K cat class IA, VCAM1, Eotaxin-2, G-protein alpha-i family, Substance P receptor, IL-5, FGR, Eotaxin-3, Fc gamma RII alpha, CD67, PKC-beta2, CCL7, PKC, p38 MAPK",1.228E-03,2.834E-03,30,"alpha-4/beta-1 integrin, ICAM1, C3b, C5a, IFN-gamma, ERK1/2, RNS2, c-Raf-1, Fibronectin, PI3K cat class IB (p110-gamma), GM-CSF, MEK1/2, ERK2 (MAPK1), Eotaxin, PRG2, ECP (RNase 3), TNF-alpha, PI3K cat class IA, VCAM1, Eotaxin-2, G-protein alpha-i family, Substance P receptor, IL-5, FGR, Eotaxin-3, Fc gamma RII alpha, PKC-beta2, CCL7, PKC, p38 MAPK",
737,FGF signaling in pancreatic cancer,46,1.234E-03,2.838E-03,2.450E-03,5.147E-03,26,"TGF-beta 1, FGFR2, ERK1/2, FGF1, Beta-catenin, VEGF-A, Shc, PI3K reg class IA (p85), Heparanase 1, PLAT (TPA), IKK-alpha, PLC-gamma 1, FGF5, MEK2(MAP2K2), HBP17, NF-kB, AKT(PKB), PI3K cat class IA, Glypican-1, FGF2, SOS, PLAU (UPA), Alpha-catenin, FGF7, MMP-14, MMP-9",1.234E-03,2.838E-03,25,"TGF-beta 1, FGFR2, ERK1/2, FGF1, Beta-catenin, VEGF-A, c-Raf-1, Shc, PI3K reg class IA (p85), Heparanase 1, PLAT (TPA), PLC-gamma 1, FGF5, MEK2(MAP2K2), HBP17, NF-kB, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, Glypican-1, FGF2, SOS, PLAU (UPA), MMP-14, MMP-9",
738,Immune response_NF-AT in immune response,51,1.237E-03,2.833E-03,1.237E-03,2.833E-03,29,"MHC class II, Calcineurin A (catalytic), NF-AT1(NFATC2), CD28, VAV-1, Rac1, IP3 receptor, Syk, I-kB, PI3K reg class IA (p85), PKC-theta, ZAP70, IKK-alpha, PLC-gamma 1, ITK, GSK3 alpha/beta, NF-kB, AKT(PKB), PI3K cat class IA, Lck, Slp76, Lyn, LAT, NF-AT, Calmodulin, CD3, CD3 zeta, PLC-gamma 2, CD86",1.589E-02,2.651E-02,24,"MHC class II, Calcineurin A (catalytic), CD28, VAV-1, IP3 receptor, Syk, I-kB, PI3K reg class IA (p85), PKC-theta, PLC-gamma 1, GSK3 alpha/beta, NF-kB, AKT(PKB), CD80, PI3K cat class IA, Lck, Slp76, Lyn, NF-AT, Calmodulin, CD3, CD3 zeta, PLC-gamma 2, CD86",
739,Regulation of angiogenesis in prostate cancer,51,1.237E-03,2.833E-03,1.237E-03,2.833E-03,29,"TGF-beta 1, TIE2, IL-1 alpha, CCL2, VEGF-A, VEGFR-2, Angiotensin II, Plasminogen, PI3K reg class IA (p85), AKT(PKB), Collagen IV, NF-kB p50/p65, TNF-R1, TNF-alpha, PI3K cat class IA, HIF1A, IL-8, TGF-beta receptor type II, EGFR, FOLH1 (GCP2), Angiopoietin 1, PGES, Plasmin, VEGFR-3, PLAU (UPA), COX-2 (PTGS2), VEGF-C, MMP-9, mTOR",3.303E-03,6.647E-03,26,"TGF-beta 1, TIE2, IL-1 alpha, CCL2, VEGF-A, VEGFR-2, Angiotensin II, PI3K reg class IA (p85), AKT(PKB), Collagen IV, NF-kB p50/p65, TNF-R1, TNF-alpha, PI3K cat class IA, HIF1A, IL-8, TGF-beta receptor type II, EGFR, Angiopoietin 1, PGES, VEGFR-3, PLAU (UPA), COX-2 (PTGS2), VEGF-C, MMP-9, mTOR",
740,Development_Gastrin in differentiation of the gastric mucosa,38,1.239E-03,2.833E-03,1.239E-03,2.833E-03,23,"CBP, VMAT2, ERK1/2, EGR1, G-protein alpha-q/11, ICRF, PKC-epsilon, IP3 receptor, PKC-theta, PLC-gamma 1, MEK2(MAP2K2), CREB1, Gastrin 17, c-Src, Chromogranin A, cPKC (conventional), CCKBR, SP3, p300, PKC-beta, PKC, PKC-alpha, G-protein alpha-q",2.268E-03,4.857E-03,21,"CBP, VMAT2, HDC, ERK1/2, c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, PKC-theta, PLC-gamma 1, MEK2(MAP2K2), CREB1, Gastrin 17, c-Src, MEK1(MAP2K1), cPKC (conventional), SP3, p300, PKC-beta, PKC, PKC-alpha",
741,Autocrine Somatotropin signaling in breast cancer,39,1.248E-03,2.862E-03,2.021E-03,4.351E-03,23,"C/EBP zeta, ERK1/2, EGR1, VEGF-A, VEGFR-2, Shc, PAX5, SOD1, MEK1/2, Catalase, c-Src, c-Myc, MEKK4(MAP3K4), Pyk2(FAK2), JAK2, MEK3(MAP2K3), SOS, Podoplanin, GPX1, STAT5, HOXA1, GCL cat, Elk-1",1.248E-03,2.862E-03,22,"p38alpha (MAPK14), C/EBP zeta, Somatotropin, ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, Shc, PAX5, MEK1/2, Catalase, c-Src, Pyk2(FAK2), JAK2, MEK3(MAP2K3), SOS, Podoplanin, GPX1, STAT5, HOXA1, GCL cat, Elk-1",
742,Development_Regulation of endothelial progenitor cell differentiation from adult stem cells,60,1.285E-03,2.935E-03,1.285E-03,2.935E-03,33,"SPHK1, VE-cadherin, TIE2, alpha-4/beta-1 integrin, ICAM1, M-CSF receptor, VEGF-A, VEGFR-2, c-Kit, PI3K reg class IA (p85), PSGL-1, GM-CSF, AMPK alpha 1 subunit, AKT(PKB), P-selectin, CXCR4, Cathepsin L, JAK2, Cathepsin G, PI3K cat class IA, VCAM1, CD133, G-protein alpha-i family, HIF-1, Angiopoietin 1, Leukocyte elastase, CSF1, alpha-V/beta-5 integrin, PI3K cat class IA (p110-alpha), Fibrinogen gamma, PAR1, Fibrinogen (fibrin), MMP-9",5.358E-03,1.009E-02,29,"SPHK1, VE-cadherin, TIE2, alpha-4/beta-1 integrin, ICAM1, M-CSF receptor, VEGF-A, VEGFR-2, c-Kit, PI3K reg class IA (p85), PSGL-1, GM-CSF, AMPK alpha 1 subunit, AKT(PKB), P-selectin, CXCR4, Cathepsin L, JAK2, Cathepsin G, PI3K cat class IA, VCAM1, CD133, G-protein alpha-i family, Angiopoietin 1, Leukocyte elastase, CSF1, PI3K cat class IA (p110-alpha), PAR1, MMP-9",
743,DNA damage_Brca1 as a transcription regulator,30,1.315E-03,3.001E-03,1.533E-03,3.378E-03,19,"ATF-1, VEGF-A, XPC, STAT1, Oct-1, GADD45 alpha, RBBP8 (CtIP), Cyclin B1, c-Myc, TERT, Brca1, SP3, ATR, NFYA, PCNA, MSH2, 14-3-3 sigma, ATM, p53",1.315E-03,3.001E-03,18,"ATF-1, VEGF-A, STAT1, Oct-1, GADD45 alpha, RBBP8 (CtIP), Cyclin B1, TERT, Chk2, Brca1, SP3, ATR, NFYA, PCNA, MSH2, 14-3-3 sigma, ATM, p53",
744,Development_Beta adrenergic receptors in brown adipocyte differentiation,36,1.317E-03,2.986E-03,1.317E-03,2.986E-03,22,"Beta-3 adrenergic receptor, PPAR-alpha, FOXC2, PKA-reg (cAMP-dependent), GLUT4, PRKAR1A, UCP1, EGR2 (Krox20), Adenylate cyclase, DIO2, CREB1, PPARGC1 (PGC1-alpha), PPAR-gamma, C/EBPbeta, MEK3(MAP2K3), ATF-2, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, p38 MAPK, PKA-cat (cAMP-dependent), LPL, C/EBPdelta",2.638E-03,5.455E-03,20,"Beta-3 adrenergic receptor, PPAR-alpha, FOXC2, UCP1, EGR2 (Krox20), Adenylate cyclase, DIO2, CREB1, PPARGC1 (PGC1-alpha), PPAR-gamma, A-FABP, C/EBPbeta, MEK3(MAP2K3), ATF-2, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, p38 MAPK, PKA-cat (cAMP-dependent), LPL, C/EBPdelta",
745,HBV signaling via protein kinases leading to HCC,36,1.317E-03,2.986E-03,1.317E-03,2.986E-03,22,"JAK1, ERK1/2, Shc, IGF-2, MEK2(MAP2K2), ERK2 (MAPK1), c-Src, c-Myc, Pyk2(FAK2), cPKC (conventional), c-Jun, SOS, Pin1, MEK4(MAP2K4), AP-1, PKC, MEKK1(MAP3K1), PKC-alpha, JNK(MAPK8-10), JNK2(MAPK9), SMAD3, MMP-9",2.638E-03,5.455E-03,20,"JAK1, ERK1/2, c-Raf-1, Shc, IGF-2, MEK2(MAP2K2), ERK2 (MAPK1), c-Src, MEK1(MAP2K1), Pyk2(FAK2), cPKC (conventional), SOS, Pin1, MEK4(MAP2K4), PKC, PKC-alpha, JNK(MAPK8-10), JNK2(MAPK9), SMAD3, MMP-9",
746,Signal transduction_Erk Interactions: Inhibition of Erk,34,1.394E-03,3.136E-03,1.394E-03,3.136E-03,21,"Calcineurin A (catalytic), VHR, ERK1/2, PKA-reg (cAMP-dependent), PTPR-epsilon, MKP-4, ZAP70, ERK2 (MAPK1), AKT(PKB), GMF, MKP-3, Lck, PP2A catalytic, Calmodulin, PKC, CD3, MKP-X, JNK(MAPK8-10), STEP, PTPRR, PKA-cat (cAMP-dependent)",2.028E-02,3.282E-02,17,"Calcineurin A (catalytic), ERK1/2, PTPR-epsilon, ERK2 (MAPK1), AKT(PKB), MKP-3, MEK1(MAP2K1), Lck, PP2A catalytic, Calmodulin, PKC, CD3, PEA15, MKP-X, JNK(MAPK8-10), PTPRR, PKA-cat (cAMP-dependent)",
747,Proinflammatory cytokine release from eosinophils in asthma,34,1.394E-03,3.136E-03,1.394E-03,3.136E-03,21,"IL-16 mature, TrkA, C5a, ERK1/2, CD28, CD48, IL-1 beta, GM-CSF, CD4, LIF, IL-13, IL-6, MIF, Eotaxin, IL-2, TNF-alpha, IL-8, IL-5, NGF, CD244, IL-16",3.068E-03,6.215E-03,19,"C5a, IFN-gamma, ERK1/2, CD28, IL-17, CD48, IL-1 beta, GM-CSF, CD4, LIF, IL-6, MIF, Eotaxin, IL-2, TNF-alpha, IL-8, IL-5, NGF, CD244",
748,Apoptosis and survival_Role of CDK5 in neuronal death and survival,34,1.394E-03,3.136E-03,1.394E-03,3.136E-03,21,"NGFR(TNFRSF16), CDK5R1 (p35), TrkA, CDK5, Apaf-1, ERK1/2, EGR1, CDK1 (p34), BAD, Shc, PI3K reg class IA (p85), Bax, Caspase-3, AKT(PKB), PI3K cat class IA, PKC-delta, c-Jun, SOS, Caspase-9, NGF, p53",3.068E-03,6.215E-03,19,"NGFR(TNFRSF16), CDK5R1 (p35), CDK5, Apaf-1, Neuregulin 1, ERK1/2, c-Raf-1, CDK1 (p34), Shc, PI3K reg class IA (p85), Bax, Caspase-3, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, SOS, Caspase-9, NGF, p53",
749,Immune response_CCR5 signaling in macrophages and T lymphocytes,58,1.412E-03,3.171E-03,1.412E-03,3.171E-03,32,"STIM1, Calcineurin A (catalytic), JAK1, ERK1/2, PLC-beta1, PI3K cat class IB (p110-gamma), STAT1, Rac1, IP3 receptor, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), NF-AT2(NFATC1), IL-2, MEKK4(MAP3K4), Tiam1, Pyk2(FAK2), JAK2, Lck, G-protein alpha-i family, MEK3(MAP2K3), c-Jun, JAK3, Paxillin, MEK4(MAP2K4), Calmodulin, PKC-alpha, ATF-2, G-protein alpha-q, JNK(MAPK8-10), PI3K reg class IB (p101), p38 MAPK",1.293E-02,2.209E-02,27,"STIM1, Calcineurin A (catalytic), JAK1, ERK1/2, PI3K cat class IB (p110-gamma), STAT1, IP3 receptor, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), NF-AT2(NFATC1), IL-2, MEK1(MAP2K1), Tiam1, Pyk2(FAK2), JAK2, Lck, G-protein alpha-i family, MEK3(MAP2K3), JAK3, MEK4(MAP2K4), STAT3, Calmodulin, PKC-alpha, ATF-2, JNK(MAPK8-10), p38 MAPK",
750,Influence of smoking on activation of EGFR signaling in lung cancer cells,44,1.437E-03,3.257E-03,2.678E-03,5.540E-03,25,"Fra-1, ATF-1, ERK1/2, PKA-reg (cAMP-dependent), RAP-1A, Shc, p38beta (MAPK11), Adenylate cyclase, MEK2(MAP2K2), MMP-2, CREB1, ERK2 (MAPK1), c-Src, B-Raf, Epiregulin, EGFR, c-Jun, SOS, MEK4(MAP2K4), MEKK1(MAP3K1), JNK(MAPK8-10), Beta-1 adrenergic receptor, ADAM17, MMP-9, PKA-cat (cAMP-dependent)",1.437E-03,3.257E-03,24,"p38alpha (MAPK14), Fra-1, ATF-1, ERK1/2, c-Raf-1, RAP-1A, Shc, Adenylate cyclase, MEK2(MAP2K2), MMP-2, CREB1, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), B-Raf, Epiregulin, EGFR, SOS, MEK4(MAP2K4), JNK(MAPK8-10), Beta-1 adrenergic receptor, ADAM17, MMP-9, PKA-cat (cAMP-dependent)",
751,Chemotaxis_Lipoxin inhibitory action on Formyl-Met-Leu-Phe-induced neutrophil chemotaxis,47,1.467E-03,3.256E-03,1.467E-03,3.256E-03,27,"PLD1, ICAM1, PKC-zeta, LSP1, LIMK1, VAV-1, FPR, PI3K cat class IB (p110-gamma), Rac1, G-protein beta/gamma, CDC42, Actin cytoskeletal, AKT(PKB), FPRL1, RhoA, Lyn, G-protein alpha-i family, F-Actin cytoskeleton, MEK3(MAP2K3), PPAPDC2, ROCK, MEKK1(MAP3K1), Fibrinogen gamma, Fibrinogen (fibrin), PI3K reg class IB (p101), p38 MAPK, Cofilin",4.296E-02,6.435E-02,21,"PLD1, ICAM1, LSP1, LIMK1, VAV-1, FPR, PI3K cat class IB (p110-gamma), G-protein beta/gamma, CDC42, Actin cytoskeletal, AKT(PKB), FPRL1, RhoA, Lyn, G-protein alpha-i family, F-Actin cytoskeleton, MEK3(MAP2K3), PPAPDC2, ROCK, p38 MAPK, Cofilin",
752,"Stem cells_Cooperation between Hedgehog, IGF-2 and HGF signaling pathways in medulloblastoma stem cells",32,1.467E-03,3.256E-03,1.467E-03,3.256E-03,20,"IRS-1, Lef-1, TCF7L2 (TCF4), Beta-catenin, Smoothened, GLI-2, BAD, Bax, GSK3 beta, PI3K reg class IA, IGF-2, AKT(PKB), c-Myc, HGF, PI3K cat class IA, PTCH1, Tcf(Lef), Caspase-9, GLI-1, HGF receptor (Met)",2.401E-02,3.832E-02,16,"TCF7L2 (TCF4), Beta-catenin, Smoothened, GLI-2, Bax, GSK3 beta, PI3K reg class IA, IGF-2, AKT(PKB), HGF, PI3K cat class IA, PTCH1, Tcf(Lef), Caspase-9, GLI-1, HGF receptor (Met)",
753,"Development_Role of Ceramide 1-phosphate, Sphingosine 1-phosphate and Complement cascade in hematopoietic stem cell homing",32,1.467E-03,3.256E-03,1.467E-03,3.256E-03,20,"alpha-4/beta-1 integrin, ERK1/2, PKC-zeta, Rac1, RAP-1A, CREB1, CDC42, AKT(PKB), C3aR, CXCR4, PGE2R2, RhoA, Tiam1, PGE2R4, S1P1 receptor, VCAM1, COX-2 (PTGS2), iC3b, C3a, MMP-9",9.787E-03,1.719E-02,17,"alpha-4/beta-1 integrin, ERK1/2, RAP-1A, CREB1, CDC42, AKT(PKB), CXCR4, PGE2R2, RhoA, Tiam1, PGE2R4, S1P1 receptor, VCAM1, COX-2 (PTGS2), iC3b, C3a, MMP-9",
754,Protein folding and maturation_Bradykinin / Kallidin maturation,32,1.467E-03,3.256E-03,1.467E-03,3.256E-03,20,"Carboxypeptidase N (reg), Neprilysin, ECE1, Plasma kallikrein, Kallidin, Meprin A, alpha, MMP-8, Prolyl endopeptidase, ACE2, Tissue kallikreins, des-Arg9-bradykinin, Carboxypeptidase N (cat), Plasmin, Bradykinin, KNG, Aminopeptidase P2, Carboxypeptidase M, CPB2, des-Arg10-kallidin, CD13",3.005E-01,3.719E-01,12,"Carboxypeptidase N (reg), Neprilysin, ECE1, Plasma kallikrein, Meprin A, alpha, MMP-8, Prolyl endopeptidase, ACE2, Tissue kallikreins, Carboxypeptidase M, CPB2, CD13",
755,Development_H3K4 demethylases in stem cell maintenance,32,1.467E-03,3.256E-03,1.467E-03,3.256E-03,20,"EGR1, Na(v) I alpha, RBB2, NRSF, IGF-2, ACM4, HOXA7, T brachyury protein, SCN2A, HDAC5, LSD1, WNT5A, PRC2 complex, TLX, DNMT1, TCF7L1 (TCF3), HOXA1, HDAC1, SCN3A, HOXA5",9.787E-03,1.719E-02,17,"Na(v) I alpha, RBB2, IGF-2, ACM4, HOXA7, SCN2A, HDAC5, LSD1, WNT5A, PRC2 complex, TLX, DNMT1, TCF7L1 (TCF3), HOXA1, HDAC1, SCN3A, HOXA5",
756,Apoptosis and survival_IL-17-induced CIKS-dependent MAPK signaling pathways,32,1.467E-03,3.256E-03,1.467E-03,3.256E-03,20,"ERK1/2, IL-17 receptor, Ubiquitin, IKK-alpha, MEK1/2, TPL2(MAP3K8), NF-kB p50/p65, UEV1A, TAK1(MAP3K7), NF-kB1 (p105), C/EBPbeta, TRAF6, MEK3(MAP2K3), MEK4(MAP2K4), AP-1, UBE1, MAP3K3, TAB1, JNK(MAPK8-10), p38 MAPK",2.401E-02,3.832E-02,16,"ERK1/2, IL-17, IL-17 receptor, Ubiquitin, MEK1/2, TPL2(MAP3K8), NF-kB p50/p65, TAK1(MAP3K7), NF-kB1 (p105), C/EBPbeta, TRAF6, MEK3(MAP2K3), MEK4(MAP2K4), MAP3K3, JNK(MAPK8-10), p38 MAPK",
757,Rb proteins signaling in multiple myeloma,18,1.507E-03,3.341E-03,1.507E-03,3.341E-03,13,"Cyclin D3, Cyclin D2, CDK4, IL-6, p16INK4, p107, CDK2, CDK6, p18, E2F4, Cyclin E, p15, JNK(MAPK8-10)",2.472E-03,5.182E-03,12,"Cyclin D2, CDK4, IL-6, p16INK4, p107, CDK2, CDK6, p18, E2F4, Cyclin E, p15, JNK(MAPK8-10)",
758,Apoptosis and survival_Granzyme A signaling,30,1.533E-03,3.378E-03,1.533E-03,3.378E-03,19,"Lamin A/C, PHAP1 (pp32), TREX1, Perforin, LAMP2, Ku70/80, Rab-27A, SET, DNA-PK, Granzyme A, Ku80, LAMP1, XRCC4, DNA ligase IV, Lamin B1, HMGB2, Ku70, p53, APEX",1.152E-02,1.992E-02,16,"Lamin A/C, LAMP2, Ku70/80, Rab-27A, SET, DNA-PK, Granzyme A, Ku80, LAMP1, XRCC4, DNA ligase IV, Lamin B1, HMGB2, Ku70, p53, APEX",
759,Transcription_Ligand-dependent activation of the ESR1/SP pathway,30,1.533E-03,3.378E-03,1.533E-03,3.378E-03,19,"CBP, VEGF-A, CDC25A, DNA polymerase alpha/primase, PCAF, TYSY, LDLR, C/EBPbeta, EGFR, HIF-1, SP3, ADA, CAD, p300, NFYA, Cyclin E2, CARM1, Cyclin E, NCOA1 (SRC1)",4.139E-03,8.058E-03,17,"CBP, VEGF-A, CDC25A, PCAF, TYSY, LDLR, C/EBPbeta, EGFR, SP3, ADA, CAD, p300, NFYA, Cyclin E2, CARM1, Cyclin E, NCOA1 (SRC1)",
760,Development_Keratinocyte differentiation,56,1.550E-03,3.405E-03,1.550E-03,3.405E-03,31,"MAD, TGF-beta 1, Keratin 10, Fra-1, Cystatin A, ERK1/2, G-protein alpha-q/11, SMAD2, PLC-beta1, IP3 receptor, NOTCH2 (2ICD), Filaggrin, IKK-alpha, PLC-gamma 1, MEK2(MAP2K2), RBP-J kappa (CBF1), c-Src, NOTCH1 (NICD), PKC-delta, ASK1 (MAP3K5), MEK3(MAP2K3), c-Jun, MKK7 (MAP2K7), JNK1(MAPK8), MEK4(MAP2K4), MEKK1(MAP3K1), PKC-alpha, Involucrin, SMAD3, CaSR, TGF-beta receptor type I",3.364E-03,6.732E-03,28,"MAD, p38alpha (MAPK14), TGF-beta 1, Keratin 10, Fra-1, Cystatin A, ERK1/2, c-Raf-1, G-protein alpha-q/11, SMAD2, IP3 receptor, NOTCH2 (2ICD), Filaggrin, PLC-gamma 1, MEK2(MAP2K2), RBP-J kappa (CBF1), c-Src, NOTCH1 (NICD), MEK1(MAP2K1), ASK1 (MAP3K5), MEK3(MAP2K3), JNK1(MAPK8), MEK4(MAP2K4), PKC-alpha, Involucrin, SMAD3, CaSR, TGF-beta receptor type I",
761,Regulation of Beta-catenin activity in colorectal cancer,56,1.550E-03,3.405E-03,1.550E-03,3.405E-03,31,"CBP, LPAR3, DVL-3, ERK1/2, Beta-catenin, PKA-reg (cAMP-dependent), IP3 receptor, LPAR2, PI3K reg class IA (p85), GSK3 beta, PLC-beta, IKK-alpha, Adenylate cyclase, MEK1/2, AKT(PKB), Axin, PGE2R2, PGE2R4, PI3K cat class IA, PKC-delta, KLF5, MAML1, c-Jun, eEF2K, p300, PKC-beta, Calmodulin, G-protein alpha-q, SNAIL1, CaSR, PKA-cat (cAMP-dependent)",8.973E-02,1.251E-01,23,"CBP, LPAR3, ERK1/2, Beta-catenin, IP3 receptor, LPAR2, PI3K reg class IA (p85), GSK3 beta, PLC-beta, Adenylate cyclase, MEK1/2, AKT(PKB), Axin, PGE2R2, PGE2R4, PI3K cat class IA, KLF5, p300, PKC-beta, Calmodulin, SNAIL1, CaSR, PKA-cat (cAMP-dependent)",
762,Development_Melanocyte development and pigmentation,49,1.581E-03,3.533E-03,3.333E-03,6.612E-03,27,"CBP, WNT3A, Lef-1, ERK1/2, Beta-catenin, PKA-reg (cAMP-dependent), TYRP2, c-Kit, TYRO, GSK3 beta, PI3K reg class IA, CREB1, AKT(PKB), alpha-MSH, MC1R, RACK1, PI3K cat class IA, B-Raf, Galpha(s)-specific peptide GPCRs, Guanylate cyclase (alpha-1/beta-1), SOS, ACTH, PKC-beta, SOX10, MITF, PKA-cat (cAMP-dependent), Frizzled",1.581E-03,3.533E-03,26,"CBP, ERK1/2, Beta-catenin, TYRP2, c-Kit, TYRO, GSK3 beta, PI3K reg class IA, CREB1, AKT(PKB), alpha-MSH, MC1R, MEK1(MAP2K1), RACK1, PI3K cat class IA, B-Raf, Galpha(s)-specific peptide GPCRs, Guanylate cyclase (alpha-1/beta-1), SOS, p90RSK1, ACTH, PKC-beta, SOX10, MITF, PKA-cat (cAMP-dependent), Frizzled",
763,Transcription_CREB signaling pathway,49,1.581E-03,3.533E-03,3.333E-03,6.612E-03,27,"IRS-1, PP1-cat, ERK1/2, MSK1/2 (RPS6KA5/4), Proenkephalin-B, PKA-reg (cAMP-dependent), CaMK IV, Rac1, Shc, PI3K reg class IA, CREB1, AKT(PKB), MLK3(MAP3K11), cPKC (conventional), PI3K cat class IA, Galpha(s)-specific amine GPCRs, MEK3(MAP2K3), SOS, PP2A catalytic, p90Rsk, Calmodulin, PKC-alpha, CDO1, LDHA, DREAM, p38 MAPK, PKA-cat (cAMP-dependent)",1.581E-03,3.533E-03,26,"PP1-cat, ERK1/2, MSK1/2 (RPS6KA5/4), Proenkephalin-B, c-Raf-1, CaMK IV, Shc, PI3K reg class IA, CREB1, AKT(PKB), MEK1(MAP2K1), MLK3(MAP3K11), cPKC (conventional), PI3K cat class IA, Galpha(s)-specific amine GPCRs, MEK3(MAP2K3), SOS, PP2A catalytic, p90Rsk, Calmodulin, PKC-alpha, CDO1, LDHA, DREAM, p38 MAPK, PKA-cat (cAMP-dependent)",
764,Glucocorticoid- and LABA-mediated inhibition of pro-inflammatory signaling in airway fibroblasts/myofibroblasts,28,1.589E-03,3.486E-03,1.589E-03,3.486E-03,18,"IL-1 alpha, ICAM1, GCR, IL-4R type I, PKA-reg (cAMP-dependent), IL-1 beta, HDAC2, GM-CSF, IL-6, NF-kB, TNF-R1, TNF-alpha, VCAM1, IL-8, c-Jun, AP-1, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent)",1.358E-02,2.312E-02,15,"IL-1 alpha, ICAM1, GCR, IL-4R type I, IL-1 beta, HDAC2, GM-CSF, IL-6, NF-kB, TNF-R1, TNF-alpha, VCAM1, IL-8, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent)",
765,Cell cycle_Sister chromatid cohesion,22,1.642E-03,3.580E-03,1.642E-03,3.580E-03,15,"Cyclin B, Separase, SMC1, DERPC, PDS5, CDK1 (p34), RFC complex, Rad21, Securin, PCNA, Mitotic cohesin complex, SMC3, RFC3, DNA polymerase sigma, Stromalins 1/2",7.411E-03,1.337E-02,13,"Cyclin B, SMC1, DERPC, PDS5, CDK1 (p34), Rad21, Securin, PCNA, Mitotic cohesin complex, SMC3, RFC3, DNA polymerase sigma, Stromalins 1/2",
766,Inhibition of GSK3 beta by lithium in major depressive disorder,22,1.642E-03,3.580E-03,1.642E-03,3.580E-03,15,"TGF-beta 1, PP1-cat, SMAD4, GSK3 beta, CREB1, AKT(PKB), IPP-2, c-Jun, TrkB, p300, SMAD3, Bim, BDNF, PAI1, TGF-beta receptor type I",7.411E-03,1.337E-02,13,"TGF-beta 1, PP1-cat, SMAD4, GSK3 beta, CREB1, AKT(PKB), TrkB, p300, SMAD3, Bim, BDNF, PAI1, TGF-beta receptor type I",
767,Development_VEGF signaling and activation,42,1.674E-03,3.723E-03,1.635E-02,2.715E-02,22,"SPHK1, ICAM1, ERK1/2, VEGF-A, VEGFR-2, I-kB, p120GAP, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), NF-kB, AKT(PKB), c-Src, PI3K cat class IA, VCAM1, Brca1, c-Jun, SP3, PKC-beta, PKC, PKC-alpha, Neurofibromin",1.674E-03,3.723E-03,23,"SPHK1, ICAM1, ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, I-kB, p120GAP, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), NF-kB, AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, VCAM1, Brca1, SP3, PKC-beta, PKC, PKC-alpha, Neurofibromin",
768,CD8+ Tc1 cells in allergic contact dermatitis,26,1.676E-03,3.723E-03,5.433E-03,1.034E-02,16,"TNF-R2, MHC class II, CD28, Perforin, IL-1 beta, Caspase-3, CD4, MHC class I, FasL(TNFSF6), Caspase-1, TNF-alpha, IL-18, CD8 alpha, CD8, FasR(CD95), CD86",1.676E-03,3.723E-03,16,"TNF-R2, MHC class II, IFN-gamma, CD28, IL-1 beta, Caspase-3, CD4, MHC class I, Caspase-1, TNF-alpha, CD80, IL-18, CD8 alpha, CD8, FasR(CD95), CD86",
769,Signal transduction_mTORC1 upstream signaling,74,1.774E-03,3.929E-03,1.151E-02,1.994E-02,36,"Raptor, MAG1, RHEB2, PLD1, ERK1/2, PRAS40, Angiotensin II, Dsh, Rac1, GSK3 beta, TBC1D7, IKK-alpha, MEK1/2, ERK2 (MAPK1), AKT(PKB), PDGF receptor, TNF-R1, Axin, TAK1(MAP3K7), TNF-alpha, PDIA3, EGFR, TRAF6, AMPK alpha subunit, IL4RA, Hamartin, HSP90 beta, PLD2, p90Rsk, WNT, TLR4, TTI2, p38 MAPK, Frizzled, FKBP8, mTOR",1.774E-03,3.929E-03,36,"p38alpha (MAPK14), Raptor, Somatotropin, MAG1, RHEB2, PLD1, ERK1/2, c-Raf-1, Angiotensin II, Dsh, GSK3 beta, TBC1D7, MEK1/2, ERK2 (MAPK1), AKT(PKB), PDGF receptor, TNF-R1, Axin, TAK1(MAP3K7), TNF-alpha, PDIA3, EGFR, TRAF6, AMPK alpha subunit, p90RSK1, IL4RA, HSP90 beta, PLD2, p90Rsk, WNT, TLR4, TTI2, p38 MAPK, Frizzled, FKBP8, mTOR",
770,Immune response_KLRK1 (NKG2D) signaling pathway,47,1.848E-03,4.088E-03,3.667E-03,7.228E-03,26,"ERK1/2, ULBP1, VAV-1, Rac1, IP3 receptor, Syk, PI3K reg class IA, ZAP70, GM-CSF, ULBP3, Fyn, AKT(PKB), MICB, JAK2, PI3K cat class IA, Lck, Slp76, c-Jun, DAP10, KLRK1 (NKG2D), AP-1, DAP12, MICA, STAT5, ULBP2, PLC-gamma 2",1.848E-03,4.088E-03,25,"IFN-gamma, ERK1/2, ULBP1, VAV-1, IP3 receptor, Syk, PI3K reg class IA, GM-CSF, ULBP3, Fyn, AKT(PKB), MICB, MEK1(MAP2K1), RAET1G, JAK2, PI3K cat class IA, Lck, Slp76, DAP10, KLRK1 (NKG2D), DAP12, MICA, STAT5, ULBP2, PLC-gamma 2",
771,Apoptosis and survival_Phosphorylation in TNF-alpha-induced NF-kB signaling,41,1.871E-03,4.051E-03,1.871E-03,4.051E-03,24,"PKA-reg (cAMP-dependent), AZI2, PKC-epsilon, Pim-1, PI3K reg class IA (p85), IKK-alpha, Adenylate cyclase, Casein kinase II, alpha chain (CSNK2A1), RIPK1, NF-kB p50/p65, TNF-R1, c-Src, TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, RelA (p65 NF-kB subunit), PKA-cat alpha, PKC-delta, Pin1, NIK(MAP3K14), NF-kB p65/p65, CDK6, TAB1, ADAM17",1.698E-02,2.783E-02,20,"AZI2, PKC-epsilon, Pim-1, PI3K reg class IA (p85), Adenylate cyclase, Casein kinase II, alpha chain (CSNK2A1), RIPK1, NF-kB p50/p65, TNF-R1, c-Src, TAK1(MAP3K7), TNF-alpha, PI3K cat class IA, RelA (p65 NF-kB subunit), PKA-cat alpha, Pin1, NIK(MAP3K14), NF-kB p65/p65, CDK6, ADAM17",
772,Development_Role of PKR1 and ILK in cardiac progenitor cells,33,1.921E-03,4.222E-03,1.753E-02,2.895E-02,18,"Prokineticin 2, alpha-4/beta-1 integrin, Lef-1, ERK1/2, Beta-catenin, G-protein alpha-q/11, Fibronectin, c-Kit, PKC-epsilon, Shc, GSK3 beta, PLC-beta, AKT(PKB), Pyk2(FAK2), ITGB1, PI3K cat class IA, Tcf(Lef), SOS",1.921E-03,4.222E-03,19,"alpha-4/beta-1 integrin, ERK1/2, Beta-catenin, c-Raf-1, G-protein alpha-q/11, Fibronectin, c-Kit, PKC-epsilon, Shc, Islet-1, GSK3 beta, PLC-beta, AKT(PKB), MEK1(MAP2K1), Pyk2(FAK2), ITGB1, PI3K cat class IA, Tcf(Lef), SOS",
773,Chemotaxis_CCL19- and CCL21-mediated chemotaxis,33,1.921E-03,4.222E-03,7.002E-03,1.281E-02,19,"ERK1/2, PKA-reg (cAMP-dependent), IP3 receptor, Adenylate cyclase, G-protein beta/gamma, PGE2R2, RhoA, Pyk2(FAK2), PGE2R4, G-protein alpha-i family, CCL19, ROCK, JNK(MAPK8-10), PLC-gamma 2, p38 MAPK, MMP-9, PKA-cat (cAMP-dependent), Cofilin, PLC-beta2",1.921E-03,4.222E-03,19,"CCL21, ERK1/2, IP3 receptor, Adenylate cyclase, G-protein beta/gamma, PGE2R2, RhoA, Pyk2(FAK2), PGE2R4, G-protein alpha-i family, CCL19, ROCK, JNK(MAPK8-10), PLC-gamma 2, p38 MAPK, MMP-9, PKA-cat (cAMP-dependent), Cofilin, PLC-beta2",
774,Development_FGF signaling in pancreatic and hepatic differentiation of embryonic stem cells,40,1.948E-03,4.265E-03,3.805E-02,5.733E-02,20,"FGFR2, WNT3A, Nkx6.1, BMP4, ERK1/2, FGF1, HNF3-beta, MEK2(MAP2K2), SOX9, CXCR4, N-cadherin, Activin A, Pdx-1 (IPF1), SOX17, FGF2, SOS, Noggin, SHP-2, HNF4-alpha, BMP2",1.948E-03,4.265E-03,22,"FGFR2, Nkx6.1, BMP4, ERK1/2, FGF1, c-Raf-1, HNF3-beta, MEK2(MAP2K2), AFP, SOX9, CXCR4, MEK1(MAP2K1), N-cadherin, PTF1-p48, Activin A, Pdx-1 (IPF1), SOX17, FGF2, SOS, Noggin, HNF4-alpha, BMP2",
775,HIV-1 signaling via CCR5 in macrophages and T lymphocytes,39,2.021E-03,4.351E-03,2.021E-03,4.351E-03,23,"STIM1, Calcineurin A (catalytic), NF-AT1(NFATC2), CCL2, PLC-beta1, Rac1, IP3 receptor, CD4, FasL(TNFSF6), MEKK4(MAP3K4), TNF-alpha, Tiam1, Pyk2(FAK2), MEK3(MAP2K3), c-Jun, SOS, MEK4(MAP2K4), Calmodulin, PKC-alpha, ATF-2, G-protein alpha-q, JNK(MAPK8-10), p38 MAPK",1.426E-01,1.900E-01,16,"STIM1, Calcineurin A (catalytic), CCL2, IP3 receptor, CD4, TNF-alpha, Tiam1, Pyk2(FAK2), MEK3(MAP2K3), SOS, MEK4(MAP2K4), Calmodulin, PKC-alpha, ATF-2, JNK(MAPK8-10), p38 MAPK",
776,Apoptosis and survival_Ubiquitination and phosphorylation in TNF-alpha-induced NF-kB signaling,39,2.021E-03,4.351E-03,2.021E-03,4.351E-03,23,"SPHK1, PKC-epsilon, Ubiquitin, c-IAP1, UBE2D3, RIPK1, UBE2D1, NF-kB p50/p65, UEV1A, TNF-R1, TAK1(MAP3K7), TNF-alpha, c-IAP2, RelA (p65 NF-kB subunit), NF-kB1 (p105), NF-kB1 (p50), PKC-delta, Cul1/Rbx1 E3 ligase, MAP3K3, RBCK1, SODD, TAB1, ADAM17",2.004E-02,3.246E-02,19,"SPHK1, PKC-epsilon, Ubiquitin, c-IAP1, UBE2D3, RIPK1, UBE2D1, NF-kB p50/p65, TNF-R1, TAK1(MAP3K7), TNF-alpha, c-IAP2, RelA (p65 NF-kB subunit), NF-kB1 (p105), NF-kB1 (p50), Cul1/Rbx1 E3 ligase, MAP3K3, SODD, ADAM17",
777,Immune response_IL-13 signaling via PI3K-ERK pathway,50,2.045E-03,4.376E-03,2.045E-03,4.376E-03,28,"SPHK1, JAK1, DCOR, IRS-2, Tyk2, IRS-1, ERK1/2, PKC-zeta, PKC-epsilon, IP3 receptor, IL13RA1, Tenascin-C, PLC-gamma 1, MEK2(MAP2K2), IL-13, COL1A2, AKT(PKB), c-Myc, JAK2, PI3K reg class IA (p85-alpha), PKC-delta, IL-4R type II, SOS, IL4RA, PI3K cat class IA (p110-delta), Calmodulin, SHP-2, Elk-1",1.194E-02,2.059E-02,24,"SPHK1, JAK1, DCOR, IRS-2, Tyk2, ERK1/2, c-Raf-1, PKC-epsilon, IP3 receptor, IL13RA1, Tenascin-C, PLC-gamma 1, MEK2(MAP2K2), COL1A2, AKT(PKB), MEK1(MAP2K1), JAK2, PI3K reg class IA (p85-alpha), IL-4R type II, SOS, IL4RA, PI3K cat class IA (p110-delta), Calmodulin, Elk-1",
778,EGF- and HGF-dependent stimulation of metastasis in gastric cancer,22,2.081E-03,4.529E-03,1.871E-02,3.069E-02,13,"ERK1/2, alpha-6/beta-4 integrin, Shc, MEK2(MAP2K2), HGF, RhoA, HIF1A, EGFR, SOS, PLAU (UPA), Paxillin, ITGB4, HGF receptor (Met)",2.081E-03,4.529E-03,14,"ERK1/2, c-Raf-1, alpha-6/beta-4 integrin, Shc, MEK2(MAP2K2), HGF, MEK1(MAP2K1), RhoA, HIF1A, EGFR, SOS, PLAU (UPA), ITGB4, HGF receptor (Met)",
779,Differences between Langerhans cells and dermal dendritic cells in allergic contact dermatitis,22,2.081E-03,4.529E-03,4.908E-02,7.156E-02,12,"MHC class II, CD28, CD4, MHC class I, ICOS, CXCR4, TNF-alpha, CCL19, CD8, PD-1, CD86, PD-L1",2.081E-03,4.529E-03,14,"MHC class II, CCL21, CD28, CD4, MHC class I, CXCR4, CD40L(TNFSF5), TNF-alpha, CD80, CCL19, CD8, PD-1, CD86, PD-L1",
780,Immune response_IL-15 signaling via JAK-STAT cascade,22,2.081E-03,4.529E-03,1.871E-02,3.069E-02,13,"STAT5A, JAK1, STAT5B, Syk, IL-15, IL-15RA, sIL-15RA, Mcl-1, JAK2, JAK3, IL-2R gamma chain, STAT5, ADAM17",2.081E-03,4.529E-03,14,"STAT5A, JAK1, STAT5B, Syk, IL-15, IL-15RA, sIL-15RA, Mcl-1, JAK2, JAK3, STAT3, IL-2R gamma chain, STAT5, ADAM17",
781,Development_Mu-type opioid receptor signaling via Beta-arrestin,22,2.081E-03,4.529E-03,4.908E-02,7.156E-02,12,"ERK1/2, GRK3, Dynamin-2, Beta-arrestin2, Dynamin-1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), Delta-type opioid receptor, G-protein alpha-i family, p90Rsk, SYP",2.081E-03,4.529E-03,14,"ERK1/2, c-Raf-1, GRK3, Dynamin-2, Beta-arrestin2, Dynamin-1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), MEK1(MAP2K1), G-protein alpha-i family, p90Rsk, STAT3, Mu-type opioid receptor",
782,Development_Growth factors in regulation of oligodendrocyte progenitor cell proliferation,67,2.094E-03,4.543E-03,1.217E-02,2.081E-02,33,"SPHK1, TrkA, IRS-1, ERK1/2, PDGF-R-alpha, FGF8, Fibronectin, Shc, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, Tenascin-C, PLC-gamma 1, alpha-V/beta-3 integrin, MEK2(MAP2K2), Fyn, AKT(PKB), HGF, PI3K cat class IA, Lyn, EGFR, PDGF-A, FGF2, ErbB4, SOS, NGF, Myelin basic protein, FGF18, PKC, SHP-2, HGF receptor (Met), Elk-1, mTOR",2.094E-03,4.543E-03,33,"SPHK1, FGF17, Neuregulin 1, ERK1/2, c-Raf-1, PDGF-R-alpha, FGF8, Fibronectin, Shc, PI3K reg class IA (p85), GSK3 beta, PI3K reg class IA, Tenascin-C, PLC-gamma 1, alpha-V/beta-3 integrin, MEK2(MAP2K2), Fyn, AKT(PKB), HGF, MEK1(MAP2K1), PI3K cat class IA, Lyn, EGFR, PDGF-A, FGF2, ErbB4, SOS, NGF, Myelin basic protein, PKC, HGF receptor (Met), Elk-1, mTOR",
783,Role of IL-2 in the enhancement of NK cell cytotoxicity in multiple sclerosis,31,2.210E-03,4.762E-03,2.663E-03,5.525E-03,19,"Apo-2L(TNFSF10), Perforin, Ubiquitin, I-kB, PI3K reg class IA (p85), FasL(TNFSF6), NF-kB, NF-kB p50/p65, IL-2, TNF-alpha, PI3K cat class IA, NF-kB1 (p50), KLRK1 (NKG2D), Granzyme A, CARD11, CX3CL1, MALT1, STAT5, Bcl-10",2.210E-03,4.762E-03,18,"IFN-gamma, Apo-2L(TNFSF10), Ubiquitin, I-kB, PI3K reg class IA (p85), NF-kB, NF-kB p50/p65, IL-2, TNF-alpha, PI3K cat class IA, NF-kB1 (p50), KLRK1 (NKG2D), Granzyme A, CARD11, CX3CL1, MALT1, STAT5, Bcl-10",
784,Alternative complement cascade disruption in age-related macular degeneration,31,2.210E-03,4.762E-03,2.663E-03,5.525E-03,19,"Factor B, C3, C3b, C5a, VEGF-A, Factor I, Factor Bb, Factor H, C5 convertase (C3b2Bb), C3aR, Factor Ba, C3 convertase (C3bBb), Properdin, CRP, C5, Amyloid beta 40, C5b, iC3b, C3a",2.210E-03,4.762E-03,18,"Factor B, C3, C3b, C5a, VEGF-A, Factor I, Factor Bb, Factor H, C5 convertase (C3b2Bb), Factor Ba, C3 convertase (C3bBb), Properdin, CRP, C5, Amyloid beta 40, C5b, iC3b, C3a",
785,Common mechanisms of Th17 cell migration,48,2.239E-03,4.745E-03,2.239E-03,4.745E-03,27,"CCL20, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, CCL25, PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, CD43, PSGL-1, CCL8, G-protein beta/gamma, Laminin 8, CCR9, P-selectin, MCAM, VCAM1, I-TAC, G-protein alpha-i family, CXCL16, CXCR3, CCL7, alpha-2/beta-1 integrin, PI3K reg class IB (p101), CCR4, Collagen I",2.706E-03,5.564E-03,25,"MIG, CCL20, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, CCL25, PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, CD43, PSGL-1, CCL8, G-protein beta/gamma, Laminin 8, P-selectin, MCAM, VCAM1, I-TAC, G-protein alpha-i family, CXCL16, CCL7, alpha-2/beta-1 integrin, CCR4, Collagen I",
786,Immune response_NF-AT signaling and leukocyte interactions,48,2.239E-03,4.745E-03,2.239E-03,4.745E-03,27,"MHC class II, Calcineurin A (catalytic), NF-AT1(NFATC2), IL-4R type I, IP3 receptor, IL13RA1, ZAP70, cPLA2, PLC-gamma 1, ITK, IL-13, FasL(TNFSF6), NF-kB, Eotaxin, NF-AT2(NFATC1), IL-2, JAK2, Lck, IL-5, IL4RA, LAT, NF-AT, COX-2 (PTGS2), CD3, FasR(CD95), Calcineurin B (regulatory), Ca(II) channels",2.860E-02,4.458E-02,22,"MHC class II, Calcineurin A (catalytic), IL-4R type I, IP3 receptor, IL13RA1, cPLA2, PLC-gamma 1, NF-kB, Eotaxin, NF-AT2(NFATC1), IL-2, CD40L(TNFSF5), JAK2, Lck, IL-5, IL4RA, NF-AT, COX-2 (PTGS2), CD3, FasR(CD95), Calcineurin B (regulatory), Ca(II) channels",
787,K-RAS signaling in lung cancer,48,2.239E-03,4.745E-03,2.239E-03,4.745E-03,27,"GRO-2, CCL2, Apaf-1, ERK1/2, ENA-78, Beta-catenin, SPRY1, Rac1, PI3K reg class IA (p85), GRO-1, MEK2(MAP2K2), PA24A, FasL(TNFSF6), AKT(PKB), Tiam1, C/EBPbeta, EGFR, c-Jun, MEK4(MAP2K4), COX-2 (PTGS2), PI3K cat class IA (p110-alpha), MEKK1(MAP3K1), ATF-2, JNK(MAPK8-10), SPRY2, MMP-9, mTOR",2.706E-03,5.564E-03,25,"GRO-2, CCL2, Apaf-1, ERK1/2, ENA-78, Beta-catenin, c-Raf-1, SPRY1, PI3K reg class IA (p85), GRO-1, MEK2(MAP2K2), PA24A, AKT(PKB), MEK1(MAP2K1), Tiam1, C/EBPbeta, EGFR, MEK4(MAP2K4), COX-2 (PTGS2), PI3K cat class IA (p110-alpha), ATF-2, JNK(MAPK8-10), SPRY2, MMP-9, mTOR",
788,Neutrophil chemotaxis in asthma,38,2.268E-03,4.857E-03,3.468E-03,6.844E-03,22,"GRO-2, CCL2, PLGF, C5a, ERK1/2, ENA-78, GRO-3, PI3K cat class IB (p110-gamma), GRO-1, MIF, G-protein beta/gamma, NF-kB, HSP70, FPRL1, PTAFR, IL-8, G-protein alpha-i family, Substance P receptor, Tissue kallikreins, CCL7, PI3K reg class IB (p101), TLR2",2.268E-03,4.857E-03,21,"GRO-2, CCL2, PLGF, C5a, ERK1/2, ENA-78, GRO-3, PI3K cat class IB (p110-gamma), GRO-1, MIF, G-protein beta/gamma, NF-kB, HSP70, FPRL1, PTAFR, IL-8, G-protein alpha-i family, Substance P receptor, Tissue kallikreins, CCL7, TLR2",
789,DNA damage_Inhibition of telomerase activity and cellular senescence,20,2.285E-03,4.880E-03,6.286E-03,1.167E-02,13,"La protein, p73, CDK4, AKT(PKB), p16INK4, p107, TERT, Brca1, PP2A catalytic, CDK2, CDK6, TEP1, p53",2.285E-03,4.880E-03,13,"La protein, p73, CDK4, AKT(PKB), p16INK4, p107, TERT, Brca1, TERC, PP2A catalytic, CDK2, CDK6, p53",
790,Neurophysiological process_Corticoliberin signaling via CRHR1 ,50,2.309E-03,4.889E-03,1.067E-02,1.858E-02,26,"GRK6, EGR1, PKA-reg (cAMP-dependent), GRK3, G-protein alpha-q/11, IP3 receptor, Beta-arrestin2, RAP-1A, PLC-beta, Adenylate cyclase, CREB1, MIF, G-protein beta/gamma, ERK2 (MAPK1), POMC, cPKC (conventional), B-Raf, NCOA2 (GRIP1/TIF2), TBX19, Calmodulin, PKC-alpha, Corticoliberin, Involucrin, NCOA1 (SRC1), Elk-1, PKA-cat (cAMP-dependent)",2.309E-03,4.889E-03,26,"GRK6, GRK3, G-protein alpha-q/11, IP3 receptor, Beta-arrestin2, RAP-1A, PLC-beta, Adenylate cyclase, CREB1, MIF, G-protein beta/gamma, ERK2 (MAPK1), MEK1(MAP2K1), POMC, cPKC (conventional), B-Raf, NCOA2 (GRIP1/TIF2), TBX19, Calmodulin, PKC-alpha, Corticoliberin, CRHR1, Involucrin, NCOA1 (SRC1), Elk-1, PKA-cat (cAMP-dependent)",
791,"Cigarette smoke-induced proliferation, metaplasia and survival of airway epithelial cells ",50,2.309E-03,4.889E-03,4.845E-03,9.401E-03,27,"ERK5 (MAPK7), Fra-1, ERK1/2, Keratin 5, Filaggrin, PI3K reg class IA (p85), p38beta (MAPK11), Keratin 14, MMP-2, CREB1, MEK1/2, c-Src, nAChR alpha-7, PI3K cat class IA, c-Cbl, EGFR, c-Jun, Fra-2, p90Rsk, PCNA, AP-1, nAChR alpha-3, Involucrin, JNK(MAPK8-10), ADAM17, Elk-1, MMP-9",2.309E-03,4.889E-03,26,"p38alpha (MAPK14), ERK5 (MAPK7), Fra-1, ERK1/2, Keratin 5, c-Raf-1, Filaggrin, PI3K reg class IA (p85), Keratin 14, MMP-2, CREB1, MEK1/2, c-Src, nAChR alpha-7, PI3K cat class IA, c-Cbl, EGFR, Fra-2, p90Rsk, PCNA, nAChR alpha-3, Involucrin, JNK(MAPK8-10), ADAM17, Elk-1, MMP-9",
792,Suppression of p53 signaling in multiple myeloma,50,2.309E-03,4.889E-03,4.173E-02,6.224E-02,24,"DR5(TNFRSF10B), p14ARF, ATF-3, Apaf-1, VEGF-A, UBCH8, Bak, Caspase-8, Bax, Survivin, MAGE-3, PCAF, Caspase-3, IL-6, GADD45 alpha, DR4(TNFRSF10A), c-Myc, Mcl-1, p53 (mitochondrial), c-Jun, Caspase-9, FasR(CD95), NOXA, p53",2.309E-03,4.889E-03,26,"DR5(TNFRSF10B), p14ARF, ATF-3, Apaf-1, miR-215-5p, VEGF-A, UBCH8, Caspase-8, Bax, Survivin, MAGE-3, PCAF, Caspase-3, IL-6, GADD45 alpha, DR4(TNFRSF10A), miR-181b-5p, Mcl-1, miR-25-3p, p53 (mitochondrial), miR-215-3p, Caspase-9, FasR(CD95), NOXA, p53, microRNA 215",
793,Apoptosis and survival_HTR1A signaling,50,2.309E-03,4.889E-03,1.067E-02,1.858E-02,26,"PP2A regulatory, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), I-kB, Shc, Bax, IKK-alpha, PP2A structural, Adenylate cyclase, Caspase-3, MEK2(MAP2K2), G-protein beta/gamma, NF-kB, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, c-Src, JAK2, PARP-1, G-protein alpha-i family, XIAP, SOS, PP2A catalytic, Calmodulin, PI3K reg class IB (p101), PKA-cat (cAMP-dependent)",2.309E-03,4.889E-03,26,"PP2A regulatory, c-Raf-1, PI3K cat class IB (p110-gamma), I-kB, Shc, Bax, PP2A structural, Adenylate cyclase, Caspase-3, MEK2(MAP2K2), G-protein beta/gamma, NF-kB, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, c-Src, MEK1(MAP2K1), JAK2, G-protein alpha-i family, XIAP, SOS, PP2A catalytic, STAT3, Calmodulin, HTR1A, PKA-cat (cAMP-dependent)",
794,Protein folding and maturation_Posttranslational processing of neuroendocrine peptides,50,2.309E-03,4.889E-03,1.930E-01,2.459E-01,21,"OT-NPI, GRP precursor, OT-Gly-Lys-Arg, NT/NN, PAM, PC1, LargeNT, NN, OT, GRP(1-17), ProGRP, Trypsin, LargeNN, GRP(1-27), NT, GRP(18-27), GRP(1-27)Gly, PCSK5, OT-Gly, CPB2, NPI",2.309E-03,4.889E-03,26,"OT-NPI, GRP precursor, Neurophysin-II, OT-Gly-Lys-Arg, NT/NN, PAM, PC1, LargeNT, NN, AVP extracellular region, OT, GRP(1-17), ProGRP, AVP-Gly-Lys-Arg, Trypsin, AVP-NPII, LargeNN, GRP(1-27), AVP-Gly, NT, GRP(18-27), GRP(1-27)Gly, PCSK5, OT-Gly, CPB2, NPI",
795,Development_Regulation of telomere length and cellular immortalization,35,2.338E-03,4.940E-03,2.338E-03,4.940E-03,21,"PINX1, hnRNP C, MRN complex, Ku70/80, TRF2, AKT(PKB), HSP90, c-Myc, TERT, hnRNP A1, PI3K cat class IA, Dyskerin (NAP57), Ku80, TRF1, PKC-alpha, PTOP, Ku70, Tankyrase 2, POT1, TEP1, Tankyrase 1",5.858E-02,8.470E-02,16,"PINX1, Ku70/80, TRF2, AKT(PKB), HSP90, TERT, PI3K cat class IA, TERC, Dyskerin (NAP57), Ku80, TRF1, PKC-alpha, PTOP, Ku70, POT1, Tankyrase 1",
796,Chemotaxis_CCL2-induced chemotaxis,55,2.401E-03,5.055E-03,2.496E-03,5.207E-03,30,"PA2G6, CCL2, ERK1/2, PI3K class II (CII-alpha), PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, Shc, PI3K reg class IA (p85), cPLA2, MEK1/2, G-protein beta/gamma, CDC42, Actin cytoskeletal, PA24A, c-Src, RhoA, Pyk2(FAK2), JAK2, PI3K cat class IA, Lyn, G-protein alpha-i family, SOS, JNK1(MAPK8), Paxillin, PKC-beta, ROCK, PI3K reg class IB (p101), p38 MAPK, PLC-beta2",2.401E-03,5.055E-03,28,"PA2G6, CCL2, ERK1/2, PI3K class II (CII-alpha), c-Raf-1, PI3K cat class IB (p110-gamma), IP3 receptor, Shc, PI3K reg class IA (p85), cPLA2, MEK1/2, G-protein beta/gamma, CDC42, Actin cytoskeletal, PA24A, c-Src, RhoA, Pyk2(FAK2), JAK2, PI3K cat class IA, Lyn, G-protein alpha-i family, SOS, JNK1(MAPK8), PKC-beta, ROCK, p38 MAPK, PLC-beta2",
797,Th2-cytokine-induced airway epithelium mucous metaplasia in COPD,70,2.429E-03,5.100E-03,2.565E-02,4.026E-02,33,"SPHK1, JAK1, IL-4R type I, Tyk2, Pendrin, ERK1/2, PP2A regulatory, G-protein alpha-q/11, Syntaxin 1A, HNF3-beta, IP3 receptor, MYH9, IL13RA1, PLC-beta, Synaptotagmin II, SOCS3, IL-13, CREB1, Actin cytoskeletal, NF-kB, Guanylate Cyclase 1, soluble, GAB2, JAK2, iNOS, Adenosine A2b receptor, PKC-delta, IL-4R type II, Protein kinase G, PP2A catalytic, IL4RA, nNOS, NF-kB p65/p65, Calmodulin",2.429E-03,5.100E-03,34,"SPHK1, JAK1, IL-4R type I, Tyk2, SNAP-25, Pendrin, ERK1/2, PP2A regulatory, G-protein alpha-q/11, HNF3-beta, MUNC13, IP3 receptor, MYH9, IL13RA1, PLC-beta, Synaptotagmin II, SOCS3, CREB1, Actin cytoskeletal, NF-kB, Guanylate Cyclase 1, soluble, GAB2, JAK2, iNOS, Adenosine A2b receptor, IL-4R type II, Protein kinase G, CFTR, PP2A catalytic, p90RSK1, IL4RA, nNOS, NF-kB p65/p65, Calmodulin",
798,TMPRSS2-ERG fusion in Prostate Cancer,46,2.450E-03,5.147E-03,2.450E-03,5.147E-03,26,"VE-cadherin, Protein C receptor (endothelial), TMPRSS2, TCF7L2 (TCF4), EED, TRIP8, HMG14, MxB, LYL1, BACE2, PRMT2, c-Myc, MxA, ITGA2B, IL-8, 21-GARP, Endoglin, ETS2, DSCR2, Rnf14 (ARA54), AP-1, SUZ12, B3GT1, PANDER, Osteonectin, ICAM2",3.172E-03,6.391E-03,24,"VE-cadherin, Protein C receptor (endothelial), TMPRSS2, TCF7L2 (TCF4), YB-1, EED, TRIP8, HMG14, MxB, LYL1, C21orf24, BACE2, PRMT2, TAL1, MxA, ITGA2B, IL-8, Endoglin, ETS2, DSCR2, SUZ12, B3GT1, Osteonectin, ICAM2",
799,Nociception_Expression and role of Nociceptin in immune system,46,2.450E-03,5.147E-03,2.450E-03,5.147E-03,26,"JAK1, CCL2, CNTF, ERK1/2, PKA-reg (cAMP-dependent), STAT1, IL-1 beta, NF-kB p65/c-Rel, LIF, CREB1, IL-6, TNF-R1, IL-2, NT-3, TNF-alpha, JAK2, RelA (p65 NF-kB subunit), Nociceptin receptor, Ca(II)channel L-type, TLR4, Nociceptin, Corticoliberin, Prepronociceptin, p38 MAPK, BDNF, PKA-cat (cAMP-dependent)",7.530E-03,1.350E-02,23,"JAK1, CCL2, CNTF, ERK1/2, STAT1, IL-1 beta, NF-kB p65/c-Rel, LIF, CREB1, IL-6, TNF-R1, IL-2, TNF-alpha, JAK2, RelA (p65 NF-kB subunit), Nociceptin receptor, STAT3, TLR4, Corticoliberin, CRHR1, p38 MAPK, BDNF, PKA-cat (cAMP-dependent)",
800,Development_WNT/Beta-catenin signaling in the cytoplasm,55,2.496E-03,5.207E-03,2.496E-03,5.207E-03,30,"Casein kinase II, alpha chains, Casein kinase I delta, MACF1, APC protein, IPMK, ROCK1, Casein kinase I epsilon, Beta-catenin, Nucleoredoxin, Dsh, PLC-beta1, Rac1, GSK3 beta, Casein kinase II, GSK3 alpha/beta, Axin2, AKT(PKB), c-Src, Axin, RhoA, LRP5/LRP6, Tcf(Lef), G-protein alpha-o, WNT, G-protein alpha-q, JNK2(MAPK9), SNAIL1, p120-catenin, PLC-beta3, Frizzled",4.267E-02,6.411E-02,24,"Casein kinase II, alpha chains, p38alpha (MAPK14), MACF1, APC protein, ROCK1, Casein kinase I epsilon, Beta-catenin, Nucleoredoxin, Dsh, GSK3 beta, Casein kinase II, GSK3 alpha/beta, Axin2, AKT(PKB), c-Src, Axin, RhoA, Tcf(Lef), G-protein alpha-o, WNT, JNK2(MAPK9), SNAIL1, PLC-beta3, Frizzled",
801,Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins,33,2.501E-03,5.210E-03,2.501E-03,5.210E-03,20,"Bcl-W, Apaf-1, BFL1, HRK, Bak, Caspase-8, BAD, Bax, VDAC 1, TNF-R1, Mcl-1, ANT, Caspase-9, BMF, Bcl-B, tBid, FasR(CD95), NOXA, Bim, Bid",1.430E-02,2.413E-02,17,"Apaf-1, BFL1, HRK, c-Raf-1, Caspase-8, Bax, VDAC 1, TNF-R1, Mcl-1, Caspase-9, BMF, Bcl-B, tBid, FasR(CD95), NOXA, Bim, Bid",
802,FGF signaling in Prostate Cancer,43,2.527E-03,5.269E-03,8.269E-02,1.154E-01,20,"FGFR2, FGF1, Matrilysin (MMP-7), FGF8, SPRY1, FGF9, Shc, PI3K reg class IA, MEK2(MAP2K2), HBP17, ERK2 (MAPK1), AKT(PKB), PI3K cat class IA, c-Cbl, FGF2, SOS, FGF7, FRS2beta, SPRY2, Elk-1",2.527E-03,5.269E-03,23,"FGFR2, FGF17, FGF1, Matrilysin (MMP-7), c-Raf-1, FGF8, SPRY1, FGF9, Shc, PI3K reg class IA, MEK2(MAP2K2), HBP17, ERK2 (MAPK1), AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, c-Cbl, FGF2, SOS, STAT3, FRS2beta, SPRY2, Elk-1",
803,Stem cells_Notch signaling in medulloblastoma stem cells,29,2.539E-03,5.279E-03,2.820E-03,5.755E-03,18,"NOTCH1 receptor, HES5, Jagged2, GLI-2, NOTCH2 (2ICD), RBP-J kappa (CBF1), NOTCH1 (NICD), HEY1, PTCH1, NOTCH2, FKHL1, DLL4, HES1, HDAC1, GLI-1, NOTCH1 (NEXT), Jagged1, ADAM17",2.539E-03,5.279E-03,17,"NOTCH1 receptor, HES5, Jagged2, GLI-2, NOTCH2 (2ICD), miR-199b-5p, RBP-J kappa (CBF1), NOTCH1 (NICD), PTCH1, NOTCH2, FKHL1, HES1, HDAC1, GLI-1, NOTCH1 (NEXT), Jagged1, ADAM17",
804,Development_Auditory hair cell differentiation in embryogenesis,29,2.539E-03,5.279E-03,2.820E-03,5.755E-03,18,"NGFR(TNFRSF16), NOTCH1 receptor, HES5, p57, BMP4, Jagged2, FGF8, FGF20, BARHL1, RBP-J kappa (CBF1), GFI-1, NOTCH1 (NICD), PROX1, HES1, ATH1, NOTCH1 (NEXT), Jagged1, ADAM17",2.539E-03,5.279E-03,17,"NGFR(TNFRSF16), NOTCH1 receptor, HES5, p57, BMP4, Jagged2, FGF8, FGF20, RBP-J kappa (CBF1), GFI-1, NOTCH1 (NICD), PROX1, HES1, ATH1, NOTCH1 (NEXT), Jagged1, ADAM17",
805,DNA damage_Role of NFBD1 in DNA damage response,13,2.616E-03,5.443E-03,2.616E-03,5.443E-03,10,"NFBD1, p53BP1, MRN complex, Nibrin, Brca1, Rad50, ATR, MRE11, ATM, p53",2.589E-02,4.101E-02,8,"NFBD1, p53BP1, Chk2, Brca1, ATR, MRE11, ATM, p53",
806,c-Myc in multiple myeloma,16,2.619E-03,5.438E-03,6.448E-03,1.188E-02,11,"GRP78, eIF4E, VEGF-A, HDAC6, IL-6, c-Myc, hnRNP A1, HIF1A, IRF4, p38 MAPK, PTBP1",2.619E-03,5.438E-03,11,"GRP78, YB-1, VEGF-A, HDAC6, IL-6, HIF1A, IRF4, STAT3, CD33, p38 MAPK, PTBP1",
807,G-protein signaling_G-Protein alpha-s signaling cascades,36,2.638E-03,5.455E-03,9.706E-03,1.715E-02,20,"ERK1/2, KPYR, PKA-reg (cAMP-dependent), RAP-1A, GSK3 beta, PDE4A, MEK2(MAP2K2), Ryanodine receptor 1, CREB1, G-protein beta/gamma, RGS2, c-Src, AK1, PKM2, B-Raf, AK5, cAMP-GEFII, Alpha adducin, PDZ-GEF1, PKA-cat (cAMP-dependent)",2.638E-03,5.455E-03,20,"ERK1/2, KPYR, c-Raf-1, RAP-1A, GSK3 beta, PDE4A, MEK2(MAP2K2), Ryanodine receptor 1, CREB1, G-protein beta/gamma, RGS2, c-Src, PKM2, MEK1(MAP2K1), B-Raf, AK5, cAMP-GEFII, Alpha adducin, PDZ-GEF1, PKA-cat (cAMP-dependent)",
808,Proliferative action of Gastrin in pancreatic cancer,44,2.678E-03,5.540E-03,2.678E-03,5.540E-03,25,"Gastrin 17-Gly, IRS-1, LARG, ERK1/2, Elk-4, PKC-epsilon, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), Gastrin 17, Progastrin, c-Src, RhoA, Pyk2(FAK2), JAK2, PI3K cat class IA, PKC-delta, CCKBR, SOS, PKC-alpha, G-protein alpha-q, Elk-1, SRF",3.720E-03,7.377E-03,23,"Gastrin 17-Gly, ERK1/2, c-Raf-1, Elk-4, PKC-epsilon, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), Gastrin 17, Progastrin, c-Src, MEK1(MAP2K1), RhoA, Pyk2(FAK2), JAK2, PI3K cat class IA, SOS, STAT3, PKC-alpha, Elk-1, SRF",
809,Type 2 diabetes (general schema),14,2.694E-03,5.562E-03,6.268E-03,1.167E-02,10,"CCL2, GLP-1 (7-36) amide, IL-1 beta, IL-6, GLP-1 (7-37), TNF-alpha, POMC, Glucagon, AGRP, GIP",2.694E-03,5.562E-03,10,"CCL2, GLP-1 (7-36) amide, IL-1 beta, IL-6, GLP-1 (7-37), TNF-alpha, POMC, Glucagon, AGRP, GIP",
810,Muscle contraction_Relaxin signaling pathway,48,2.706E-03,5.564E-03,5.354E-03,1.027E-02,26,"PI3K cat class IA (p110-beta), ERK1/2, PKC-zeta, VEGF-A, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), RAP-1A, I-kB, PDE4A, Endothelin-1, MMP-2, CREB1, G-protein beta/gamma, NF-kB, AKT(PKB), B-Raf, iNOS, G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, PDE4C, p90Rsk, LGR7, EDNRB, MMP-9, PKA-cat (cAMP-dependent)",2.706E-03,5.564E-03,25,"PI3K cat class IA (p110-beta), ERK1/2, VEGF-A, PI3K cat class IB (p110-gamma), RAP-1A, I-kB, PDE4A, Endothelin-1, MMP-2, CREB1, G-protein beta/gamma, NF-kB, AKT(PKB), MEK1(MAP2K1), B-Raf, iNOS, G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, PDE4C, p90Rsk, LGR7, EDNRB, MMP-9, PKA-cat (cAMP-dependent)",
811,Aryl hydrocarbon receptor signaling,53,2.749E-03,5.650E-03,2.749E-03,5.650E-03,29,"CYP1B1, CYP1A1, AHR, UGT1A1, ARNT2, TGM3, CDC42, c-Myc, CYP2S1, BAFF(TNFSF13B), ARNT, Brca1, HIF1A, IL-8, Epiregulin, HIF-1, HIF1A/ARNT2, p300, RIP140, COX-2 (PTGS2), DNA polymerase kappa, CYP4A11, GSTA1, HES1, AHR/ARNT complex, SLUG, CXCL13, NRF2, UGT1A6",8.613E-02,1.204E-01,22,"CYP1B1, CYP1A1, AHR, UGT1A1, ARNT2, CDC42, CYP2S1, BAFF(TNFSF13B), Brca1, HIF1A, IL-8, Epiregulin, HIF1A/ARNT2, p300, RIP140, COX-2 (PTGS2), CYP4A11, HES1, SLUG, CXCL13, NRF2, UGT1A6",
812,Chemotaxis_Inhibitory action of lipoxins on IL-8- and Leukotriene B4-induced neutrophil migration,53,2.749E-03,5.650E-03,2.749E-03,5.650E-03,29,"PLD1, ICAM1, ERK1/2, PKC-zeta, Alpha-actinin, Rac2, LIMK1, Actin, PI3K cat class IB (p110-gamma), Rac1, Talin, MLCP (reg), G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), MYLK1, MLCK, MLCP (cat), FPRL1, ITGB2, IL-8, G-protein alpha-i family, Myosin II, PPAPDC2, Actomyosin, MRLC, MELC, PI3K reg class IB (p101), Cofilin",6.388E-03,1.176E-02,26,"PLD1, ICAM1, ERK1/2, Alpha-actinin, Rac2, LIMK1, Actin, PI3K cat class IB (p110-gamma), Talin, MLCP (reg), G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), MYLK1, MLCK, MLCP (cat), FPRL1, ITGB2, IL-8, G-protein alpha-i family, Myosin II, PPAPDC2, Actomyosin, MRLC, MELC, Cofilin",
813,Translation_Translation regulation by Alpha-1 adrenergic receptors,53,2.749E-03,5.650E-03,2.749E-03,5.650E-03,29,"RHEB2, PLD1, PI3K cat class IA (p110-beta), eIF4E, PRK1, PKC-epsilon, PLC-beta1, IP3 receptor, Shc, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), Alpha-1B adrenergic receptor, c-Src, RhoA, Pyk2(FAK2), PI3K reg class IA (p85-alpha), PKC-delta, G-protein alpha-o, eEF2K, eIF4G1/3, SOS1, PLD2, 4E-BP1, Calmodulin, eIF4A, G-protein alpha-q, Alpha-1D adrenergic receptor, mTOR",1.353E-02,2.307E-02,25,"RHEB2, PLD1, PI3K cat class IA (p110-beta), PRK1, c-Raf-1, PKC-epsilon, IP3 receptor, Shc, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), Alpha-1B adrenergic receptor, c-Src, MEK1(MAP2K1), RhoA, Pyk2(FAK2), PI3K reg class IA (p85-alpha), G-protein alpha-o, eIF4G1/3, SOS1, PLD2, Calmodulin, eIF4A, Alpha-1D adrenergic receptor, mTOR",
814,EGFR signaling pathway in lung cancer,53,2.816E-03,5.774E-03,6.213E-03,1.166E-02,28,"ERK1/2, PGE2R1, EGR1, VEGF-A, Carbonic anhydrase IX, Shc, PI3K reg class IA (p85), IKK-alpha, IL-6, TGF-alpha, NF-kB, AKT(PKB), c-Src, Mcl-1, CXCR4, HGF, JAK2, PI3K cat class IA, HIF1A, EGFR, c-Jun, SOS, COX-2 (PTGS2), STAT5, HGF receptor (Met), ADAM17, MMP-9, mTOR",2.816E-03,5.774E-03,27,"Neuregulin 1, ERK1/2, PGE2R1, VEGF-A, Carbonic anhydrase IX, Shc, PI3K reg class IA (p85), IL-6, TGF-alpha, NF-kB, AKT(PKB), c-Src, Mcl-1, CXCR4, HGF, JAK2, PI3K cat class IA, HIF1A, EGFR, SOS, STAT3, COX-2 (PTGS2), STAT5, HGF receptor (Met), ADAM17, MMP-9, mTOR",
815,G-protein signaling_G-Protein alpha-i signaling cascades,27,2.908E-03,5.931E-03,1.143E-01,1.541E-01,13,"ERK1/2, PKA-reg (cAMP-dependent), RAP-1A, Shc, MEK2(MAP2K2), G-protein beta/gamma, c-Src, B-Raf, G-protein alpha-i family, SOS, Caveolin-1, RGS14, PKA-cat (cAMP-dependent)",2.908E-03,5.931E-03,16,"ERK1/2, c-Raf-1, RAP-1A, Shc, MEK2(MAP2K2), G-protein beta/gamma, c-Src, MEK1(MAP2K1), B-Raf, RGS7, G-protein alpha-i family, SOS, STAT3, Caveolin-1, RGS14, PKA-cat (cAMP-dependent)",
816,HCV-dependent cytoplasmic signaling leading to HCC,27,2.908E-03,5.931E-03,2.966E-03,6.028E-03,17,"ERK1/2, CDK1 (p34), BAD, ERK2 (MAPK1), AKT(PKB), Cyclin B1, 14-3-3 epsilon, PI3K reg class IA (p85-alpha), PKR, c-Jun, 14-3-3 beta/alpha, PI3K cat class IA (p110-alpha), PKC, ATF-2, p38 MAPK, Elk-1, PKA-cat (cAMP-dependent)",2.908E-03,5.931E-03,16,"ERK1/2, c-Raf-1, CDK1 (p34), ERK2 (MAPK1), AKT(PKB), Cyclin B1, MEK1(MAP2K1), 14-3-3 epsilon, PI3K reg class IA (p85-alpha), PKR, PI3K cat class IA (p110-alpha), PKC, ATF-2, p38 MAPK, Elk-1, PKA-cat (cAMP-dependent)",
817,EGFR signaling pathway in colorectal cancer,60,2.935E-03,5.981E-03,2.935E-03,5.981E-03,32,"PAR2, ERK1/2, HB-EGF, Matrilysin (MMP-7), BAD, I-kB, Shc, PI3K reg class IA (p85), GSK3 beta, Thrombin, FKHR, Trypsin I, IKK-alpha, MEK1/2, TGF-alpha, NF-kB, c-Src, PGE2R4, RelA (p65 NF-kB subunit), B-Raf, Epiregulin, EGFR, SOS, p90Rsk, ACM3, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), NT, FOXO3A, PAR1, MMP-10, ADAM17",1.104E-02,1.911E-02,28,"PAR2, ERK1/2, HB-EGF, Matrilysin (MMP-7), I-kB, Shc, PI3K reg class IA (p85), GSK3 beta, FKHR, Trypsin I, MEK1/2, TGF-alpha, NF-kB, c-Src, PGE2R4, RelA (p65 NF-kB subunit), B-Raf, Epiregulin, EGFR, SOS, p90Rsk, ACM3, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), NT, PAR1, MMP-10, ADAM17",
818,Main growth factor signaling cascades in multiple myeloma cells,41,2.955E-03,6.011E-03,1.157E-02,1.994E-02,22,"IRS-2, IRS-1, VEGF-A, VEGFR-2, BAD, I-kB, Shc, PI3K reg class IA (p85), PI3K reg class IA, FKHR, IKK-alpha, N-Ras, MEK2(MAP2K2), GSK3 alpha/beta, NF-kB, ERK2 (MAPK1), AKT(PKB), PI3K cat class IA, PI3K reg class IA (p85-alpha), HIF1A, FGF2, SOS",2.955E-03,6.011E-03,22,"IRS-2, VEGF-A, c-Raf-1, VEGFR-2, I-kB, Shc, PI3K reg class IA (p85), PI3K reg class IA, FKHR, N-Ras, MEK2(MAP2K2), GSK3 alpha/beta, NF-kB, ERK2 (MAPK1), AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, PI3K reg class IA (p85-alpha), HIF1A, FGF2, SOS, STAT3",
819,Development_Muscle progenitor cell migration in hypaxial myogenesis,41,2.955E-03,6.011E-03,1.157E-02,1.994E-02,22,"NOTCH1 receptor, ERK1/2, MEF2C, FGF8, SPRY1, Shc, G-protein beta/gamma, RBP-J kappa (CBF1), c-Src, CXCR4, NOTCH1 (NICD), HGF, G-protein alpha-i family, MAML1, SOS, HES1, SHP-2, SNAIL1, LBX1, NOTCH1 (NEXT), HGF receptor (Met), ADAM17",2.955E-03,6.011E-03,22,"NOTCH1 receptor, ERK1/2, MEF2C, c-Raf-1, FGF8, SPRY1, Shc, G-protein beta/gamma, RBP-J kappa (CBF1), c-Src, CXCR4, NOTCH1 (NICD), HGF, MEK1(MAP2K1), G-protein alpha-i family, SOS, HES1, SNAIL1, LBX1, NOTCH1 (NEXT), HGF receptor (Met), ADAM17",
820,Neurophysiological process_GABA-A receptor life cycle,27,2.966E-03,6.028E-03,2.966E-03,6.028E-03,17,"NSF, AP complex 2 medium (mu) chain, PP1-cat, Ubiquilin-1, Dynamin-1, Dynein 1, cytoplasmic, heavy chain, GABA-A receptor, GABA-A receptor beta-2 subunit, c-Src, Tubulin (in microtubules), GABARAP, PLCL2, GABA-A receptor alpha-1 subunit, Clathrin light chain, PLCL1, Dynamin, Dynein 1, cytoplasmic, intermediate chains",2.369E-02,3.793E-02,14,"AP complex 2 medium (mu) chain, PP1-cat, Ubiquilin-1, Dynamin-1, Dynein 1, cytoplasmic, heavy chain, GABA-A receptor, c-Src, Tubulin (in microtubules), GABARAP, PLCL2, Clathrin light chain, PLCL1, Dynamin, Dynein 1, cytoplasmic, intermediate chains",
821,Immune response_IL-11 signaling via JAK/STAT,34,3.068E-03,6.215E-03,4.081E-03,7.992E-03,20,"GFAP, JAK1, RANKL(TNFSF11), Pim-1, STAT1, IL11RA, Survivin, A2M, SOCS3, REG3G, CYP19, UCP3, ADAM10, PPAR-gamma, Metallothionein-II, JAK2, Leukocyte elastase, TIMP1, sIL11-RA, IL-11",3.068E-03,6.215E-03,19,"GFAP, JAK1, RANKL(TNFSF11), Pim-1, STAT1, Survivin, A2M, SOCS3, REG3G, UCP3, ADAM10, PPAR-gamma, Metallothionein-II, A-FABP, JAK2, Leukocyte elastase, TIMP1, STAT3, IL-11",
822,IGF-1 receptor/EGFR cooperation in lung cancer,25,3.093E-03,6.260E-03,3.093E-03,6.260E-03,16,"RHEB2, IRS-2, IRS-1, PKC-zeta, 14-3-3 theta, BAD, Bax, Survivin, PI3K reg class IA, AKT(PKB), PI3K cat class IA, PKC-delta, EGFR, p90Rsk, 4E-BP1, mTOR",1.366E-01,1.829E-01,11,"RHEB2, IRS-2, 14-3-3 theta, Bax, Survivin, PI3K reg class IA, AKT(PKB), PI3K cat class IA, EGFR, p90Rsk, mTOR",
823,Immune response_LPS-induced platelet activation,25,3.093E-03,6.260E-03,3.093E-03,6.260E-03,16,"MD-2, IL-1 beta, CD14, Thrombin, alpha-IIb/beta-3 integrin, MyD88, PSGL-1, P-selectin, LBP, Guanylate cyclase (alpha-1/beta-1), COX-2 (PTGS2), TLR4, PAR1, Fibrinogen (fibrin), Collagen I, TLR2",2.812E-02,4.406E-02,13,"MD-2, IL-1 beta, CD14, alpha-IIb/beta-3 integrin, PSGL-1, P-selectin, CD40L(TNFSF5), Guanylate cyclase (alpha-1/beta-1), COX-2 (PTGS2), TLR4, PAR1, Collagen I, TLR2",
824,Fenofibrate in treatment of type 2 diabetes and metabolic syndrome X,25,3.093E-03,6.260E-03,3.093E-03,6.260E-03,16,"APOA2, Fibrinogen beta, PPAR-alpha, RBP4, ABCA1, ACSL1, SR-BI, Acyl-CoA synthetase, APOA1, FATP1, Fibrinogen alpha, APOC3, Fibrinogen gamma, Fibrinogen (fibrin), PAI1, LPL",2.812E-02,4.406E-02,13,"APOA2, PPAR-alpha, APOA5, RBP4, ABCA1, SR-BI, Acyl-CoA synthetase, APOA1, FATP1, Fibrinogen alpha, LXR-alpha, PAI1, LPL",
825,Development_Endothelin-1/EDNRA transactivation of EGFR,46,3.172E-03,6.391E-03,2.723E-02,4.248E-02,23,"RHEB2, ERK1/2, HB-EGF, G-protein alpha-q/11, IP3 receptor, Shc, ADAM9, PI3K reg class IA, PLC-beta, Endothelin-1, MEK2(MAP2K2), AKT(PKB), c-Src, Pyk2(FAK2), PI3K cat class IA, PKC-delta, EGFR, SOS, Calmodulin, STAT5, EDNRA, Collagen I, mTOR",3.172E-03,6.391E-03,24,"RHEB2, ERK1/2, HB-EGF, c-Raf-1, G-protein alpha-q/11, IP3 receptor, Shc, ADAM9, PI3K reg class IA, PLC-beta, Endothelin-1, MEK2(MAP2K2), AKT(PKB), c-Src, MEK1(MAP2K1), Pyk2(FAK2), PI3K cat class IA, EGFR, SOS, Calmodulin, STAT5, EDNRA, Collagen I, mTOR",
826,EGFR signaling in Prostate Cancer,46,3.172E-03,6.391E-03,5.206E-02,7.569E-02,22,"ERK1/2, HB-EGF, Shc, PI3K reg class IA (p85), IKK-alpha, N-Ras, MEK2(MAP2K2), TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Src, c-Myc, PI3K cat class IA, RelA (p65 NF-kB subunit), c-Cbl, EGFR, ErbB4, SOS, NCOA2 (GRIP1/TIF2), PLC-gamma, Caveolin-1, mTOR",3.172E-03,6.391E-03,24,"Neuregulin 1, ERK1/2, HB-EGF, c-Raf-1, Shc, PI3K reg class IA (p85), N-Ras, MEK2(MAP2K2), TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, RelA (p65 NF-kB subunit), c-Cbl, EGFR, ErbB4, SOS, NCOA2 (GRIP1/TIF2), STAT3, PLC-gamma, Caveolin-1, mTOR",
827,Development_Role of Activin A in cell differentiation and proliferation,40,3.186E-03,6.406E-03,3.186E-03,6.406E-03,23,"MAD, LH-beta, Oct-3/4, PKA-reg (cAMP-dependent), SMAD4, SMAD2, STAR, Adenylate cyclase, ActRIIA, CREB1, Lefty-2, c-Myc, LH receptor, Activin A, Lefty-1, NODAL, SF1, CYP11A1, OTX1, ActRIIB, p15, SMAD3, PKA-cat (cAMP-dependent)",2.703E-02,4.263E-02,19,"MAD, LH-beta, Oct-3/4, SMAD4, SMAD2, Adenylate cyclase, ActRIIA, CREB1, Lefty-2, FSHR, Activin A, NODAL, SF1, CYP11A1, OTX1, ActRIIB, p15, SMAD3, PKA-cat (cAMP-dependent)",
828,Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing,40,3.186E-03,6.406E-03,3.186E-03,6.406E-03,23,"HDAC9, HDAC4, CDC25A, HP1, CDK1 (p34), MBD2, HDAC2, Cyclin A2, Mi-2 alpha, CtBP, HP1 gamma, Suv39H1, Mi-2, MeCP2, Sin3A, SUMO-1, MEF2, HDAC5, Cyclin E, DNMT1, HDAC1, MBD3, HP1 alpha",5.125E-03,9.760E-03,21,"HDAC9, HDAC4, CDC25A, HP1, CDK1 (p34), MBD2, HDAC2, Cyclin A2, Mi-2 alpha, CtBP, HP1 gamma, Mi-2, MeCP2, Sin3A, SUMO-1, MEF2, HDAC5, Cyclin E, DNMT1, HDAC1, HP1 alpha",
829,Th2-cytokines-induced mucous metaplasia in asthma,40,3.186E-03,6.406E-03,3.186E-03,6.406E-03,23,"JAK1, IRS-2, IL-4R type I, Tyk2, Mucin 16, IRS-1, G6NT, ERK1/2, HNF3-beta, GCNT3, IL13RA1, PI3K reg class IA, IL-13, MEK1/2, JAK2, PI3K cat class IA, SOX17, IL-4R type II, Uteroglobin, SOS, IL4RA, JAK3, SHP-2",5.125E-03,9.760E-03,21,"JAK1, IRS-2, IL-4R type I, Tyk2, Mucin 16, G6NT, ERK1/2, c-Raf-1, HNF3-beta, GCNT3, IL13RA1, PI3K reg class IA, MEK1/2, Centrin-1, JAK2, PI3K cat class IA, SOX17, IL-4R type II, SOS, IL4RA, JAK3",
830,Recurrent gene fusions in Prostate Cancer,40,3.186E-03,6.406E-03,3.186E-03,6.406E-03,23,"DGK-beta, USP10, RBM4, TMPRSS2, S2P, APCL, Elk-4, ZNF370, HPR, PEA3, Cyclophilin A, NDRG1, RBM14, DND1, hnRNP A2, INPP4A, HJURP, ZNF621, MRPS10, SLTM, 4EHP, ER81, ERM",5.440E-02,7.919E-02,18,"DGK-beta, USP10, TMPRSS2, S2P, APCL, Elk-4, HPR, PEA3, C15orf21, NDRG1, hnRNP A2, INPP4A, HJURP, ZNF621, SLTM, 4EHP, ER81, ERM",
831,FGF signaling in gastric cancer,23,3.190E-03,6.406E-03,3.190E-03,6.406E-03,15,"PLD1, FGFR2, FGF1, Beta-catenin, Shc, MEK1/2, ERK2 (MAPK1), c-Src, FGF2, SOS, PLAU (UPA), FGF7, SHP-2, FIGC, MMP-9",3.772E-03,7.449E-03,14,"PLD1, FGFR2, FGF1, Beta-catenin, c-Raf-1, Shc, MEK1/2, ERK2 (MAPK1), c-Src, FGF2, SOS, PLAU (UPA), FIGC, MMP-9",
832,Brca1 and Brca2 in breast cancer,19,3.238E-03,6.463E-03,3.238E-03,6.463E-03,13,"Brca2, Rad51, Chk1, MRN complex, GADD45 alpha, Nibrin, Tubulin gamma, Brca1, Rad50, ATR, p300, MSH2, Brca1/Bard1",1.141E-01,1.552E-01,9,"Brca2, Chk1, GADD45 alpha, Tubulin gamma, Brca1, ATR, p300, MSH2, Brca1/Bard1",
833,Development_Role of HGF in hematopoietic stem cell mobilization,21,3.244E-03,6.463E-03,3.244E-03,6.463E-03,14,"RECK, RHEB2, SGK1, PI3K reg class IA, MMP-2, AKT(PKB), HGF, PI3K cat class IA, HIF1A, FOXO3A, MMP-14, HGF receptor (Met), MMP-9, mTOR",4.262E-03,8.263E-03,13,"RECK, RHEB2, SGK1, PI3K reg class IA, MMP-2, AKT(PKB), HGF, PI3K cat class IA, HIF1A, MMP-14, HGF receptor (Met), MMP-9, mTOR",
834,Role of ZNF202 in regulation of expression of genes involved in atherosclerosis,21,3.244E-03,6.463E-03,3.244E-03,6.463E-03,14,"LIPC (HL), Beta-3 adrenergic receptor, LCAT, HDL proteins, VEGF-A, ABCA1, PEMT, APOA4, APOE, APOC3, ZNF202, PLTP, HNF4-alpha, LPL",4.262E-03,8.263E-03,13,"LIPC (HL), Beta-3 adrenergic receptor, LCAT, HDL proteins, VEGF-A, ABCA1, PEMT, APOA4, APOE, ZNF202, PLTP, HNF4-alpha, LPL",
835,Defective macrophage-mediated bacterial phagocytosis in COPD,25,3.319E-03,6.652E-03,9.754E-03,1.715E-02,15,"MSR1, HDAC6, C6orf134, Calreticulin, CDC42, AKT(PKB), LRP1, Tubulin (in microtubules), SR-BI, Sirtuin2, MARCO, PI3K cat class IA (p110-alpha), CR1, Tubulin alpha, NRF2",3.319E-03,6.652E-03,15,"MSR1, HDAC6, C6orf134, Calreticulin, CDC42, AKT(PKB), LRP1, Tubulin (in microtubules), SR-BI, Sirtuin2, MARCO, CR1, PI3K cat class IA (p110-alpha), Tubulin alpha, NRF2",
836,Gamma-secretase regulation of gastrointestinal epithelial cell development,25,3.319E-03,6.652E-03,9.754E-03,1.715E-02,15,"NOTCH1 receptor, p57, PAX4, PAX6, NOTCH2 (2ICD), NeuroD1, RBP-J kappa (CBF1), NOTCH1 (NICD), HEY1, NOTCH2, HES1, ATH1, NOTCH1 (NEXT), Jagged1, ADAM17",3.319E-03,6.652E-03,15,"NOTCH1 receptor, p57, PAX4, PAX6, NOTCH2 (2ICD), NeuroD1, RBP-J kappa (CBF1), NOTCH1 (NICD), PTF1-p48, NOTCH2, HES1, ATH1, NOTCH1 (NEXT), Jagged1, ADAM17",
837,Blood coagulation_Platelet microparticle generation,72,3.376E-03,6.689E-03,3.376E-03,6.689E-03,37,"STIM1, GP-IB beta, SLC21A2, PLA2G7, TRPC6, Fibronectin, IP3 receptor, IL-1 beta, Thrombin, PLC-beta, alpha-IIb/beta-3 integrin, MSN (moesin), cPLA2, Caspase-3, Actin cytoskeletal, Calpain 1(mu), Fodrin (spectrin), MYLK1, P-selectin, ITGB1, cPKC (conventional), PIP5KIII, PTP-1B, TBXA2R, Tissue factor, MyHC, Coagulation factor V, Talin-1, Calmodulin, PKC, P2Y1, Alpha-fodrin, G-protein alpha-q, PAR1, Filamin A, Fibrinogen (fibrin), Collagen I",1.600E-02,2.657E-02,32,"STIM1, SLC21A2, PLA2G7, TRPC6, Fibronectin, IP3 receptor, IL-1 beta, PLC-beta, alpha-IIb/beta-3 integrin, MSN (moesin), cPLA2, Caspase-3, Actin cytoskeletal, Calpain 1(mu), Fodrin (spectrin), MYLK1, P-selectin, ITGB1, cPKC (conventional), PIP5KIII, TBXA2R, Tissue factor, MyHC, Coagulation factor V, Talin-1, Calmodulin, PKC, P2Y1, Alpha-fodrin, PAR1, Filamin A, Collagen I",
838,Development_PACAP signaling in neural cells,39,3.457E-03,6.891E-03,1.283E-02,2.186E-02,21,"Apaf-1, ATF-1, ERK1/2, p90RSK2(RPS6KA3), PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, RAP-1A, Bax, PLC-beta, Caspase-3, MEK2(MAP2K2), CREB1, cPKC (conventional), B-Raf, cAMP-GEFII, Caspase-9, PACAP receptor 1, PACAP, Elk-1, PKA-cat (cAMP-dependent)",3.457E-03,6.891E-03,21,"Apaf-1, ATF-1, ERK1/2, p90RSK2(RPS6KA3), G-protein alpha-q/11, IP3 receptor, RAP-1A, Bax, PLC-beta, Caspase-3, MEK2(MAP2K2), CREB1, MEK1(MAP2K1), cPKC (conventional), B-Raf, cAMP-GEFII, Caspase-9, PACAP receptor 1, PACAP, Elk-1, PKA-cat (cAMP-dependent)",
839,TrkB signaling in Huntington's disease,39,3.457E-03,6.891E-03,2.813E-02,4.376E-02,20,"NGFR(TNFRSF16), ERK1/2, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), CREB1, Dopamine D2 receptor, PI3K cat class IA, SOS, TrkB, NR2A, p90Rsk, Calmodulin, PKC, CaMK II alpha, GluR1, BDNF, Elk-1",3.457E-03,6.891E-03,21,"NGFR(TNFRSF16), ERK1/2, c-Raf-1, IP3 receptor, Shc, PI3K reg class IA (p85), PLC-gamma 1, MEK2(MAP2K2), CREB1, Dopamine D2 receptor, MEK1(MAP2K1), PI3K cat class IA, SOS, TrkB, NR2A, p90Rsk, Calmodulin, PKC, CaMK II alpha, BDNF, Elk-1",
840,Translation _Regulation of EIF2 activity,39,3.457E-03,6.891E-03,2.813E-02,4.376E-02,20,"Casein kinase II, alpha chains, IRS-2, IRS-1, PP1-cat, ERK1/2, Shc, GCN2, PI3K reg class IA, MEK2(MAP2K2), GSK3 alpha/beta, AKT(PKB), Casein kinase II, beta chain (Phosvitin), PI3K cat class IA, c-Cbl, PKR, EGFR, DYRK1a, SOS, DYRK2, Casein kinase I",3.457E-03,6.891E-03,21,"Casein kinase II, alpha chains, IRS-2, PP1-cat, ERK1/2, c-Raf-1, Shc, GCN2, PI3K reg class IA, MEK2(MAP2K2), GSK3 alpha/beta, AKT(PKB), MEK1(MAP2K1), Casein kinase II, beta chain (Phosvitin), PI3K cat class IA, c-Cbl, PKR, EGFR, DYRK1a, SOS, DYRK2, Casein kinase I",
841,Signal transduction_Cyclic AMP signaling,38,3.468E-03,6.844E-03,3.468E-03,6.844E-03,22,"Calcineurin A (catalytic), KDELR, PKC-zeta, PKA-reg (cAMP-dependent), CaMK IV, Adenylate cyclase type VII, RAP-1A, Ryanodine receptor 1, GSK3 alpha/beta, CREB1, G-protein beta/gamma, Adenylate cyclase type III, PKC-delta, cAMP-GEFII, G-protein alpha-i family, PHK gamma, Adenylate cyclase type VIII, Calmodulin, PKC, PKC-alpha, RAP-2A, PKA-cat (cAMP-dependent)",6.019E-03,1.116E-02,20,"Calcineurin A (catalytic), KDELR, CaMK IV, Adenylate cyclase type VII, RAP-1A, Ryanodine receptor 1, GSK3 alpha/beta, CREB1, G-protein beta/gamma, Adenylate cyclase type III, Phospholamban, cAMP-GEFII, G-protein alpha-i family, PHK gamma, Adenylate cyclase type VIII, Calmodulin, PKC, PKC-alpha, RAP-2A, PKA-cat (cAMP-dependent)",
842,Role of Endothelin-1 in inflammation and vasoconstriction in Sickle cell disease,38,3.468E-03,6.844E-03,3.468E-03,6.844E-03,22,"CCL2, PLGF, ERK1/2, Endothelin-3, p47-phox, PI3K reg class IA (p85), p38beta (MAPK11), Endothelin-1, Casein kinase II, AKT(PKB), PI3K cat class IA, RelA (p65 NF-kB subunit), HIF1A, IL-8, c-Jun, P4HB, SK4/IK1, JNK1(MAPK8), AP-1, EDNRB, PKC-alpha, EDNRA",6.019E-03,1.116E-02,20,"p38alpha (MAPK14), CCL2, PLGF, ERK1/2, Endothelin-3, p47-phox, PI3K reg class IA (p85), Endothelin-1, Casein kinase II, AKT(PKB), PI3K cat class IA, RelA (p65 NF-kB subunit), HIF1A, IL-8, P4HB, SK4/IK1, JNK1(MAPK8), EDNRB, PKC-alpha, EDNRA",
843,Main chemotherapy drugs and their action in SCLC cells,100,3.681E-03,7.327E-03,4.163E-02,6.216E-02,44,"DR5(TNFRSF10B), CCL2, RANKL(TNFSF11), Apaf-1, RPS6, ERK1/2, Apo-2L(TNFSF10), PKC-epsilon, MDR1, CDK1 (p34), BAD, Bax, GSK3 beta, IKK-alpha, Caspase-3, AKT(PKB), DR4(TNFRSF10A), c-Src, TNF-alpha, G-protein alpha-12 family, RelA (p65 NF-kB subunit), PKC-delta, IL-8, EGFR, Cyclin D, Caspase-9, JNK1(MAPK8), PLAU (UPA), RANK(TNFRSF11A), CDK2, PKC-beta, GPX1, PKC-alpha, Cyclin E, tBid, c-Abl, TOP2 alpha, Cyclin A, JNK(MAPK8-10), Caveolin-1, p53, p38 MAPK, mTOR, Bid",3.681E-03,7.327E-03,45,"p38alpha (MAPK14), DR5(TNFRSF10B), CCL2, RANKL(TNFSF11), Apaf-1, RPS6, ERK1/2, c-Raf-1, Apo-2L(TNFSF10), PKC-epsilon, MDR1, CDK1 (p34), Bax, GSK3 beta, Caspase-3, AKT(PKB), DR4(TNFRSF10A), c-Src, TNF-alpha, MEK1(MAP2K1), G-protein alpha-12 family, RelA (p65 NF-kB subunit), IL-8, EGFR, Cyclin D, Caspase-9, Glutaredoxin 1, JNK1(MAPK8), PLAU (UPA), RANK(TNFRSF11A), CDK2, PKC-beta, GPX1, PKC-alpha, Cyclin E, tBid, c-Abl, TOP2 alpha, Cyclin A, JNK(MAPK8-10), Caveolin-1, p53, p38 MAPK, mTOR, Bid",
844,Signal transduction_HTR2A signaling outside the nervous system,74,3.692E-03,7.339E-03,1.151E-02,1.994E-02,36,"TGF-beta 1, PLD1, IRS-1, ERK1/2, HTR2A, HB-EGF, EGR1, G-protein alpha-q/11, MLCP (reg), PI3K reg class IA (p85), PLC-beta, CDK4, Adenylate cyclase, MEK1/2, AKT(PKB), c-Src, MLCP (cat), RhoA, JAK2, cPKC (conventional), PI3K cat class IA, EGFR, G-protein alpha-i family, Ca(II)channel L-type, HB-EGF(mature), CaMK II delta, COX-2 (PTGS2), p130CAS, PKC-beta, ROCK, Calmodulin, PKC, Caveolin-1, ADAM17, p38 MAPK, mTOR",3.692E-03,7.339E-03,35,"TGF-beta 1, PLD1, ERK1/2, HTR2A, HB-EGF, c-Raf-1, G-protein alpha-q/11, MLCP (reg), PI3K reg class IA (p85), PLC-beta, CDK4, Adenylate cyclase, MEK1/2, AKT(PKB), c-Src, MLCP (cat), RhoA, JAK2, cPKC (conventional), PI3K cat class IA, EGFR, G-protein alpha-i family, HB-EGF(mature), CaMK II delta, STAT3, COX-2 (PTGS2), p130CAS, PKC-beta, ROCK, Calmodulin, PKC, Caveolin-1, ADAM17, p38 MAPK, mTOR",
845,Immune response_IL-13 signaling via JAK-STAT,44,3.720E-03,7.377E-03,6.537E-03,1.203E-02,24,"JAK1, CCL2, Tyk2, SOCS1, IL1RN, STAT1, IL13RA1, SPRR2B, IL-13, MMP-8, COL1A2, Eotaxin, UGRP2, JAK2, iNOS, RSNB, PKC-delta, IL-4R type II, Eotaxin-3, IL4RA, SCCA-1, SCCA-2, HSD3B1, STAT5",3.720E-03,7.377E-03,23,"JAK1, CCL2, Tyk2, SOCS1, IL1RN, STAT1, IL13RA1, SPRR2B, IL13RA2, MMP-8, COL1A2, Eotaxin, UGRP2, JAK2, iNOS, IL-4R type II, Eotaxin-3, IL4RA, SCCA-1, STAT3, SCCA-2, HSD3B1, STAT5",
846,Cigarette smoke components TCDD and Benzo[a]pyrene and receptor AHR signaling in lung epithelial cells,36,3.767E-03,7.404E-03,3.767E-03,7.404E-03,21,"TGF-beta 1, HYEP, CYP1B1, CYP1A1, CCL2, TGIF, SMAD4, SMAD2, AHR, IL-1 beta, TGF-alpha, TNF-alpha, ARNT, TGF-beta receptor type II, Uteroglobin, p300, COX-2 (PTGS2), AHR/ARNT complex, HDAC1, SMAD3, TGF-beta receptor type I",1.715E-02,2.806E-02,18,"TGF-beta 1, HYEP, CYP1B1, CYP1A1, CCL2, TGIF, SMAD4, SMAD2, AHR, IL-1 beta, TGF-alpha, TNF-alpha, TGF-beta receptor type II, p300, COX-2 (PTGS2), HDAC1, SMAD3, TGF-beta receptor type I",
847,Role of Leptin in regulation of eating behavior in obesity,23,3.772E-03,7.449E-03,2.938E-02,4.546E-02,13,"ERK1/2, FKHR, SOCS3, AKT(PKB), NF-kB p50/p65, POMC, JAK2, NPY, AMPK alpha subunit, AGRP, PTP-1B, Leptin receptor, mTOR",3.772E-03,7.449E-03,14,"ERK1/2, FKHR, SOCS3, AKT(PKB), NF-kB p50/p65, MEK1(MAP2K1), POMC, JAK2, NPY, AMPK alpha subunit, AGRP, Leptin receptor, STAT3, mTOR",
848,Inhibition of apoptosis in pancreatic cancer,59,3.950E-03,7.750E-03,1.867E-02,3.069E-02,29,"EG-VEGF, Apaf-1, Neuropilin-1, ERK1/2, 14-3-3, VEGF-A, BAD, PI3K reg class IA (p85), Bax, IKK-alpha, Casein kinase II, alpha chain (CSNK2A1), IL-6, Mucin 4, HMGI/Y, AKT(PKB), Progastrin, Mcl-1, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, G-protein alpha-i family, ALOX5, PGES, Caspase-9, COX-2 (PTGS2), PKR2, STAT5, p53",3.950E-03,7.750E-03,29,"EG-VEGF, Apaf-1, Neuropilin-1, ERK1/2, 14-3-3, VEGF-A, PI3K reg class IA (p85), Bax, Casein kinase II, alpha chain (CSNK2A1), IL-6, Mucin 4, HMGI/Y, AKT(PKB), Progastrin, Mcl-1, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, G-protein alpha-i family, ALOX5, PGES, Caspase-9, STAT3, COX-2 (PTGS2), PKR2, ALOX12, STAT5, p53",
849,Deregulation of PSD-95-dependent signaling in Huntington's disease,37,4.045E-03,7.915E-03,3.145E-02,4.816E-02,19,"ERK1/2, Bax, NR2, CREB1, MEK1/2, ERK2 (MAPK1), c-Src, RelA (p65 NF-kB subunit), B-Raf, ASK1 (MAP3K5), nNOS, NR2A, p90Rsk, NR2B, ATF-2, NR2D, PSD-95, p38 MAPK, BDNF",4.045E-03,7.915E-03,20,"p38alpha (MAPK14), ERK1/2, c-Raf-1, Bax, NR2, CREB1, MEK1/2, ERK2 (MAPK1), c-Src, RelA (p65 NF-kB subunit), B-Raf, ASK1 (MAP3K5), NR2A, nNOS, p90Rsk, NR2B, ATF-2, PSD-95, p38 MAPK, BDNF",
850,Th2 cell migration in asthma,34,4.081E-03,7.992E-03,4.081E-03,7.992E-03,20,"IL-16 mature, Histamine H4 receptor, alpha-4/beta-1 integrin, ICAM1, CD44, GRK3, PI3K cat class IB (p110-gamma), Beta-arrestin2, CD4, G-protein beta/gamma, Eotaxin, c-Src, VCAM1, Lck, PI3K reg class IA (p85-alpha), G-protein alpha-i family, PI3K cat class IA (p110-alpha), Beta-2 adrenergic receptor, PI3K reg class IB (p101), CCR4",8.318E-03,1.484E-02,18,"alpha-4/beta-1 integrin, ICAM1, CD44, GRK3, PI3K cat class IB (p110-gamma), Beta-arrestin2, CD4, G-protein beta/gamma, Eotaxin, c-Src, VCAM1, Lck, PI3K reg class IA (p85-alpha), CRTH2, G-protein alpha-i family, PI3K cat class IA (p110-alpha), Beta-2 adrenergic receptor, CCR4",
851,Cell adhesion_Gap junctions,30,4.139E-03,8.058E-03,1.297E-02,2.196E-02,17,"Connexin 26, Connexin 32, Connexin 50, Connexin 46, Actin, ZO-2, c-Src, Connexin 31, Tubulin (in microtubules), Tubulin beta, Connexin 37, ZO-1, Tubulin alpha, PKC, Connexin 36, Connexin 45, Caveolin-1",4.139E-03,8.058E-03,17,"Connexin 26, Connexin 50, Connexin 46, Actin, ZO-2, c-Src, Connexin 31, Tubulin (in microtubules), Tubulin beta, Connexin 37, ZO-1, Tubulin alpha, PKC, Connexin 43, Connexin 36, Connexin 45, Caveolin-1",
852,Development_Role of G-CSF in hematopoietic stem cell mobilization,21,4.262E-03,8.263E-03,3.251E-02,4.953E-02,12,"JAK1, ICAM1, C5a, DPP4, CXCR4, GFI-1, S1P1 receptor, Cathepsin G, Leukocyte elastase, Carboxypeptidase M, MMP-14, MMP-9",4.262E-03,8.263E-03,13,"JAK1, ICAM1, C5a, DPP4, CXCR4, GFI-1, S1P1 receptor, Cathepsin G, Leukocyte elastase, STAT3, Carboxypeptidase M, MMP-14, MMP-9",
853,Cell cycle_Role of Nek in cell cycle regulation,32,4.410E-03,8.613E-03,4.410E-03,8.613E-03,19,"Nek2A, IRS-1, MAD2a, RCC1, CDK1 (p34), NEK9, MAD1 (mitotic checkpoint), PI3K reg class IA, NEK7, Cyclin B1, TPX2, Tubulin (in microtubules), Tubulin beta, Tubulin gamma, PI3K cat class IA, Aurora-A, Tubulin alpha, NEK1, HEC",9.787E-03,1.719E-02,17,"Nek2A, MAD2a, RCC1, CDK1 (p34), NEK9, MAD1 (mitotic checkpoint), PI3K reg class IA, NEK7, Cyclin B1, TPX2, Tubulin (in microtubules), Tubulin beta, Tubulin gamma, PI3K cat class IA, Tubulin alpha, NEK1, HEC",
854,"Chemotaxis_CCL16-, CCL20-, CXCL16- and CCL25-mediated cell migration",43,4.432E-03,8.644E-03,4.432E-03,8.644E-03,24,"Histamine H4 receptor, CCL20, CCL25, PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, MMP-2, G-protein beta/gamma, CCR9, MMP-8, AKT(PKB), Stromelysin-1, MLCK, RhoA, MMP-13, PKC-delta, G-protein alpha-i family, CXCL16, ROCK, Calmodulin, MMP-11, MMP-10, PI3K reg class IB (p101), MMP-9",3.033E-02,4.709E-02,20,"CCL20, CCL25, PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, MMP-2, G-protein beta/gamma, MMP-8, AKT(PKB), Stromelysin-1, MLCK, RhoA, MMP-13, G-protein alpha-i family, CXCL16, ROCK, Calmodulin, MMP-11, MMP-10, MMP-9",
855,"Role of microRNAs in cell migration, survival and angiogenesis in colorectal cancer",67,4.459E-03,8.636E-03,1.567E-01,2.050E-01,28,"Fra-1, Neuropilin-1, SOCS1, VEGF-A, SMAD4, PP2A cat (alpha), UHRF2, MMP-2, PBX3, CDC42, AKT(PKB), Tiam1, PGE2R4, HIF1A, TGF-beta receptor type II, Thrombospondin 1, COX-2 (PTGS2), ELAVL1 (HuR), UFO, MMP-16, DNMT1, MMP-11, CTGF, SPRY2, FLI1, p53, HGF receptor (Met), MMP-9",4.459E-03,8.636E-03,32,"Fra-1, Neuropilin-1, SOCS1, VEGF-A, SMAD4, PP2A cat (alpha), miR-1-3p, UHRF2, MMP-2, PBX3, CDC42, AKT(PKB), Tiam1, PGE2R4, HIF1A, TGF-beta receptor type II, Thrombospondin 1, COX-2 (PTGS2), ELAVL1 (HuR), miR-139-5p, UFO, MMP-16, DNMT1, miR-320-3p, MMP-11, CTGF, SPRY2, FLI1, p53, HGF receptor (Met), miR-499-5p, MMP-9",
856,Development_Beta-adrenergic receptor-induced regulation of ERK,47,4.554E-03,8.795E-03,8.473E-03,1.527E-02,25,"CD44, Beta-3 adrenergic receptor, ERK1/2, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, Adenylate cyclase, MEK2(MAP2K2), G-protein beta/gamma, c-Src, PLC-epsilon, B-Raf, PKA-cat alpha, G-protein alpha-i family, c-Jun, SOS, PP2A catalytic, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PDZ-GEF1, PI3K reg class IB (p101), PKA-cat (cAMP-dependent), RAP-2B",4.554E-03,8.795E-03,24,"CD44, Beta-3 adrenergic receptor, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, Shc, Adenylate cyclase, MEK2(MAP2K2), G-protein beta/gamma, c-Src, PLC-epsilon, MEK1(MAP2K1), B-Raf, PKA-cat alpha, G-protein alpha-i family, SOS, PP2A catalytic, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PDZ-GEF1, PKA-cat (cAMP-dependent), RAP-2B",
857,Development_Non-genomic action of Retinoic acid in cell differentiation,57,4.635E-03,8.931E-03,3.841E-02,5.782E-02,27,"RARbeta, PI3K cat class IA (p110-beta), ERK1/2, VEGF-A, p90RSK2(RPS6KA3), VAV-1, Rac1, IP3 receptor, PI3K reg class IA (p85), Ryanodine receptor 1, CREB1, MEK1/2, AKT(PKB), c-Src, RhoA, PI3K reg class IA (p85-alpha), ROCK2, PKA-cat alpha, HIF1A, JNK1(MAPK8), p90Rsk, COX-2 (PTGS2), PKC-alpha, PLC-gamma, TGM2, p38gamma (MAPK12), PKA-cat (cAMP-dependent)",4.635E-03,8.931E-03,28,"RARbeta, PI3K cat class IA (p110-beta), ERK1/2, VEGF-A, p90RSK2(RPS6KA3), c-Raf-1, VAV-1, IP3 receptor, PI3K reg class IA (p85), Ryanodine receptor 1, CREB1, MEK1/2, AKT(PKB), c-Src, RhoA, PI3K reg class IA (p85-alpha), ROCK2, PKA-cat alpha, HIF1A, p90RSK1, JNK1(MAPK8), p90Rsk, COX-2 (PTGS2), PKC-alpha, PLC-gamma, TGM2, p38gamma (MAPK12), PKA-cat (cAMP-dependent)",
858,Influence of bone marrow cell environment on progression of multiple myeloma,52,4.636E-03,8.931E-03,9.596E-03,1.711E-02,27,"alpha-4/beta-1 integrin, CD44, VEGF-A, Fibronectin, PI3K cat class IB (p110-gamma), IP3 receptor, IL-1 beta, PI3K reg class IA, IL-6, CXCR4, TNF-alpha, HGF, ITGB1, PI3K cat class IA, VCAM1, PTCH1, alpha-5/beta-1 integrin, FGF2, Ihh, CD21, RHAMM, HAS1, PKC-alpha, PLC-gamma, HGF receptor (Met), PI3K reg class IB (p101), Collagen I",4.636E-03,8.931E-03,26,"alpha-4/beta-1 integrin, CD44, VEGF-A, Fibronectin, PI3K cat class IB (p110-gamma), IP3 receptor, IL-1 beta, PI3K reg class IA, IL-6, CXCR4, TNF-alpha, HGF, ITGB1, PI3K cat class IA, VCAM1, PTCH1, alpha-5/beta-1 integrin, FGF2, Ihh, CD21, RHAMM, HAS1, PKC-alpha, PLC-gamma, HGF receptor (Met), Collagen I",
859,Development_Schema: Adult neuron differentiation in the Subventricular and Subgranular Zones,35,4.733E-03,9.071E-03,6.406E-03,1.182E-02,20,"VMAT2, NCAM1, GFAP, WNT3A, Chordin-like 1, SLC17A7, Vimentin, SLC17A6, MAP2, Nestin, NT-3, GAD1, GDNF, Noggin, PROX1, WNT5A, GAD2, DLX2, BDNF, NEFH",4.733E-03,9.071E-03,19,"VMAT2, NCAM1, GFAP, Chordin-like 1, NEFM, SLC17A7, Vimentin, SLC17A6, MAP2, Nestin, GAD1, GDNF, Noggin, PROX1, WNT5A, GAD2, DLX2, BDNF, NEFH",
860,Cytoskeleton remodeling_RalA regulation pathway,30,4.749E-03,9.239E-03,4.749E-03,9.239E-03,18,"PLD1, AP complex 2 medium (mu) chain, Sec5, FPR, Rac1, Beta-arrestin2, RAP-1A, Sec6, Sec15B, CDC42, RGL, F-Actin cytoskeleton, Aurora-A, HSF1, Calmodulin, Filamin A, RalA, RalBP1",6.266E-02,8.998E-02,14,"PLD1, AP complex 2 medium (mu) chain, Sec5, FPR, Beta-arrestin2, RAP-1A, Sec6, Sec15B, CDC42, RGL, F-Actin cytoskeleton, Calmodulin, Filamin A, RalBP1",
861,Immune response_Innate immune response to RNA viral infection,28,4.801E-03,9.190E-03,1.426E-02,2.394E-02,16,"VISA, Caspase-8, IFN-beta, I-kB, MDA-5, IFN-alpha, RIPK1, NF-kB, RIG-I, TRAF3, IL-8, TANK, Caspase-10, IRF7, TLR7, TLR3",4.801E-03,9.190E-03,16,"VISA, Caspase-8, IFN-beta, I-kB, MDA-5, IFN-alpha, RIPK1, NF-kB, RIG-I, TRAF3, IL-8, TANK, Caspase-10, IRF7, TLR7, TLR3",
862,Transport_The role of AVP in regulation of Aquaporin 2 and renal water reabsorption,50,4.845E-03,9.401E-03,4.845E-03,9.401E-03,27,"ERK1/2, PKA-reg (cAMP-dependent), MYH9, RAP-1A, Ryanodine receptor 1, CREB1, Actin cytoskeletal, SPA1, Syntaxin 4, VAMP2, MLCK, ACTB, Adenylate cyclase type III, VAMP3, MRLC2, Myosin II, Non-muscle myosin IIA, Actin cytoplasmic 2, AKAP7 gamma, MyHC, Calmodulin, Annexin II, V2 receptor, MRLC, Tropomyosin-1, Aquaporin 2, PKA-cat (cAMP-dependent)",5.446E-03,1.023E-02,25,"p38alpha (MAPK14), ERK1/2, MYH9, RAP-1A, Ryanodine receptor 1, CREB1, Actin cytoskeletal, SPA1, VAMP2, MLCK, ACTB, Adenylate cyclase type III, VAMP3, MRLC2, AVP extracellular region, Myosin II, Non-muscle myosin IIA, Actin cytoplasmic 2, AKAP7 gamma, MyHC, Calmodulin, Annexin II, MRLC, Tropomyosin-1, PKA-cat (cAMP-dependent)",
863,Possible pathway of TGF-beta 1-dependent inhibition of CFTR expression,41,4.867E-03,9.407E-03,4.867E-03,9.407E-03,23,"TGF-beta 1, GADD45 beta, SMAD4, SMAD2, Rac1, Beta-arrestin2, TAK1(MAP3K7), MEKK4(MAP3K4), MLK3(MAP3K11), PI3K reg class IA (p85-alpha), SMAD7, TGF-beta receptor type II, TRAF6, MEK3(MAP2K3), TAB3, MEK4(MAP2K4), PI3K cat class IA (p110-alpha), MEKK1(MAP3K1), TAB1, Beta-2 adrenergic receptor, SMAD3, p38 MAPK, TGF-beta receptor type I",1.698E-02,2.783E-02,20,"TGF-beta 1, GADD45 beta, SMAD4, SMAD2, Beta-arrestin2, TAK1(MAP3K7), MLK3(MAP3K11), PI3K reg class IA (p85-alpha), SMAD7, TGF-beta receptor type II, TRAF6, MEK3(MAP2K3), CFTR, TAB3, MEK4(MAP2K4), PI3K cat class IA (p110-alpha), Beta-2 adrenergic receptor, SMAD3, p38 MAPK, TGF-beta receptor type I",
864,Apoptosis and survival_Phosphorylation and acetylation in TNF-alpha-induced NF-kB signaling,41,4.867E-03,9.407E-03,4.867E-03,9.407E-03,23,"CBP, ERK1/2, PKC-zeta, IP3 receptor, PI3K reg class IA (p85), IKK-alpha, RIPK1, DGK-alpha, NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, Sequestosome 1(p62), PI3K cat class IA, RelA (p65 NF-kB subunit), PKA-cat alpha, PKC-delta, NIK(MAP3K14), p300, PKC-alpha, PKC-lambda/iota, PLC-gamma 2, ADAM17",7.403E-03,1.337E-02,21,"p38alpha (MAPK14), CBP, ERK1/2, IP3 receptor, PI3K reg class IA (p85), RIPK1, DGK-alpha, NF-kB p50/p65, TNF-R1, c-Src, TNF-alpha, Sequestosome 1(p62), PI3K cat class IA, RelA (p65 NF-kB subunit), PKA-cat alpha, NIK(MAP3K14), p300, PKC-alpha, PKC-lambda/iota, PLC-gamma 2, ADAM17",
865,Cell adhesion_Role of CDK5 in cell adhesion,10,4.985E-03,9.623E-03,4.985E-03,9.623E-03,8,"CDK5R1 (p35), CDK5, Beta-catenin, Talin, c-Src, ITGB1, Tcf(Lef), Alpha-catenin",1.484E-02,2.486E-02,7,"CDK5R1 (p35), CDK5, Beta-catenin, Talin, c-Src, ITGB1, Tcf(Lef)",
866,Immune response_IL-4-responsive genes in type 2 immunity,70,5.043E-03,9.641E-03,7.178E-02,1.012E-01,31,"COL1A1, IL-31, c-Rel (NF-kB subunit), CCL2, IL-4R type I, IL-10, IL1RN, Fibronectin, STAT1, FKHR, IL-13, CREB1, COL1A2, Eotaxin, AKT(PKB), NF-kB p50/p65, P-selectin, PPAR-gamma, VCAM1, APRIL(TNFSF13), Eotaxin-2, IL-5, IL-4R type II, Eotaxin-3, IL4RA, NF-kB p50/RelB, CCL7, COX-2 (PTGS2), IGHG1, ACTA2, Elk-1",5.043E-03,9.641E-03,33,"COL1A1, c-Rel (NF-kB subunit), CCL2, IL-4R type I, IL-10, IL1RN, Fibronectin, STAT1, FKHR, CREB1, IL13RA2, COL1A2, Eotaxin, AKT(PKB), NF-kB p50/p65, P-selectin, PPAR-gamma, CD40L(TNFSF5), VCAM1, APRIL(TNFSF13), Eotaxin-2, IL-5, IL-4R type II, Eotaxin-3, IL4RA, NF-kB p50/RelB, CCL7, STAT3, COX-2 (PTGS2), IGHG1, ACTA2, IGHG3, Elk-1",
867,Role of nicotine in pathogenesis of SCLC,57,5.056E-03,9.747E-03,5.056E-03,9.747E-03,30,"HTR1D, ERK1/2, SLC21A2, EGR1, VEGF-A, GRP precursor, PLC-beta1, IP3 receptor, Bax, Survivin, CREB1, MEK1/2, AKT(PKB), Calpain 1(mu), c-Src, c-Myc, CXCR4, nAChR alpha-7, XIAP, FGF2, TBXA2R, Calpain 2(m), CXCR3, PCNA, GRP(1-27), PKC-alpha, PKC-lambda/iota, P/Q-type calcium channel alpha-1A subunit, THAS, N-type Ca(II) channel alpha1B",9.836E-03,1.724E-02,27,"HTR1D, ERK1/2, SLC21A2, VEGF-A, GRP precursor, c-Raf-1, IP3 receptor, Bax, Survivin, CREB1, MEK1/2, AKT(PKB), Calpain 1(mu), c-Src, CXCR4, nAChR alpha-7, XIAP, FGF2, TBXA2R, Calpain 2(m), PCNA, GRP(1-27), PKC-alpha, PKC-lambda/iota, P/Q-type calcium channel alpha-1A subunit, THAS, HTR1A",
868,Oxidative stress in adipocyte dysfunction in type 2 diabetes and metabolic syndrome X,64,5.113E-03,9.832E-03,5.113E-03,9.832E-03,33,"GPX3, NOX4, IRS-2, SOD2, CCL2, IRS-1, Xanthine oxidase, gp91-phox, GLUT4, p47-phox, PI3K reg class IA (p85), SOD1, IL-6, AKT(PKB), Catalase, TNF-alpha, Heme oxygenase 1, PI3K cat class IA, RelA (p65 NF-kB subunit), KEAP1, NF-kB1 (p50), Cytochrome b-558, p22-phox, AL3A2, APOE, JNK1(MAPK8), RAGE, NOX4/p22-phox, Small LDL, GPX1, PLA2, NRF2, PAI1",8.065E-03,1.442E-02,30,"NOX4, IRS-2, SOD2, CCL2, Xanthine oxidase, gp91-phox, p47-phox, PI3K reg class IA (p85), IL-6, AKT(PKB), Catalase, TNF-alpha, Heme oxygenase 1, A-FABP, PI3K cat class IA, RelA (p65 NF-kB subunit), KEAP1, NF-kB1 (p50), Cytochrome b-558, p22-phox, APOE, p67-phox, JNK1(MAPK8), RAGE, NOX4/p22-phox, Small LDL, GPX1, PLA2, NRF2, PAI1",
869,Development_FGF2-induced self-renewal of adult neural stem cells,40,5.125E-03,9.760E-03,1.821E-02,3.000E-02,21,"NOTCH1 receptor, ERK1/2, Syndecan-4, IP3 receptor, Cyclin D2, Shc, PI3K reg class IA, PLC-gamma 1, CREB1, NeuroD1, AKT(PKB), MBD1, PI3K cat class IA, FGF2, SOS, PKC, HES1, SHP-2, Jagged1, Syndecan-2, Syndecan-3",5.125E-03,9.760E-03,21,"NOTCH1 receptor, ERK1/2, Syndecan-4, c-Raf-1, IP3 receptor, Cyclin D2, Shc, PI3K reg class IA, PLC-gamma 1, CREB1, NeuroD1, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, FGF2, SOS, PKC, HES1, Jagged1, Syndecan-2, Syndecan-3",
870,Development_FGF10 in development of subcutaneous white adipose tissue in embryogenesis,17,5.297E-03,1.004E-02,1.021E-01,1.391E-01,9,"FGFR2, ERK1/2, Cyclin D2, Shc, MEK2(MAP2K2), PPAR-gamma, C/EBPbeta, c-Jun, SOS",5.297E-03,1.004E-02,11,"FGFR2, ERK1/2, c-Raf-1, Cyclin D2, Shc, MEK2(MAP2K2), PPAR-gamma, MEK1(MAP2K1), A-FABP, C/EBPbeta, SOS",
871,DeltaF508-CFTR traffic / ER-to-Golgi in CF,17,5.297E-03,1.004E-02,1.021E-01,1.391E-01,9,"PIST (CAL), Ubiquitin, Sec31, Sec23, Syntaxin 6, Sec24, PREB, SEC13L, TC10",5.297E-03,1.004E-02,11,"PIST (CAL), Ubiquitin, Sec31, Sec23, Syntaxin 6, CFTR, MAST205, Sec24, PREB, SEC13L, TC10",
872,wtCFTR traffic / ER-to-Golgi (normal),17,5.297E-03,1.004E-02,1.021E-01,1.391E-01,9,"PIST (CAL), Ubiquitin, Sec31, Sec23, Syntaxin 6, Sec24, PREB, SEC13L, TC10",5.297E-03,1.004E-02,11,"PIST (CAL), Ubiquitin, Sec31, Sec23, Syntaxin 6, CFTR, MAST205, Sec24, PREB, SEC13L, TC10",
873,Aberrant lipid trafficking and metabolism in age-related macular degeneration pathogenesis,60,5.358E-03,1.009E-02,1.785E-01,2.296E-01,25,"CYP27A1, C/EBP zeta, BACE1, Apaf-1, APP-C99, APP, PI3K reg class IA (p85), LDLR, Caspase-3, APOB, LDL, ABCA1, PPAR-gamma, TNF-alpha, SR-BI, APOE, Caspase-9, LAMP1, PI3K cat class IA (p110-alpha), Rab-5A, Caspase-12, CRP, HDL, TLR2, Amyloid beta 42",5.358E-03,1.009E-02,29,"CYP27A1, C/EBP zeta, BACE1, Apaf-1, IFN-gamma, APP-C99, IL-17, APP, PI3K reg class IA (p85), LDLR, Caspase-3, APOB, LDL, ABCA1, PPAR-gamma, TNF-alpha, APCS, SR-BI, APOE, Caspase-9, LAMP1, PI3K cat class IA (p110-alpha), Rab-5A, Caspase-12, CRP, HDL, miR-33b-5p, TLR2, Amyloid beta 42",
874,Development_Thyroliberin signaling,60,5.358E-03,1.009E-02,6.301E-03,1.167E-02,31,"CBP, ERK1/2, PKA-reg (cAMP-dependent), G-protein beta4/gamma2, G-protein alpha-q/11, PKC-epsilon, G-protein alpha-i2, PLC-beta1, IP3 receptor, Shc, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, TRH receptor, c-Src, RGS4, G-protein beta2/gamma2, PKC-delta, ETS1, SP3, SOS, nNOS, PKC-beta, Calmodulin, PKC-alpha, CaMK II alpha, G-protein alpha-q, Elk-1, PKA-cat (cAMP-dependent), Prolactin",5.358E-03,1.009E-02,29,"CBP, ERK1/2, c-Raf-1, G-protein beta4/gamma2, G-protein alpha-q/11, PKC-epsilon, G-protein alpha-i2, IP3 receptor, Shc, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, TRH receptor, c-Src, MEK1(MAP2K1), RGS4, G-protein beta2/gamma2, ETS1, SP3, SOS, nNOS, PKC-beta, Calmodulin, PKC-alpha, CaMK II alpha, Elk-1, PKA-cat (cAMP-dependent), Prolactin",
875,Hedgehog signaling in prostate cancer,26,5.433E-03,1.034E-02,5.433E-03,1.034E-02,16,"IBP6, KIF27, Smoothened, GLI-2, IGF-2, Nestin, HSP90, c-Myc, PTCH1, Stathmin, Ihh, GLI-3, Perlecan, SNAIL1, GLI-1, CDC37",5.560E-03,1.038E-02,15,"IBP6, Smoothened, GLI-2, IGF-2, Nestin, HSP90, PTCH1, Stathmin, Ihh, GLI-3, Perlecan, HIP, SNAIL1, GLI-1, CDC37",
876,Muscle contraction_Delta-type opioid receptor in smooth muscle contraction,26,5.433E-03,1.034E-02,5.433E-03,1.034E-02,16,"PI3K cat class IB (p110-gamma), IP3 receptor, MLCP (reg), G-protein beta/gamma, Leu-enkephalin, MLCP (cat), Metenkefalin, Delta-type opioid receptor, G-protein alpha-i family, MYRL2, Myosin II, CPI-17, MRLC, PLC-delta 1, PI3K reg class IB (p101), PLC-beta3",1.601E-02,2.657E-02,14,"PI3K cat class IB (p110-gamma), IP3 receptor, MLCP (reg), G-protein beta/gamma, Leu-enkephalin, MLCP (cat), Metenkefalin, G-protein alpha-i family, MYRL2, Myosin II, CPI-17, MRLC, PLC-delta 1, PLC-beta3",
877,Cell adhesion_Endothelial cell contacts by junctional mechanisms,26,5.433E-03,1.034E-02,5.433E-03,1.034E-02,16,"VE-cadherin, JAM2, Beta-catenin, Alpha-actinin, Vimentin, Claudin-1, ZO-2, RAP-1A, MAGI-1(BAIAP1), Desmoplakin, Actin cytoskeletal, Connexin 37, N-cadherin, ZO-1, Alpha-catenin, p120-catenin",1.601E-02,2.657E-02,14,"VE-cadherin, Beta-catenin, Alpha-actinin, Vimentin, Claudin-1, ZO-2, RAP-1A, MAGI-1(BAIAP1), Desmoplakin, Actin cytoskeletal, Connexin 37, N-cadherin, ZO-1, Connexin 43",
878,Proteases and EGFR-induced mucin synthesis in normal and asthmatic epithelium,55,5.440E-03,1.023E-02,1.178E-02,2.022E-02,28,"ICAM1, CD44, PAR2, ERK1/2, G-protein alpha-q/11, HNF3-beta, p47-phox, IP3 receptor, HAT, PLC-beta, GM-CSF, CREB1, TGF-alpha, NF-kB, TNF-alpha, HIF1A, PKC-delta, EGFR, IL-5, SP3, Leukocyte elastase, DUOX1, PKC-beta, PKC-alpha, PLC-gamma, Fibrinogen (fibrin), Kallikrein 1, ADAM17",5.440E-03,1.023E-02,27,"ICAM1, CD44, PAR2, ERK1/2, G-protein alpha-q/11, HNF3-beta, p47-phox, IP3 receptor, HAT, PLC-beta, GM-CSF, CREB1, TGF-alpha, NF-kB, TNF-alpha, HIF1A, EGFR, IL-5, SP3, Leukocyte elastase, p90RSK1, p67-phox, DUOX1, PKC-beta, PKC-alpha, PLC-gamma, ADAM17",
879,Neurophysiological process_Dopamine D2 receptor transactivation of PDGFR in CNS,26,5.560E-03,1.038E-02,1.565E-02,2.618E-02,15,"PP2A regulatory, IP3 receptor, PLC-gamma 1, PP2A structural, G-protein beta/gamma, Striatin, PDGF receptor, c-Src, Dopamine D2 receptor, G-protein alpha-i family, PP2A catalytic, NR2B, Calmodulin, PKC, PDGF-R-beta",5.560E-03,1.038E-02,15,"PP2A regulatory, IP3 receptor, PLC-gamma 1, PP2A structural, G-protein beta/gamma, Striatin, PDGF receptor, c-Src, Dopamine D2 receptor, G-protein alpha-i family, PP2A catalytic, NR2B, Calmodulin, PKC, PDGF-R-beta",
880,CAR signaling via cross-talk / Human Version,26,5.560E-03,1.038E-02,8.605E-02,1.196E-01,13,"GCR, ECHP, PPAR-alpha, FKHR, PPARGC1 (PGC1-alpha), INSIG1, NCOA2 (GRIP1/TIF2), CYP2B6, PPCKC, CYP2C9, CYP7A1, NCOA1 (SRC1), HNF4-alpha",5.560E-03,1.038E-02,15,"CYP2C8, GCR, ECHP, PPAR-alpha, FKHR, PPARGC1 (PGC1-alpha), INSIG1, CYP3A4, G6PT, NCOA2 (GRIP1/TIF2), PPCKC, CYP2C9, CYP7A1, NCOA1 (SRC1), HNF4-alpha",
881,Prolactin/ JAK2 signaling in breast cancer,24,5.757E-03,1.093E-02,5.757E-03,1.093E-02,15,"SPHK1, STAT5A, JAK1, STAT5B, STAT1, GSK3 beta, c-Src, PKM2, JAK2, Cyclophilin A, Bcl-6, SK4/IK1, SHP-2, STAT5, Prolactin",6.428E-03,1.180E-02,14,"SPHK1, STAT5A, JAK1, STAT5B, STAT1, GSK3 beta, c-Src, PKM2, JAK2, Bcl-6, SK4/IK1, STAT3, STAT5, Prolactin",
882,Immune response_Regulatory role of C1q in platelet activation,15,5.784E-03,1.077E-02,1.290E-02,2.186E-02,10,"C3b, PSGL-1, P-selectin, GC1QBP, Fc gamma RII alpha, Collagen III, PKC, CRP, alpha-2/beta-1 integrin, Collagen I",5.784E-03,1.077E-02,10,"C3b, PSGL-1, P-selectin, GC1QBP, Fc gamma RII alpha, Collagen III, PKC, CRP, alpha-2/beta-1 integrin, Collagen I",
883,Stem cells_Aberrant Hedgehog signaling in medulloblastoma stem cells,15,5.784E-03,1.077E-02,1.290E-02,2.186E-02,10,"PTCH2, Smoothened, GLI-2, Cyclin D2, IGF-2, KCTD11, PTCH1, ZIC1, GLI-1, SFRP1",5.784E-03,1.077E-02,10,"PTCH2, Smoothened, GLI-2, Cyclin D2, IGF-2, KCTD11, PTCH1, ZIC1, GLI-1, SFRP1",
884,Transport_Macropinocytosis,12,5.814E-03,1.102E-02,5.814E-03,1.102E-02,9,"ANKFY1, SNX5, Rab-7, Actin cytoskeletal, Tubulin (in microtubules), SNX1, LAMP1, Rab-5A, Rab-34",5.199E-02,7.620E-02,7,"ANKFY1, SNX5, Actin cytoskeletal, Tubulin (in microtubules), LAMP1, Rab-5A, Rab-34",
885,Immune response_Inhibitory action of Lipoxins on pro-inflammatory TNF-alpha signaling,46,5.917E-03,1.120E-02,5.917E-03,1.120E-02,25,"TNF-R2, PLD1, JAK1, SOCS1, 14-3-3, PKC-zeta, IL-1 beta, I-kB, PI3K reg class IA (p85), FKHR, IKK-alpha, RIPK1, IL-6, AKT(PKB), NF-kB p50/p65, TNF-R1, TNF-alpha, FPRL1, PI3K cat class IA, IL-8, PPAPDC2, NIK(MAP3K14), CDK2, Cyclin E, SHP-2",7.530E-03,1.350E-02,23,"TNF-R2, PLD1, JAK1, SOCS1, 14-3-3, IL-1 beta, I-kB, PI3K reg class IA (p85), FKHR, RIPK1, IL-6, AKT(PKB), NF-kB p50/p65, TNF-R1, TNF-alpha, FPRL1, PI3K cat class IA, IL-8, PPAPDC2, NIK(MAP3K14), CDK2, STAT3, Cyclin E",
886,Insulin-like growth factor family signaling in melanoma,38,6.019E-03,1.116E-02,8.799E-03,1.582E-02,21,"IRS-1, ERK1/2, Beta-catenin, VEGF-A, Beta-arrestin2, IBP3, GSK3 beta, PI3K reg class IA, PLC-gamma 1, IGF-2, AKT(PKB), PI3K cat class IA, IL-8, c-Jun, PKC, Cyclin E, ATM, PLC-gamma, Cyclin A, p53, p38 MAPK",6.019E-03,1.116E-02,20,"ERK1/2, Beta-catenin, VEGF-A, Beta-arrestin2, IBP3, GSK3 beta, PI3K reg class IA, PLC-gamma 1, IGF-2, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, IL-8, PKC, Cyclin E, ATM, PLC-gamma, Cyclin A, p53, p38 MAPK",
887,Transition of Monoclonal gammopathy of undetermined significance to active multiple myeloma (schema),22,6.049E-03,1.138E-02,6.049E-03,1.138E-02,14,"NCAM1, Cyclin D3, RANKL(TNFSF11), Cyclin D2, MMP-2, TRF2, Osteoprotegerin, p16INK4, Ig light chain, WHSC1, c-Maf, p15, MMP-9, Tankyrase 1",2.232E-02,3.596E-02,12,"NCAM1, RANKL(TNFSF11), Cyclin D2, MMP-2, TRF2, Osteoprotegerin, p16INK4, WHSC1, c-Maf, p15, MMP-9, Tankyrase 1",
888,Development_Generation of pancreatic beta-cells from embryonic stem cells (late stages),22,6.049E-03,1.138E-02,6.049E-03,1.138E-02,14,"GLUT2, Nkx6.1, BMP4, PAX4, HNF3-beta, PAX6, IGF-2, NeuroD1, Nkx2.2, SOX9, HGF, Pdx-1 (IPF1), FGF2, Betacellulin",7.411E-03,1.337E-02,13,"GLUT2, Nkx6.1, BMP4, PAX4, HNF3-beta, PAX6, IGF-2, NeuroD1, SOX9, HGF, Pdx-1 (IPF1), FGF2, Betacellulin",
889,Microsatellite instability in gastric cancer,22,6.049E-03,1.138E-02,6.049E-03,1.138E-02,14,"EXO1, DNA polymerase eta, MSH6, Bax, RFC complex, p16INK4, PMS1, MutSalpha complex, MSH3, TGF-beta receptor type II, IGF-2 receptor, MutSbeta complex, PCNA, MSH2",5.730E-02,8.309E-02,11,"EXO1, DNA polymerase eta, MSH6, Bax, p16INK4, PMS1, MutSalpha complex, TGF-beta receptor type II, IGF-2 receptor, PCNA, MSH2",
890,Role of Huntingtin in regulation of BDNF in Huntington's disease,22,6.049E-03,1.138E-02,6.049E-03,1.138E-02,14,"CBP, Calcineurin A (catalytic), DCTN1(p150Glued), Hap-1, PI3K reg class IA, NRSF, CREB1, AKT(PKB), PI3K cat class IA, RelA (p65 NF-kB subunit), Calcipressin 1, PSD-95, Kinesin light chain, BDNF",2.232E-02,3.596E-02,12,"CBP, Calcineurin A (catalytic), DCTN1(p150Glued), PI3K reg class IA, CREB1, AKT(PKB), PI3K cat class IA, RelA (p65 NF-kB subunit), Calcipressin 1, PSD-95, Kinesin light chain, BDNF",
891,Development_H3K9 demethylases in pluripotency maintenance of stem cells,22,6.049E-03,1.138E-02,6.049E-03,1.138E-02,14,"Oct-3/4, MSX1, HP1, ZFP57, FGF5, RING2, AKT(PKB), GASC1, GATA-6, CDX2, T brachyury protein, JMJD1A, G9a, LBP9",7.411E-03,1.337E-02,13,"Oct-3/4, MSX1, HP1, ZFP57, FGF5, RING2, AKT(PKB), GASC1, GATA-6, CDX2, JMJD1A, G9a, LBP9",
892,Degranulation of lung mast cells,63,6.113E-03,1.132E-02,1.507E-02,2.524E-02,31,"Beta-hexosaminidase, STIM1, C5a, c-Kit, VAV-1, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, PI3K reg class IA (p85), PLC-gamma 1, Chymase, Urocortin, G-protein beta/gamma, Fyn, Neurokinin-2 receptor, GAB2, PGE2R2, cPKC (conventional), PTAFR, PI3K cat class IA, Slp76, Lyn, G-protein alpha-i family, Substance P receptor, Tryptase, SK4/IK1, Bradykinin, P2Y1, Beta-2 adrenergic receptor, Calcineurin B (regulatory), PLC-beta2",6.113E-03,1.132E-02,30,"Beta-hexosaminidase, STIM1, C5a, c-Kit, VAV-1, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, PI3K reg class IA (p85), PLC-gamma 1, Urocortin, G-protein beta/gamma, Fyn, Neurokinin-2 receptor, GAB2, PGE2R2, cPKC (conventional), PTAFR, PI3K cat class IA, Slp76, Lyn, G-protein alpha-i family, Substance P receptor, Tryptase, SK4/IK1, P2Y1, CRHR1, Beta-2 adrenergic receptor, Calcineurin B (regulatory), PLC-beta2",
893,"Development_Insulin, IGF-1 and TNF-alpha in brown adipocyte differentiation",53,6.213E-03,1.166E-02,6.213E-03,1.166E-02,28,"COX II, IRS-2, Beta-3 adrenergic receptor, PI3K cat class IA (p110-beta), IRS-1, PPAR-alpha, ERK1/2, FOXC2, GLUT4, PRKAR1A, UCP1, FKHR, CREB1, PPARGC1 (PGC1-alpha), AKT(PKB), INSIG1, TNF-R1, PPAR-gamma, TNF-alpha, G3P2, PI3K reg class IA (p85-alpha), C/EBPbeta, AKT2, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent), mTOR, C/EBPdelta",1.353E-02,2.307E-02,25,"COX II, IRS-2, Beta-3 adrenergic receptor, PI3K cat class IA (p110-beta), PPAR-alpha, ERK1/2, FOXC2, UCP1, FKHR, CREB1, PPARGC1 (PGC1-alpha), AKT(PKB), INSIG1, TNF-R1, PPAR-gamma, TNF-alpha, MEK1(MAP2K1), A-FABP, PI3K reg class IA (p85-alpha), C/EBPbeta, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent), mTOR, C/EBPdelta",
894,Asthma-specific pathways of airway smooth muscle cell proliferation,14,6.268E-03,1.167E-02,6.268E-03,1.167E-02,10,"NRF1, GCR, eIF4E, CaMK IV, Calreticulin, Ca-ATPase2, CREB1, PPARGC1 (PGC1-alpha), TFAM, Calmodulin",4.385E-02,6.561E-02,8,"NRF1, GCR, CaMK IV, Calreticulin, Ca-ATPase2, CREB1, PPARGC1 (PGC1-alpha), Calmodulin",
895,IL-6 signaling in tumor-associated monocytes/macrophages in breast cancer,14,6.268E-03,1.167E-02,6.268E-03,1.167E-02,10,"TGF-beta 1, JAK1, Fra-1, VEGF-A, IL-6, JAK2, c-Jun, c-Jun/Fra-1, Cathepsin B, MMP-9",1.243E-02,2.127E-02,9,"TGF-beta 1, JAK1, Fra-1, VEGF-A, IL-6, JAK2, Cathepsin B, STAT3, MMP-9",
896,Regulation of caspase activity in Huntington's disease,20,6.286E-03,1.167E-02,6.286E-03,1.167E-02,13,"Calcineurin A (catalytic), Caspase-6, Apaf-1, Caspase-3, Caspase-2, HSP40, HSP90, HSP70, Caspase-1, HIP1, Caspase-9, Caspase-12, Calcineurin B (regulatory)",8.516E-03,1.517E-02,12,"Calcineurin A (catalytic), Caspase-6, Apaf-1, Caspase-3, Caspase-2, HSP90, HSP70, Caspase-1, HIP1, Caspase-9, Caspase-12, Calcineurin B (regulatory)",
897,Translation_Non-genomic (rapid) action of Androgen Receptor,43,6.292E-03,1.161E-02,2.255E-02,3.597E-02,22,"IRS-1, HB-EGF, Beta-catenin, Dsh, Shc, GSK3 beta, NF-kB, ERK2 (MAPK1), AKT(PKB), c-Src, PI3K reg class IA (p85-alpha), Tcf(Lef), EGFR, SOS, 4E-BP1, PI3K cat class IA (p110-alpha), WNT, FOXO3A, SRD5A1, Caveolin-1, Frizzled, mTOR",6.292E-03,1.161E-02,22,"Neuregulin 1, HB-EGF, Beta-catenin, c-Raf-1, Dsh, Shc, GSK3 beta, NF-kB, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), PI3K reg class IA (p85-alpha), Tcf(Lef), EGFR, SOS, PI3K cat class IA (p110-alpha), WNT, SRD5A1, Caveolin-1, Frizzled, mTOR",
898,Development_EPO-induced PI3K/AKT pathway and Ca(2+) influx,43,6.292E-03,1.161E-02,1.043E-02,1.826E-02,23,"IRS-2, HBZ, G-protein alpha-i2, VAV-1, Rac1, IP3 receptor, Syk, Shc, PI3K reg class IA (p85), PLC-gamma 1, SHIP, AKT(PKB), IP3R2, GAB2, JAK2, PI3K cat class IA, c-Cbl, HBB, Lyn, Alpha1-globin, TRPC3, HBG1, PLC-gamma",6.292E-03,1.161E-02,22,"IRS-2, GATA-1, HBZ, G-protein alpha-i2, VAV-1, IP3 receptor, Syk, Shc, PI3K reg class IA (p85), PLC-gamma 1, AKT(PKB), IP3R2, GAB2, JAK2, PI3K cat class IA, c-Cbl, HBB, Lyn, Alpha1-globin, TRPC3, HBG1, PLC-gamma",
899,Immune response_LTBR1 signaling,60,6.301E-03,1.167E-02,6.301E-03,1.167E-02,31,"CRM1, ERK1/2, G-protein alpha-q/11, PI3K cat class IB (p110-gamma), p47-phox, Rac1, IP3 receptor, Syk, RAP-1A, I-kB, PLC-beta, IKK-alpha, Adenylate cyclase, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, PI3K cat class IA, AUF1, G-protein alpha-15, iNOS, PKC-delta, G-protein alpha-i family, YES, nNOS, COX-2 (PTGS2), Calmodulin, PKC, JNK(MAPK8-10), PI3K reg class IB (p101), PLC-beta2",1.104E-02,1.911E-02,28,"CRM1, ERK1/2, c-Raf-1, G-protein alpha-q/11, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, Syk, RAP-1A, I-kB, PLC-beta, Adenylate cyclase, MEK1/2, G-protein beta/gamma, AKT(PKB), NF-kB p50/p65, PI3K cat class IA, AUF1, G-protein alpha-15, iNOS, G-protein alpha-i family, YES, nNOS, COX-2 (PTGS2), Calmodulin, PKC, JNK(MAPK8-10), PLC-beta2",
900,Non-genomic signaling of ESR2 (membrane) in lung cancer cells,53,6.388E-03,1.176E-02,2.585E-02,4.049E-02,26,"ERK1/2, HB-EGF, VEGF-A, PKA-reg (cAMP-dependent), Shc, PI3K reg class IA (p85), N-Ras, Adenylate cyclase, MEK2(MAP2K2), CYP19, CREB1, TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Src, nAChR alpha-7, PI3K cat class IA, EGFR, G-protein alpha-i family, SOS, HB-EGF(mature), Beta-1 adrenergic receptor, Caveolin-1, ADAM17, Elk-1, PKA-cat (cAMP-dependent)",6.388E-03,1.176E-02,26,"ERK1/2, HB-EGF, VEGF-A, c-Raf-1, Shc, PI3K reg class IA (p85), N-Ras, Adenylate cyclase, MEK2(MAP2K2), CREB1, TGF-alpha, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), nAChR alpha-7, PI3K cat class IA, EGFR, G-protein alpha-i family, SOS, HB-EGF(mature), Beta-1 adrenergic receptor, Caveolin-1, ADAM17, Elk-1, PKA-cat (cAMP-dependent)",
901,Development_Signaling of Beta-adrenergic receptors via Beta-arrestins,24,6.428E-03,1.180E-02,9.728E-02,1.334E-01,12,"GRK6, ERK1/2, GRK3, Beta-arrestin2, Shc, MEK2(MAP2K2), c-Src, SOS, GRK5, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",6.428E-03,1.180E-02,14,"GRK6, ERK1/2, c-Raf-1, GRK3, Beta-arrestin2, Shc, MEK2(MAP2K2), c-Src, MEK1(MAP2K1), SOS, GRK5, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",
902,Development_FGF and BMP signaling in early embryonic hepatogenesis,31,6.481E-03,1.187E-02,1.945E-02,3.184E-02,17,"BMP receptor 2, BMP4, HNF1-alpha, ERK1/2, FGF1, SMAD4, HNF3-beta, MEK2(MAP2K2), Pdx-1 (IPF1), FGF2, SOS, HHEX (PRH), SHP-2, BMPR1A, SMAD1, HNF4-alpha, BMP2",6.481E-03,1.187E-02,17,"BMP receptor 2, BMP4, ERK1/2, FGF1, c-Raf-1, SMAD4, HNF3-beta, MEK2(MAP2K2), AFP, MEK1(MAP2K1), Pdx-1 (IPF1), FGF2, SOS, HHEX (PRH), BMPR1A, HNF4-alpha, BMP2",
903,Development_Transactivation of PDGFR in non-neuronal cells by Dopamine D2 receptor,31,6.481E-03,1.187E-02,8.978E-02,1.245E-01,15,"PKC-epsilon, IP3 receptor, Shc, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), PDGF receptor, c-Src, Dopamine D2 receptor, PI3K cat class IA, G-protein alpha-i family, SOS, PDGF-R-beta",6.481E-03,1.187E-02,17,"c-Raf-1, PKC-epsilon, IP3 receptor, Shc, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), PDGF receptor, c-Src, Dopamine D2 receptor, MEK1(MAP2K1), PI3K cat class IA, G-protein alpha-i family, SOS, PDGF-R-beta",
904,Regulation of lipid metabolism_Stimulation of Arachidonic acid production by ACM receptors,72,6.740E-03,1.239E-02,6.740E-03,1.239E-02,36,"PLD1, alphaAPPs, BACE1, ERK1/2, ARHGEF1 (p115RhoGEF), APP, LPP2, PLC-beta1, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, betaAPPs, ADAM9, cPLA2, G-protein beta/gamma, CDC42, ACM5, ADAM10, LPP1, c-Src, LPP3, BETA-PIX, RhoA, Pyk2(FAK2), ACM2, MEK3(MAP2K3), G-protein alpha-i3, PLD2, ACM3, Calmodulin, PKC, MEKK1(MAP3K1), PKC-alpha, G-protein alpha-q, ADAM17, p38 MAPK",1.600E-02,2.657E-02,32,"PLD1, alphaAPPs, BACE1, ERK1/2, ARHGEF1 (p115RhoGEF), c-Raf-1, APP, LPP2, PI3K cat class IB (p110-gamma), IP3 receptor, betaAPPs, ADAM9, cPLA2, G-protein beta/gamma, CDC42, ACM5, ADAM10, LPP1, c-Src, LPP3, MEK1(MAP2K1), RhoA, Pyk2(FAK2), MEK3(MAP2K3), G-protein alpha-i3, PLD2, ACM3, Calmodulin, PKC, PKC-alpha, ADAM17, p38 MAPK",
905,G-protein signaling_N-RAS regulation pathway,33,7.002E-03,1.281E-02,7.002E-03,1.281E-02,19,"MHC class II, A-Raf-1, IP3 receptor, Shc, ZAP70, PLC-gamma 1, N-Ras, CD4, Lck, B-Raf, CALDAG-GEFI, EGFR, SOS, LAT, ICMT, RGL1, CD3, CD3 zeta, RASGRF1",3.316E-02,5.089E-02,16,"MHC class II, c-Raf-1, IP3 receptor, Shc, PLC-gamma 1, N-Ras, CD4, Lck, B-Raf, EGFR, SOS, ICMT, RGL1, CD3, CD3 zeta, RASGRF1",
906,IL-2 as a growth factor for T cells in multiple sclerosis,33,7.002E-03,1.281E-02,7.002E-03,1.281E-02,19,"STAT5A, Cyclin D3, Cyclin D2, PI3K reg class IA (p85), GSK3 beta, CDK4, FKHR, CREB1, NF-kB, AKT(PKB), c-Myc, IL-2, PI3K cat class IA, JAK3, CDK2, PCNA, Cyclin E, FOXO3A, mTOR",3.316E-02,5.089E-02,16,"STAT5A, Cyclin D2, PI3K reg class IA (p85), GSK3 beta, CDK4, FKHR, CREB1, NF-kB, AKT(PKB), IL-2, PI3K cat class IA, JAK3, CDK2, PCNA, Cyclin E, mTOR",
907,PR action in breast cancer: stimulation of cell growth and proliferation,36,7.074E-03,1.293E-02,4.776E-02,7.012E-02,18,"STAT5A, JAK1, ERK1/2, HB-EGF, Shc, MMP-2, MEK1/2, c-Src, c-Myc, JAK2, EGFR, SOS, WNT1, CDK2, Cyclin E, Cyclin A, NCOA1 (SRC1), MMP-9",7.074E-03,1.293E-02,19,"STAT5A, JAK1, Neuregulin 1, ERK1/2, HB-EGF, c-Raf-1, Shc, MMP-2, MEK1/2, c-Src, JAK2, EGFR, SOS, CDK2, STAT3, Cyclin E, Cyclin A, NCOA1 (SRC1), MMP-9",
908,Immune response_Neurotensin-induced activation of IL-8 in colonocytes,41,7.403E-03,1.337E-02,1.157E-02,1.994E-02,22,"PLC-beta1, Rac1, IP3 receptor, I-kB, Shc, MEK2(MAP2K2), G-protein beta/gamma, CDC42, NF-kB, ERK2 (MAPK1), c-Src, Pyk2(FAK2), GEFT, RelA (p65 NF-kB subunit), IL-8, G-protein alpha-i family, SOS, NIK(MAP3K14), Calmodulin, PKC-alpha, NT, G-protein alpha-q",7.403E-03,1.337E-02,21,"c-Raf-1, IP3 receptor, I-kB, Shc, MEK2(MAP2K2), G-protein beta/gamma, CDC42, NF-kB, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), Pyk2(FAK2), GEFT, RelA (p65 NF-kB subunit), IL-8, G-protein alpha-i family, SOS, NIK(MAP3K14), Calmodulin, PKC-alpha, NT",
909,Immune response_TLR2-induced platelet activation,41,7.403E-03,1.337E-02,1.157E-02,1.994E-02,22,"TLR1, ERK1/2, SLC21A2, IP3 receptor, IL-1 beta, PI3K reg class IA (p85), PLC-beta, alpha-IIb/beta-3 integrin, cPLA2, AKT(PKB), PPBP, P-selectin, PI3K cat class IA, TBXA2R, PKC-alpha, P2X1, PLC-gamma, P2Y1, G-protein alpha-q, PF4, p38 MAPK, TLR2",7.403E-03,1.337E-02,21,"TLR1, ERK1/2, SLC21A2, IP3 receptor, IL-1 beta, PI3K reg class IA (p85), PLC-beta, alpha-IIb/beta-3 integrin, cPLA2, AKT(PKB), PPBP, P-selectin, PI3K cat class IA, TBXA2R, PKC-alpha, P2X1, PLC-gamma, P2Y1, PF4, p38 MAPK, TLR2",
910,PXR signaling via cross-talk / Rodent version,22,7.411E-03,1.337E-02,1.102E-01,1.491E-01,11,"GCR, HNF3-beta, FKHR, CREB1, PPARGC1 (PGC1-alpha), PPAR-gamma, PPCKC, SULT2A1, CYP2C9, CYP7A1, HNF4-alpha",7.411E-03,1.337E-02,13,"CYP2C8, GCR, HNF3-beta, FKHR, CREB1, PPARGC1 (PGC1-alpha), PPAR-gamma, G6PT, PPCKC, SULT2A1, CYP2C9, CYP7A1, HNF4-alpha",
911,Development_Dopamine-induced expression of CNTF in adult neurogenesis,22,7.411E-03,1.337E-02,4.908E-02,7.156E-02,12,"NOTCH1 receptor, GFAP, JAK1, CNTF, STAT1, Dopamine D2 receptor, JAK2, CNTFR alpha, G-protein alpha-i family, NOTCH1 precursor, LIFR, Furin",7.411E-03,1.337E-02,13,"NOTCH1 receptor, GFAP, JAK1, CNTF, STAT1, Dopamine D3 receptor, Dopamine D2 receptor, JAK2, G-protein alpha-i family, STAT3, NOTCH1 precursor, LIFR, Furin",
912,PXR signaling via cross-talk / Human Version,22,7.411E-03,1.337E-02,1.102E-01,1.491E-01,11,"GCR, HNF3-beta, FKHR, CREB1, PPARGC1 (PGC1-alpha), PPAR-gamma, PPCKC, SULT2A1, CYP2C9, CYP7A1, HNF4-alpha",7.411E-03,1.337E-02,13,"CYP2C8, GCR, HNF3-beta, FKHR, CREB1, PPARGC1 (PGC1-alpha), PPAR-gamma, G6PT, PPCKC, SULT2A1, CYP2C9, CYP7A1, HNF4-alpha",
913,Inflammatory factors-induced expression of mucins in normal and asthmatic epithelium,51,7.506E-03,1.350E-02,9.172E-02,1.263E-01,23,"JAK1, ERK1/2, p90RSK2(RPS6KA3), IL-17 receptor, IL-1 beta, I-kB, Shc, MEK2(MAP2K2), CREB1, IL-6, NF-kB p50/p65, TNF-R1, C3aR, TNF-alpha, JAK2, PTAFR, IL-8, ALOX5, SOS, COX-2 (PTGS2), Histamine H1 receptor, SHP-2, C3a",7.506E-03,1.350E-02,25,"JAK1, ERK1/2, p90RSK2(RPS6KA3), IL-17, c-Raf-1, IL-17 receptor, IL-1 beta, I-kB, Shc, MEK2(MAP2K2), CREB1, IL-6, NF-kB p50/p65, TNF-R1, TNF-alpha, MEK1(MAP2K1), JAK2, PTAFR, IL-8, ALOX5, SOS, p90RSK1, COX-2 (PTGS2), Histamine H1 receptor, C3a",
914,Anti-apoptotic action of ErbB2 in breast cancer,51,7.506E-03,1.350E-02,1.460E-02,2.448E-02,26,"MAD, RHEB2, ERK1/2, Rac1, BAD, I-kB, Shc, PI3K reg class IA (p85), Survivin, Caspase-3, MEK1/2, AKT(PKB), Calpain 1(mu), NF-kB p50/p65, c-Src, c-Myc, TERT, EGFR, c-Jun, ErbB4, SOS, PI3K cat class IA (p110-alpha), HUNK, ITGA5, Bim, mTOR",7.506E-03,1.350E-02,25,"MAD, RHEB2, Neuregulin 1, ERK1/2, c-Raf-1, I-kB, Shc, PI3K reg class IA (p85), Survivin, Caspase-3, MEK1/2, AKT(PKB), Calpain 1(mu), NF-kB p50/p65, c-Src, TERT, EGFR, ErbB4, SOS, STAT3, PI3K cat class IA (p110-alpha), HUNK, ITGA5, Bim, mTOR",
915,Development_G-protein-mediated regulation of MAPK-ERK signaling,46,7.530E-03,1.350E-02,2.723E-02,4.248E-02,23,"PKA-reg (cAMP-dependent), G-protein alpha-q/11, PKC-epsilon, IP3 receptor, RAP-1A, Shc, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, M-Ras, ERK2 (MAPK1), GMF, c-Src, Pyk2(FAK2), G-protein alpha-12 family, B-Raf, G-protein alpha-i family, SOS, RASA2, Calmodulin, R-Ras, Elk-1, PKA-cat (cAMP-dependent)",7.530E-03,1.350E-02,23,"c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, RAP-1A, Shc, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, M-Ras, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), Pyk2(FAK2), G-protein alpha-12 family, B-Raf, G-protein alpha-i family, SOS, RASA2, Calmodulin, R-Ras, Elk-1, PKA-cat (cAMP-dependent)",
916,Neurophysiological process_NMDA-dependent postsynaptic long-term potentiation in CA1 hippocampal neurons,82,7.573E-03,1.383E-02,7.573E-03,1.383E-02,40,"mGluR1, Protein kinase G 2, eIF4E, ERK1/2, PKA-reg (cAMP-dependent), RASGRF2, CaMK IV, PLC-beta1, IP3 receptor, RAP-1A, Shc, NR2, CREB1, MEK1/2, Guanylate Cyclase 1, soluble, ERK2 (MAPK1), AKT(PKB), c-Src, Pyk2(FAK2), PI3K reg class IA (p85-alpha), B-Raf, Protein kinase G, SOS, MNK1, NR2A, p90Rsk, NR2B, 4E-BP1, PI3K cat class IA (p110-alpha), Adenylate cyclase type VIII, Calmodulin, PKC-alpha, GluR1, G-protein alpha-q, RASGRF1, Ryanodine receptor 2, BDNF, PKA-cat (cAMP-dependent), mTOR, PLC-beta2",1.381E-02,2.349E-02,36,"mGluR1, Protein kinase G 2, ERK1/2, c-Raf-1, RASGRF2, Ryanodine receptor 3, CaMK IV, IP3 receptor, RAP-1A, Shc, NR2, CREB1, MEK1/2, Guanylate Cyclase 1, soluble, ERK2 (MAPK1), AKT(PKB), c-Src, Pyk2(FAK2), PI3K reg class IA (p85-alpha), B-Raf, Protein kinase G, SOS, MNK1, NR2A, p90Rsk, NR2B, PI3K cat class IA (p110-alpha), Adenylate cyclase type VIII, Calmodulin, PKC-alpha, RASGRF1, Ryanodine receptor 2, BDNF, PKA-cat (cAMP-dependent), mTOR, PLC-beta2",
917,Pro-oncogenic action of PTHrP in breast cancer,29,7.585E-03,1.358E-02,2.158E-02,3.471E-02,16,"ERK1/2, VEGF-A, G-protein alpha-q/11, IP3 receptor, Bax, PLC-beta, MEK1/2, ITGB1, MMP-13, c-Jun, ITGA6, ITGA3, PKC-alpha, ITGB4, PTHrP, ITGA5",7.585E-03,1.358E-02,16,"ERK1/2, VEGF-A, c-Raf-1, G-protein alpha-q/11, IP3 receptor, Bax, PLC-beta, MEK1/2, ITGB1, MMP-13, ITGA6, ITGA3, PKC-alpha, ITGB4, PTHrP, ITGA5",
918,Development_Inhibition of angiogenesis by PEDF,31,7.638E-03,1.387E-02,7.638E-03,1.387E-02,18,"NF-AT1(NFATC2), Apaf-1, VEGF-A, VEGFR-2, Caspase-8, Bax, Caspase-3, PA24A, FasL(TNFSF6), PPAR-gamma, Caspase-9, JNK1(MAPK8), PEDF (serpinF1), FasR(CD95), c-FLIP(Short), JNK2(MAPK9), p53, p38 MAPK",1.690E-02,2.783E-02,16,"Apaf-1, VEGF-A, VEGFR-2, Caspase-8, Bax, Caspase-3, PA24A, PPAR-gamma, Caspase-9, JNK1(MAPK8), PEDF (serpinF1), FasR(CD95), c-FLIP(Short), JNK2(MAPK9), p53, p38 MAPK",
919,IL-1 beta-dependent CFTR expression,31,7.638E-03,1.387E-02,7.638E-03,1.387E-02,18,"Ubiquitin, IL-1 beta, I-kB, IRAK4, MyD88, IKK-alpha, NF-kB p50/p65, UEV1A, TAK1(MAP3K7), TRAF6, IL1RAP, NIK(MAP3K14), TAB3, Pellino 1, Pellino 2, MEKK1(MAP3K1), IRAK1, TAB1",8.187E-02,1.149E-01,14,"Ubiquitin, IL-1 beta, I-kB, IRAK4, NF-kB p50/p65, TAK1(MAP3K7), TRAF6, IL1RAP, CFTR, NIK(MAP3K14), TAB3, Pellino 1, Pellino 2, IRAK1",
920,Muscle contraction_ACM regulation of smooth muscle contraction,56,7.771E-03,1.409E-02,7.771E-03,1.409E-02,29,"TRPC5, PLD1, ARHGEF1 (p115RhoGEF), PKC-epsilon, PLC-beta1, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, MLCP (reg), Ryanodine receptor 1, G-protein beta/gamma, CDC42, c-Src, LPP3, MLCK, MLCP (cat), BETA-PIX, RhoA, ACM2, G-protein alpha-i3, CPI-17, ACM3, ROCK, Calmodulin, PKC, MRLC, G-protein alpha-q, PLC-beta3, Ryanodine receptor 2",1.514E-02,2.532E-02,26,"TRPC5, TRPC4, PLD1, ARHGEF1 (p115RhoGEF), Ryanodine receptor 3, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, MLCP (reg), Ryanodine receptor 1, G-protein beta/gamma, CDC42, c-Src, LPP3, MLCK, MLCP (cat), RhoA, G-protein alpha-i3, CPI-17, ACM3, ROCK, Calmodulin, PKC, MRLC, PLC-beta3, Ryanodine receptor 2",
921,G-protein signaling_Rap1A regulation pathway,40,7.972E-03,1.440E-02,7.972E-03,1.440E-02,22,"RASA3, CrkL, RAP-1A, MAGI-1(BAIAP1), p120GAP, ZAP70, Rap1GDS1, M-Ras, SPA1, B-Raf, CALDAG-GEFI, cAMP-GEFII, G-protein alpha-i family, C3G, NEDD4, KAP3, CalDAG-GEFIII, CD3, PLC-delta 1, Krit1, PDZ-GEF1, PKA-cat (cAMP-dependent)",2.703E-02,4.263E-02,19,"RASA3, CrkL, c-Raf-1, RAP-1A, MAGI-1(BAIAP1), p120GAP, Rap1GDS1, M-Ras, SPA1, B-Raf, cAMP-GEFII, G-protein alpha-i family, KAP3, CalDAG-GEFIII, CD3, PLC-delta 1, Krit1, PDZ-GEF1, PKA-cat (cAMP-dependent)",
922,Neurophysiological process_ACM1 and ACM2 in neuronal membrane polarization,40,7.972E-03,1.440E-02,7.972E-03,1.440E-02,22,"Kir2.3, Kir2.1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, PLC-beta1, IP3 receptor, G-protein alpha-i1, G-protein beta/gamma, c-Src, RhoA, Pyk2(FAK2), ACM2, G-protein alpha-o, G-protein alpha-i3, Kv1.2, G-protein beta1/gamma2, PTPR-alpha, PKC-alpha, G-protein alpha-q, KCNQ2, PLC-beta3, PLC-beta2",5.440E-02,7.919E-02,18,"Kir2.3, Kir2.1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, IP3 receptor, G-protein alpha-i1, G-protein beta/gamma, c-Src, RhoA, Pyk2(FAK2), G-protein alpha-o, G-protein alpha-i3, Kv1.2, G-protein beta1/gamma2, PTPR-alpha, PKC-alpha, PLC-beta3, PLC-beta2",
923,Cell adhesion_IL-8 family-dependent cell migration and adhesion,40,7.972E-03,1.440E-02,7.972E-03,1.440E-02,22,"GRO-2, ICAM1, ERK1/2, ENA-78, GRO-3, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, RAP-1A, GRO-1, G-protein beta/gamma, PPBP, RhoA, CALDAG-GEFI, ITGB2, PKC-delta, IL-8, G-protein alpha-i family, GCP2, PI3K reg class IB (p101), p38 MAPK, PLC-beta2",2.703E-02,4.263E-02,19,"GRO-2, ICAM1, ERK1/2, ENA-78, GRO-3, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, GRO-1, G-protein beta/gamma, PPBP, MEK1(MAP2K1), RhoA, ITGB2, IL-8, G-protein alpha-i family, GCP2, p38 MAPK, PLC-beta2",
924,Complement pathway disruption in thrombotic microangiopathy,39,8.716E-03,1.548E-02,1.283E-02,2.186E-02,21,"C3, C3b, C5a, IL-1 beta, PSGL-1, Factor I, Factor H, MYLK1, C5 convertase (C3b2Bb), P-selectin, C3aR, cPKC (conventional), PTAFR, IL-8, C3 convertase (C3bBb), Properdin, Calmodulin, PKC, C5, C5b, C3a",8.716E-03,1.548E-02,20,"C3, C3b, C5a, IL-1 beta, PSGL-1, Factor I, Factor H, MYLK1, C5 convertase (C3b2Bb), P-selectin, cPKC (conventional), PTAFR, IL-8, C3 convertase (C3bBb), Properdin, Calmodulin, PKC, C5, C5b, C3a",
925,Activation of Notch signaling in breast cancer,39,8.716E-03,1.548E-02,1.283E-02,2.186E-02,21,"Jagged2, MAML2, Rac1, p63, Tenascin-C, NOTCH4, SIM2, PEA3, RBP-J kappa (CBF1), NUMB, NOTCH1 (NICD), HEY1, HIF1A, c-Jun, TCF8, HES1, NOTCH1 precursor, SNAIL1, Jagged1, p38 MAPK, mTOR",8.716E-03,1.548E-02,20,"Neuregulin 1, Jagged2, MAML2, p63, Tenascin-C, NOTCH4, SIM2, PEA3, RBP-J kappa (CBF1), NUMB, NOTCH1 (NICD), HIF1A, TCF8, STAT3, HES1, NOTCH1 precursor, SNAIL1, Jagged1, p38 MAPK, mTOR",
926,Impaired macrophage phagocytic function in asthma,38,8.799E-03,1.582E-02,8.799E-03,1.582E-02,21,"TNF-R2, Rac1, CD14, SOD1, Calreticulin, PA24A, TNF-R1, LRP1, TNF-alpha, RhoA, CED-6, GCL reg, Leukocyte elastase, GSTP1, TIM-3, ROCK, CR1, iC3b, GCL cat, NRF2, MMP-9",3.191E-02,4.918E-02,18,"TNF-R2, CD14, Calreticulin, PA24A, TNF-R1, LRP1, TNF-alpha, RhoA, CED-6, GCL reg, Leukocyte elastase, GSTP1, ROCK, CR1, iC3b, GCL cat, NRF2, MMP-9",
927,Bacterial infections in CF airways,49,8.825E-03,1.565E-02,1.626E-02,2.712E-02,25,"TLR1, TLR5, TRAM, JAK1, MD-2, IRF1, Cathepsin S, IFN-beta, STAT1, CD14, MyD88, GM-CSF, NF-kB, TNF-alpha, Cathepsin L, JAK2, iNOS, TRAF3, IL-8, IFN-gamma receptor, Cathepsin B, TLR4, FasR(CD95), TRIF (TICAM1), TLR2",8.825E-03,1.565E-02,24,"TLR1, TRAM, JAK1, IFN-gamma, MD-2, IRF1, Cathepsin S, IFN-beta, STAT1, CD14, GM-CSF, NF-kB, TNF-alpha, Cathepsin L, JAK2, iNOS, TRAF3, IL-8, CFTR, IFN-gamma receptor, Cathepsin B, TLR4, FasR(CD95), TLR2",
928,CAR signaling via cross-talk / Rodent version,27,8.876E-03,1.570E-02,1.143E-01,1.541E-01,13,"GCR, ECHP, PPAR-alpha, FKHR, PPARGC1 (PGC1-alpha), INSIG1, NCOA2 (GRIP1/TIF2), CYP2B6, PPCKC, CYP2C9, CYP7A1, NCOA1 (SRC1), HNF4-alpha",8.876E-03,1.570E-02,15,"CYP2C8, GCR, ECHP, PPAR-alpha, FKHR, PPARGC1 (PGC1-alpha), INSIG1, CYP3A4, G6PT, NCOA2 (GRIP1/TIF2), PPCKC, CYP2C9, CYP7A1, NCOA1 (SRC1), HNF4-alpha",
929,Regulatory T cells in murine model of contact hypersensitivity,27,8.876E-03,1.570E-02,9.021E-03,1.616E-02,16,"TNF-R2, MHC class II, ICAM1, IL-10, 5'-NTD, PSGL-1, CD4, MHC class I, CTLA-4, FasL(TNFSF6), NF-kB, TNF-R1, P-selectin, TNF-alpha, CD8, FasR(CD95)",8.876E-03,1.570E-02,15,"TNF-R2, MHC class II, ICAM1, IL-10, 5'-NTD, PSGL-1, CD4, MHC class I, CTLA-4, NF-kB, TNF-R1, P-selectin, TNF-alpha, CD8, FasR(CD95)",
930,Aminoglycoside- and cisplatin-induced hair cell death,112,8.919E-03,1.602E-02,8.919E-03,1.602E-02,52,"TRMU, Calcineurin A (catalytic), LMO4, NOX4, Apaf-1, gp91-phox, ERK1/2, Beta-catenin, HDAC4, HDAC3, Caspase-8, TRPA1, p47-phox, STAT1, Rac1, IL-1 beta, Shc, Bax, TMC1, GSK3 beta, Caspase-3, IL-13, IL-6, FasL(TNFSF6), NF-kB, ZAK, Calpain 1(mu), Caspase-1, TNF-alpha, SLC22A2, RelA (p65 NF-kB subunit), PARP-1, iNOS, c-Jun, KCNQ4, Caspase-9, LSD1, MKK7 (MAP2K7), Calpain 2(m), MEK4(MAP2K4), COX-2 (PTGS2), AP-1, CX3CL1, PKC, ACON, JNK(MAPK8-10), HDAC1, c-FLIP, p53, Calcineurin B (regulatory), p38 MAPK, G9a",5.514E-02,8.018E-02,44,"TRMU, Calcineurin A (catalytic), LMO4, NOX4, Apaf-1, gp91-phox, ERK1/2, Beta-catenin, HDAC4, HDAC3, Caspase-8, TRPA1, p47-phox, STAT1, IL-1 beta, Shc, Bax, TMC1, GSK3 beta, Caspase-3, IL-6, NF-kB, ZAK, Calpain 1(mu), Caspase-1, TNF-alpha, SLC22A2, RelA (p65 NF-kB subunit), iNOS, Caspase-9, p67-phox, LSD1, Calpain 2(m), MEK4(MAP2K4), COX-2 (PTGS2), CX3CL1, PKC, JNK(MAPK8-10), HDAC1, c-FLIP, p53, Calcineurin B (regulatory), p38 MAPK, G9a",
931,G-protein signaling_Proinsulin C-peptide signaling,52,9.596E-03,1.711E-02,9.596E-03,1.711E-02,27,"ERK1/2, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, I-kB, PI3K reg class IA (p85), ATP1A1, PI3K reg class IA, PLC-beta, IKK-alpha, MEK2(MAP2K2), G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, PI3K cat class IA, PI3K reg class IA (p85-alpha), PKC-delta, G-protein alpha-i family, c-Jun, SOS, COX-2 (PTGS2), ATP1B1, PKC-alpha, PI3K reg class IB (p101), Elk-1",1.016E-02,1.775E-02,25,"ERK1/2, c-Raf-1, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, I-kB, PI3K reg class IA (p85), ATP1A1, PI3K reg class IA, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, NF-kB, AKT(PKB), NF-kB p50/p65, c-Src, MEK1(MAP2K1), PI3K cat class IA, PI3K reg class IA (p85-alpha), G-protein alpha-i family, SOS, COX-2 (PTGS2), ATP1B1, PKC-alpha, Elk-1",
932,Glucagon-induced glucose upregulation in type 2 diabetes in liver ,52,9.596E-03,1.711E-02,9.596E-03,1.711E-02,27,"CBP, Calcineurin A (catalytic), GYS2, KPYR, PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, Adenylate cyclase, QIK, Casein kinase II, CREB1, PPARGC1 (PGC1-alpha), GCGR, Glucagon, iNOS, G-protein alpha-i family, p300, PPCKC, 14-3-3 beta/alpha, Calmodulin, PYGL, CaMK II alpha, HNF4-alpha, PLC-beta3, Calcineurin B (regulatory), PKA-cat (cAMP-dependent)",2.079E-02,3.361E-02,24,"CBP, Calcineurin A (catalytic), KPYR, G-protein alpha-q/11, IP3 receptor, PLC-beta, Adenylate cyclase, QIK, Casein kinase II, CREB1, PPARGC1 (PGC1-alpha), Glucagon, iNOS, G-protein alpha-i family, G6PT, p300, PPCKC, Calmodulin, PYGL, CaMK II alpha, HNF4-alpha, PLC-beta3, Calcineurin B (regulatory), PKA-cat (cAMP-dependent)",
933,Development_Hedgehog and PTH signaling pathways in bone and cartilage development,36,9.706E-03,1.715E-02,9.706E-03,1.715E-02,20,"COL1A1, RANKL(TNFSF11), EGR1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, Smoothened, GLI-2, PLC-beta, Cyclin A2, CREB1, COL1A2, Osteopontin, MMP-13, PTCH1, Osteocalcin, Ihh, RUNX2, PTHrP, GLI-1, PKA-cat (cAMP-dependent)",1.715E-02,2.806E-02,18,"COL1A1, RANKL(TNFSF11), G-protein alpha-q/11, Smoothened, GLI-2, PLC-beta, Cyclin A2, CREB1, COL1A2, Osteopontin, MMP-13, PTCH1, Osteocalcin, Ihh, RUNX2, PTHrP, GLI-1, PKA-cat (cAMP-dependent)",
934,Populations of skin dendritic cells involved in contact hypersensitivity,18,9.738E-03,1.719E-02,6.157E-02,8.814E-02,10,"MHC class II, Langerin, CD83, ITGAE, Ep-CAM, CD45, CD1d, LY75, EMR1, CD86",9.738E-03,1.719E-02,11,"CD1a, MHC class II, Langerin, CD83, ITGAE, Ep-CAM, CD45, CD1d, LY75, EMR1, CD86",
935,Putative pathways of activation of monoclonal protein secretion in multiple myeloma,25,9.754E-03,1.715E-02,9.754E-03,1.715E-02,15,"GRP78, IGHM, DNAJB11, PAX5, ARMET, Kappa chain (Ig light chain), Cyclophilin B, EDEM, BOB1, IgJ, Oct-2, SRP-alpha, DNAJC3, BLIMP1 (PRDI-BF1), ERP5",2.812E-02,4.406E-02,13,"GRP78, DNAJB11, PAX5, ARMET, Cyclophilin B, EDEM, BOB1, IgJ, Ig heavy chain, Oct-2, SRP-alpha, BLIMP1 (PRDI-BF1), ERP5",
936,HBV-dependent transcription regulation leading to HCC,25,9.754E-03,1.715E-02,9.754E-03,1.715E-02,15,"CBP, TGF-beta 1, ATF-3, EGR1, EGR2 (Krox20), MMP-2, CREB1, FasL(TNFSF6), PPAR-gamma, IL-8, Pin1, p300, PCNA, MMP-14, HDAC1",1.038E-02,1.803E-02,14,"CBP, TGF-beta 1, ATF-3, EGR2 (Krox20), MMP-2, CREB1, PPAR-gamma, IL-8, Pin1, p300, PCNA, MMP-14, LXR-alpha, HDAC1",
937,Apoptosis and survival_Role of nuclear PI3K in NGF/ TrkA signaling,25,9.754E-03,1.715E-02,9.754E-03,1.715E-02,15,"TrkA, PKC-zeta, HRK, PI3K reg class IA (p85), Nucleophosmin, PLC-gamma 1, DFF40 (CAD), AKT(PKB), PI3K cat class IA, PKC-delta, 14-3-3 gamma, NGF, Nucleolin, Zyxin, Bim",1.366E-01,1.829E-01,11,"HRK, PI3K reg class IA (p85), PLC-gamma 1, DFF40 (CAD), AKT(PKB), PI3K cat class IA, 14-3-3 gamma, NGF, Nucleolin, Zyxin, Bim",
938,G-protein signaling_K-RAS regulation pathway,25,9.754E-03,1.715E-02,9.754E-03,1.715E-02,15,"A-Raf-1, Shc, PKC-theta, RASSF1, Rap1GDS1, Lck, B-Raf, CALDAG-GEFI, EGFR, SOS, KAP3, PI3K cat class IA (p110-alpha), ICMT, RGL1, RASGRF1",1.038E-02,1.803E-02,14,"c-Raf-1, Shc, PKC-theta, RASSF1, Rap1GDS1, Lck, B-Raf, EGFR, SOS, KAP3, PI3K cat class IA (p110-alpha), ICMT, RGL1, RASGRF1",
939,Development_Transcription regulation of granulocyte development,32,9.787E-03,1.719E-02,6.020E-02,8.652E-02,16,"MAD, JAK1, gp91-phox, p47-phox, SOCS3, C/EBPepsilon, c-Myc, JAK2, CD45, Leukocyte elastase, AML1 (RUNX1), PKC, STAT5, LRG, c-Fes, CD13",9.787E-03,1.719E-02,17,"MAD, JAK1, gp91-phox, GATA-1, p47-phox, SOCS3, JAK2, CD45, Leukocyte elastase, p67-phox, AML1 (RUNX1), STAT3, PKC, STAT5, LRG, c-Fes, CD13",
940,Th2 cytokine-induced alternative activation of alveolar macrophages in asthma,32,9.787E-03,1.719E-02,1.179E-02,2.022E-02,18,"IL-4R type I, SLC3A2, TSLP, CHIA, IL-13, Eotaxin, CXCR4, CHI3L1, Eotaxin-2, RSNB, IL-5, IL-4R type II, IL4RA, IRF4, ST2(L), IL-33, TGM2, TSLPR",9.787E-03,1.719E-02,17,"IL-4R type I, CLEC10A, SLC3A2, TSLP, CHIA, Eotaxin, CXCR4, CHI3L1, Eotaxin-2, IL-5, IL-4R type II, IL4RA, IRF4, ST2(L), IL-33, TGM2, TSLPR",
941,Transcription_Epigenetic regulation of gene expression,57,9.836E-03,1.724E-02,2.080E-02,3.357E-02,28,"SMYD2, HDAC9, HAT1, CBP, UTX, HDAC4, HDAC3, HDAC6, RBB2, Tip60, MLL1 (HRX), SUV39H2, HDAC2, PCAF, EZH2, AOF1, Suv39H1, GASC1, LSD1, JMJD1A, Sirtuin2, p300, CARM1, HDAC8, DNMT1, HDAC1, SMCY, G9a",9.836E-03,1.724E-02,27,"SMYD2, HDAC9, HAT1, CBP, UTX, HDAC4, HDAC3, HDAC6, RBB2, Tip60, MLL1 (HRX), SUV39H2, HDAC2, PCAF, EZH2, AOF1, GASC1, LSD1, JMJD1A, Sirtuin2, p300, CARM1, HDAC8, DNMT1, HDAC1, SMCY, G9a",
942,Development_FGF-family signaling,52,1.016E-02,1.775E-02,1.960E-02,3.204E-02,26,"FGFR2, FGF1, FGF8, PKC-epsilon, FGF9, Rac1, IP3 receptor, Shc, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), MLK3(MAP3K11), PI3K cat class IA, PKC-delta, FGF2, SOS, PKC-beta, FGF3, FGF7, PKC-alpha, SHP-2, Perlecan, p38 MAPK, FGF19",1.016E-02,1.775E-02,25,"FGFR2, FGF1, c-Raf-1, FGF8, PKC-epsilon, FGF9, IP3 receptor, Shc, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), MEK1(MAP2K1), MLK3(MAP3K11), PI3K cat class IA, FGF2, SOS, PKC-beta, FGF3, FGF16, PKC-alpha, Perlecan, p38 MAPK, FGF19",
943,Immune response_PGE2 common pathways,47,1.038E-02,1.803E-02,1.135E-01,1.534E-01,21,"PI3K cat class IA (p110-beta), SLC21A2, PKA-reg (cAMP-dependent), PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), PGE2R2, PGE2R4, G-protein alpha-i family, PGES, G-protein beta1/gamma2, COX-2 (PTGS2), ABCC4, PKA-cat (cAMP-dependent)",1.038E-02,1.803E-02,23,"PI3K cat class IA (p110-beta), SLC21A2, c-Raf-1, PKC-epsilon, PI3K cat class IB (p110-gamma), IP3 receptor, COX-1 (PTGS1), PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), PGE2R2, MEK1(MAP2K1), PGE2R4, G-protein alpha-i family, PGES, G-protein beta1/gamma2, COX-2 (PTGS2), ABCC4, PKA-cat (cAMP-dependent)",
944,Apoptosis and survival_Apoptotic Activin A signaling,25,1.038E-02,1.803E-02,6.264E-02,8.941E-02,13,"SMAD4, SMAD2, p120GAP, MEK2(MAP2K2), ActRIIA, DOK1, SHIP, ERK2 (MAPK1), AKT(PKB), Activin A, ActRIIB, SMAD3, p53",1.038E-02,1.803E-02,14,"c-Raf-1, SMAD4, SMAD2, p120GAP, MEK2(MAP2K2), ActRIIA, DOK1, ERK2 (MAPK1), AKT(PKB), MEK1(MAP2K1), Activin A, ActRIIB, SMAD3, p53",
945,"TNF-alpha, IL-1 beta induce dyslipidemia and inflammation in obesity and type 2 diabetes in adipocytes ",42,1.044E-02,1.811E-02,1.635E-02,2.715E-02,22,"TNF-R2, CCL2, ERK1/2, PKA-reg (cAMP-dependent), IL-1 beta, AZGP1, IL-6, NF-kB, TNF-R1, BAFF(TNFSF13B), TNF-alpha, PTX3, LIPIN1, iNOS, NF-kB1 (p50), CIDE-A, APOE, HSD11B1, COX-2 (PTGS2), ADAM17, PAI1, PKA-cat (cAMP-dependent)",1.044E-02,1.811E-02,21,"TNF-R2, CCL2, ERK1/2, IL-1 beta, AZGP1, IL-6, NF-kB, TNF-R1, BAFF(TNFSF13B), TNF-alpha, PTX3, LIPIN1, iNOS, NF-kB1 (p50), CIDE-A, APOE, HSD11B1, COX-2 (PTGS2), ADAM17, PAI1, PKA-cat (cAMP-dependent)",
946,G-protein signaling_Cross-talk between Ras-family GTPases,23,1.050E-02,1.835E-02,1.050E-02,1.835E-02,14,"PLD1, Rac1, RAP-1A, p120GAP, CDC42, M-Ras, AKT(PKB), RhoA, Tiam1, PI3K cat class IA, B-Raf, RhoGAP5, RalA, RalBP1",1.214E-02,2.079E-02,13,"PLD1, c-Raf-1, RAP-1A, p120GAP, CDC42, M-Ras, AKT(PKB), RhoA, Tiam1, PI3K cat class IA, B-Raf, RhoGAP5, RalBP1",
947,Proteases and EGFR-activated mucin production in airway epithelium in COPD,50,1.067E-02,1.858E-02,1.067E-02,1.858E-02,26,"CD44, ERK1/2, p47-phox, Rac1, ATF-2/c-Jun, CREB1, PPARGC1 (PGC1-alpha), TGF-alpha, NF-kB, AKT(PKB), PPAR-gamma, TNF-alpha, PI3K cat class IA, HIF1A, PKC-delta, EGFR, c-Jun, Leukocyte elastase, DUOX1, AP-1, ATF-2, GCL cat, Kallikrein 1, ADAM17, p38 MAPK, MMP-9",2.438E-02,3.886E-02,23,"CD44, Neuregulin 1, ERK1/2, p47-phox, CREB1, PPARGC1 (PGC1-alpha), TGF-alpha, NF-kB, AKT(PKB), PPAR-gamma, TNF-alpha, PI3K cat class IA, HIF1A, EGFR, Leukocyte elastase, p90RSK1, p67-phox, DUOX1, ATF-2, GCL cat, ADAM17, p38 MAPK, MMP-9",
948,Stem cells_Inhibition of Hedgehog signaling in medulloblastoma stem cells,41,1.157E-02,1.994E-02,1.157E-02,1.994E-02,22,"FGFR2, ERK1/2, FGF1, PKA-reg (cAMP-dependent), CRK, Smoothened, Rac1, GLI-2, Shc, MEK2(MAP2K2), PTCH1, DOCK1, FGF2, SOS, MEK4(MAP2K4), PACAP receptor 1, MEKK1(MAP3K1), SHP-2, PACAP, JNK(MAPK8-10), GLI-1, PKA-cat (cAMP-dependent)",1.698E-02,2.783E-02,20,"FGFR2, ERK1/2, FGF1, CRK, c-Raf-1, Smoothened, GLI-2, Shc, MEK2(MAP2K2), MEK1(MAP2K1), PTCH1, DOCK1, FGF2, SOS, MEK4(MAP2K4), PACAP receptor 1, PACAP, JNK(MAPK8-10), GLI-1, PKA-cat (cAMP-dependent)",
949,Development_Fetal brown fat cell differentiation,55,1.178E-02,2.022E-02,1.178E-02,2.022E-02,28,"STAT5A, IRS-2, Beta-3 adrenergic receptor, IRS-1, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), GLUT4, STAT5B, UCP1, Shc, PI3K reg class IA (p85), GSK3 beta, IGF-2, Adenylate cyclase, MEK2(MAP2K2), CREB1, PPARGC1 (PGC1-alpha), AKT(PKB), c-Myc, PPAR-gamma, JAK2, PI3K cat class IA, C/EBPbeta, SOS, IGF-2 receptor, PKA-cat (cAMP-dependent), Prolactin",2.291E-02,3.681E-02,25,"STAT5A, IRS-2, Beta-3 adrenergic receptor, ERK1/2, c-Raf-1, STAT5B, UCP1, Shc, PI3K reg class IA (p85), GSK3 beta, IGF-2, Adenylate cyclase, MEK2(MAP2K2), CREB1, PPARGC1 (PGC1-alpha), AKT(PKB), PPAR-gamma, MEK1(MAP2K1), JAK2, PI3K cat class IA, C/EBPbeta, SOS, IGF-2 receptor, PKA-cat (cAMP-dependent), Prolactin",
950,Role of IL-6 in obesity and type 2 diabetes in adipocytes,32,1.179E-02,2.022E-02,1.179E-02,2.022E-02,18,"JAK1, CCL2, Tyk2, IRS-1, ERK1/2, SOCS1, GLUT4, HP, SOCS3, IL-6, PPARGC1 (PGC1-alpha), PPAR-gamma, JAK2, PKC-delta, CRP, SHP-2, STAT5, PAI1",5.283E-02,7.728E-02,15,"JAK1, CCL2, Tyk2, ERK1/2, SOCS1, HP, SOCS3, IL-6, PPARGC1 (PGC1-alpha), PPAR-gamma, JAK2, STAT3, CRP, STAT5, PAI1",
951,Inhibition of WNT5A-dependent non-canonical pathway in colorectal cancer,19,1.191E-02,2.039E-02,1.191E-02,2.039E-02,12,"CRM1, APC protein, Lef-1, Beta-catenin, FZD2, c-Myc, TAK1(MAP3K7), TCF7 (TCF1), c-Jun, WNT5A, Calmodulin, PKC-alpha",4.753E-02,7.035E-02,10,"CRM1, APC protein, Beta-catenin, FZD2, TAK1(MAP3K7), TCF7 (TCF1), ROR-alpha, WNT5A, Calmodulin, PKC-alpha",
952,Ethanol/Acetaldehyde-dependent stimulation of MMP-9 expression in HCC,19,1.191E-02,2.039E-02,1.191E-02,2.039E-02,12,"Skp2/TrCP/FBXW, ADH4, NF-kB, c-Jun, ADH1, JNK1(MAPK8), Cul1/Rbx1 E3 ligase, ADHG, JNK(MAPK8-10), JNK2(MAPK9), p38 MAPK, MMP-9",1.656E-02,2.738E-02,11,"Skp2/TrCP/FBXW, ADH4, NF-kB, ADH1, JNK1(MAPK8), Cul1/Rbx1 E3 ligase, ADHG, JNK(MAPK8-10), JNK2(MAPK9), p38 MAPK, MMP-9",
953,Immune response_Inflammasome in inflammatory response,35,1.211E-02,2.079E-02,1.580E-02,2.638E-02,19,"Caspase-5, NALP2, Biglycan, CARD8, CARD12, IL-1 beta, I-kB, P2X7, NF-kB, TNF-R1, Caspase-1, TNF-alpha, IL-18, RIPK2, Pannexin-1, CARD7, TLR4, Nod1, NALP3",1.211E-02,2.079E-02,18,"Caspase-5, NALP2, Biglycan, CARD12, IL-1 beta, I-kB, P2X7, NF-kB, TNF-R1, Caspase-1, TNF-alpha, IL-18, RIPK2, Pannexin-1, CARD7, TLR4, Nod1, NALP3",
954,Altered Ca2+ handling in heart failure,35,1.211E-02,2.079E-02,3.519E-02,5.317E-02,18,"Calcineurin A (catalytic), PP1-cat, S100A1, Adenylate cyclase, Ca-ATPase2, BIN1 (Amphiphysin II), G-protein beta/gamma, G-protein alpha-i family, PP2A catalytic, FKBP1B, CaMK II delta, Calmodulin, NCX1, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, Calcineurin B (regulatory), Ryanodine receptor 2, PKA-cat (cAMP-dependent)",1.211E-02,2.079E-02,18,"Calcineurin A (catalytic), PP1-cat, Adenylate cyclase, Ca-ATPase2, BIN1 (Amphiphysin II), G-protein beta/gamma, Phospholamban, G-protein alpha-i family, PP2A catalytic, FKBP1B, CaMK II delta, Calmodulin, NCX1, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, Calcineurin B (regulatory), Ryanodine receptor 2, PKA-cat (cAMP-dependent)",
955,Development_Ligand-dependent activation of the ESR1/AP-1 pathway,15,1.290E-02,2.186E-02,1.290E-02,2.186E-02,10,"CBP, HDAC4, c-Jun, p300, RIP140, NCOA2 (GRIP1/TIF2), AP-1, NCOA1 (SRC1), HDAC1, CtBP1",1.671E-01,2.186E-01,7,"CBP, HDAC4, p300, RIP140, NCOA2 (GRIP1/TIF2), NCOA1 (SRC1), HDAC1",
956,HSP22 and BAG-3-dependend macroautophagy in Huntington's disease,15,1.290E-02,2.186E-02,1.290E-02,2.186E-02,10,"ATF-4, GCN2, Sequestosome 1(p62), MAP1LC3B, APG7, HSP20, MAP1LC3A, APG5, Beclin 1, APG12",1.671E-01,2.186E-01,7,"GCN2, Sequestosome 1(p62), MAP1LC3B, APG7, HSP20, MAP1LC3A, APG5",
957,SHH signaling in oligodendrocyte precursor cells differentiation in multiple sclerosis,13,1.301E-02,2.199E-02,1.301E-02,2.199E-02,9,"Smoothened, GLI-2, Nkx2.2, PTCH1, SOX10, Myelin basic protein, OLIG2, MAG, GLI-1",2.589E-02,4.101E-02,8,"IFN-gamma, Smoothened, GLI-2, PTCH1, SOX10, Myelin basic protein, OLIG2, GLI-1",
958,Blood coagulation_GPIb-IX-V-dependent platelet activation,77,1.331E-02,2.244E-02,1.331E-02,2.244E-02,37,"PREL1, PI3K cat class IA (p110-beta), GP-IB beta, Alpha-actinin, Actin, IP3 receptor, Syk, Talin, RAP-1A, PI3K reg class IA (p85), alpha-IIb/beta-3 integrin, cPLA2, Fyn, ERK2 (MAPK1), Syntaxin 4, c-Src, MEKK4(MAP3K4), Pyk2(FAK2), VAMP3, PI3K reg class IA (p85-alpha), CALDAG-GEFI, ITGB3, Lyn, RAP-1B, Guanylate cyclase (alpha-1/beta-1), 14-3-3 zeta/delta, MEK3(MAP2K3), Fc gamma RII alpha, LAT, PI3K cat class IA (p110-alpha), Calmodulin, PKC-alpha, Filamin A, Fibrinogen (fibrin), PLC-gamma 2, Collagen I, Cofilin",1.488E-02,2.491E-02,34,"p38alpha (MAPK14), PREL1, PI3K cat class IA (p110-beta), Alpha-actinin, c-Raf-1, Actin, IP3 receptor, Syk, Talin, RAP-1A, PI3K reg class IA (p85), alpha-IIb/beta-3 integrin, cPLA2, Fyn, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), Pyk2(FAK2), VAMP3, PI3K reg class IA (p85-alpha), ITGB3, Lyn, RAP-1B, Guanylate cyclase (alpha-1/beta-1), 14-3-3 zeta/delta, MEK3(MAP2K3), Fc gamma RII alpha, PI3K cat class IA (p110-alpha), Calmodulin, PKC-alpha, Filamin A, PLC-gamma 2, Collagen I, Cofilin",
959,Development_Adiponectin signaling,48,1.404E-02,2.386E-02,1.374E-01,1.821E-01,21,"ERK1/2, HB-EGF, A-Raf-1, APPL1, IP3 receptor, Shc, PLC-beta, Caspase-3, MEK2(MAP2K2), IL-6, AKT(PKB), HSP90, c-Src, Casein kinase II, beta chain (Phosvitin), JAK2, PI3K cat class IA, AMPK alpha subunit, Leukocyte elastase, FGF2, SOS, Calmodulin",1.404E-02,2.386E-02,23,"p38alpha (MAPK14), ERK1/2, HB-EGF, APPL1, IP3 receptor, Shc, PLC-beta, Caspase-3, MEK2(MAP2K2), IL-6, AKT(PKB), HSP90, c-Src, MEK1(MAP2K1), Casein kinase II, beta chain (Phosvitin), JAK2, PI3K cat class IA, AMPK alpha subunit, Leukocyte elastase, FGF2, SOS, STAT3, Calmodulin",
960,Inhibition of tumor suppressive pathways in pancreatic cancer,21,1.419E-02,2.402E-02,3.251E-02,4.953E-02,12,"p14ARF, Brca2, SMAD4, Rad51, p73, Bax, CDK4, p16INK4, CDK6, p15, SNAIL1, p53",1.419E-02,2.402E-02,12,"p14ARF, Brca2, SMAD4, p73, Bax, CDK4, PIG3, p16INK4, CDK6, p15, SNAIL1, p53",
961,HCV-dependent transcription regulation leading to HCC,21,1.419E-02,2.402E-02,7.964E-02,1.116E-01,11,"PML, UBF, p73, Bax, CDK4, SKP2, HSP70, CDK2, Cyclin E, p53, PKA-cat (cAMP-dependent)",1.419E-02,2.402E-02,12,"PML, UBF, p73, Bax, CDK4, SKP2, HSP70, CDK2, STAT3, Cyclin E, p53, PKA-cat (cAMP-dependent)",
962,p53 signaling in Prostate Cancer,33,1.430E-02,2.413E-02,3.941E-02,5.901E-02,17,"DR5(TNFRSF10B), Apaf-1, Bak, IBP3, ABCC1, PI3K reg class IA (p85), EZH2, AKT(PKB), DR4(TNFRSF10A), Tubulin (in microtubules), PI3K cat class IA, p53 (mitochondrial), Stathmin, MAP4, NOXA, HDAC1, p53",1.430E-02,2.413E-02,17,"DR5(TNFRSF10B), Apaf-1, IBP3, ABCC1, PI3K reg class IA (p85), EZH2, AKT(PKB), DR4(TNFRSF10A), Tubulin (in microtubules), PI3K cat class IA, p53 (mitochondrial), Stathmin, MAP4, microRNA 34c, NOXA, HDAC1, p53",
963,Immune response_iC3b-induced phagocytosis via alpha-M/beta-2 integrin,61,1.434E-02,2.417E-02,3.099E-02,4.770E-02,29,"SPHK1, PLD1, PREL1, Rac2, mDIA2(DIAPH3), PI3K cat class III (Vps34), VAV-1, p47-phox, Rac1, IP3 receptor, Syk, Talin, RAP-1A, PI3K reg class IA (p85), Profilin II, DIA1, PI4KII, CDC42, Actin cytoskeletal, Profilin I, RhoA, PI3K cat class IA, ITGB2, Myosin II, PLD2, PKC, I5P2, iC3b, PLC-gamma 2",1.434E-02,2.417E-02,28,"SPHK1, PLD1, PREL1, Rac2, mDIA2(DIAPH3), PI3K cat class III (Vps34), VAV-1, p47-phox, IP3 receptor, Syk, Talin, RAP-1A, PI3K reg class IA (p85), Profilin II, DIA1, PI4KII, CDC42, Actin cytoskeletal, Profilin I, RhoA, PI3K cat class IA, ITGB2, Myosin II, PLD2, PKC, I5P2, iC3b, PLC-gamma 2",
964,Prostaglandins and leukotrienes-mediated induction of expression of mucins in normal and asthmatic epithelium ,43,1.440E-02,2.421E-02,1.407E-01,1.858E-01,19,"ERK1/2, p90RSK2(RPS6KA3), PKA-reg (cAMP-dependent), G-protein alpha-q/11, PKC-epsilon, IP3 receptor, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, NF-kB, PGE2R2, PGE2R4, EGFR, G-protein alpha-i family, PGF2aR, PKC-alpha, PKA-cat (cAMP-dependent)",1.440E-02,2.421E-02,21,"ERK1/2, p90RSK2(RPS6KA3), c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, NF-kB, PGE2R2, MEK1(MAP2K1), PGE2R4, EGFR, G-protein alpha-i family, PGF2aR, p90RSK1, PKC-alpha, PKA-cat (cAMP-dependent)",
965,Role of platelets in allograft rejection,43,1.440E-02,2.421E-02,8.269E-02,1.154E-01,20,"ICAM1, GP-IB beta, SLC21A2, IL-1 beta, Thrombin, alpha-IIb/beta-3 integrin, PSGL-1, alpha-V/beta-3 integrin, P-selectin, TNF-alpha, TGF-beta, TBXA2R, Tissue factor, Collagen III, P2Y1, PAR1, Fibrinogen (fibrin), PF4, Collagen I, Kainate receptor",1.440E-02,2.421E-02,21,"ICAM1, IFN-gamma, SLC21A2, sCD40L, IL-1 beta, COX-1 (PTGS1), alpha-IIb/beta-3 integrin, PSGL-1, alpha-V/beta-3 integrin, P-selectin, CD40L(TNFSF5), TNF-alpha, TGF-beta, TBXA2R, Tissue factor, Collagen III, P2Y1, PAR1, PF4, Collagen I, Kainate receptor",
966,Substance P-mediated inflammation and pain in Sickle cell disease,38,1.452E-02,2.439E-02,4.261E-02,6.343E-02,19,"alpha-4/beta-1 integrin, ICAM1, IP3 receptor, IL-1 beta, CD14, PLC-beta, PSGL-1, GM-CSF, IL-6, G-protein beta/gamma, NF-kB, NF-kB p50/p65, TNF-R1, TNF-alpha, VCAM1, IL-8, Substance P receptor, Tissue factor, G-protein alpha-q",1.452E-02,2.439E-02,19,"alpha-4/beta-1 integrin, ICAM1, IFN-gamma, IP3 receptor, IL-1 beta, CD14, PLC-beta, PSGL-1, GM-CSF, IL-6, G-protein beta/gamma, NF-kB, NF-kB p50/p65, TNF-R1, TNF-alpha, VCAM1, IL-8, Substance P receptor, Tissue factor",
967,Transport_Rab-9 regulation pathway,10,1.484E-02,2.486E-02,2.675E-02,4.182E-02,7,"TIP47, GDI2, RABGDIA, PIP5KIII, IGF-2 receptor, Rab-9, CD-MPR",1.484E-02,2.486E-02,7,"TIP47, GDI2, RABGDIA, PIP5KIII, IGF-2 receptor, Rab-9, CD-MPR",
968,Neurophysiological process_Ephrin-B receptors in dendritic spine morphogenesis and synaptogenesis,35,1.580E-02,2.638E-02,1.580E-02,2.638E-02,19,"NCK1, Syntaxin 1A, Dynamin-2, SHANK, Rac1, GABA-A receptor, CDC42, Actin cytoskeletal, Fyn, BETA-PIX, Drebrin, Intersectin, GRIP, Ephrin-B, N-WASP, Ephrin-B receptor 2, PSD-95, Ephrin-B receptors, Syndecan-2",1.112E-01,1.518E-01,15,"NCK1, SNAP-25, Dynamin-2, SHANK, GABA-A receptor, CDC42, Actin cytoskeletal, Fyn, Drebrin, Intersectin, Ephrin-B, Ephrin-B receptor 2, PSD-95, Ephrin-B receptors, Syndecan-2",
969,Pioglitazone and Rosiglitazone in treatment of type 2 diabetes and metabolic syndrome X,26,1.601E-02,2.657E-02,3.922E-02,5.884E-02,14,"GLUT2, IRS-2, GLUT4, Resistin, IL-6, ABCA1, PPAR-gamma, TNF-alpha, SR-BI, VLDLR, PPCKC, HXK4, SORBS1, LPL",1.601E-02,2.657E-02,14,"GLUT2, IRS-2, IL-6, ABCA1, PPAR-gamma, TNF-alpha, A-FABP, SR-BI, VLDLR, PPCKC, LXR-alpha, HXK4, SORBS1, LPL",
970,Apoptosis and survival_BAD phosphorylation,42,1.635E-02,2.715E-02,1.635E-02,2.715E-02,22,"Calcineurin A (catalytic), IRS-1, ERK1/2, 14-3-3, PKA-reg (cAMP-dependent), PP2C, CDK1 (p34), BAD, Shc, Bax, PI3K reg class IA, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), PI3K cat class IA, EGFR, SOS, PP2A catalytic, JNK1(MAPK8), p90Rsk, Beclin 1, PKA-cat (cAMP-dependent)",2.292E-02,3.681E-02,20,"Calcineurin A (catalytic), ERK1/2, 14-3-3, c-Raf-1, PP2C, CDK1 (p34), Shc, Bax, PI3K reg class IA, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, EGFR, SOS, PP2A catalytic, JNK1(MAPK8), p90Rsk, PKA-cat (cAMP-dependent)",
971,Translation_Insulin regulation of translation,42,1.635E-02,2.715E-02,1.635E-02,2.715E-02,22,"RHEB2, IRS-2, IRS-1, RPS6, PP1-cat, eIF4E, ERK1/2, PKC-zeta, Shc, GSK3 beta, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), PI3K cat class IA, eEF2K, eIF4H, SOS, eIF4G1/3, Hamartin, 4E-BP1, eIF4A, mTOR",4.629E-02,6.885E-02,19,"RHEB2, IRS-2, RPS6, PP1-cat, ERK1/2, c-Raf-1, Shc, GSK3 beta, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, eIF4H, SOS, p90RSK1, eIF4G1/3, eIF4A, mTOR",
972,Protein folding_Membrane trafficking and signal transduction of G-alpha (i) heterotrimeric G-protein,19,1.656E-02,2.738E-02,9.006E-02,1.245E-01,10,"PI3K cat class IB (p110-gamma), PLC-beta, G-protein gamma, G-protein beta/gamma, RGS4, G-protein alpha-i family, G-protein beta, ICMT, RGS13, CAAX prenyl protease 2",1.656E-02,2.738E-02,11,"PI3K cat class IB (p110-gamma), PLC-beta, G-protein gamma, G-protein beta/gamma, RGS4, RGS7, G-protein alpha-i family, G-protein beta, ICMT, RGS13, CAAX prenyl protease 2",
973,Transcription_Role of VDR in regulation of genes involved in osteoporosis,59,1.676E-02,2.769E-02,3.450E-02,5.239E-02,28,"COL1A1, IL-1 alpha, GCR, Fra-1, Calcitonin, RANKL(TNFSF11), IL-1 beta, Calreticulin, CYP24A1, CYP19, IL-6, FasL(TNFSF6), Osteoprotegerin, Carbonic anhydrase II, CALB1, TNF-alpha, Osteopontin, Osteocalcin, CDX2, c-Jun, RANK(TNFRSF11A), PKC-beta, CYP27B1, TRPC3, RUNX2, SMAD3, PKA-cat (cAMP-dependent), TGF-beta receptor type I",1.676E-02,2.769E-02,27,"COL1A1, IL-1 alpha, GCR, Fra-1, Calcitonin, RANKL(TNFSF11), IFN-gamma, IL-1 beta, Calreticulin, CYP24A1, IL-6, Osteoprotegerin, Carbonic anhydrase II, CYP3A4, CALB1, TNF-alpha, Osteopontin, Osteocalcin, CDX2, RANK(TNFRSF11A), PKC-beta, CYP27B1, TRPC3, RUNX2, SMAD3, PKA-cat (cAMP-dependent), TGF-beta receptor type I",
974,NETosis in SLE,31,1.690E-02,2.783E-02,8.978E-02,1.245E-01,15,"HMGB1, ERK1/2, IFN-alpha/beta receptor, p47-phox, IL-1 beta, IFN-alpha, IL-18, Leukocyte elastase, Pin1, Fc gamma RII alpha, PAD4, PKC, TLR7, Alpha-defensin, p38 MAPK",1.690E-02,2.783E-02,16,"HMGB1, ERK1/2, IFN-alpha/beta receptor, p47-phox, IL-1 beta, IFN-alpha, IL-18, Leukocyte elastase, Pin1, p67-phox, Fc gamma RII alpha, PAD4, PKC, TLR7, Alpha-defensin, p38 MAPK",
975,Development_Activation of ERK by Kappa-type opioid receptor,31,1.690E-02,2.783E-02,4.417E-02,6.536E-02,16,"PKC-zeta, PI3K cat class IB (p110-gamma), IP3 receptor, Shc, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), c-Src, Pyk2(FAK2), G-protein alpha-i family, SOS, Dynorphin A(1-13), Kappa-type opioid receptor, PKC-alpha, PI3K reg class IB (p101)",1.690E-02,2.783E-02,16,"c-Raf-1, PI3K cat class IB (p110-gamma), IP3 receptor, Shc, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), Pyk2(FAK2), G-protein alpha-i family, SOS, Dynorphin A(1-13), Kappa-type opioid receptor, PKC-alpha",
976,Development_Regulation of lung epithelial progenitor cell differentiation,41,1.698E-02,2.783E-02,2.518E-02,3.963E-02,21,"SMAD5, NOTCH1 receptor, FGFR2, WNT3A, BMP4, Beta-catenin, SMAD4, FZD2, RBP-J kappa (CBF1), Tcf(Lef), GATA-6, O-fucose, SMAD9 (SMAD8), Uteroglobin, Podoplanin, WNT, BMPR1A, SMAD1, Jagged1, Frizzled, ERM",1.698E-02,2.783E-02,20,"p38alpha (MAPK14), SMAD5, NOTCH1 receptor, FGFR2, BMP4, Beta-catenin, SMAD4, FZD2, RBP-J kappa (CBF1), Tcf(Lef), GATA-6, O-fucose, SMAD9 (SMAD8), Podoplanin, STAT3, WNT, BMPR1A, Jagged1, Frizzled, ERM",
977,CFTR folding and maturation (normal and CF),24,1.713E-02,2.839E-02,1.713E-02,2.839E-02,14,"MA1B1, GANAB, UGCGL1, Sti1, DNAJB6 (Hdj-1), HSP40, HSP70, PARP-1, EDEM, Hdj-2, HSP90 beta, HSPBP1, Calnexin, FKBP8",2.030E-01,2.617E-01,10,"GANAB, UGCGL1, DNAJB6 (Hdj-1), HSP70, EDEM, CFTR, Hdj-2, HSP90 beta, Calnexin, FKBP8",
978,Immune response_TLR3 and TLR4 induced TICAM1-specific signaling pathway,33,1.753E-02,2.895E-02,1.753E-02,2.895E-02,18,"TRAM, MD-2, IFN-beta, PI3K reg class IA (p85), CD14, IFN-alpha, RIPK1, NF-kB, AKT(PKB), c-Src, PI3K cat class IA, TRAF3, TRAF6, TANK, TLR4, Beclin 1, TRIF (TICAM1), TLR3",3.316E-02,5.089E-02,16,"TRAM, MD-2, IFN-beta, PI3K reg class IA (p85), CD14, IFN-alpha, RIPK1, NF-kB, AKT(PKB), c-Src, PI3K cat class IA, TRAF3, TRAF6, TANK, TLR4, TLR3",
979,Development_Self-renewal and pluripotency maintenance of human embryonic stem cells,33,1.753E-02,2.895E-02,1.753E-02,2.895E-02,18,"p14ARF, WNT3A, Oct-3/4, BMP4, CRIPTO, PAX6, Eomesodermin, CGB3, Lefty-2, c-Myc, GATA-6, NODAL, CDX2, T brachyury protein, FGF2, ITGA6, WNT1, p53",1.304E-01,1.755E-01,14,"p14ARF, Oct-3/4, BMP4, CRIPTO, PAX6, Eomesodermin, CGB3, Lefty-2, GATA-6, NODAL, CDX2, FGF2, ITGA6, p53",
980,Role of ER stress in obesity and type 2 diabetes,54,1.758E-02,2.900E-02,1.758E-02,2.900E-02,27,"GRP78, C/EBP zeta, IRS-2, ATF-3, IRS-1, S2P, ATF-6 alpha (90kDa), GLUT4, PI3K reg class IA (p85), HMGCS1, LDLR, Resistin, HMDH, CREB1, PPAR-gamma, ATF-6 alpha (50kDa), PI3K cat class IA, PI3K reg class IA (p85-alpha), PKR, PTP-1B, SREBP2 (nuclear), JNK1(MAPK8), S1P, FDPS, AKT2, FDFT1, HXK4",1.032E-01,1.423E-01,22,"GRP78, C/EBP zeta, IRS-2, ATF-3, S2P, ATF-6 alpha (90kDa), PI3K reg class IA (p85), LDLR, HMDH, CREB1, PPAR-gamma, ATF-6 alpha (50kDa), PI3K cat class IA, PI3K reg class IA (p85-alpha), PKR, G6PT, SREBP2 (nuclear), JNK1(MAPK8), S1P, FDPS, FDFT1, HXK4",
981,Membrane-bound ESR1: interaction with G-proteins signaling,54,1.774E-02,2.899E-02,3.352E-02,5.102E-02,26,"ADAM12, ERK1/2, HB-EGF, PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, Cyclin D2, Shc, Adenylate cyclase, MEK2(MAP2K2), MMP-2, CREB1, G-protein beta/gamma, Striatin, c-Src, EGFR, G-protein alpha-i family, SOS, PKC-alpha, MMP-14, G-protein alpha-q, Caveolin-1, Elk-1, MMP-9, PKA-cat (cAMP-dependent), PLC-beta2",1.774E-02,2.899E-02,25,"ADAM12, ERK1/2, HB-EGF, c-Raf-1, IP3 receptor, Cyclin D2, Shc, Adenylate cyclase, MEK2(MAP2K2), MMP-2, CREB1, G-protein beta/gamma, Striatin, c-Src, MEK1(MAP2K1), EGFR, G-protein alpha-i family, SOS, PKC-alpha, MMP-14, Caveolin-1, Elk-1, MMP-9, PKA-cat (cAMP-dependent), PLC-beta2",
982,Development_Alpha-2 adrenergic receptor activation of ERK,62,1.838E-02,3.000E-02,1.626E-01,2.119E-01,26,"ADAM12, ERK1/2, HB-EGF, G-protein alpha-i2, IP3 receptor, G-protein alpha-i1, Shc, PI3K reg class IA, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, Pyk2(FAK2), PI3K cat class IA, PI3K reg class IA (p85-alpha), EGFR, G-protein alpha-i family, G-protein alpha-o, c-Jun, G-protein alpha-i3, SOS, Calmodulin, PLC-beta3, PLC-beta2",1.838E-02,3.000E-02,28,"CYP2C8, ADAM12, ERK1/2, HB-EGF, c-Raf-1, G-protein alpha-i2, IP3 receptor, G-protein alpha-i1, Shc, PI3K reg class IA, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), Pyk2(FAK2), PI3K cat class IA, PI3K reg class IA (p85-alpha), EGFR, G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, SOS, Calmodulin, PLC-beta3, PLC-beta2",
983,wtCFTR traffic / Sorting endosome formation (normal),22,1.871E-02,3.069E-02,1.871E-02,3.069E-02,13,"NSF, USP10, COMMD1 (MURR1), PI3K cat class III (Vps34), Ubiquitin, RABGEF1, Rab-7, Syntaxin 12, VAMP2, PI3K reg class III (p150), c-Cbl, Rab-5A, Rabenosyn-5",5.730E-02,8.309E-02,11,"USP10, SNAP-25, PI3K cat class III (Vps34), Ubiquitin, Syntaxin 12, VAMP2, PI3K reg class III (p150), c-Cbl, CFTR, Rab-5A, Rabenosyn-5",
984,Tissue factor signaling in lung cancer,24,1.890E-02,3.081E-02,4.386E-02,6.503E-02,13,"ERK1/2, VEGF-A, Coagulation factor X, Thrombin, MEK2(MAP2K2), AKT(PKB), Tissue factor, Coagulation factor V, PI3K cat class IA (p110-alpha), PAR1, Fibrinogen (fibrin), p53, mTOR",1.890E-02,3.081E-02,13,"ERK1/2, VEGF-A, Coagulation factor X, c-Raf-1, MEK2(MAP2K2), AKT(PKB), MEK1(MAP2K1), Tissue factor, Coagulation factor V, PI3K cat class IA (p110-alpha), PAR1, p53, mTOR",
985,Putative glucocorticoid- and LABA-mediated inhibition of pro-fibrotic signaling in airway fibroblasts/myofibroblasts,31,1.945E-02,3.184E-02,1.945E-02,3.184E-02,17,"TGF-beta 1, GCR, ERK1/2, PKA-reg (cAMP-dependent), Fibronectin, c-Jun, TIMP1, Collagen III, AP-1, ACTA2, JNK(MAPK8-10), Beta-2 adrenergic receptor, SMAD3, p38 MAPK, MMP-9, PKA-cat (cAMP-dependent), TGF-beta receptor type I",8.187E-02,1.149E-01,14,"TGF-beta 1, GCR, ERK1/2, Fibronectin, TIMP1, Collagen III, ACTA2, JNK(MAPK8-10), Beta-2 adrenergic receptor, SMAD3, p38 MAPK, MMP-9, PKA-cat (cAMP-dependent), TGF-beta receptor type I",
986,Immune response_CRTH2 signaling in Th2 cells,44,1.945E-02,3.161E-02,3.042E-02,4.687E-02,22,"Calcineurin A (catalytic), ICAM1, Apaf-1, 14-3-3, PI3K cat class IB (p110-gamma), IP3 receptor, BAD, Bax, GSK3 beta, PLC-beta, Adenylate cyclase, IL-13, G-protein beta/gamma, AKT(PKB), NF-AT2(NFATC1), ITGB2, G-protein alpha-i family, IL-5, Caspase-9, Calmodulin, PKC, PI3K reg class IB (p101)",1.945E-02,3.161E-02,21,"Calcineurin A (catalytic), ICAM1, Apaf-1, 14-3-3, PI3K cat class IB (p110-gamma), IP3 receptor, Bax, GSK3 beta, PLC-beta, Adenylate cyclase, G-protein beta/gamma, AKT(PKB), NF-AT2(NFATC1), CD40L(TNFSF5), ITGB2, CRTH2, G-protein alpha-i family, IL-5, Caspase-9, Calmodulin, PKC",
987,Arachidonic acid metabolites production in eosinophils in asthma,44,1.945E-02,3.161E-02,1.031E-01,1.402E-01,20,"IL-16 mature, alpha-4/beta-1 integrin, ICAM1, PGD2R, ALOX5AP, Fibronectin, cPLA2, GM-CSF, CD4, PA24A, Eotaxin, PTAFR, G-protein alpha-i family, IL-5, ALOX5, COX-2 (PTGS2), PKC, JNK(MAPK8-10), p38 MAPK, PKA-cat (cAMP-dependent)",1.945E-02,3.161E-02,21,"alpha-4/beta-1 integrin, ICAM1, PGD2R, ALOX5AP, Fibronectin, COX-1 (PTGS1), cPLA2, GM-CSF, CD4, PA24A, Eotaxin, PTAFR, CRTH2, G-protein alpha-i family, IL-5, ALOX5, COX-2 (PTGS2), PKC, JNK(MAPK8-10), p38 MAPK, PKA-cat (cAMP-dependent)",
988,Development_S1P1 signaling pathway,44,1.945E-02,3.161E-02,3.042E-02,4.687E-02,22,"CD44, G-protein alpha-i2, VAV-1, Rac1, IP3 receptor, G-protein alpha-i1, GSK3 beta, PLC-beta, Adenylate cyclase, G-protein beta/gamma, CDC42, AKT(PKB), c-Src, RhoA, Tiam1, S1P1 receptor, PI3K reg class IA (p85-alpha), G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, CD69, PI3K cat class IA (p110-alpha)",1.945E-02,3.161E-02,21,"CD44, G-protein alpha-i2, VAV-1, IP3 receptor, G-protein alpha-i1, GSK3 beta, PLC-beta, Adenylate cyclase, G-protein beta/gamma, CDC42, AKT(PKB), c-Src, RhoA, Tiam1, S1P1 receptor, PI3K reg class IA (p85-alpha), G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, CD69, PI3K cat class IA (p110-alpha)",
989,Nicotine signaling in chromaffin cells,45,2.021E-02,3.280E-02,2.021E-02,3.280E-02,23,"APC protein, ERK1/2, Beta-catenin, p90RSK2(RPS6KA3), PKA-reg (cAMP-dependent), nAChR, Ryanodine receptor 1, CREB1, DBH, MEK1/2, MAPRPE1(EB1), VAMP2, N-cadherin, Chromogranin A, nAChR alpha-5, nAChR beta-4, nAChR alpha3/beta4, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, nAChR alpha-3, PSD-95, PKA-cat (cAMP-dependent)",2.578E-02,4.092E-02,21,"SNAP-25, APC protein, ERK1/2, Beta-catenin, p90RSK2(RPS6KA3), c-Raf-1, Ryanodine receptor 1, CREB1, MEK1/2, MAPRPE1(EB1), VAMP2, N-cadherin, nAChR alpha-5, nAChR beta-4, nAChR alpha3/beta4, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, nAChR alpha-3, PSD-95, PKA-cat (cAMP-dependent)",
990,Regulation of relaxation of airway smooth muscle cells,45,2.021E-02,3.280E-02,2.021E-02,3.280E-02,23,"PGD2R, 14-3-3, PKA-reg (cAMP-dependent), Rac1, IP3 receptor, Prostacyclin receptor, G-protein beta/gamma, VIP, Guanylate Cyclase 1, soluble, c-Src, MLCK, PGE2R2, RhoA, PGE2R4, PKA-cat alpha, RAP-1B, F-Actin cytoskeleton, Protein kinase G, HSP20, PACAP, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent), Cofilin",5.030E-02,7.394E-02,20,"PGD2R, 14-3-3, IP3 receptor, G-protein beta/gamma, Guanylate Cyclase 1, soluble, c-Src, MLCK, PGE2R2, RhoA, PGE2R4, PKA-cat gamma, PKA-cat alpha, RAP-1B, F-Actin cytoskeleton, Protein kinase G, HSP20, PACAP, Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent), Cofilin",
991,Neurophysiological process_Glutamic acid regulation of Dopamine D1A receptor signaling,45,2.021E-02,3.280E-02,2.021E-02,3.280E-02,23,"mGluR1, CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PP1-cat, Casein kinase I epsilon, PP2A regulatory, Proenkephalin-B, PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, PP2A structural, CREB1, Striatin, GABA-A receptor beta-2 subunit, GABA-A receptor beta-1 subunit, PP2A catalytic, DARPP-32, Calmodulin, G-protein alpha-q, Calcineurin B (regulatory), PKA-cat (cAMP-dependent), PLC-beta2",1.523E-01,2.011E-01,18,"mGluR1, CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PP1-cat, Casein kinase I epsilon, PP2A regulatory, Proenkephalin-B, IP3 receptor, PP2A structural, CREB1, Striatin, PP2A catalytic, DARPP-32, Calmodulin, Calcineurin B (regulatory), PKA-cat (cAMP-dependent), PLC-beta2",
992,Development_Activation of ERK by Alpha-1 adrenergic receptors,45,2.021E-02,3.280E-02,2.021E-02,3.280E-02,23,"PI3K cat class IA (p110-beta), ERK1/2, PKC-epsilon, PLC-beta1, IP3 receptor, Shc, MEK2(MAP2K2), G-protein beta/gamma, Alpha-1B adrenergic receptor, c-Src, Pyk2(FAK2), G-protein alpha-15, PI3K reg class IA (p85-alpha), PKC-delta, G-protein alpha-o, c-Jun, SOS1, Calmodulin, PKC-alpha, PLC-delta 1, TGM2, G-protein alpha-q, Alpha-1D adrenergic receptor",2.578E-02,4.092E-02,21,"PI3K cat class IA (p110-beta), ERK1/2, c-Raf-1, PKC-epsilon, IP3 receptor, Shc, MEK2(MAP2K2), G-protein beta/gamma, Alpha-1B adrenergic receptor, c-Src, MEK1(MAP2K1), Pyk2(FAK2), G-protein alpha-15, PI3K reg class IA (p85-alpha), G-protein alpha-o, SOS1, Calmodulin, PKC-alpha, PLC-delta 1, TGM2, Alpha-1D adrenergic receptor",
993,Proinflammatory mediators production and activation of basophils in asthma,45,2.021E-02,3.280E-02,2.021E-02,3.280E-02,23,"TrkA, MHC class II, Calcineurin A (catalytic), DHA2, ERK1/2, ENPP3, I-kB, PI3K reg class IA (p85), IKK-alpha, IL-13, NF-kB, AKT(PKB), NF-AT2(NFATC1), PI3K cat class IA, HIF1A, IL-8, Leptin receptor, NGF, ST2(L), ITGA4, IL-33, Calcineurin B (regulatory), p38 MAPK",5.030E-02,7.394E-02,20,"MHC class II, Calcineurin A (catalytic), DHA2, ERK1/2, I-kB, PI3K reg class IA (p85), NF-kB, AKT(PKB), NF-AT2(NFATC1), PI3K cat class IA, HIF1A, CRTH2, IL-8, Leptin receptor, NGF, ST2(L), ITGA4, IL-33, Calcineurin B (regulatory), p38 MAPK",
994,G-protein signaling_Regulation of Cyclic AMP levels by ACM,45,2.021E-02,3.280E-02,2.021E-02,3.280E-02,23,"PDE1A, G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, Adenylate cyclase type VII, PLC-beta, ACM4, G-protein beta/gamma, ACM5, PLC-epsilon, Adenylate cyclase type III, PKC-delta, ACM2, G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, ACM3, PDE1C, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, G-protein alpha-q, RAP-2B",5.030E-02,7.394E-02,20,"PDE1A, G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, Adenylate cyclase type VII, PLC-beta, ACM4, G-protein beta/gamma, ACM5, PLC-epsilon, Adenylate cyclase type III, G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, ACM3, PDE1C, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, RAP-2B",
995,Activation of Ca2+-dependent neuronal cell death in Huntington's disease,38,2.029E-02,3.284E-02,2.029E-02,3.284E-02,20,"Calcineurin A (catalytic), PP1-cat, Hap-1, Bax, Caspase-3, Calpain 1(mu), Calcineurin A (alpha), Thioredoxin, ASK1 (MAP3K5), DAPK1, c-Jun, MKK7 (MAP2K7), nNOS, JNK1(MAPK8), MEK4(MAP2K4), ATF-2, PSD-95, JNK2(MAPK9), Calcineurin B (regulatory), p38 MAPK",1.173E-01,1.587E-01,16,"Calcineurin A (catalytic), PP1-cat, Bax, Caspase-3, Calpain 1(mu), Calcineurin A (alpha), ASK1 (MAP3K5), DAPK1, nNOS, JNK1(MAPK8), MEK4(MAP2K4), ATF-2, PSD-95, JNK2(MAPK9), Calcineurin B (regulatory), p38 MAPK",
996,Development_Mu-type opioid receptor signaling,38,2.029E-02,3.284E-02,2.029E-02,3.284E-02,20,"STAT5A, RHEB2, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, beta-Endorphin extracellular region, G-protein beta/gamma, CDC42, AKT(PKB), c-Src, G-protein alpha-i family, SOS, MKK7 (MAP2K7), MEK4(MAP2K4), 4E-BP1, MEKK1(MAP3K1), JNK(MAPK8-10), PI3K reg class IB (p101), PLC-beta3, mTOR",1.173E-01,1.587E-01,16,"STAT5A, RHEB2, PI3K cat class IB (p110-gamma), IP3 receptor, beta-Endorphin extracellular region, G-protein beta/gamma, CDC42, AKT(PKB), c-Src, G-protein alpha-i family, SOS, MEK4(MAP2K4), Mu-type opioid receptor, JNK(MAPK8-10), PLC-beta3, mTOR",
997,Regulation of degradation of wtCFTR,20,2.035E-02,3.288E-02,2.035E-02,3.288E-02,12,"NPL4, Ubiquitin, BAG-2, UBE2J1, UBE2D1, HSP90, RNF5, SEC61 complex, HSC70, UBE1, HSPBP1, MJD (ataxin-3)",6.867E-02,9.796E-02,10,"NPL4, Ubiquitin, BAG-2, UBE2J1, UBE2D1, HSP90, RNF5, SEC61 complex, CFTR, MJD (ataxin-3)",
998,Cigarette smoke-mediated regulation of NRF2-antioxidant pathway in airway epithelial cells,29,2.158E-02,3.471E-02,2.158E-02,3.471E-02,16,"CYP1B1, GSTO1, UGT1A4, Pirin, Catalase, Heme oxygenase 1, KEAP1, PKC-delta, SRX1, GCL reg, DJ-1, PRDX1, GSTA1, GCL cat, TXNRD1, NRF2",2.979E-01,3.690E-01,11,"CYP1B1, UGT1A4, Pirin, Catalase, Heme oxygenase 1, KEAP1, SRX1, GCL reg, GCL cat, TXNRD1, NRF2",
999,EZH2 in Prostate Cancer,29,2.158E-02,3.471E-02,2.158E-02,3.471E-02,16,"AIP1 (DAB2ip), RUNX3, DARC, EED, VAV-1, Keratin 17, Follistatin, EZH2, YY1, Alpha-synuclein, Cathepsin G, ITGB2, WNT2, SUZ12, HDAC1, Ephrin-B receptor 6",4.670E-02,6.934E-02,14,"RUNX3, DARC, EED, VAV-1, Keratin 17, Follistatin, EZH2, Alpha-synuclein, Cathepsin G, ITGB2, WNT2, SUZ12, HDAC1, Ephrin-B receptor 6",
1000,Regulation of CFTR activity (normal and CF),62,2.176E-02,3.497E-02,2.176E-02,3.497E-02,30,"Casein kinase II, alpha chains, Calcineurin A (catalytic), Protein kinase G 2, COMMD1 (MURR1), AMPK beta subunit, PGE2R1, PP2A regulatory, PKA-reg (cAMP-dependent), PP2C, Syntaxin 1A, PKC-epsilon, Syk, LPAR2, PP2A structural, Adenylate cyclase, AMPK alpha 1 subunit, S100A10, Tubulin (in microtubules), Casein kinase II, beta chain (Phosvitin), RACK1, PGE2R4, Annexin V, Adenosine A2b receptor, MUNC18, G-protein alpha-i family, PP2A catalytic, Annexin II, Beta-2 adrenergic receptor, Filamin A, PKA-cat (cAMP-dependent)",3.378E-02,5.168E-02,27,"Casein kinase II, alpha chains, Calcineurin A (catalytic), Protein kinase G 2, AMPK beta subunit, PGE2R1, PP2A regulatory, PP2C, PKC-epsilon, Syk, LPAR2, PP2A structural, Adenylate cyclase, AMPK alpha 1 subunit, S100A10, Tubulin (in microtubules), Casein kinase II, beta chain (Phosvitin), RACK1, PGE2R4, Annexin V, Adenosine A2b receptor, G-protein alpha-i family, CFTR, PP2A catalytic, Annexin II, Beta-2 adrenergic receptor, Filamin A, PKA-cat (cAMP-dependent)",
1001,"Role of inflammasome in macrophages, adipocytes and pancreatic beta cells in type 2 diabetes",18,2.202E-02,3.531E-02,2.202E-02,3.531E-02,11,"IL1RN, CARD8, IL-1 beta, NF-kB, Caspase-1, Thioredoxin, IL-18, p300, Cathepsin B, NRF2, NALP3",8.258E-02,1.157E-01,9,"IL1RN, IL-1 beta, NF-kB, Caspase-1, IL-18, p300, Cathepsin B, NRF2, NALP3",
1002,Androgen signaling in HCC,18,2.202E-02,3.531E-02,2.202E-02,3.531E-02,11,"TGF-beta 1, Peg10, GADD45 beta, EGR1, SIAH1, GADD45 alpha, TERT, HGF, SRD5A1, p53, HGF receptor (Met)",3.123E-02,4.833E-02,10,"TGF-beta 1, Peg10, GADD45 beta, SIAH1, GADD45 alpha, TERT, HGF, SRD5A1, p53, HGF receptor (Met)",
1003,Development_S1P4 receptor signaling pathway,22,2.232E-02,3.596E-02,2.135E-01,2.700E-01,10,"ERK1/2, IP3 receptor, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, CDC42, RhoA, G-protein alpha-12 family, G-protein alpha-i family, Elk-1",2.232E-02,3.596E-02,12,"ERK1/2, c-Raf-1, IP3 receptor, PLC-beta, MEK2(MAP2K2), G-protein beta/gamma, CDC42, MEK1(MAP2K1), RhoA, G-protein alpha-12 family, G-protein alpha-i family, Elk-1",
1004,"Nicotine signaling in dopaminergic neurons, Pt. 2 - axon terminal",43,2.255E-02,3.597E-02,2.255E-02,3.597E-02,22,"CDK5R1 (p35), CDK5, Calcineurin A (catalytic), PP1-cat, Casein kinase I epsilon, PKA-reg (cAMP-dependent), IP3 receptor, Plasminogen, PLC-beta, PLAT (TPA), CREB1, VAMP2, Dopamine D2 receptor, G-protein alpha-i family, Plasmin, DARPP-32, Calmodulin, G-protein alpha-q, PAR1, Calcineurin B (regulatory), PAI1, PKA-cat (cAMP-dependent)",5.891E-02,8.493E-02,19,"CDK5R1 (p35), CDK5, Calcineurin A (catalytic), SNAP-25, PP1-cat, Casein kinase I epsilon, IP3 receptor, PLC-beta, PLAT (TPA), CREB1, VAMP2, Dopamine D2 receptor, G-protein alpha-i family, DARPP-32, Calmodulin, PAR1, Calcineurin B (regulatory), PAI1, PKA-cat (cAMP-dependent)",
1005,ESR1 (membrane) 36 kDa isoform signaling in breast cancer,43,2.255E-02,3.597E-02,2.255E-02,3.597E-02,22,"STAT5A, RANKL(TNFSF11), ERK1/2, IP3 receptor, Shc, PI3K reg class IA, PLC-beta, AL1A1, MEK1/2, AKT(PKB), HSP90, c-Src, c-Myc, CXCR4, PI3K cat class IA, EGFR, c-Jun, SOS, PKC-alpha, G-protein alpha-q, JNK(MAPK8-10), SNAIL1",3.033E-02,4.709E-02,20,"STAT5A, RANKL(TNFSF11), ERK1/2, c-Raf-1, IP3 receptor, Shc, PI3K reg class IA, PLC-beta, AL1A1, MEK1/2, AKT(PKB), HSP90, c-Src, CXCR4, PI3K cat class IA, EGFR, SOS, PKC-alpha, JNK(MAPK8-10), SNAIL1",
1006,Development_S1P3 receptor signaling pathway,43,2.255E-02,3.597E-02,2.255E-02,3.597E-02,22,"CD44, ROCK1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, PI3K reg class IA, PLC-beta, Adenylate cyclase, G-protein beta/gamma, AKT(PKB), PDGF receptor, c-Src, RhoA, Tiam1, PI3K cat class IA, ROCK2, G-protein alpha-i family, Calmodulin, G-protein alpha-q, PI3K reg class IB (p101)",5.891E-02,8.493E-02,19,"CD44, ROCK1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, PI3K reg class IA, PLC-beta, Adenylate cyclase, G-protein beta/gamma, AKT(PKB), PDGF receptor, c-Src, RhoA, Tiam1, PI3K cat class IA, ROCK2, G-protein alpha-i family, Calmodulin",
1007,Prolactin/ ERK signaling in breast cancer,36,2.261E-02,3.599E-02,2.261E-02,3.599E-02,19,"SPHK1, ERK1/2, Rac1, Shc, PI3K reg class IA (p85), GSK3 beta, MMP-2, MEK1/2, AKT(PKB), c-Src, c-Myc, JAK2, PI3K cat class IA, c-Jun, SOS, NEK3, Paxillin, Elk-1, Prolactin",7.528E-02,1.066E-01,16,"SPHK1, ERK1/2, c-Raf-1, Shc, PI3K reg class IA (p85), GSK3 beta, MMP-2, MEK1/2, AKT(PKB), c-Src, JAK2, PI3K cat class IA, SOS, NEK3, Elk-1, Prolactin",
1008,"Development_Lipoxin inhibitory action on PDGF, EGF and LTD4 signaling",36,2.261E-02,3.599E-02,2.261E-02,3.599E-02,19,"PLD1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, AHR, PI3K reg class IA (p85), PLC-gamma 1, Adenylate cyclase, CysLT2 receptor, c-Src, FPRL1, RhoA, Thioredoxin, PRDX2, EGFR, G-protein alpha-i family, PPAPDC2, SHP-2, PKA-cat (cAMP-dependent), PDGF-R-beta",1.369E-01,1.830E-01,15,"PLD1, G-protein alpha-q/11, AHR, PI3K reg class IA (p85), PLC-gamma 1, Adenylate cyclase, CysLT2 receptor, c-Src, FPRL1, RhoA, EGFR, G-protein alpha-i family, PPAPDC2, PKA-cat (cAMP-dependent), PDGF-R-beta",
1009,Development_Delta-type opioid receptor mediated cardioprotection,37,2.367E-02,3.793E-02,1.160E-01,1.559E-01,17,"ADAM12, HB-EGF, GSK3 beta, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, JAK2, PI3K cat class IA, Metenkefalin, Delta-type opioid receptor, PKC-delta, EGFR, G-protein alpha-i family",2.367E-02,3.793E-02,18,"ADAM12, HB-EGF, c-Raf-1, GSK3 beta, PI3K reg class IA, PLC-gamma 1, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), c-Src, MEK1(MAP2K1), JAK2, PI3K cat class IA, Metenkefalin, EGFR, G-protein alpha-i family, STAT3",
1010,Activation of osteoclast differentiation in bone lesions formation in multiple myeloma,27,2.369E-02,3.793E-02,5.568E-02,8.048E-02,14,"alpha-4/beta-1 integrin, RANKL(TNFSF11), ERK1/2, IKK-alpha, MEK2(MAP2K2), Osteoprotegerin, NF-AT2(NFATC1), Sequestosome 1(p62), VCAM1, RelA (p65 NF-kB subunit), TRAF6, RANK(TNFRSF11A), PKC-lambda/iota, p38 MAPK",2.369E-02,3.793E-02,14,"alpha-4/beta-1 integrin, RANKL(TNFSF11), ERK1/2, MEK2(MAP2K2), Osteoprotegerin, NF-AT2(NFATC1), MEK1(MAP2K1), Sequestosome 1(p62), VCAM1, RelA (p65 NF-kB subunit), TRAF6, RANK(TNFRSF11A), PKC-lambda/iota, p38 MAPK",
1011,Development_Generation of pancreatic beta-cells from induced pluripotent stem cells,27,2.393E-02,3.796E-02,2.393E-02,3.796E-02,15,"GLUT2, WNT3A, Oct-3/4, Nkx6.1, HNF3-beta, NeuroD1, Nkx2.2, c-Myc, SOX9, Activin A, Pdx-1 (IPF1), SOX17, FGF2, Noggin, FGF7",2.108E-01,2.709E-01,11,"GLUT2, Oct-3/4, Nkx6.1, HNF3-beta, NeuroD1, SOX9, Activin A, Pdx-1 (IPF1), SOX17, FGF2, Noggin",
1012,DeltaF508-CFTR traffic / Sorting endosome formation in CF,27,2.393E-02,3.796E-02,2.393E-02,3.796E-02,15,"NSF, USP10, COMMD1 (MURR1), PI3K cat class III (Vps34), Ubiquitin, RABGEF1, Rab-7, Syntaxin 12, VAMP2, PI3K reg class III (p150), Hrs, c-Cbl, Rab-5A, Rabenosyn-5, STAM2",1.150E-01,1.561E-01,12,"USP10, SNAP-25, PI3K cat class III (Vps34), Ubiquitin, Syntaxin 12, VAMP2, PI3K reg class III (p150), Hrs, c-Cbl, CFTR, Rab-5A, Rabenosyn-5",
1013,Signal transduction_mTORC1 downstream signaling,60,2.423E-02,3.840E-02,2.423E-02,3.840E-02,29,"SC5D, Rictor, IRS-1, RPS6, PPAR-alpha, eIF4E, ATF-4, SGK1, VEGF-A, CBP80, TFEB, UBF, BAD, GSK3 beta, YY1, PPAR-gamma, PDIP46, LIPIN1, HIF1A, Cyclin D, eEF2K, CAD, SREBP2 (nuclear), ULK2, 4E-BP1, eIF4A, ATG13, p53, PFKP",1.693E-01,2.211E-01,23,"SC5D, PDK1, Rictor, RPS6, PPAR-alpha, SGK1, VEGF-A, CBP80, TFEB, UBF, GSK3 beta, PPAR-gamma, PDIP46, LIPIN1, HIF1A, Cyclin D, CAD, SREBP2 (nuclear), ULK2, STAT3, eIF4A, p53, PFKP",
1014,Putative role of Estrogen receptor and Androgen receptor signaling in progression of lung cancer,58,2.501E-02,3.982E-02,4.837E-02,7.094E-02,27,"CYP1B1, RHEB2, CYP1A1, TMPRSS2, Apaf-1, ERK1/2, 14-3-3, BAD, Shc, Bax, Caspase-3, MEK2(MAP2K2), CYP19, CREB1, ERK2 (MAPK1), c-Src, EGFR, G-protein alpha-i family, TAS2R50, SOS, Caspase-9, NCOA2 (GRIP1/TIF2), NCOA1 (SRC1), SRD5A1, Caveolin-1, p38 MAPK, mTOR",2.501E-02,3.982E-02,26,"CYP1B1, RHEB2, CYP1A1, TMPRSS2, Apaf-1, ERK1/2, 14-3-3, c-Raf-1, Shc, Bax, Caspase-3, MEK2(MAP2K2), CREB1, ERK2 (MAPK1), c-Src, MEK1(MAP2K1), EGFR, G-protein alpha-i family, SOS, Caspase-9, NCOA2 (GRIP1/TIF2), NCOA1 (SRC1), SRD5A1, Caveolin-1, p38 MAPK, mTOR",
1015,Signaling Transduction_Role of MIF as an intracellular mediator,41,2.518E-02,3.963E-02,2.518E-02,3.963E-02,21,"CDC25A, HDAC3, FGF8, Vimentin, IL-1 beta, Bax, MIF, PRSS11 (HtrA1), RelA (p65 NF-kB subunit), PARP-1, IL-18, c-Jun, Cul1/Rbx1 E3 ligase, Cullin 1, FGF18, JNK(MAPK8-10), HDAC1, p53, Bim, COPS6, NALP3",6.902E-02,9.809E-02,18,"CDC25A, HDAC3, FGF8, Vimentin, IL-1 beta, Bax, MIF, PRSS11 (HtrA1), RelA (p65 NF-kB subunit), IL-18, Cul1/Rbx1 E3 ligase, Cullin 1, JNK(MAPK8-10), HDAC1, p53, Bim, COPS6, NALP3",
1016,Mechanism of action of CCR4 antagonists in asthma and atopic dermatitis (Variant 1),34,2.522E-02,3.963E-02,2.522E-02,3.963E-02,18,"alpha-4/beta-1 integrin, ICAM1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, G-protein beta/gamma, Cytohesin1, c-Src, ITGB1, VCAM1, CALDAG-GEFI, ITGB2, PKC-delta, G-protein alpha-i family, PLC-beta3, CCR4, PLC-beta2",4.460E-02,6.641E-02,16,"alpha-4/beta-1 integrin, ICAM1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, G-protein beta/gamma, Cytohesin1, c-Src, ITGB1, VCAM1, ITGB2, G-protein alpha-i family, PLC-beta3, CCR4, PLC-beta2",
1017,CCR4-dependent immune cell chemotaxis in asthma and atopic dermatitis ,34,2.522E-02,3.963E-02,2.522E-02,3.963E-02,18,"alpha-4/beta-1 integrin, ICAM1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, G-protein beta/gamma, Cytohesin1, c-Src, ITGB1, VCAM1, CALDAG-GEFI, ITGB2, PKC-delta, G-protein alpha-i family, PLC-beta3, CCR4, PLC-beta2",4.460E-02,6.641E-02,16,"alpha-4/beta-1 integrin, ICAM1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, G-protein beta/gamma, Cytohesin1, c-Src, ITGB1, VCAM1, ITGB2, G-protein alpha-i family, PLC-beta3, CCR4, PLC-beta2",
1018,Chemotaxis_CCR4-induced chemotaxis of immune cells,34,2.522E-02,3.963E-02,2.522E-02,3.963E-02,18,"alpha-4/beta-1 integrin, ICAM1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, G-protein beta/gamma, Cytohesin1, c-Src, ITGB1, VCAM1, CALDAG-GEFI, ITGB2, PKC-delta, G-protein alpha-i family, PLC-beta3, CCR4, PLC-beta2",4.460E-02,6.641E-02,16,"alpha-4/beta-1 integrin, ICAM1, PI3K cat class IB (p110-gamma), IP3 receptor, Talin, RAP-1A, G-protein beta/gamma, Cytohesin1, c-Src, ITGB1, VCAM1, ITGB2, G-protein alpha-i family, PLC-beta3, CCR4, PLC-beta2",
1019,G-protein signaling_G-Protein alpha-q signaling cascades,34,2.522E-02,3.963E-02,2.522E-02,3.963E-02,18,"LARG, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, I-kB, Shc, PLC-beta, IKK-alpha, G-protein beta/gamma, NF-kB, AKT(PKB), RGS2, RhoA, Pyk2(FAK2), PI3K cat class IA, SOS, ROCK, PLC-gamma",4.460E-02,6.641E-02,16,"G-protein alpha-q/11, PKC-epsilon, IP3 receptor, I-kB, Shc, PLC-beta, G-protein beta/gamma, NF-kB, AKT(PKB), RGS2, RhoA, Pyk2(FAK2), PI3K cat class IA, SOS, ROCK, PLC-gamma",
1020,Development_Membrane-bound ESR1: interaction with growth factors signaling,45,2.578E-02,4.092E-02,1.264E-01,1.690E-01,20,"CBP, IRS-1, ERK1/2, Shc, PI3K reg class IA, PELP1, MEK2(MAP2K2), GSK3 alpha/beta, CREB1, N-CoR, AKT(PKB), c-Src, PI3K cat class IA, B-Raf, SOS, p300, p130CAS, NCOA1 (SRC1), Caveolin-1, Elk-1",2.578E-02,4.092E-02,21,"CBP, ERK1/2, Shc, PI3K reg class IA, PELP1, MEK2(MAP2K2), GSK3 alpha/beta, CREB1, N-CoR, AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, B-Raf, SOS, p90RSK1, p300, p130CAS, NCOA1 (SRC1), Caveolin-1, Elk-1",
1021,ENaC regulation in normal and CF airways ,53,2.585E-02,4.049E-02,2.585E-02,4.049E-02,26,"GCR, SERPINE2, ERK1/2, PKA-reg (cAMP-dependent), Matriptase, G-protein alpha-q/11, Syntaxin 1A, RAP-1A, PI3K reg class IA, PLC-beta, Endothelin-1, Adenylate cyclase, G-protein beta/gamma, c-Src, cPKC (conventional), WWP2, PI3K cat class IA, Protein kinase G, AMPK alpha subunit, C3G, NEDD4, EDNRB, NEDD4L, Beta-2 adrenergic receptor, Furin, PKA-cat (cAMP-dependent)",4.965E-02,7.320E-02,23,"GCR, SERPINE2, ERK1/2, Matriptase, G-protein alpha-q/11, RAP-1A, PI3K reg class IA, PLC-beta, Endothelin-1, Adenylate cyclase, G-protein beta/gamma, c-Src, cPKC (conventional), WWP2, PI3K cat class IA, Protein kinase G, AMPK alpha subunit, CFTR, EDNRB, NEDD4L, Beta-2 adrenergic receptor, Furin, PKA-cat (cAMP-dependent)",
1022,Development_Schema: Embryonal myogenesis,12,2.628E-02,4.113E-02,2.628E-02,4.113E-02,8,"WNT3A, BMP4, FGF8, WNT7A, CXCR4, HGF, WNT1, HGF receptor (Met)",1.479E-01,1.963E-01,6,"BMP4, FGF8, WNT7A, CXCR4, HGF, HGF receptor (Met)",
1023,Role of Langerin+ dermal dendritic cells in contact hypersensitivity,20,2.639E-02,4.175E-02,2.429E-01,3.033E-01,9,"GLG1, Langerin, CCL2, PSGL-1, ITGAE, FLT3 ligand, P-selectin, ITGB2, CCL19",2.639E-02,4.175E-02,11,"GLG1, Langerin, CCL21, CCL2, PSGL-1, ITGAE, FLT3 ligand, P-selectin, ITGB2, CCL19, STAT3",
1024,Role of Nicotine-induced Leptin resistance in hypothalamus in development of obesity,25,2.812E-02,4.406E-02,2.346E-01,2.934E-01,11,"ERK1/2, FKHR, SOCS3, AKT(PKB), POMC, JAK2, NPY, AMPK alpha subunit, AGRP, Leptin receptor, mTOR",2.812E-02,4.406E-02,13,"ERK1/2, FKHR, SOCS3, AKT(PKB), MEK1(MAP2K1), POMC, JAK2, NPY, AMPK alpha subunit, AGRP, Leptin receptor, STAT3, mTOR",
1025,Development_Cross-talk between VEGF and Angiopoietin 1 signaling pathways,25,2.812E-02,4.406E-02,6.264E-02,8.941E-02,13,"TIE2, ICAM1, VEGF-A, VEGFR-2, IP3 receptor, I-kB, RIPK1, NF-kB, c-Src, VCAM1, Angiopoietin 1, PKC-alpha, PLC-gamma",2.812E-02,4.406E-02,13,"TIE2, ICAM1, VEGF-A, VEGFR-2, IP3 receptor, I-kB, RIPK1, NF-kB, c-Src, VCAM1, Angiopoietin 1, PKC-alpha, PLC-gamma",
1026,Development_Schema: Histone H3 demethylases in stem cells,32,2.814E-02,4.376E-02,2.814E-02,4.376E-02,17,"HOXA13, p14ARF, UTX, HP1, RBB2, NRSF, HOXA7, p16INK4, GASC1, SCN2A, LSD1, Bcl-6, HOXA11, BCoR, PRC2 complex, p15, HOXA1",5.283E-02,7.728E-02,15,"HOXA13, p14ARF, UTX, HP1, RBB2, HOXA7, p16INK4, GASC1, SCN2A, LSD1, Bcl-6, HOXA11, PRC2 complex, p15, HOXA1",
1027,Development_Osteopontin signaling in osteoclasts,30,2.847E-02,4.443E-02,6.771E-02,9.602E-02,15,"CD44, Gelsolin, Syk, MSN (moesin), alpha-V/beta-3 integrin, CDC42, Actin cytoskeletal, c-Src, RhoA, Pyk2(FAK2), Osteopontin, PI3K reg class IA (p85-alpha), ROCK2, p130CAS, PI3K cat class IA (p110-alpha)",2.847E-02,4.443E-02,15,"CD44, Gelsolin, Syk, MSN (moesin), alpha-V/beta-3 integrin, CDC42, Actin cytoskeletal, c-Src, RhoA, Pyk2(FAK2), Osteopontin, PI3K reg class IA (p85-alpha), ROCK2, p130CAS, PI3K cat class IA (p110-alpha)",
1028,Retinoic acid maintains mucocilliary differentiation and mucins expression in normal and asthmatic airway epithelium,30,2.847E-02,4.443E-02,3.528E-01,4.292E-01,12,"RARbeta, ERK1/2, p90RSK2(RPS6KA3), GCNT3, MEK2(MAP2K2), IL-13, CREB1, Mucin 4, TNF-alpha, CYP26A1, Leukocyte elastase, PKC-alpha",2.847E-02,4.443E-02,15,"RARbeta, ERK1/2, p90RSK2(RPS6KA3), c-Raf-1, GCNT3, MEK2(MAP2K2), SPRR1A, CREB1, Mucin 4, TNF-alpha, MEK1(MAP2K1), CYP26A1, Leukocyte elastase, p90RSK1, PKC-alpha",
1029,"Immune response_Mast cell proliferation, differentiation and survival",30,2.847E-02,4.443E-02,3.141E-02,4.815E-02,16,"ERK1/2, c-Kit, Syk, Shc, PI3K reg class IA (p85), Fyn, SHIP, AKT(PKB), GAB2, JAK2, Lyn, PI3K cat class IA (p110-alpha), SHP-2, STAT5, JNK(MAPK8-10), MITF",2.847E-02,4.443E-02,15,"ERK1/2, c-Kit, Syk, Shc, PI3K reg class IA (p85), Fyn, AKT(PKB), GAB2, JAK2, Lyn, STAT3, PI3K cat class IA (p110-alpha), STAT5, JNK(MAPK8-10), MITF",
1030,Development_Transcription factors in segregation of hepatocytic lineage,30,2.847E-02,4.443E-02,3.141E-02,4.815E-02,16,"TGF-beta 1, p14ARF, FGFR2, HNF1-alpha, Beta-catenin, A2M, Activin, Follistatin, GGTL3, p16INK4, Keratin 7, Activin A, TGF-beta receptor type II, HHEX (PRH), HGF receptor (Met), HNF4-alpha",2.847E-02,4.443E-02,15,"TGF-beta 1, p14ARF, FGFR2, Beta-catenin, A2M, Activin, Follistatin, AFP, GGTL3, p16INK4, Activin A, TGF-beta receptor type II, HHEX (PRH), HGF receptor (Met), HNF4-alpha",
1031,Immune response_Fc epsilon RI pathway: calcium-dependent signaling,68,2.849E-02,4.425E-02,2.849E-02,4.425E-02,32,"TRPC5, STIM1, DOCK5, PLD1, ERK1/2, Rac1, IP3 receptor, Fc epsilon RI alpha, Syk, GSK3 beta, NCK2, TRPC1, ERM proteins, cPLA2, CDC42, Fyn, AKT(PKB), c-Src, GAB2, RhoA, Lyn, FGR, Myosin II, PP2A catalytic, SK4/IK1, PLD2, PKC-beta2, Paxillin, ROCK, Calmodulin, PKC-alpha, SHP-2",3.816E-02,5.785E-02,29,"TRPC5, STIM1, PLD1, ERK1/2, IP3 receptor, Fc epsilon RI alpha, Syk, GSK3 beta, NCK2, TRPC1, ERM proteins, cPLA2, CDC42, Fyn, AKT(PKB), c-Src, GAB2, RhoA, Lyn, FGR, Myosin II, Fc epsilon RI beta, PP2A catalytic, SK4/IK1, PLD2, PKC-beta2, ROCK, Calmodulin, PKC-alpha",
1032,Impaired inhibitory action of lipoxins on neutrophil migration in CF,56,2.918E-02,4.544E-02,3.007E-02,4.643E-02,27,"PLD1, ICAM1, ERK1/2, PKC-zeta, Alpha-actinin, Rac2, LIMK1, PI3K cat class IB (p110-gamma), Rac1, Talin, MLCP (reg), G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), MYLK1, MLCK, MLCP (cat), FPRL1, ITGB2, IL-8, G-protein alpha-i family, Myosin II, PPAPDC2, MRLC, MELC, PI3K reg class IB (p101), Cofilin",2.918E-02,4.544E-02,25,"PLD1, ICAM1, ERK1/2, Alpha-actinin, Rac2, LIMK1, PI3K cat class IB (p110-gamma), Talin, MLCP (reg), G-protein beta/gamma, Actin cytoskeletal, AKT(PKB), MYLK1, MLCK, MLCP (cat), FPRL1, ITGB2, IL-8, G-protein alpha-i family, Myosin II, CFTR, PPAPDC2, MRLC, MELC, Cofilin",
1033,Translation_Opioid receptors in regulation of translation ,23,2.938E-02,4.546E-02,2.938E-02,4.546E-02,13,"RHEB2, PI3K cat class IB (p110-gamma), G-protein beta/gamma, AKT(PKB), Leu-enkephalin, Metenkefalin, Delta-type opioid receptor, G-protein alpha-i family, Dynorphin A(1-13), Kappa-type opioid receptor, 4E-BP1, PI3K reg class IB (p101), mTOR",7.919E-02,1.115E-01,11,"RHEB2, PI3K cat class IB (p110-gamma), G-protein beta/gamma, AKT(PKB), Leu-enkephalin, Metenkefalin, G-protein alpha-i family, Dynorphin A(1-13), Kappa-type opioid receptor, Mu-type opioid receptor, mTOR",
1034,Cytoskeleton remodeling_CDC42 in cellular processes,23,2.938E-02,4.546E-02,2.938E-02,4.546E-02,13,"CEP3, PKC-zeta, CEP2, LIMK1, CDC42, Actin cytoskeletal, COPG2, MLK3(MAP3K11), Destrin, F-Actin cytoskeleton, MRCKalpha, N-WASP, Cofilin",2.902E-01,3.598E-01,9,"CEP3, c-Raf-1, LIMK1, CDC42, Actin cytoskeletal, COPG2, MLK3(MAP3K11), F-Actin cytoskeleton, Cofilin",
1035,Apoptosis and survival_NO signaling in apoptosis,23,2.938E-02,4.546E-02,2.938E-02,4.546E-02,13,"Bak, Rac1, Bax, SIAH1, Mcl-1, G3P2, iNOS, ASK1 (MAP3K5), Guanylate cyclase (alpha-1/beta-1), MKK7 (MAP2K7), nNOS, JNK1(MAPK8), p38 MAPK",2.902E-01,3.598E-01,9,"Bax, SIAH1, Mcl-1, iNOS, ASK1 (MAP3K5), Guanylate cyclase (alpha-1/beta-1), nNOS, JNK1(MAPK8), p38 MAPK",
1036,Platelet activation as a result of endothelial dysfunction after stenting,56,3.007E-02,4.643E-02,3.007E-02,4.643E-02,27,"ARHGEF1 (p115RhoGEF), PKA-reg (cAMP-dependent), PDE3A, IP3 receptor, Plasminogen, Prostacyclin receptor, Thrombin, alpha-IIb/beta-3 integrin, PLAT (TPA), VASP, Adenylate cyclase, Actin cytoskeletal, RhoA, G-protein alpha-i family, Guanylate cyclase (alpha-1/beta-1), PDE2A, Plasmin, TBXA2R, PKC, P2Y1, G-protein alpha-q, PAR1, Fibrinogen (fibrin), PLC-beta3, PKA-cat (cAMP-dependent), Collagen I, PLC-beta2",2.161E-01,2.771E-01,21,"ARHGEF1 (p115RhoGEF), PDE3A, IP3 receptor, alpha-IIb/beta-3 integrin, PLAT (TPA), VASP, Adenylate cyclase, Actin cytoskeletal, RhoA, G-protein alpha-i family, Guanylate cyclase (alpha-1/beta-1), PDE2A, TBXA2R, PKC, P2Y1, PAR1, PLC-beta3, IRAG, PKA-cat (cAMP-dependent), Collagen I, PLC-beta2",
1037,Role of platelets in the initiation of in-stent restenosis,43,3.033E-02,4.709E-02,4.495E-02,6.632E-02,21,"TGF-beta 1, ICAM1, CCL2, GP-IB beta, Thrombin, alpha-IIb/beta-3 integrin, PSGL-1, alpha-V/beta-3 integrin, PPBP, P-selectin, IL-8, PDGF-A, TBXA2R, Tissue factor, Collagen III, P2Y1, PAR1, Fibrinogen (fibrin), ICAM2, PF4, Collagen I",3.033E-02,4.709E-02,20,"TGF-beta 1, ICAM1, CCL2, sCD40L, alpha-IIb/beta-3 integrin, PSGL-1, alpha-V/beta-3 integrin, PPBP, P-selectin, CD40L(TNFSF5), IL-8, PDGF-A, TBXA2R, Tissue factor, Collagen III, P2Y1, PAR1, ICAM2, PF4, Collagen I",
1038,FGF2 in multiple myeloma,18,3.123E-02,4.833E-02,6.157E-02,8.814E-02,10,"FGFR2, Heparanase 1, PI3K reg class IA, FKHR, IL-6, MEK1/2, ERK2 (MAPK1), AKT(PKB), PI3K cat class IA, FGF2",3.123E-02,4.833E-02,10,"FGFR2, Heparanase 1, PI3K reg class IA, FKHR, IL-6, MEK1/2, ERK2 (MAPK1), AKT(PKB), PI3K cat class IA, FGF2",
1039,Inhibition of Calcitriol/ VDR signaling in colorectal cancer,51,3.136E-02,4.848E-02,5.319E-02,7.725E-02,24,"DKK4, G0/G1switch 2, CYP27A1, SMRT, APC protein, TCF7L2 (TCF4), DKK1, ID1, Beta-catenin, Kallikrein 6 (Neurosin), ZO-2, CYP24A1, c-Myc, FOXF1, Plectin 1, ZO-1, c-Jun, Thrombospondin 1, Kallikrein 10 (KLK10), CYP27B1, Vinculin, SLUG, SNAIL1, Filamin A",3.136E-02,4.848E-02,23,"G0/G1switch 2, CYP27A1, SMRT, APC protein, TCF7L2 (TCF4), DKK1, ID1, Beta-catenin, Kallikrein 6 (Neurosin), ZO-2, CYP24A1, Cystatin D, FOXF1, Plectin 1, ZO-1, Thrombospondin 1, Kallikrein 10 (KLK10), CYP27B1, Keratin 13, Vinculin, SLUG, SNAIL1, Filamin A",
1040,Stem cells_Neovascularization of glioblastoma in response to hypoxia,30,3.141E-02,4.815E-02,3.141E-02,4.815E-02,16,"VHL, VEGF-A, VEGFR-2, IP3 receptor, Ubiquitin, I-kB, PLC-gamma 1, NF-kB p50/p65, c-Src, CXCR4, ARNT, CD133, HIF1A, HIF-1, PKC-alpha, HIF-prolyl hydroxylase",6.266E-02,8.998E-02,14,"VHL, VEGF-A, VEGFR-2, IP3 receptor, Ubiquitin, I-kB, PLC-gamma 1, NF-kB p50/p65, c-Src, CXCR4, CD133, HIF1A, PKC-alpha, HIF-prolyl hydroxylase",
1041,Signal transduction_Additional pathways of NF-kB activation (in the nucleus),30,3.141E-02,4.815E-02,3.141E-02,4.815E-02,16,"CBP, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), I-kB, STO, IKK-alpha, Adenylate cyclase, NF-kB p50/p65, RelA (p65 NF-kB subunit), NF-kB1 (p50), PKA-cat alpha, PKC-delta, NIK(MAP3K14), p300, CDK6",6.266E-02,8.998E-02,14,"p38alpha (MAPK14), CBP, ERK1/2, I-kB, STO, Adenylate cyclase, NF-kB p50/p65, RelA (p65 NF-kB subunit), NF-kB1 (p50), PKA-cat alpha, p90RSK1, NIK(MAP3K14), p300, CDK6",
1042,"Dysregulation of Adiponectin secretion from adipocytes in obesity, type 2 diabetes and metabolic syndrome X",38,3.191E-02,4.918E-02,4.261E-02,6.343E-02,19,"IL-18R1, CDK5, ATF-3, ERK1/2, GSTK1, ERO1Lalpha, FKHR, ERp44, CREB1, AKT(PKB), PPAR-gamma, TNF-alpha, ACSL1, IL-18, IL18RAP, CDK5R1 (p25), CRP, AKT2, JNK(MAPK8-10)",3.191E-02,4.918E-02,18,"IL-18R1, CDK5, ATF-3, ERK1/2, GSTK1, ERO1Lalpha, FKHR, ERp44, CREB1, AKT(PKB), PPAR-gamma, TNF-alpha, MEK1(MAP2K1), IL-18, IL18RAP, CDK5R1 (p25), CRP, JNK(MAPK8-10)",
1043,IgE- and MGF-induced Fyn-mediated activation of lung mast cells in asthma,49,3.219E-02,4.924E-02,3.219E-02,4.924E-02,24,"SPHK1, PLD1, c-Kit, Syk, ABCC1, Shc, PI3K reg class IA (p85), PAG, N-Ras, Fyn, SHIP, AKT(PKB), GAB2, RhoA, S1P1 receptor, PKC-delta, Lyn, SOS, Csk, S1P2 receptor, PI3K cat class IA (p110-alpha), SHP-2, JNK(MAPK8-10), p38 MAPK",6.719E-02,9.622E-02,21,"SPHK1, PLD1, c-Kit, Syk, ABCC1, Shc, PI3K reg class IA (p85), PAG, N-Ras, Fyn, AKT(PKB), GAB2, RhoA, S1P1 receptor, Lyn, SOS, Csk, S1P2 receptor, PI3K cat class IA (p110-alpha), JNK(MAPK8-10), p38 MAPK",
1044,Possible regulation of HSF-1/ chaperone pathway in Huntington's disease,21,3.251E-02,4.953E-02,3.251E-02,4.953E-02,12,"GSK3 alpha/beta, HSP40, HSP90, HSP70, PLK1, HSP90 beta, HSF1, Calmodulin, PKC-alpha, SUMO-2, JNK(MAPK8-10), PLA2",1.936E-01,2.504E-01,9,"GSK3 alpha/beta, HSP90, HSP70, PLK1, HSP90 beta, Calmodulin, PKC-alpha, JNK(MAPK8-10), PLA2",
1045,Gamma-secretase regulation of mammary cell development,21,3.251E-02,4.953E-02,3.251E-02,4.953E-02,12,"STAT5A, HB-EGF, Bak, NOTCH4 (ICD4), NOTCH4, RBP-J kappa (CBF1), ErbB4(CTF), ErbB4, ErbB4(ICD), DLL4, HES1, ADAM17",3.981E-02,6.018E-02,11,"STAT5A, Neuregulin 1, HB-EGF, NOTCH4 (ICD4), NOTCH4, RBP-J kappa (CBF1), ErbB4(CTF), ErbB4, ErbB4(ICD), HES1, ADAM17",
1046,Muscle contraction_Oxytocin signaling in uterus and mammary gland,62,3.378E-02,5.168E-02,1.067E-01,1.449E-01,27,"LARG, ERK1/2, HB-EGF, G-protein alpha-q/11, PLC-beta1, IP3 receptor, OTR, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, RhoA, cPKC (conventional), EGFR, PGF2aR, OT, PGES, G-protein alpha-i3, PP2A catalytic, COX-2 (PTGS2), PKC-beta, ROCK, AKR1C3, Calmodulin, PKC, PKC-alpha, PLC-beta3, PLC-beta2",3.378E-02,5.168E-02,27,"ERK1/2, HB-EGF, c-Raf-1, G-protein alpha-q/11, IP3 receptor, OTR, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, MEK1(MAP2K1), RhoA, cPKC (conventional), EGFR, PGF2aR, OT, PGES, G-protein alpha-i3, PP2A catalytic, COX-2 (PTGS2), PKC-beta, ROCK, AKR1C3, Calmodulin, PKC, PKC-alpha, PLC-beta3, PLC-beta2",
1047,Development_Regulation of CDK5 in CNS,28,3.381E-02,5.168E-02,3.509E-02,5.313E-02,15,"CBP, CDK5R1 (p35), TrkA, CDK5, ERK1/2, EGR1, PKA-reg (cAMP-dependent), Shc, MEK2(MAP2K2), CREB1, SOS, TrkB, NGF, BDNF, PKA-cat (cAMP-dependent)",3.381E-02,5.168E-02,14,"CBP, CDK5R1 (p35), CDK5, ERK1/2, c-Raf-1, Shc, MEK2(MAP2K2), CREB1, MEK1(MAP2K1), SOS, TrkB, NGF, BDNF, PKA-cat (cAMP-dependent)",
1048,Development_Delta-type opioid receptor signaling via G-protein alpha-14,28,3.381E-02,5.168E-02,7.627E-02,1.070E-01,14,"PKC-epsilon, PLC-beta1, Rac1, IP3 receptor, Shc, MEK2(MAP2K2), c-Src, Pyk2(FAK2), JAK2, Metenkefalin, Delta-type opioid receptor, SOS, Calmodulin, PKC-alpha",3.381E-02,5.168E-02,14,"c-Raf-1, PKC-epsilon, IP3 receptor, Shc, MEK2(MAP2K2), c-Src, MEK1(MAP2K1), Pyk2(FAK2), JAK2, Metenkefalin, SOS, STAT3, Calmodulin, PKC-alpha",
1049,Immune response_PIP3 signaling in B lymphocytes,42,3.401E-02,5.171E-02,3.401E-02,5.171E-02,21,"BCAP, TEC, VAV-1, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, Syk, PI3K reg class IA, PLC-beta, G-protein beta/gamma, SHIP, AKT(PKB), PI3K cat class IA, CD45, Lyn, p90Rsk, PKC-beta, PLC-gamma, FOXO3A, DAPP1, PI3K reg class IB (p101)",1.477E-01,1.963E-01,17,"BCAP, TEC, VAV-1, PI3K cat class IB (p110-gamma), IP3 receptor, Syk, PI3K reg class IA, PLC-beta, G-protein beta/gamma, AKT(PKB), PI3K cat class IA, CD45, Lyn, p90Rsk, PKC-beta, PLC-gamma, DAPP1",
1050,Growth factors in regulation of oligodendrocyte precursor cells proliferation in multiple sclerosis,54,3.405E-02,5.194E-02,1.005E-01,1.377E-01,24,"SPHK1, TrkA, ERK1/2, PDGF-R-alpha, Fibronectin, Shc, PI3K reg class IA (p85), PI3K reg class IA, PLC-gamma 1, alpha-V/beta-3 integrin, MEK2(MAP2K2), AKT(PKB), HGF, PI3K cat class IA, PDGF-A, FGF2, SOS, NGF, Myelin basic protein, PKC, SHP-2, HGF receptor (Met), Elk-1, mTOR",3.405E-02,5.194E-02,24,"SPHK1, ERK1/2, c-Raf-1, PDGF-R-alpha, Fibronectin, Shc, PI3K reg class IA (p85), PI3K reg class IA, PLC-gamma 1, alpha-V/beta-3 integrin, MEK2(MAP2K2), AKT(PKB), HGF, MEK1(MAP2K1), PI3K cat class IA, PDGF-A, FGF2, SOS, NGF, Myelin basic protein, PKC, HGF receptor (Met), Elk-1, mTOR",
1051,Apoptosis and survival_IL-17-induced CIKS-dependent NF-kB signaling and mRNA stabilization,28,3.509E-02,5.313E-02,3.509E-02,5.313E-02,15,"IL-17 receptor, Ubiquitin, I-kB, SFRS1 (SF2), IKK-alpha, USP25, NF-kB p50/p65, UEV1A, TAK1(MAP3K7), TRAF3, TRAF6, NIK(MAP3K14), Cul1/Rbx1 E3 ligase, UBE1, TAB1",2.530E-01,3.184E-01,11,"IL-17, IL-17 receptor, Ubiquitin, I-kB, USP25, NF-kB p50/p65, TAK1(MAP3K7), TRAF3, TRAF6, NIK(MAP3K14), Cul1/Rbx1 E3 ligase",
1052,Mitogenic action of Estradiol / ESR1 (nuclear) in breast cancer,28,3.509E-02,5.313E-02,3.509E-02,5.313E-02,15,"CDC25A, DNA polymerase alpha/primase, ATF-2/c-Jun, CDK4, IKK-alpha, Oct-1, c-Myc, TERT, CAD, NFYA, Cyclin E2, CDK2, CARM1, Cyclin E, SGOL2",2.530E-01,3.184E-01,11,"CDC25A, CDK4, Oct-1, TERT, CAD, NFYA, Cyclin E2, CDK2, CARM1, Cyclin E, SGOL2",
1053,Eosinophil chemotaxis in asthma,64,3.517E-02,5.317E-02,3.517E-02,5.317E-02,30,"Secretoneurin, NGFR(TNFRSF16), Histamine H4 receptor, TrkA, CCL20, IP10, C5a, HTR2A, VEGF-A, PI3K cat class IB (p110-gamma), CCL8, GM-CSF, G-protein beta/gamma, VIP, Eotaxin, Oxoeicosanoid receptor 1, C3aR, S1P1 receptor, PTAFR, Eotaxin-2, IL-8, G-protein alpha-i family, IL-5, Eotaxin-3, CGRP, CXCR3, CCL7, NGF, C3a, PI3K reg class IB (p101)",1.318E-01,1.772E-01,25,"Secretoneurin, NGFR(TNFRSF16), CCL20, IP10, C5a, HTR2A, VEGF-A, PI3K cat class IB (p110-gamma), CCL8, GM-CSF, G-protein beta/gamma, Eotaxin, Oxoeicosanoid receptor 1, S1P1 receptor, PTAFR, Eotaxin-2, CRTH2, IL-8, G-protein alpha-i family, IL-5, Eotaxin-3, CGRP, CCL7, NGF, C3a",
1054,Immune response_Fc gamma R-mediated phagocytosis in macrophages,47,3.595E-02,5.428E-02,3.595E-02,5.428E-02,23,"PLD1, PKC-epsilon, Gelsolin, VAV-1, Rac1, IP3 receptor, Syk, Profilin, PI3K reg class IA, PLC-gamma 1, CDC42, Actin cytoskeletal, RhoA, Pyk2(FAK2), PI3K cat class IA, Lyn, F-Actin cytoskeleton, Myosin II, Fc gamma RII alpha, Paxillin, Vinculin, PKC-alpha, Cytohesin3",4.296E-02,6.435E-02,21,"PLD1, PKC-epsilon, Gelsolin, VAV-1, IP3 receptor, Syk, Profilin, PI3K reg class IA, PLC-gamma 1, CDC42, Actin cytoskeletal, RhoA, Pyk2(FAK2), PI3K cat class IA, Lyn, F-Actin cytoskeleton, Myosin II, Fc gamma RII alpha, Vinculin, PKC-alpha, Cytohesin3",
1055,MicroRNAs in melanoma,57,3.667E-02,5.588E-02,3.397E-01,4.159E-01,22,"Cyclin D3, RUNX3, BMP4, c-Kit, E2F3, NF-AT5, Bax, CDK4, N-Ras, Calponin-1, Mcl-1, Osteopontin, ITGB3, ETS1, TGF-beta receptor type II, FGF2, Cadherin 11, ITGA3, FOXO3A, HGF receptor (Met), CtBP1, MITF",3.667E-02,5.588E-02,25,"miR-34c-5p, RUNX3, BMP4, miR-221-3p, c-Kit, E2F3, NF-AT5, Bax, CDK4, N-Ras, miR-199a-3p, Calponin-1, Mcl-1, Osteopontin, ITGB3, ETS1, TGF-beta receptor type II, FGF2, miR-34b-3p, miR-203-3p, Cadherin 11, ITGA3, microRNA 221, HGF receptor (Met), MITF",
1056,G-protein signaling_Rap2B regulation pathway,7,3.685E-02,5.611E-02,5.677E-02,8.190E-02,5,"M-Ras, PLC-epsilon, Beta-1 adrenergic receptor, PDZ-GEF1, RAP-2B",3.685E-02,5.611E-02,5,"M-Ras, PLC-epsilon, Beta-1 adrenergic receptor, PDZ-GEF1, RAP-2B",
1057,Sorafenib-induced inhibition of cell proliferation and angiogenesis in HCC,16,3.699E-02,5.626E-02,1.631E-01,2.120E-01,8,"ERK1/2, VEGF-A, VEGFR-2, RASSF1, MEK1/2, ERK2 (MAPK1), B-Raf, PDGF-R-beta",3.699E-02,5.626E-02,9,"ERK1/2, VEGF-A, c-Raf-1, VEGFR-2, RASSF1, MEK1/2, ERK2 (MAPK1), B-Raf, PDGF-R-beta",
1058,G-protein signaling_Rac2 regulation pathway,36,3.770E-02,5.723E-02,1.607E-01,2.096E-01,16,"ABR, gp91-phox, Rac2, VAV-1, p47-phox, PI3K reg class IA (p85), Tiam1, iNOS, BCR, Cytochrome b-558, p22-phox, SP3, RDX (radixin), RhoGDI alpha, RacGAP1, PLC-beta2",3.770E-02,5.723E-02,17,"ABR, gp91-phox, Rac2, VAV-1, p47-phox, PI3K reg class IA (p85), Tiam1, iNOS, BCR, Cytochrome b-558, p22-phox, SP3, RDX (radixin), p67-phox, RhoGDI alpha, RacGAP1, PLC-beta2",
1059,Development_SSTR2 in regulation of cell proliferation,36,3.770E-02,5.723E-02,4.776E-02,7.012E-02,18,"ERK1/2, RAP-1A, PI3K reg class IA (p85), MEK2(MAP2K2), G-protein beta/gamma, Guanylate Cyclase 1, soluble, AKT(PKB), c-Src, PI3K cat class IA, B-Raf, G-protein alpha-i family, SOS, nNOS, CDK2, Somatostatin, Cyclin E, SHP-2, Elk-1",3.770E-02,5.723E-02,17,"ERK1/2, RAP-1A, PI3K reg class IA (p85), MEK2(MAP2K2), G-protein beta/gamma, Guanylate Cyclase 1, soluble, AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, B-Raf, G-protein alpha-i family, SOS, nNOS, CDK2, Cyclin E, Elk-1",
1060,Activation of Cortisol production in major depressive disorder,40,3.805E-02,5.733E-02,3.805E-02,5.733E-02,20,"SPHK1, FDX1, ERK1/2, PKA-reg (cAMP-dependent), MDR1, STAR, DIA1, CREB1, IL-6, MEK1/2, TNF-R1, TNF-alpha, RhoA, SF1, CYP17, ACTH, CYP11A1, ATF-2, CYP21A2, PKA-cat (cAMP-dependent)",1.005E-01,1.386E-01,17,"SPHK1, FDX1, ERK1/2, MDR1, DIA1, CREB1, IL-6, MEK1/2, TNF-R1, TNF-alpha, RhoA, SF1, ACTH, CYP11A1, ATF-2, CYP21A2, PKA-cat (cAMP-dependent)",
1061,Apoptosis and survival_TNF-alpha-induced ROS-dependent Caspase-3 signaling,60,3.921E-02,5.939E-02,1.179E-01,1.583E-01,26,"PI3K cat class IA (p110-beta), Apaf-1, gp91-phox, Rac2, VAV-1, p47-phox, Rac1, PI3K reg class IA (p85), Bax, SOD1, Caspase-3, RIPK1, TNF-R1, TNF-alpha, Cytochrome b-558, p22-phox, ASK1 (MAP3K5), MEK3(MAP2K3), Caspase-9, MKK7 (MAP2K7), PI3K cat class IA (p110-delta), MEK4(MAP2K4), GPX1, MAP3K3, JNK(MAPK8-10), ADAM17",3.921E-02,5.939E-02,26,"p38alpha (MAPK14), PI3K cat class IA (p110-beta), Apaf-1, gp91-phox, Rac2, VAV-1, p47-phox, PI3K reg class IA (p85), Bax, Caspase-3, RIPK1, TNF-R1, TNF-alpha, Cytochrome b-558, p22-phox, ASK1 (MAP3K5), MEK3(MAP2K3), Caspase-9, p67-phox, Glutaredoxin 1, PI3K cat class IA (p110-delta), MEK4(MAP2K4), GPX1, MAP3K3, JNK(MAPK8-10), ADAM17",
1062,Nicotine / nAChR alpha-3/nAChR beta-2 signaling in NSCLC,26,3.922E-02,5.884E-02,3.922E-02,5.884E-02,14,"CDC25A, E2F3, E2F2, Survivin, TYSY, AKT(PKB), c-Src, PI3K reg class IA (p85-alpha), XIAP, p300, nAChR beta-2, PI3K cat class IA (p110-delta), PKC-alpha, nAChR alpha-3",4.022E-02,6.062E-02,13,"CDC25A, E2F3, E2F2, Survivin, TYSY, AKT(PKB), c-Src, PI3K reg class IA (p85-alpha), XIAP, p300, PI3K cat class IA (p110-delta), PKC-alpha, nAChR alpha-3",
1063,Cell cycle_Initiation of mitosis,26,3.922E-02,5.884E-02,3.922E-02,5.884E-02,14,"Cyclin B2, CDK1 (p34), Lamin B, AKT(PKB), Cyclin B1, c-Myc, PLK1, CDC25C, CDC25B, MYRL2, FOXM1, Nucleolin, Kinase MYT1, KNSL1",4.022E-02,6.062E-02,13,"Cyclin B2, CDK1 (p34), Lamin B, AKT(PKB), Cyclin B1, PLK1, CDC25C, CDC25B, MYRL2, FOXM1, p90RSK1, Nucleolin, KNSL1",
1064,Development_Ligand-independent activation of ESR1 and ESR2,44,3.940E-02,5.962E-02,2.586E-01,3.222E-01,18,"CBP, IRS-1, ERK1/2, PKA-reg (cAMP-dependent), Shc, PI3K reg class IA, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), PI3K cat class IA, EGFR, SOS, p300, NCOA2 (GRIP1/TIF2), PI3K cat class IA (p110-alpha), NCOA1 (SRC1), Caveolin-1, PKA-cat (cAMP-dependent)",3.940E-02,5.962E-02,20,"CBP, Neuregulin 1, ERK1/2, c-Raf-1, Shc, PI3K reg class IA, MEK2(MAP2K2), ERK2 (MAPK1), AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, EGFR, SOS, p90RSK1, p300, NCOA2 (GRIP1/TIF2), PI3K cat class IA (p110-alpha), NCOA1 (SRC1), Caveolin-1, PKA-cat (cAMP-dependent)",
1065,SDF-1 axis in endothelial progenitor cell recruitment in healing myocardial infarction,33,3.941E-02,5.901E-02,3.941E-02,5.901E-02,17,"TIE2, RHEB2, ICAM1, RPS6, Rac2, PI3K cat class IB (p110-gamma), Rac1, FKHR, G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), CXCR4, Heme oxygenase 1, HIF1A, Angiopoietin 1, PI3K reg class IB (p101), mTOR",6.922E-02,9.827E-02,15,"TIE2, RHEB2, ICAM1, RPS6, Rac2, PI3K cat class IB (p110-gamma), FKHR, G-protein beta/gamma, ERK2 (MAPK1), AKT(PKB), CXCR4, Heme oxygenase 1, HIF1A, Angiopoietin 1, mTOR",
1066,Transition of Smoldering multiple myeloma to active multiple myeloma (schema),17,3.960E-02,5.924E-02,3.960E-02,5.924E-02,10,"CCL2, IL-1 beta, N-Ras, IL-6, NF-kB, c-Myc, IL-8, Ig light chain, p18, p53",1.378E-01,1.840E-01,8,"CCL2, IL-1 beta, N-Ras, IL-6, NF-kB, IL-8, p18, p53",
1067,Angiotensin II Signaling in Cardiac Hypertrophy,72,3.970E-02,5.933E-02,3.970E-02,5.933E-02,33,"CBP, Calcineurin A (catalytic), ERK1/2, HDAC4, TRPC6, G-protein alpha-q/11, Angiotensin II, CaMK IV, PKC-epsilon, IP3 receptor, SOD1, TRPC1, G-protein beta/gamma, Cyclophilin B, NF-kB, Thioredoxin, ASK1 (MAP3K5), ATRAP, MEF2A, Ca(II)channel L-type, HDAC5, p300, MEK4(MAP2K4), Calmodulin, TRPC3, PKC-alpha, NCX1, SLC4A3, JNK(MAPK8-10), PLC-beta3, Calcineurin B (regulatory), p38 MAPK, SRF",4.858E-02,7.184E-02,30,"CBP, Calcineurin A (catalytic), ERK1/2, HDAC4, TRPC6, G-protein alpha-q/11, Angiotensin II, CaMK IV, PKC-epsilon, IP3 receptor, TRPC1, G-protein beta/gamma, Cyclophilin B, NF-kB, ASK1 (MAP3K5), ATRAP, MEF2A, HDAC5, p300, MEK4(MAP2K4), Calmodulin, TRPC3, PKC-alpha, NCX1, SLC4A3, JNK(MAPK8-10), PLC-beta3, Calcineurin B (regulatory), p38 MAPK, SRF",
1068,Hypothetical role of microRNAs in fibrosis development after myocardial infarction,26,4.022E-02,6.062E-02,8.605E-02,1.196E-01,13,"COL1A1, TGF-beta 1, Fibrillin 1, MMP-2, COL1A2, AKT(PKB), PI3K cat class IA, TGF-beta receptor type II, Collagen III, SMAD3, CTGF, Collagen I, TGF-beta receptor type I",4.022E-02,6.062E-02,13,"COL1A1, TGF-beta 1, Fibrillin 1, MMP-2, COL1A2, AKT(PKB), PI3K cat class IA, TGF-beta receptor type II, Collagen III, SMAD3, CTGF, Collagen I, TGF-beta receptor type I",
1069,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,39,4.209E-02,6.330E-02,1.747E-01,2.251E-01,17,"CYP27A1, SLC21A2, UGT1A4, ALAS1, MDR1, UGT1A1, CYP24A1, CYP2C19, SR-BI, ELOVL6, CYP2B6, CYP11A1, SULT2A1, CYP3A7, CYP2C9, CYP7A1, UGT1A6",4.209E-02,6.330E-02,18,"CYP2C8, CYP27A1, SLC21A2, UGT1A4, ALAS1, MDR1, UGT1A1, CYP24A1, CYP3A4, SR-BI, G6PT, ELOVL6, CYP11A1, SULT2A1, CYP3A7, CYP2C9, CYP7A1, UGT1A6",
1070,Immune response_PGE2 in immune and neuroendocrine system interactions,47,4.296E-02,6.435E-02,2.708E-01,3.354E-01,19,"GCR, IL-1 beta, GABA-A receptor, cPLA2, G-protein beta/gamma, NF-kB, NF-kB p50/p65, TNF-R1, TNF-alpha, PGE2R4, G-protein alpha-i family, PGF2aR, PGES, ACTH, COX-2 (PTGS2), P/Q-type calcium channel alpha-1A subunit, TLR4, Corticoliberin, p38 MAPK",4.296E-02,6.435E-02,21,"p38alpha (MAPK14), GCR, IL-1 beta, COX-1 (PTGS1), GABA-A receptor, cPLA2, G-protein beta/gamma, NF-kB, NF-kB p50/p65, TNF-R1, TNF-alpha, PGE2R4, G-protein alpha-i family, PGF2aR, PGES, ACTH, COX-2 (PTGS2), P/Q-type calcium channel alpha-1A subunit, TLR4, Corticoliberin, p38 MAPK",
1071,Oxidative stress_Role of Sirtuin1 and PGC1-alpha in activation of antioxidant defense system,60,4.348E-02,6.460E-02,4.348E-02,6.460E-02,28,"SOD2, AMPK beta subunit, SLC7A11, AMPK gamma subunit, SOD1, FKHR, PPARGC1 (PGC1-alpha), PBEF, Catalase, PPAR-gamma, Sequestosome 1(p62), Thioredoxin, Heme oxygenase 1, Sestrin 3, KEAP1, Sestrin 2, GCL reg, MT-TRX, MSRA, AMPK alpha subunit, PRDX1, GSTP1, GPX1, FOXO3A, GCL cat, p53, TXNRD1, NRF2",1.693E-01,2.211E-01,23,"SOD2, AMPK beta subunit, SLC7A11, AMPK gamma subunit, FKHR, PPARGC1 (PGC1-alpha), PBEF, Catalase, PPAR-gamma, Sequestosome 1(p62), Heme oxygenase 1, Sestrin 3, KEAP1, Sestrin 2, GCL reg, MSRA, AMPK alpha subunit, GSTP1, GPX1, GCL cat, p53, TXNRD1, NRF2",
1072,Stimulation of gastric acid secretion in gastric cancer,60,4.348E-02,6.460E-02,4.348E-02,6.460E-02,28,"Gastrin 17-Gly, VMAT2, ATP4A, Kir2.1, ERK1/2, EGR1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, PKC-epsilon, IP3 receptor, PLC-beta, PLC-gamma 1, Adenylate cyclase, MEK2(MAP2K2), CREB1, Gastrin 17, Progastrin, c-Src, Chromogranin A, CCKBR, Histamine H2 receptor, ACM3, PKC-beta, Calmodulin, PKC-alpha, ATP4B, G-protein alpha-q, PKA-cat (cAMP-dependent)",6.763E-02,9.676E-02,25,"Gastrin 17-Gly, VMAT2, ATP4A, Kir2.1, HDC, ERK1/2, c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, PLC-beta, PLC-gamma 1, Adenylate cyclase, MEK2(MAP2K2), CREB1, Gastrin 17, Progastrin, c-Src, MEK1(MAP2K1), Histamine H2 receptor, ACM3, PKC-beta, Calmodulin, PKC-alpha, PKA-cat (cAMP-dependent)",
1073,Huntingtin-depended transcription deregulation in Huntington's Disease,24,4.386E-02,6.503E-02,4.386E-02,6.503E-02,13,"CBP, NGFR(TNFRSF16), TFIIF, beta subunit, Enkephalin A, CTIP2, N-CoR, Ephexin, Dopamine D2 receptor, TBP, NFYA, TCERG1 (CA150), CtBP1, BDNF",1.056E-01,1.445E-01,11,"CBP, NGFR(TNFRSF16), TFIIF, beta subunit, Enkephalin A, CTIP2, N-CoR, Ephexin, Dopamine D2 receptor, NFYA, TCERG1 (CA150), BDNF",
1074,"Development_NCAM1-mediated neurite outgrowth, synapse assembly and neuronal survival",75,4.391E-02,6.504E-02,4.391E-02,6.504E-02,34,"NCAM1, Spectrin, ERK1/2, PKA-reg (cAMP-dependent), LIMK1, IP3 receptor, Shc, AP-2 alpha subunits, PLC-gamma 1, Casein kinase II, CREB1, MEK1/2, CDC42, Fyn, Ca(II)channel T-type, AKT(PKB), BETA-PIX, Guanylate cyclase (alpha-1/beta-1), Protein kinase G, Ca(II)channel N-type, Ca(II)channel L-type, SOS, nNOS, NR2B, GDNF, PKC-beta, Calmodulin, PKC, PTPR-alpha, Agrin, GluR1, PSD-95, PKA-cat (cAMP-dependent), Cofilin",5.072E-02,7.449E-02,31,"Neuromodulin, NCAM1, Spectrin, ERK1/2, c-Raf-1, LIMK1, IP3 receptor, Shc, AP-2 alpha subunits, PLC-gamma 1, Casein kinase II, CREB1, MEK1/2, CDC42, Fyn, Ca(II)channel T-type, AKT(PKB), Guanylate cyclase (alpha-1/beta-1), Protein kinase G, SOS, nNOS, NR2B, GDNF, PKC-beta, Calmodulin, PKC, PTPR-alpha, Agrin, PSD-95, PKA-cat (cAMP-dependent), Cofilin",
1075,G-protein signaling_G-Protein beta/gamma signaling cascades,34,4.460E-02,6.641E-02,1.030E-01,1.402E-01,16,"ERK1/2, PKA-reg (cAMP-dependent), Dynamin-2, PI3K cat class IB (p110-gamma), Shc, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), c-Src, G-protein alpha-15, SOS, PLC-gamma, Caveolin-1, PI3K reg class IB (p101), PKA-cat (cAMP-dependent), PLC-beta2",4.460E-02,6.641E-02,16,"ERK1/2, c-Raf-1, Dynamin-2, PI3K cat class IB (p110-gamma), Shc, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), c-Src, MEK1(MAP2K1), G-protein alpha-15, SOS, PLC-gamma, Caveolin-1, PKA-cat (cAMP-dependent), PLC-beta2",
1076,Role of Insulin in regulation of eating behavior in obesity,43,4.495E-02,6.632E-02,4.495E-02,6.632E-02,21,"IRS-2, SOD2, IRS-1, PKC-theta, SOD1, FKHR, SOCS3, AKT(PKB), NF-kB p50/p65, POMC, RelA (p65 NF-kB subunit), NF-kB1 (p50), Cytochrome b-558, NPY, AGRP, PTP-1B, p300, JNK1(MAPK8), Acyl-CoA synthetase, GPX1, TLR4",1.056E-01,1.445E-01,18,"IRS-2, SOD2, PKC-theta, FKHR, SOCS3, AKT(PKB), NF-kB p50/p65, POMC, RelA (p65 NF-kB subunit), NF-kB1 (p50), Cytochrome b-558, NPY, AGRP, p300, JNK1(MAPK8), Acyl-CoA synthetase, GPX1, TLR4",
1077,Oxidative stress_Role of IL-8 signaling pathway in respiratory burst,48,4.659E-02,6.861E-02,4.659E-02,6.861E-02,23,"PLD1, gp91-phox, ERK1/2, PKC-zeta, Rac2, PKC-epsilon, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, G-protein beta/gamma, AKT(PKB), Cytochrome b-558, p22-phox, PKC-delta, IL-8, G-protein alpha-i family, PKC-beta2, PKC-beta1, PKC-alpha, PI3K reg class IB (p101), PLC-beta3, p38 MAPK, PLC-beta2",5.412E-02,7.910E-02,21,"PLD1, gp91-phox, ERK1/2, Rac2, PKC-epsilon, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, G-protein beta/gamma, AKT(PKB), Cytochrome b-558, p22-phox, IL-8, G-protein alpha-i family, p67-phox, PKC-beta2, PKC-beta1, PKC-alpha, PLC-beta3, p38 MAPK, PLC-beta2",
1078,Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression,29,4.670E-02,6.934E-02,4.956E-02,7.220E-02,15,"RHEB2, nAChR beta, PI3K reg class IA (p85), GSK3 beta, FKHR, nAChR, GSK3 alpha/beta, Fyn, AKT(PKB), c-Src, nAChR alpha-7, PI3K cat class IA, nAChR alpha, 4E-BP1, mTOR",4.670E-02,6.934E-02,14,"RHEB2, c-Raf-1, nAChR beta, PI3K reg class IA (p85), GSK3 beta, FKHR, GSK3 alpha/beta, Fyn, AKT(PKB), c-Src, nAChR alpha-7, PI3K cat class IA, nAChR alpha, mTOR",
1079,Anti-apoptotic pathways in endoplasmic reticulum stress response in multiple myeloma,19,4.753E-02,7.035E-02,9.006E-02,1.245E-01,10,"GRP78, PP1-cat, Endoplasmin, S2P, GADD34, ATF-6 alpha (90kDa), Calreticulin, ATF-6 alpha (50kDa), S1P, p38 MAPK",4.753E-02,7.035E-02,10,"GRP78, PP1-cat, Endoplasmin, S2P, GADD34, ATF-6 alpha (90kDa), Calreticulin, ATF-6 alpha (50kDa), S1P, p38 MAPK",
1080,HCV-mediated liver damage and predisposition to HCC progression via p53,19,4.753E-02,7.035E-02,3.405E-01,4.159E-01,8,"ERK1/2, CDK1 (p34), p73, Bax, CDK4, SOS, CDK2, p53",4.753E-02,7.035E-02,10,"ERK1/2, c-Raf-1, CDK1 (p34), p73, Bax, CDK4, MEK1(MAP2K1), SOS, CDK2, p53",
1081,Chemotaxis_CCR1 signaling,53,4.770E-02,7.012E-02,4.770E-02,7.012E-02,25,"ERK1/2, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, I-kB, PLC-beta, IKK-alpha, CCL8, cPLA2, Adenylate cyclase, IL-6, MEK1/2, G-protein beta/gamma, NF-kB, c-Src, G-protein alpha-15, PKC-delta, IL-8, G-protein alpha-i family, G-protein alpha-o, CCL7, Calmodulin, PI3K reg class IB (p101), p38 MAPK, MMP-9",4.965E-02,7.320E-02,23,"ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), IP3 receptor, I-kB, PLC-beta, CCL8, cPLA2, Adenylate cyclase, IL-6, MEK1/2, G-protein beta/gamma, NF-kB, c-Src, G-protein alpha-15, IL-8, G-protein alpha-i family, G-protein alpha-o, CCL7, STAT3, Calmodulin, p38 MAPK, MMP-9",
1082,Ubiquitin-proteasome system in Huntington's disease,22,4.908E-02,7.156E-02,4.908E-02,7.156E-02,12,"UBE3A (E6-AP), PSME3, Ubiquitin, NR2, CDC34, HIP-2, PSMC2, PSMB9, NR2A, NR2B, PKC-alpha, p53",1.262E-01,1.700E-01,10,"UBE3A (E6-AP), PSME3, Ubiquitin, NR2, PSMC2, PSMB9, NR2A, NR2B, PKC-alpha, p53",
1083,Translation_Role of Retinoic acid signaling in the initiation of translation,22,4.908E-02,7.156E-02,4.908E-02,7.156E-02,12,"CRM1, RPS6, eIF4E, ERK1/2, MAP2, PUR-alpha, MEK1/2, FMR1, 4E-BP1, CaMK II alpha, GluR1, mTOR",1.262E-01,1.700E-01,10,"CRM1, RPS6, ERK1/2, c-Raf-1, MAP2, PUR-alpha, MEK1/2, FMR1, CaMK II alpha, mTOR",
1084,T regulatory cell migration in asthma,22,4.908E-02,7.156E-02,4.908E-02,7.156E-02,12,"IL-16 mature, Histamine H4 receptor, PI3K cat class IB (p110-gamma), CD4, G-protein beta/gamma, AKT(PKB), Lck, PI3K reg class IA (p85-alpha), G-protein alpha-i family, PI3K cat class IA (p110-alpha), PI3K reg class IB (p101), CCR4",2.402E-01,3.049E-01,9,"PI3K cat class IB (p110-gamma), CD4, G-protein beta/gamma, AKT(PKB), Lck, PI3K reg class IA (p85-alpha), G-protein alpha-i family, PI3K cat class IA (p110-alpha), CCR4",
1085,G-protein signaling_RAC1 in cellular process,37,4.963E-02,7.320E-02,6.322E-02,8.999E-02,18,"NCK1, PLD1, gp91-phox, PKC-zeta, NckAP1, p47-phox, Rac1, CDC42, Actin cytoskeletal, WASF1(WAVE1), RhoA, MLK3(MAP3K11), HSPC300, Cytochrome b-558, p22-phox, F-Actin cytoskeleton, JNK(MAPK8-10), WASF2",4.963E-02,7.320E-02,17,"NCK1, PLD1, gp91-phox, NckAP1, p47-phox, CDC42, Actin cytoskeletal, WASF1(WAVE1), RhoA, MLK3(MAP3K11), HSPC300, Cytochrome b-558, p22-phox, F-Actin cytoskeleton, p67-phox, JNK(MAPK8-10), WASF2",
1086,G-protein signaling_Rap1B regulation pathway,11,5.145E-02,7.487E-02,5.145E-02,7.487E-02,7,"RASA3, Rap1GDS1, RAP-1B, C3G, KAP3, CAAX prenyl protease 2, PKA-cat (cAMP-dependent)",9.992E-02,1.382E-01,6,"RASA3, Rap1GDS1, RAP-1B, KAP3, CAAX prenyl protease 2, PKA-cat (cAMP-dependent)",
1087,Transcription_Mechanism of repression of the transcription of Retinoid-target genes in the absence of lignad,12,5.199E-02,7.620E-02,8.669E-02,1.204E-01,7,"SMRT, HDAC3, HDAC2, N-CoR, Sin3A, HDAC1, SAP30",5.199E-02,7.620E-02,7,"SMRT, HDAC3, HDAC2, N-CoR, Sin3A, HDAC1, SAP30",
1088,Development_Histone acetylation in embryonic stem cells,34,5.359E-02,7.776E-02,5.359E-02,7.776E-02,17,"Oct-3/4, DKK1, HNF3-beta, Tip60, HDAC2, FGF5, c-Myc, Sin3A, GATA-6, NODAL, GCNF, LSD1, CDK2, SNAIL1, HDAC1, MBD3, p53",8.865E-02,1.237E-01,15,"Oct-3/4, DKK1, HNF3-beta, Tip60, HDAC2, FGF5, Sin3A, GATA-6, NODAL, GCNF, LSD1, CDK2, SNAIL1, HDAC1, p53",
1089,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,40,5.440E-02,7.919E-02,1.286E-01,1.714E-01,18,"ALAS1, MDR1, UGT1A1, CYP24A1, AL1A1, CYP2C19, CYP2E1, CYP2B6, GSTP1, PPCKC, SULT2A1, CYP3A7, ADHG, CYP2C9, ABCC4, CYP7A1, NCOA1 (SRC1), UGT1A6",5.440E-02,7.919E-02,18,"CYP2C8, ALAS1, MDR1, UGT1A1, CYP24A1, AL1A1, CYP3A4, SHP, GSTP1, PPCKC, SULT2A1, CYP3A7, ADHG, CYP2C9, ABCC4, CYP7A1, NCOA1 (SRC1), UGT1A6",
1090,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,40,5.440E-02,7.919E-02,1.286E-01,1.714E-01,18,"ALAS1, MDR1, UGT1A1, CYP24A1, AL1A1, CYP2C19, CYP2E1, CYP2B6, GSTP1, PPCKC, SULT2A1, CYP3A7, ADHG, CYP2C9, ABCC4, CYP7A1, NCOA1 (SRC1), UGT1A6",5.440E-02,7.919E-02,18,"CYP2C8, ALAS1, MDR1, UGT1A1, CYP24A1, AL1A1, CYP3A4, SHP, GSTP1, PPCKC, SULT2A1, CYP3A7, ADHG, CYP2C9, ABCC4, CYP7A1, NCOA1 (SRC1), UGT1A6",
1091,Development_FGF2-dependent induction of EMT,20,5.496E-02,7.951E-02,5.496E-02,7.951E-02,11,"Rac1, IL-1 beta, PI3K reg class IA (p85), IKK-alpha, CDC42, AKT(PKB), RhoA, PI3K cat class IA, FGF2, AP-1, Collagen I",2.845E-01,3.538E-01,8,"IL-1 beta, PI3K reg class IA (p85), CDC42, AKT(PKB), RhoA, PI3K cat class IA, FGF2, Collagen I",
1092,Development_H3K36 demethylation in stem cell maintenance,20,5.496E-02,7.951E-02,5.496E-02,7.951E-02,11,"p14ARF, CDK4, RING2, EZH2, p16INK4, Bcl-6, BCoR, CDK6, PRC2 complex, p15, p53",6.867E-02,9.796E-02,10,"p14ARF, CDK4, RING2, EZH2, p16INK4, Bcl-6, CDK6, PRC2 complex, p15, p53",
1093,CCL2 in Prostate Cancer,20,5.496E-02,7.951E-02,5.496E-02,7.951E-02,11,"CCL2, VEGF-A, PI3K cat class IB (p110-gamma), Rac1, Survivin, G-protein beta/gamma, AKT(PKB), G-protein alpha-i family, PCNT1, PI3K reg class IB (p101), mTOR",2.845E-01,3.538E-01,8,"CCL2, VEGF-A, PI3K cat class IB (p110-gamma), Survivin, G-protein beta/gamma, AKT(PKB), G-protein alpha-i family, mTOR",
1094,Pancreatic cancer cell resistance to Tarceva (erlotinib),27,5.557E-02,8.074E-02,2.079E-01,2.640E-01,12,"HB-EGF, Beta-catenin, Vimentin, PI3K reg class IA (p85), TGF-alpha, TWIST1, AKT(PKB), PI3K cat class IA, EGFR, TCF8, SNAIL1, mTOR",5.557E-02,8.074E-02,13,"Neuregulin 1, HB-EGF, Beta-catenin, Vimentin, PI3K reg class IA (p85), TGF-alpha, TWIST1, AKT(PKB), PI3K cat class IA, EGFR, TCF8, SNAIL1, mTOR",
1095,Deregulation of Ca2+-dependent neuronal cell survival in Huntington's disease,39,5.637E-02,8.140E-02,5.637E-02,8.140E-02,19,"Calcineurin A (catalytic), PP1-cat, Lef-1, Beta-catenin, CaMK IV, PI3K cat class IB (p110-gamma), Hap-1, PI3K reg class IA (p85), GSK3 beta, CREB1, AKT(PKB), PI3K cat class IA, Calcipressin 1, nNOS, Calmodulin, CaMK II alpha, PSD-95, Calcineurin B (regulatory), BDNF",8.089E-02,1.138E-01,17,"Calcineurin A (catalytic), PP1-cat, Beta-catenin, CaMK IV, PI3K cat class IB (p110-gamma), PI3K reg class IA (p85), GSK3 beta, CREB1, AKT(PKB), PI3K cat class IA, Calcipressin 1, nNOS, Calmodulin, CaMK II alpha, PSD-95, Calcineurin B (regulatory), BDNF",
1096,Pro-oncogenic action of Androgen receptor in breast cancer,35,5.858E-02,8.470E-02,7.098E-02,1.002E-01,17,"ERK1/2, Beta-catenin, SGK1, FGF8, WDR77, TMF1, CREB1, TCF8, Kallikrein 15, FKBP5, AKR1C3, RUNX2, FHL2, WNT7B, NCOA1 (SRC1), SRD5A1, Elk-1",5.858E-02,8.470E-02,16,"ERK1/2, Beta-catenin, SGK1, FGF8, WDR77, CREB1, p90RSK1, TCF8, FKBP5, AKR1C3, RUNX2, FHL2, WNT7B, NCOA1 (SRC1), SRD5A1, Elk-1",
1097,Oxidative stress_NOX and DUOX families of NADPH oxidases ,35,5.858E-02,8.470E-02,7.098E-02,1.002E-01,17,"NOX4, gp91-phox, Rac2, FISH, p47-phox, Rac1, NOXO1, NOX5, Cytochrome b-558, p22-phox, SH3PXD2B, DUOXA2, DUOX2, DUOX1, NOX4/p22-phox, Calmodulin, DUOXA1",5.858E-02,8.470E-02,16,"NOX4, gp91-phox, Rac2, FISH, p47-phox, NOX5, Cytochrome b-558, p22-phox, SH3PXD2B, DUOXA2, DUOX2, p67-phox, DUOX1, NOX4/p22-phox, Calmodulin, DUOXA1",
1098,Renin-Angiotensin-Aldosterone System,62,5.866E-02,8.473E-02,1.067E-01,1.449E-01,27,"PLD1, ATF-1, ERK1/2, CaMK I, G-protein alpha-q/11, Angiotensin II, PKC-epsilon, MDR1, Rac1, IP3 receptor, STAR, PLC-beta, cPLA2, CREB1, G-protein beta/gamma, CDC42, RGS2, JAK2, MLK3(MAP3K11), PPAP2, MEK3(MAP2K3), PLD2, PKC-beta, Angiotensin I, Calmodulin, PKC-alpha, Angiotensinogen",5.866E-02,8.473E-02,26,"p38alpha (MAPK14), PLD1, ATF-1, ERK1/2, CaMK I, G-protein alpha-q/11, Angiotensin II, PKC-epsilon, MDR1, IP3 receptor, PLC-beta, cPLA2, CREB1, G-protein beta/gamma, CDC42, RGS2, JAK2, MLK3(MAP3K11), PPAP2, MEK3(MAP2K3), PLD2, PKC-beta, Angiotensin I, Calmodulin, PKC-alpha, Angiotensinogen",
1099,Transcription_N-CoR/ SMRT complex-mediated epigenetic gene silencing,49,5.934E-02,8.544E-02,5.934E-02,8.544E-02,23,"SMRT, BRG1, HDAC4, HDAC3, Ubiquitin, BAF155, UBE2D1, N-CoR, TBLR1, NF-kB, RBP-J kappa (CBF1), REV-ERBalpha, HESX1, Sin3A, GPS2, c-Jun, HDAC5, JNK1(MAPK8), AP-1, PIT1, SAP30, BAF47, RXRB",1.828E-01,2.374E-01,19,"SMRT, BRG1, HDAC4, HDAC3, Ubiquitin, BAF155, UBE2D1, N-CoR, TBLR1, NF-kB, RBP-J kappa (CBF1), HESX1, Sin3A, GPS2, HDAC5, JNK1(MAPK8), SAP30, BAF47, RXRB",
1100,Demyelination in multiple sclerosis,49,5.934E-02,8.544E-02,5.934E-02,8.544E-02,23,"DR5(TNFRSF10B), Apo-2L(TNFSF10), Caspase-8, Caspase-3, P2X7, FasL(TNFSF6), AKT(PKB), DR4(TNFRSF10A), TNF-R1, Stromelysin-1, TNF-alpha, PARP-1, iNOS, MEK3(MAP2K3), JNK1(MAPK8), MEK4(MAP2K4), Myelin basic protein, MEKK1(MAP3K1), FasR(CD95), JNK(MAPK8-10), p53, p38 MAPK, MMP-9",1.147E-01,1.559E-01,20,"DR5(TNFRSF10B), Apo-2L(TNFSF10), Caspase-8, Caspase-3, P2X7, AKT(PKB), DR4(TNFRSF10A), TNF-R1, Stromelysin-1, TNF-alpha, iNOS, MEK3(MAP2K3), JNK1(MAPK8), MEK4(MAP2K4), Myelin basic protein, FasR(CD95), JNK(MAPK8-10), p53, p38 MAPK, MMP-9",
1101,Inhibition of LKB1 / AMPK signaling in breast cancer,32,6.020E-02,8.652E-02,6.020E-02,8.652E-02,16,"NRF1, PP2A cat (alpha), Vimentin, GSK3 beta, HMDH, CYP19, IL-6, PPARGC1 (PGC1-alpha), AMPK alpha 1 subunit, TWIST1, AKT(PKB), HIF1A, TFAM, 4E-BP1, SNAIL1, mTOR",1.863E-01,2.417E-01,13,"NRF1, PP2A cat (alpha), Vimentin, GSK3 beta, HMDH, IL-6, PPARGC1 (PGC1-alpha), AMPK alpha 1 subunit, TWIST1, AKT(PKB), HIF1A, SNAIL1, mTOR",
1102,GTP metabolism,54,6.122E-02,8.818E-02,1.585E-01,2.069E-01,23,"PDE6A, PDE10A, Guanylate cyclase B (NPR2), PDE1A, Guanylate cyclase A (NPR1), KPYR, PDE3A, Guanylate cyclase C (GC-C), GUCY1A3, Guanylate Cyclase 1, soluble, PKM2, ITPA, PDE5A, NDPK 7, PDE9A, PDE2A, Guanylate cyclase alpha, Guanylate cyclase beta, PDE6D, PDE1C, Guanylate cyclase 2F (RETGC2), GUCY1B1, PDE6H",6.122E-02,8.818E-02,23,"PDE6A, PDE10A, Guanylate cyclase B (NPR2), PDE1A, Guanylate cyclase A (NPR1), KPYR, PDE3A, Guanylate cyclase C (GC-C), GUCY1A3, Guanylate Cyclase 1, soluble, PKM2, ITPA, PDE5A, NDPK 7, PDE9A, PDE2A, Guanylate cyclase alpha, Guanylate cyclase beta, PDE6D, PDE1C, Guanylate cyclase 2F (RETGC2), GUCY1B1, PDE6H",
1103,Multiple myeloma (general schema),18,6.157E-02,8.814E-02,6.157E-02,8.814E-02,10,"Cyclin D3, RANKL(TNFSF11), DKK1, VEGF-A, N-Ras, IL-6, c-Myc, FGF2, WHSC1, c-Maf",1.819E-01,2.367E-01,8,"RANKL(TNFSF11), DKK1, VEGF-A, N-Ras, IL-6, FGF2, WHSC1, c-Maf",
1104,Stem cells_CD30 signaling in transformed embryonic stem cells,18,6.157E-02,8.814E-02,6.157E-02,8.814E-02,10,"Oct-3/4, PLAP, I-kB, CD30(TNFRSF8), NF-kB p50/p65, c-Myc, NIK(MAP3K14), CD30L (TNFSF8), TRAF1, SALL4",1.819E-01,2.367E-01,8,"Oct-3/4, PLAP, I-kB, CD30(TNFRSF8), NF-kB p50/p65, NIK(MAP3K14), TRAF1, SALL4",
1105,Tinnitus-associated changes in auditory pathway ,82,6.293E-02,8.974E-02,6.293E-02,8.974E-02,36,"mGluR1, mGluR5, Glycine receptor beta chain, mGluR7, GluR4, NR2C, SLC17A7, SLC17A6, GABA-A receptor, nAChR, Glycine receptor, GABA-A receptor alpha-2 subunit, GABA-A receptor gamma-3 subunit, GLRA, GABA-A receptor beta-2 subunit, GRID1, GABA-A receptor alpha-4 subunit, GluR6, GBR1, mGluR8, GABA-A receptor beta-1 subunit, mGluR3, GABA-A receptor alpha-1 subunit, GAD1, nNOS, NR2A, NR2B, nAChR alpha-9, CLAT, GAD2, HCN2, GRM6, GluR1, NR2D, GRM2, KCNQ2",2.772E-01,3.456E-01,29,"mGluR1, mGluR5, Glycine receptor beta chain, mGluR7, GluR4, NR2C, SLC17A7, SLC17A6, GABA-A receptor, GluR3, Glycine receptor, GABA-A receptor alpha-3 subunit, GABRG1, GLRA, GRID1, GluR6, GBR1, mGluR8, GAD1, NR2A, nNOS, NR2B, nAChR alpha-9, CLAT, GAD2, HCN2, GRM6, GRM2, GRID2",
1106,Transcription_CoREST complex-mediated epigenetic gene silencing,37,6.322E-02,8.999E-02,6.322E-02,8.999E-02,18,"GFI1B, BRG1, HDAC2, NRSF, CtBP, Tubulin beta 3, GFI-1, BHC80, Sin3A, SCN2A, LSD1, STMN2, CLAT, CtBP2, SNAIL1, HDAC1, CtBP1, G9a",9.483E-02,1.319E-01,16,"GFI1B, BRG1, HDAC2, CtBP, Tubulin beta 3, GFI-1, Sin3A, SCN2A, LSD1, STMN2, CLAT, CtBP2, ELAC2, SNAIL1, HDAC1, G9a",
1107,IgE-dependent production of pro-inflammatory mediators by neutrophils in asthma,38,6.398E-02,9.170E-02,2.319E-01,2.906E-01,16,"Calcineurin A (catalytic), ERK1/2, Fc epsilon RI alpha, GM-CSF, NF-kB, ECP (RNase 3), NF-AT2(NFATC1), Neurokinin-2 receptor, IL-8, Substance P receptor, Leukocyte elastase, JNK1(MAPK8), COX-2 (PTGS2), Calmodulin, Alpha-defensin, p38 MAPK",6.398E-02,9.170E-02,17,"Calcineurin A (catalytic), HDC, ERK1/2, Fc epsilon RI alpha, GM-CSF, NF-kB, ECP (RNase 3), NF-AT2(NFATC1), Neurokinin-2 receptor, IL-8, Substance P receptor, Leukocyte elastase, JNK1(MAPK8), COX-2 (PTGS2), Calmodulin, Alpha-defensin, p38 MAPK",
1108,Role of TNF-alpha in type 2 diabetes in skeletal muscle cells,42,6.514E-02,9.263E-02,6.514E-02,9.263E-02,20,"IRS-1, PKC-epsilon, PKC-theta, p38beta (MAPK11), SOCS3, PPARGC1 (PGC1-alpha), ERK2 (MAPK1), TNF-R1, TNF-alpha, HGK(MAP4K4), RelA (p65 NF-kB subunit), PKC-delta, AMPK alpha subunit, PTP-1B, JNK1(MAPK8), MEK4(MAP2K4), MEKK1(MAP3K1), PKC-alpha, Mitofusin 2, ADAM17",2.343E-01,2.978E-01,16,"PKC-epsilon, PKC-theta, SOCS3, PPARGC1 (PGC1-alpha), ERK2 (MAPK1), TNF-R1, TNF-alpha, MEK1(MAP2K1), HGK(MAP4K4), RelA (p65 NF-kB subunit), AMPK alpha subunit, JNK1(MAPK8), MEK4(MAP2K4), PKC-alpha, Mitofusin 2, ADAM17",
1109,Regulation of lipid metabolism_Insulin signaling: generic cascades,47,6.624E-02,9.411E-02,6.624E-02,9.411E-02,22,"RHEB2, IRS-2, IRS-1, RPS6, PP1-cat, ERK1/2, PKC-zeta, PKA-reg (cAMP-dependent), GLUT4, Shc, GSK3 beta, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), PI3K cat class IA, eEF2K, SOS, PDHA (somatic), 4E-BP1, AKT2, PKA-cat (cAMP-dependent), mTOR",3.066E-01,3.770E-01,17,"RHEB2, IRS-2, RPS6, PP1-cat, ERK1/2, c-Raf-1, Shc, GSK3 beta, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, SOS, p90RSK1, PKA-cat (cAMP-dependent), mTOR",
1110,Nicotine signaling in cholinergic neurons,52,6.672E-02,9.471E-02,6.672E-02,9.471E-02,24,"TrkA, Shc, GSK3 beta, PI3K reg class IA, PLC-gamma 1, nAChR, CREB1, G-protein beta/gamma, Guanylate Cyclase 1, soluble, ERK2 (MAPK1), VAMP2, Dopamine D2 receptor, PI3K cat class IA, ACM2, nNOS, nAChR alpha-5, NGF, nAChR alpha3/beta4, CLAT, Calmodulin, P/Q-type calcium channel alpha-1A subunit, nAChR alpha-3, N-type Ca(II) channel alpha1B, SLC18A3",1.187E-01,1.604E-01,21,"SNAP-25, Shc, GSK3 beta, PI3K reg class IA, PLC-gamma 1, CREB1, G-protein beta/gamma, Guanylate Cyclase 1, soluble, ERK2 (MAPK1), VAMP2, Dopamine D2 receptor, PI3K cat class IA, nNOS, nAChR alpha-5, NGF, nAChR alpha3/beta4, CLAT, Calmodulin, P/Q-type calcium channel alpha-1A subunit, nAChR alpha-3, SLC18A3",
1111,PR action in breast cancer: stimulation of metastasis,20,6.867E-02,9.796E-02,1.252E-01,1.675E-01,10,"IRS-2, SOD2, c-Src, RhoA, PI3K reg class IA (p85-alpha), ROCK2, Tissue factor, PI3K cat class IA (p110-alpha), ATP1B1, PAR1",6.867E-02,9.796E-02,10,"IRS-2, SOD2, c-Src, RhoA, PI3K reg class IA (p85-alpha), ROCK2, Tissue factor, PI3K cat class IA (p110-alpha), ATP1B1, PAR1",
1112,Neurophysiological process_Regulation of intrinsic membrane properties and excitability of cortical pyramidal neurons,74,6.890E-02,9.809E-02,9.225E-02,1.267E-01,32,"TRPC5, mGluR1, Calcineurin A (catalytic), mGluR5, HTR2A, PKA-reg (cAMP-dependent), Na(v) I alpha, G-protein alpha-q/11, PLC-beta1, IP3 receptor, HTR2C (HTR1C), PLC-gamma 1, Adenylate cyclase, G-protein beta/gamma, Nav1.6, Dopamine D2 receptor, cPKC (conventional), HCN1, G-protein alpha-i family, SCN2A, SK1, Kv1.2, TrkB, ACM3, Calmodulin, PKC, G-protein alpha-q, KCNQ2, N-type Ca(II) channel alpha1B, Calcineurin B (regulatory), BDNF, PKA-cat (cAMP-dependent)",6.890E-02,9.809E-02,30,"TRPC5, mGluR1, TRPC4, Calcineurin A (catalytic), mGluR5, HTR2A, Na(v) I alpha, G-protein alpha-q/11, IP3 receptor, PLC-gamma 1, Adenylate cyclase, G-protein beta/gamma, Nav1.6, Dopamine D2 receptor, cPKC (conventional), HCN1, G-protein alpha-i family, SCN2A, SK1, Kv1.2, TrkB, NAV1.9, ACM3, Calmodulin, PKC, HPCA, HTR1A, Calcineurin B (regulatory), BDNF, PKA-cat (cAMP-dependent)",
1113,G-protein signaling_RhoB regulation pathway,16,6.901E-02,9.776E-02,6.901E-02,9.776E-02,9,"PRK1, mDIA2(DIAPH3), Rhophilin 2, ARHGEF2, DIA1, PLC-epsilon, RhoGDI gamma, RhoGDI alpha, GrinchGEF",9.971E-02,1.380E-01,8,"PRK1, mDIA2(DIAPH3), Rhophilin 2, ARHGEF2, DIA1, PLC-epsilon, RhoGDI alpha, GrinchGEF",
1114,Regulation of metabolism_Bile acids regulation of glucose and lipid metabolism via FXR,41,6.902E-02,9.809E-02,1.568E-01,2.050E-01,18,"VLDL, HNF1-alpha, PPAR-alpha, APOC2, HNF3-beta, FKHR, ANGPTL3, APOB, GSK3 alpha/beta, AKT(PKB), HNF3, APOE, MTP, FXR, PPCKC, CYP7A1, PLTP, HNF4-alpha",6.902E-02,9.809E-02,18,"PPAR-alpha, HNF3-beta, FKHR, ANGPTL3, APOB, GSK3 alpha/beta, AKT(PKB), HNF3, G6PT, APOE, MTP, FXR, SHP, PPCKC, LXR-alpha, CYP7A1, PLTP, HNF4-alpha",
1115,Apoptosis and survival_Beta-2 adrenergic receptor anti-apoptotic action,23,7.057E-02,9.988E-02,7.057E-02,9.988E-02,12,"PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), Adenylate cyclase type VII, FKHR, G-protein beta/gamma, AKT(PKB), PI3K reg class IA (p85-alpha), G-protein alpha-i family, PI3K cat class IA (p110-alpha), Beta-2 adrenergic receptor, PI3K reg class IB (p101), PKA-cat (cAMP-dependent)",1.624E-01,2.136E-01,10,"PI3K cat class IB (p110-gamma), Adenylate cyclase type VII, FKHR, G-protein beta/gamma, AKT(PKB), PI3K reg class IA (p85-alpha), G-protein alpha-i family, PI3K cat class IA (p110-alpha), Beta-2 adrenergic receptor, PKA-cat (cAMP-dependent)",
1116,G-protein signaling_S1P2 receptor signaling pathway,35,7.098E-02,1.002E-01,7.098E-02,1.002E-01,17,"ROCK1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, PLC-beta1, PI3K cat class IB (p110-gamma), IP3 receptor, Adenylate cyclase type VII, Adenylate cyclase, G-protein beta/gamma, AKT(PKB), RhoA, G-protein alpha-12, G-protein alpha-i family, S1P2 receptor, G-protein alpha-q, PI3K reg class IB (p101), PLC-beta3",1.920E-01,2.487E-01,14,"ROCK1, ARHGEF1 (p115RhoGEF), G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, Adenylate cyclase type VII, Adenylate cyclase, G-protein beta/gamma, AKT(PKB), RhoA, G-protein alpha-12, G-protein alpha-i family, S1P2 receptor, PLC-beta3",
1117,Signal transduction_mTORC2 upstream signaling,65,7.282E-02,1.026E-01,7.282E-02,1.026E-01,29,"Rictor, PLD1, WNT3A, RPS6, Rac1, TBC1D7, PI3K reg class IA, RPL5, RPL26, IKK-alpha, Protor-2, AKT(PKB), HSP70, LRP5/LRP6, Sestrin 3, PI3K cat class IA, V1a receptor, EGFR, IL4RA, p300, Hamartin, HSP90 beta, PLD2, PI3K cat class IA (p110-alpha), TTI2, NIP7, RIT, Frizzled, mTOR",1.521E-01,2.011E-01,25,"Rictor, PLD1, RPS6, TBC1D7, PI3K reg class IA, RPL5, RPL26, Protor-2, AKT(PKB), HSP70, Sestrin 3, PI3K cat class IA, V1a receptor, EGFR, AVP extracellular region, IL4RA, p300, HSP90 beta, PLD2, PI3K cat class IA (p110-alpha), TTI2, NIP7, RIT, Frizzled, mTOR",
1118,Role of glycosphingolipids in inhibition of Insulin signaling,40,7.295E-02,1.027E-01,7.295E-02,1.027E-01,19,"IRS-1, PKC-zeta, CRK, GLUT4, Rac1, SOCS3, Actin cytoskeletal, AKT(PKB), VAMP2, PI3K reg class IA (p85-alpha), c-Cbl, TBCD4, B4G6, C3G, PI3K cat class IA (p110-alpha), Rab-10, SORBS1, Caveolin-1, TC10",5.201E-01,6.186E-01,13,"CRK, SOCS3, Actin cytoskeletal, AKT(PKB), VAMP2, PI3K reg class IA (p85-alpha), c-Cbl, TBCD4, B4G6, PI3K cat class IA (p110-alpha), SORBS1, Caveolin-1, TC10",
1119,Immune response_T regulatory cell-mediated modulation of antigen-presenting cell functions,66,7.341E-02,1.041E-01,3.662E-01,4.433E-01,25,"IDO1, MHC class II, ICAM1, IL-10, 5'-NTD, PKA-reg (cAMP-dependent), IRF1, STAT1, 3HAO, RAP-1A, NF-kB2 (p100), B7-H4, IKK-alpha, SLC7A5, NF-kB p52/RelB, CTLA-4, NF-kB, TNF-alpha, KYNU, IFNGR1, NF-kB2 (p52), NIK(MAP3K14), IL-12 beta, PKA-cat (cAMP-dependent), CD86",7.341E-02,1.041E-01,27,"IRF8, IDO1, MHC class II, ICAM1, IL-10, IFN-gamma, 5'-NTD, IRF1, STAT1, 3HAO, RAP-1A, NF-kB2 (p100), B7-H4, SLC7A5, NF-kB p52/RelB, CTLA-4, NF-kB, TNF-alpha, KYNU, IFNGR1, CD80, NF-kB2 (p52), NIK(MAP3K14), Connexin 43, IL-12 beta, PKA-cat (cAMP-dependent), CD86",
1120,Chemotaxis_C5a-induced chemotaxis,44,7.374E-02,1.045E-01,1.693E-01,2.186E-01,19,"SPHK1, PLD1, C5a, ERK1/2, PI3K cat class IB (p110-gamma), Rac1, IP3 receptor, RAP-1A, PLC-beta, MEK1/2, G-protein beta/gamma, CDC42, Actin cytoskeletal, G-protein alpha-15, B-Raf, CALDAG-GEFI, G-protein alpha-i family, F-Actin cytoskeleton, ALPHA-PIX",7.374E-02,1.045E-01,19,"SPHK1, p38alpha (MAPK14), PLD1, C5a, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), IP3 receptor, RAP-1A, PLC-beta, MEK1/2, G-protein beta/gamma, CDC42, Actin cytoskeletal, G-protein alpha-15, B-Raf, G-protein alpha-i family, F-Actin cytoskeleton, ALPHA-PIX",
1121,SCAP/SREBP Transcriptional Control of Cholesterol and FA Biosynthesis,45,7.399E-02,1.040E-01,7.399E-02,1.040E-01,21,"ELOVL1, SCD5, INSIG2, GSK3 beta, HMGCS1, EBP, Resistin, HMDH, INSIG1, TNF-alpha, FADS2, ELOVL6, SREBP2 (nuclear), LSS, SREBP2 precursor, DHCR7, IDI1, FDPS, SREBP2 (Golgi membrane), FDFT1, GPAM",1.523E-01,2.011E-01,18,"ELOVL1, SCD5, GSK3 beta, EBP, HMDH, INSIG1, TNF-alpha, FADS2, ELOVL6, SREBP2 (nuclear), LSS, SREBP2 precursor, DHCR7, IDI1, FDPS, SREBP2 (Golgi membrane), FDFT1, GPAM",
1122,Hyaluronic acid/ CD44 signaling in cancer,58,7.793E-02,1.101E-01,1.301E-01,1.729E-01,25,"CD44, LARG, ARHGEF1 (p115RhoGEF), PKC-epsilon, MDR1, Rac1, CDC42, Actin cytoskeletal, DROSHA, TWIST1, ERK2 (MAPK1), Collagen IV, c-Src, PLC-epsilon, Ankyrin 1, RhoA, Tiam1, IQGAP1, HOXD10, ROCK, PI3K cat class IA (p110-alpha), Calmodulin, Filamin A, Elk-1, MMP-9",7.793E-02,1.101E-01,24,"CD44, ARHGEF1 (p115RhoGEF), PKC-epsilon, MDR1, CDC42, Actin cytoskeletal, DROSHA, TWIST1, ERK2 (MAPK1), Collagen IV, c-Src, PLC-epsilon, Ankyrin 1, RhoA, Tiam1, IQGAP1, STAT3, HOXD10, ROCK, PI3K cat class IA (p110-alpha), Calmodulin, Filamin A, Elk-1, MMP-9",
1123,NMDA-independent presynaptic long-term potentiation in Huntington's disease,58,7.793E-02,1.101E-01,8.168E-02,1.142E-01,26,"mGluR1, mGluR5, PKA-reg (cAMP-dependent), Syntaxin 1A, PKC-epsilon, IP3 receptor, GABA-A receptor, PLC-beta, PLC-gamma 1, Actin cytoskeletal, c-Src, VAMP2, Complexin 2, HCN1, GluR6, CACNA1E, HCN, Csk, TrkB, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, G-protein alpha-q, Ryanodine receptor 2, BDNF, PKA-cat (cAMP-dependent)",7.793E-02,1.101E-01,24,"mGluR1, mGluR5, SNAP-25, MUNC13-1, PKC-epsilon, IP3 receptor, GABA-A receptor, PLC-beta, PLC-gamma 1, Actin cytoskeletal, c-Src, VAMP2, HCN1, GluR6, CACNA1E, HCN, Csk, TrkB, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, Ryanodine receptor 2, BDNF, PKA-cat (cAMP-dependent)",
1124,Neurophysiological process_Circadian rhythm,47,7.815E-02,1.102E-01,1.814E-01,2.331E-01,20,"BMAL1, Casein kinase I delta, Protein kinase G 2, NPAS2, ERK1/2, Casein kinase I epsilon, PER3, CLOCK, MEK2(MAP2K2), CREB1, Guanylate Cyclase 1, soluble, DEC1 (Stra13), REV-ERBalpha, DEC2, nNOS, p90Rsk, PACAP receptor 1, Calmodulin, PACAP, LDHA",7.815E-02,1.102E-01,20,"BMAL1, Protein kinase G 2, NPAS2, ERK1/2, Casein kinase I epsilon, c-Raf-1, PER3, MEK2(MAP2K2), CREB1, Guanylate Cyclase 1, soluble, DEC1 (Stra13), MEK1(MAP2K1), DEC2, ROR-alpha, nNOS, p90Rsk, PACAP receptor 1, Calmodulin, PACAP, LDHA",
1125,Stem cells_MMP-14-induced COX-2 expression in glioblastoma stem cells,23,7.919E-02,1.115E-01,1.465E-01,1.926E-01,11,"VEGF-A, cPLA2, MMP-2, NF-kB, AKT(PKB), NF-kB p50/p65, CD133, NF-kB1 (p50), PGES, COX-2 (PTGS2), MMP-14",7.919E-02,1.115E-01,11,"VEGF-A, cPLA2, MMP-2, NF-kB, AKT(PKB), NF-kB p50/p65, CD133, NF-kB1 (p50), PGES, COX-2 (PTGS2), MMP-14",
1126,Development_Generation of pancreatic beta-cells from embryonic stem cells (early stages),21,7.964E-02,1.116E-01,7.964E-02,1.116E-01,11,"WNT3A, Oct-3/4, HNF3-beta, SOX9, CXCR4, Activin A, Pdx-1 (IPF1), SOX17, Noggin, FGF7, HNF4-alpha",1.936E-01,2.504E-01,9,"Oct-3/4, HNF3-beta, SOX9, CXCR4, Activin A, Pdx-1 (IPF1), SOX17, Noggin, HNF4-alpha",
1127,HCV-mediated liver damage and predisposition to HCC via cell stress,63,8.059E-02,1.128E-01,8.059E-02,1.128E-01,28,"IL-1 alpha, GRP78, C/EBP zeta, JAK1, SOD2, Apaf-1, Endoplasmin, S2P, ATF-6 alpha (90kDa), Bak, Bax, SOD1, MyD88, Calreticulin, Caspase-3, Ca-ATPase2, IL-6, NF-kB, TNF-R1, c-Src, c-Myc, ATF-6 alpha (50kDa), TNF-alpha, JAK2, PARP-1, Caspase-9, Calpain 2(m), S1P",1.132E-01,1.542E-01,25,"p38alpha (MAPK14), IL-1 alpha, GRP78, C/EBP zeta, JAK1, SOD2, Apaf-1, Endoplasmin, S2P, ATF-6 alpha (90kDa), Bax, Calreticulin, Caspase-3, Ca-ATPase2, IL-6, NF-kB, TNF-R1, c-Src, ATF-6 alpha (50kDa), TNF-alpha, JAK2, Caspase-9, Calpain 2(m), S1P, STAT3",
1128,Cytoskeleton remodeling_RalB regulation pathway,13,8.243E-02,1.156E-01,1.324E-01,1.757E-01,7,"Sec5, Exo84, Calmodulin, RalB, PLC-delta 1, RalBP1, RIT",8.243E-02,1.156E-01,7,"Sec5, Exo84, Calmodulin, RalB, PLC-delta 1, RalBP1, RIT",
1129,Protein folding and maturation_Angiotensin system maturation,48,8.286E-02,1.155E-01,8.286E-02,1.155E-01,22,"Neprilysin, Angiotensin (1-7), Angiotensin (1-9), Angiotensin II, IRAP, AGTR2, Chymase, Angiotensin (2-10), Meprin A, alpha, MMP-8, Prolyl endopeptidase, ACE2, Cathepsin G, MC-CPA, Leukocyte elastase, Angiotensin IV, Cathepsin A, Angiotensin I, Angiotensin III, Angiotensinogen, Kallikrein 1, CD13",9.531E-02,1.324E-01,20,"Neprilysin, Angiotensin (1-7), Angiotensin (1-9), Angiotensin II, AGTR2, Angiotensin (2-10), Meprin A, alpha, MMP-8, Prolyl endopeptidase, ACE2, Cathepsin G, MC-CPA, Leukocyte elastase, Angiotensin IV, Cathepsin A, Angiotensin I, Angiotensin III, Angiotensinogen, MAS1, CD13",
1130,CREB1-dependent transcription deregulation in Huntington's Disease,26,8.605E-02,1.196E-01,8.605E-02,1.196E-01,13,"CBP, SOD2, UCP1, SOD1, CTIP2, CREB1, PPARGC1 (PGC1-alpha), ACADM, PPAR-gamma, TFAM, LDHB, GPX1, BDNF",1.717E-01,2.240E-01,11,"CBP, SOD2, UCP1, CTIP2, CREB1, PPARGC1 (PGC1-alpha), ACADM, PPAR-gamma, LDHB, GPX1, BDNF",
1131,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,42,8.608E-02,1.204E-01,2.849E-01,3.520E-01,17,"CYP27A1, SLC21A2, UGT1A4, ALAS1, MDR1, UGT1A1, CYP24A1, CYP2C19, SR-BI, ELOVL6, CYP2B6, CYP11A1, SULT2A1, CYP3A7, CYP2C9, CYP7A1, UGT1A6",8.608E-02,1.204E-01,18,"CYP2C8, CYP27A1, SLC21A2, UGT1A4, ALAS1, MDR1, UGT1A1, CYP24A1, CYP3A4, SR-BI, G6PT, ELOVL6, CYP11A1, SULT2A1, CYP3A7, CYP2C9, CYP7A1, UGT1A6",
1132,Signal transduction_HTR2A-dependent arachidonic acid production,26,8.858E-02,1.237E-01,1.663E-01,2.156E-01,12,"PLD1, ERK1/2, HTR2A, G-protein alpha-q/11, PLC-beta, cPLA2, RhoA-related, G-protein beta/gamma, G-protein alpha-12 family, G-protein alpha-i family, COX-2 (PTGS2), p38 MAPK",8.858E-02,1.237E-01,12,"PLD1, ERK1/2, HTR2A, G-protein alpha-q/11, PLC-beta, cPLA2, RhoA-related, G-protein beta/gamma, G-protein alpha-12 family, G-protein alpha-i family, COX-2 (PTGS2), p38 MAPK",
1133,Schema: Initiation of T cell recruitment in allergic contact dermatitis,19,9.006E-02,1.245E-01,9.006E-02,1.245E-01,10,"IP10, alpha-4/beta-1 integrin, ICAM1, C5a, MHC class I, CD5, TNF-alpha, VCAM1, CD1d, CXCR3",1.141E-01,1.552E-01,9,"IP10, alpha-4/beta-1 integrin, ICAM1, C5a, IFN-gamma, MHC class I, TNF-alpha, VCAM1, CD1d",
1134,Development_Beta-adrenergic receptors signaling via Cyclic AMP,51,9.172E-02,1.263E-01,9.172E-02,1.263E-01,23,"Beta-3 adrenergic receptor, PKA-reg (cAMP-dependent), PDE3A, UCP1, Troponin C, cardiac, Adenylate cyclase, Ca-ATPase2, PPARGC1 (PGC1-alpha), CDC42, PPAR-gamma, PHK gamma (muscle), MEKK4(MAP3K4), BETA-PIX, AKAP6, MEK3(MAP2K3), PP2A catalytic, Ca-ATPase1, Calmodulin, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, p38 MAPK, Ryanodine receptor 2, PKA-cat (cAMP-dependent)",9.943E-02,1.379E-01,21,"Beta-3 adrenergic receptor, PDE3A, UCP1, Troponin C, cardiac, Adenylate cyclase, Ca-ATPase2, PPARGC1 (PGC1-alpha), CDC42, PPAR-gamma, PHK gamma (muscle), Phospholamban, AKAP6, MEK3(MAP2K3), PP2A catalytic, Ca-ATPase1, Calmodulin, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, p38 MAPK, Ryanodine receptor 2, PKA-cat (cAMP-dependent)",
1135,Higher ESR1 / ESR2 ratio in breast cancer,36,9.174E-02,1.263E-01,9.174E-02,1.263E-01,17,"ITGA1, ID1, VEGF-A, CDC25A, Cyclin A2, GADD45 alpha, N-CoR, SKP2, AKT(PKB), Cyclin B1, c-Myc, ARNT, HIF1A, c-Jun, FOXM1, NCOA2 (GRIP1/TIF2), Cyclin E",2.271E-01,2.899E-01,14,"ITGA1, ID1, VEGF-A, CDC25A, Cyclin A2, GADD45 alpha, N-CoR, SKP2, AKT(PKB), Cyclin B1, HIF1A, FOXM1, NCOA2 (GRIP1/TIF2), Cyclin E",
1136,Endothelial cell apoptosis in COPD,36,9.174E-02,1.263E-01,9.174E-02,1.263E-01,17,"SOD2, Neuropilin-1, BFL1, VEGF-A, VEGFR-2, BAD, Survivin, PI3K reg class IA, Caspase-3, NF-kB, AKT(PKB), PI3K cat class IA, XIAP, Glypican-1, Caspase-9, Caspase-7, GPX1",1.369E-01,1.830E-01,15,"SOD2, Neuropilin-1, BFL1, VEGF-A, VEGFR-2, Survivin, PI3K reg class IA, Caspase-3, NF-kB, AKT(PKB), PI3K cat class IA, XIAP, Glypican-1, Caspase-9, GPX1",
1137,DNA damage_Nucleotide excision repair,36,9.174E-02,1.263E-01,9.174E-02,1.263E-01,17,"XPC, XPF, Ubiquitin, ERCC-1, POLD reg (p68), XPG, RFC complex, RAD23A, ERCC6, DDB1, POLR2A, POLD cat (p125), Cul4/DDB1/Rbx1 E3 ligase, PCNA, RPA4, RPA1, RPA2",4.825E-01,5.775E-01,12,"XPF, Ubiquitin, ERCC-1, POLD reg (p68), XPG, RAD23A, POLR2A, POLD cat (p125), PCNA, RPA4, RPA1, RPA2",
1138,dCTP/dUTP metabolism,74,9.225E-02,1.267E-01,9.225E-02,1.267E-01,32,"dUTPase (DUT), DNA polymerase zeta, RRM2, KCY, POLA1, DNA polymerase alpha/primase, AK3, XRN2, AK2, TK1, POLD reg (p68), Ribonucleotide reductase, PD-ECGF (TdRPase), POLE3 (YBL1), RRM1, AK1, TK2, POLE4, NDPK 7, AK5, DCTD, DNA polymerase beta, POLE2, POLD cat (p125), NT5M, DNA polymerase theta, NT5C3, POLA2, CDD, POLG cat, Small RR subunit, DCK",2.252E-01,2.878E-01,27,"dUTPase (DUT), DNA polymerase zeta, RRM2, KCY, POLA1, AK3, XRN2, AK2, TK1, POLD reg (p68), Ribonucleotide reductase, PD-ECGF (TdRPase), RRM1, TK2, POLE4, NDPK 7, AK5, DCTD, DNA polymerase beta, POLD cat (p125), NT5M, DNA polymerase theta, NT5C3, POLA2, CDD, Small RR subunit, DCK",
1139,Tumor metabolic pathways promoting development of Treg cells,96,9.482E-02,1.319E-01,1.553E-01,2.036E-01,39,"SDHA, Helios, TGF-beta 1, MHC class II, HMGB1, c-Rel (NF-kB subunit), IL-10, CD28, 5'-NTD, TSLP, STAT5B, I-kB, NF-kB p65/c-Rel, CD4, CTLA-4, ICOS, c-Src, c-Myc, IL-2R alpha chain, CXCR4, IL-2, ARNT, JAK2, RelA (p65 NF-kB subunit), HIF1A, TGF-beta receptor type II, AMPK alpha subunit, SLC16A3, TIM-3, STAT5, PD-1, HIF-prolyl hydroxylase, FUMH, LDHA, CCR10, CCR4, CD86, PD-L1, TSLPR",9.482E-02,1.319E-01,37,"SDHA, Helios, PDK1, TGF-beta 1, MHC class II, HMGB1, c-Rel (NF-kB subunit), IL-10, CD28, 5'-NTD, TSLP, STAT5B, I-kB, NF-kB p65/c-Rel, CD4, CTLA-4, c-Src, CXCR4, IL-2, JAK2, CD80, RelA (p65 NF-kB subunit), HIF1A, TGF-beta receptor type II, AMPK alpha subunit, SLC16A3, STAT3, STAT5, PD-1, HIF-prolyl hydroxylase, FUMH, LDHA, CCR10, CCR4, CD86, PD-L1, TSLPR",
1140,A shift in alveolar macrophage phenotype in COPD,37,9.483E-02,1.319E-01,1.160E-01,1.559E-01,17,"MHC class II, CD44, BACH1, Matrilysin (MMP-7), CD14, CD209, MMP-2, MHC class I, AKT(PKB), Heme oxygenase 1, CD68, iNOS, KEAP1, MARCO, HYAL2, NRF2, CD86",9.483E-02,1.319E-01,16,"MHC class II, CD44, BACH1, Matrilysin (MMP-7), CD14, MMP-2, MHC class I, AKT(PKB), Heme oxygenase 1, CD68, iNOS, KEAP1, MARCO, HYAL2, NRF2, CD86",
1141,Development_SSTR1 in regulation of cell proliferation and migration,29,9.696E-02,1.346E-01,1.012E-01,1.385E-01,14,"ROCK1, ERK1/2, EGR1, PI3K cat class IB (p110-gamma), MEK2(MAP2K2), G-protein beta/gamma, c-Src, GAB2, RhoA, G-protein alpha-i3, Somatostatin, SHP-2, PI3K reg class IB (p101), Elk-1",9.696E-02,1.346E-01,13,"ROCK1, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), MEK2(MAP2K2), G-protein beta/gamma, c-Src, GAB2, MEK1(MAP2K1), RhoA, G-protein alpha-i3, SSTR1, Elk-1",
1142,Sitagliptin in treatment of type 2 diabetes and metabolic syndrome X,10,9.700E-02,1.331E-01,9.700E-02,1.331E-01,6,"GLP-1 (7-36) amide, GLP-1 receptor, DPP4, GLP-1 (7-37), GCGR, Glucagon",1.822E-01,2.369E-01,5,"GLP-1 (7-36) amide, GLP-1 receptor, DPP4, GLP-1 (7-37), Glucagon",
1143,wtCFTR and deltaF508 traffic / Late endosome and lysosome (normal and CF),16,9.971E-02,1.380E-01,1.631E-01,2.120E-01,8,"PI3K cat class III (Vps34), Rab-7, Syntaxin 6, PI3K reg class III (p150), Rab-27A, Syntaxin 8, RILP (Rab interacting lysosomal protein), Rab-9",9.971E-02,1.380E-01,8,"PI3K cat class III (Vps34), Syntaxin 6, PI3K reg class III (p150), Rab-27A, CFTR, Syntaxin 8, RILP (Rab interacting lysosomal protein), Rab-9",
1144,IL-6 signaling in Prostate Cancer,40,1.005E-01,1.386E-01,2.088E-01,2.648E-01,17,"JAK1, IRS-1, Pim-1, Shc, PI3K reg class IA, MEK2(MAP2K2), IL-6, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, Mcl-1, PI3K cat class IA, SOS, BMX, AP-1, SHP-2, NCOA1 (SRC1)",1.005E-01,1.386E-01,17,"JAK1, c-Raf-1, Pim-1, Shc, PI3K reg class IA, MEK2(MAP2K2), IL-6, ERK2 (MAPK1), AKT(PKB), NF-kB p50/p65, Mcl-1, MEK1(MAP2K1), PI3K cat class IA, SOS, STAT3, BMX, NCOA1 (SRC1)",
1145,Inhibition of Vitamin D pathway in Prostate Cancer,40,1.005E-01,1.386E-01,1.286E-01,1.714E-01,18,"CYP27A1, TRIP15, VDB, SMRT, PPAR-alpha, MKP-5, IBP3, CDK4, CYP24A1, IL-6, N-CoR, GFI-1, Osteocalcin, CDK2, CDK6, CYP27B1, RUNX2, SMAD3",1.005E-01,1.386E-01,17,"p38alpha (MAPK14), CYP27A1, SMRT, PPAR-alpha, MKP-5, IBP3, CDK4, CYP24A1, IL-6, N-CoR, GFI-1, Osteocalcin, CDK2, CDK6, CYP27B1, RUNX2, SMAD3",
1146,Transcription_Transcription factor Tubby signaling pathways,17,1.021E-01,1.391E-01,1.021E-01,1.391E-01,9,"TUB, G-protein alpha-q/11, PLC-beta, HTR2C (HTR1C), JAK2, PKC, PLC-gamma, c-Abl, G-protein alpha-q",2.768E-01,3.454E-01,7,"TUB, G-protein alpha-q/11, PLC-beta, JAK2, PKC, PLC-gamma, c-Abl",
1147,G-protein signaling_Rap2A regulation pathway,17,1.021E-01,1.391E-01,1.021E-01,1.391E-01,9,"PKA-reg (cAMP-dependent), M-Ras, RPIP8, SPA1, cAMP-GEFII, G-protein alpha-i family, RAP-2A, RGS14, PKA-cat (cAMP-dependent)",2.768E-01,3.454E-01,7,"M-Ras, SPA1, cAMP-GEFII, G-protein alpha-i family, RAP-2A, RGS14, PKA-cat (cAMP-dependent)",
1148,Putative pathways for stimulation of fat cell differentiation by Bisphenol A,32,1.045E-01,1.438E-01,1.159E-01,1.559E-01,15,"GCR, TCF7L2 (TCF4), Beta-catenin, GLUT4, PI3K reg class IA, FKHR, CREB1, PPARGC1 (PGC1-alpha), AKT(PKB), PPAR-gamma, PI3K cat class IA, C/EBPbeta, PERC, Esrrg, LPL",1.045E-01,1.438E-01,14,"GCR, TCF7L2 (TCF4), Beta-catenin, PI3K reg class IA, FKHR, CREB1, PPARGC1 (PGC1-alpha), AKT(PKB), PPAR-gamma, A-FABP, PI3K cat class IA, C/EBPbeta, PERC, LPL",
1149,"Triacylglycerol biosynthesis in obesity and diabetes mellitus, type II",24,1.056E-01,1.445E-01,1.882E-01,2.407E-01,11,"PLCA, MOGAT3, LPP2, MOGAT2, LPP1, LPP3, PLCD, MOGAT1, GPAM, PLCB, PLCE",1.056E-01,1.445E-01,11,"PLCA, MOGAT3, LPP2, MOGAT2, LPP1, LPP3, PLCD, MOGAT1, GPAM, PLCB, PLCE",
1150,Retinoic acid regulation of oligodendrocyte differentiation in multiple sclerosis,24,1.056E-01,1.445E-01,1.882E-01,2.407E-01,11,"UGT8, DHA2, BMP4, STRA6, PDGF-R-alpha, PPAR-beta(delta), RBP4, TNF-alpha, Myelin basic protein, GALC, BMP2",1.056E-01,1.445E-01,11,"UGT8, DHA2, BMP4, STRA6, PDGF-R-alpha, PPAR-beta(delta), RBP4, TNF-alpha, Myelin basic protein, GALC, BMP2",
1151,"Mechanism of action of DGAT1 inhibitors in obesity and diabetes mellitus, type II (Variant 1)",24,1.056E-01,1.445E-01,1.882E-01,2.407E-01,11,"PLCA, MOGAT3, LPP2, MOGAT2, LPP1, LPP3, PLCD, MOGAT1, GPAM, PLCB, PLCE",1.056E-01,1.445E-01,11,"PLCA, MOGAT3, LPP2, MOGAT2, LPP1, LPP3, PLCD, MOGAT1, GPAM, PLCB, PLCE",
1152,"POMC, alpha-MSH and AGRP in regulation of food intake and energy expenditure in obesity in hypothalamus",43,1.056E-01,1.445E-01,1.407E-01,1.858E-01,19,"proACTH, PKA-reg (cAMP-dependent), IP3 receptor, PLC-beta, PC1, CREB1, MC4R, MEK1/2, ERK2 (MAPK1), alpha-MSH, POMC, G-protein alpha-i family, AGRP, PKC-alpha, beta-LPH, G-protein alpha-q, Beta-MSH / Beta-Endorphin, BDNF, PKA-cat (cAMP-dependent)",1.056E-01,1.445E-01,18,"proACTH, c-Raf-1, IP3 receptor, PLC-beta, PC1, CREB1, MEK1/2, ERK2 (MAPK1), alpha-MSH, POMC, G-protein alpha-i family, AGRP, AVP-NPII, PKC-alpha, beta-LPH, Beta-MSH / Beta-Endorphin, BDNF, PKA-cat (cAMP-dependent)",
1153,Proinflammatory mediators release and arachidonic acid metabolites production in basophils in asthma,57,1.068E-01,1.459E-01,1.686E-01,2.182E-01,24,"TrkA, C5a, ERK1/2, IP3 receptor, Syk, Shc, PI3K reg class IA (p85), PLC-beta, cPLA2, IL-13, MEK1/2, G-protein beta/gamma, Eotaxin, GAB2, PI3K cat class IA, Lyn, G-protein alpha-i family, MEK3(MAP2K3), IL-5, SOS, NGF, PLC-gamma, p38 MAPK, LPCAT2",1.068E-01,1.459E-01,23,"C5a, ERK1/2, c-Raf-1, IP3 receptor, Syk, Shc, PI3K reg class IA (p85), PLC-beta, cPLA2, MEK1/2, G-protein beta/gamma, Eotaxin, GAB2, PI3K cat class IA, Lyn, G-protein alpha-i family, IL-5, MEK3(MAP2K3), SOS, NGF, PLC-gamma, p38 MAPK, LPCAT2",
1154,Ca(2+)-dependent NF-AT signaling in cardiac hypertrophy,57,1.092E-01,1.480E-01,1.092E-01,1.480E-01,25,"Calcineurin A (catalytic), MEF2C, HAND1, PKA-reg (cAMP-dependent), TRPC6, G-protein alpha-q/11, Angiotensin II, PLC-beta1, IP3 receptor, G-protein beta/gamma, Alpha-1B adrenergic receptor, G-protein alpha-i family, MEF2A, MEF2, HAND2, CSX (Nkx2.5), PKC-beta, Calmodulin, TRPC3, PKC-alpha, NCX1, G-protein alpha-q, Beta-1 adrenergic receptor, PLC-beta3, PKA-cat (cAMP-dependent)",1.666E-01,2.182E-01,22,"Calcineurin A (catalytic), MEF2C, HAND1, TRPC6, G-protein alpha-q/11, Angiotensin II, IP3 receptor, G-protein beta/gamma, Alpha-1B adrenergic receptor, G-protein alpha-i family, MEF2A, MEF2, HAND2, CSX (Nkx2.5), PKC-beta, Calmodulin, TRPC3, PKC-alpha, NCX1, Beta-1 adrenergic receptor, PLC-beta3, PKA-cat (cAMP-dependent)",
1155,Regulation of intrinsic membrane properties and excitability of striatopallidal medium spiny neurons in Huntington's disease,57,1.092E-01,1.480E-01,1.092E-01,1.480E-01,25,"Calcineurin A (catalytic), Kir2.3, PDE10A, Na(v) I alpha, G-protein alpha-q/11, SHANK, PLC-beta1, IP3 receptor, G-protein beta/gamma, Guanylate Cyclase 1, soluble, Dopamine D2 receptor, Kv4.2 channel, cPKC (conventional), G-protein alpha-i family, PDE9A, SCN2A, Kv1.2, Calmodulin, PKC, P/Q-type calcium channel alpha-1A subunit, SK3, Homer, KCNQ2, N-type Ca(II) channel alpha1B, Calcineurin B (regulatory)",2.451E-01,3.105E-01,21,"Calcineurin A (catalytic), Kir2.3, PDE10A, Na(v) I alpha, G-protein alpha-q/11, SHANK, IP3 receptor, G-protein beta/gamma, Guanylate Cyclase 1, soluble, Dopamine D2 receptor, Kv4.2 channel, cPKC (conventional), G-protein alpha-i family, PDE9A, SCN2A, Kv1.2, Calmodulin, PKC, P/Q-type calcium channel alpha-1A subunit, Homer, Calcineurin B (regulatory)",
1156,Transcription_PPAR Pathway,63,1.132E-01,1.542E-01,4.595E-01,5.500E-01,23,"IRS-1, SMRT, PPAR-alpha, ERK1/2, PKA-reg (cAMP-dependent), Shc, PPAR-beta(delta), PI3K reg class IA, N-CoR, AKT(PKB), PDGF receptor, PPAR-gamma, TAK1(MAP3K7), PI3K cat class IA, XIAP, MEK3(MAP2K3), SOS, COX-2 (PTGS2), PTGIS, NCOA1 (SRC1), p38 MAPK, PKA-cat (cAMP-dependent), TGF-beta receptor type I",1.132E-01,1.542E-01,25,"p38alpha (MAPK14), SMRT, PPAR-alpha, ERK1/2, c-Raf-1, Shc, PPAR-beta(delta), PI3K reg class IA, N-CoR, AKT(PKB), PDGF receptor, PPAR-gamma, TAK1(MAP3K7), MEK1(MAP2K1), PI3K cat class IA, XIAP, MEK3(MAP2K3), SOS, SHP, COX-2 (PTGS2), PTGIS, NCOA1 (SRC1), p38 MAPK, PKA-cat (cAMP-dependent), TGF-beta receptor type I",
1157,Transport_HDL-mediated reverse cholesterol transport,42,1.151E-01,1.551E-01,1.151E-01,1.551E-01,19,"LIPC (HL), CES1, APOA2, LCAT, Nascent HDL, CETP, LIPE, Large alpha-1 HDL, ABCA1, LIPA, SR-BI, Pre beta-1 HDL, Small HDL, APOE, APOA1, Medium HDL, PLTP, HDL, Large apoE-rich HDL",1.477E-01,1.963E-01,17,"LIPC (HL), CES1, APOA2, LCAT, Nascent HDL, CETP, LIPE, ABCA1, LIPA, SR-BI, Pre beta-1 HDL, Small HDL, APOE, APOA1, PLTP, HDL, Large apoE-rich HDL",
1158,Apoptosis and survival_Anti-apoptotic action of membrane-bound ESR1,38,1.173E-01,1.587E-01,4.755E-01,5.673E-01,14,"ERK1/2, PKC-epsilon, BAD, PI3K reg class IA (p85), Bax, MEK2(MAP2K2), CREB1, AKT(PKB), c-Src, PI3K cat class IA, ASK1 (MAP3K5), MEK4(MAP2K4), PKC-alpha, JNK(MAPK8-10)",1.173E-01,1.587E-01,16,"ERK1/2, c-Raf-1, PKC-epsilon, PI3K reg class IA (p85), Bax, MEK2(MAP2K2), CREB1, AKT(PKB), c-Src, MEK1(MAP2K1), PI3K cat class IA, ASK1 (MAP3K5), p90RSK1, MEK4(MAP2K4), PKC-alpha, JNK(MAPK8-10)",
1159,"Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP",38,1.173E-01,1.587E-01,2.319E-01,2.906E-01,16,"CBP, AMPK beta subunit, AMPK gamma subunit, S2P, CREM (activators), LDLR, CREB1, YY1, Importin (karyopherin)-beta, AMPK alpha subunit, SREBP2 (nuclear), SREBP2 precursor, S1P, CYP51A1, SREBP2 (Golgi membrane), Caveolin-1",1.173E-01,1.587E-01,16,"CBP, AMPK beta subunit, AMPK gamma subunit, S2P, CREM (activators), LDLR, CREB1, Importin (karyopherin)-beta, AMPK alpha subunit, SREBP2 (nuclear), SREBP2 precursor, S1P, CYP51A1, SREBP2 (Golgi membrane), LXR-alpha, Caveolin-1",
1160,Translation_(L)-selenoaminoacids incorporation in proteins during translation,41,1.227E-01,1.658E-01,1.568E-01,2.050E-01,18,"Selenoprotein N, Selenoprotein K, GPX3, TXNRD3, GPX6, SELS, DIO2, DIO3, SelT, SEPHS1, SEP15, Selenoprotein H, SECP43, GPX1, SelM, SELI, TXNRD1, Selenoprotein V",1.227E-01,1.658E-01,17,"Selenoprotein N, Selenoprotein K, TXNRD3, GPX6, SELS, DIO2, DIO3, SelT, SEPHS1, SEP15, Selenoprotein H, SECP43, GPX1, SelM, SELI, TXNRD1, Selenoprotein V",
1161,Stem cells_Putative pathways of telomerase regulation in glioblastoma stem cells,20,1.252E-01,1.675E-01,1.252E-01,1.675E-01,10,"PI3K cat class IB (p110-gamma), AKT(PKB), HSP90, c-Myc, TERT, PI3K cat class IA, PP2A catalytic, Dyskerin (NAP57), TEP1, p53",1.513E-01,2.004E-01,9,"PI3K cat class IB (p110-gamma), AKT(PKB), HSP90, TERT, PI3K cat class IA, TERC, PP2A catalytic, Dyskerin (NAP57), p53",
1162,Role of XBP1 protein in multiple myeloma,20,1.252E-01,1.675E-01,1.252E-01,1.675E-01,10,"GRP78, DNAJB11, PAX5, IL-6, PSMA5, EDEM, BOB1, DNAJC3, BLIMP1 (PRDI-BF1), ERP5",2.845E-01,3.538E-01,8,"GRP78, DNAJB11, PAX5, IL-6, EDEM, BOB1, BLIMP1 (PRDI-BF1), ERP5",
1163,Development_TGF-beta-induction of EMT via ROS,20,1.252E-01,1.675E-01,1.252E-01,1.675E-01,10,"TGF-beta 1, NOX4, Rac1, Shc, SOD1, TGF-beta receptor type II, SOS, NOX4/p22-phox, p38 MAPK, TGF-beta receptor type I",1.513E-01,2.004E-01,9,"p38alpha (MAPK14), TGF-beta 1, NOX4, Shc, TGF-beta receptor type II, SOS, NOX4/p22-phox, p38 MAPK, TGF-beta receptor type I",
1164,Signal transduction_Leptin signaling in non-neuronal cells,58,1.258E-01,1.697E-01,1.301E-01,1.729E-01,25,"Casein kinase II, alpha chains, IRS-2, IRS-1, STAT1, I-kB, PI3K reg class IA (p85), PPAR-beta(delta), IL-6, UCP3, AKT(PKB), NF-kB p50/p65, PPAR-gamma, JAK2, ACSL1, PI3K cat class IA, RelA (p65 NF-kB subunit), Kv2.1, cAMP-GEFII, IL-8, AMPK alpha subunit, Leptin receptor, p300, SENP2, SH2B, Calmodulin",1.258E-01,1.697E-01,23,"Casein kinase II, alpha chains, TRPC4, IRS-2, STAT1, I-kB, PI3K reg class IA (p85), PPAR-beta(delta), IL-6, UCP3, AKT(PKB), NF-kB p50/p65, PPAR-gamma, JAK2, PI3K cat class IA, RelA (p65 NF-kB subunit), Kv2.1, cAMP-GEFII, IL-8, AMPK alpha subunit, Leptin receptor, p300, STAT3, Calmodulin",
1165,HSP70 and HSP40-dependent folding in Huntington's disease,25,1.293E-01,1.722E-01,1.293E-01,1.722E-01,12,"Sti1, Ubiquitin, PSMD1, DNAJB6 (Hdj-1), HSP40, HSP90, HSP70, HSC70, Hdj-2, HSP90 beta, ST13 (Hip), SGTB",3.961E-01,4.795E-01,9,"Ubiquitin, PSMD1, DNAJB6 (Hdj-1), HSP90, HSP70, Hdj-2, HSP90 beta, ST13 (Hip), SGTB",
1166,Immune response_Lipoxins and Resolvin E1 inhibitory action on neutrophil functions,35,1.301E-01,1.729E-01,1.301E-01,1.729E-01,16,"PLD1, ERK1/2, PKC-zeta, PI3K cat class IB (p110-gamma), I-kB, SOD1, IKK-alpha, NFKBIB, G-protein beta/gamma, NF-kB, FPRL1, IL-8, G-protein alpha-i family, PPAPDC2, NIK(MAP3K14), PI3K reg class IB (p101)",4.367E-01,5.261E-01,12,"PLD1, ERK1/2, PI3K cat class IB (p110-gamma), I-kB, NFKBIB, G-protein beta/gamma, NF-kB, FPRL1, IL-8, G-protein alpha-i family, PPAPDC2, NIK(MAP3K14)",
1167,Role of proinflammatory cytokines in activation of p53 in major depressive disorder,47,1.322E-01,1.776E-01,3.788E-01,4.567E-01,18,"IDO1, Apaf-1, Caspase-4, 3HAO, Bax, IFN-alpha, Caspase-3, GADD45 alpha, NF-kB, TNF-alpha, KYNU, TGF-beta, Caspase-9, TrkB, NOXA, JNK(MAPK8-10), p53, BDNF",1.322E-01,1.776E-01,19,"IDO1, Apaf-1, IFN-gamma, Caspase-4, 3HAO, Bax, IFN-alpha, Caspase-3, GADD45 alpha, NF-kB, TNF-alpha, KYNU, TGF-beta, Caspase-9, TrkB, NOXA, JNK(MAPK8-10), p53, BDNF",
1168,Neurophysiological process_Leptin signaling in neurons,50,1.363E-01,1.829E-01,1.930E-01,2.459E-01,21,"Casein kinase II, alpha chains, TRPC5, IRS-2, PI3K cat class IA (p110-beta), IRS-1, RPS6, PI3K reg class IA (p85), GSK3 beta, FKHR, AKT(PKB), POMC, JAK2, IFT88, NPY, AMPK alpha subunit, AGRP, Leptin receptor, SH2B, PI3K cat class IA (p110-alpha), PLC-gamma, mTOR",1.363E-01,1.829E-01,20,"Casein kinase II, alpha chains, TRPC5, IRS-2, PI3K cat class IA (p110-beta), RPS6, PI3K reg class IA (p85), GSK3 beta, FKHR, AKT(PKB), POMC, JAK2, IFT88, NPY, AMPK alpha subunit, AGRP, Leptin receptor, STAT3, PI3K cat class IA (p110-alpha), PLC-gamma, mTOR",
1169,Development_Role of Thyroid hormone in regulation of oligodendrocyte differentiation,48,1.374E-01,1.821E-01,1.374E-01,1.821E-01,21,"UGT8, p14ARF, TCF7L2 (TCF4), MOG, OATP-F, PDGF-R-alpha, Cyclin D2, p73, TAT1, p19, AKT(PKB), PI3K reg class IA (p85-alpha), ID4, 4E-BP1, NGF, Myelin basic protein, PI3K cat class IA (p110-alpha), p15, MAG, p53, mTOR",1.564E-01,2.060E-01,19,"UGT8, p14ARF, TCF7L2 (TCF4), MOG, OATP-F, PDGF-R-alpha, Cyclin D2, p73, TAT1, p19, AKT(PKB), PI3K reg class IA (p85-alpha), ID4, NGF, Myelin basic protein, PI3K cat class IA (p110-alpha), p15, p53, mTOR",
1170,Regulation of metabolism_Role of Adiponectin in regulation of metabolism,43,1.407E-01,1.858E-01,1.407E-01,1.858E-01,19,"Raptor, H-FABP, RHEB2, SOD2, IRS-1, PPAR-alpha, GLUT4, APPL1, CREB1, PPARGC1 (PGC1-alpha), ACADM, AMPK alpha subunit, TFAM, Hamartin, PPCKC, PI3K cat class IA (p110-alpha), Rab-5A, AKT2, mTOR",2.693E-01,3.375E-01,16,"p38alpha (MAPK14), Raptor, H-FABP, RHEB2, SOD2, PPAR-alpha, APPL1, CREB1, PPARGC1 (PGC1-alpha), ACADM, G6PT, AMPK alpha subunit, PPCKC, PI3K cat class IA (p110-alpha), Rab-5A, mTOR",
1171,Signal transduction_Modulation of calcium and potassium channels by Adenosine A1 receptor,43,1.407E-01,1.858E-01,1.407E-01,1.858E-01,19,"PKA-reg (cAMP-dependent), IP3 receptor, cPLA2, Adenylate cyclase, G-protein beta/gamma, cPKC (conventional), G-protein alpha-i family, Ca(II)channel N-type, CACNA1E, Ca(II)channel R-type, Ca(II)channel L-type, CYP4A11, Calmodulin, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, Ca(II)channel P/Q-type, N-type Ca(II) channel alpha1B, PLC-beta3, PKA-cat (cAMP-dependent)",3.849E-01,4.686E-01,15,"IP3 receptor, cPLA2, Adenylate cyclase, G-protein beta/gamma, cPKC (conventional), G-protein alpha-i family, CACNA1E, Ca(II)channel R-type, CYP4A11, Calmodulin, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, Ca(II)channel P/Q-type, PLC-beta3, PKA-cat (cAMP-dependent)",
1172,Atorvastatin in treatment of type 2 diabetes and metabolic syndrome X,39,1.426E-01,1.900E-01,1.747E-01,2.251E-01,17,"LIPC (HL), GPX3, PPAR-alpha, CETP, Rac1, HMDH, ERK2 (MAPK1), RhoA, p22-phox, APOE, SREBP2 (nuclear), APOA1, OATP8, SOD3 (EC-SOD), APOC3, OATP-B, PLTP",1.426E-01,1.900E-01,16,"LIPC (HL), PPAR-alpha, CETP, HMDH, ERK2 (MAPK1), PON1, MEK1(MAP2K1), RhoA, p22-phox, APOE, SREBP2 (nuclear), APOA1, OATP8, SOD3 (EC-SOD), OATP-B, PLTP",
1173,NRSF-dependent transcription deregulation in Huntington's Disease,39,1.426E-01,1.900E-01,3.910E-01,4.702E-01,15,"Enkephalin A, V-ATPase H subunit, HDAC2, NRSF, ACM4, PLOD3, Dopamine D2 receptor, ITGB1, VAMP3, Sin3A, nAChR beta-2, CLAT, HDAC1, SLC18A3, BDNF",1.426E-01,1.900E-01,16,"SNAP-25, Enkephalin A, microRNA 132, HDAC2, Dopamine D3 receptor, ACM4, PLOD3, Dopamine D2 receptor, ITGB1, VAMP3, Sin3A, miR-132-3p, CLAT, HDAC1, SLC18A3, BDNF",
1174,Cytoskeleton remodeling_ACM3 and ACM4 in keratinocyte migration,38,1.437E-01,1.896E-01,1.437E-01,1.896E-01,17,"ROCK1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, PLC-beta, ACM4, Guanylate Cyclase 1, soluble, RhoA, iNOS, ROCK2, G-protein alpha-i family, G-protein alpha-o, ACM3, Calmodulin, G-protein alpha-q, PKA-cat (cAMP-dependent)",1.970E-01,2.543E-01,15,"ROCK1, G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, PLC-beta, ACM4, Guanylate Cyclase 1, soluble, RhoA, iNOS, ROCK2, G-protein alpha-i family, G-protein alpha-o, ACM3, Calmodulin, PKA-cat (cAMP-dependent)",
1175,Development_Activation of astroglial cells proliferation by ACM3,33,1.460E-01,1.924E-01,1.460E-01,1.924E-01,15,"PLD1, eIF4E, ARHGEF1 (p115RhoGEF), PKC-zeta, PLC-beta1, IP3 receptor, PI3K reg class IA (p85), AKT(PKB), RhoA, PI3K cat class IA, PLD2, ACM3, 4E-BP1, G-protein alpha-q, mTOR",6.361E-01,7.447E-01,10,"PLD1, ARHGEF1 (p115RhoGEF), IP3 receptor, PI3K reg class IA (p85), AKT(PKB), RhoA, PI3K cat class IA, PLD2, ACM3, mTOR",
1176,Development_EGFR signaling via PIP3,23,1.465E-01,1.926E-01,1.465E-01,1.926E-01,11,"IRS-2, IRS-1, Rac1, PI3K reg class IA, AKT(PKB), PI3K cat class IA, c-Cbl, EGFR, MKK7 (MAP2K7), MEK4(MAP2K4), JNK(MAPK8-10)",4.549E-01,5.463E-01,8,"IRS-2, PI3K reg class IA, AKT(PKB), PI3K cat class IA, c-Cbl, EGFR, MEK4(MAP2K4), JNK(MAPK8-10)",
1177,KLF6 and regulation of KLF6 alternative splicing in HCC,23,1.465E-01,1.926E-01,1.465E-01,1.926E-01,11,"Shc, Bax, CDK4, SFRS1 (SF2), Caspase-3, PI3K cat class IA, PARP-1, EGFR, KLF6, SOS, p53",2.902E-01,3.598E-01,9,"Shc, Bax, CDK4, Caspase-3, PI3K cat class IA, EGFR, KLF6, SOS, p53",
1178,Platelet activation during ADAM-TS13-deficient thrombotic microangiopathy development,28,1.472E-01,1.931E-01,1.472E-01,1.931E-01,13,"Fibronectin, alpha-IIb/beta-3 integrin, PSGL-1, Calpain 1(mu), Collagen VI, P-selectin, CALDAG-GEFI, RAP-1B, Fc gamma RII alpha, Coagulation factor VIII, Collagen III, Fibrinogen (fibrin), Collagen I",2.530E-01,3.184E-01,11,"Fibronectin, alpha-IIb/beta-3 integrin, PSGL-1, Calpain 1(mu), Collagen VI, P-selectin, RAP-1B, Fc gamma RII alpha, Coagulation factor VIII, Collagen III, Collagen I",
1179,Muscle contraction_nNOS signaling in skeletal muscle ,28,1.472E-01,1.931E-01,1.472E-01,1.931E-01,13,"Syntrophin A, Dystroglycan, Syntrophin B2, Syntrophin B1, Dystrophin, Actin, nAChR, Ryanodine receptor 1, Calpain 1(mu), nNOS, Calmodulin, SLC18A3, Dystrobrevin beta",3.944E-01,4.782E-01,10,"Syntrophin A, Syntrophin B2, Dystrophin, Actin, Ryanodine receptor 1, Calpain 1(mu), nNOS, Calmodulin, SLC18A3, Dystrobrevin beta",
1180,Dual role of p53 in transcription deregulation in Huntington's Disease,12,1.479E-01,1.963E-01,2.166E-01,2.735E-01,6,"CBP, CBF2, Bax, Sin3A, MAP1LC3A, p53",1.479E-01,1.963E-01,6,"CBP, CBF2, Bax, Sin3A, MAP1LC3A, p53",
1181,Regulatory T cells in human allergic contact dermatitis,7,1.501E-01,1.991E-01,2.028E-01,2.580E-01,4,"MHC class II, IL-10, PSGL-1, MHC class I",1.501E-01,1.991E-01,4,"MHC class II, IL-10, PSGL-1, MHC class I",
1182,Mechanisms of K-RAS addiction in lung cancer cells,31,1.530E-01,2.019E-01,1.640E-01,2.128E-01,14,"c-Rel (NF-kB subunit), ERK1/2, Sec5, Vimentin, BAD, Syk, AKT(PKB), NF-kB1 (p105), IL-8, TCF8, PI3K cat class IA (p110-alpha), RalB, Stk33, ITGB6",1.530E-01,2.019E-01,13,"c-Rel (NF-kB subunit), ERK1/2, Sec5, Vimentin, Syk, AKT(PKB), NF-kB1 (p105), IL-8, TCF8, PI3K cat class IA (p110-alpha), RalB, Stk33, ITGB6",
1183,Production of reactive oxygen species and arachidonic acid metabolites by neutrophils in asthma,68,1.546E-01,2.038E-01,3.403E-01,4.159E-01,26,"SOD2, C5a, ERK1/2, ALOX5AP, PKC-zeta, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, PI3K reg class IA (p85), PLC-beta, AP-2 alpha subunits, GM-CSF, G-protein beta/gamma, PA24A, PRG2, TNF-alpha, PTAFR, PI3K cat class IA, IL-8, G-protein alpha-i family, Substance P receptor, ALOX5, PKC, p38 MAPK, LPCAT2, PLC-beta2",1.546E-01,2.038E-01,26,"SOD2, C5a, ERK1/2, ALOX5AP, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, PI3K reg class IA (p85), PLC-beta, AP-2 alpha subunits, GM-CSF, G-protein beta/gamma, PA24A, PRG2, TNF-alpha, PTAFR, PI3K cat class IA, IL-8, G-protein alpha-i family, Substance P receptor, ALOX5, p67-phox, PKC, p38 MAPK, LPCAT2, PLC-beta2",
1184,Regulation of AKT(PKB)/ GSK3 beta cascade in bipolar disorder,54,1.585E-01,2.069E-01,1.585E-01,2.069E-01,23,"TrkA, IRS-1, G-protein alpha-i2, PI3K cat class IB (p110-gamma), G-protein alpha-i1, Shc, PI3K reg class IA (p85), GSK3 beta, G-protein beta/gamma, AKT(PKB), PI3K cat class IA, G-protein alpha-i family, FGF2, ErbB4, G-protein alpha-i3, SOS, TrkB, NGF, GDNF, 14-3-3 beta/alpha, Calmodulin, SHP-2, BDNF",1.635E-01,2.148E-01,21,"Neuregulin 1, G-protein alpha-i2, PI3K cat class IB (p110-gamma), G-protein alpha-i1, Shc, PI3K reg class IA (p85), GSK3 beta, G-protein beta/gamma, AKT(PKB), PI3K cat class IA, G-protein alpha-i family, FGF2, ErbB4, G-protein alpha-i3, SOS, TrkB, NGF, GDNF, Calmodulin, HTR1A, BDNF",
1185,Cytoskeleton remodeling_ESR1 action on cytoskeleton remodeling and cell migration,23,1.624E-01,2.136E-01,2.651E-01,3.296E-01,10,"PI3K reg class IA (p85), MSN (moesin), ERM proteins, AKT(PKB), c-Src, RhoA, PI3K cat class IA, ROCK2, F-Actin cytoskeleton, p130CAS",1.624E-01,2.136E-01,10,"PI3K reg class IA (p85), MSN (moesin), ERM proteins, AKT(PKB), c-Src, RhoA, PI3K cat class IA, ROCK2, F-Actin cytoskeleton, p130CAS",
1186,Intercellular relations in asthma (general schema),16,1.631E-01,2.120E-01,1.631E-01,2.120E-01,8,"ICAM1, TSLP, GM-CSF, IL-13, TNF-alpha, VCAM1, ACM2, IL-5",2.195E-01,2.807E-01,7,"ICAM1, IL-17, TSLP, GM-CSF, TNF-alpha, VCAM1, IL-5",
1187,Neurophysiological process_Kappa-type opioid receptor in transmission of nerve impulses,31,1.640E-01,2.128E-01,1.640E-01,2.128E-01,14,"Kir3.4, Proenkephalin-B, CREM (activators), CREB1, G-protein beta/gamma, G-protein alpha-i family, Dynorphin A(1-13), NHE3, Kappa-type opioid receptor, AP-1, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B, DREAM, PKA-cat (cAMP-dependent)",2.577E-01,3.237E-01,12,"Kir3.4, Proenkephalin-B, CREM (activators), CREB1, G-protein beta/gamma, G-protein alpha-i family, Dynorphin A(1-13), NHE3, Kappa-type opioid receptor, P/Q-type calcium channel alpha-1A subunit, DREAM, PKA-cat (cAMP-dependent)",
1188,Development_Retinoic acid and retinoic acid receptors in regulation of oligodendrocyte differentiation,37,1.655E-01,2.171E-01,3.005E-01,3.702E-01,15,"UGT8, p14ARF, DHA2, BMP4, STRA6, PDGF-R-alpha, p73, PPAR-beta(delta), RBP4, p19, Myelin basic protein, p15, GALC, p53, BMP2",1.655E-01,2.171E-01,15,"UGT8, p14ARF, DHA2, BMP4, STRA6, PDGF-R-alpha, p73, PPAR-beta(delta), RBP4, p19, Myelin basic protein, p15, GALC, p53, BMP2",
1189,Apoptosis and survival_Anti-apoptotic action of nuclear ESR1 and ESR2,37,1.655E-01,2.171E-01,3.005E-01,3.702E-01,15,"SOD2, ERK1/2, Bax, MEK2(MAP2K2), Guanylate Cyclase 1, soluble, NF-kB p50/p65, c-Myc, Thioredoxin, NF-kB1 (p50), ASK1 (MAP3K5), MEK3(MAP2K3), c-Jun, nNOS, JNK1(MAPK8), MEK4(MAP2K4)",1.655E-01,2.171E-01,15,"p38alpha (MAPK14), SOD2, ERK1/2, c-Raf-1, Bax, MEK2(MAP2K2), Guanylate Cyclase 1, soluble, NF-kB p50/p65, MEK1(MAP2K1), NF-kB1 (p50), ASK1 (MAP3K5), MEK3(MAP2K3), nNOS, JNK1(MAPK8), MEK4(MAP2K4)",
1190,HCV-dependent regulation of RNA polymerases leading to HCC,21,1.666E-01,2.157E-01,1.666E-01,2.157E-01,10,"PML, TAFI48, TAF(I)63, UBF, p73, TFIID, HSP70, TBP, TFIIB, p53",3.404E-01,4.164E-01,8,"PML, TAFI48, TAF(I)63, UBF, p73, HSP70, TFIIB, p53",
1191,Impaired Lipoxin A4 signaling in CF,44,1.693E-01,2.186E-01,1.693E-01,2.186E-01,19,"PLD1, PKA-reg (cAMP-dependent), G-protein alpha-q/11, AHR, PI3K reg class IA (p85), PLC-gamma 1, Adenylate cyclase, CysLT2 receptor, c-Src, FPRL1, RhoA, Thioredoxin, PRDX2, EGFR, G-protein alpha-i family, PPAPDC2, SHP-2, PKA-cat (cAMP-dependent), PDGF-R-beta",3.060E-01,3.769E-01,16,"PLD1, G-protein alpha-q/11, AHR, PI3K reg class IA (p85), PLC-gamma 1, Adenylate cyclase, CysLT2 receptor, c-Src, FPRL1, RhoA, EGFR, G-protein alpha-i family, CFTR, PPAPDC2, PKA-cat (cAMP-dependent), PDGF-R-beta",
1192,Apoptosis and survival_Inhibition of ROS-induced apoptosis by 17beta-estradiol,44,1.693E-01,2.186E-01,1.693E-01,2.186E-01,19,"SOD2, gp91-phox, p47-phox, Rac1, I-kB, Bax, SOD1, NF-kB p50/p65, Thioredoxin, NF-kB1 (p50), Cytochrome b-558, p22-phox, PKC-delta, ASK1 (MAP3K5), MEK3(MAP2K3), JNK1(MAPK8), MEK4(MAP2K4), GPX1, 14-3-3 sigma",2.051E-01,2.638E-01,17,"p38alpha (MAPK14), SOD2, gp91-phox, p47-phox, I-kB, Bax, NF-kB p50/p65, NF-kB1 (p50), Cytochrome b-558, p22-phox, ASK1 (MAP3K5), MEK3(MAP2K3), p67-phox, JNK1(MAPK8), MEK4(MAP2K4), GPX1, 14-3-3 sigma",
1193,Cigarette smoke-induced oxidative stress and apoptosis in airway epithelial cells,60,1.785E-01,2.296E-01,1.785E-01,2.296E-01,25,"GRP78, C/EBP zeta, SOD2, Apaf-1, Caspase-4, Bax, SOD1, Caspase-3, GADD45 alpha, VDAC 1, FasL(TNFSF6), Mcl-1, Thioredoxin, ASK1 (MAP3K5), c-Jun, Caspase-9, MKK7 (MAP2K7), PRDX1, JNK1(MAPK8), MEK4(MAP2K4), tBid, JNK(MAPK8-10), JNK2(MAPK9), p53, p38 MAPK",4.453E-01,5.356E-01,20,"GRP78, C/EBP zeta, SOD2, Apaf-1, Caspase-4, Bax, Caspase-3, GADD45 alpha, VDAC 1, Mcl-1, ASK1 (MAP3K5), Caspase-9, JNK1(MAPK8), MEK4(MAP2K4), tBid, Glutaredoxin, JNK(MAPK8-10), JNK2(MAPK9), p53, p38 MAPK",
1194,Beta-adrenergic-dependent CFTR expression,18,1.819E-01,2.367E-01,2.771E-01,3.426E-01,8,"Beta-3 adrenergic receptor, ATF-1, PKA-reg (cAMP-dependent), Adenylate cyclase, CREB1, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",1.819E-01,2.367E-01,8,"Beta-3 adrenergic receptor, ATF-1, Adenylate cyclase, CREB1, CFTR, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",
1195,Immune response  _Sialic-acid receptors (Siglecs) signaling,14,1.874E-01,2.407E-01,1.874E-01,2.407E-01,7,"CD43, HP, CD22, Sialoadhesin, CD45, Lyn, SHP-2",2.661E-01,3.340E-01,6,"CD43, HP, Sialoadhesin, CD45, Lyn, CD33",
1196,Transport_ACM3 signaling in salivary glands,42,1.880E-01,2.407E-01,1.880E-01,2.407E-01,18,"PKA-reg (cAMP-dependent), G-protein alpha-q/11, Syntaxin 1A, IP3 receptor, G-protein alpha-i1, PLC-beta, Guanylate Cyclase 1, soluble, MLCK, G-protein alpha-i family, Protein kinase G, G-protein alpha-i3, nNOS, ACM3, Adenylate cyclase type VIII, Calmodulin, PKC, G-protein alpha-q, PKA-cat (cAMP-dependent)",2.343E-01,2.978E-01,16,"SNAP-25, G-protein alpha-q/11, IP3 receptor, G-protein alpha-i1, PLC-beta, Guanylate Cyclase 1, soluble, MLCK, G-protein alpha-i family, Protein kinase G, G-protein alpha-i3, nNOS, ACM3, Adenylate cyclase type VIII, Calmodulin, PKC, PKA-cat (cAMP-dependent)",
1197,Inhibition of GTPase prenylation by statins in asthma and COPD,42,1.880E-01,2.407E-01,1.880E-01,2.407E-01,18,"ERK1/2, Rac1, I-kB, IKK-alpha, HMDH, GM-CSF, IL-6, CDC42, AKT(PKB), NF-kB p50/p65, PPAR-gamma, TNF-alpha, RhoA, RelA (p65 NF-kB subunit), IL-8, COX-2 (PTGS2), ROCK, p38 MAPK",2.343E-01,2.978E-01,16,"ERK1/2, I-kB, HMDH, GM-CSF, IL-6, CDC42, AKT(PKB), NF-kB p50/p65, PPAR-gamma, TNF-alpha, RhoA, RelA (p65 NF-kB subunit), IL-8, COX-2 (PTGS2), ROCK, p38 MAPK",
1198,Signal transduction_Amino acid-dependent mTORC1 activation,96,1.887E-01,2.447E-01,2.109E-01,2.672E-01,38,"Raptor, RHEB2, PLD1, SLC38A2, SLC3A2, IPMK, SLC36A4, PI3K cat class III (Vps34), SLC36A1, GLSK, SLC7A5, ASCT2 (SLC1A5), Folliculin, SEH1L, C7orf59, SLC38A9, RRAGA/D, Sequestosome 1(p62), PI3K reg class III (p150), CAT-1 (SLC7A1), RagA, Sestrin 2, TRAF6, MEK3(MAP2K3), CAT-3, Rab-1A, FLCN/FNIP1, LAPTM4B, RagC, RagD, WDR59, Calmodulin, MAP3K3, RRAGA/C, SEC13L, DEPDC5, FLCN/FNIP2, mTOR",1.887E-01,2.447E-01,35,"Raptor, RHEB2, PLD1, SLC38A2, SLC3A2, SLC36A4, PI3K cat class III (Vps34), SLC36A1, GLSK, SLC7A5, Folliculin, SEH1L, C7orf59, SLC38A9, RRAGA/D, Sequestosome 1(p62), PI3K reg class III (p150), CAT-1 (SLC7A1), RagA, Sestrin 2, TRAF6, MEK3(MAP2K3), CAT-3, FLCN/FNIP1, LAPTM4B, RagC, RagD, WDR59, Calmodulin, MAP3K3, RRAGA/C, SEC13L, DEPDC5, FLCN/FNIP2, mTOR",
1199,Development_Alpha-1 adrenergic receptors signaling via Cyclic AMP,19,1.899E-01,2.424E-01,1.899E-01,2.424E-01,9,"CBP, PKA-reg (cAMP-dependent), FKHR, Adenylate cyclase, CREB1, Alpha-1B adrenergic receptor, p300, FOXO3A, PKA-cat (cAMP-dependent)",3.989E-01,4.821E-01,7,"CBP, FKHR, Adenylate cyclase, CREB1, Alpha-1B adrenergic receptor, p300, PKA-cat (cAMP-dependent)",
1200,Cytoskeleton remodeling_Alpha-1A adrenergic receptor-dependent inhibition of PI3K,19,1.899E-01,2.424E-01,1.899E-01,2.424E-01,9,"AKT(PKB), MLCK, PI3K reg class IA (p85-alpha), Myosin II, PI3K cat class IA (p110-alpha), Calmodulin, MRLC, G-protein alpha-q, MELC",2.312E-01,2.947E-01,8,"AKT(PKB), MLCK, PI3K reg class IA (p85-alpha), Myosin II, PI3K cat class IA (p110-alpha), Calmodulin, MRLC, MELC",
1201,HDL dyslipidemia in type 2 diabetes and metabolic syndrome X,38,1.970E-01,2.543E-01,3.451E-01,4.208E-01,15,"LIPC (HL), LCAT, Nascent HDL, CETP, LIPE, Large alpha-1 HDL, ABCA1, S1P1 receptor, Pre beta-1 HDL, Small HDL, APOE, Small LDL, APOA1, PLTP, HDL",1.970E-01,2.543E-01,15,"LIPC (HL), LCAT, Nascent HDL, CETP, LIPE, ABCA1, PON1, S1P1 receptor, Pre beta-1 HDL, Small HDL, APOE, Small LDL, APOA1, PLTP, HDL",
1202,Immune response_Reactive oxygen species (ROS) in IL-4 signaling,66,1.973E-01,2.512E-01,1.973E-01,2.512E-01,27,"JAK1, IL-4R type I, gp91-phox, PKA-reg (cAMP-dependent), PDE3A, p47-phox, Rac1, NOXO1, NOX5, cPKC (conventional), iNOS, Cytochrome b-558, p22-phox, PKA-cat alpha, Guanylate cyclase (alpha-1/beta-1), IL-4R type II, DUOXA2, DUOX2, PTP-1B, PP2A catalytic, IL4RA, DUOX1, SK4/IK1, Calmodulin, PKC, PKC-alpha, DUOXA1",2.486E-01,3.144E-01,24,"JAK1, IL-4R type I, gp91-phox, PDE3A, p47-phox, NOX5, cPKC (conventional), iNOS, Cytochrome b-558, p22-phox, PKA-cat alpha, Guanylate cyclase (alpha-1/beta-1), IL-4R type II, DUOXA2, DUOX2, PP2A catalytic, p67-phox, IL4RA, DUOX1, SK4/IK1, Calmodulin, PKC, PKC-alpha, DUOXA1",
1203,Development_Growth hormone-releasing hormone (GH-RH) signaling,41,2.013E-01,2.597E-01,6.131E-01,7.165E-01,14,"CBP, ERK1/2, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, cPKC (conventional), GH-RH receptor, PIT1, PKA-cat (cAMP-dependent)",2.013E-01,2.597E-01,16,"CBP, Somatotropin, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), IP3 receptor, PLC-beta, Adenylate cyclase, MEK2(MAP2K2), CREB1, G-protein beta/gamma, MEK1(MAP2K1), cPKC (conventional), NAV1.9, GH-RH receptor, PKA-cat (cAMP-dependent)",
1204,Role of mevalonate pathway in multiple myeloma,44,2.051E-01,2.638E-01,3.684E-01,4.455E-01,17,"RHEB2, ERK1/2, Lamin A/C, RAP-1A, Rab-6, MVD, HMDH, N-Ras, MEK1/2, Mcl-1, RhoA, PI3K cat class IA, IDI1, ROCK, PI3K cat class IA (p110-alpha), FDPS, IDI2",2.051E-01,2.638E-01,17,"RHEB2, ERK1/2, Lamin A/C, c-Raf-1, RAP-1A, Rab-6, MVD, HMDH, N-Ras, MEK1/2, Mcl-1, RhoA, PI3K cat class IA, IDI1, ROCK, PI3K cat class IA (p110-alpha), FDPS",
1205,Translation_Regulation of translation initiation,27,2.079E-01,2.640E-01,2.079E-01,2.640E-01,12,"RPS6, eIF4E, eIF1A, eIF5B (IF-2), PABPC4, RACK1, eIF3S4, eIF3S7, eIF4G1/3, PABPC1, eIF4A, eIF5",3.439E-01,4.204E-01,10,"RPS6, eIF1A, eIF5B (IF-2), PABPC4, RACK1, eIF3S4, eIF3S7, eIF4G1/3, PABPC1, eIF4A",
1206,Neurophysiological process_Netrin-1 in regulation of axon guidance,40,2.088E-01,2.648E-01,2.088E-01,2.648E-01,17,"TRIO, Calcineurin A (catalytic), NCK1, PP1-cat, PKA-reg (cAMP-dependent), Rac1, IP3 receptor, MENA, Ryanodine receptor 1, CDC42, Fyn, DARPP-32, Calmodulin, N-WASP, PLC-gamma, Ryanodine receptor 2, PKA-cat (cAMP-dependent)",3.868E-01,4.702E-01,14,"TRIO, Calcineurin A (catalytic), NCK1, PP1-cat, IP3 receptor, MENA, Ryanodine receptor 1, CDC42, Fyn, DARPP-32, Calmodulin, PLC-gamma, Ryanodine receptor 2, PKA-cat (cAMP-dependent)",
1207,TGF-beta signaling via microRNA in breast cancer,50,2.113E-01,2.714E-01,7.293E-01,8.392E-01,16,"TGF-beta 1, FGFR2, ATF-3, SMAD4, SIP1 (ZFHX1B), DROSHA, RhoA, TGF-beta 2, ETS1, 14-3-3 zeta/delta, TCF8, MSH2, SLUG, ATM, SMAD3, TGF-beta receptor type I",2.113E-01,2.714E-01,19,"TGF-beta 1, FGFR2, ATF-3, SMAD4, SIP1 (ZFHX1B), DROSHA, RhoA, TGF-beta 2, Chk2, ETS1, microRNA 200a, 14-3-3 zeta/delta, TCF8, MSH2, SLUG, ATM, miR-200a-3p, SMAD3, TGF-beta receptor type I",
1208,Transcription_CREM signaling in testis,22,2.135E-01,2.700E-01,2.135E-01,2.700E-01,10,"CBP, TSSK2, ACT, PKA-reg (cAMP-dependent), CREM (activators), LDHC, CREB1, KIF17, CREM (repressors), PKA-cat (cAMP-dependent)",2.402E-01,3.049E-01,9,"CBP, ACT, CREM (activators), CREB1, KIF17, FSHR, CREM (repressors), ODF1, PKA-cat (cAMP-dependent)",
1209,Neurophysiological process_Long-term depression in cerebellum,53,2.139E-01,2.745E-01,7.288E-01,8.392E-01,17,"mGluR1, ERK1/2, IP3 receptor, Galpha(s)-specific CRF GPCRs, PLC-beta, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, PA24A, Guanylate Cyclase 1, soluble, Protein kinase G, PP2A catalytic, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, Corticoliberin, G-protein alpha-q, Ryanodine receptor 2",2.139E-01,2.745E-01,20,"G-substrate, mGluR1, ERK1/2, c-Raf-1, IP3 receptor, Galpha(s)-specific CRF GPCRs, PLC-beta, cPLA2, MEK2(MAP2K2), G-protein beta/gamma, PA24A, Guanylate Cyclase 1, soluble, MEK1(MAP2K1), Protein kinase G, PP2A catalytic, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, Corticoliberin, GRID2, Ryanodine receptor 2",
1210,Transport_RAB1A regulation pathway,12,2.166E-01,2.735E-01,2.166E-01,2.735E-01,6,"SNAPs, Rab-1A, Iporin, REP-1, TBC1D20, REP-2",3.244E-01,3.975E-01,5,"SNAPs, Iporin, REP-1, TBC1D20, REP-2",
1211,Inhibition of mast cell functions by Siglecs in asthma,30,2.172E-01,2.780E-01,3.528E-01,4.292E-01,12,"STIM1, IP3 receptor, Fc epsilon RI alpha, Syk, PLC-gamma 1, CD22, Slp76, Lyn, Siglec-8, LAT, GRAP2, Siglec-10",2.172E-01,2.780E-01,12,"STIM1, IP3 receptor, Fc epsilon RI alpha, Syk, PLC-gamma 1, Slp76, Lyn, Siglec-8, Fc epsilon RI beta, GRAP2, CD33, Siglec-10",
1212,Inhibition of mast cell functions by Fc gamma RII beta in asthma,30,2.172E-01,2.780E-01,2.259E-01,2.835E-01,13,"c-Kit, IP3 receptor, Syk, Shc, PI3K reg class IA (p85), p120GAP, PLC-gamma 1, DOK1, SHIP, AKT(PKB), Lyn, SOS, PI3K cat class IA (p110-alpha)",2.172E-01,2.780E-01,12,"c-Kit, IP3 receptor, Syk, Shc, PI3K reg class IA (p85), p120GAP, PLC-gamma 1, DOK1, AKT(PKB), Lyn, SOS, PI3K cat class IA (p110-alpha)",
1213,Immune response_TLR ligands,35,2.172E-01,2.737E-01,2.172E-01,2.737E-01,15,"TLR1, TLR5, HMGB1, TLR10, MD-2, Fibronectin, CD14, TLR9, HSP70, LBP, TLR6, TLR4, TLR7, TLR8, TLR2",3.025E-01,3.741E-01,13,"TLR1, HMGB1, TLR10, MD-2, Fibronectin, CD14, TLR9, HSP70, TLR6, TLR4, TLR7, TLR8, TLR2",
1214,LRRK2 in neuronal apoptosis in Parkinson's disease,17,2.173E-01,2.737E-01,2.173E-01,2.737E-01,8,"MPTP complex, Apaf-1, Caspase-8, Caspase-3, VDAC 1, ANT, Thioredoxin, Caspase-9",6.707E-01,7.804E-01,5,"Apaf-1, Caspase-8, Caspase-3, VDAC 1, Caspase-9",
1215,G-protein signaling_Rac3 regulation pathway,17,2.173E-01,2.737E-01,2.173E-01,2.737E-01,8,"F-Actin, HNF1-alpha, Neurabin-1, Actin cytoplasmic 2, DOCK7, PLC-beta3, NRBP, PLC-beta2",2.768E-01,3.454E-01,7,"F-Actin, Neurabin-1, Actin cytoplasmic 2, DOCK7, PLC-beta3, NRBP, PLC-beta2",
1216,Impaired inhibitory action of lipoxins and Resolvin E1 on neutrophil functions in CF,43,2.221E-01,2.795E-01,2.221E-01,2.795E-01,18,"PLD1, ERK1/2, PKC-zeta, PI3K cat class IB (p110-gamma), IL-1 beta, I-kB, SOD1, IKK-alpha, NFKBIB, G-protein beta/gamma, NF-kB, TNF-alpha, FPRL1, IL-8, G-protein alpha-i family, PPAPDC2, NIK(MAP3K14), PI3K reg class IB (p101)",3.849E-01,4.686E-01,15,"PLD1, ERK1/2, PI3K cat class IB (p110-gamma), IL-1 beta, I-kB, NFKBIB, G-protein beta/gamma, NF-kB, TNF-alpha, FPRL1, IL-8, G-protein alpha-i family, CFTR, PPAPDC2, NIK(MAP3K14)",
1217,Reactive oxygen and nitrogen species production in eosinophils in asthma,59,2.251E-01,2.829E-01,2.251E-01,2.829E-01,24,"ICAM1, C5a, PKC-zeta, PKC-epsilon, PI3K reg class IA (p85), SOD1, GM-CSF, Eotaxin, C3aR, ITGB1, PTAFR, PI3K cat class IA, VCAM1, iNOS, Eotaxin-2, ITGB2, Cytochrome b-558, PKC-delta, IL-5, Histamine H1 receptor, ST2(L), ITGA4, IL-33, C3a",3.072E-01,3.770E-01,21,"ICAM1, C5a, PKC-epsilon, PI3K reg class IA (p85), GM-CSF, Eotaxin, ITGB1, PTAFR, PI3K cat class IA, VCAM1, iNOS, Eotaxin-2, ITGB2, Cytochrome b-558, CRTH2, IL-5, Histamine H1 receptor, ST2(L), ITGA4, IL-33, C3a",
1218,Development_G-CSF-induced myeloid differentiation,30,2.259E-01,2.835E-01,2.259E-01,2.835E-01,13,"JAK1, Tyk2, NGAL, ERK1/2, SOCS3, C/EBPepsilon, MEK1/2, c-Myc, GFI-1, JAK2, ITGB2, c-Jun, SHP-2",3.447E-01,4.210E-01,11,"JAK1, Tyk2, NGAL, ERK1/2, c-Raf-1, SOCS3, MEK1/2, GFI-1, JAK2, ITGB2, STAT3",
1219,Immune responses in asthma (schema),8,2.274E-01,2.901E-01,2.974E-01,3.671E-01,4,"IL-1 beta, IL-13, TNF-alpha, IL-5",2.274E-01,2.901E-01,4,"IL-17, IL-1 beta, TNF-alpha, IL-5",
1220,Zinc deficiency in Prostate Cancer,25,2.346E-01,2.934E-01,2.346E-01,2.934E-01,11,"ICAM1, VEGF-A, IKK-alpha, NFKBIB, CREB1, IL-6, NF-kB, c-IAP2, IL-8, ACON, MMP-9",3.961E-01,4.795E-01,9,"ICAM1, VEGF-A, NFKBIB, CREB1, IL-6, NF-kB, c-IAP2, IL-8, MMP-9",
1221,Cytoskeleton remodeling_Thyroliberin in cytoskeleton remodeling,33,2.424E-01,3.029E-01,2.424E-01,3.029E-01,14,"PKA-reg (cAMP-dependent), G-protein beta4/gamma2, PKC-epsilon, G-protein alpha-i2, PLC-beta1, IP3 receptor, GSK3 beta, Adenylate cyclase, TRH receptor, G-protein beta2/gamma2, PKC-beta, PKC-alpha, G-protein alpha-q, PKA-cat (cAMP-dependent)",4.886E-01,5.840E-01,11,"G-protein beta4/gamma2, PKC-epsilon, G-protein alpha-i2, IP3 receptor, GSK3 beta, Adenylate cyclase, TRH receptor, G-protein beta2/gamma2, PKC-beta, PKC-alpha, PKA-cat (cAMP-dependent)",
1222,Regulation of lipid metabolism_Insulin regulation of glycogen metabolism ,57,2.451E-01,3.105E-01,3.397E-01,4.159E-01,22,"IRS-2, GYS2, IRS-1, PP1-cat, ERK1/2, PKA-reg (cAMP-dependent), GLUT4, Shc, PI3K reg class IA, FKHR, MEK2(MAP2K2), GSK3 alpha/beta, AKT(PKB), PHK gamma (muscle), PI3K cat class IA, PHK gamma, SOS, Calmodulin, PYGL, AKT2, HXK4, PKA-cat (cAMP-dependent)",2.451E-01,3.105E-01,21,"IRS-2, PP1-cat, ERK1/2, c-Raf-1, Shc, PI3K reg class IA, FKHR, MEK2(MAP2K2), GSK3 alpha/beta, AKT(PKB), PHK gamma (muscle), MEK1(MAP2K1), PI3K cat class IA, G6PT, PHK gamma, SOS, p90RSK1, Calmodulin, PYGL, HXK4, PKA-cat (cAMP-dependent)",
1223,Regulation of lipid metabolism_Regulation of lipid metabolism by niacin and isoprenaline,49,2.466E-01,3.077E-01,2.466E-01,3.077E-01,20,"VLDL, Calcineurin A (catalytic), Beta-3 adrenergic receptor, PKC-zeta, PKA-reg (cAMP-dependent), CaMK IV, Adenylate cyclase type VII, Adenylate cyclase type III, GPR109A, PKC-delta, G-protein alpha-i family, MTP, VLDL2, Adenylate cyclase type VIII, Calmodulin, PKC, PKC-alpha, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",6.222E-01,7.302E-01,15,"Calcineurin A (catalytic), Beta-3 adrenergic receptor, CaMK IV, Adenylate cyclase type VII, Adenylate cyclase type III, GPR109A, G-protein alpha-i family, MTP, Adenylate cyclase type VIII, Calmodulin, PKC, PKC-alpha, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, PKA-cat (cAMP-dependent)",
1224,Putative pathways of hormone action in neurofibromatosis type 1,25,2.473E-01,3.131E-01,3.769E-01,4.555E-01,10,"EGR1, EGR2 (Krox20), PI3K reg class IA (p85), PI3K reg class IA, PI3K cat class IA, PI3K reg class IA (p85-alpha), Adrenomedullin, Myelin P0 protein, PMP22, Neurofibromin",2.473E-01,3.131E-01,10,"Somatotropin, EGR2 (Krox20), PI3K reg class IA (p85), PI3K reg class IA, PI3K cat class IA, PI3K reg class IA (p85-alpha), Adrenomedullin, Myelin P0 protein, PMP22, Neurofibromin",
1225,Role of microRNAs in cell proliferation in colorectal cancer,69,2.494E-01,3.152E-01,4.724E-01,5.640E-01,25,"ERK5 (MAPK7), p57, IRS-1, APC protein, PI3K class II (CII-alpha), Beta-catenin, E2F3, UHRF2, CDK4, MIF, CDC42, c-Myc, PGE2R4, DTL (hCdt2), CCKBR, c-Jun, SNX1, Cul4/DDB1/Rbx1 E3 ligase, Cyclin E2, CDK6, RhoE, DNMT1, FLI1, p53, HGF receptor (Met)",2.494E-01,3.152E-01,25,"ERK5 (MAPK7), miR-148b-5p, p57, APC protein, miR-215-5p, miR-221-3p, PI3K class II (CII-alpha), Beta-catenin, E2F3, UHRF2, CDK4, MIF, CDC42, PGE2R4, DTL (hCdt2), miR-126-3p, miR-27a-3p, Cyclin E2, CDK6, RhoE, DNMT1, miR-320-3p, FLI1, p53, HGF receptor (Met)",
1226,ATP/ITP metabolism,123,2.509E-01,3.168E-01,2.683E-01,3.334E-01,47,"RRM2, PR44 (DIS3), POLR2B, RPB6, 5'-NTD, RRP40, POLR2D, RRP43, AMP deaminase, AK3, AK2, RPB5, PPA5, ACYP2, Ribonucleotide reductase, AMP deaminase 2, ALPP, PM/SCL-100, ADAR3, POLR2J, PM/SCL-75, RRM1, AK1, ITPA, POLR3F, NDPK 7, ADAR2, AK5, ADAR1, ADA, POLR2G, AMD3, POLR2A, RPA16, RRP42, ADSL, 5'-NT1A, 5'-NT1B, POLR2C, POLR1A, KAD7, RRP4, ACYP1, PNPH, RPA39, HPRT, Small RR subunit",2.509E-01,3.168E-01,43,"RRM2, POLR2B, RPB6, 5'-NTD, RRP40, POLR2D, RRP43, AMP deaminase, AK3, AMP deaminase 1, AK2, PPA5, ACYP2, Ribonucleotide reductase, AMP deaminase 2, ALPP, PM/SCL-100, POLR2J, PM/SCL-75, RRM1, ITPA, POLR3F, NDPK 7, ADAR2, AK5, ADAR1, ADA, POLR2G, AMD3, POLR2A, RPA16, RRP42, ADSL, 5'-NT1A, 5'-NT1B, POLR2C, POLR1A, KAD7, ACYP1, PNPH, RPA39, HPRT, Small RR subunit",
1227,Neurophysiological process_GABA-B receptor signaling in presynaptic nerve terminals,28,2.530E-01,3.159E-01,2.534E-01,3.159E-01,12,"Syntaxin 1A, G-protein beta/gamma, VAMP2, Adenylate cyclase type III, MUNC18, cAMP-GEFII, G-protein alpha-i family, GBR1, G-protein alpha-o, Calmodulin, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B",2.530E-01,3.184E-01,11,"SNAP-25, MUNC13-1, G-protein beta/gamma, VAMP2, Adenylate cyclase type III, cAMP-GEFII, G-protein alpha-i family, GBR1, G-protein alpha-o, Calmodulin, P/Q-type calcium channel alpha-1A subunit",
1228,Arachidonic acid metabolites production in alveolar macrophages in asthma,31,2.577E-01,3.237E-01,2.705E-01,3.354E-01,13,"CCL2, IL-1 beta, Endothelin-1, cPLA2, GM-CSF, IL-13, NF-kB, TNF-alpha, IL-8, ALOX5, COX-2 (PTGS2), TLR4, TLR2",2.577E-01,3.237E-01,12,"CCL2, IL-1 beta, Endothelin-1, cPLA2, GM-CSF, NF-kB, TNF-alpha, IL-8, ALOX5, COX-2 (PTGS2), TLR4, TLR2",
1229,Transcription_ChREBP regulation pathway,23,2.651E-01,3.296E-01,2.651E-01,3.296E-01,10,"AMPK beta subunit, AMPK gamma subunit, KPYR, PKA-reg (cAMP-dependent), G-protein beta/gamma, G-protein alpha-i family, AMPK alpha subunit, PP2A catalytic, Acyl-CoA synthetase, PKA-cat (cAMP-dependent)",2.902E-01,3.598E-01,9,"AMPK beta subunit, AMPK gamma subunit, KPYR, G-protein beta/gamma, G-protein alpha-i family, AMPK alpha subunit, PP2A catalytic, Acyl-CoA synthetase, PKA-cat (cAMP-dependent)",
1230,Role of Thyroid hormone in regulation of oligodendrocyte differentiation in multiple sclerosis,55,2.687E-01,3.336E-01,2.687E-01,3.336E-01,22,"UGT8, p14ARF, TCF7L2 (TCF4), MOG, OATP-F, PDGF-R-alpha, Cyclin D2, p73, TAT1, p19, DIO3, AKT(PKB), PI3K reg class IA (p85-alpha), ID4, 4E-BP1, NGF, Myelin basic protein, PI3K cat class IA (p110-alpha), p15, MAG, p53, mTOR",2.747E-01,3.440E-01,20,"UGT8, p14ARF, TCF7L2 (TCF4), MOG, OATP-F, PDGF-R-alpha, Cyclin D2, p73, TAT1, p19, DIO3, AKT(PKB), PI3K reg class IA (p85-alpha), ID4, NGF, Myelin basic protein, PI3K cat class IA (p110-alpha), p15, p53, mTOR",
1231,Environmental factors-induced inflammatory signaling in normal and asthmatic airway epithelium,43,2.693E-01,3.375E-01,5.735E-01,6.734E-01,15,"ICAM1, ERK1/2, TSLP, IL-1 beta, PLC-beta, GM-CSF, IL-6, NF-kB, Eotaxin, TNF-alpha, iNOS, IL-8, PKC, sICAM1, p38 MAPK",2.693E-01,3.375E-01,16,"p38alpha (MAPK14), ICAM1, ERK1/2, TSLP, IL-1 beta, PLC-beta, GM-CSF, IL-6, NF-kB, Eotaxin, TNF-alpha, iNOS, IL-8, PKC, sICAM1, p38 MAPK",
1232,wtCFTR and deltaF508 traffic / Membrane expression (normal and CF),47,2.708E-01,3.354E-01,2.708E-01,3.354E-01,19,"PKA-reg (cAMP-dependent), Syntaxin 1A, PKC-epsilon, Rac1, Ubiquitin, Calreticulin, EHD1, Tubulin (in microtubules), HGF, RACK1, Annexin V, MUNC18, Rabenosyn-5, Rab11-FIP2, NEDD4L, Beta-2 adrenergic receptor, Filamin A, HGF receptor (Met), PKA-cat (cAMP-dependent)",5.466E-01,6.490E-01,15,"PKC-epsilon, Ubiquitin, Calreticulin, Tubulin (in microtubules), HGF, RACK1, Annexin V, CFTR, Rabenosyn-5, Rab11-FIP2, NEDD4L, Beta-2 adrenergic receptor, Filamin A, HGF receptor (Met), PKA-cat (cAMP-dependent)",
1233,"VLDL, LDL dyslipidemia in type 2 diabetes and metabolic syndrome X",39,2.717E-01,3.363E-01,2.717E-01,3.363E-01,16,"LIPC (HL), MSR1, VLDL1 remnant, CETP, Biglycan proteoglycan, Versican proteoglycan, LDLR, APOB, SR-BI, VLDL1, APOE, MTP, Small LDL, APOC3, Decorin proteoglycan, LPL",4.768E-01,5.716E-01,13,"LIPC (HL), MSR1, CETP, Biglycan proteoglycan, Versican proteoglycan, LDLR, APOB, SR-BI, APOE, MTP, Small LDL, Decorin proteoglycan, LPL",
1234,Induction of mucin secretion in  airway goblet cells by purinergic receptors,61,2.761E-01,3.454E-01,3.854E-01,4.639E-01,23,"Myosin Va, PP2A regulatory, G-protein alpha-q/11, Syntaxin 1A, PKC-epsilon, IP3 receptor, MYH9, PLC-beta, Synaptotagmin II, Actin cytoskeletal, NF-kB, Guanylate Cyclase 1, soluble, Syntaxin 4, HSP70, TNF-R1, TNF-alpha, iNOS, MUNC18, PKC-delta, Protein kinase G, PP2A catalytic, SK4/IK1, PKC-alpha",2.761E-01,3.454E-01,22,"SNAP-25, Myosin Va, PP2A regulatory, G-protein alpha-q/11, PKC-epsilon, MUNC13, IP3 receptor, MYH9, PLC-beta, Synaptotagmin II, Actin cytoskeletal, NF-kB, Guanylate Cyclase 1, soluble, HSP70, TNF-R1, TNF-alpha, iNOS, Protein kinase G, CFTR, PP2A catalytic, SK4/IK1, PKC-alpha",
1235,Regulation of beta-adrenergic receptors signaling in pancreatic cancer,41,3.052E-01,3.769E-01,3.572E-01,4.337E-01,16,"ERK1/2, VEGF-A, PKA-reg (cAMP-dependent), cPLA2, Adenylate cyclase, CREB1, IL-6, nAChR alpha-7, EGFR, G-protein alpha-i family, GBR1, COX-2 (PTGS2), Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, Elk-1, PKA-cat (cAMP-dependent)",3.052E-01,3.769E-01,15,"ERK1/2, VEGF-A, cPLA2, Adenylate cyclase, CREB1, IL-6, nAChR alpha-7, EGFR, G-protein alpha-i family, GBR1, COX-2 (PTGS2), Beta-2 adrenergic receptor, Beta-1 adrenergic receptor, Elk-1, PKA-cat (cAMP-dependent)",
1236,Regulation of lipid metabolism_Alpha-1 adrenergic receptors signaling via arachidonic acid,71,3.060E-01,3.769E-01,4.436E-01,5.322E-01,26,"PLD1, ERK1/2, PRK1, LPP2, PLC-beta1, IP3 receptor, Shc, cPLA2, MEK1/2, G-protein beta/gamma, Alpha-1B adrenergic receptor, LPP1, c-Src, LPP3, RhoA, Pyk2(FAK2), G-protein alpha-o, SOS1, PLD2, Paxillin, COX-2 (PTGS2), PTGIS, Calmodulin, PKC-alpha, G-protein alpha-q, Alpha-1D adrenergic receptor",3.060E-01,3.769E-01,25,"PLD1, ERK1/2, PRK1, c-Raf-1, LPP2, IP3 receptor, Shc, COX-1 (PTGS1), cPLA2, MEK1/2, G-protein beta/gamma, Alpha-1B adrenergic receptor, LPP1, c-Src, LPP3, RhoA, Pyk2(FAK2), G-protein alpha-o, SOS1, PLD2, COX-2 (PTGS2), PTGIS, Calmodulin, PKC-alpha, Alpha-1D adrenergic receptor",
1237,Transport_cAMP/ Ca(2+)-dependent Insulin secretion,44,3.060E-01,3.769E-01,4.912E-01,5.846E-01,16,"PKA-reg (cAMP-dependent), Syntaxin 1A, Piccolo, PKC-epsilon, IP3 receptor, RAP-1A, PLC-epsilon, VAMP2, RIMS2, cAMP-GEFII, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, Ryanodine receptor 2, PKA-cat (cAMP-dependent), RAP-2B",3.060E-01,3.769E-01,16,"SNAP-25, Piccolo, MUNC13-1, PKC-epsilon, IP3 receptor, RAP-1A, PLC-epsilon, VAMP2, RIMS2, cAMP-GEFII, Adenylate cyclase type VIII, Calmodulin, PKC-alpha, Ryanodine receptor 2, PKA-cat (cAMP-dependent), RAP-2B",
1238,Regulation of metabolism_Triiodothyronine and Thyroxine signaling,44,3.060E-01,3.769E-01,4.912E-01,5.846E-01,16,"SMRT, OATP-F, TAT1, DIO2, N-CoR, DIO3, PI3K reg class IA (p85-alpha), HIF1A, SLC16A3, PI3K cat class IA (p110-alpha), Calcipressin 2, NCOA1 (SRC1), Beta-2 adrenergic receptor, RXRB, PFKP, mTOR",3.060E-01,3.769E-01,16,"SMRT, OATP-F, TAT1, DIO2, N-CoR, DIO3, PI3K reg class IA (p85-alpha), HIF1A, SLC16A3, PI3K cat class IA (p110-alpha), Calcipressin 2, NCOA1 (SRC1), Beta-2 adrenergic receptor, RXRB, PFKP, mTOR",
1239,Signal transduction_Production and main functions of biologically active prostaglandins and Thromboxane A2,59,3.072E-01,3.770E-01,6.297E-01,7.348E-01,20,"PGD2R, SLC21A2, PGE2R1, PGDS, Prostacyclin receptor, PPAR-beta(delta), cPLA2, PPAR-gamma, PGE2R2, PGE2R4, PGF2aR, PGES, TBXA2R, COX-2 (PTGS2), PGHD, PTGIS, AKR1C3, THAS, CBR1, ABCC4",3.072E-01,3.770E-01,21,"PGD2R, SLC21A2, PGE2R1, COX-1 (PTGS1), PGDS, PPAR-beta(delta), cPLA2, PPAR-gamma, PGE2R2, PGE2R4, CRTH2, PGF2aR, PGES, TBXA2R, COX-2 (PTGS2), PGHD, PTGIS, AKR1C3, THAS, CBR1, ABCC4",
1240,Dysregulation of direct glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes  ,53,3.072E-01,3.770E-01,5.111E-01,6.049E-01,19,"Kv6.1, Kv2.2, Syntaxin 1A, PAX6, KCNH2, NeuroD1, Proglucagon, VAMP2, Glucagon, Kv2.1, iNOS, HIPK2, CDX2, CACNA1E, SCN9A, p300, c-Maf, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B",3.072E-01,3.770E-01,19,"Kv6.1, Kv2.2, SNAP-25, MUNC13-1, PAX6, KCNH2, NeuroD1, Proglucagon, VAMP2, Glucagon, Kv2.1, iNOS, HIPK2, CDX2, CACNA1E, SCN9A, p300, c-Maf, P/Q-type calcium channel alpha-1A subunit",
1241,Neurophysiological process_Delta-type opioid receptor in the nervous system,40,3.137E-01,3.859E-01,3.137E-01,3.859E-01,16,"PDE1A, PKA-reg (cAMP-dependent), IP3 receptor, CLCA4, CREB1, G-protein beta/gamma, Leu-enkephalin, Metenkefalin, PKA-cat alpha, Delta-type opioid receptor, G-protein alpha-i family, PDE1C, Calmodulin, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B, PLC-beta2",5.201E-01,6.186E-01,13,"PDE1A, IP3 receptor, CLCA4, CREB1, G-protein beta/gamma, Leu-enkephalin, Metenkefalin, PKA-cat alpha, G-protein alpha-i family, PDE1C, Calmodulin, P/Q-type calcium channel alpha-1A subunit, PLC-beta2",
1242,Role of Ghrelin in activation eating behavior in obesity,40,3.137E-01,3.859E-01,3.137E-01,3.859E-01,16,"GHS-R, PKA-reg (cAMP-dependent), G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, Adenylate cyclase type VII, PLC-beta, FKHR, CREB1, G-protein beta/gamma, NPY, AMPK alpha subunit, AGRP, Calmodulin, N-type Ca(II) channel alpha1B, PKA-cat (cAMP-dependent)",3.868E-01,4.702E-01,14,"GHS-R, G-protein alpha-q/11, G-protein alpha-i2, IP3 receptor, Adenylate cyclase type VII, PLC-beta, FKHR, CREB1, G-protein beta/gamma, NPY, AMPK alpha subunit, AGRP, Calmodulin, PKA-cat (cAMP-dependent)",
1243,Mechanism of action of CCR4 antagonists in asthma and atopic dermatitis (Variant 2),1,3.177E-01,3.897E-01,3.518E-01,4.286E-01,1,CCR4,3.177E-01,3.897E-01,1,CCR4,
1244,Apoptosis and survival_NO signaling in survival,24,3.200E-01,3.933E-01,3.200E-01,3.933E-01,10,"PI3K cat class IA (p110-beta), IRS-1, BAD, AKT(PKB), c-Src, PI3K reg class IA (p85-alpha), Guanylate cyclase (alpha-1/beta-1), nNOS, PI3K cat class IA (p110-delta), p38 MAPK",5.111E-01,6.089E-01,8,"PI3K cat class IA (p110-beta), AKT(PKB), c-Src, PI3K reg class IA (p85-alpha), Guanylate cyclase (alpha-1/beta-1), nNOS, PI3K cat class IA (p110-delta), p38 MAPK",
1245,Regulation of intrinsic membrane properties and excitability of striatonigral medium spiny neurons in Huntington's disease,62,3.228E-01,3.964E-01,3.228E-01,3.964E-01,24,"PP1-cat, PDE10A, PKA-reg (cAMP-dependent), Na(v) I alpha, G-protein alpha-q/11, SHANK, PLC-beta1, IP3 receptor, Guanylate Cyclase 1, soluble, Kv4.2 channel, cPKC (conventional), PDE9A, SCN2A, DARPP-32, Kv1.2, G-protein alpha-olf, Calmodulin, PKC, P/Q-type calcium channel alpha-1A subunit, SK3, Homer, KCNQ2, N-type Ca(II) channel alpha1B, PKA-cat (cAMP-dependent)",6.228E-01,7.302E-01,19,"PP1-cat, PDE10A, Na(v) I alpha, G-protein alpha-q/11, SHANK, IP3 receptor, Guanylate Cyclase 1, soluble, Kv4.2 channel, cPKC (conventional), PDE9A, SCN2A, DARPP-32, Kv1.2, G-protein alpha-olf, Calmodulin, PKC, P/Q-type calcium channel alpha-1A subunit, Homer, PKA-cat (cAMP-dependent)",
1246,Neurophysiological process_Thyroliberin in cell hyperpolarization and excitability,35,3.320E-01,4.075E-01,3.320E-01,4.075E-01,14,"ERG2, Kir3.4, G-protein beta4/gamma2, G-protein alpha-i2, PLC-beta1, IP3 receptor, KCNH2, TRH receptor, RhoA, cPKC (conventional), PP2A catalytic, PKC-beta2, PKC-alpha, G-protein alpha-q",4.367E-01,5.261E-01,12,"ERG2, Kir3.4, G-protein beta4/gamma2, G-protein alpha-i2, IP3 receptor, KCNH2, TRH receptor, RhoA, cPKC (conventional), PP2A catalytic, PKC-beta2, PKC-alpha",
1247,Transport_ACM3 signaling in lacrimal glands,75,3.345E-01,4.096E-01,6.728E-01,7.790E-01,25,"STIM1, PLD1, ERK1/2, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, ATP1A1, CD14, TRPC1, Lactoperoxidase, PLC-beta, MEK2(MAP2K2), c-Src, Pyk2(FAK2), SLC4A1, NKCC1, LBP, PKC-delta, SK4/IK1, ACM3, SLC12A4, Calmodulin, PKC-alpha, CLCN3, Mucin 7",3.345E-01,4.096E-01,26,"STIM1, PLD1, ERK1/2, c-Raf-1, G-protein alpha-q/11, PKC-epsilon, IP3 receptor, ATP1A1, CD14, TRPC1, Lactoperoxidase, PLC-beta, MEK2(MAP2K2), c-Src, MEK1(MAP2K1), Pyk2(FAK2), SLC4A1, NKCC1, CFTR, SK4/IK1, ACM3, SLC12A4, Calmodulin, PKC-alpha, Lacritin, Mucin 7",
1248,Role of EPAS1 in obesity,11,3.364E-01,4.125E-01,3.364E-01,4.125E-01,5,"GLUT4, C/EBPbeta, SP3, EPAS1, C/EBPdelta",4.824E-01,5.775E-01,4,"C/EBPbeta, SP3, EPAS1, C/EBPdelta",
1249,Lipoprotein metabolism,68,3.403E-01,4.159E-01,3.403E-01,4.159E-01,26,"LIPC (HL), APOA2, Chylomicron remnant, LCAT, APOC2, Nascent HDL, CETP, LDLR, Nascent chylomicrons, APOB, ABCA1, Large LDL, Mature chylomicrons, APOA4, SR-BI, VLDLR, VLDL1, Pre beta-1 HDL, APOE, MTP, VLDL2, Small LDL, APOA1, Medium HDL, PLTP, LPL",6.080E-01,7.157E-01,21,"LIPC (HL), APOA2, Chylomicron remnant, LCAT, Nascent HDL, CETP, LDLR, Nascent chylomicrons, APOB, ABCA1, Large LDL, APOA4, SR-BI, VLDLR, Pre beta-1 HDL, APOE, MTP, Small LDL, APOA1, PLTP, LPL",
1250,Nicotine signaling in glutamatergic neurons,33,3.451E-01,4.211E-01,5.087E-01,6.025E-01,12,"mGluR1, mGluR5, mGluR7, PKA-reg (cAMP-dependent), G-protein beta/gamma, VAMP2, G-protein alpha-i family, Calmodulin, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, CaMK II alpha, PKA-cat (cAMP-dependent)",3.451E-01,4.211E-01,12,"mGluR1, mGluR5, SNAP-25, mGluR7, G-protein beta/gamma, VAMP2, G-protein alpha-i family, Calmodulin, PKC-alpha, P/Q-type calcium channel alpha-1A subunit, CaMK II alpha, PKA-cat (cAMP-dependent)",
1251,Cholesterol and Sphingolipid transport / Distribution to the intracellular membrane compartments (normal and CF),38,3.451E-01,4.208E-01,3.451E-01,4.208E-01,15,"MENTHO, StARD4, Beta-arrestin2, NPC2, ORP1, Rab-7, OSBPL5, TIP47, Vps4-A, PBR, LIPA, Hrs, Rab-9, MLN64, NPC1",5.711E-01,6.760E-01,12,"MENTHO, StARD4, Beta-arrestin2, NPC2, ORP1, TIP47, Vps4-A, PBR, LIPA, Hrs, Rab-9, NPC1",
1252,Immune response_Distinct metabolic pathways in naive and effector CD8+ T cells,74,3.564E-01,4.332E-01,3.564E-01,4.332E-01,28,"IL-7, RHEB2, SLC38A2, SLC3A2, ERK1/2, CD28, MDH1, PI3K reg class IA (p85), GLSK, SLC7A5, ASCT2 (SLC1A5), GLSL, Fyn, AKT(PKB), c-Myc, IL-2, ARNT, JAK2, PI3K cat class IA, Lck, HIF1A, Pim-2, HIF-1, Hamartin, 4E-BP1, AP-4, STAT5, mTOR",8.972E-01,9.973E-01,19,"IL-7, RHEB2, SLC38A2, SLC3A2, ERK1/2, CD28, MDH1, PI3K reg class IA (p85), GLSK, SLC7A5, Fyn, AKT(PKB), IL-2, JAK2, PI3K cat class IA, Lck, HIF1A, STAT5, mTOR",
1253,Stem cells_mGluR3 signaling in glioblastoma stem cells,52,3.583E-01,4.347E-01,3.583E-01,4.347E-01,20,"SLC7A11, ERK1/2, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), Shc, Adenylate cyclase, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), c-Src, GLAST1/EAAT1, PKA-cat alpha, G-protein alpha-i family, SLC1A1/EAAT3, mGluR3, SOS, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B, PI3K reg class IB (p101), PKA-cat (cAMP-dependent)",4.954E-01,5.911E-01,17,"SLC7A11, ERK1/2, c-Raf-1, PI3K cat class IB (p110-gamma), Shc, Adenylate cyclase, MEK2(MAP2K2), G-protein beta/gamma, AKT(PKB), c-Src, GLAST1/EAAT1, MEK1(MAP2K1), PKA-cat alpha, G-protein alpha-i family, SOS, P/Q-type calcium channel alpha-1A subunit, PKA-cat (cAMP-dependent)",
1254,Regulation of Adenylate cyclase and IMPA1 by lithium in major depressive disorder,22,3.601E-01,4.365E-01,3.601E-01,4.365E-01,9,"IMPA1, PKA-reg (cAMP-dependent), G-protein alpha-i2, G-protein alpha-i1, Adenylate cyclase, CREB1, G-protein alpha-i family, BDNF, PKA-cat (cAMP-dependent)",3.976E-01,4.810E-01,8,"IMPA1, G-protein alpha-i2, G-protein alpha-i1, Adenylate cyclase, CREB1, G-protein alpha-i family, BDNF, PKA-cat (cAMP-dependent)",
1255,Transport_RAB3 regulation pathway,14,3.649E-01,4.420E-01,3.649E-01,4.420E-01,6,"NSF, Rab-3B, Rab-3, RPH3AL, RAB3GAP, Rabconnectin-3",6.970E-01,8.052E-01,4,"Rab-3B, Rab-3, RPH3AL, RAB3GAP",
1256,Transport_Intracellular cholesterol transport,83,3.784E-01,4.567E-01,3.784E-01,4.567E-01,31,"MENTHO, PLEKHA3 (FAPP1), CES1, Caveolin-2, VIP36, StARD4, Dynamin-2, CETP, SMS1, NPC2, Rab-7, LDLR, TIP47, ABCA1, PBR, LIPA, EHD1, SR-BI, VLDLR, SOAT1, APOA1, Rab-5A, Rabenosyn-5, APOER2, Rab-9, Rab11-FIP2, EHD3, MLN64, NPC1, Caveolin-1, HDL",3.898E-01,4.734E-01,28,"MENTHO, PLEKHA3 (FAPP1), CES1, Caveolin-2, VIP36, StARD4, Dynamin-2, CETP, SMS1, NPC2, LDLR, TIP47, ABCA1, PBR, LIPA, SR-BI, VLDLR, SOAT1, APOA1, Rab-5A, Rabenosyn-5, APOER2, Rab-9, Rab11-FIP2, EHD3, NPC1, Caveolin-1, HDL",
1257,Transport_Alpha-2 adrenergic receptor regulation of ion channels,47,3.788E-01,4.567E-01,3.788E-01,4.567E-01,18,"PKC-zeta, PKA-reg (cAMP-dependent), G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, G-protein alpha-i1, Sorcin, G-protein beta/gamma, AKT(PKB), G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, PKC, G-protein alpha-q, N-type Ca(II) channel alpha1B, PLC-beta3, PKA-cat (cAMP-dependent), PLC-beta2",6.678E-01,7.776E-01,14,"G-protein alpha-i2, PI3K cat class IB (p110-gamma), IP3 receptor, G-protein alpha-i1, Sorcin, G-protein beta/gamma, AKT(PKB), G-protein alpha-i family, G-protein alpha-o, G-protein alpha-i3, PKC, PLC-beta3, PKA-cat (cAMP-dependent), PLC-beta2",
1258,Influence of low doses of Arsenite on Glucose stimulated Insulin secretion in pancreatic cells,36,3.794E-01,4.570E-01,3.794E-01,4.570E-01,14,"SOD2, ATF-4, Syntaxin 1A, SOD1, Catalase, VAMP2, Thioredoxin, Heme oxygenase 1, KEAP1, SRX1, GCL reg, PRDX1, GCL cat, NRF2",7.526E-01,8.621E-01,10,"SOD2, SNAP-25, Catalase, VAMP2, Heme oxygenase 1, KEAP1, SRX1, GCL reg, GCL cat, NRF2",
1259,Neurophysiological process_HTR1A receptor signaling in neuronal cells,43,3.849E-01,4.686E-01,4.465E-01,5.353E-01,16,"Kir3.4, PP1-cat, PKA-reg (cAMP-dependent), PI3K cat class IB (p110-gamma), PLC-beta, Adenylate cyclase, MAP2, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), G-protein alpha-i family, P/Q-type calcium channel alpha-1A subunit, GluR1, N-type Ca(II) channel alpha1B, PI3K reg class IB (p101), PKA-cat (cAMP-dependent)",3.849E-01,4.686E-01,15,"Kir3.4, PP1-cat, c-Raf-1, PI3K cat class IB (p110-gamma), PLC-beta, Adenylate cyclase, MAP2, MEK2(MAP2K2), G-protein beta/gamma, ERK2 (MAPK1), MEK1(MAP2K1), G-protein alpha-i family, P/Q-type calcium channel alpha-1A subunit, HTR1A, PKA-cat (cAMP-dependent)",
1260,Possible influence of low doses of Arsenite on glucose uptake in muscle,28,3.917E-01,4.706E-01,3.917E-01,4.706E-01,11,"IRS-2, IRS-1, MEF2C, PKC-zeta, GLUT4, PI3K reg class IA, AKT(PKB), PI3K cat class IA, PTGIS, PKC-lambda/iota, mTOR",7.085E-01,8.160E-01,8,"IRS-2, MEF2C, PI3K reg class IA, AKT(PKB), PI3K cat class IA, PTGIS, PKC-lambda/iota, mTOR",
1261,Regulation of lipid metabolism_FXR-dependent negative-feedback regulation of bile acids concentration,31,3.926E-01,4.764E-01,9.030E-01,1.000E+00,8,"CYP8B1, FXR, CYP2B6, SULT2A1, BAAT, CYP7A1, HNF4-alpha, FGF19",3.926E-01,4.764E-01,11,"CYP3A4, PON1, CYP8B1, FXR, SHP, SULT2A1, BAAT, LXR-alpha, CYP7A1, HNF4-alpha, FGF19",
1262,Transport_Low density lipoproteins assembly and remodeling,34,4.167E-01,5.003E-01,4.167E-01,5.003E-01,13,"LIPC (HL), APOC2, VLDL1 remnant, CETP, IDL1, IDL2, APOB, Large LDL, VLDL1, MTP, VLDL2, Small LDL, LPL",8.911E-01,9.920E-01,8,"LIPC (HL), APOA5, CETP, APOB, Large LDL, MTP, Small LDL, LPL",
1263,Immune response_Inhibitory action of lipoxins on superoxide production induced by IL-8 and Leukotriene B4 in neutrophils,50,4.191E-01,5.061E-01,5.049E-01,5.989E-01,18,"PLD1, gp91-phox, PKC-zeta, Rac2, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, G-protein beta/gamma, FPRL1, G-protein alpha-15, Cytochrome b-558, p22-phox, IL-8, G-protein alpha-i family, PPAPDC2, PKC-alpha, PI3K reg class IB (p101), PLC-beta2",4.191E-01,5.061E-01,17,"PLD1, gp91-phox, Rac2, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, G-protein beta/gamma, FPRL1, G-protein alpha-15, Cytochrome b-558, p22-phox, IL-8, G-protein alpha-i family, PPAPDC2, p67-phox, PKC-alpha, PLC-beta2",
1264,Development_Oxytocin receptor signaling,41,4.292E-01,5.178E-01,4.836E-01,5.765E-01,15,"MEF2C, G-protein alpha-q/11, PLC-beta1, IP3 receptor, OTR, G-protein beta/gamma, Guanylate Cyclase 1, soluble, cPKC (conventional), iNOS, OT, CSX (Nkx2.5), nNOS, Calmodulin, PLC-beta3, PLC-beta2",4.292E-01,5.178E-01,14,"MEF2C, G-protein alpha-q/11, IP3 receptor, OTR, G-protein beta/gamma, Guanylate Cyclase 1, soluble, cPKC (conventional), iNOS, OT, CSX (Nkx2.5), nNOS, Calmodulin, PLC-beta3, PLC-beta2",
1265,O-glycan biosynthesis,63,4.416E-01,5.316E-01,8.336E-01,9.476E-01,19,"GALNTL2, GALNT12, G6NT, B4GT1, GALNT11, GCNT3, GCNT2, GALNT13, GALNT1, B4GT2, B3GT2, SIAT4B, B3GT4, GALNT9, GALNT2, C1GALT1, B3GT1, GALNT14, GALNT3",4.416E-01,5.316E-01,21,"GALNT15, GALNT5, GALNTL2, GALNT12, G6NT, B4GT1, GCNT3, GCNT2, GALNT13, GALNT1, B4GT2, B3GT2, SIAT4B, B3GT4, GALNT9, GALNT2, C1GALT1, B3GT1, SIA7A, GALNT14, GALNT3",
1266,Impaired inhibitory action of lipoxins on ROS production in neutrophils in CF,54,4.532E-01,5.446E-01,5.510E-01,6.485E-01,19,"PLD1, gp91-phox, PKC-zeta, Rac2, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, SOD1, G-protein beta/gamma, FPRL1, G-protein alpha-15, Cytochrome b-558, p22-phox, IL-8, G-protein alpha-i family, PPAPDC2, PKC-alpha, PI3K reg class IB (p101), PLC-beta2",4.532E-01,5.446E-01,18,"PLD1, gp91-phox, Rac2, PI3K cat class IB (p110-gamma), p47-phox, IP3 receptor, G-protein beta/gamma, FPRL1, G-protein alpha-15, Cytochrome b-558, p22-phox, IL-8, G-protein alpha-i family, CFTR, PPAPDC2, p67-phox, PKC-alpha, PLC-beta2",
1267,microRNA in Prostate Cancer,51,4.574E-01,5.488E-01,5.460E-01,6.441E-01,18,"CD44, WNT3A, ROCK1, Bak, PKC-epsilon, GLSK, EZH2, DROSHA, c-Myc, Dicer, eIF2C1 (Argonaute-1), CDK6, Exportin 5, Tropomyosin-1, DGCR8, HDAC1, p53, Bim",4.574E-01,5.488E-01,17,"CD44, ROCK1, PKC-epsilon, microRNA 126, GLSK, EZH2, DROSHA, eIF2C1 (Argonaute-1), CDK6, Exportin 5, microRNA 221, microRNA 34c, Tropomyosin-1, DGCR8, HDAC1, p53, Bim",
1268,dATP/dITP metabolism,94,4.587E-01,5.495E-01,4.587E-01,5.495E-01,34,"DNA polymerase zeta, RRM2, KPYR, 5'-NTD, POLA1, DNA polymerase alpha/primase, AK3, XRN2, 8ODP, AK2, PPA5, DGUOK, POLD reg (p68), Ribonucleotide reductase, POLE3 (YBL1), RRM1, AK1, PKM2, ITPA, POLE4, NDPK 7, AK5, ADA, DNA polymerase beta, POLE2, POLD cat (p125), ADSL, 5'-NT1B, DNA polymerase theta, PNPH, POLA2, POLG cat, Small RR subunit, DCK",6.147E-01,7.225E-01,29,"DNA polymerase zeta, RRM2, KPYR, 5'-NTD, POLA1, AK3, XRN2, 8ODP, AK2, PPA5, DGUOK, POLD reg (p68), Ribonucleotide reductase, RRM1, PKM2, ITPA, POLE4, NDPK 7, AK5, ADA, DNA polymerase beta, POLD cat (p125), ADSL, 5'-NT1B, DNA polymerase theta, PNPH, POLA2, Small RR subunit, DCK",
1269,Action of lithium on synaptic transmission and autophagy,35,4.667E-01,5.581E-01,4.667E-01,5.581E-01,13,"SMIT, IMPA1, PP2A regulatory, PKA-reg (cAMP-dependent), Beta-arrestin2, Adenylate cyclase type VII, GSK3 beta, PLC-beta, Adenylate cyclase, Dopamine D2 receptor, PP2A catalytic, PKC-alpha, PKA-cat (cAMP-dependent)",5.808E-01,6.858E-01,11,"IMPA1, PP2A regulatory, Beta-arrestin2, Adenylate cyclase type VII, GSK3 beta, PLC-beta, Adenylate cyclase, Dopamine D2 receptor, PP2A catalytic, PKC-alpha, PKA-cat (cAMP-dependent)",
1270,Nicotine signaling (general schema),21,4.705E-01,5.622E-01,4.705E-01,5.622E-01,8,"mGluR1, GABA-A receptor, nAChR, nAChR alpha-7, nAChR alpha-5, nAChR beta-4, HTR3, nAChR alpha-3",5.206E-01,6.186E-01,7,"mGluR1, GABA-A receptor, nAChR alpha-7, nAChR alpha-5, nAChR beta-4, HTR3, nAChR alpha-3",
1271,Muscle contraction_Role of kappa-type opioid receptor in heart,33,4.886E-01,5.840E-01,6.513E-01,7.577E-01,11,"Beta-3 adrenergic receptor, PKC-epsilon, IP3 receptor, PLC-beta, Adenylate cyclase, G-protein beta/gamma, G-protein alpha-i family, Dynorphin A(1-13), Kappa-type opioid receptor, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor",4.886E-01,5.840E-01,11,"Beta-3 adrenergic receptor, PKC-epsilon, IP3 receptor, PLC-beta, Adenylate cyclase, G-protein beta/gamma, G-protein alpha-i family, Dynorphin A(1-13), Kappa-type opioid receptor, Beta-2 adrenergic receptor, Beta-1 adrenergic receptor",
1272,Insulin-dependent stimulation of SREBP-1 in type 2 diabetes in liver,27,4.918E-01,5.848E-01,4.918E-01,5.848E-01,10,"IRS-2, IRS-1, S2P, INSIG2, INSIG1, PI3K reg class IA (p85-alpha), S1P, PKC-beta, PI3K cat class IA (p110-alpha), PKC-lambda/iota",5.028E-01,5.994E-01,9,"IRS-2, S2P, INSIG1, PI3K reg class IA (p85-alpha), S1P, PKC-beta, PI3K cat class IA (p110-alpha), PKC-lambda/iota, LXR-alpha",
1273,Transport_Aldosterone-mediated regulation of ENaC sodium transport,30,4.954E-01,5.911E-01,7.817E-01,8.926E-01,9,"GCR, SGK1, MEK1/2, ERK2 (MAPK1), AKT(PKB), MCR, PI3K cat class IA (p110-alpha), ICMT, NEDD4L",4.954E-01,5.911E-01,10,"GCR, SGK1, c-Raf-1, MEK1/2, ERK2 (MAPK1), AKT(PKB), MCR, PI3K cat class IA (p110-alpha), ICMT, NEDD4L",
1274,"Regulation of lipid metabolism_RXR-dependent regulation of lipid metabolism via PPAR, RAR and VDR",30,5.006E-01,5.944E-01,5.006E-01,5.944E-01,11,"RARbeta, PPAR-alpha, CYP24A1, CYP19, ACADM, PPAR-gamma, ACSL1, NCOA2 (GRIP1/TIF2), APOA1, ADHG, APOC3",6.494E-01,7.574E-01,9,"RARbeta, PPAR-alpha, CYP24A1, ACADM, PPAR-gamma, NCOA2 (GRIP1/TIF2), SHP, APOA1, ADHG",
1275,Role of prenatal nicotine exposure in apoptosis and proliferation of pancreatic beta cells,30,5.006E-01,5.944E-01,5.006E-01,5.944E-01,11,"SOD2, Bax, Caspase-3, FasL(TNFSF6), nAChR alpha-7, nAChR beta-2, nAChR alpha-6, nAChR beta-4, GPX1, nAChR alpha-3, FasR(CD95)",6.494E-01,7.574E-01,9,"SOD2, Bax, Caspase-3, nAChR alpha-7, nAChR beta-3, nAChR beta-4, GPX1, nAChR alpha-3, FasR(CD95)",
1276,Prolactin signaling in Prostate Cancer,33,5.087E-01,6.025E-01,5.087E-01,6.025E-01,12,"STAT5A, PKC-epsilon, STAT5B, c-Src, JAK2, c-Jun, PDHA (somatic), AP-1, PDH alpha, PLC-gamma, ACON, Prolactin",8.697E-01,9.740E-01,8,"STAT5A, PKC-epsilon, STAT5B, c-Src, JAK2, PDH alpha, PLC-gamma, Prolactin",
1277,Statin action on the PI3K/ Akt pathway in COPD,36,5.161E-01,6.103E-01,5.161E-01,6.103E-01,13,"Apo-2L(TNFSF10), PI3K reg class IA, FKHR, HMDH, FasL(TNFSF6), AKT(PKB), HSP90, RhoA, PI3K cat class IA, ROCK, FOXO3A, Bim, mTOR",6.240E-01,7.311E-01,11,"Apo-2L(TNFSF10), PI3K reg class IA, FKHR, HMDH, AKT(PKB), HSP90, RhoA, PI3K cat class IA, ROCK, Bim, mTOR",
1278,Mitochondrial dysfunction in neurodegenerative diseases,59,5.226E-01,6.175E-01,5.226E-01,6.175E-01,21,"SDHA, mGluR1, MPTP complex, SOD2, mGluR5, IP3 receptor, Hap-1, Bax, SOD1, PLC-beta, SDHB, VDAC 1, UCP3, ANT, Dopamine D2 receptor, G3P2, ODP2, ACON, TGM2, PSD-95, G-protein alpha-q",9.325E-01,1.000E+00,14,"SDHA, mGluR1, SOD2, mGluR5, IP3 receptor, Bax, PLC-beta, SDHB, VDAC 1, UCP3, Dopamine D2 receptor, ODP2, TGM2, PSD-95",
1279,TTP metabolism,68,5.379E-01,6.352E-01,5.379E-01,6.352E-01,24,"Thymidylate kinase, DNA polymerase zeta, POLA1, DNA polymerase alpha/primase, XRN2, BUP1, DPYD, TYSY, TK1, POLD reg (p68), PD-ECGF (TdRPase), POLE3 (YBL1), TK2, POLE4, NDPK 7, UDP, DNA polymerase beta, POLE2, POLD cat (p125), NT5M, DNA polymerase theta, DPYS, POLA2, POLG cat",7.049E-01,8.137E-01,20,"Thymidylate kinase, DNA polymerase zeta, POLA1, XRN2, BUP1, DPYD, TYSY, TK1, POLD reg (p68), PD-ECGF (TdRPase), TK2, POLE4, NDPK 7, UDP, DNA polymerase beta, POLD cat (p125), NT5M, DNA polymerase theta, DPYS, POLA2",
1280,Neurophysiological process_Role of CDK5 in presynaptic signaling,28,5.474E-01,6.448E-01,5.474E-01,6.448E-01,10,"CDK5R1 (p35), CDK5, Syntaxin 1A, SYNJ1, Dynamin-1, VAMP2, MUNC18, P/Q-type calcium channel alpha-1A subunit, Beta-adaptin 2, Endophilin A1",5.542E-01,6.570E-01,9,"CDK5R1 (p35), CDK5, SNAP-25, SYNJ1, Dynamin-1, VAMP2, P/Q-type calcium channel alpha-1A subunit, Beta-adaptin 2, Endophilin A1",
1281,GLP-1 in inhibition of insulin secretion in type 2 diabetes,28,5.474E-01,6.448E-01,5.474E-01,6.448E-01,10,"GLP-1 (7-36) amide, PKC-zeta, GLP-1 receptor, IGF-2, GLP-1 (7-37), Kv2.1, EGFR, Adenylate cyclase type VIII, Calmodulin, Betacellulin",5.542E-01,6.570E-01,9,"GLP-1 (7-36) amide, GLP-1 receptor, IGF-2, GLP-1 (7-37), Kv2.1, EGFR, Adenylate cyclase type VIII, Calmodulin, Betacellulin",
1282,Influence of low doses of Arsenite on glucose uptake in adipocytes,31,5.533E-01,6.508E-01,5.533E-01,6.508E-01,11,"IRS-2, IRS-1, PKC-zeta, GLUT4, PI3K reg class IA, AKT(PKB), PPAR-gamma, Tubulin (in microtubules), PI3K cat class IA, KIF3B, PKC-lambda/iota",8.168E-01,9.251E-01,8,"IRS-2, PI3K reg class IA, AKT(PKB), PPAR-gamma, Tubulin (in microtubules), A-FABP, PI3K cat class IA, PKC-lambda/iota",
1283,wtCFTR and deltaF508-CFTR traffic / Generic schema (normal and CF),38,5.711E-01,6.760E-01,7.339E-01,8.433E-01,12,"PIST (CAL), Ubiquitin, Rab-7, Syntaxin 12, VAMP2, Syntaxin 6, Hrs, Rab-27A, Syntaxin 8, Rab-5A, Rab-9, STAM2",5.711E-01,6.760E-01,12,"PIST (CAL), SNAP-25, Ubiquitin, Syntaxin 12, VAMP2, Syntaxin 6, Hrs, Rab-27A, CFTR, Syntaxin 8, Rab-5A, Rab-9",
1284,N-Glycan biosynthesis p2,43,5.735E-01,6.734E-01,5.735E-01,6.734E-01,15,"MA1B1, GANAB, B4GT1, GNT-III, B4GT4, MGAT2, MA1A2, B4GT5, MA1A1, B4GT2, MGAT4B, GNT-V, GCS1, MGAT1, MA2A1",6.419E-01,7.509E-01,13,"GANAB, B4GT1, GNT-III, B4GT4, MGAT2, MA1A2, B4GT5, MA1A1, B4GT2, MGAT4B, GNT-V, MGAT1, MA2A1",
1285,Transcription_Role of the non-genomic action of Retinoic acid and phosphorylation of Retinoic acid receptors in the initiation of transcription,35,5.808E-01,6.858E-01,6.070E-01,7.099E-01,12,"RARbeta, STRA6, RBP4, c-Src, PKC-delta, CYP26A1, Flotillin-2, G-protein alpha-q, XPB, Vinexin, p38 MAPK, PKA-cat (cAMP-dependent)",5.808E-01,6.858E-01,11,"p38alpha (MAPK14), RARbeta, STRA6, RBP4, c-Src, CYP26A1, Flotillin-2, XPB, Vinexin, p38 MAPK, PKA-cat (cAMP-dependent)",
1286,Keratan sulfate metabolism p.1,35,5.808E-01,6.858E-01,7.361E-01,8.451E-01,11,"B4GT1, B4GT4, B3GN6, B4GT5, CHST3, B4GT2, CHST2, B3GN7, SIAT6, CHST6, B3GN1",5.808E-01,6.858E-01,11,"B4GT1, B4GT4, B3GN6, B4GT5, CHST3, B4GT2, CHST2, B3GN7, SIAT6, CHST6, B3GN1",
1287,Immune response_PD-1-induced metabolic changes in T cells,49,5.820E-01,6.828E-01,5.820E-01,6.828E-01,17,"Casein kinase II, alpha chains, PD-L2, SLC38A2, ERK1/2, CD28, PI3K reg class IA (p85), ZAP70, Fyn, AKT(PKB), IL-2, PI3K cat class IA, Lck, Csk, SHP-2, CD3 zeta, PD-1, PD-L1",6.222E-01,7.302E-01,15,"Casein kinase II, alpha chains, PD-L2, SLC38A2, ERK1/2, CD28, PI3K reg class IA (p85), Fyn, AKT(PKB), IL-2, PI3K cat class IA, Lck, Csk, CD3 zeta, PD-1, PD-L1",
1288,HBV regulation of DNA repair and apoptosis leading to HCC,14,5.830E-01,6.835E-01,5.830E-01,6.835E-01,5,"TERT, DDB1, XPB, p53, XPD",6.970E-01,8.052E-01,4,"AFP, TERT, XPB, p53",
1289,"Nicotine signaling in dopaminergic neurons, Pt. 1 - cell body",48,5.851E-01,6.904E-01,6.580E-01,7.637E-01,16,"mGluR1, Calcineurin A (catalytic), mGluR5, IP3 receptor, GABA-A receptor, PLC-beta, CREB1, VAMP2, Dopamine D2 receptor, nAChR alpha-7, G-protein alpha-i family, nAChR beta-2, nAChR alpha-6, Calmodulin, G-protein alpha-q, Calcineurin B (regulatory)",5.851E-01,6.904E-01,15,"mGluR1, Calcineurin A (catalytic), mGluR5, SNAP-25, IP3 receptor, GABA-A receptor, PLC-beta, CREB1, VAMP2, Dopamine D2 receptor, nAChR alpha-7, G-protein alpha-i family, nAChR beta-3, Calmodulin, Calcineurin B (regulatory)",
1290,Regulation of lipid metabolism_Regulation of fatty acid synthesis: NLTP and EHHADH,20,5.901E-01,6.914E-01,5.901E-01,6.914E-01,7,"ECHP, ACAA2, PPAR-alpha, PPAR-gamma, Acetyl-CoA acyltransferase, FXR, TR4",6.495E-01,7.574E-01,6,"ECHP, ACAA2, PPAR-alpha, PPAR-gamma, FXR, TR4",
1291,Chylomicron dyslipidemia in type 2 diabetes and metabolic syndrome X,42,6.030E-01,7.106E-01,6.550E-01,7.608E-01,14,"Chylomicron remnant, APOC2, CETP, LDLR, Nascent chylomicrons, APOB, Sec23, Mature chylomicrons, APOA4, VAMP7, L-FABP, APOE, MTP, LPL",6.030E-01,7.106E-01,13,"Chylomicron remnant, APOA5, CETP, LDLR, Nascent chylomicrons, APOB, Sec23, APOA4, VAMP7, L-FABP, APOE, MTP, LPL",
1292,Adiponectin in pathogenesis of type 2 diabetes,29,6.032E-01,7.106E-01,9.292E-01,1.000E+00,7,"H-FABP, PPAR-alpha, CREB1, PPARGC1 (PGC1-alpha), ACADM, AMPK alpha subunit, PPCKC",6.032E-01,7.106E-01,9,"p38alpha (MAPK14), H-FABP, PPAR-alpha, CREB1, PPARGC1 (PGC1-alpha), ACADM, G6PT, AMPK alpha subunit, PPCKC",
1293,Stem cells_Role of ion channels in glioblastoma cell invasion,32,6.038E-01,7.068E-01,6.038E-01,7.068E-01,11,"GluR4, ATP1A1, ATP1B2, Kir1.2, NKCC1, NCC27, SLC12A4, CLCN2, GluR1, SLC12A6, CLCN3",8.450E-01,9.535E-01,8,"GluR4, ATP1A1, ATP1B2, Kir1.2, NKCC1, NCC27, SLC12A4, SLC12A6",
1294,Keratan sulfate metabolism p.2,39,6.131E-01,7.211E-01,6.537E-01,7.598E-01,13,"B4GT1, B4GT4, B3GN6, SIAT4C, B4GT5, CHST3, CHST4, B4GT2, CHST2, B3GN7, SIAT6, SIAT4B, B3GN1",6.131E-01,7.211E-01,12,"B4GT1, B4GT4, B3GN6, B4GT5, CHST3, CHST4, B4GT2, CHST2, B3GN7, SIAT6, SIAT4B, B3GN1",
1295,Neurophysiological process_Melatonin signaling,44,6.160E-01,7.194E-01,6.160E-01,7.194E-01,15,"PKA-reg (cAMP-dependent), GLUT4, IP3 receptor, Adenylate cyclase, SULT1E1, CYP19, CREB1, G-protein beta/gamma, G-protein alpha-i family, ALOX5, Melatonin receptor 1B, Calmodulin, Melatonin receptor 1A, PKA-cat (cAMP-dependent), PLC-beta2",6.787E-01,7.889E-01,13,"IP3 receptor, Adenylate cyclase, SULT1E1, CREB1, G-protein beta/gamma, ROR-alpha, G-protein alpha-i family, ALOX5, Melatonin receptor 1B, Calmodulin, Melatonin receptor 1A, PKA-cat (cAMP-dependent), PLC-beta2",
1296,Neurophysiological process_Mu-type opioid receptor-mediated analgesia,30,6.494E-01,7.572E-01,6.504E-01,7.572E-01,10,"CBP, PKA-reg (cAMP-dependent), Adenylate cyclase type VII, beta-Endorphin extracellular region, CREB1, G-protein beta/gamma, G-protein alpha-i family, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B, PKA-cat (cAMP-dependent)",6.494E-01,7.574E-01,9,"CBP, Adenylate cyclase type VII, beta-Endorphin extracellular region, CREB1, G-protein beta/gamma, G-protein alpha-i family, Mu-type opioid receptor, P/Q-type calcium channel alpha-1A subunit, PKA-cat (cAMP-dependent)",
1297,Transcription_Mechanism of activation of the transcription of Retinoid-target genes,24,6.496E-01,7.571E-01,6.496E-01,7.571E-01,8,"CBP, Cyclin D3, TFIIB, p300, NCOA2 (GRIP1/TIF2), CARM1, NCOA1 (SRC1), PKA-cat (cAMP-dependent)",6.814E-01,7.909E-01,7,"CBP, TFIIB, p300, NCOA2 (GRIP1/TIF2), CARM1, NCOA1 (SRC1), PKA-cat (cAMP-dependent)",
1298,Neurophysiological process_GABA-B receptor-mediated regulation of glutamate signaling in Purkinje cells,27,6.498E-01,7.571E-01,6.498E-01,7.571E-01,9,"mGluR1, PLC-beta1, IP3 receptor, TRPC1, G-protein beta/gamma, G-protein alpha-i family, GBR1, G-protein alpha-o, G-protein alpha-q",8.031E-01,9.124E-01,7,"mGluR1, IP3 receptor, TRPC1, G-protein beta/gamma, G-protein alpha-i family, GBR1, G-protein alpha-o",
1299,Putative pathways of n-3 and n-6 fatty acids in obesity and type 2 diabetes,51,6.596E-01,7.649E-01,6.596E-01,7.649E-01,17,"ATF-1, EGR1, PKA-reg (cAMP-dependent), GLUT4, G-protein alpha-q/11, Prostacyclin receptor, Adenylate cyclase, CREB1, AKT(PKB), PPAR-gamma, C/EBPbeta, PGES, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), PTGIS, PKA-cat (cAMP-dependent), C/EBPdelta",6.913E-01,8.005E-01,15,"ATF-1, G-protein alpha-q/11, COX-1 (PTGS1), Adenylate cyclase, CREB1, AKT(PKB), PPAR-gamma, C/EBPbeta, PGES, COX-2 (PTGS2), PI3K cat class IA (p110-alpha), PTGIS, LXR-alpha, PKA-cat (cAMP-dependent), C/EBPdelta",
1300,Triacylglycerol metabolism p.1,60,6.629E-01,7.725E-01,8.359E-01,9.495E-01,18,"PLCA, GPD2, ACSL5, ALDR, ACSL4, AKR1C1, AL7A1, AK1BA, GNPAT, PLCD, TPI1, ACSL6, AL1B1, ACSL1, AL3A2, GPAM, PLCB, PLCE",6.629E-01,7.725E-01,18,"PLCA, GPD2, ACSL5, ALDR, GKP2, ACSL4, AKR1C4, AKR1C1, AL7A1, AK1BA, GNPAT, PLCD, TPI1, ACSL6, AL1B1, GPAM, PLCB, PLCE",
1301,CTP/UTP metabolism,107,6.655E-01,7.712E-01,6.655E-01,7.712E-01,36,"KCY, PR44 (DIS3), POLR2B, RPB6, RRP40, POLR2D, RRP43, AK3, AK2, BUP1, DPYD, RPB5, PD-ECGF (TdRPase), PM/SCL-100, POLR2J, PM/SCL-75, AK1, ITPA, POLR3F, NDPK 7, UDP, AK5, POLR2G, POLR2A, RPA16, NT5M, RRP42, POLR2C, POLR1A, RRP4, DPYS, UCK2, CTP synthase, CDD, RPA39, PCY1B",6.955E-01,8.048E-01,32,"KCY, POLR2B, RPB6, RRP40, POLR2D, RRP43, AK3, AK2, BUP1, DPYD, PD-ECGF (TdRPase), PM/SCL-100, POLR2J, PM/SCL-75, ITPA, POLR3F, NDPK 7, UDP, AK5, POLR2G, POLR2A, RPA16, NT5M, RRP42, POLR2C, POLR1A, DPYS, UCK2, CTP synthase, CDD, RPA39, PCY1B",
1302,GTP-XTP metabolism,90,6.792E-01,7.879E-01,6.810E-01,7.879E-01,30,"GMPS, Xanthine oxidase, Guanine deaminase, PR44 (DIS3), POLR2B, RPB6, 5'-NTD, RRP40, POLR2D, RRP43, RPB5, PPA5, PM/SCL-100, POLR2J, PM/SCL-75, ITPA, POLR3F, NDPK 7, POLR2G, POLR2A, RPA16, RRP42, GUAC, 5'-NT1B, POLR2C, POLR1A, RRP4, PNPH, RPA39, HPRT",6.792E-01,7.889E-01,27,"GMPS, Xanthine oxidase, Guanine deaminase, POLR2B, RPB6, 5'-NTD, RRP40, POLR2D, RRP43, PPA5, PM/SCL-100, POLR2J, PM/SCL-75, ITPA, POLR3F, NDPK 7, POLR2G, POLR2A, RPA16, RRP42, GUAC, 5'-NT1B, POLR2C, POLR1A, PNPH, RPA39, HPRT",
1303,Huntington's disease (general schema),3,6.825E-01,7.915E-01,7.277E-01,8.387E-01,1,BDNF,6.825E-01,7.915E-01,1,BDNF,
1304,Development_Schema: Methods of somatic cell reprogramming into induced pluripotent stem cells,6,6.844E-01,7.912E-01,6.844E-01,7.912E-01,2,"Oct-3/4, c-Myc",8.992E-01,9.980E-01,1,Oct-3/4,
1305,Neurophysiological process_GABAergic neurotransmission,51,6.913E-01,8.005E-01,7.612E-01,8.719E-01,16,"SLC7A6, ALDR, AATC, GABA-A receptor, GLSK, SSDH, G-protein beta/gamma, GAT1, SLC7A7, SLC32A1, G-protein alpha-i family, GBR1, G-protein alpha-o, GAD1, GAD2, SLC6A11",6.913E-01,8.005E-01,15,"SLC7A6, ALDR, GABA-A receptor, GLSK, SSDH, G-protein beta/gamma, GAT1, SLC7A7, SLC32A1, G-protein alpha-i family, GBR1, G-protein alpha-o, GAD1, GAD2, SLC6A11",
1306,Neurophysiological process_Glucose-excited neurons of arcuate nucleus (rodent model),40,6.945E-01,8.023E-01,6.945E-01,8.023E-01,13,"RHEB2, GLUT3, GLUT4, SLC5A1, POMC, AMPK alpha subunit, SGLT3, EPAS1/ARNT, EPAS1, HIF-prolyl hydroxylase, HXK4, N-type Ca(II) channel alpha1B, mTOR",8.637E-01,9.679E-01,10,"RHEB2, GLUT3, SLC5A1, POMC, AMPK alpha subunit, SGLT3, EPAS1, HIF-prolyl hydroxylase, HXK4, mTOR",
1307,dGTP metabolism,64,6.982E-01,8.059E-01,6.982E-01,8.059E-01,21,"DNA polymerase zeta, POLA1, DNA polymerase alpha/primase, XRN2, 8ODP, PPA5, DGUOK, POLD reg (p68), Ribonucleotide reductase, POLE3 (YBL1), POLE4, NDPK 7, DNA polymerase beta, POLE2, POLD cat (p125), 5'-NT1B, DNA polymerase theta, PNPH, POLA2, POLG cat, DCK",8.494E-01,9.569E-01,17,"DNA polymerase zeta, POLA1, XRN2, 8ODP, PPA5, DGUOK, POLD reg (p68), Ribonucleotide reductase, POLE4, NDPK 7, DNA polymerase beta, POLD cat (p125), 5'-NT1B, DNA polymerase theta, PNPH, POLA2, DCK",
1308,Role of Diethylhexyl Phthalate and Tributyltin in fat cell differentiation ,28,7.085E-01,8.160E-01,9.625E-01,1.000E+00,6,"PPARGC1 (PGC1-alpha), N-CoR, PPAR-gamma, ACSL1, NCOA2 (GRIP1/TIF2), LPL",7.085E-01,8.160E-01,8,"PPARGC1 (PGC1-alpha), N-CoR, PPAR-gamma, DLK, A-FABP, NCOA2 (GRIP1/TIF2), LXR-alpha, LPL",
1309,Pro-oncogenic action of Androgen receptor in ovarian cancer,28,7.085E-01,8.160E-01,9.111E-01,1.000E+00,7,"ELKS, TGF-beta receptor type II, Endoglin, TGF-beta receptor type III (betaglycan), SHBG, GSTP1, TGF-beta receptor type I",7.085E-01,8.160E-01,8,"ELKS, TGF-beta receptor type II, HSD17B3, Endoglin, TGF-beta receptor type III (betaglycan), SHBG, GSTP1, TGF-beta receptor type I",
1310,Estradiol metabolism,42,7.254E-01,8.348E-01,9.197E-01,1.000E+00,11,"CYP1B1, CYP1A1, UGT1A4, UGT1A1, SULT1E1, CYP2C19, UGT1A10, UGT2B7, CYP2D6, SULT2A1, CYP2C9",7.254E-01,8.348E-01,12,"CYP2C8, CYP1B1, CYP1A1, UGT1A4, UGT1A1, SULT1E1, CYP3A4, UGT1A10, UGT2B7, CYP2D6, SULT2A1, CYP2C9",
1311,Development_Role of nicotinamide in G-CSF-induced granulopoiesis,13,7.264E-01,8.379E-01,7.264E-01,8.379E-01,4,"Lef-1, ID1, PBEF, C/EBPbeta",8.338E-01,9.429E-01,3,"ID1, PBEF, C/EBPbeta",
1312,Neurophysiological process_Dopamine D2 receptor signaling in CNS,47,7.300E-01,8.394E-01,7.300E-01,8.394E-01,15,"VMAT2, Calcineurin A (catalytic), Kir3.4, PKA-reg (cAMP-dependent), PLC-beta1, IP3 receptor, Adenylate cyclase type VII, G-protein beta/gamma, Dopamine D2 receptor, G-protein alpha-i family, CACNA1E, Adenylate cyclase type VIII, N-type Ca(II) channel alpha1B, Calcineurin B (regulatory), PKA-cat (cAMP-dependent)",8.603E-01,9.671E-01,12,"VMAT2, Calcineurin A (catalytic), Kir3.4, IP3 receptor, Adenylate cyclase type VII, G-protein beta/gamma, Dopamine D2 receptor, G-protein alpha-i family, CACNA1E, Adenylate cyclase type VIII, Calcineurin B (regulatory), PKA-cat (cAMP-dependent)",
1313,Androstenedione and testosterone biosynthesis and metabolism p.2,32,7.320E-01,8.411E-01,9.655E-01,1.000E+00,7,"UGT1A4, UGT1A1, AKR1C1, UGT1A10, AKR1C2, AKR1C3, SRD5A1",7.320E-01,8.411E-01,9,"AK1D1, UGT1A4, UGT1A1, AKR1C4, AKR1C1, UGT1A10, AKR1C2, AKR1C3, SRD5A1",
1314,Regulation of lipid metabolism_G-alpha(q) regulation of lipid metabolism,59,7.320E-01,8.411E-01,8.788E-01,9.915E-01,17,"LCAT, ERK1/2, APOC2, G-protein alpha-q/11, IP3 receptor, APOC1, PLC-beta, cPLA2, LDL, ABCA1, PPAR-gamma, GPR109A, COX-2 (PTGS2), PKC, G-protein alpha-q, PLTP, LPL",7.320E-01,8.411E-01,17,"LCAT, ERK1/2, G-protein alpha-q/11, IP3 receptor, COX-1 (PTGS1), APOC1, PLC-beta, cPLA2, LDL, ABCA1, PPAR-gamma, GPR109A, COX-2 (PTGS2), PKC, LXR-alpha, PLTP, LPL",
1315,Neurophysiological process _Visual perception,29,7.423E-01,8.517E-01,7.423E-01,8.517E-01,9,"CNGA1, CNG-alpha, Rhodopsin kinase (GRK1), Recoverin, Transducin, rod-specific, RGS9, G-beta5, Guanylate cyclase 2F (RETGC2), Calmodulin",7.486E-01,8.596E-01,8,"CNGA1, CNG-alpha, Rhodopsin kinase (GRK1), Recoverin, RGS9, G-beta5, Guanylate cyclase 2F (RETGC2), Calmodulin",
1316,Neurophysiological process_GABA-B receptor signaling at postsynaptic sides of synapses,26,7.468E-01,8.561E-01,7.468E-01,8.561E-01,8,"Kir3.4, ATF-4, G-protein beta/gamma, G-protein alpha-i family, GBR1, G-protein alpha-o, Calmodulin, GRK5",7.672E-01,8.768E-01,7,"Kir3.4, G-protein beta/gamma, G-protein alpha-i family, GBR1, G-protein alpha-o, Calmodulin, GRK5",
1317,Metabolic syndrome X (general schema),15,7.523E-01,8.621E-01,8.311E-01,9.456E-01,4,"IL-1 beta, IL-6, TNF-alpha, PAI1",7.523E-01,8.621E-01,4,"IL-1 beta, IL-6, TNF-alpha, PAI1",
1318,Nitrogen metabolism,36,7.526E-01,8.621E-01,8.668E-01,9.794E-01,10,"Carbonic anhydrase XIII, Carbonic anhydrase III, Carbonic anhydrase I, Carbonic anhydrase IX, GLSK, GLSL, Carbonic anhydrase II, GCST, Carbonic anhydrase VI, Carbonic anhydrase VA (mitochondrial)",7.526E-01,8.621E-01,10,"Carbonic anhydrase XIII, Carbonic anhydrase III, Carbonic anhydrase I, Carbonic anhydrase IX, GLSK, Carbonic anhydrase II, GCST, Carbonic anhydrase VI, Carbonic anhydrase IV, Carbonic anhydrase VII",
1319,Chondroitin sulfate and dermatan sulfate metabolism,60,7.593E-01,8.691E-01,9.385E-01,1.000E+00,16,"CHSY1, NCAG1, CHGUT, CHSS3, CHSTC, XYLT1, CHST7, CHST3, CGAT2, SART2, B3GA1, B4GT7, CGAT1, CHSTB, CHSS2, B3GT6",7.593E-01,8.691E-01,17,"CHSY1, NCAG1, CHGUT, CHSS3, CHSTC, CHSTD, XYLT1, CHST7, CHST3, CGAT2, SART2, B3GA1, B4GT7, CGAT1, CHSTB, CHSS2, B3GT6",
1320,Immune response_Production and main functions of biologically active leukotrienes and Lipoxin A4,50,7.633E-01,8.731E-01,9.376E-01,1.000E+00,13,"PPAR-alpha, ALOX5AP, ABCC1, cPLA2, CysLT2 receptor, MGST2, FPRL1, ABCC10, ALOX5, GGT5, ABCA8, MDP1, ABCC4",7.633E-01,8.731E-01,14,"PPAR-alpha, ALOX5AP, ABCC1, cPLA2, CysLT2 receptor, MGST2, FPRL1, ABCC10, ALOX5, GGT5, ALOX12, ABCA8, MDP1, ABCC4",
1321,Nociception_Pro-nociceptive action of Nociceptin in spinal cord at low doses,39,7.696E-01,8.809E-01,7.696E-01,8.809E-01,12,"GABA-A receptor, NR2, Glycine receptor, PGE2R4, Substance P receptor, Nociceptin receptor, nNOS, NR2A, Histamine H1 receptor, Calmodulin, Nociceptin, Prepronociceptin",8.405E-01,9.490E-01,10,"GABA-A receptor, NR2, Glycine receptor, PGE2R4, Substance P receptor, Nociceptin receptor, NR2A, nNOS, Histamine H1 receptor, Calmodulin",
1322,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 2 activity in muscle,19,7.712E-01,8.808E-01,8.540E-01,9.667E-01,5,"AMPK beta subunit, AMPK gamma subunit, MYF6, AMPK alpha subunit, PP2A catalytic",7.712E-01,8.808E-01,5,"AMPK beta subunit, AMPK gamma subunit, MYF6, AMPK alpha subunit, PP2A catalytic",
1323,Glycolysis and gluconeogenesis,94,7.792E-01,8.912E-01,7.792E-01,8.912E-01,30,"ALDOB, GLUT2, PGAM4, G3PT, KPYR, GALM, GLUT3, ENO1, GLUT4, MDH1, PGK1, F16Q, ADPGK, LDHC, LDH6B, ALDOC, ENO3, PKM2, G3P2, TPI1, HXK3, GPI, PGAM1, LDHB, PPCKC, PMGE, ENO2, HXK4, LDHA, PFKP",8.850E-01,9.888E-01,25,"ALDOB, GLUT2, PGAM4, KPYR, GLUT3, ENO1, MDH1, PGK1, F16Q, ADPGK, LDH6B, ALDOC, ENO3, PKM2, TPI1, G6PT, IGRP, PGAM1, LDHB, PPCKC, PMGE, ENO2, HXK4, LDHA, PFKP",
1324,PDGF activation of prostacyclin synthesis ,30,7.817E-01,8.926E-01,7.817E-01,8.926E-01,9,"IP3 receptor, Prostacyclin receptor, PLC-gamma 1, PA24A, COX-2 (PTGS2), PTGIS, Calmodulin, PKC-alpha, PDGF-R-beta",7.847E-01,8.945E-01,8,"IP3 receptor, PLC-gamma 1, PA24A, COX-2 (PTGS2), PTGIS, Calmodulin, PKC-alpha, PDGF-R-beta",
1325,Retinol metabolism,70,7.822E-01,8.926E-01,7.822E-01,8.926E-01,22,"CYP1B1, RDH12, DHA2, CYP1A1, CRABP1, BCDO, Xanthine oxidase, BCDP, CYP2C18, AL1A1, CYP2C19, DHA6, DHRS3, CYP2E1, RPE65, UGT2B7, CYP2B6, RDH11, LRAT, CYP4A11, CYP3A7, CYP2C9",8.906E-01,9.920E-01,18,"CYP2C8, CYP1B1, DHA2, CYP1A1, Xanthine oxidase, BCDP, AL1A1, CYP3A4, DHA6, DHRS3, RPE65, UGT2B7, RDH11, LRAT, CYP4A11, CYP3A7, CYP2C9, RDH5",
1326,Mechanism of Maraviroc action in HIV Infections,4,7.834E-01,8.940E-01,8.235E-01,9.376E-01,1,CD4,7.834E-01,8.940E-01,1,CD4,
1327,Cholehepatic circulation of bile acids / Rodent version,37,7.850E-01,8.945E-01,8.893E-01,9.966E-01,10,"HYEP, AKR1C1, BSEP, GSTA5, SLC10A2, L-FABP, OATP8, SULT2A1, BAAT, ABCC4",7.850E-01,8.945E-01,10,"HYEP, AKR1C1, BSEP, GSTA5, SLC10A2, L-FABP, OATP8, SULT2A1, BAAT, ABCC4",
1328,Neurophysiological process_Sweet taste signaling,27,7.877E-01,8.981E-01,7.877E-01,8.981E-01,8,"TRPM5, IP3R3, P2X3, TAS1R3, TAS1R2, P2Y4, Pannexin-1, PLC-beta2",9.023E-01,1.000E+00,6,"IP3R3, P2X3, TAS1R2, P2Y4, Pannexin-1, PLC-beta2",
1329,"Mechanism of Pioglitazone/ Metformin and Rosiglitazone/ Metformin  cooperative action in Diabetes mellitus, Type 2",16,7.995E-01,9.103E-01,8.695E-01,9.817E-01,4,"AMPK gamma subunit, SLC22A1, PPAR-gamma, AMPK alpha subunit",7.995E-01,9.103E-01,4,"AMPK gamma subunit, SLC22A1, PPAR-gamma, AMPK alpha subunit",
1330,Glomerular filtration and renal reabsorption of bile acids / Rodent version,27,8.031E-01,9.124E-01,8.892E-01,9.966E-01,7,"HYEP, AKR1C1, GSTA5, SLC10A2, L-FABP, OATP8, ABCC4",8.031E-01,9.124E-01,7,"HYEP, AKR1C1, GSTA5, SLC10A2, L-FABP, OATP8, ABCC4",
1331,Triacylglycerol metabolism p.2,27,8.031E-01,9.124E-01,8.892E-01,9.966E-01,7,"LIPC (HL), LPP2, LIPE, LPP1, LPP3, CEL, LPL",8.031E-01,9.124E-01,7,"LIPC (HL), LPP2, LIPE, LIPG, LPP1, LPP3, LPL",
1332,Glycogen metabolism,37,8.060E-01,9.183E-01,8.060E-01,9.183E-01,11,"UGPA2, GYS2, GALM, PYGB, GDE, HXK3, GPI, PYGL, GLGB, PGMU, HXK4",9.734E-01,1.000E+00,7,"UGPA2, PYGB, GDE, PYGL, GLGB, PGMU, HXK4",
1333,Regulation of microRNAs in colorectal cancer,62,8.081E-01,9.173E-01,9.951E-01,1.000E+00,13,"TCF7L2 (TCF4), PTP4A3, MECOM, DROSHA, AKT(PKB), c-Src, c-Myc, RelA (p65 NF-kB subunit), EGFR, Csk, LIN-28B, p53, HGF receptor (Met)",8.081E-01,9.173E-01,17,"miR-215-5p, TCF7L2 (TCF4), PTP4A3, miR-1-3p, MECOM, DROSHA, AKT(PKB), c-Src, RelA (p65 NF-kB subunit), EGFR, microRNA 1-1, Csk, STAT3, LIN-28B, p53, HGF receptor (Met), microRNA 215",
1334,Neurophysiological process_Olfactory transduction,20,8.118E-01,9.201E-01,8.853E-01,9.947E-01,5,"Olfactory receptor, Adenylate cyclase type III, G-protein alpha-olf, Calmodulin, RIC8B",8.118E-01,9.201E-01,5,"Olfactory receptor, Adenylate cyclase type III, G-protein alpha-olf, Calmodulin, RIC8B",
1335,Mechanisms of hapten presentation to T cells in allergic contact dermatitis,20,8.118E-01,9.201E-01,8.853E-01,9.947E-01,5,"MHC class II, CD4, MHC class I, ADHX, CD8",8.118E-01,9.201E-01,5,"MHC class II, CD4, MHC class I, ADHX, CD8",
1336,Muscle contraction_Regulation of eNOS activity in cardiomyocytes,56,8.278E-01,9.369E-01,8.820E-01,9.936E-01,16,"PKA-reg (cAMP-dependent), PDE3A, IP3 receptor, PLC-beta, Ca-ATPase2, G-protein beta/gamma, Guanylate Cyclase 1, soluble, AKAP6, ACM2, G-protein alpha-i family, PDE2A, Ca-ATPase1, Calmodulin, Beta-1 adrenergic receptor, Ryanodine receptor 2, PKA-cat (cAMP-dependent)",8.278E-01,9.369E-01,15,"PDE3A, IP3 receptor, PLC-beta, Ca-ATPase2, G-protein beta/gamma, Guanylate Cyclase 1, soluble, Phospholamban, AKAP6, G-protein alpha-i family, PDE2A, Ca-ATPase1, Calmodulin, Beta-1 adrenergic receptor, Ryanodine receptor 2, PKA-cat (cAMP-dependent)",
1337,Butanoic acid metabolism,39,8.405E-01,9.490E-01,9.250E-01,1.000E+00,10,"ECHP, ACAA2, ACSM3, ACDS, MCT1 (SLC16A1), ACAT1, SLC4A2, CTMP, MCT4, ACOT9",8.405E-01,9.490E-01,10,"ECHP, ACAA2, ACSM3, ACDS, MCT1 (SLC16A1), ACAT1, SLC4A2, CTMP, MCT4, ACOT9",
1338,Glucose-excited neurons of arcuate nucleus in obesity (rodent model),35,8.407E-01,9.540E-01,8.407E-01,9.540E-01,10,"RHEB2, GLUT3, GLUT4, POMC, AMPK alpha subunit, EPAS1/ARNT, EPAS1, HXK4, N-type Ca(II) channel alpha1B, mTOR",9.586E-01,1.000E+00,7,"RHEB2, GLUT3, POMC, AMPK alpha subunit, EPAS1, HXK4, mTOR",
1339,Dysregulation of indirect glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes ,54,8.411E-01,9.540E-01,8.411E-01,9.540E-01,16,"IRS-2, IRS-1, GLP-1 (7-36) amide, Syntaxin 1A, PAX6, GABA-A receptor, PI3K reg class IA, GABA-A receptor alpha-2 subunit, GLP-1 (7-37), Proglucagon, GABA-A receptor beta-2 subunit, VAMP2, Glucagon, PI3K cat class IA, GABA-A receptor alpha-1 subunit, GIP",9.167E-01,1.000E+00,13,"IRS-2, SNAP-25, GLP-1 (7-36) amide, MUNC13-1, PAX6, GABA-A receptor, PI3K reg class IA, GLP-1 (7-37), Proglucagon, VAMP2, Glucagon, PI3K cat class IA, GIP",
1340,Role of prenatal nicotine exposure in inhibition of pancreatic beta cells differentiation and function,21,8.464E-01,9.542E-01,9.106E-01,1.000E+00,5,"GLUT2, Nkx6.1, PAX6, Pdx-1 (IPF1), HXK4",8.464E-01,9.542E-01,5,"GLUT2, Nkx6.1, PAX6, Pdx-1 (IPF1), HXK4",
1341,Neurophysiological process_Glucose-excited neurons of ventromedial nucleus (rodent model),32,8.470E-01,9.599E-01,8.470E-01,9.599E-01,9,"GLUT2, GLUT3, GLUT4, SLC5A1, GABA-A receptor, Glucagon, SGLT3, HXK4, N-type Ca(II) channel alpha1B",9.227E-01,1.000E+00,7,"GLUT2, GLUT3, SLC5A1, GABA-A receptor, Glucagon, SGLT3, HXK4",
1342,"Mechanism of Pioglitazone and Rosiglitazon action in Diabetes mellitus, Type 2",5,8.522E-01,9.594E-01,8.856E-01,9.947E-01,1,PPAR-gamma,8.522E-01,9.594E-01,1,PPAR-gamma,
1343,Cholesterol and Sphingolipid transport / Recycling to plasma membrane in lung (normal and CF),29,8.543E-01,9.667E-01,8.543E-01,9.667E-01,8,"ABCA1, PA24A, EHD1, APOA1, Rab11-FIP2, EHD3, Caveolin-1, HDL",8.621E-01,9.676E-01,7,"ABCA1, PA24A, APOA1, Rab11-FIP2, EHD3, Caveolin-1, HDL",
1344,Neurophysiological process_PGE2-induced pain processing,47,8.603E-01,9.671E-01,9.415E-01,1.000E+00,12,"Glycine receptor beta chain, SLC21A2, PKA-reg (cAMP-dependent), cPLA2, Glycine receptor, Adenylate cyclase, GLRA, PGE2R2, PGE2R4, PGES, COX-2 (PTGS2), PKA-cat (cAMP-dependent)",8.603E-01,9.671E-01,12,"Glycine receptor beta chain, SLC21A2, COX-1 (PTGS1), cPLA2, Glycine receptor, Adenylate cyclase, GLRA, PGE2R2, PGE2R4, PGES, COX-2 (PTGS2), PKA-cat (cAMP-dependent)",
1345,Cholesterol and Sphingolipid transport / Influx to the early endosome in lung (normal and CF),29,8.621E-01,9.676E-01,9.292E-01,1.000E+00,7,"Caveolin-2, Dynamin-2, LDLR, Rab-5A, Rabenosyn-5, LRP6, Caveolin-1",8.621E-01,9.676E-01,7,"Caveolin-2, Dynamin-2, LDLR, Rab-5A, Rabenosyn-5, LRP6, Caveolin-1",
1346,Enterohepatic circulation of bile acids / Rodent version,40,8.637E-01,9.679E-01,9.388E-01,1.000E+00,10,"HYEP, AKR1C1, BSEP, GSTA5, SLC10A2, L-FABP, OATP8, SULT2A1, BAAT, ABCC4",8.637E-01,9.679E-01,10,"HYEP, AKR1C1, BSEP, GSTA5, SLC10A2, L-FABP, OATP8, SULT2A1, BAAT, ABCC4",
1347,Arachidonic acid production,74,8.666E-01,9.794E-01,8.666E-01,9.794E-01,22,"ELOVL7, PA2G6, ELOVL5, ACSL5, PLC-beta1, THEM2, ACSL4, PLC-zeta, PLC-gamma 1, PLC-eta 2, iPLA2-epsilon, PA24A, PLC-epsilon, FADS2, FADS1, TER, PLC-delta 1, KAR, Pnpla8, PLC-beta3, PLC-gamma 2, PLC-beta2",8.972E-01,9.973E-01,19,"PA2G6, ACSL5, ACSL4, PLC-zeta, PLC-gamma 1, PA2GE, iPLA2-epsilon, PA24A, PLC-epsilon, FADS2, FADS1, TER, PLC-delta 1, KAR, PLA2G2D, Pnpla8, PLC-beta3, PLC-gamma 2, PLC-beta2",
1348,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 1 activity,18,8.720E-01,9.757E-01,9.241E-01,1.000E+00,4,"AMPK beta subunit, AMPK gamma subunit, AMPK alpha subunit, SREBP2 (nuclear)",8.720E-01,9.757E-01,4,"AMPK beta subunit, AMPK gamma subunit, AMPK alpha subunit, SREBP2 (nuclear)",
1349,Neurophysiological process_nNOS signaling in neuronal synapses,30,8.807E-01,9.928E-01,8.807E-01,9.928E-01,8,"Calcineurin A (catalytic), MPTP complex, GOCAP1, NR2, nNOS, NR2B, Calmodulin, PSD-95",9.488E-01,1.000E+00,6,"Calcineurin A (catalytic), NR2, nNOS, NR2B, Calmodulin, PSD-95",
1350,Neurophysiological process_Glucose-inhibited neurons of ventromedial and arcuate nuclei (rodent model),41,8.841E-01,9.885E-01,9.030E-01,1.000E+00,11,"GLUT2, GLUT3, GLUT4, Guanylate Cyclase 1, soluble, Glucagon, NPY, AMPK alpha subunit, SGLT3, nNOS, HXK4, N-type Ca(II) channel alpha1B",8.841E-01,9.885E-01,10,"GLUT2, GLUT3, Guanylate Cyclase 1, soluble, Glucagon, NPY, AMPK alpha subunit, CFTR, SGLT3, nNOS, HXK4",
1351,Production of arachidonic acid derivatives by mast cells in asthma,30,8.856E-01,9.888E-01,9.929E-01,1.000E+00,5,"ERK1/2, c-Kit, PLA2G1B, cPLA2, COX-2 (PTGS2)",8.856E-01,9.888E-01,7,"ERK1/2, c-Kit, COX-1 (PTGS1), cPLA2, PA2GE, COX-2 (PTGS2), PLA2G2D",
1352,Mechanism of gemcitabine action in pancreatic cancer,52,8.870E-01,9.895E-01,9.211E-01,1.000E+00,14,"KCY, CNT3 (SLC28A3), DNA polymerase alpha/primase, TYSY, Ribonucleotide reductase, Ku70/80, RRM1, DNA-PK, DCTD, 5'-NT1A, CDD, p53, CNT1, DCK",8.870E-01,9.895E-01,13,"KCY, CNT3 (SLC28A3), TYSY, Ribonucleotide reductase, Ku70/80, RRM1, DNA-PK, DCTD, 5'-NT1A, CDD, p53, CNT1, DCK",
1353,Cannabinoid receptor signaling in nicotine addiction,34,8.911E-01,9.920E-01,9.498E-01,1.000E+00,8,"G-protein alpha-i2, G-protein alpha-i1, G-protein beta/gamma, nAChR alpha-7, G-protein alpha-i family, G-protein alpha-i3, P/Q-type calcium channel alpha-1A subunit, N-type Ca(II) channel alpha1B",8.911E-01,9.920E-01,8,"SNAP-25, G-protein alpha-i2, G-protein alpha-i1, G-protein beta/gamma, nAChR alpha-7, G-protein alpha-i family, G-protein alpha-i3, P/Q-type calcium channel alpha-1A subunit",
1354,Mechanisms of deltaF508 CFTR activation by S-nitrosoglutathione,47,8.934E-01,1.000E+00,8.934E-01,1.000E+00,13,"TXNRD3, Sti1, SOD1, HSP90, HSP70, ADHX, Ceruloplasmin, iNOS, HSC70, IL-8, SP3, nNOS, TXNRD1",9.213E-01,1.000E+00,11,"TXNRD3, HSP90, HSP70, ADHX, Ceruloplasmin, iNOS, IL-8, SP3, CFTR, nNOS, TXNRD1",
1355,Regulation of lipid metabolism_Regulation of fatty acid synthase activity in hepatocytes,19,8.988E-01,9.980E-01,9.838E-01,1.000E+00,3,"S2P, S1P, RXRB",8.988E-01,9.980E-01,4,"S2P, S1P, LXR-alpha, RXRB",
1356,Serotonin modulation of dopamine release in nicotine addiction,42,9.019E-01,1.000E+00,9.197E-01,1.000E+00,11,"SERT, GABA-A receptor, PLC-beta, HTR2C (HTR1C), Adenylate cyclase, G-protein beta/gamma, G-protein alpha-i family, nAChR beta-4, HTR3, PKC, G-protein alpha-q",9.019E-01,1.000E+00,10,"SERT, GABA-A receptor, PLC-beta, Adenylate cyclase, G-protein beta/gamma, G-protein alpha-i family, nAChR beta-4, HTR3, PKC, HTR1A",
1357,Plasmalogen biosynthesis,64,9.058E-01,1.000E+00,9.700E-01,1.000E+00,16,"PLCA, ENPP2, PLD1, ADAS, PLCF, LPP2, PEMT, LPP1, GNPAT, LPP3, PLCD, PLD2, PLCB, PLA2, CEPT1, PLCE",9.058E-01,1.000E+00,16,"PLCA, ENPP2, PLD1, ADAS, PLCF, LPP2, PEMT, LPP1, GNPAT, LPP3, PLCD, PLD2, PLCB, PLA2, CEPT1, PLCE",
1358,Folic acid metabolism,64,9.079E-01,1.000E+00,9.079E-01,1.000E+00,18,"FR-alpha, C1TC, DHFR, FTCD, MTHFD2L, MTHFR, GGH, FOLC2, ALDH1L2, SHMT1, GCST, SLC19A1, FMT, C1TM, FOLH1 (GCP2), SLC25A32, FOLC1, SLC22A6",9.452E-01,1.000E+00,15,"FR-alpha, DHFR, FTCD, MTHFD2L, MTHFR, GGH, FOLC2, ALDH1L2, SHMT1, GCST, SLC19A1, FMT, C1TM, SLC25A32, FOLC1",
1359,Neurophysiological process_Bitter taste signaling,28,9.111E-01,1.000E+00,9.111E-01,1.000E+00,7,"TRPM5, IP3R3, P2X3, P2Y4, Pannexin-1, T2R taste receptors, PLC-beta2",9.208E-01,1.000E+00,6,"IP3R3, P2X3, P2Y4, Pannexin-1, T2R taste receptors, PLC-beta2",
1360,Nicotine signaling in GABAergic neurons,39,9.134E-01,1.000E+00,9.250E-01,1.000E+00,10,"Syntaxin 1A, GABA-A receptor, nAChR, CREB1, G-protein beta/gamma, GAT1, Dopamine D2 receptor, G-protein alpha-i family, Calmodulin, N-type Ca(II) channel alpha1B",9.134E-01,1.000E+00,9,"SNAP-25, GABA-A receptor, CREB1, G-protein beta/gamma, GAT1, Dopamine D2 receptor, G-protein alpha-i family, Calmodulin, Mu-type opioid receptor",
1361,L-Phenylalanine metabolism,74,9.136E-01,1.000E+00,9.136E-01,1.000E+00,21,"SNAT, SLC38A2, SLC6A15, SLC3A2, MDH1, AATC, TAT1, SLC7A5, AL1A1, MIF, GLYAT, SLC7A10, SLC43A1, SLC38A9, SLC7A9, PAH, SLC6A19, KAT1, OXLA, SLC43A2, MAOB",9.369E-01,1.000E+00,18,"SNAT, SLC38A2, SLC6A15, SLC3A2, rBAT, MDH1, TAT1, SLC7A5, AL1A1, MIF, GLYAT, SLC6A20, SLC43A1, SLC38A9, SLC6A19, KAT1, OXLA, SLC43A2",
1362,Riboflavin metabolism,14,9.183E-01,1.000E+00,9.183E-01,1.000E+00,3,"ENPP2, ENPP3, PPA5",9.645E-01,1.000E+00,2,"ENPP2, PPA5",
1363,Development_MicroRNA-dependent regulation of EMT,24,9.199E-01,1.000E+00,9.971E-01,1.000E+00,3,"SIP1 (ZFHX1B), TGF-beta 2, TCF8",9.199E-01,1.000E+00,5,"SIP1 (ZFHX1B), TGF-beta 2, microRNA 200a, TCF8, miR-200a-3p",
1364,Mitochondrial ketone bodies biosynthesis and metabolism,24,9.199E-01,1.000E+00,9.596E-01,1.000E+00,5,"ACAA2, ACAT2, HMGCL, ACAT1, SCOT",9.199E-01,1.000E+00,5,"ACAA2, ACAT2, HMGCL, ACAT1, SCOT",
1365,Axonal degeneration in multiple sclerosis,49,9.250E-01,1.000E+00,9.250E-01,1.000E+00,13,"MPTP complex, ATP1A1, Ryanodine receptor 1, Nav1.6, Calpain 1(mu), iNOS, GluR6, NDUFA6, SCN2A, Neurofascin, NCX1, N-type Ca(II) channel alpha1B, Ryanodine receptor 2",9.884E-01,1.000E+00,9,"ATP1A1, Ryanodine receptor 1, Nav1.6, Calpain 1(mu), iNOS, GluR6, SCN2A, NCX1, Ryanodine receptor 2",
1366,Heparan sulfate/heparin metabolism,62,9.254E-01,1.000E+00,9.951E-01,1.000E+00,13,"3-OST-3A, EXTL3, 3-OST-3B, Exostosin-like 2, HS6ST2, Exostosin-1, 2-OST, Exostosin-2, HSST1, GLCE, HSST3, HS6ST1, 3-OST1",9.254E-01,1.000E+00,15,"EXTL1, 3-OST-3A, EXTL3, 3-OST-3B, Exostosin-like 2, HS6ST2, Exostosin-1, 2-OST, Exostosin-2, GLCE, 3-OST4, HSST3, HS6ST1, OST2, 3-OST1",
1367,Androstenedione and testosterone biosynthesis and metabolism p.3,40,9.278E-01,1.000E+00,9.960E-01,1.000E+00,7,"UGT1A10, UGT2B7, AKR1C2, HSD11B1, AKR1C3, SULT2A1, SRD5A1",9.278E-01,1.000E+00,9,"AK1D1, AKR1C4, UGT1A10, UGT2B7, AKR1C2, HSD11B1, AKR1C3, SULT2A1, SRD5A1",
1368,Niacin-HDL metabolism,46,9.293E-01,1.000E+00,9.293E-01,1.000E+00,12,"VLDL, LIPC (HL), HDL proteins, PAM, APOB, LDL, GLYAT, SR-BI, NNMT, CYP2E1, APOA1, DGAT2",9.520E-01,1.000E+00,10,"LIPC (HL), HDL proteins, PAM, APOB, LDL, GLYAT, SR-BI, NNMT, APOA1, DGAT2",
1369,L-Methionine metabolism,59,9.325E-01,1.000E+00,9.594E-01,1.000E+00,15,"SLC38A2, SN2, MTAP, SLC6A15, MRI1, SLC38A4, MTCBP-1, BHMT2, BHMT, SLC7A7, SLC6A19, KAT1, DNMT1, CCBL2, MAT2A",9.325E-01,1.000E+00,14,"SLC38A2, SN2, MTAP, SLC6A15, MRI1, SLC38A4, MTCBP-1, BHMT2, BHMT, SLC6A20, SLC7A7, SLC6A19, KAT1, DNMT1",
1370,Regulation of lipid metabolism_Insulin regulation of fatty acid metabolism,89,9.376E-01,1.000E+00,9.376E-01,1.000E+00,25,"IRS-2, ELOVL1, IRS-1, ERK1/2, S2P, PKA-reg (cAMP-dependent), GLUT4, INSIG2, Shc, GSK3 beta, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), ACSL1, PI3K cat class IA, FADS2, ELOVL6, SOS, PDHA (somatic), S1P, ODP2, PDH alpha, AKT2, HXK4, PKA-cat (cAMP-dependent)",9.802E-01,1.000E+00,20,"IRS-2, ELOVL1, ERK1/2, S2P, c-Raf-1, Shc, GSK3 beta, PI3K reg class IA, MEK2(MAP2K2), AKT(PKB), MEK1(MAP2K1), PI3K cat class IA, FADS2, ELOVL6, SOS, S1P, ODP2, PDH alpha, HXK4, PKA-cat (cAMP-dependent)",
1371,Cholesterol and Sphingolipid transport / Transport from Golgi and ER to the apical membrane (normal and CF),37,9.384E-01,1.000E+00,9.754E-01,1.000E+00,8,"PLEKHA3 (FAPP1), CES1, VIP36, CETP, SMS1, ABCA1, SOAT1, Caveolin-1",9.384E-01,1.000E+00,8,"PLEKHA3 (FAPP1), CES1, VIP36, CETP, SMS1, ABCA1, SOAT1, Caveolin-1",
1372,Glutathione metabolism,71,9.494E-01,1.000E+00,9.494E-01,1.000E+00,19,"GPX3, 5-oxoprolinase, GSTO1, GPX6, GSTK1, MAAI, GGTL3, GSTA5, GPX7, MGST2, GSTT2, GCL reg, GSTA2, MGST, GSTP1, GPX1, GSTA1, GCL cat, CD13",9.832E-01,1.000E+00,15,"5-oxoprolinase, GPX6, GSTK1, GGTL3, GSTA5, GPX7, MGST2, GSTT2, GCL reg, GSTA2, MGST, GSTP1, GPX1, GCL cat, CD13",
1373,"SREBP1 cross-talk with PXR, CAR and LXR",26,9.496E-01,1.000E+00,9.769E-01,1.000E+00,5,"INSIG2, PPARGC1 (PGC1-alpha), INSIG1, CYP2B6, NCOA1 (SRC1)",9.496E-01,1.000E+00,5,"PPARGC1 (PGC1-alpha), INSIG1, CYP3A4, LXR-alpha, NCOA1 (SRC1)",
1374,Transcription_FXR-regulated cholesterol and bile acids cellular transport,42,9.506E-01,1.000E+00,9.932E-01,1.000E+00,8,"MDR1, BSEP, SLC10A2, SR-BI, FXR, OATP8, HNF4-alpha, OSTbeta",9.506E-01,1.000E+00,9,"MDR1, BSEP, SLC10A2, SR-BI, FXR, SHP, OATP8, HNF4-alpha, OSTbeta",
1375,CFTR-dependent regulation of ion channels in CF,42,9.506E-01,1.000E+00,9.932E-01,1.000E+00,8,"PKA-reg (cAMP-dependent), G-protein alpha-q/11, IP3 receptor, PLC-beta, Actin cytoskeletal, YES, SK4/IK1, PKA-cat (cAMP-dependent)",9.506E-01,1.000E+00,9,"G-protein alpha-q/11, IP3 receptor, YAP1 (YAp65), PLC-beta, Actin cytoskeletal, YES, CFTR, SK4/IK1, PKA-cat (cAMP-dependent)",
1376,Amitraz-induced inhibition of Insulin secretion,22,9.519E-01,1.000E+00,9.765E-01,1.000E+00,4,"G-protein alpha-i2, G-protein alpha-i1, G-protein alpha-i family, G-protein alpha-i3",9.519E-01,1.000E+00,4,"G-protein alpha-i2, G-protein alpha-i1, G-protein alpha-i family, G-protein alpha-i3",
1377,"SREBP1 cross-talk with PXR, CAR and LXR/ Rodent version",31,9.591E-01,1.000E+00,9.832E-01,1.000E+00,6,"INSIG2, PPARGC1 (PGC1-alpha), INSIG1, CYP2B6, CYP7A1, NCOA1 (SRC1)",9.591E-01,1.000E+00,6,"PPARGC1 (PGC1-alpha), INSIG1, CYP3A4, LXR-alpha, CYP7A1, NCOA1 (SRC1)",
1378,Renal secretion of inorganic electrolytes,59,9.594E-01,1.000E+00,9.594E-01,1.000E+00,15,"SLC4A4, VILIP3, ATP1A1, SLC12A3, Carbonic anhydrase II, Epithelial calcium channel, CALB1, PMCA1, NHE3, SLC12A4, NCX1, Aquaporin 4, SLC34A1, Aquaporin 2, Aquaporin 1",9.822E-01,1.000E+00,12,"SLC4A4, VILIP3, ATP1A1, Carbonic anhydrase II, CALB1, NHE3, SLC12A4, Carbonic anhydrase IV, NCX1, Aquaporin 4, SLC34A1, Aquaporin 1",
1379,Stem cells_Cytotoxic effect of temozolomide on glioblastoma cells,27,9.604E-01,1.000E+00,9.827E-01,1.000E+00,5,"MSH6, Ubiquitin, MutSalpha complex, MSH2, p53",9.604E-01,1.000E+00,5,"MSH6, Ubiquitin, MutSalpha complex, MSH2, p53",
1380,ATP metabolism,107,9.644E-01,1.000E+00,9.823E-01,1.000E+00,28,"PDE7B, NMNA1, ENPP2, PDE10A, ENPP3, KPYR, PDE3A, PDE7A, AK3, Adenylate cyclase type VII, BPNT1, AK2, NMNA2, PDE4A, AK1, PKM2, Adenylate cyclase type III, ITPA, NDPK 7, AK5, CD38, PDE2A, PDE4C, PDE8A, PDE1C, Adenylate cyclase type VIII, BST1, PAPSS1",9.644E-01,1.000E+00,26,"PDE7B, NMNA1, ENPP2, PDE10A, KPYR, PDE3A, PDE7A, AK3, Adenylate cyclase type VII, AK2, NMNA2, PDE4A, PKM2, Adenylate cyclase type III, ITPA, NDPK 7, AK5, CD38, PDE2A, PDE4C, PDE8A, PDE1C, Adenylate cyclase type VIII, BST1, Connexin 43, PAPSS1",
1381,Globo-(isoglobo) series GSL Metabolism,48,9.672E-01,1.000E+00,9.899E-01,1.000E+00,10,"Beta-hexosaminidase, NAGA, G3ST1, HEXB, FUT2, ABO system transferase, AGAL, GBGT1, SIA7E, HEXA",9.672E-01,1.000E+00,10,"Beta-hexosaminidase, NAGA, G3ST1, HEXB, FUT2, ABO system transferase, AGAL, GBGT1, SIA7E, HEXA",
1382,L-Threonine metabolism,50,9.680E-01,1.000E+00,9.680E-01,1.000E+00,12,"BCKD-E1beta, SLC38A2, SLC6A15, SLC3A2, SLC38A4, DLDH, ASCT2 (SLC1A5), SLC7A10, SLC7A9, LDHB, SDHL, BCKD-E2",9.989E-01,1.000E+00,7,"SLC38A2, SLC6A15, SLC3A2, SLC38A4, rBAT, DLDH, LDHB",
1383,Regulation of lipid metabolism_PPAR regulation of lipid metabolism,47,9.711E-01,1.000E+00,9.711E-01,1.000E+00,11,"HADHA, ECHP, ACAA2, PPAR-alpha, UCP1, Fatty acid-binding protein, ACADM, Acetyl-CoA acyltransferase, ACSL1, FATP1, I-FABP",9.822E-01,1.000E+00,9,"HADHA, ECHP, ACAA2, PPAR-alpha, UCP1, Fatty acid-binding protein, ACADM, FATP1, I-FABP",
1384,Neolacto-series GSL Metabolism p.1,72,9.727E-01,1.000E+00,9.877E-01,1.000E+00,17,"NAGA, B4GT1, FUT2, FUT3, ABO system transferase, B4GT4, B3GN6, G3ST3, FUT4, SIAT4C, SIA10, CHSTA, B4GT2, B3GT4, FUT5, B3GA1, B3GNT5",9.727E-01,1.000E+00,16,"NAGA, B4GT1, FUT2, FUT3, ABO system transferase, B4GT4, B3GN6, G3ST3, FUT4, SIA10, CHSTA, B4GT2, B3GT4, FUT5, B3GA1, B3GNT5",
1385,Phosphatidylinositol metabolism,85,9.746E-01,1.000E+00,9.746E-01,1.000E+00,22,"IMPA1, PLA1A, PIGA, MINP1, SYNJ2, IMPA2, SYNJ1, PLC-beta1, PLC-gamma 1, IP3KA, MTMR6, PIP5KIII, INPP4A, PI52A, INPP, 3-PAP, MTM1, PLC-delta 1, I5P2, PLC-beta3, PLC-gamma 2, PLC-beta2",9.794E-01,1.000E+00,19,"IMPA1, PLA1A, PIGA, MINP1, IMPA2, SYNJ1, PLC-gamma 1, IP3KA, MTMR6, PIP5KIII, INPP4A, PI52A, INPP, MTM1, PLC-delta 1, I5P2, PLC-beta3, PLC-gamma 2, PLC-beta2",
1386,Neolacto-series GSL Metabolism p.2,61,9.746E-01,1.000E+00,9.862E-01,1.000E+00,14,"B4GT1, FUT3, B4GT4, B3GN6, FUT4, SIAT4C, SIA10, CHST4, SIA7E, B4GT2, CHST2, FUT5, B3GNT5, B3GN1",9.746E-01,1.000E+00,13,"B4GT1, FUT3, B4GT4, B3GN6, FUT4, SIA10, CHST4, SIA7E, B4GT2, CHST2, FUT5, B3GNT5, B3GN1",
1387,Anandamide biosynthesis and metabolism,46,9.780E-01,1.000E+00,9.837E-01,1.000E+00,10,"ENPP2, NAPE PLD, PTPN22, PLA2G1B, PLC-zeta, PLC-beta, PA24A, PLC-epsilon, PLC-delta, PLC-gamma",9.780E-01,1.000E+00,9,"ENPP2, NAPE PLD, PTPN22, PLC-zeta, PLC-beta, PA24A, PLC-epsilon, PLC-delta, PLC-gamma",
1388,Stem cells_Excitotoxicity of Glutamate in glioblastoma,45,9.795E-01,1.000E+00,9.795E-01,1.000E+00,10,"SLC7A11, AATC, G-protein beta/gamma, GLAST1/EAAT1, GCL reg, G-protein alpha-i family, SLC1A1/EAAT3, mGluR3, CDO1, GCL cat",9.961E-01,1.000E+00,7,"SLC7A11, G-protein beta/gamma, GLAST1/EAAT1, GCL reg, G-protein alpha-i family, CDO1, GCL cat",
1389,Pentose phosphate pathway,34,9.797E-01,1.000E+00,9.928E-01,1.000E+00,6,"RPIA, TKT, 6PGD, 6PGL, RPE, G6PE",9.797E-01,1.000E+00,6,"RPIA, TKT, 6PGD, 6PGL, RPE, G6PE",
1390,Heme metabolism,103,9.801E-01,1.000E+00,9.801E-01,1.000E+00,27,"DHPR, UGT1A4, ALAS1, Ferritin, FECH, Apotransferrin, UGT1A1, FTL, FTH1, HCCS, Catalase, DCUP, HEM4, Heme oxygenase 1, ALAS2, Ceruloplasmin, UGT1A10, Holotransferrin, CPOX, Neuroglobin, BGLR, CYP2B6, TfR1, TfR2, Ferritin mitochondrial, HMBS, UGT1A6",9.931E-01,1.000E+00,22,"UGT1A4, ALAS1, Ferritin, Apotransferrin, UGT1A1, FTL, FTH1, HCCS, Catalase, DCUP, HEM4, Heme oxygenase 1, ALAS2, Ceruloplasmin, UGT1A10, Holotransferrin, CPOX, Neuroglobin, TfR1, TfR2, HMBS, UGT1A6",
1391,Cortisol biosynthesis from Cholesterol,38,9.808E-01,1.000E+00,9.808E-01,1.000E+00,8,"STAR, CYP2C19, PBR, CYP17, CYP2D6, CYP11A1, HSD3B1, CYP21A2",9.925E-01,1.000E+00,6,"HSD17B2, PBR, CYP2D6, CYP11A1, HSD3B1, CYP21A2",
1392,Ascorbate metabolism,23,9.828E-01,1.000E+00,9.828E-01,1.000E+00,4,"Arylsulfatase A, GSTO1, PAM, DBH",9.982E-01,1.000E+00,2,"Arylsulfatase A, PAM",
1393,Antioxidant effects of statins in COPD,60,9.830E-01,1.000E+00,9.830E-01,1.000E+00,14,"SOD2, gp91-phox, Rac2, p47-phox, Rac1, SOD1, HMDH, Catalase, RhoA, Thioredoxin, Cytochrome b-558, p22-phox, GPX1, Caveolin-1",9.854E-01,1.000E+00,12,"SOD2, gp91-phox, Rac2, p47-phox, HMDH, Catalase, RhoA, Cytochrome b-558, p22-phox, p67-phox, GPX1, Caveolin-1",
1394,Transport_Regulation of ATP-binding transporters by Retinoic acid and orphan nuclear receptor PXR,39,9.831E-01,1.000E+00,9.996E-01,1.000E+00,5,"APOA2, ABCG4, MDR1, ABCA1, APOE",9.831E-01,1.000E+00,7,"APOA2, ABCG4, MDR1, ABCA1, CYP3A4, APOE, LXR-alpha",
1395,Glyoxylate metabolism,26,9.834E-01,1.000E+00,9.934E-01,1.000E+00,4,"MCT1 (SLC16A1), PXMP2, HAOX1, LDHA",9.834E-01,1.000E+00,4,"MCT1 (SLC16A1), PXMP2, HAOX1, LDHA",
1396,L-Alanine and L-cysteine metabolism,46,9.837E-01,1.000E+00,9.837E-01,1.000E+00,10,"AATC, LDHC, CTH, LDH6B, CBS, THTM, LDHB, CDO1, HAOX1, LDHA",9.969E-01,1.000E+00,7,"CTH, LDH6B, CBS, LDHB, CDO1, HAOX1, LDHA",
1397,Estrone metabolism,35,9.841E-01,1.000E+00,9.997E-01,1.000E+00,4,"SULT1E1, CYP2C19, HSD17B7, CYP2C9",9.841E-01,1.000E+00,6,"HSD17B2, SULT1E1, CYP3A4, HSD17B3, HSD17B7, CYP2C9",
1398,Beta-alanine metabolism,35,9.841E-01,1.000E+00,9.946E-01,1.000E+00,6,"BUP1, DPYD, CPGL2, GAD1, GAD2, DPYS",9.841E-01,1.000E+00,6,"BUP1, DPYD, CPGL2, GAD1, GAD2, DPYS",
1399,"Mechanism of Pioglitazone/Glimepiride and Rosiglitazone/Glimepiride cooperative action in Diabetes mellitus, Type 2",11,9.851E-01,1.000E+00,9.915E-01,1.000E+00,1,PPAR-gamma,9.851E-01,1.000E+00,1,PPAR-gamma,
1400,Transcription_Effect of Folic acid on genome stability,60,9.854E-01,1.000E+00,9.922E-01,1.000E+00,13,"FR-alpha, DHFR, MTHFR, GGH, TYSY, SHMT1, FTH1, ADH4, IRP1, ADH1, ADH6, DNMT1, MAT2A",9.854E-01,1.000E+00,12,"FR-alpha, DHFR, MTHFR, GGH, TYSY, SHMT1, FTH1, ADH4, IRP1, ADH1, ADH6, DNMT1",
1401,Neolacto-series GSL Metabolism p.3,68,9.857E-01,1.000E+00,9.935E-01,1.000E+00,15,"B4GT1, GCNT2, FUT2, ABO system transferase, B4GT4, B3GN6, FUT4, SIAT4C, SIA10, CHSTA, B4GT2, B3GT4, B3GA1, B3GNT5, B3GN1",9.857E-01,1.000E+00,14,"B4GT1, GCNT2, FUT2, ABO system transferase, B4GT4, B3GN6, FUT4, SIA10, CHSTA, B4GT2, B3GT4, B3GA1, B3GNT5, B3GN1",
1402,Thiamine metabolism,44,9.860E-01,1.000E+00,9.960E-01,1.000E+00,8,"SLC19A3, HACL1, SLC22A1, MATE1, MATE2, Slc35f3, SLC22A2, SLC19A1",9.860E-01,1.000E+00,8,"SLC19A3, HACL1, SLC22A1, MATE1, MATE2, Slc35f3, SLC22A2, SLC19A1",
1403,Leukotriene 4 biosynthesis and metabolism,40,9.866E-01,1.000E+00,9.884E-01,1.000E+00,8,"MGST2, ADHX, AL3A2, ALOX5, CYP4F3, GGT5, LTB4DH, MDP1",9.866E-01,1.000E+00,7,"MGST2, ADHX, ALOX5, CYP4F3, GGT5, LTB4DH, MDP1",
1404,Transport_GPR40 signaling pathway in beta cells,47,9.872E-01,1.000E+00,9.872E-01,1.000E+00,10,"Kv2.2, G-protein alpha-q/11, IP3 receptor, PLC-beta, GPR40, GFPT1, Kv2.1, Pdx-1 (IPF1), UAP1, OGT (GlcNAc transferase)",9.930E-01,1.000E+00,8,"Kv2.2, G-protein alpha-q/11, IP3 receptor, PLC-beta, GPR40, Kv2.1, Pdx-1 (IPF1), OGT (GlcNAc transferase)",
1405,Acetylcholine biosynthesis and metabolism,32,9.873E-01,1.000E+00,9.873E-01,1.000E+00,6,"PA2G6, PEMT, PA24A, LPPL, CLAT, ACES",9.888E-01,1.000E+00,5,"PA2G6, PEMT, PA24A, CLAT, ACES",
1406,Unsaturated fatty acid biosynthesis,65,9.876E-01,1.000E+00,9.876E-01,1.000E+00,15,"ELOVL7, ELOVL5, ELOVL1, ACSL5, PTPLB, ACSL4, PTPLA, ACSL6, ACSL1, FADS2, ELOVL6, FADS1, TER, ELOVL4, KAR",9.947E-01,1.000E+00,12,"ELOVL1, ACSL5, PTPLB, ACSL4, PTPLA, ACSL6, FADS2, ELOVL6, FADS1, TER, ELOVL4, KAR",
1407,Phospholipid metabolism p.1,58,9.903E-01,1.000E+00,9.979E-01,1.000E+00,11,"PLCA, PLD1, PLA1A, GPD2, LPP2, PHL1, LPP1, LPP3, MBOAT1, GPAM, PTSS1",9.903E-01,1.000E+00,11,"PLCA, PLD1, PLA1A, GPD2, LPP2, PHL1, LPP1, LPP3, MBOAT1, GPAM, PTSS1",
1408,Aflatoxin B1-dependent induction of HCC,33,9.904E-01,1.000E+00,9.904E-01,1.000E+00,6,"IRS-1, N-Ras, IGF-2, TNF-alpha, TBP, p53",9.914E-01,1.000E+00,5,"N-Ras, IGF-2, CYP3A4, TNF-alpha, p53",
1409,Galactose metabolism,63,9.911E-01,1.000E+00,9.911E-01,1.000E+00,14,"GYS2, B4GT1, LALBA, PYGB, Lactose synthase, AGAL, HXK3, GALE, B4GT2, Glycogen phosphorylase, PYGL, ALD2, PGMU, HXK4",9.920E-01,1.000E+00,12,"B4GT1, LALBA, PYGB, Lactose synthase, AGAL, G6PT, B4GT2, Glycogen phosphorylase, PYGL, ALD2, PGMU, HXK4",
1410,Mitochondrial unsaturated fatty acid beta-oxidation,45,9.916E-01,1.000E+00,9.916E-01,1.000E+00,9,"HADHA, ACAA2, ACSL5, ACSL4, ACADM, Acetyl-CoA acyltransferase, ACSL6, ACSL1, HADHB",9.988E-01,1.000E+00,6,"HADHA, ACAA2, ACSL5, ACSL4, ACADM, ACSL6",
1411,Vitamin D2 (ergocalciferol) metabolism,29,9.928E-01,1.000E+00,9.995E-01,1.000E+00,3,"CYP27A1, CYP24A1, CYP2C9",9.928E-01,1.000E+00,4,"CYP27A1, CYP24A1, CYP3A4, CYP2C9",
1412,Fatty Acid Omega Oxidation,30,9.929E-01,1.000E+00,9.929E-01,1.000E+00,5,"ECHP, ADH4, ADHX, AL3A2, CYP4A11",9.946E-01,1.000E+00,4,"ECHP, ADH4, ADHX, CYP4A11",
1413,Disruption of methionine metabolism in induction and progression of HCC,42,9.932E-01,1.000E+00,9.932E-01,1.000E+00,8,"MAT2B, ADH4, BHMT, CBS, c-Myc, ADH1, DNMT1, MAT2A",9.974E-01,1.000E+00,6,"MAT2B, ADH4, BHMT, CBS, ADH1, DNMT1",
1414,Sphingolipid metabolism,107,9.933E-01,1.000E+00,9.971E-01,1.000E+00,25,"GLCM, GALC, SPHK1, UGT8, GBA2, Arylsulfatase A, G3ST1, BGAL, ASAH2, LPP2, SPT3, Acid sphingomyelinase, SMS1, SPP lyase, SGPP2, LASS1, LPP1, LPP3, AGAL, CERK1, B4G6, FVT1, LASS5, SPT1, SMPD4",9.933E-01,1.000E+00,23,"SPHK1, UGT8, GBA2, Arylsulfatase A, G3ST1, BGAL, LPP2, SPT3, Acid sphingomyelinase, SMS1, SGPP2, LASS1, LPP1, LPP3, AGAL, ENPP7, CERK1, B4G6, FVT1, SPT1, SMPD4, GLCM, GALC",
1415,Regulation of CFTR gating (normal and CF),34,9.934E-01,1.000E+00,9.980E-01,1.000E+00,5,"PKA-reg (cAMP-dependent), Adenylate cyclase, AMPK alpha 1 subunit, Calumenin, PKA-cat (cAMP-dependent)",9.934E-01,1.000E+00,5,"Adenylate cyclase, AMPK alpha 1 subunit, CFTR, Calumenin, PKA-cat (cAMP-dependent)",
1416,Serotonin - melatonin biosynthesis and metabolism,46,9.935E-01,1.000E+00,9.935E-01,1.000E+00,9,"SNAT, IDO1, CYP1B1, CYP1A1, ALDR, MAOA, CYP2C19, CYP2D6, MAOB",9.969E-01,1.000E+00,7,"SNAT, IDO1, CYP1B1, CYP1A1, ALDR, MAOA, CYP2D6",
1417,Tricarbonic acid cycle,61,9.938E-01,1.000E+00,9.938E-01,1.000E+00,13,"SDHA, IDH3, IDH3G, DLDH, SDHB, MDH2, ODO1, IDH3B, IDH3A, SDHD, ACON, FUMH, SUCB1",9.980E-01,1.000E+00,10,"SDHA, IDH3, IDH3G, DLDH, SDHB, ODO1, IDH3B, IDH3A, SDHD, FUMH",
1418,CoA biosynthesis,52,9.941E-01,1.000E+00,9.963E-01,1.000E+00,10,"PANK1, ACSL5, PANK2, ACSL4, PPCDC, CTE2, ACSL6, ACSL1, VNN1, PANK4",9.941E-01,1.000E+00,9,"PANK1, ACSL5, PANK2, ACSL4, PPCDC, CTE2, ACSL6, VNN1, PANK4",
1419,De novo IMP biosynthesis,39,9.942E-01,1.000E+00,9.946E-01,1.000E+00,7,"PPAT, GART, PRPS2, PRPS1, ADSL, PFAS, PAICS",9.942E-01,1.000E+00,6,"GART, PRPS2, PRPS1L1, PRPS1, ADSL, PFAS",
1420,Putative pathways of Oleic acid sensing in ventromedial hypothalamus in obesity (rodent model),30,9.946E-01,1.000E+00,9.982E-01,1.000E+00,4,"ACSL4, CTE2, ACSL6, FATP1",9.946E-01,1.000E+00,4,"ACSL4, CTE2, ACSL6, FATP1",
1421,Linoleic acid metabolism,31,9.948E-01,1.000E+00,9.948E-01,1.000E+00,5,"PA2G6, CYP2C19, PA24A, FADS2, CYP2E1",9.992E-01,1.000E+00,3,"PA2G6, PA24A, FADS2",
1422,L-Tryptophan metabolism (part 1),80,9.951E-01,1.000E+00,9.951E-01,1.000E+00,18,"IDO1, SLC38A2, SLC3A2, SLC36A4, ALDR, MAOA, IDO2, TAT1, SLC7A5, ASCT2 (SLC1A5), AL1A1, SLC43A1, SLC7A9, SLC6A19, OXLA, SLC43A2, TPH1, MAOB",9.970E-01,1.000E+00,15,"IDO1, SLC38A2, SLC3A2, SLC36A4, ALDR, MAOA, IDO2, TAT1, SLC7A5, AL1A1, SLC43A1, SLC6A19, OXLA, SLC43A2, TPH1",
1423,Histamine metabolism,27,9.952E-01,1.000E+00,9.952E-01,1.000E+00,4,"HNMT, MAOA, AL1B1, MAOB",9.971E-01,1.000E+00,3,"HDC, MAOA, AL1B1",
1424,"Metabolism of L-cysteine, D-cysteine and L-cystine",119,9.959E-01,1.000E+00,9.959E-01,1.000E+00,29,"SLC38A2, SLC6A15, SLC3A2, SLC7A11, SLC38A4, TXNL5, SLC36A1, AATC, LDHC, CTH, LDH6B, CBS, SLC7A10, THTM, GLAST1/EAAT1, SLC25A13, Thioredoxin, SLC7A9, Ceruloplasmin, GCL reg, Aralar1 (SLC25A12), SLC1A1/EAAT3, Cystinosin, LDHB, SLC6A19, DAAO, CDO1, GCL cat, LDHA",9.996E-01,1.000E+00,22,"SLC38A2, SLC6A15, SLC3A2, SLC7A11, SLC38A4, rBAT, TXNL5, SLC36A1, CTH, LDH6B, CBS, GLAST1/EAAT1, SLC25A13, Ceruloplasmin, GCL reg, Aralar1 (SLC25A12), Cystinosin, LDHB, SLC6A19, CDO1, GCL cat, LDHA",
1425,Lacto-series GSL Metabolism,63,9.961E-01,1.000E+00,9.961E-01,1.000E+00,13,"NAGA, FUT2, FUT3, FUCO, ABO system transferase, G3ST3, AGAL, SIAT4C, B3GNT3, SIA7E, B3GT2, B3GNT5, B3GT1",9.967E-01,1.000E+00,11,"NAGA, FUT2, FUT3, FUCO, ABO system transferase, G3ST3, AGAL, SIA7E, B3GT2, B3GNT5, B3GT1",
1426,Ganglioside Metabolism p1,54,9.963E-01,1.000E+00,9.978E-01,1.000E+00,10,"Beta-hexosaminidase, NEU2, BGAL, SIAT8E, HEXB, B3GT4, Acetyl-coenzyme A transporter, HEXA, GALGT, SIAT8A",9.963E-01,1.000E+00,9,"Beta-hexosaminidase, NEU2, BGAL, SIAT8E, HEXB, B3GT4, HEXA, GALGT, SIAT8A",
1427,Interconnectivity between Folic acid and Fluorouracil pathways in gastric cancer,91,9.963E-01,1.000E+00,9.990E-01,1.000E+00,19,"FR-alpha, CES1, DHFR, MTHFR, ABCB5, BUP1, DPYD, TYSY, SHMT1, Ribonucleotide reductase, PD-ECGF (TdRPase), SLC19A1, UDP, DPYS, UCK2, ABCC4, CDD, Aquaporin 9, SLC22A6",9.963E-01,1.000E+00,18,"FR-alpha, CES1, DHFR, MTHFR, ABCB5, BUP1, DPYD, TYSY, SHMT1, Ribonucleotide reductase, PD-ECGF (TdRPase), SLC19A1, UDP, DPYS, UCK2, ABCC4, CDD, Aquaporin 9",
1428,Aminosugar metabolism,60,9.967E-01,1.000E+00,9.967E-01,1.000E+00,12,"GLUT2, GFPT2, GLUT4, GFPT1, NPL, GALE, GPI, GNPI, UAP1, NANP, HXK4, UDP-GlcNAc- 2-epimerase",9.999E-01,1.000E+00,7,"GLUT2, GFPT2, NPL, GNPI, NANP, HXK4, UDP-GlcNAc- 2-epimerase",
1429,Phospholipid metabolism p.3,33,9.972E-01,1.000E+00,9.972E-01,1.000E+00,5,"PLA1A, LCAT, LPCAT1, PA24A, LRAT",9.978E-01,1.000E+00,4,"PLA1A, LCAT, PA24A, LRAT",
1430,Taurine and hypotaurine metabolism,22,9.975E-01,1.000E+00,9.991E-01,1.000E+00,2,"BAAT, CDO1",9.975E-01,1.000E+00,2,"BAAT, CDO1",
1431,Sulfur metabolism,42,9.977E-01,1.000E+00,9.977E-01,1.000E+00,7,"AATC, CTH, CBS, THTM, CDO1, GCL cat, PAPSS1",9.993E-01,1.000E+00,5,"CTH, CBS, CDO1, GCL cat, PAPSS1",
1432,Vitamin B3 and NAD+ metabolism,125,9.978E-01,1.000E+00,9.993E-01,1.000E+00,28,"NMNA1, SLC22A13, Xanthine oxidase, ENPP3, 5'-NTD, NRK1, PAM, SLC36A1, NMNA2, MATE1, MATE2, ALPP, MCT1 (SLC16A1), PBEF, MIBP, GLYAT, PMP34, SLC22A2, CD38, NNMT, ALPL, CYP2E1, SLC16A3, NADK2, NNTM, BST1, NT5C3, PNPH",9.978E-01,1.000E+00,26,"NMNA1, SLC22A13, Xanthine oxidase, 5'-NTD, NRK1, PAM, SLC36A1, NMNA2, MATE1, MATE2, ALPP, MCT1 (SLC16A1), PBEF, GLYAT, PMP34, SLC22A2, CD38, NNMT, ALPL, SLC16A3, NADK2, NNTM, BST1, NT5C3, PNPH, Connexin 43",
1433,Aldosterone biosynthesis and metabolism,38,9.978E-01,1.000E+00,1.000E+00,1.000E+00,3,"UGT2B7, HSD11B1, CYP21A2",9.978E-01,1.000E+00,5,"AK1D1, AKR1C4, UGT2B7, HSD11B1, CYP21A2",
1434,Prostaglandin 1 biosynthesis and metabolism,57,9.982E-01,1.000E+00,9.999E-01,1.000E+00,8,"PPT2, PGES, FADS1, Acyl-CoA synthetase, COX-2 (PTGS2), PTGIS, THAS, CBR1",9.982E-01,1.000E+00,9,"PPT2, COX-1 (PTGS1), PGES, FADS1, Acyl-CoA synthetase, COX-2 (PTGS2), PTGIS, THAS, CBR1",
1435,Metabolism in pancreatic cancer cells,66,9.983E-01,1.000E+00,9.993E-01,1.000E+00,12,"GLUT2, SLC7A11, GLUT3, GLUT4, RPIA, GLSK, TKT, HIF1A, GLUT5, RPE, GPX1, GCL cat",9.983E-01,1.000E+00,11,"GLUT2, SLC7A11, GLUT3, RPIA, GLSK, TKT, HIF1A, GLUT5, RPE, GPX1, GCL cat",
1436,n-3 Polyunsaturated fatty acid biosynthesis,63,9.984E-01,1.000E+00,9.984E-01,1.000E+00,12,"ELOVL5, ECHP, ELOVL1, ACSL5, ACSL4, ACSL6, ACSL1, FADS2, FADS1, TER, ELOVL4, KAR",9.988E-01,1.000E+00,10,"ECHP, ELOVL1, ACSL5, ACSL4, ACSL6, FADS2, FADS1, TER, ELOVL4, KAR",
1437,Ganglioside Metabolism p2,44,9.985E-01,1.000E+00,9.987E-01,1.000E+00,7,"NEU2, SIAT8E, SIAT4C, SIA7C, SIA7E, SIAT4B, SIAT8A",9.985E-01,1.000E+00,6,"NEU2, SIAT8E, SIA7C, SIA7E, SIAT4B, SIAT8A",
1438,Androstenedione and testosterone biosynthesis and metabolism p.1,54,9.987E-01,1.000E+00,9.999E-01,1.000E+00,7,"CYP1A1, CYP2C19, CYP17, SULT2A1, CYP3A7, CYP2C9, HSD3B1",9.987E-01,1.000E+00,8,"CYP1A1, HSD17B2, CYP3A4, HSD17B3, SULT2A1, CYP3A7, CYP2C9, HSD3B1",
1439,Polyamine metabolism,64,9.988E-01,1.000E+00,9.988E-01,1.000E+00,12,"DCOR, MAOA, SPSY, ARG2, Spermine oxidase, SAT2, SPEB, AMD1, SPEE, SSAT, ADC, MAOB",9.990E-01,1.000E+00,10,"DCOR, MAOA, SPSY, Spermine oxidase, SAT2, SPEB, AMD1, SPEE, SSAT, ADC",
1440,L-Carnitine biosynthesis,30,9.989E-01,1.000E+00,9.997E-01,1.000E+00,3,"TMLH, BBOX1, SLC22A16",9.989E-01,1.000E+00,3,"TMLH, BBOX1, SLC22A16",
1441,Fructose metabolism,81,9.990E-01,1.000E+00,9.992E-01,1.000E+00,16,"ALDOB, F264, ALDR, GALM, AMYS, F16Q, F263, F262, AK1BA, PMM1, ALDOC, HXK3, GPI, MANA, HXK4, PFKP",9.990E-01,1.000E+00,14,"ALDOB, F264, ALDR, AMYS, F16Q, F263, F262, AK1BA, PMM1, ALDOC, G6PT, IGRP, HXK4, PFKP",
1442,n-6 Polyunsaturated fatty acid biosynthesis,61,9.990E-01,1.000E+00,9.990E-01,1.000E+00,11,"ELOVL7, ELOVL5, ECHP, ELOVL1, ACSL5, ACSL4, FADS2, FADS1, TER, ELOVL4, KAR",9.993E-01,1.000E+00,9,"ECHP, ELOVL1, ACSL5, ACSL4, FADS2, FADS1, TER, ELOVL4, KAR",
1443,Urea cycle,36,9.991E-01,1.000E+00,9.998E-01,1.000E+00,4,"OTC, SLC25A15 (ORC1), ASSY, Aquaporin 9",9.991E-01,1.000E+00,4,"OTC, SLC25A15 (ORC1), ASSY, Aquaporin 9",
1444,Cortisone biosynthesis and metabolism,51,9.992E-01,1.000E+00,1.000E+00,1.000E+00,6,"CYP17, AKR1C2, HSD11B1, AKR1C3, HSD3B1, CYP21A2",9.992E-01,1.000E+00,7,"AK1D1, AKR1C4, AKR1C2, HSD11B1, AKR1C3, HSD3B1, CYP21A2",
1445,UMP biosynthesis,19,9.993E-01,1.000E+00,9.997E-01,1.000E+00,1,CAD,9.993E-01,1.000E+00,1,CAD,
1446,Estrogen biosynthesis,42,9.993E-01,1.000E+00,1.000E+00,1.000E+00,4,"CYP19, CYP2C19, HSD17B7, CYP2C9",9.993E-01,1.000E+00,5,"HSD17B2, CYP3A4, HSD17B3, HSD17B7, CYP2C9",
1447,Renal secretion of drugs / Rodent version ,47,9.993E-01,1.000E+00,9.999E-01,1.000E+00,6,"SLC22A1, MDR1, SLC22A2, SLC22A3, ABCC4, SLC22A6",9.993E-01,1.000E+00,6,"SLC22A1, MDR1, SLC22A2, SLC22A3, SLC17A1, ABCC4",
1448,Metabolism of L-Proline and derivatives,74,9.993E-01,1.000E+00,9.993E-01,1.000E+00,14,"SLC38A2, SLC6A15, SLC36A4, SLC36A2, SLC36A1, DHDPSL, PRODH2, OAT, SLC6A12, SLC6A19, SLC6A17, DAAO, P5CR2, L3HYPDH",9.997E-01,1.000E+00,11,"SLC38A2, SLC6A15, SLC36A4, SLC36A2, SLC36A1, SLC6A20, PRODH2, SLC6A12, SLC6A19, P5CR2, L3HYPDH",
1449,L-Arginine metabolism,79,9.994E-01,1.000E+00,9.998E-01,1.000E+00,14,"KCRM, OTC, DCOR, SPSY, AL1A1, ARG2, iNOS, SPEB, nNOS, AMD1, SPEE, ASSY, bNOS, ADC",9.994E-01,1.000E+00,13,"KCRM, OTC, DCOR, SPSY, AL1A1, iNOS, SPEB, nNOS, AMD1, SPEE, KCRB, ASSY, ADC",
1450,Propionate metabolism p.2,63,9.994E-01,1.000E+00,9.994E-01,1.000E+00,11,"HADHA, ACAA2, BUP1, ACAT2, HMGCL, ACADM, ACAT1, Acetyl-CoA acyltransferase, HADHB, HIBCH, SCOT",9.999E-01,1.000E+00,8,"HADHA, ACAA2, BUP1, ACAT2, HMGCL, ACADM, ACAT1, SCOT",
1451,Glycine and L-Serine metabolism,133,9.995E-01,1.000E+00,9.995E-01,1.000E+00,30,"SLC38A2, SN2, SLC6A15, Serine racemase, SLC3A2, SLC36A2, SLC38A4, DLDH, SLC36A1, GCSH, SHMT1, ASCT2 (SLC1A5), AL7A1, BHMT, SLC7A10, SERA, SERB, GCST, SLC7A9, SARDH, SLC44A1, PSAT, SLC6A19, SLC6A17, SDHL, SFXN1, SLC6A18, PIPOX, M2GD, GlyT1",9.997E-01,1.000E+00,25,"SLC38A2, SN2, SLC6A15, Serine racemase, SLC3A2, SLC36A2, SLC38A4, rBAT, DLDH, SLC36A1, GCSH, SHMT1, AL7A1, BHMT, SERA, SERB, GCST, GlyT2, SLC44A1, PSAT, SLC6A19, SLC6A18, PIPOX, M2GD, GlyT1",
1452,Protein folding and maturation_Insulin processing,20,9.995E-01,1.000E+00,9.998E-01,1.000E+00,1,PC1,9.995E-01,1.000E+00,1,PC1,
1453,Gamma-aminobutyrate (GABA) biosynthesis and metabolism,52,9.996E-01,1.000E+00,9.996E-01,1.000E+00,8,"MAOA, AATC, SSDH, SAT2, GAD1, GAD2, SSAT, MAOB",9.998E-01,1.000E+00,6,"MAOA, SSDH, SAT2, GAD1, GAD2, SSAT",
1454,Vitamin B6 metabolism,34,9.997E-01,1.000E+00,9.999E-01,1.000E+00,3,"PDXK, ALPL, PDXP",9.997E-01,1.000E+00,3,"PDXK, ALPL, PDXP",
1455,L-Lysine metabolism,93,9.997E-01,1.000E+00,9.997E-01,1.000E+00,18,"AGPHD1, ECHP, ACAA2, SLC38A4, DLDH, ACAT2, AL7A1, ACAT1, SLC7A7, CAT-1 (SLC7A1), SLC7A9, AADAT, CAT-3, AASS, SLC25A15 (ORC1), PIPOX, AGXT2L2, CCBL2",9.999E-01,1.000E+00,14,"ECHP, ACAA2, SLC38A4, DLDH, ACAT2, AL7A1, ACAT1, SLC7A7, CAT-1 (SLC7A1), AADAT, CAT-3, AASS, SLC25A15 (ORC1), PIPOX",
1456,Pyruvate metabolism,66,9.998E-01,1.000E+00,9.998E-01,1.000E+00,11,"SLC25A11, DLDH, ME3, VDAC 1, MCT1 (SLC16A1), MDH2, MCT2, ME2, SLC16A3, ODP2, PDH alpha",9.998E-01,1.000E+00,9,"DLDH, ME3, VDAC 1, MCT1 (SLC16A1), MCT2, ME2, SLC16A3, ODP2, PDH alpha",
1457,Propionate metabolism p.1,36,9.998E-01,1.000E+00,9.998E-01,1.000E+00,4,"3HIDH, THEM2, PCCA, BCKD-E2",1.000E+00,1.000E+00,1,3HIDH,
1458,Impaired NO signaling in CF airways,52,9.998E-01,1.000E+00,1.000E+00,1.000E+00,5,"Protein kinase G 2, PDE5A, iNOS, Protein kinase G, nNOS",9.998E-01,1.000E+00,6,"Protein kinase G 2, PDE5A, iNOS, Protein kinase G, CFTR, nNOS",
1459,Phospholipid metabolism p.2,47,9.998E-01,1.000E+00,9.999E-01,1.000E+00,6,"PLD1, NAPE PLD, PEMT, LPP1, EKI1, PCY1B",9.998E-01,1.000E+00,5,"PLD1, NAPE PLD, PEMT, LPP1, PCY1B",
1460,HETE and HPETE biosynthesis and metabolism,82,9.999E-01,1.000E+00,1.000E+00,1.000E+00,10,"MGST2, ALOX5, CYP4F3, CYP2E1, COX-2 (PTGS2), PTGIS, CYP4A11, GPX1, THAS, CYP2C9",9.999E-01,1.000E+00,12,"CYP2C8, COX-1 (PTGS1), MGST2, ALOX5, CYP4F3, COX-2 (PTGS2), PTGIS, CYP4A11, GPX1, ALOX12, THAS, CYP2C9",
1461,Androgen biosynthetic pathways,82,9.999E-01,1.000E+00,1.000E+00,1.000E+00,12,"STAR, AKR1C1, CYP2C19, PBR, CYP17, AKR1C2, HSD11B1, CYP11A1, AKR1C3, SULT2A1, HSD3B1, SRD5A1",9.999E-01,1.000E+00,12,"HSD17B2, AKR1C4, AKR1C1, PBR, HSD17B3, AKR1C2, HSD11B1, CYP11A1, AKR1C3, SULT2A1, HSD3B1, SRD5A1",
1462,Renal secretion of organic electrolytes / Rodent version ,75,9.999E-01,1.000E+00,1.000E+00,1.000E+00,8,"SLC22A11, SLC22A1, ABCC1, ATP1A1, SLC22A2, SLC13A3, ABCC4, SLC22A6",9.999E-01,1.000E+00,10,"SLC22A11, SLC22A12, SLC22A1, ABCC1, ATP1A1, SLC22A2, SLC17A1, SLC13A3, PEPT2, ABCC4",
1463,Prostaglandin 2 biosynthesis and metabolism,86,1.000E+00,1.000E+00,1.000E+00,1.000E+00,12,"PGDS, PGES, PRDX1, Carbonyl reductase [NADPH] 3, COX-2 (PTGS2), PGHD, PTGIS, AKR1C3, LTB4DH, THAS, CBR1, PRDX4",1.000E+00,1.000E+00,12,"COX-1 (PTGS1), PGDS, PGES, Carbonyl reductase [NADPH] 3, COX-2 (PTGS2), PGHD, PTGIS, AKR1C3, LTB4DH, THAS, CBR1, PRDX4",
1464,Immune response_The effect of IDO1 on T cell metabolism,89,1.000E+00,1.000E+00,1.000E+00,1.000E+00,15,"IDO1, SLC38A2, MDH1, TIGAR (C12orf5), GCN2, F263, GLSK, SLC7A5, ASCT2 (SLC1A5), GLSL, PKM2, ODP2, LDHA, p53, mTOR",1.000E+00,1.000E+00,12,"IDO1, SLC38A2, MDH1, GCN2, F263, GLSK, SLC7A5, PKM2, ODP2, LDHA, p53, mTOR",
1465,Aspartate and asparagine metabolism,73,1.000E+00,1.000E+00,1.000E+00,1.000E+00,11,"OXDD, OTC, AATC, CAD, GAD1, ADSL, GAD2, ACY2, ASSY, ASNS, PAICS",1.000E+00,1.000E+00,9,"OXDD, OTC, CAD, GAD1, ADSL, GAD2, ACY2, ASSY, ASNS",
1466,"N-Acylethanolamines, HSRL5-transacylation pathway",27,1.000E+00,1.000E+00,1.000E+00,1.000E+00,1,ENPP2,1.000E+00,1.000E+00,1,ENPP2,
1467,Vitamin B7 (biotin) metabolism,47,1.000E+00,1.000E+00,1.000E+00,1.000E+00,4,"SPC22, SPC18, BTD, BPL1",1.000E+00,1.000E+00,4,"SPC22, SPC18, BTD, BPL1",
1468,"Leucine, isoleucine and valine metabolism",43,1.000E+00,1.000E+00,1.000E+00,1.000E+00,4,"BCKD-E1beta, DLDH, BCAT1, BCKD-E2",1.000E+00,1.000E+00,2,"DLDH, BCAT1",
1469,Vitamin D3 metabolic C-23 and C-24 pathways,43,1.000E+00,1.000E+00,1.000E+00,1.000E+00,3,"CYP27A1, CYP24A1, CYP27B1",1.000E+00,1.000E+00,3,"CYP27A1, CYP24A1, CYP27B1",
1470,Selenoamino acid metabolism,54,1.000E+00,1.000E+00,1.000E+00,1.000E+00,6,"HNMT, CTH, CBS, SCLY, PSTK, MAT2A",1.000E+00,1.000E+00,4,"CTH, CBS, SCLY, PSTK",
1471,Cholesterol Biosynthesis,103,1.000E+00,1.000E+00,1.000E+00,1.000E+00,17,"SC5D, SC4MOL, NSDHL, HMGCS1, MVD, EBP, HMDH, ACAT1, LSS, DHCR7, IDI1, HSD17B7, CYP51A1, FDPS, IDI2, FDFT1, DHC24",1.000E+00,1.000E+00,14,"SC5D, SC4MOL, NSDHL, MVD, EBP, HMDH, ACAT1, LSS, DHCR7, IDI1, HSD17B7, CYP51A1, FDPS, FDFT1",
1472,Tyrosine metabolism p.2 (melanin),83,1.000E+00,1.000E+00,1.000E+00,1.000E+00,12,"Xanthine oxidase, ACAA2, MAOA, TYRP2, TYRO, AATC, ACAT2, MIF, MAAI, ACAT1, SCOT, MAOB",1.000E+00,1.000E+00,10,"Xanthine oxidase, ACAA2, MAOA, TYRP2, TYRO, ACAT2, AL3A1, MIF, ACAT1, SCOT",
1473,Ubiquinone metabolism,74,1.000E+00,1.000E+00,1.000E+00,1.000E+00,10,"NDUFS5, COQ3, coenzyme Q2 homolog, prenyltransferase (yeast), NDUFB7, NDUFA11, NDUFA6, NDUFB2, NDUFV2, NDUFS6, NDUFB3",1.000E+00,1.000E+00,4,"NDUFS5, coenzyme Q2 homolog, prenyltransferase (yeast), NDUFA11, NDUFS6",
1474,Oxidative phosphorylation,41,1.000E+00,1.000E+00,1.000E+00,1.000E+00,3,"SLC25A4, SLC25A5, SLC25A31",1.000E+00,1.000E+00,1,SLC25A31,
1475,N-Acylethanolamines. N-Acyltransferase pathway,32,1.000E+00,1.000E+00,1.000E+00,1.000E+00,1,NAPE PLD,1.000E+00,1.000E+00,1,NAPE PLD,
1476,Histidine-glutamate-glutamine metabolism,95,1.000E+00,1.000E+00,1.000E+00,1.000E+00,14,"AMDHD1, GMPS, GFPT2, FTCD, PPAT, AATC, GLSK, GFPT1, SSDH, GLSL, CAD, GAD1, GAD2, P5CR2",1.000E+00,1.000E+00,12,"AMDHD1, GMPS, GFPT2, HDC, FTCD, GLSK, SSDH, HUTU, CAD, GAD1, GAD2, P5CR2",
1477,L-Tryptophan metabolism (part 2),97,1.000E+00,1.000E+00,1.000E+00,1.000E+00,13,"ECHP, ACAA2, DLDH, 3HAO, ACAT2, ACAT1, SLC25A21, KYNU, SULT1B1, AADAT, KAT1, ACMSD, CCBL2",1.000E+00,1.000E+00,12,"ECHP, ACAA2, DLDH, 3HAO, ACAT2, ACAT1, SLC25A21, KYNU, SULT1B1, AADAT, KAT1, ACMSD",
1478,"Leucine, isoleucine and valine metabolism.p.2",79,1.000E+00,1.000E+00,1.000E+00,1.000E+00,10,"HADHA, ACAA2, HMGCL, ACAT1, Acetyl-CoA acyltransferase, PCCA, AUMH, HADHB, HIBCH, SCOT",1.000E+00,1.000E+00,6,"HADHA, ACAA2, HMGCL, ACAT1, AUMH, SCOT",
1479,Tyrosine metabolism p.1 (dopamine) ,70,1.000E+00,1.000E+00,1.000E+00,1.000E+00,8,"MAOA, TYRO, AL1A1, DBH, AL1B1, PNMT, PAH, MAOB",1.000E+00,1.000E+00,6,"MAOA, TYRO, AL3A1, AL1A1, ADHB, AL1B1",
1480,Alcohol metabolism predisposition of HCC development,52,1.000E+00,1.000E+00,1.000E+00,1.000E+00,4,"ADH4, ADH1, CYP2E1, ADHG",1.000E+00,1.000E+00,3,"ADH4, ADH1, ADHG",
1481,Mitochondrial beta-oxidation of long-chain saturated fatty acids,125,1.000E+00,1.000E+00,1.000E+00,1.000E+00,20,"HADHA, H-FABP, ACAA2, ACSL5, FACVL1, VLCSH1, E-FABP, ACADL, ACSL4, ACDS, ACADM, ACAT1, Acetyl-CoA acyltransferase, ACSL6, ACSL1, L-FABP, HADHB, ACAD-9, FATP1, I-FABP",1.000E+00,1.000E+00,17,"HADHA, H-FABP, ACAA2, ACSL5, FACVL1, VLCSH1, E-FABP, ACADL, ACSL4, ACDS, ACADM, ACAT1, ACSL6, A-FABP, L-FABP, FATP1, I-FABP",
1482,N-Glycan biosynthesis p1,72,1.000E+00,1.000E+00,1.000E+00,1.000E+00,8,"RIB2, RIB1, ALG2, OST48, DHDDS, ALG6, ALG11, ALG9",1.000E+00,1.000E+00,5,"RIB2, RIB1, OST48, DHDDS, ALG9",
1483,"N-Acylethanolamines, Phospholipase A2 pathway",40,1.000E+00,1.000E+00,1.000E+00,1.000E+00,2,"ENPP2, PLA2G1B",1.000E+00,1.000E+00,1,ENPP2,
1484,Cholesterol metabolism,87,1.000E+00,1.000E+00,1.000E+00,1.000E+00,6,"CYP27A1, FACVL1, CYP8B1, BAAT, CYP7A1, CYP7B1",1.000E+00,1.000E+00,9,"CYP27A1, AK1D1, FACVL1, AKR1C4, ADHB, CYP8B1, BAAT, CYP7A1, CYP7B1",
1485,Peroxisomal branched chain fatty acid oxidation,84,1.000E+00,1.000E+00,1.000E+00,1.000E+00,10,"HADHA, HACL1, ACAA2, FACVL1, ACADL, PAHX, Acetyl-CoA acyltransferase, PCCA, AL3A2, HADHB",1.000E+00,1.000E+00,6,"HADHA, HACL1, ACAA2, FACVL1, ACADL, PAHX",
1486,Nicotine metabolism in liver,56,1.000E+00,1.000E+00,1.000E+00,1.000E+00,4,"FMO3, UGT1A4, UGT2B7, CYP2B6",1.000E+00,1.000E+00,3,"FMO3, UGT1A4, UGT2B7",
1487,Catecholamine metabolism,75,1.000E+00,1.000E+00,1.000E+00,1.000E+00,7,"MAOA, AL1A1, DBH, AL1B1, PNMT, CYP2D6, MAOB",1.000E+00,1.000E+00,6,"MAOA, AL3A1, AL1A1, ADHB, AL1B1, CYP2D6",
1488,Bile Acid Biosynthesis,94,1.000E+00,1.000E+00,1.000E+00,1.000E+00,6,"CYP27A1, VLCSH1, BSEP, CYP8B1, BAAT, CYP7A1",1.000E+00,1.000E+00,9,"CYP27A1, AK1D1, VLCSH1, AKR1C4, BSEP, ADHB, CYP8B1, BAAT, CYP7A1",
1489,Arsenite metabolism and transport,54,1.000E+00,1.000E+00,1.000E+00,1.000E+00,3,"AS3MT, GSTO1, Aquaporin 9",1.000E+00,1.000E+00,2,"AS3MT, Aquaporin 9",
1490,Aminoacyl-tRNA biosynthesis in mitochondrion,81,1.000E+00,1.000E+00,1.000E+00,1.000E+00,6,"AARSL, LeuRS, VARSL, FARS2, CARS2, SYWM",1.000E+00,1.000E+00,6,"AARSL, LeuRS, VARSL, FARS2, CARS2, SYWM",
1491,Vitamin E (alfa-tocopherol) metabolism,81,1.000E+00,1.000E+00,1.000E+00,1.000E+00,6,"ECHP, ACSL5, FACVL1, ACSL4, ACSL6, ACSL1",1.000E+00,1.000E+00,5,"ECHP, ACSL5, FACVL1, ACSL4, ACSL6",
1492,Peroxysomal straight-chain fatty acid beta-oxidation,74,1.000E+00,1.000E+00,1.000E+00,1.000E+00,3,"ECHP, FACVL1, ACSL4",1.000E+00,1.000E+00,3,"ECHP, FACVL1, ACSL4",
1493,Vitamin K metabolism,97,1.000E+00,1.000E+00,1.000E+00,1.000E+00,4,"VKOR, UBIAD1, CYP4F11, NRHQR2",1.000E+00,1.000E+00,3,"VKOR, UBIAD1, CYP4F11",
1494,Saturated fatty acids synthesis to hexadecanoic acid,101,1.000E+00,1.000E+00,1.000E+00,1.000E+00,3,"THEM2, HTD2, MECR",1.000E+00,1.000E+00,2,"OLAH, MECR",
,,,,,,,,,,,,,
